Society for N e u r o sc i e n c e

Final program

November 14, 2010

Sunday
San Diego
California
Scientific Sessions Listings
Sessions 110 – 309
Information at a Glance
Important Phone Numbers
Annual Meeting Headquarters Office — Logistics and Programming
Logistics
San Diego Convention Center: Sails Pavilion, (619) 525-6600 *

Programming
San Diego Convention Center: Sails Pavilion, (619) 525-6605 **

Society Executive Meeting Room

San Diego Convention Center: Room 13, (619) 525-6650 ***

General Information Booths

San Diego Convention Center
Lobby A, (619) 525-6670

Lobby D, (619) 525-6671

Sails Pavilion, (619) 525-6672

Press Offices
Press Room
San Diego Convention Center: Room 15B, (619) 525-6640

Exhibit Management
San Diego Convention Center: Lobby D, (619) 525-6660

First Aid and Hospital Numbers

First Aid Room
San Diego Convention Center: Lobby C, (619) 525-6615

Scripps Mercy Hospital

4077 5th Avenue
San Diego, CA 92103
(619) 294-8111

* Annual meeting logistics, audiovisual, and advance registration inquiries.

** Sessioning information for symposia, minisymposia, nanosymposia, poster sessions, special lectures, and socials for the 2010 and 2011 annual meetings.
*** Matters of Council, Committees, and Past Presidents.

Key to Poster Floor by Themes

The poster floor will begin with Theme A and end with Theme H. Refer to the poster floor map at the end of this booklet.

Theme
A Development
B Neural Excitability, Synapses, and Glia: Cellular Mechanisms
C Disorders of the Nervous System
D Sensory and Motor Systems
E Homeostatic and Neuroendocrine Systems
F Cognition and Behavior
G Novel Methods and Technology Development
H History, Teaching, Public Awareness, and Societal Impacts in Neuroscience

NOTE: Theme H Posters will be located in Halls B-H beginning at 1 p.m. on Saturday, Nov. 13, and will remain posted until 5 p.m., Sunday, Nov. 14.
Sunday Highlights
✍ Preregistration Required  $ Course Fee   Professional Development  ` Networking  � Public Outreach
Special Lecture Navigating the SfN Meeting  Grant Writing in the New NIH Format 
Neurogenetics of Circadian Clocks in 10:30 a.m. – noon Sunday, Nov. 14, 2 – 5 p.m.
Mammals  CME San Diego Convention Center: Room 3 San Diego Convention Center: Room 3
Joseph S. Takahashi, PhD — University of Texas
Southwestern Medical Center/Howard Hughes Medical Special Lecture Peter and Patricia Gruber Lecture
Institute
Joining the Dots: Epigenetics, Plasticity, and the Brain Circuits for Active Vision
8:30 – 9:40 a.m.
Circadian Clock  CME Robert H. Wurtz, PhD — National Eye Institute/National
San Diego Convention Center: Ballroom 20
Paolo Sassone-Corsi, PhD — University of California, Irvine Institutes of Health
11:30 a.m. – 12:40 p.m. Support contributed by: Peter and Patricia Gruber
Symposium San Diego Convention Center: Ballroom 20 Foundation
New Advances in Calcium Signaling in Neuronal Sunday, Nov. 14, 2:30 – 3:40 p.m.
Function and Disease  CME Chapters Workshop ✍ ` San Diego Convention Center: Ballroom 20
Chair: Shmuel Muallem, PhD
Maximizing Resources Available to Chapters
8:30 – 11 a.m.
11:45 a.m. – 1:30 p.m. NSF Funding Opportunities
San Diego Convention Center: Room 6A
San Diego Convention Center: Room 11 for Research and Education
Symposium in Neuroscience* 
Special Lecture Sunday, Nov. 14, 4 – 5:30 p.m.
The Critical Role of Cues and Contexts in Connecting Motor Circuits  CME San Diego Convention Center: Room 10
Reward: Relevance for Addiction  CME Silvia Arber, PhD — Biozentrum, University of Basel
Chair: Paul Vezina, PhD 1 – 2:10 p.m.
8:30 – 11 a.m. San Diego Convention Center: Ballroom 20
Presidential Special Lecture
San Diego Convention Center: Room 6F Motivational Neuronal Circuits for Value,
Salience, and Information  CME
Minisymposium Social Issues Roundtable � Okihide Hikosaka, MD, PhD — National Eye Institute/
Child Poverty and Human Capital: National Institutes of Health
AKTion in the Brain: Emerging Roles for PI3K/ New Insights from Neuroscience Support contributed by: Johnson & Johnson
Akt Signaling in Development, Cognition, and 1 – 3 p.m. Sunday, Nov. 14, 5:15 – 6:25 p.m.
Psychiatric Disease  CME San Diego Convention Center: Room 10 San Diego Convention Center: Ballroom 20
Chair: Thomas F. Franke, MD, PhD
Co-chair: Daniel R. Weinberger, MD
8:30 – 11 a.m. Symposium Careers Away From the Bench* 
San Diego Convention Center: Room 6E AD-360°: Non-Amyloid Mechanisms in Sunday, Nov. 14, 6:30 – 8 p.m.
Alzheimer’s Disease Pathogenesis  CME San Diego Convention Center: Room 4
Minisymposium Chair: Sanjay W. Pimplikar, PhD
Functional Modulation of the Primary
1:30 – 4 p.m. Neuroscience Departments and
San Diego Convention Center: Room 6A
Motor Cortex: From Animal Models to Programs Reception `
Clinical Applications CME Sunday, Nov. 14, 6:30 – 8 p.m.
Chair: Robert Chen, MB, BChir, MSc Symposium San Diego Marriott Hotel & Marina: Marina Ballroom E
Co-chair: John Rothwell, PhD Removing Brakes on Adult Brain Plasticity:
8:30 – 11 a.m. Molecular, Cellular, and Behavioral
San Diego Convention Center: Room 29D Interventions  CME
Chair: Daphne Bavelier, PhD
Minisymposium 1:30 – 4 p.m.
San Diego Convention Center: Room 6B
Genomic and Epigenomic Diversity of Brain DNA:
What Is It For?  CME
Chair: John Satterlee, PhD Symposium
8:30 – 11 a.m. Ringing Ears: The Neuroscience of Tinnitus  CME
San Diego Conference Center: Room 30E Chair: Larry E. Roberts, PhD
Co-chair: James Kaltenbach, PhD
1:30 – 4 p.m.
How to Write a Manuscript: San Diego Convention Center: Room 6F
Getting Your Paper Accepted 
9 a.m. – noon Minisymposium
San Diego Convention Center: Room 4
Exploring Interdisciplinary Pathways: Enriching
Neuroscience Research by Connecting to
Fred Kavli Distinguished International Educational Practice and Theory
Scientist Lecture Chair: Mary Helen Immordino-Yang, EdD
Understanding Sound Processing in the Auditory Co-chair: Thomas Carew, PhD
System: Advances Rooted in the Genetic 1:30 – 4 p.m.
Approach  CME San Diego Convention Center: Room 29D
Christine Petit, MD, PhD — College de France & Pasteur
Institute Minisymposium
Support contributed by: The Kavli Foundation Regulation of the Postsynaptic Cytoskeleton:
10 – 11:10 a.m. Roles in Development, Plasticity, and
San Diego Convention Center: Ballroom 20 Disorders  CME
Chair: Scott Soderling, PhD *Presented by an SfN partner organization
1:30 – 4 p.m.
San Diego Convention Center: Room 30E
www.sfn.org/am2010  I
Plan to Attend
Monday, Nov. 15
Special Lecture
Modern Genetic and Viral Tools for the
Dissection of Neural Circuits  CME
Edward M. Callaway, PhD — The Salk Institute for
Biological Studies
8:30 – 9:40 a.m.
San Diego Convention Center: Ballroom 20

David Kopf Lecture on Neuroethics

The Neuroscience Revolution and Society
Henry T. Greely, JD — Stanford University
Support contributed by: David Kopf Instruments
10 – 11:10 a.m.
San Diego Convention Center: Ballroom 20

Special Lecture
Learning and Memory Mechanisms in Songbirds
and Humans: Sleep On It!  CME
Dan Margoliash, PhD — University of Chicago
11:30 a.m. – 12:40 p.m.
San Diego Convention Center: Ballroom 20

Special Presentation
A Neuroscience “Moonshot”: Rallying a New
Global Race for Brain Research
Rep. Patrick J. Kennedy (D-RI) — U.S. House
of Representatives
1 – 2 p.m.
San Diego Convention Center: Ballroom 20

Albert and Ellen Grass Lecture

Dendrites, From Form to Function  CME
Yuh Nung Jan, PhD and Lily Jan, PhD — University of
California, San Francisco
Support contributed by: The Grass Foundation
3:15 – 4:25 p.m.
San Diego Convention Center: Ballroom 20

Presidential Special Lecture

Learning to See Late in Life  CME
Pawan Sinha, PhD — Massachusetts Institute of
Technology
Support contributed by: Pfizer, Inc.
5:15 – 6:25 p.m.
San Diego Convention Center: Ballroom 20

II  Neuroscience 2010

Chronological List of Sunday Sessions
Theme Descriptions
A Development F Cognition and Behavior
B Neural Excitability, Synapses, and Glia: Cellular Mechanisms G Novel Methods and Technology Development
C Disorders of the Nervous System H History, Teaching, Public Awareness, and Societal Impacts
D Sensory and Motor Systems in Neuroscience
E Homeostatic and Neuroendocrine Systems
All Posters will be presented in the San Diego Convention Center, Halls B-H. All lecture, symposia, minisymposia, and nanosymposia rooms are in the
San Diego Convention Center.
NOTE: Theme H Posters will be located in Halls B-H beginning at 1 p.m. on Saturday, Nov. 13, and will remain posted until 5 p.m., Sunday, Nov. 14.

Session Poster-Board CME

Theme Title Presentation Type Location Session Time
Number Number Credit

Featured Programs

110 E Neurogenetics of Circadian Clocks in Mammals Special Lecture Ballroom 20 8:30 – 9:40 a.m. 1.25

111 F The Critical Role of Cues and Contexts in Reward: Relevance for Addiction Symposium Room 6F 8:30 – 11 a.m. 2.5

112 B New Advances in Calcium Signaling in Neuronal Function and Disease Symposium Room 6A 8:30 – 11 a.m. 2.5

AKTion in the Brain: Emerging Roles for PI3K/Akt Signaling in Development,

113 C Minisymposium Room 6E 8:30 – 11 a.m. 2.5
Cognition, and Psychiatric Disease

Functional Modulation of the Primary Motor Cortex: From Animal Models to

114 D Minisymposium Room 29D 8:30 – 11 a.m. 2.5
Clinical Applications

115 A Genomic and Epigenomic Diversity of Brain DNA: What Is It for? Minisymposium Room 30E 8:30 – 11 a.m. 2.5

Fred Kavli Distinguished

Understanding Sound Processing in the Auditory System: Advances Rooted
116 International Scientist Ballroom 20 10 – 11:10 a.m. 1.25
in the Genetic Approach
Lecture

11:30 a.m. – 
117 B Joining the Dots: Epigenetics, Plasticity, and the Circadian Clock Special Lecture Ballroom 20 1.25
12:40 p.m.

Nanosymposia (8 a.m.–noon)
118 A Stem Cells and Neural Progenitors from Humans Nanosymposium Room 25A 8 – 10:15 a.m.

119 C Alzheimer’s Disease: Cholesterol and APOE Nanosymposium Room 31C 8 – 10 a.m.

120 C Neurodevelopmental Disorders II Nanosymposium Room 10 8 – 10:45 a.m.

121 C Epilepsy: Human Studies I Nanosymposium Room 6B 8 – 10:15 a.m.

122 C Ischemia: Inflammation and Molecular Mechanisms Nanosymposium Room 32B 8 – 11:15 a.m.

123 C Mitochondria in Health and Disease Nanosymposium Room 23A 8 – 9:45 a.m.

124 D Neural Correlates of Olfactory Behavior Nanosymposium Room 1B 8 – 9:45 a.m.

125 D Multisensory Interactions Nanosymposium Room 33C 8 – 11:15 a.m.

126 D Striate Cortex: Functional Organization and Plasticity Nanosymposium Room 5B 8 – 11 a.m.

127 F Visual Attention Nanosymposium Room 7B 8 – 10:45 a.m.

128 F Reading Studies Nanosymposium Room 24A 8 – 10:30 a.m.

129 F Neural Bases of Reward Nanosymposium Room 2 8 – 11:30 a.m.

Posters (8 a.m.–noon)
130 A Cell Migration I Poster A1-B9 Halls B-H 8 a.m. – noon

131 A Mouse ESCs and iPSCs Poster B10-B22 Halls B-H 8 a.m. – noon

132 A Axon Guidance and Growth: Growth Cone Poster B23-C12 Halls B-H 8 a.m. – noon

133 A Axon Growth and Guidance Poster C13-C33 Halls B-H 8 a.m. – noon

134 A Synapse Formation: Molecular Mechanisms Poster C34-D16 Halls B-H 8 a.m. – noon

135 A Synapse Formation: Presynaptic Mechanisms Poster D17-D32 Halls B-H 8 a.m. – noon

www.sfn.org/am2010  III
 Session Poster-Board CME
Theme Title Presentation Type Location Session Time
Number Number Credit

Posters (8 a.m.–noon)

136 B Signaling Cascades Poster D33-E12 Halls B-H 8 a.m. – noon

137 B Glycine and GABAB Receptors Poster E13-E32 Halls B-H 8 a.m. – noon

138 B Muscarinic Receptors Poster E33-E42 Halls B-H 8 a.m. – noon

139 B Calcium Channel Physiology I Poster E43-F16 Halls B-H 8 a.m. – noon

140 B Synaptic Transmission: Modulation by Peptides and Amines Poster F17-F37 Halls B-H 8 a.m. – noon

141 B LTD Poster F38-G5 Halls B-H 8 a.m. – noon

142 B Spike Timing-Dependent Plasticity Poster G6-G22 Halls B-H 8 a.m. – noon

143 B Homeostatic Plasticity Poster G23-G46 Halls B-H 8 a.m. – noon

144 B MicroRNAs in Plasticity Poster G47-H1 Halls B-H 8 a.m. – noon

145 C Alzheimer’s Disease: Animal and Cellular Models Poster H2-H22 Halls B-H 8 a.m. – noon

146 C Motor Neuron Pathology Disease Poster H23-H42 Halls B-H 8 a.m. – noon

147 C Autism: Genetic and Animal Models II Poster H43-H58 Halls B-H 8 a.m. – noon

148 C Rett Syndrome Poster H59-I2 Halls B-H 8 a.m. – noon

149 C Angelman and Other Neurodevelopmental Disorders Poster I3-I13 Halls B-H 8 a.m. – noon

150 C Epilepsy: Networks Poster I13-I39 Halls B-H 8 a.m. – noon

151 C Epilepsy: Seizure Mechanisms Poster I40-J13 Halls B-H 8 a.m. – noon

152 C Ischemia: Cellular and Molecular Mechanisms: Inflammation Poster J14-K12 Halls B-H 8 a.m. – noon

153 C Ischemia: Neuroprotection I Poster K13-M10 Halls B-H 8 a.m. – noon

154 C Spinal Cord Injury: Inflammation Poster M11-N8 Halls B-H 8 a.m. – noon

155 C Spinal Cord Injury: Therapeutic Strategies I Poster N9-O9 Halls B-H 8 a.m. – noon

156 C Cell Death Mechanisms: Excitotoxicty and Calcium Poster O10-P13 Halls B-H 8 a.m. – noon

157 C Neurotoxicity and Neurodegeneration I Poster P14-R1 Halls B-H 8 a.m. – noon

158 C Sensory Disorders: Somatosensation and Pain: Animal Models Poster R2-S1 Halls B-H 8 a.m. – noon

159 C Psychotropic Drug Effects in Animal Model Systems Poster S2-T16 Halls B-H 8 a.m. – noon

160 C Anxiety Disorders: Human Biomarkers and Treatment Studies Poster T17-U10 Halls B-H 8 a.m. – noon

161 C Anxiety Disorders: Animal Models of Medial Temporal Lobe/mPFC Systems Poster U11-V8 Halls B-H 8 a.m. – noon

162 C Anxiety Disorders: Experimental Therapeutics Poster V9-W9 Halls B-H 8 a.m. – noon

163 C Learning, Memory, and Addiction Poster W10-Y2 Halls B-H 8 a.m. – noon

164 C Cocaine: Brain Mechanisms Poster Y3-Z11 Halls B-H 8 a.m. – noon

165 C Cannabinoids: Developmental Effects Poster Z12-AA7 Halls B-H 8 a.m. – noon

166 C Regulation of Behavior by Peptide Signaling Poster AA8-BB8 Halls B-H 8 a.m. – noon

167 C Peptide Regulation and Action Poster BB9-CC7 Halls B-H 8 a.m. – noon

168 C Regulation of Behavior by Aminergic Signaling Poster CC8-EE7 Halls B-H 8 a.m. – noon

169 D Auditory Processing: Adaptation, Learning, and Memory Poster EE8-FF4 Halls B-H 8 a.m. – noon

170 D Auditory Processing: Perception, Action, and Behavior Poster FF5-GG11 Halls B-H 8 a.m. – noon

171 D Retina: Photoreceptors Poster GG12-II5 Halls B-H 8 a.m. – noon

172 D Visual Cognition: Attention and Decision Making I Poster II6-JJ6 Halls B-H 8 a.m. – noon

173 D Vision: Spatial Attention Poster JJ7-KK7 Halls B-H 8 a.m. – noon

174 D Nociceptive Transduction Mechanisms: Ion Channels and Receptors Poster KK8-LL2 Halls B-H 8 a.m. – noon

Neuropathic Pain: Neurotrophins, Neurotransmitters, and Inflammatory

175 D Poster LL3-MM12 Halls B-H 8 a.m. – noon
Mediators

176 D Neuropathic Pain: Signaling Mechanisms and Models Poster MM13-OO5 Halls B-H 8 a.m. – noon

177 D Receptors and Mechanisms of Transduction Poster OO6-OO13 Halls B-H 8 a.m. – noon

IV  Neuroscience 2010

Session Poster-Board CME
Theme Title Presentation Type Location Session Time
Number Number Credit

Posters (8 a.m.–noon)

178 D Tactile/Somatosensory: Functional Studies Poster OO14-PP16 Halls B-H 8 a.m. – noon

179 D Reflexes and Reflex Modulation Poster PP17-RR7 Halls B-H 8 a.m. – noon

180 D Motor Unit Recordings Poster RR8-SS2 Halls B-H 8 a.m. – noon

181 D EMG, Stimulation, and Kinematics Poster SS3-SS19 Halls B-H 8 a.m. – noon

182 D Posture and Gait: Afferent Control Poster SS20-UU3 Halls B-H 8 a.m. – noon

183 D Posture and Gait: Control and Integration Poster UU4-VV17 Halls B-H 8 a.m. – noon

184 D Voluntary Reaching: Action and Perception Poster VV18-WW8 Halls B-H 8 a.m. – noon

185 E HPG Axis: Gonadotropin Release Poster WW9-WW19 Halls B-H 8 a.m. – noon

186 E Steroids and Plasticity: Cortex, Hippocampus, and Basal Ganglia Poster WW20-XX20 Halls B-H 8 a.m. – noon

187 E Parental Behavior Poster YY1-ZZ7 Halls B-H 8 a.m. – noon

188 E Central Respiratory Chemoreception Poster ZZ8-AAA20 Halls B-H 8 a.m. – noon

AAA21-
189 E Early Life Experience: Postnatal Maternal Factors Poster Halls B-H 8 a.m. – noon
BBB14

BBB15-
190 E Stress-Modulated Pathways: Brainstem, Hypothalamus, and Endocrine Poster Halls B-H 8 a.m. – noon
CCC16

191 E Food Intake and Energy Balance: Neuropeptides I Poster CCC17-FFF4 Halls B-H 8 a.m. – noon

192 E Brain Blood Flow Functional Imaging Poster FFF5-GGG3 Halls B-H 8 a.m. – noon

193 F Long-Term Memory: Space and Navigation Poster GGG4-GGG17 Halls B-H 8 a.m. – noon

GGG18-
194 F Long-Term Memory: Encoding Poster Halls B-H 8 a.m. – noon
HHH12

HHH13-
195 F Disorders of Attention and Cognition Poster Halls B-H 8 a.m. – noon
HHH28

HHH29-
196 F Syntax and Semantics Poster Halls B-H 8 a.m. – noon
HHH45

197 F Human Memory Behavior Poster HHH46-III24 Halls B-H 8 a.m. – noon

198 F Decision Making: Gaming, Gambling, Risk, and Reward Poster III25-III41 Halls B-H 8 a.m. – noon

199 F Social Cognition: Attention, Imitation, and Perception of Self Versus Others Poster III42-JJJ11 Halls B-H 8 a.m. – noon

200 F Learning and Memory: Cognitive Flexibility Poster JJJ12-JJJ40 Halls B-H 8 a.m. – noon

201 F Network Activity: Attention Poster JJJ41-KKK13 Halls B-H 8 a.m. – noon

KKK14-
202 F Learning and Memory Systems: Hippocampus II Poster Halls B-H 8 a.m. – noon
KKK43

KKK44-
203 F Learning and Memory: Gamma and Theta Activity Poster Halls B-H 8 a.m. – noon
KKK63

204 F Learning and Memory: Genes and Aging Poster KKK64-LLL17 Halls B-H 8 a.m. – noon

205 F Aging: Dementia, Animals, and People Poster LLL18-LLL35 Halls B-H 8 a.m. – noon

206 F Neuroethology: Diverse Motor Behaviors Poster LLL36-LLL45 Halls B-H 8 a.m. – noon

207 F Neuroethology: Vocal Communication-Neurophysiology and Behavior Poster LLL46-LLL61 Halls B-H 8 a.m. – noon

LLL62-
208 G Data Analysis and Simulation Methodology Poster Halls B-H 8 a.m. – noon
MMM22

MMM23-
209 G Data Analysis and Statistics Poster Halls B-H 8 a.m. – noon
MMM34

Featured Programs
210 A Connecting Motor Circuits Special Lecture Ballroom 20 1 – 2:10 p.m. 1.25

212 D Ringing Ears: The Neuroscience of Tinnitus Symposium Room 6F 1:30 – 4 p.m. 2.5

Removing Brakes on Adult Brain Plasticity: Molecular, Cellular, and

213 D Symposium Room 6B 1:30 – 4 p.m. 2.5
Behavioral Interventions

www.sfn.org/am2010  V
 Session Poster-Board CME
Theme Title Presentation Type Location Session Time
Number Number Credit

Featured Programs

214 C AD-360°: Nonamyloid Mechanisms in Alzheimer’s Disease Pathogenesis Symposium Room 6A 1:30 – 4 p.m. 2.5

Exploring Interdisciplinary Pathways: Enriching Neuroscience Research by

215 H Minisymposium Room 29D 1:30 – 4 p.m.
Connecting to Educational Practice and Theory

Regulation of the Postsynaptic Cytoskeleton: Roles in Development,

216 B Minisymposium Room 30E 1:30 – 4 p.m. 2.5
Plasticity, and Disorders

Peter and Patricia Gruber

217 Brain Circuits for Active Vision Ballroom 20 2:30 – 3:40 p.m.
Lecture

218 Motivational Neuronal Circuits for Value, Salience, and Information Presidential Special Lecture Ballroom 20 5:15 – 6:25 p.m. 1.25

Nanosymposia (1–5 p.m.)

219 B Signaling by Neurotrophins and Other Neuromodulators Nanosymposium Room 6E 1 – 2:45 p.m.

Alzheimer’s Disease: Anti-Abeta Therapy, Pyroglutamate, APP Processing,

220 C Nanosymposium Room 32B 1 – 4:30 p.m.
Inflammation, Immunization

221 C Autism: Genetic and Animal Models I Nanosymposium Room 25A 1 – 3 p.m

222 C Epilepsy: Mechanisms Nanosymposium Room 24A 1 – 3 p.m.

223 C Demyelinating Disorders: Cellular Mechanisms Nanosymposium Room 31C 1 – 4 p.m.

224 C Neurotoxicity and Neurodegeneration II Nanosymposium Room 23A 1 – 3 p.m.

225 C New Molecular Targets in Psychotic Diagnoses Nanosymposium Room 4 1 – 3 p.m.

226 D Extrastriate Cortex: Functional Organization I Nanosymposium Room 33C 1 – 3:30 p.m.

227 D Brain Machine Interface Nanosymposium Room 5B 1 – 3:30 p.m.

228 E The Bed Nucleus of the Stria Terminalis: Linking Stress, Addiction, and Affect Nanosymposium Room 1B 1 – 3:45 p.m.

229 F Prefrontal-Subcortical Interactions in Health and Disease Nanosymposium Room 2 1 – 4 p.m.

230 G Neuroinformatics and Connectomics Nanosymposium Room 7B 1 – 3:15 p.m.

Posters (1–5 p.m.)

231 A Patterning of Spinal Cord, Cerebellum, and Hindbrain Poster A1-B10 Halls B-H 1 – 5 p.m.

232 A Neuronal Differentiation I Poster B11-C10 Halls B-H 1 – 5 p.m.

233 A Proliferation II Poster C11-C22 Halls B-H 1 – 5 p.m.

234 A Development: Activity-Dependent Remodeling of Synapses Poster C23-D7 Halls B-H 1 – 5 p.m.

235 A Regeneration in CNS Poster D8-D29 Halls B-H 1 – 5 p.m.

236 B Nicotinic Acetylcholine Receptors: Potential Therapeutic Applications Poster D30-E10 Halls B-H 1 – 5 p.m.

237 B Non-NMDA Glutamate Receptors: Localization and Trafficking Poster E11-E26 Halls B-H 1 – 5 p.m.

238 B Non-NMDA Glutamate Receptors: Physiology Poster E27-E45 Halls B-H 1 – 5 p.m.

239 B GABAA Receptors: Structure and Trafficking Poster E46-F13 Halls B-H 1 – 5 p.m.

240 B Calcium Channel Physiology II Poster F14-F40 Halls B-H 1 – 5 p.m.

241 B Neurotransmitter Release: Vesicle Docking and Fusion Poster F41-G4 Halls B-H 1 – 5 p.m.

242 B Neurotransmitter Release: Vesicle Recycling and Biogenesis Poster G5-G26 Halls B-H 1 – 5 p.m.

243 B LTP: Physiology and Behavior I Poster G27-G47 Halls B-H 1 – 5 p.m.

244 B Transcription and Translation in Plasticity II Poster G48-H11 Halls B-H 1 – 5 p.m.

245 B Of Cells and Nets Poster H12-H23 Halls B-H 1 – 5 p.m.

246 B Dendritic Excitability and Synaptic Integration Poster H24-H46 Halls B-H 1 – 5 p.m.

247 C Alzheimer’s Disease: Abeta, Energy Metabolism, Cell Signaling, Autophagy Poster H47-I6 Halls B-H 1 – 5 p.m.

248 C Alzheimer’s Disease: Role of Cholesterol and APOE in the CNS Poster I7-I25 Halls B-H 1 – 5 p.m.

249 C Tau: Cellular Pathways, Role in AD, and Neurodegeneration Poster I26-J8 Halls B-H 1 – 5 p.m.

250 C Parkinson’s Disease: In Vivo Therapies Poster J9-K18 Halls B-H 1 – 5 p.m.

VI  Neuroscience 2010

Session Poster-Board CME
Theme Title Presentation Type Location Session Time
Number Number Credit

Posters (1–5 p.m.)

251 C Metabolism and Toxicity of Alpha-Synuclein II Poster K19-M10 Halls B-H 1 – 5 p.m.

252 C Mitochondria in Parkinson’s Disease Poster M11-N15 Halls B-H 1 – 5 p.m.

253 C Ataxias Poster N16-O15 Halls B-H 1 – 5 p.m.

254 C Epilepsy: Channels and Receptors Poster O16-Q3 Halls B-H 1 – 5 p.m.

255 C Epilepsy: GABA Poster Q4-R13 Halls B-H 1 – 5 p.m.

256 C Ischemia: Models I Poster R14-T8 Halls B-H 1 – 5 p.m.

257 C Demyelination Disorders: Cellular Mechanisms of Pathology Poster T9-U13 Halls B-H 1 – 5 p.m.

258 C Demyelinating Disorders: Cellular Mechanisms of Repair Poster U14-V11 Halls B-H 1 – 5 p.m.

259 C Spinal Cord Injury: Posture and Locomotion Poster V12-X7 Halls B-H 1 – 5 p.m.

260 C Neuroinflammation: Cellular and Molecular Mechanisms I Poster X8-Y7 Halls B-H 1 – 5 p.m.

261 C Mechanisms of Cell Death: Oxidative Stress Poster Y8-AA1 Halls B-H 1 – 5 p.m.

262 C Neuro-Oncology I Poster AA2-BB13 Halls B-H 1 – 5 p.m.

263 C Approaches to Gene Therapy in Clinical Neuroscience Poster BB14-CC10 Halls B-H 1 – 5 p.m.

264 C Human Brain Imaging in Psychiatric Illnesses Poster CC11-EE12 Halls B-H 1 – 5 p.m.

265 C Anxiety Disorders: Animal Models of Molecular and Biochemical Effects Poster EE13-FF12 Halls B-H 1 – 5 p.m.

266 C Neural Plasticity and Addiction I Poster FF13-GG13 Halls B-H 1 – 5 p.m.

267 C Alcohol: Behavioral Poster GG14-HH11 Halls B-H 1 – 5 p.m.

268 C Nicotine: Reinforcement, Seeking, and Reinstatement Poster HH12-II4 Halls B-H 1 – 5 p.m.

269 C Nicotine: Developmental Effects Poster II5-JJ6 Halls B-H 1 – 5 p.m.

270 C Amphetamines: Reinforcement Poster JJ7-KK6 Halls B-H 1 – 5 p.m.

271 C Opioids: Transgenerational and Developmental Effects Poster KK7-KK18 Halls B-H 1 – 5 p.m.

272 C Addiction: Translational and Clinical Studies Poster KK19-LL10 Halls B-H 1 – 5 p.m.

273 D Odor Coding: Antennal Lobe Poster LL11-NN2 Halls B-H 1 – 5 p.m.

274 D Auditory and Multisensory Processing: Visual-Auditory Interactions Poster NN3-NN12 Halls B-H 1 – 5 p.m.

275 D Auditory Processing: Vocalizations and Natural Sounds Poster NN13-PP5 Halls B-H 1 – 5 p.m.

276 D Subcortical Visual Pathways: LGN Poster PP6-QQ5 Halls B-H 1 – 5 p.m.

277 D Striate Cortex: Local Circuitry Poster QQ6-QQ20 Halls B-H 1 – 5 p.m.

278 D Visual Motion: Behavioral Studies Poster RR1-RR11 Halls B-H 1 – 5 p.m.

279 D Visual Learning and Categorization Poster RR12-SS8 Halls B-H 1 – 5 p.m.

280 D Eye Movements and Perception Poster SS9-TT9 Halls B-H 1 – 5 p.m.

281 D Nociceptive Transduction Mechanisms: TRP Channels Poster TT10-VV7 Halls B-H 1 – 5 p.m.

282 D Spinal Cord Nociceptive Processing: Pharmacology Poster VV8-VV20 Halls B-H 1 – 5 p.m.

283 D Inflammatory Pain: Inflammatory Mediators Poster VV21-XX3 Halls B-H 1 – 5 p.m.

284 D Cortical Plasticity and Reorganization Poster XX4-XX18 Halls B-H 1 – 5 p.m.

285 D Tactile/Somatosensory: Functional Organization Poster XX19-AAA1 Halls B-H 1 – 5 p.m.

286 D Spinal Cord Injury: Plasticity II Poster AAA2-AAA21 Halls B-H 1 – 5 p.m.

AAA22-
287 D Modulation of Rhythmic Pattern Generation: Invertebrate Poster Halls B-H 1 – 5 p.m.
BBB21

BBB22-
288 D Modulation of Rhythmic Motor Pattern Generation: Vertebrate Poster Halls B-H 1 – 5 p.m.
CCC11

289 D Afferent Control of Rhythmic Motor Pattern Generation Poster CCC12-DDD1 Halls B-H 1 – 5 p.m.

290 D Descending Control of Rhythmic Motor Pattern Generation Poster DDD2-EEE7 Halls B-H 1 – 5 p.m.

291 D Finger and Grasp Control: Effects of Age and Pathology Poster EEE8-FFF18 Halls B-H 1 – 5 p.m.

www.sfn.org/am2010  VII
 Session Poster-Board CME
Theme Title Presentation Type Location Session Time
Number Number Credit

Posters (1–5 p.m.)

292 D Voluntary Reaching: Adaptation and Generalization Poster FFF19-GGG20 Halls B-H 1 – 5 p.m.

GGG21-
293 D Bimanual and Interlimb Movement Control Poster Halls B-H 1 – 5 p.m.
HHH27

HHH28-
294 D BMI: Locomotion Poster Halls B-H 1 – 5 p.m.
HHH37

295 D BMI: Sensory Interface Poster HHH38-III11 Halls B-H 1 – 5 p.m.

296 E Hormones and Cognition: Gonadal Steroids Poster III12-III33 Halls B-H 1 – 5 p.m.

297 E Neuroimmunology: Behavioral Effects Poster III34-JJJ3 Halls B-H 1 – 5 p.m.

298 E Respiratory Rhythm and Pattern Generation Poster JJJ4-JJJ30 Halls B-H 1 – 5 p.m.

299 E Food Intake and Energy Balance: Monoamines and Amino Acids Poster JJJ31-KKK8 Halls B-H 1 – 5 p.m.

300 E Sleep: Systems and Physiology Poster KKK9-KKK39 Halls B-H 1 – 5 p.m.

KKK40-
301 F Neural Mechanisms: Reward, Emotion, and Pharmacology Poster Halls B-H 1 – 5 p.m.
KKK55

KKK56-
302 F Cognitive Development: Neural Systems Poster Halls B-H 1 – 5 p.m.
KKK70

303 F Social Cognition: Interpersonal Function Poster LLL1-LLL16 Halls B-H 1 – 5 p.m.

304 F Attentional Mechanisms: Neural Studies Poster LLL17-LLL42 Halls B-H 1 – 5 p.m.

305 F Reward: Drug Motivational Mechanisms Poster LLL43-LLL59 Halls B-H 1 – 5 p.m.

306 F Motivation and Emotion: Neurocircuitry of Decision Making II Poster LLL60-MMM6 Halls B-H 1 – 5 p.m.

MMM7-
307 F Emotions: Social Communication Poster Halls B-H 1 – 5 p.m.
MMM27

MMM28-
308 F Neuroethology: Vision and Integration Poster Halls B-H 1 – 5 p.m.
MMM41

MMM42-
309 G New Tools for the Study of Neurodegeneration and Neuroprotection Poster Halls B-H 1 – 5 p.m.
MMM52

Workshops, Meetings & Events

W16 How to Write a Manuscript: Getting Your Paper Accepted Workshops/Meetings Room 4 9 a.m. – noon

10:30 a.m. – 
W17 Navigating the SfN Meeting Workshops/Meetings Room 3
noon

11:45 a.m. – 
W18 Chapters Workshop: Maximizing Resources Available to Chapters Workshops/Meetings Room 11
1:30 p.m.

Social Issues Roundtable — Child Poverty and Human Capital:

211 Social Issues Roundtable Room 10 1 – 3 p.m.
New Insights from Neuroscience

W19 Grant Writing in the New NIH Format Workshops/Meetings Room 3 2 – 5 p.m.

W20 NSF Funding Opportunities for Research and Education in Neuroscience* Workshops/Meetings Room 10 4 – 5:30 p.m.

W21 Careers Away from the Bench* Workshops/Meetings Room 4 6:30 – 8 p.m.

San Diego Marriott

Neuroscience Departments and Programs Reception
W22 Workshops/Meetings Hotel & Marina: 6:30 – 8 p.m.
and Award Presentation
Marina Ballroom E

VIII  Neuroscience 2010

Sunday Workshops, Meetings & Events
✍ Preregistration Required  $ Course Fee   Professional Development  ` Networking  � Public Outreach
Sunday, Nov. 14
How to Write a Manuscript:
Getting Your Paper Accepted 
Sunday, Nov. 14, 9 a.m. – noon
San Diego Convention Center: Room 4
Organizer: Daniel McGowan, PhD
Contact: Liz Larabell, llarabell@sfn.org
With increased competition for journal
space and higher rates of rejection, often
because of language, researchers who are not
native English speakers are disadvantaged in
efforts to publish their findings. Comprising
a presentation in three sections — prepara-
tions before writing, manuscript structure,
and tips for getting published — and a
panel discussion with the editors of top
journals, this workshop aims to improve
publication success rates for research-
ers who are not native English speakers.
Navigating the SfN Meeting 
Sunday, Nov. 14, 10:30 a.m. – noon
San Diego Convention Center: Room 3
Organizers: Jennifer Yates, PhD; David Riddle, PhD
Contact: Liz Larabell, llarabell@sfn.org
See Saturday listing for event description.
Chapters Workshop ✍ `
Maximizing Resources Available to Chapters
Sunday, Nov. 14, 11:45 a.m. – 1:30 p.m.
San Diego Convention Center: Room 11
Contact: Danielle Hanafin, dhanafin@sfn.org
Chapter representatives and members should
attend this workshop to learn how to success-
fully apply for SfN grants and travel awards,
and how to make the most of the chapter
resources offered by the Society. Lunch will be
provided. Registration is required to attend this
event. To register, contact chapters@sfn.org.
Social Issues Roundtable �
Child Poverty and Human Capital:
New Insights from Neuroscience
Sunday, Nov. 14, 1 – 3 p.m.
San Diego Convention Center: Room 10
Organizer: Martha Farah, PhD
Speakers: James J. Heckman, PhD; Sebastian Lipina,
PhD; Michael J. Meaney, PhD; Helen J. Neville, PhD
Contact: Laura Martin, lmartin@sfn.org
Poverty diminishes the health and well-being
of those who are poor and limits their social
and economic contributions to society. The
impact of poverty on the developing indi-
vidual is complex, but most of the causal
pathways involve the brain. At this round-
table we will draw on human and animal
research to address the neural mechanisms
whereby childhood poverty impacts human
capital, and discuss the economic and policy
implications of this new knowledge.
Grant Writing in the New NIH Format 
Sunday, Nov. 14, 2 – 5 p.m.
San Diego Convention Center: Room 3
Organizer: Frances E. Jensen, MD
Contact: Liz Larabell, larabell@sfn.org
Need help navigating the new NIH grant
proposal format? This session will address fre-
quently encountered challenges and questions
about writing in the new format, from perspec-
tives on both sides of the fence — PI applicants
and peer reviewers. Join experts from the NIH
and an established investigator, who has suc-
cessfully competed for and reviewed grants,
as they lead you through the many facets of
the new process. Learn about potential pitfalls
and what it takes to meet the requirements of
the new review criteria. Panel members have
hands-on experience with the new format and
will share valuable do’s and don’ts to improve
your chances for successful submissions.
Find faculty and speakers at www.sfn.org/workshops  IX
NSF Funding Opportunities
for Research and Education
in Neuroscience* 
Sunday, Nov. 14, 4 – 5:30 p.m.
San Diego Convention Center: Room 10
Contact: Diane M. Witt, PhD, dwitt@nsf.gov
Hear the latest word from NSF program
officers on funding opportunities for
neuroscientists, including all areas of basic
neuroscience research and networking,
education and training, career development
opportunities, and large-scale multidisciplinary
centers. Talk with neuroscientists who have
been successful in receiving NSF funding.
General information about the agency, the
review process, and tips for writing successful
proposals also will be presented. NSG also
will maintain an exhibit booth featuring
relevant publications and program officers
available for extended conversation.
Careers Away From the Bench* 
Sunday, Nov. 14, 6:30 – 8 p.m.
San Diego Convention Center: Room 4
Contact: Brianna Blaser, PhD, bblaser@aaas.org
What career opportunities are available
outside of academic or industrial research?
Increasingly, PhD-level scientists are becom-
ing aware of other career opportunities
beyond bench research. This AAAS work-
shop considers what career paths in these
so-called “nontraditional” areas might look
like. Attendees will learn more about the
types of alternative careers available, how to
parlay their current skills and values into a
new area, ways to research career options,
and how to develop the skills they might
need for a career away from the bench.
Neuroscience Departments and
Programs Reception `
Sunday, Nov. 14, 6:30 – 8 p.m.
San Diego Marriott Hotel & Marina: Marina Ballroom E
Contact: Andrew Wallace, awallace@sfn.org
Join the SfN Committee on Neuroscience
Departments and Programs for its
annual reception and presentation of the
Award for Education in Neuroscience.
*Presented by an SfN partner organization
Sunday Socials
Sunday, Nov. 14, 6:45 – 8:45 p.m.
Auditory Neuroscience Social
Social with Brief Presentation
San Diego Marriott Hotel & Marina: Marriott Hall Salon 1
Chairs: Xiaoqin Wang, Jonathan B. Fritz
Guests: X. Wang, J. Fritz, D. Polley, F. Theunissen, J.
McDermott, P. Kanold, R. Liu, Y. Cohen, J. Schnupp,
J. Groh, L. Romanski, A. Zador, C. Miller, T. Gentner, J.
Middlebrooks (and many more...)
This event brings together researchers working
or interested in the field of auditory neurosci-
ence to have a fun night with humorous pre-
sentations on what is “hot,” “cool,” and “fool-
ish” in this field around the globe. Students,
postdocs, and faculty members are all invited.
Behavioral and Cognitive Neuroscience
Social: Brains! Brains! We Want Brains!
Purely Social
San Diego Marriott Hotel & Marina: Marriott Hall Salon 6
Chair: Deanna M. Barch
Guests: H. Moore, S. Floresco, E. Miller, T. Braver, R.
Buckner, M. Sarter, M. Banich, P. Whalen, L. Ungerleider,
C. Ranganath, M. Corbetta, M. Farah, A. MacDonald, J.
Fiez, E. Smith
“I believe in an open mind, but not so
open that your brains fall out.” — Arthur
Hays Sulzberger. Let your brains hang out
with your neuroscientist friends! Come
join us for a drink and bring your best
brain quote or joke! All are welcome.
Cajal Club Social
Award Presentation and Social
San Diego Marriott Hotel & Marina: Marriott Hall Salon 4
Chair: John Rubenstein
Guests: Arturo Alvarez-Buylla, Fred Gage,
Jeffrey Macklis, John Rubenstein, Gordon Shepherd,
Clifford Saper
The Cajal Club social will host a discussion
on Plasticity and Repair of the Adult Cerebral
Cortex by Arturo Alvarez-Buylla, Fred Gage
and Jeffrey Macklis, and moderated by John
Rubenstein. The discussants will review the
roles of neurogenesis in the olfactory bulb
and hippocampus, and more controversial
aspects of neurogenesis in the neocortex.
They also will consider the possibility of cell
transplantation, with normal and engineered
cells, to treat neural disorders. We encour-
age audience participation in addressing the
controversies of this important subject. Prior
X  Neuroscience 2010
to the panel discussion, there will be infor-
mal socializing and the presentation of the
prestigious Krieg Cortical Kudos awards and
the Palay award for structural neuroscience.
These awards will be presented by Gordon
Shepherd and Clifford Saper, respectively.
Cell Survival and Death Social
Purely Social
San Diego Marriott Hotel & Marina: Marriott Hall Salon 2
Chair: Mohanish Deshmukh
Guests: R. Freeman, C. Henderson, K. Herrup, R. Ratan,
C. Troy, L. Green, D. Kaplan
Are you interested in knowing how cells
make decisions of survival and death?
How do cells activate apoptosis, autophagy,
or necrosis? Or have you been mesmer-
ized with these questions and have ideas
and stories to share? Here is a fun and
stimulating opportunity to meet your col-
leagues and experts in this exciting field.
Clinical Neuroscience Social:
Creative Career Options in a
Changing Landscape
Social with Brief Presentation
San Diego Marriott Hotel & Marina: New York, Orlando
Chair: Helen S. Mayberg
Guests: Daniel Weinberger, Walter Koroshetz,
Huseini Manji
This social is a great opportunity for post-
docs, graduate students, medical students,
and residents who are considering careers
in clinical and translational aspects of neu-
roscience. Meet successful basic and clinical
scientists from diverse settings, including
government, academic, nonprofit and indus-
try. Guest experts will discuss the advantages
and disadvantages of academic and industry
based career paths in context of an evolving
translational neuroscience world. Join us to
share your questions and open discussion.
Excitatory Amino Acids Social
Purely Social
San Diego Marriott Hotel & Marina: Torrey 1
Chair: Massimo Scanziani
Guests: M. Häusser, R.L. Huganir, J.T.R. Isaac,
J.S. Isaacson, R. Malinow, R.C. Malenka, C.J. McBain,
T. Nakagawa, R. A. Nicoll, G.N. Patrick, C. Rosenmund,
S.M. Thompson
Come to discuss, over a drink, excita-
tion, inhibition, and how these oppos-
ing forces interact through circuits of
neurons. A great chance for students and
postdocs to meet and chat informally
with specialists from all over the world.
Neuroethology/Invertebrate
Neurobiology Social
Purely Social
San Diego Marriott Hotel & Marina: Marriott Hall Salon 5
Chair: Farzan Nadim
This purely social event is a gathering to
celebrate the study of behavior and inver-
tebrate research in neuroscience, to meet
old friends and make new ones. All are
welcome. Post-docs and graduate stu-
dents are especially encouraged to drop
by for socialization and networking.
Neuroinformatics and Genomics Social
Social with Brief Presentation
San Diego Marriott Hotel & Marina: Columbia 1 & 2
Chair: Maryann E. Martone
Guests: I. Zaslavsky, E. De Schutter, C. Ingrahm
With the amount of neuroscience data and
tools available through the web increas-
ing astronomically, the need for standards
and platforms for neuroscience data has
become increasingly important. This social
will present the activities of the International
Neuroinformatics Coordinating Facility
(INCF), an international organization
designed to provide a platform for neurosci-
entists around the world to come together.
Neuroscience Education
Outreach Social
Social with Brief Presenation
San Diego Marriott Hotel & Marina: Atlanta, Chicago
Chairs: Claudia Lieberwirth, Sophia Liang
Join us for the third annual Neuroscience
Education Outreach Social. Reaching out
to the public and educating them about the
importance of brain research and about the
wonders of the brain can be seen as one
of the most rewarding experiences. Let’s
share ideas, become inspired, and most
importantly inspire others to participate
in education outreach. All are welcome!
Spinal Cord Injury Social
Purely Social
San Diego Marriott Hotel & Marina: Marriott Hall Salon 3
Chair: Jerry Silver
Guest: Dana McTigue
This social is intended to bring together
researchers interested in spinal cord injury.
www.sfn.org/socials
 Sunday Satellite Events & Non-SfN Socials
Full descriptions and the latest details on these satellite events and socials not sponsored by SfN are
available online at www.sfn.org/satellites. These events also are available in the online Neuroscience
Meeting Planner (NMP). Attendees can access the NMP on-site or at www.sfn.org/nmp.

Title For More Information Time Location Room

Sunday, November 14
Manchester Ballroom
4th Annual Julius Axelrod Symposium nwilson@dixongroup.com 6:30 – 10 p.m. Manchester Grand Hyatt
ABC
An Interdisciplinary Approach to the Study of
rey.sn@juno.com 6:30 – 8 p.m. Manchester Grand Hyatt Ford ABC
Memory: Humanistic Data for Neuroscience
San Diego Marriott
Arab Neuroscientists Social info@arabneuroscientists.org 6:30 – 8:30 p.m. Point Loma
Hotel & Marina

 Careers Away From the Bench sciencecareers.org/outreach 6:30 – 8 p.m. Convention Center Room 4
San Diego Marriott Manchester Rooms
Dutch Neuroscience Social Nite 2010 www.cncr.nl/mcn/index.html 7 – 10 p.m.
Hotel & Marina 1&2
Evelyn F. McKnight Brain Research Foundation San Diego Marriott Marina Ballroom
vhixon@nrc.uab.edu 6:30 – 9 p.m.
Poster Reception Hotel & Marina Salon G
g.tec’s Spike Recording and Analysis Workshop vogt@gtec.at 6:30 – 9:30 p.m. Convention Center Room 27B
IBRO Alumni Reception www.ibro.info 6:30 – 8:30 p.m. Convention Center 32AB
LGBTQ Neuroscience Social lgbt.social@gmail.com 7 – 9 p.m. Hilton Bayfront Indigo 204B
Loyola University Chicago Stritch School of Medicine
kjones1@lumc.edu 6:30 – 8:30 p.m. Hilton Bayfront Sapphire 400
Neuroscience Institute Reception
Neuroscience Downunder Australian SfN Chapter
mark.bellingham@uq.edu.au 6:30 – 8:30 p.m. Manchester Grand Hyatt Emma ABC
Social

 NSF Funding Opportunities for Research and

www.nsf.gov/div/index.jsp?div=IOS 4 – 5:30 p.m. Convention Center Room 10
Education in Neuroscience
www.brownpapertickets.com/ Lyceum Space Theatre,
Patient HM 7 – 8:30 p.m.
event/118853 79 Horton Plaza
Rapid Isolation of Purified Neural Cell Populations: San Diego Marriott San Diego Ballroom
www.miltenyibiotec.com 6:30 – 8:30 p.m.
Advanced Technologies in Neuroscience Hotel & Marina Salon A
Society for Neuroeconomics, Decision-Making Social glimcher@cns.nyu.edu 6:30 – 8:30 p.m. Hilton Bayfront Indigo 204A
San Diego Marriott
Standford Neurosciences Program Alumni Reception larkspur@stanford.edu 6:30 – 7:30 p.m. Salona
Hotel & Marina
The Semblance Hypothesis of Memory: A Presentation www.semblancehypothesis.org 6:30 – 8 p.m. Convention Center 27A
San Diego Marriott
University of Chicago Reception neuroscience.uchicago.edu 6:30 – 8 p.m. Bayside Pavilion
Hotel & Marina
San Diego Marriott
University of Toronto Neuroscience Program Reception www.neuroscience.utoronto.ca 6:30 – 8:30 p.m. Cardiff
Hotel & Marina
US-JAPAN Brain Research Cooperative Program San Diego Marriott
chambers@ninds.nih.gov 6:30 – 8:30 p.m. Santa Rosa
(BRCP) Social Hotel & Marina

*Presented by an SfN partner organization

www.sfn.org/satellites  XI
Notes

XII  Neuroscience 2010

 Complete Session Listing
Sunday AM
SPECIAL LECTURE San Diego Convention Center
110. • Neurogenetics of Circadian Clocks in Mammals  CME
Sun. 8:30 AM - 9:40 AM — Ballroom 20
Speaker: J. S. TAKAHASHI, Univ. of Texas Southwestern
Med. Center, Howard Hughes Med. Inst.
Tremendous progress has been made in our understanding
of the molecular mechanisms of circadian clocks in animals.
Genetic analysis has revealed a conserved set of genes
that form a transcriptional autoregulatory feedback loop
to generate cell autonomous circadian oscillations. The
discovery of clock genes has led to the realization that
circadian gene expression is widespread throughout the
body in mammals. In addition to the central control of
circadian rhythms, it is now appreciated that circadian
control in peripheral tissues impacts a wide variety of
physiological systems.
SYMPOSIUM San Diego Convention Center
111. The Critical Role of Cues and Contexts in Reward:
Relevance for Addiction  CME
Sun. 8:30 AM - 11:00 AM — Room 6F
Chair: P. VEZINA
It has become increasingly clear that interactions between
primary rewards and the stimuli associated with them are
very complex and involve much more than the simple
elicitation of conditional responses by drug-paired cues.
The purpose of this Symposium is to discuss the critical role
played by reward related cues and contexts in the control
of drug-induced behaviors in both human and non-human
animals as well as the potential neurobiological mechanisms
involved, with an emphasis on how they may contribute to
addictive behavior.
8:30 111.1 Introduction.
8:35 111.2  •  The role of associative and non-associative
processes in nicotine self-administration and smoking. E.
DONNY. Univ. of Pittsburgh.
9:10 111.3 Contextual control over the expression of stimulant
sensitization. P. VEZINA. The Univ. of Chicago.
9:45 111.4 Cue-induced drug motivation in human addiction:
new modulators. A. R. CHILDRESS. Univ. of Pennsylvania
Sch. of Med.
10:20 111.5 Individual differences in the attribution of incentive
salience to reward cues: implications for addiction. T. E.
ROBINSON. Univ. of Michigan.
10:55 111.6 Closing Remarks.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
Sun. AM
SYMPOSIUM San Diego Convention Center
112. New Advances in Calcium Signaling in Neuronal
Function and Disease  CME
Sun. 8:30 AM - 11:00 AM — Room 6A
Chair: S. MUALLEM
Ca2+ controls virtually all neuronal function and aberrant
Ca2+ signaling leads to neurodegeneration. Major strides
that have been made recently in Ca2+ signaling that will be
discussed in this symposium are the inositol pyrophosphates
and inositol polyphosphates and their kinases in the context
of their role in cell life and death. The function of the IP3
receptors as signal converters that translates information
from IP3 to Ca2+ signals. The properties and physiological
roles of the Orai channels and the Presenilins as passive ER
Ca2+ leak channels and its implications in AD pathogenesis.
8:30 112.1 Introduction.
8:35 112.2 Inositol pyrophosphates as molecular messengers.
S. H. SNYDER. Johns Hopkins Univ. Sch. Med.
9:10 112.3 Structure and function of inositol
1,4,5-trisphosphate receptor. T. MICHIKAWA. RIKEN Brain
Sci. Inst.
9:45 112.4 Presenilins, neuronal calcium signaling and
Alzheimer’s disease. I. BEZPROZVANNY. UT Southwestern
Med. Ctr. Dallas.
10:20 112.5 Function and role of the Orai channels. A. RAO.
Harvard Med. Sch.
10:55 112.6 Closing Remarks.
MINISYMPOSIUM San Diego Convention Center
113. • AKTion in the Brain: Emerging Roles for PI3K/Akt
Signaling in Development, Cognition, and Psychiatric
Disease  CME
Sun. 8:30 AM - 11:00 AM — Room 6E
Chair: T. F. FRANKE
Co-Chair: D. R. WEINBERGER
Exciting new research suggests a role for phospatidyinolitol
3-kinase (PI3K)/Akt in normal and pathological cognition.
Here, we seek to provide a forum for the rigorous
evaluation of relationships between PI3K/Akt signaling
and the mammalian target of rapamycin (mTOR), and
neurodevelopment, behavior and mental illness. By
highlighting advances in our understanding of these
signaling components, we will critically evaluate evidence for
their involvement in addiction, autism and schizophrenia.
8:30 113.1 Introduction.
8:35 113.2  •  DISC1 regulation of adult hippocampal
neurogenesis via AKT-mTOR signaling pathway. J. KIM.
Johns Hopkins Univ.
8:55 113.3  •  Genetic dissection identifies PIK3CD as a
modulator of NRG1 signal transduction, cell migration,
cognition, and risk for schizophrenia. A. J. LAW. Natl. Inst. of
Mental Hlth.
Neuroscience 2010  |  Sunday AM  |  1 
9:15 113.4  •  The role of translational control in memory and
disease. C. A. HOEFFER. New York Univ.
9:35 113.5 IRS2-Akt signaling regulates stress- and drug-
induced plasticity. S. J. RUSSO. Mount Sinai Sch. of Med.
9:55 113.6  •  The lean and obese brain: dysfunctions in Akt
signaling. A. R. DAVIS. Vanderbilt Univ.
10:15 113.7  •  Regulation of Akt by arrestins: a new avenue for
mental disorders. J. BEAULIEU. Univ. Laval/CRULRG.
10:35 113.8 Closing Remarks.
MINISYMPOSIUM San Diego Convention Center
114. Functional Modulation of the Primary Motor Cortex:
From Animal Models to Clinical Applications  CME
Sun. 8:30 AM - 11:00 AM — Room 29D
Chair: R. CHEN
Co-Chair: J. C. ROTHWELL
Primary motor cortex plays important role in the planning
and execution of movement and motor cortical functions
depend on the cortical excitability. This minisymposium will
discuss recent experimental findings regarding the functional
modulation of motor cortical organization and excitability
in non-human primates and in humans, using invasive and
non-invasive brain stimulation, and functional neuroimaging.
8:30 114.1 Introduction.
8:35 114.2 Closed-loop stimulation: a new paradigm for
neurorehabilitation. A. JACKSON. Newcastle Univ.
8:55 114.3 Excitability of intracortical circuits in primary motor
cortex and findings in movement disorders. Z. NI. Toronto
Western Res. Inst.
9:15 114.4 Functional modulation of primary motor cortex
during action selection. S. BESTMANN. UCL Inst. of Neurol.
9:35 114.5 The functional role of interhemispheric interactions
in human motor control. M. A. PEREZ. Dept. of Physical
Med. and Rehabil.
9:55 114.6 Modulation of motor cortical excitability by
stimulation of the posterior parietal cortex and findings in
stroke. G. KOCH. Fondazione Santa Lucia, IRCCS.
10:15 114.7 Combining magnetic stimulation and neuroimaging
to study functional and structural interhemispheric
connectivity and findings in multiple sclerosis. M. WAHL.
Univ. Clin. Frankfurt am Main.
10:35 114.8 Closing Remarks.
MINISYMPOSIUM San Diego Convention Center
115. Genomic and Epigenomic Diversity of Brain DNA:
What Is It for?  CME
Sun. 8:30 AM - 11:00 AM — Room 30E
Chair: J. SATTERLEE
Overall this minisymposium will provide a broad introduction
to the recent and unanticipated discoveries of genomic and
epigenomic diversity in the nervous system and will provide
insights into the role of this diversity in neurobiological
function and brain disease.
8:30 115.1 Introduction.
2  |  Society for Neuroscience
8:35 115.2  •  Neuronal DNA content variation (DCV) with
regional and individual differences in the human brain. J. W.
WESTRA. Genstruct Inc.
8:55 115.3 Modulation of LINE1 retrotransposition during
mammalian neurogenesis. M. C. MARCHETTO. Salk Inst.
9:15 115.4 DNA methylation: A dynamic and stable regulator
of behavorial memory. C. A. MILLER. The Scripps Res. Inst.
9:35 115.5 Dnmt3a regulates reward behavior and spine
plasticity in the nucleus accumbens. Q. LAPLANT. Mt. Sinai
Sch. of Med.
9:55 115.6 CpA methylation and neuronal plasticity. S.
LOMVARDAS. UCSF Mission Bay.
10:15 115.7 5-hydroxymethylcytosine in neuronal genomes. S.
KRIAUCIONIS. The Rockefeller Univ.
10:35 115.8 Closing Remarks.
FRED KAVLI DISTINGUISHED INTERNATIONAL SCIENTIST
LECTURE San Diego Convention Center
116. Understanding Sound Processing in the Auditory
System: Advances Rooted in the Genetic Approach  CME
Sun. 10:00 AM - 11:10 AM — Ballroom 20
Speaker: C. PETIT, INSERM UMRS 587
Support contributed by The Kavli Foundation
Gain an understanding of the principles of acoustic signal
processing underlying auditory scene analysis as well as
perception of music and spoken language with emphasis on
how the cochlea and auditory neurons operate. Advances
in deciphering molecular mechanisms of sound processing
will be illustrated for the mechanoelectrical transduction.
In addition, hear about the physiological properties of the
auditory organ revealed by the study of mouse models
lacking specific cochlear structures.
SPECIAL LECTURE San Diego Convention Center
117. Joining the Dots: Epigenetics, Plasticity, and the
Circadian Clock  CME
Sun. 11:30 AM - 12:40 PM — Ballroom 20
Speaker: P. SASSONE-CORSI, Univ. of California-Irvine.
Neuronal plasticity is intimately associated to genomic
control. Yet, there is much more to the genome than DNA
sequence, permitting variability beyond the double helix.
Plasticity may be obtained through epigenetic mechanisms,
based on a variety of DNA and chromatin remodeling
processes. Complex programs of gene expression
characterize most neuronal functions, among which
circadian cycles represent a paradigm for dynamic chromatin
transitions. Recent advances reveal unexpected links
between circadian regulators, chromatin remodeling and
cellular metabolism.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
NANOSYMPOSIUM
118. Stem Cells and Neural Progenitors from Humans
Theme A: Development
Sun. 8:00 AM — San Diego Convention Center, Room 25A
8:00 118.1 Modeling retinal development and disease
with human pluripotent stem cells. J. S. MEYER*; E. E.
CAPOWSKI; A. D. VERHOEVEN; K. A. WALLACE; L.
S. WRIGHT; S. HOWDEN; S. TIAN; R. STEWART; J. A.
THOMSON; D. M. GAMM. Univ. Wisconsin, IUPUI, Univ. of
Wisconsin.
8:15 118.2 Investigating synapse formation and function
using human ES and iPS cell-derived forebrain neurons.
J. KIM*; C. A. SANCHEZ; M. O’SULLIVAN; M. ISRAEL; K.
BRENNAND; L. S. B. GOLDSTEIN; F. H. GAGE; A. GHOSH.
UCSD, Salk Inst. for Biol. Studies.
8:30 118.3 Genetic engineering of multipotent human
neural stem cells for multimodal imaging of structural
repair in experimental stroke model. M. DAADI*; S. HU; J.
KLAUSNER; Z. LI; G. SUN; J. C. WU; G. K. STEINBERG.
Stanford Univ., Stanford Inst. for Neuro-Innovation and
Translational Neurosciences, Dept. of Neurosurg., Med. &
Radiology, Mol. Imaging Program.
8:45 118.4 Nanotopographical cues enhance the neuronal
differentiation of human embryonic stem cells. S. ANKAM; K.
S. LIM; A. A. KYWE MOE; J. GOH; E. K. YIM*. Natl. Univ. of
Singapore, Duke-NUS Grad. Med. Sch.
9:00 118.5 Generation of Schwann cells from human
embryonic stem cells. L. ZIEGLER; R. S. GOLDSTEIN*. Bar-
Ilan Univ.
9:15 118.6 Induction of pluripotent stem cells to model Rett
syndrome. N. FARRA*; W. ZHANG; A. HOTTA; P. PASCERI;
A. Y. L. CHEUNG; M. W. SALTER; J. ELLIS. Hosp. For Sick
Children, Univ. of Toronto, Hosp. for Sick Children, Ctr. for
iPS Cell Res. & Application, Kyoto Univ., Ontario Human
Induced Pluripotent Stem Cell Facility.
9:30 118.7  •  Antidepressants modulate human hippocampal
neurogenesis by activating the glucocorticoid receptor.
C. ANACKER*; P. A. ZUNSZAIN; A. CATTANEO; L. A.
CARVALHO; S. THURET; J. PRICE; C. M. PARIANTE. Inst.
of Psychiatry, King’s Col. London.
9:45 118.8 Pleiotrophin regulation of β-catenin dependent
signaling in PDGFRα+ fetal human glial progenitor cells. C.
R. MCCLAIN*; F. J. SIM; S. A. GOLDMAN. Univ. Rochester.
10:00 118.9 Differences in neural differentiation propensity
among cell lines of human pluripotent stem cells. A.
MORIZANE*; D. DOI; T. KIKUCHI; J. TAKAHASHI. Kyoto
Univ., Ctr. for iPS Cell Res. and Application, Kyoto Univ.
NANOSYMPOSIUM
119. Alzheimer’s Disease: Cholesterol and APOE
Theme C: Disorders of the Nervous System
Sun. 8:00 AM — San Diego Convention Center, Room 31C
8:00 119.1 Cholesterol accumulates in the vicinity of
amyloid deposits in brain tissue. S. SOLÉ DOMÈNECH*;
P. SJÖVALL; V. VUJOCEVIć; S. SALVE; A. CODITA; M.
SCHALLING; F. M. LAFERLA; L. GIMÉNEZ-LLORT; P.
NILSSON; L. TERENIUS; B. JOHANSSON. Karolinska
Institutet, SP Tech. Res. Inst. of Sweden, Univ. of California
Irvine, Univ. Autònoma de Barcelona, Linköpings Universitet.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
8:15 119.2 Reducing cholesterol but not FPP levels activates
SREBP-2 in neural cells. U. IGBAVBOA; G. P. ECKERT;
G. P. HOOFF; W. E. MULLER; Y. WANG; W. G. WOOD*.
Univ. of Minnesota, Goethe Univ., China Med. University/
University of Minnesota.
8:30 119.3 The role of apolipoprotein E genotype and
cyclophilin A in Alzheimer’s disease neurovascular
Sun. AM
uncoupling. B. V. ZLOKOVIC*; R. D. BELL; A. SAGARE; I.
SINGH; B. C. BERK; D. M. HOLTZMAN; R. DEANE. Univ.
Rochester, SMD, Washington Univ. Sch. of Med.
8:45 119.4 Effects of specific DHA and -cholesterol containing
diets on cognition, cerebral metabolism and hemodynamics,
in APP/PS1 Alzheimer mice, and ApoE4 and ApoE ko mouse
models of vascular factors in Alzheimer’s Disease. A. J.
KILIAAN*; V. ZERBI; C. I. F. JANSSEN; D. VAN ROOIJ;
B. ZINNHARDT; L. M. BROERSEN; A. HEERSCHAP; D.
JANSEN. Radboud Univ. Nijmegen Med. Ctr., Danone Res.
BV.
9:00 119.5 Cognition, cerebral metabolism and
hemodynamics, and neuropathology in APP/PS1 Alzheimer
mice, and ApoE4 and ApoE ko mouse models of vascular
factors in Alzheimer’s disease. D. JANSEN*; V. ZERBI;
C. I. F. JANSSEN; D. VAN ROOIJ; B. ZINNHARDT; A.
HEERSCHAP; A. J. KILIAAN. Radboud Univ. Nijmegen Med.
Ctr.
9:15 119.6 Does presenilin activity play a role in the
development of late onset Alzheimer’s disease? S. P.
AROLD; C. A. MILLER; H. VINTERS; G. COLE; E. TENG; K.
GYLYS*. UCLA, USC, Sepulveda VAMC GRECC.
9:30 119.7 Modulation of cholesterol, farnesyl- and
geranylgeranylpyrophosphate in neuroblastoma SH-SY5Y-
APP695 cells - Impact on amyloid beta-protein production.
G. P. ECKERT*; G. P. HOOFF; I. PETERS; W. G. WOOD; W.
E. MULLER. Goethe-University/Department of Pharmacol.,
Univ. of Minnesota.
9:45 119.8 Apolipoprotein E modulates cellular response to
estrogen by interacting with estrogen receptor in neuronal
cells. Q. ZHAO*; C. COLTON. Duke Univ.
NANOSYMPOSIUM
120. Neurodevelopmental Disorders II
Theme C: Disorders of the Nervous System
Sun. 8:00 AM — San Diego Convention Center, Room 10
8:00 120.1 MeCP2 deficiency in GABAergic neurons
recapitulates Rett syndrome phenotypes. H. CHAO*; H.
CHEN; R. C. SAMACO; M. XUE; M. CHAHROUR; J. YOO;
J. L. NEUL; S. GONG; N. HEINTZ; M. EKKER; J. L. R.
RUBENSTEIN; J. L. NOEBELS; C. ROSENMUND; H. Y.
ZOGHBI. Baylor Col. of Med., Univ. of California at San
NANOSYMPOSIUM
Diego, Children’s Hosp. Boston, Rockefeller Univ., Howard
Hughes Med. Inst., Univ. of Ottawa, Univ. of California at San
Francisco, Charite Universitaetsmedizin.
8:15 120.2 Age-dependent dysregulation of presynaptic
calcium, synaptic plasticity, and spatial memory in a mouse
model of 22q11 deletion syndrome. L. R. EARLS*; G.
FRICKE; I. BAYAZITOV; R. BERRY; E. ILLINGWORTH; G.
MITTLEMAN; S. S. ZAKHARENKO. St Jude Children’s Res.
Hosp, Dulbecco Telethon Inst. of Genet. and Med., Univ. of
Memphis, St Jude Children’s Res. Hosp.
Neuroscience 2010  |  Sunday AM  |  3 
 8:30 120.3 Characterization of a new microtubule-associated
protein critical for cortical development. F. FRANCIS*; F.
PHAN DINH TUY; M. KIELAR; K. BOUTOURLINSKY; R.
OLASO; A. BOLAND; W. CARPENTIER; E. WELKER; A.
CROQUELOIS. Inst. du Fer à Moulin, Univ. of Lausanne, Ctr.
Natl. de Genotypage, Fac. of Med. UPMC.
8:45 120.4 Development of the pituitary in healthy children
and children with isolated cleft lip and/or palate. E. VAN
DER PLAS*; C. J. CASPELL; A. M. AERTS; J. CANADY; L.
RICHMAN; E. TSALIKIAN; J. D. DAWSON; P. NOPOULOS.
Univ. of Iowa.
9:00 120.5 L-serine supplementation: a new treatment for
hereditary sensory neuropathy type 1. B. P. SCHMIDT*;
K. GAROFALO; T. HORNEMANN; C. WIDDICOMBE; O.
GIANNIKOPOULOS; A. PENNO; R. BROWN; F. EICHLER.
Massachusetts Gen. Hospital, Dept. of Neurology, Harvard
Med. Sch., Inst. for Clin. Chemistry, Univ. Hosp. Zurich, Dept.
of Neurology, Univ. of Massachusetts Med. Sch.
9:15 120.6 Identification of client proteins involved in cysteine
string protein alpha (cspα)-mediated neuroprotection. Y.
ZHANG; M. HENDERSON; T. WU; C. COANGELO; S. S.
CHANDRA*. Yale Univ., Keck Yale/NIDA Neuroproteomic
Ctr.
9:30 120.7 A comprehensive assessment of structural
connectivity in young male premutation carriers. J. WANG*;
D. HESSL; F. TASSONE; A. SCHNEIDER; C. IWAHASHI; P.
HAGERMAN; S. RIVERA. Univ. of California, Davis.
9:45 120.8 The autophagy-linked FYVE protein (Alfy) is
required for survival and implicates a role for selective
macroautophagy in brain development. J. M. DRAGICH*; J.
BOSCO; A. YAMAMOTO. Columbia Univ.
10:00 120.9 Modeling adrenoleukodystrophy in Drosophila. S.
JOHRI*; A. SIVACHENKO; B. HOWARD; A. LETSOU. Univ.
of Utah.
10:15 120.10 Local axonal protection by wlds as revealed by
conditional regulation of protein stabilization. J. T. WANG*; Z.
A. MEDRESS; B. A. BARRES. Stanford Univ. Sch. of Med.
10:30 120.11 Single-cell knockout of Tsc1 in utero generates
cortical tuber-like lesions and heterotopic nodules with
cytomegalic neurons. D. M. FELICIANO*; T. SU; A.
BORDEY. Yale Univ.
NANOSYMPOSIUM
121. Epilepsy: Human Studies I
Theme C: Disorders of the Nervous System
Sun. 8:00 AM — San Diego Convention Center, Room 6B
8:00 121.1 Interhemispheric activation asymmetry within
hippocampal subfields in unilateral temporal lobe epilepsy. S.
NANOSYMPOSIUM
DAS*; D. MECHANIC-HAMILTON; M. KORCZYKOWSKI; J.
PLUTA; J. DETRE; P. YUSHKEVICH. Univ. Pennsylvania.
8:15 121.2 EEG-fMRI seeded connectivity as a predictor of the
surgical outcome of epilepsy. M. NEGISHI; R. MARTUZZI;
D. D. SPENCER; R. T. CONSTABLE*. Yale Univ.
8:30 121.3 Detection of multiple, single unit activity from
continuous, long-duration, high-frequency recordings in
patients with epilepsy. M. R. BOWER*; M. STEAD; G.
WORRELL. Mayo Clin.
4  |  Society for Neuroscience
8:45 121.4 Inactivated action potentials during interictal
spikes in human epileptic neocortex: implications for high-
frequency oscillations and for epileptogenesis. B. GREGER*;
K. THOMSON; P. HOUSE; C. SCHEVON; L. SHAO; R.
EMERSON; G. MCKHANN; R. GOODMAN; E. DUDEK.
Univ. of Utah, Columbia Univ.
9:00 121.5  •  Multiplexed, high-density active electrodes using
flexible silicon electronics. J. VIVENTI; L. VIGELAND; D.
KIM; V. R. TIRUVADI; J. A. ROGERS; D. CONTRERAS;
B. LITT*. Univ. of Pennsylvania, Univ. of Illinois at Urbana-
Champaign.
9:15 121.6 Spike-triggered traveling waves in human
temporal neocortex. C. A. SCHEVON*; A. TREVELYAN;
R. R. GOODMAN; G. MCKHANN; R. G. EMERSON; M.
CARANDINI. Columbia Univ., Univ. of Newcastle, Columbia
Unversity, Univ. Col. London.
9:30 121.7 Gene therapy for epilepsy - Dissecting the role of
somatostatin as a neuroprotective agent. R. ZAFAR*; M. A.
KING; C. J. FRAZIER; P. R. CARNEY. Univ. Florida.
9:45 121.8 Brain structural changes in a rat model of
temporal lobe epilepsy observed using enhanced MRI. M.
B. PAREKH*; W. TRIPLETT; P. R. CARNEY; T. H. MARECI.
Univ. Florida.
10:00 121.9 Status epilepticus affects hippocampal structure
and infusate distribution profiles. S. KANTOROVICH*;
G. W. ASTARY; M. PAREKH; T. H. MARECI; M.
SARNTINORANONT; P. R. CARNEY. Univ. of Florida.
NANOSYMPOSIUM
122. Ischemia: Inflammation and Molecular Mechanisms
Theme C: Disorders of the Nervous System
Sun. 8:00 AM — San Diego Convention Center, Room 32B
8:00 122.1 Study of hyperthermia on the change of ATP and
IL-1β in the ischemically injured rat brain. C. C. PEGG*; J.
KULACZ; C. HE; K. KATTNER; A. STROINK; C. WANG.
Illinois State Univ., Central Illinois Neurosci. Fndn.
8:15 122.2 Dihydrotestosterone reduces infarct size and
is immunosuppressive after experimental stroke. S. E.
DZIENNIS*; K. AKIYOSHI; S. SUBRAMANIAN; H. OFFNER;
P. D. HURN. Oregon Hlth. & Sci. Univ., Portland Veterans
Affairs Med. Ctr.
8:30 122.3 APT102 protects the ischemically injured brain in
rats. C. WANG*; A. P. SHABANZADEH; C. HE; C. C. PEGG.
Illinois State Univ., Central Illinois Neurosci. Fndn.
8:45 122.4 Matrix metalloproteinase-2/9 mediate severe blood
brain barrier damage at the superacute phase of cerebral
ischemia in rats. X. JIN*; K. J. LIU; J. LIU; R. PAN; Y. YANG;
W. LIU. Univ. of New Mexico, Hlth. Sci. Center, Univ. of New
Mexico.
9:00 122.5 Attenuated inflammatory immune response in aged
mice following cerebral ischemic infarct. M. W. SIEBER*;
C. FRAHM; R. A. CLAUS; O. W. WITTE. Univ. Hosp. Jena/
Dept. of Neurol., Univ. Hosp. Jena/ Dept. of Anaesthesiology
and Intensive Care Therapy.
9:15 122.6 Erythropoietin increases expression of microRNAs
in cerebrocortical neurons. L. FLETCHER*; M. ZIU; S.
SPRAGUE; D. F. JIMENEZ; M. DIGICAYLIOGLU. UT Hlth.
Sci. Ctr.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
9:30 122.7 The PGE2 EP4 receptor is protective in a model of
cerebral ischemia. K. I. ANDREASSON*; X. LIANG; L. LIN;
H. TANIGUCHI; C. ANACKER; Q. WANG. Stanford Univ.
Sch. Med.
9:45 122.8 Imaging the innate immune cells after experimental
stroke. J. NEUMANN*; M. G. RIEK-BURCHARDT; M. G.
GUNZER; K. G. REYMANN. Dept. of Neurol., Leibniz Inst.
for Neurobio., Inst. for Mol. and Clin. Immunol.
10:00 122.9 Enriched environment improves functional recovery
by attenuation of inflammation and inhibition of the stromal-
derived-factor 1/CXC receptor 4 pathway after stroke. K.
RUSCHER*; E. KURIC; Y. LIU; A. LOURENÇO INÁCIO; S.
ISSAZADEH-NAVIKAS; T. WIELOCH. Univ. of Lund, Univ. of
Copenhagen.
10:15 122.10  •  Purified type A polyphenols from cinnamon
protect glial cells from ischemic injury by attenuating
mitochondrial dysfunction and regulating intracellular calcium
level. K. S. PANICKAR*; M. M. POLANSKY; J. F. URBAN,
Jr; D. J. GRAVES; R. A. ANDERSON. Diet, Genomics, &
Immunol. Lab, USDA, Univ. of California.
10:30 122.11  •  D609 protection through cell cycle regulation
after stroke. R. M. ADIBHATLA*; J. F. HATCHER. Univ. of
Wisconsin Sch. Med. Pub Hlth.
10:45 122.12 Treatment of stroke by disrupting DAPK1-NMDA
receptor NR2B interaction. X. XU*; W. TU; W. ZHANG; N.
JIA; Y. LU. LSU Hlth. Sci. Ctr., Univ. of Central Florida.
11:00 122.13 Role of microRNA-29c in ischemic brain damage.
G. PANDI; V. P. NAKKA; A. DHARAP; W. B. POTTER; A.
ROOPRA; R. VEMUGANTI*. Univ. Wisconsin-Madison.
NANOSYMPOSIUM
123. Mitochondria in Health and Disease
Theme C: Disorders of the Nervous System
Sun. 8:00 AM — San Diego Convention Center, Room 23A
8:00 123.1 Permeability transition pore modulates
mitochondrial Ca2+ and ATP levels in adult neurons under
oxidative stress. A. G. BARSUKOVA*; D. BOURDETTE; M.
FORTE. Oregon Hlth. & Sci. Univ., Oregon Helth & Sci. Univ.
8:15 123.2 The mitochondrial protein prohibitin (PHB) reduces
superoxide production and protects brain cells from different
injury modalities. P. ZHOU*; L. QIAN; H. KURINAMI; G.
MANFREDI; C. IADECOLA. Weill Med. Coll Cornell Univ.
8:30 123.3 Principles of mitochondrial fusion and fission cycle
in neurons. A. KAASIK*; M. CAGALINEC; D. SAFIULINA; M.
LIIV; J. LIIV; V. CHOUBEY. Univ. of Tartu.
8:45 123.4 Brain mitochondria remove hydrogen peroxide
in a respiration-dependent manner via the thioredoxin/
peroxiredoxin system. D. A. DRECHSEL; L. LIANG*; M.
PATEL, Ph.D. Univ. of Colorado Denver.
9:00 123.5 Neuroprotective effects of anthocyanins on
neuronal death induced by mitochondrial oxidative stress. D.
A. LINSEMAN*; W. HULICK; N. KELSEY. Univ. of Denver.
9:15 123.6 BH3-only transcriptional activation in Bax-mediated
apoptosis. K. K. AMBACHER; R. RYLETT*; K. B. PITZUL; S.
P. CREGAN. Univ. Western Ontario.
9:30 123.7 The Wallerian degeneration slow (Wlds) gene
provides neuroprotective effects against the impairment of
mitochondrial electron transport chain in primary cultured
mouse cortical neurons. S. TOKUNAGA*; T. ARAKI. Waseda
Univ., Natl. Inst. of Neuroscience, NCNP.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
NANOSYMPOSIUM
124. Neural Correlates of Olfactory Behavior
Theme D: Sensory and Motor Systems
Sun. 8:00 AM — San Diego Convention Center, Room 1B
8:00 124.1 Going with the Flow: A microfluidic approach to
Sun. AM
the behavioral analysis of chemotaxis in C. elegans. K. E.
MCCORMICK*; M. SOTTILE; S. LOCKERY. Univ. of Oregon.
8:15 124.2 The vomeronasal organ mediates interspecies
defensive behaviors through detection of protein pheromone
homologs. F. PAPES*; D. W. LOGAN; L. STOWERS. State
Univ. of Campinas, The Scripps Res. Inst.
8:30 124.3 A functional glomerular map in the mouse
accessory olfactory bulb. J. P. MEEKS*; G. F. HAMMEN; D.
TURAGA; T. E. HOLY. Washington Univ. Sch. of Med.
8:45 124.4 Molecular mechanisms of pheromone mediated
behavior. L. T. STOWERS*. Scripps Res. Inst.
9:00 124.5 Genetic analysis of olfactory processing and
function in mice. A. FLEISCHMANN*; D. L. SOSULSKI; R.
AXEL. Columbia Univ.
9:15 124.6 Representational learning mechanisms within the
olfactory bulb. T. A. CLELAND*. Cornell Univ.
9:30 124.7 The genetic and neuronal basis of food preference
behavior in Caenorhabditis elegans. E. E. GLATER*; C. I.
BARGMANN. The Rockefeller Univ., Howard Hughes Med.
Institute, The Rockefeller Univ.
NANOSYMPOSIUM
125. Multisensory Interactions
Theme D: Sensory and Motor Systems
Sun. 8:00 AM — San Diego Convention Center, Room 33C
8:00 125.1 One-shot recalibration of auditory space by vision.
L. SHAMS*; D. WOZNY. UCLA, Max Planck Inst. for Human
Cognitive and Brain Sci.
8:15 125.2 Better late than now: Visual stimuli after sounds
shift auditory space in humans and monkeys. D. S. PAGES*;
J. M. GROH. Duke Univ.
8:30 125.3 A brain region consisting of neurons with moderate
sensitivity for voices. C. PERRODIN; C. KAYSER; N. K.
LOGOTHETIS; C. I. PETKOV*. Max Planck Inst. for Biol.
Cybernetics, Univ. of Manchester, Newcastle Univ.
8:45 125.4 Visual influences on voice-sensitive neurons.
C. PERRODIN*; C. KAYSER; N. K. LOGOTHETIS; C. I.
PETKOV. Max Planck Inst. For Biol. Cybernetics, Div. of
Imaging Sci. and Biomed. Engineering, Univ. of Manchester,
Inst. of Neuroscience, Newcastle Univ.
NANOSYMPOSIUM
9:00 125.5 Different coding formats in the same primate SC
neurons: A visual place code but auditory rate code. J. LEE*;
J. M. GROH. Duke Univ.
9:15 125.6 A normalization model of multisensory integration.
T. OSHIRO*; D. E. ANGELAKI; G. C. DEANGELIS. Univ. of
Rochester, Washington Univ.
9:30 125.7 Bayesian priors are encoded independently
from likelihoods in human multisensory perception. U. R.
BEIERHOLM*; L. SHAMS. UCLA.
9:45 125.8 Multisensory integration and the space near the
hand: An fMRI study. G. GENTILE; C. BROZZOLI; V. I.
PETKOVA; H. EHRSSON*. Karolinska Inst. Dept. Neurosci.
Neuroscience 2010  |  Sunday AM  |  5 
 10:00 125.9 Multisensory integration in auditory cortex
depends on behavioral goal. N. VANATTEVELDT*; B. S.
PETERSON; B. VAN DOORN; B. GUNTER; D. SEMANEK;
C. E. SCHROEDER. Columbia Univ. Col. of Physicians
and Surgeons, Maastricht Univ., Nathan S. Kline Inst. for
Psychiatric Res.
10:15 125.10 Left fusiform gyrus integrates visual, auditory,
and tactile cues of manipulable objects. T. KASSUBA*; C.
KLINGE; C. HÖLIG; M. MAREIKE; M. PTITO; B. RÖDER; H.
R. SIEBNER. Copenhagen Univ. Hosp. Hvidovre, Univ. Med.
Ctr. Hamburg-Eppendorf, Christian-Albrechts-University Kiel,
Univ. de Montréal, Quebec, Canada, Univ. of Hamburg.
10:30 125.11 A large-scale analysis of synesthesia reveals
clustering of subtypes and influence of grapheme shape on
color associations. D. M. EAGLEMAN*. Baylor Col. of Med.
10:45 125.12 Exploring the experienced unity of consciousness
and its binding mechanism by neuroscientific synesthesia
research. A. MROCZKO*. Max Planck Inst. For Brain Res.,
Johannes Gutenberg Univ.
11:00 125.13 Brain networks observed with fMRI during movie
presentation. A. KONRAD*; G. VUCUREVIC. Univ. Med. Ctr.
NANOSYMPOSIUM
126. Striate Cortex: Functional Organization and Plasticity
Theme D: Sensory and Motor Systems
Sun. 8:00 AM — San Diego Convention Center, Room 5B
8:00 126.1 Normalization in a nonlinear circuit model of V1. D.
B. RUBIN*; K. D. MILLER. Columbia Univ.
8:15 126.2 Contrast dependence of summation field size and
surround properties in a nonlinear circuit model of V1. K. D.
MILLER*; D. B. RUBIN. Columbia Univ.
8:30 126.3 Moiré interference of retinal ganglion cell mosaics
generates periodic orientation maps in visual cortex. S.
PAIK*; D. L. RINGACH. Univ. of California at Los Angeles.
8:45 126.4 Mapping the monosynaptic inputs to a single visual
cortical neuron in vivo. J. H. MARSHEL*; T. MORI; K. J.
NIELSEN; E. M. CALLAWAY. The Salk Inst. for Biol. Studies,
UCSD.
9:00 126.5 Functional role of pulvinar input to primary visual
cortex in the primate. G. PURUSHOTHAMAN*; R. MARION;
S. WALSTON; K. LI; D. YAMPOLSKY; Y. JIANG; V.
CASAGRANDE. Vanderbilt Univ.
9:15 126.6 Recurrent excitatory and inhibitory connections in
layer 4 of cat visual cortex. O. OHANA*; H. PORTNER; D.
KUHL; K. A. C. MARTIN. Inst. for Mol. and Cell. Cognition,
ZMNH, ETH, Inst. of Neuroinformatics, UZH/ETH.
9:30 126.7 Layer-specific correlated variability and local
NANOSYMPOSIUM
synchronization. B. J. HANSEN*; V. DRAGOI. Univ. Texas
Med. Sch.
9:45 126.8 The impact of recurrent connections on the spatial
organization of neuronal selectivities. M. KASCHUBE*.
Princeton Univ.
10:00 126.9 Representation of ocular dominance columns in
owl monkeys and galagos. T. TAKAHATA*; J. H. KAAS.
Vanderbilt Univ.
10:15 126.10 Plasticity of inhibitory axonal arbors in visual cortex
following retinal lesions. S. A. MARIK*; H. YAMAHACHI; C.
D. GILBERT. The Rockefeller Univ.
6  |  Society for Neuroscience
10:30 126.11 Network mechanisms for sleep-dependent
consolidation of plasticity in the visual cortex. S. J. ATON*; J.
SEIBT; M. DUMOULIN; T. COLEMAN; M. G. FRANK. Univ.
Pennsylvania.
10:45 126.12 Functional reorganization of visual cortex with
central pathology. D. C. REITSMA*; M. J. MACIEJEWSKI; V.
SZEDER; J. L. ULMER; W. M. MUELLER; B. F. REMLER; E.
A. DEYOE. Med. Col. of Wisconsin.
NANOSYMPOSIUM
127. Visual Attention
Theme F: Cognition and Behavior
Sun. 8:00 AM — San Diego Convention Center, Room 7B
8:00 127.1 Reward-driven prioritization of attentional
allocation. J. LEE*; S. SHOMSTEIN. George Washington
Univ.
8:15 127.2 The role of visual cortex in resolving response
competition. T. A. KELLEY*; G. REES; N. LAVIE. Univ. Col.
London.
8:30 127.3 The functional significance of spatially global
feature-based attention. E. F. ESTER*; J. T. SERENCES; E.
AWH. Univ. of Oregon, UCSD.
8:45 127.4 Frontal-to-parietal causal streams along the dorsal
frontoparietal network exclusively mediate voluntary covert
orienting of attention. T. J. OZAKI*; S. OGAWA. RIKEN Brain
Sci. Inst., Tohoku Fukushi Univ.
9:00 127.5 Developmental differences in the functional
organization of the visual attention network. S. R.
FRIEDMAN-HILL*; M. R. WAGMAN; S. E. GEX; A. M.
SPEER; E. LEIBENLUFT; D. S. PINE; L. G. UNGERLEIDER.
Natl. Inst. of Mental Hlth., Natl. Inst. of Mental Health, NIH.
9:15 127.6 The microgenesis of object-based vis-à-vis space-
based visual attention. L. H. MOYA*; S. SHOMSTEIN; A.
BAGIC; M. BEHRMANN. Carnegie Mellon Univ., George
Washington Univ., Univ. of Pittsburgh.
9:30 127.7 Lower frontoparietal activation predicts
compromised conflict processing in alcoholism: An fMRI
study. T. SCHULTE*; E. MULLER-OEHRING; E. V.
SULLIVAN; A. PFEFFERBAUM. SRI Intl., Stanford Univ.
9:45 127.8 Uncertainty and object-based attentional capture.
S. S. SHOMSTEIN*; E. WING; S. LARSEN. George
Washington Univ., Duke Univ.
10:00 127.9  •  Blocking cholinergic muscarinic receptors reduces
response selectivity during selective attention in visual
processing regions but not in parietal cortex. M. L. FUREY*;
E. M. HOFFMAN; W. C. DREVETS. NIMH, NIH, Oklahoma
Univ. Sch. of Community Med.
10:15 127.10 Manipulations of perceptual load reveal age-related
differences in extrastriate push-pull discriminatory signal.
T. W. SCHMITZ*; M. L. DIXON; A. K. ANDERSON; E. DE
ROSA. Univ. Toronto, Univ. of British Columbia.
10:30 127.11 Thetaburst TMS stimulation over right FEF leads
to reduced BOLD signal locally but enhanced activation
in ventral attention plus default networks, affecting both
maintenance and shifts of spatial attention. K. HEINEN*;
E. FEREDOES; C. RUFF; J. BROOKS; J. DRIVER. Inst.
of Cognitive Neurosci., Lab. for Social and Neural Systems
Res.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
NANOSYMPOSIUM
128. Reading Studies
Theme F: Cognition and Behavior
Sun. 8:00 AM — San Diego Convention Center, Room 24A
8:00 128.1 Cortical systems for early semantic processing in
word recognition. W. W. GRAVES*; S. BAILLET; R. DESAI;
J. R. BINDER. Med. Coll Wisconsin.
8:15 128.2 Rapid cortical plasticity underlying novel word
learning in the human brain. Y. Y. SHTYROV*; V. NIKULIN;
F. PULVERMULLER. Med. Res. Council, Charité -
Universitätsmedizin Berlin.
8:30 128.3  •  What’s the story? An fMRI investigation of
fluent reading networks. C. F. BENJAMIN*; M. LEE; R.
STEINHORN; N. GAAB. Children’s Hosp. Boston, Harvard
Med. Sch.
8:45 128.4 Neural correlates of reading high versus low
phonologically consistent words. A. C. RAJA BEHARELLE*;
E. H. MOK; E. ZINCHENKO; A. R. MCINTOSH; S. L.
SMALL. Rotman Res. Inst., Univ. of Chicago.
9:00 128.5 Direct comparison of reading and matching tasks
reveals task contingent stimulus effects in the reading
pathway. A. C. VOGEL*; F. M. MIEZIN; S. E. PETERSEN; B.
L. SCHLAGGAR. Washington Univ.
9:15 128.6 Missing-letter effect: Correlational analysis of brain
activations (fMRI) reveals that reading when reading while
searching for target letters is like reading. A. J. NEWMAN*;
S. KENNY; J. SAINT-AUBIN; R. M. KLEIN. Dalhousie Univ.,
Univ. de Moncton.
9:30 128.7 Transient impairment of word processing following
eye movements. S. TEMEREANCA*; M. S. HAMALAINEN;
E. HALGREN; E. N. BROWN. Martinos Ctr, Harvard Med.
Sch., Univ. of California at San Diego, Massachusetts Inst.
Technol.
9:45 128.8  •  Chronometric TMS shows hemispheric
asymmetries in the time course of ventral occipito-temporal
processing consistent for both visual words and objects. K.
J. KAWABATA DUNCAN*; C. J. PRICE; J. T. DEVLIN. Univ.
Col. London.
10:00 128.9 Theta burst TMS over premotor cortex affects
language understanding: Implications for the embodiment of
concepts. R. WILLEMS*; L. LABRUNA; M. D’ESPOSITO; R.
IVRY; D. CASASANTO. Helen Wills Neurosci. Inst., MPI for
Psycholinguistic.
10:15 128.10 Investigating domain specificity of language-
sensitive cortex using individually defined functional ROIs. E.
FEDORENKO*; N. KANWISHER. MIT.
NANOSYMPOSIUM
129. Neural Bases of Reward
Theme F: Cognition and Behavior
Sun. 8:00 AM — San Diego Convention Center, Room 2
8:00 129.1 Intravascular food reward. A. J. OLIVEIRA-MAIA*;
C. D. ROBERTS; Q. D. WALKER; C. KUHN; S. A. SIMON;
M. A. L. NICOLELIS. Champalimaud Neurosci. Program,
Inst. Gulbenkian De Ciência, Duke Univ. Med. Ctr., Edmond
and Lily Safra Intl. Inst. of Neurosci. of Natal.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
8:15 129.2 Serotonin transporter genotype modulates
extinction retention in humans. C. HARTLEY*; E. A.
PHELPS; B. J. CASEY; C. E. GLATT. New York Univ., Weill
Cornell Med. Col.
8:30 129.3  •  Place your bet: The neural correlates of risk-
sensitive decision-making. B. STUDER*; A. APERGIS-
SCHOUTE; T. ROBBINS; L. CLARK. Univ. of Cambridge.
Sun. AM
8:45 129.4 Sleep deprivation alters neural mechanisms for
economic evaluation of social rewards. C. LIBEDINSKY*; D.
SMITH; P. NAMBURI; V. CHEN; C. S. TENG; S. HUETTEL;
M. W. L. CHEE. Duke-NUS Grad. Med. Sch., Duke Univ.
9:00 129.5 Willingness to wait is associated with neural
coupling between dorsolateral prefrontal cortex and episodic
imagery network. S. LUO*; G. AINSLIE; L. GIRAGOSIAN;
D. POLLINI; J. MONTEROSSO. USC, Coatesville Veterans
Affairs Med. Ctr.
9:15 129.6 Reinforcement learning algorithms predict changes
in activity within the superior colliculus in response to
changes in saccade value. D. M. MILSTEIN*; R. WEBB; M.
C. DORRIS. Queen’s Univ.
9:30 129.7 The effect of contextual framing on the aesthetic
appraisal of visual artworks. S. PARK*; Y. LEE; C. CHUNG;
J. JEONG. Korea Advanced Inst. In Sci. and Technol., Korea
Advanced Inst. of Sci. and Technol.
9:45 129.8  •  Well-trained rhesus monkeys are risk averse for
fluid rewards. H. YAMADA*; P. W. GLIMCHER. New York
Univ.
10:00 129.9 Is altered taste sensitivity and food reward
processing cause or consequence of obesity? A. C. SHIN*;
H. BERTHOUD. Pennington Biomed. Res. Center, LSU
Systems.
10:15 129.10 Expected value of information overlaps with
reward circuits in humans. F. FILIMON*; J. D. NELSON; T.
J. SEJNOWSKI; M. I. SERENO; G. W. COTTRELL. Max
Planck Inst. For Human Develop., Salk Inst. for Biol. Studies,
Birkbeck Col., UCSD.
10:30 129.11 Sipometer: Validation of a new device for
measuring food reward in humans. H. R. KISSILEFF*; K.
AGENOR; A. SCLAFANI. St Lukes Roosevelt Hosp, Barnard
Col., Brooklyn Col.
10:45 129.12 Comparing apples and oranges: evidence for
a unified subjective value representation in the brain. D.
LEVY*; P. W. GLIMCHER. NYU.
11:00 129.13 Neural representations of reward in interpersonal
attraction. J. C. COOPER*; S. DUNNE; M. FUREY; J. P.
O’DOHERTY. Trinity Col. Dublin.
11:15 129.14 Value representations in the primate orbitofrontal
cortex during cost-benefit decision making. D. L. KIMMEL*;
A. RANGEL; W. T. NEWSOME. Stanford Univ. Sch. Med., NANOSYMPOSIUM
Caltech, Howard Hughes Med. Inst.
POSTER
130. Cell Migration I
Theme A: Development
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 A1 130.1 Determination of the site of origin
and settling patterns of suprachiasmatic nucleus (SCN)
precursors in the anterior hypothalamus of mouse (C57BL/6)
embryo. C. S. KABRITA*; F. C. DAVIS. Notre Dame Univ.,
Northeastern Univ.
Neuroscience 2010  |  Sunday AM  |  7 
9:00 A2 130.2 Centrosomal protein ninein may control 11:00 B6 130.16 Celsr1-3 differentially regulate migration
interkinetic nuclear migration in neuroepithelial cells. H. of facial branchiomotor neurons in mice. Y. QU*; A. M.
SHINOHARA*; T. MIYATA; M. TAKAHASHI; N. OSUMI. Div. GOFFINET; F. TISSIR. Univ. catholique de Louvain.
of Developmental Neurosci. Tohoku Univesity Sch. of Med.,
8:00 B7 130.17  Tracking cells from the blood to the
Dept. of Anat. and Cell Biology, Grad. Sch. of Medicine,
brain: Using MRI and SPIOs to trace HSC migration in
Nagoya Univ.
Procambarus clarkii. A. G. OTOPALIK; J. L. BENTON; Y.
10:00 A3 130.3 Sept14 is involved in neuronal migration ZHANG; B. S. BELTZ; N. H. KOLODNY*. Wellesley Col.,
via interaction with Sept4. T. SHINODA*; H. ITO; K. SUDO; Wellesley Coll.
I. IWAMOTO; R. MORISHITA; K. NAGATA. Aichi Human
9:00 B8 130.18 Thyroid hormone induces neuronal
Service Ctr.
cerebellar migration and Bergmann glia differentiation
11:00 A4 130.4 Protein transduction of Tat-p38 MAP through Epidermal Growth Factor/MAP kinase pathway. C.
kinase enhances adult neural progenitor cell migration. M. M. ELLER; R. MARTINEZ; F. C. GOMES*. Federal Univ. of
HAMANOUE*; H. J. OKANO; T. MIZUNO; S. SHIBATA; H. Rio De Janeiro.
OKANO; K. TAKAMATSU. Toho Univesity Sch. of Medicine,
10:00 B9 130.19 Continuous infusion of stromal cell-
Dept. of Physiol., Keio University, Sch. of Med.
derived factor-1 alpha significantly promotes the migration
8:00 A5 130.5 Migration of sympathetic preganglionic rate of neural progenitor cells quantitatively characterized by
neurons in the spinal cord of a C3G deficient mouse MRI. C. CHANG*; C. V. CHEN; C. HSIEH. Inst. of Biomed.
suggests that C3G acts in the Reelin/ApoER2/Vldlr/Src/ Sciences, Academia Sinica.
Fyn/Dab1/CrkL signaling pathway. J. W. YIP*; Y. L. YIP; T.
THOMAS; A. K. VOSS. Univ. Pittsburgh Sch. Med., Walter
and Eliza Hall Inst. of Med. Res. POSTER
9:00 A6 130.6 Dynamics of centrosome and Golgi
131. Mouse ESCs and iPSCs
apparatus in neocortical pyramidal neurons during the
transition of migration mode from multipolar to locomotion, Theme A: Development
and formation of axon-like fiber. A. SAKAKIBARA*; T. SATO;
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
M. MASAOKA; M. OGAWA; T. MIYATA. Dept. Anat. and Cell
Biology, Nagoya Univ. Sch. of Med., RIKEN BSI. 8:00 B10 131.1 A study on mechanism of CoCl2-induced
apoptosis in the mouse embryonic stem cell. S. PARK; J.
10:00 A7 130.7 Dab2IP-L regulates radial neuronal
LEE; Y. JEONG; S. WOO; W. KIM*; J. JUNG. Dent. Sci. Res.
migration in the developing mouse neocortex. G. LEE*; S.
Institute, 2nd Stage of Brain Korean 21 for Sch. of Dentistry,
KIM; R. HOMAYOUNI; G. D’ARCANGELO. Rutgers Univ.,
Chonnam Natl. Univ.
Univ. of Tennessee Hlth. Sci. Ctr., Univ. of Memphis.
9:00 B11 131.2 Micro environmental effects of feeder
11:00 A8 130.8  Robo4 regulates the radial migration of
cells on proliferation and differentiation of mouse embryonic
cortical neurons during development. W. ZHENG*; A. GENG;
stem cells. K. KITAZAWA; T. TODA; B. YAMANOHA*. Fac
P. LI; X. YUAN. Inst. of Neurosci.
Engineer, Soka Univ.
8:00 A9 130.9 Midline neocortical nodular heterotopias
10:00 B12 131.3 Novel Wnt mimetics stabilize β-catenin
and partial callosal agenesis in a spontaneous mutation
in mouse Embryonic Stem cells, and can promote neuronal
of a BXD recombinant inbred strain. G. D. ROSEN*; N.
differentiation. L. A. KIRBY*; K. A. KOPPITCH; L. MEHR;
AZOULAY; E. G. GRIFFIN; A. J. NEWBURY; Z. LI; X.
B. NOBLE; P. DE LIJSER; N. V. PATEL. California State
WANG; L. LU; R. W. WILLIAMS. Beth Israel Deaconess
University, Fullerton, Ctr. for Applied Biotech. Studies, CSU-
Med. Ctr., Univ. Tenn Hlth. Sci. Ctr.
Fullerton.
9:00 A10 130.10 Roles of SMN in positioning MMC(m)
11:00 B13 131.4 Using mouse embryonic stem cells to
motor neurons in the ventral neural tube. C. E. KRULL*; F.
generate layer 5 cortical pyramidal neurons. F. YU; L. D.
SU; M. SAHIN. Univ. Michigan, Univ. of Michigan, Childrens’
RECHT; J. M. WEIMANN*. Stanford Univ. Sch. Med.
Hosp. and Harvard Univ.
8:00 B14 131.5 Quantifying activity in nascent neuronal
10:00 B1 130.11 Acute exposure to methylmercury inhibits
networks from embryonic stem cells. N. ADAMS*; D.
the migration of granule cells in the developing mouse
FRANKEL; E. SERNAGOR. Newcastle Univ., Newcastle
cerebellum. Y. KOMURO*; Y. LI; H. KOMURO. Lerner Res.
Univ. Med. Sch.
Inst. Cleveland Clin. Fndtn.
9:00 B15 131.6 Expression of components of the
11:00 B2 130.12 A dual role of EphA4 signaling in the
kallikrein-kinin system during neural differentiation of mouse
basal telencephalon during interneuron migration. A.
embryonic stem cells. I. C. NASCIMENTO*; M. FORNAZARI;
STEINECKE*; J. RUDOLPH; G. ZIMMER; S. BARCHMANN;
A. A. NERY; H. ULRICH. Lab. of Neuroscience, Inst. of
J. BOLZ. Inst. Allgemeine Zoologie Und Tierphysiologie FSU
Chemistry, Univ. of São Paulo (USP.
Jena.
10:00 B16 131.7 Fezl temporally regulates forebrain
8:00 B3 130.13 Ephrin-B3 reverse signaling in the basal
patterning and cortical development from mouse embryonic
telencephalon during interneuron migration. J. RUDOLPH; A.
stem cells. E. M. BOISVERT*; Z. WANG; X. ZHANG; M.
STEINECKE; G. ZIMMER; J. BOLZ*. Univ. Jena.
GUO; A. FASHOYIN; Z. DU; S. ZHANG; X. LI. UCHC, Univ.
9:00 B4 130.14 brain development abnormality in the of Wisconsin-Madison.
mice lacking in the enzymes synthesizing chondroitin
11:00 B17 131.8 Motoneurons derived from mouse
sulfate. M. IGARASHI*; S. HIGA ONAGA; Y. WATANABE; K.
induced pluripotent stem cells exhibit characteristics of
TAKEUCHI. Niigata Univ, Grad Sch. Med. Dent. Sci.
developing postural motoneurons. J. TOMA*; J. SCOTT; J.
10:00 B5 130.15 LKB1-mediated control of GSK3beta and BARTLETT; V. RAFUSE. Dalhousie Univ.
APC regulates centrosomal forward movement and neuronal
migration. N. ASADA*; K. SANADA. The Univ. of Tokyo.

8  |  Society for Neuroscience • Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
8:00 B18 131.9 Analysis of DNA methylation-independent
regulatory mechanisms of astrocyte specific gene expression
in embryonic stem cells. S. URAYAMA*; T. TAKIZAWA; Y.
HORI; J. KOHYAMA; K. NAKASHIMA. Nara Inst. of Sci. and
Technol.
9:00 B19 131.10 Gli2 induces neurogenesis in P19 EC
cells via direct upregulation of Ascl1/Mash1. T. PORTER*;
A. VORONOVA; A. FISCHER; A. AL-MADHOUN; I.
SKERJANC. Dept. of Biochemistry, Microbiology and
Immunology, Univ. of Ottawa.
10:00 B20 131.11 New mechanism in Retinoic Acid
Receptor signaling underlies neurogenic differentiation of
embryonic stem cells (ESC). . E. K. STACHOWIAK*; Y.
LEE; S. NARLA; A. PARIKH; E. S. TZANAKAKIS; M. K.
STACHOWIAK. SUNY, Buffalo.
11:00 B21 131.12 Extrinsic control of the differentiation and
excitability of Neurogenin-induced neurons with nanofiber
substrates and neurotrophin exposure. E. K. PURCELL*; G.
W. HILL; M. K. LEACH; J. M. COREY; R. A. ALTSCHULER;
R. K. DUNCAN. Univ. of Michigan.
8:00 B22 131.13  •  Involvement of neurotransmitters on
the proliferation of mouse induced pluripotent stem cells. T.
ISHIZUKA*; Y. WATANABE. Natl. Def. Med. Col.
POSTER
132. Axon Guidance and Growth: Growth Cone
Theme A: Development
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 B23 132.1 Substrate dependent effects of ethanol on
growth cone responses to guidance cues. D. L. BENSON*;
B. SEPULVEDA; I. CARCEA; S. R. J. SALTON. Mt Sinai
Sch. Med.
9:00 B24 132.2  •  The role of the Arp2/3 complex in the
motile leading margin of chick neuronal growth cones. J.
SAN MIGUEL-RUIZ; P. C. LETOURNEAU*; B. M. MARSICK.
Univ. Minnesota.
10:00 B25 132.3 Identifying downstream effectors of
Nkx2.8/9 that may facilitate SACMN axon exit from the spinal
cord. A. B. BRAVO*; Z. KAPRIELIAN. AECOM.
11:00 B26 132.4 Ca2+ influx through mechanosensitive
TRPC1 channels activates calpain to inhibit spinal axon
outgrowth. P. C. KERSTEIN*; B. JACQUES-FRICKE; J.
RENGIFO; T. M. GOMEZ. Univ. of Wisconsin.
8:00 B27 132.5 GAP-43 phosphorylation and axon
behavior in the developing visual system of transgenic
zebrafish. J. B. FORECKI*; A. J. UDVADIA. Univ. of
Wisconsin-Milwaukee.
9:00 B28 132.6 Zipcode binding protein 1 regulates axon
guidance and the transport and translation of β-actin mRNA.
K. WELSHHANS*; G. J. BASSELL. Emory Univ. SOM.
10:00 C1 132.7 Carbon monoxide as a modulator of
growth cone motility. S. ESTES*; V. REHDER. Georgia State
Univ.
11:00 C2 132.8 Growth cones require M6-glycoproteins
for normal structure and function. P. DE MONASTERIO-
SCHRADER; U. FÜNFSCHILLING; M. MITKOVSKI; A. Z.
BURZYNSKA; M. KLUGMANN; L. DIMOU; S. PAPIOL; K.
A. NAVE*; H. B. WERNER. Max Planck Inst. Exp Med.,
Johannes Gutenberg Univ. Mainz, Ludwig-Maximilians Univ.
Munich.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
8:00 C3 132.9 Regulation of axon arborization and
cytoskeleton organization by adenomatous polyposis coli
(APC). Y. CHEN*; W. D. SNIDER. UNC-Chapel Hill.
9:00 C4 132.10 Mitochondrial functions and dynamics
underlie axon outgrowth ability. M. STEKETEE*; J. L.
GOLDBERG. Ophthalmology, Bascom Palmer Eye Institute,
Univ. of Miami.
Sun. AM
10:00 C5 132.11 Inactivation of axonal EphA4 stimulates
axon growth of nasal retinal ganglion cells. J. I. DI NAPOLI;
L. FIORE; C. ALONSO; A. J. RODRIGUEZ CELÍN; E.
B. PASQUALE; N. G. CARRI; G. E. SCICOLONE*. Inst.
of Cell Biol. and Neuroscience. Sch. of Medicine, UBA,
Interdisciplinary Group of Theoretical Biology. Favaloro
University., The Burnham Inst., Inst. of Mol. Biology, IMBICE
(CIC, CONICET), Facultad Med. UBA.
11:00 C6 132.12 Syndecan and Dallylike cooperate
with Slit and Robo to control guidance in the Drosophila
embryonic central nervous system. K. G. JOHNSON*; M. M.
COURSE; A. SMART. Pomona Col.
8:00 C7 132.13 Quantitative comparison of traction
dynamics of growth cone and neuronal motility in 2D and 3D
hydrogel substrates. H. LEE*; C. FRANCK. Brown Univ.
9:00 C8 132.14 Dynamic responses of retinal ganglion
cell axon growth cones to netrin-1 as they innervate their
in vivo target. N. J. SHIRKEY*; C. MANITT; L. ZUNIGA; S.
COHEN-CORY. Univ. California, Irvine, McGill Univ.
10:00 C9 132.15 Beta-catenin signals through Wnt and
Cadherin factors to regulate growth cone protrusions and
pathfinding of optic axons in vivo. M. MORA; A. WILEY; T. M.
ELUL*. Touro Univ.
11:00 C10 132.16 14-3-3 proteins regulate axonal growth
cone responses by regulating PKA activity. C. KENT*;
T. SHIMADA; B. RITTER; P. S. MCPHERSON; P. T.
YAM; F. CHARRON; D. GUILLET; P. W. WISEMAN; A. E.
FOURNIER. Montreal Neurolog. Inst., Inst. de Recherches
Cliniques de Montréal (IRCM), McGill Univ.
8:00 C11 132.17 Genetic interactions between FAK and
integrin in Drosophila neuronal development in dissociated
cultures. L. LIU; C. WU*. Sountheast Univ., Univ. Iowa.
9:00 C12 132.18 App and adhesion of axonal growth
cones. L. SOSA*; G. C. SIMON; A. ESTRADA-BERNAL; N.
POSTMA; K. H. PFENNINGER. Univ. of Colorado Denver.
POSTER
133. Axon Growth and Guidance
Theme A: Development
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 C13 133.1 TrkB neurotrophin receptor complexes
with EphAs and modulates repellent activity of EphA forward
signaling for RGC axons. Y. LIM*; T. MCLAUGHLIN; T.
SUNG; K. LEE; L. F. REICHARDT; D. D. M. O’LEARY. Salk
Inst., UCSF.
9:00 C14 133.2 Ectopic expression of ephrin-A5 under
the EphA8 promoter at the anterior region of the superior
colliculus. H. NOH; S. PARK; S. PARK*. Sookmyung Women
Univ.
10:00 C15 133.3 EphrinA5 modulates neurotrophin-
stimulated gene expression and growth cone motility in an
SRF-dependent manner. C. MEIER*; B. KNÖLL. Tuebingen
Univ.
Neuroscience 2010  |  Sunday AM  |  9 
11:00 C16 133.4 T-cadherin regulates cardiac myocyte
innervation via contact-mediated inhibition of sympathetic
neuron growth. J. J. BAADE; J. MOON; J. A. LUTHER*; S.
BIRREN. Brandeis Univ.
8:00 C17 133.5 From mitochondria to nucleus, Pgc-
1 translocation may be one of the key factors for neurite
extension in N2a cells. Y. KAMBE*; A. MIYATA. Kagoshima
Univ.
9:00 C18 133.6 Cyclic nucleotide-dependent switching of
mammalian axon guidance depends on gradient steepness.
G. J. GOODHILL*; A. W. THOMPSON; Z. PUJIC; D.
MORTIMER; L. J. RICHARDS. Univ. of Queensland, The
Univ. of Queensland.
10:00 C19 133.7 A novel function of Ca2+ in axon
specification acting through the CaMKK/CaMKI pathway. S.
NAKAMUTA*; Y. FUNAHASHI; T. NAMBA; H. KAMIGUCHI;
K. KAIBUCHI. Nagoya Univ. Grad. Sch. of Med., RIKEN
Brain Sci. Inst.
11:00 C20 133.8 RGMa reduction underlies hippocampal
mossy fiber sprouting. E. SHIMIZU*; S. NAKAHARA;
T. YAMASHITA; N. MATSUKI; R. KOYAMA. Lab. Chem
Pharmacol, Grad Sch. Pharm Sci, Univ. Tokyo, Dept Mol
Neurosci, Grad Sch. Med, Osaka Univ.
8:00 C21 133.9 Statins promote axonal regeneration in
the presence of myelin. H. LI; E. NIKULINA; J. HOU; W. S.
YANG; T. SPENCER*; G. F. CROFT; H. WICHTERLE; M. T.
FILBIN; B. R. STOCKWELL; C. E. HENDERSON. Columbia
Univ., Hunter College, City Univ. of New York, Howard
Hughes Med. Institute, Columbia Univ.
9:00 C22 133.10 The functional roles of RGMa domains
within early embryonic vertebrate development. G. J. LAH*;
B. KEY. The Univ. of Queensland.
10:00 C23 133.11 Heparan sulfate 6-O-endosulfatases are
required for neural network formation. T. OKADA; K. KEINO-
MASU; S. NAGAMINE; S. KUNITA; S. TAKAHASHI; M.
MASU*. Univ. Tsukuba.
11:00 C24 133.12 A relative signalling model for the
formation of a continuous topographic map. N. BEVINS*; M.
REBER; G. E. LEMKE. Salk Inst. For Biol. Studies, UCSD,
INSERM.
8:00 C25 133.13 Parasympathetic nerves and
organogenesis: Neurturin and VIP modulate neuronal-
epithelial crosstalk during salivary gland development. C.
L. HADDOX*; S. M. KNOX; M. P. HOFFMAN. Natl. Inst. of
Health, NIDCR.
9:00 C26 133.14 Reelin is required for class-specific
retinogeniculate targeting. M. A. FOX*; J. SU; C. HANER; W.
GUIDO. Virginia Commonwealth Univ.
10:00 C27 133.15 Robo3 is a DCC co-receptor mediating
attraction of precerebellar neurons by floor plate. A. C.
CHEDOTAL*; P. ZELINA; Y. ZAGAR. Vision Institute,
INSERM U968.
11:00 C28 133.16 Longitudinal axons navigate through the
brain by balancing netrin attraction and slit repulsion. G. S.
MASTICK*; W. T. FARMER; M. KIM; S. A. MCMAHON; P.
FABRE; F. CHARRON. Univ. Nevada, Reno, IRCM.
8:00 C29 133.17 In vivo activation of channelrhodopsin-2
reveals that normal patterns of spontaneous activity and
not neurotransmitter signaling are required for motoneuron
guidance and expression of guidance molecules. K.
KASTANENKA*; L. T. LANDMESSER. Case Western
Reserve Univ.
10  |  Society for Neuroscience
9:00 C30 133.18 Engineering of in vitro heterogeneous
neuronal networks using multi-layered microfluidics
technology. C. D. JAMES; C. J. FORSYTHE; T. L.
WHEELER*; J. V. COHN. Sandia Natl. Lab., Syst. Planning
Corp., US Navy.
10:00 C31 133.19 Axons of the chick spinal cord, but not the
statoacoustic ganglion, are responsive to Wnts in vitro. K. N.
FANTETTI*; Y. ZOU; D. M. FEKETE. Purdue Univ., UCSD.
11:00 C32 133.20 Bone Morphogenetic Protein 4 as a
mediator of estrogen-induced sensory axon plasticity. A.
BHATTACHERJEE*; P. G. SMITH. Univ. of Kansas Med. Ctr.
8:00 C33 133.21 Hydrogen sulfide causes S-sulfhydration
of PTEN and decreases its activity. R. XU*; M. M. GADALLA;
M. S. VANDIVER; B. D. PAUL; A. CHAKRABORTY; N. SEN;
T. M. MA; A. K. MUSTAFA; S. H. SNYDER. Johns Hopkins
Univ. Sch. of Med.
POSTER
134. Synapse Formation: Molecular Mechanisms
Theme A: Development
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 C34 134.1 Microtubules regulate BDNF-induced
synaptic PSD95 localization during synaptic growth and
remodeling. X. HU*; L. BALLO; C. VIESSELMANN; J.
BALLWEG; E. MERRIAM; E. W. DENT. Univ. Wisconsin,
Univ. of Wisconsin.
9:00 C35 134.2 Odor-induced remodeling of olfactory
bulb microcircuits revealed by monosynaptic tracing. B. R.
ARENKIEL*; H. HASEGAWA; J. YI; R. S. LARSEN; M. L.
WALLACE; B. D. PHILPOT; F. WANG; M. D. EHLERS. Duke
Univ. Med. Ctr., Univ. of North Carolina, Chapel Hill, Duke
University, Dept of Neurobio., Howard Hughes Med. Inst.
10:00 C36 134.3 Identification of an astrocyte-secreted
protein that is sufficient to induce fully functional synapse
formation. N. J. ALLEN*; C. CHAKRABORTY; N. NOURI; B.
A. BARRES. Stanford Univ.
11:00 C37 134.4 Elucidating the function of Class
4 Semaphorins in GABAergic synapse formation.
M. STEARNS KUZIRIAN; A. RAISSI; S. PEASE; I.
CHUDOTVOROVA; S. PARADIS*. Brandeis Univ.
8:00 C38 134.5 Glial cells decipher the state of synaptic
competition at developing mammalians neuromuscular
junctions. H. DARABID*; R. ROBITAILLE. Univ. De Montréal,
group GRSNC of FRSQ.
9:00 D1 134.6 Developmental effects of serotonin 1A
receptor mediated signaling. P. BANERJEE*. City Univ. New
York Staten Isla.
10:00 D2 134.7 Aberrant memory and altered gene
transcription programs in calcium-response factor knockout
mice. A. E. WEST*; K. A. MCDOWELL; A. N. HUTCHINSON;
A. R. PFENNING; T. KIM; W. C. WETSEL. Duke Univ. Med.
Ctr., Children’s Hosp.
11:00 D3 134.8 Trophic factor induced activity acts on
both the somal and axonal compartment of postsynaptic
neuron LPeD1 and is mediated by protein kinase C. C. C.
LUK*; J. A. ANDREWS; A. LEE; W. ZAIDI; N. I. SYED. Univ.
of Calgary.
8:00 D4 134.9 Effects of wnt proteins on neuromuscular
junction formation. B. ZHANG*; C. LIANG; W. XIONG; L.
MEI. Med. Coll Georgia.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
9:00 D5 134.10 Cyclosporine A increases synapse
formation in rat hippocampal neurons in vitro. A. IWAMI*;
J. THAO; M. YANG; A. BLEE; K. M. COLLINS; J. R. DAY.
CSU Chico, Pleasant Valley High Sch., Univ. of Texas,
Southwestern Med. Sch.
10:00 D6 134.11 The role of Reelin in forebrain synapse
development. A. VENTRUTI; J. DOMOGAUER; T. M.
KAZDOBA; G. D’ARCANGELO*. Rutgers, The State
Universty of New Jersey.
11:00 D7 134.12 LRP4 stabilizes MuSK protein in the
neuromuscular junction. C. SHEN*. IMMAG Med. Col. of
Georgia.
8:00 D8 134.13 Role of lysosomal processing in
modulating activity-dependent synaptic development at the
Drosophila neuromuscular junction. V. VALAKH*; M. AI; A.
DIANTONIO. Washington Univ. In St Louis.
9:00 D9 134.14 Roles of metabolites from
docosahexaenoic acid in hippocampal neuronal
development and synaptogenesis. Z. XIONG*; J. LEE; K.
KEVALA; H. MOON; H. KIM. NIH/NIAAA.
10:00 D10 134.15 The pro-inflammatory cytokines IL-6 and
IL-1b alter the initial establishment of cortical connections.
M. M. COBB; M. L. ESTES; P. A. GARAY; A. MCALLISTER*.
UC Davis.
11:00 D11 134.16  •  A new neuronal glycine transporter
mutation in mouse and its use in the study of activity-
dependent neuromuscular junction formation and
maintenance. L. P. BOGDANIK*; H. D. CHAPMAN; D. V.
SERREZE; R. W. BURGESS. The Jackson Lab.
8:00 D12 134.17 Developmental expression of synapse-
associated genes in hRhodopsin-GFP knock-in retinal cell
cultures. J. A. FULLER*; K. J. WAHLIN; D. J. ZACK. Johns
Hopkins Sch. Med.
9:00 D13 134.18 An outer-mitochondrial kinase and
phosphatase regulate synapse development and plasticity
through the mitochondrial fission enzyme Drp1. A. S.
DICKEY*; S. STRACK. Univ. Iowa.
10:00 D14 134.19 Sema3E-plexinD1 signaling controls
dendritic spine formation and excitatory synaptic specificity
in the striatum. J. B. DING*; W. OH; B. L. SABATINI; C. GU.
Harvard Med. Sch.
11:00 D15 134.20 Localizing SK2 channels and α9/10-
nAChRs at olivocochlear postsynaptic sites. E. K. STORER*;
M. H. JACOB. Tufts Univ. Sch. of Med.
8:00 D16 134.21 Antidepresant fluoxetine suppresses
neurite outgrowth and perturbs synapse formation and
synaptic transmission between Lymnaea neurons. F. XU*; C.
LUK; M. P. RICHARD; W. ZAIDI; S. FARKAS; A. GETZ; A.
LEE; J. VAN MINNEN; N. I. SYED. Univ. Calgary.
POSTER
135. Synapse Formation: Presynaptic Mechanisms
Theme A: Development
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 D17 135.1 Defects in axonal transport causes
synaptic defects by downregulating BMP signaling. S.
GUNAWARDENA*; M. J. KANG; M. MICHIEWICZ; S. FYE;
T. J. KACZYNSKI. SUNY At Buffalo.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
9:00 D18 135.2 Spatial and temporal specificity of
distinct presynaptic organizers. A. B. TOTH*; L. ZHANG; A.
TERAUCHI; H. UMEMORI. Univ. of Michigan Med. Sch.
10:00 D19 135.3 Presynaptic fragile X mental retardation
protein is required for neuroligin-1-mediated presynaptic
differentiation. H. E. BERK-RAUCH*; M. R. AKINS; J. R.
FALLON. Brown Univ.
Sun. AM
11:00 D20 135.4 Rapid actin polymerization is essential
for synaptic vesicle precursor trafficking and recruitment to
nascent CNS synapses. V. LYLES*; A. K. MCALLISTER. UC
Davis.
8:00 D21 135.5 Role of presynaptic activity and CaMKII
in retrograde Semaphorin signaling and synaptic refinement.
H. S. KESHISHIAN*; R. A. CARRILLO; D. P. OLSEN. Yale
Univ., Caltech.
9:00 D22 135.6 The role of RABX-5 in regulating RAB-5
endosomal compartments and synaptic vesicle formation in
C. elegans. S. B. SANN*; M. M. CRANE; H. LU; Y. JIN. UC
San Diego, Georgia Inst. of Technol., Howard Hughes Med.
Inst.
10:00 D23 135.7 Coordination of synaptic vesicle and
active zone protein trafficking in developing cortical neurons.
L. A. D. BURY; S. L. SABO*. Case Western Reserve Univ.
Sch. of Med.
11:00 D24 135.8 Axonal α7 nicotinic ACh receptors
modulate presynaptic NMDAR expression and structural
plasticity of glutamatergic presynaptic boutons during early
synaptic development. H. LIN; S. VICINI; F. HSU; S. DOSHI;
H. TAKANO; D. A. COULTER; D. R. LYNCH*. The Children’s
Hosp. of Philadelphia, Georgetown Univ. Sch. of Med., Hosp
Univ. Pennsylvania.
8:00 D25 135.9 Cryo-electron tomography of synaptic
vesicle packets in developing neurons. D. VANHECKE; N.
SCHROD; W. BAUMEISTER; V. LUCIC*. Max Planck Inst. of
Biochem., Max Planck Inst. Biochemist.
9:00 D26 135.10 Synapse dynamics during the initial
establishment of cortical connections. L. A. NEEDLEMAN*;
A. K. MCALLISTER. UC Davis.
10:00 D27 135.11 Developmental changes in the
spontaneous depolarization wave in the mouse embryo:
mechanisms underlying spatial segregation. Y. MOMOSE-
SATO*; K. SATO. Kanto Gakuin Univ., Col. Human & Envrn.
Studies, Komazawa Women’s Univ., Fac. Human Hlth.
11:00 D28 135.12 Reliability and stereotypy of transmission
evolve during development at the mouse calyx of Held
in vivo. B. ENGLITZ*; M. SONNTAG; M. TYPLT; R.
RÜBSAMEN. Univ. of Maryland, Col. Park, Univ. of Leipzig,
Max Planck Inst. for Mathematics in the Sci.
8:00 D29 135.13 Identification of newly synthesized,
synapse-specific proteomes at different stages of brain
development. P. LANDGRAF; T. KAEHNE; K. RICHTER; K.
SMALLA*; A. MUELLER; E. R. ANTILEO; D. C. DIETERICH.
Leibniz Inst. for Neurobio., Otto-von-Guericke Univ.
Magdeburg.
9:00 D30 135.14 Differential effect of prenatal patterned
and unpatterned high decibel sound on spatial learning
and synaptophysin expression in chick hippocampus and
brainstem auditory nuclei. T. SANYAL (CHATTERJEE); T. C.
NAG; T. S. ROY; S. WADHWA*. All India Inst. Med. Sci.
10:00 D31 135.15 Identification of muscle-derived
retrograde factors for NMJ formation. A. BARIK*; H. WU; W.
XIONG; L. MEI. Med. Col. of Georgia.
Neuroscience 2010  |  Sunday AM  |  11 
11:00 D32 135.16   How do astrocyte-secreted proteins
hevin and SPARC regulate CNS synaptogenesis? A. FENG*;
M. M. BOLTON; H. KUCUKDERELI; C. EROGLU. Cell Biol.,
Duke Univ. Med. Ctr.
POSTER
136. Signaling Cascades
Theme B: Neural Excitability, Synapses, and Glia:
Cellular Mechanisms
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 D33 136.1 Sigma-1 receptor agonist cutamesine
enhances the secretion of brain-derived neurotrophic factor
from neuroblastoma cells. M. FUJIMOTO*; T. HAYASHI;
R. URFER; S. MITA; T. SU. NIDA, NIH, DHHS, M’s Sci.
Cooperation.
9:00 D34 136.2 Association of PCBP1 and PCBP2
with processing bodies in catecholaminergic cell lines. K.
TAKEUCHI*; Y. ZHANG; D. I. YULE; A. W. TANK. Univ. of
Rochester, Iwate Med. Univ.
10:00 D35 136.3 Neurosteroids, allopregnanolone and
progesterone, induce autophagy without cell death in
cultured mouse astrocytes. H. KIM*; S. LEE; J. KOH. Univ.
Ulsan Col., Univ. Ulsan of Col.
11:00 D36 136.4 Signaling cascade for delta-opioid
receptor-induced inhibition of GABA synaptic transmission.
Z. ZHANG; Z. Z. PAN*. UT-MD Anderson Cancer Ctr.
8:00 D37 136.5  •  Distribution of GABAergic neuronal
populations in the nervous system of Octopus vulgaris: An
immunofluorescence study. G. PONTE; G. FIORITO; D. B.
EDELMAN*. Stazione Zoologica Anton Dohrn di Napoli, The
Neurosciences Inst.
9:00 D38 136.6 Fluvoxamine and sigma-1 receptor
agonists dehydroepiandrosterone (DHEA)-sulfate induces
the Ser473-phosphorylation of Akt-1 in PC12 cells. K.
OSADA*; M. NAKANO; Y. OGAWA; T. HAGA; M. ASAKURA;
H. MATSUI; N. YAMAGUCHI. 2-16-1 Sugao.
10:00 D39 136.7 Characterization of Slitrk4 in neurons. I.
DINCHEVA*; F. LEE. Weill Cornell Med. Col.
11:00 D40 136.8 Cholinergic neurons regulate and
utilize GDNF secreted by C2C12 skeletal muscle cells. J.
VIANNEY*; J. M. SPITSBERGEN. Western Michigan Univ.
8:00 D41 136.9 Acetyl-l-carnitine mediated
neuroprotection in hypoxia is regulated by nrf-2 regulated
signaling mechanism. S. B. SINGH; K. BARHWAL; S. HOTA;
L. T. RAO*. Inst. of High Altitude Res., NIMHANS.
9:00 D42 136.10 PKC-dependent regulation of HuD mRNA
stabilizing protein at hippocampal neuron synapses. C. LIM*;
D. L. ALKON. Blanchette Rockefeller Neurosciences Inst.
10:00 E1 136.11 K-ras increases dor expression in mcf7
cells. S. CHEN*; G. WEN; Y. XIA. Yale Univ., Hainan Med.
Col.
11:00 E2 136.12 The role of SRF cofactors MKL1
and MKL2 in neurons. K. KALITA-BYKOWSKA*; B.
KUZNIEWSKA; E. REJMAK; M. HETMAN; L. KACZMAREK.
Nencki Inst. of Exptl. Biol., Univ. of Louisville.
8:00 E3 136.13 Serotonin-enhanced survival of Helisoma
trivolvis embryos during anoxia may involve increased
mitochondrial membrane potential. J. I. GOLDBERG*; R.
TAM; R. B. SHARTAU. Univ. of Calgary.
12  |  Society for Neuroscience
9:00 E4 136.14 Does Wnt signaling regulate learning-
induced mossy fiber remodeling? N. TABATADZE*; A.
SCHOOK; B. LIN; R. MCGONIGAL; A. ROUTTENBERG.
Northwestern Univ.
10:00 E5 136.15 Plasticity in neurotransmitters segregation
in the rat superior cervical ganglion in vivo: Effects of
axotomy. A. VEGA; F. CIFUENTES; M. A. MORALES*. Inst.
Invest Biomedicas UNAM.
11:00 E6 136.16 Ceramide-containing lipid microdomains
regulate the subcellular distribution of sigma-1 receptors.
T. HAYASHI*; M. FUJIMOTO; E. HAYASHI; T. SU. Cell
Neurobiol Resch Branch, IRP, NIDA, NIH.
8:00 E7 136.17 Searching for the Go effector in the
mammalian neuroendocrine system. E. MARRON*; C. F.
ERXLEBEN; D. L. ARMSTRONG. NIEHS.
E8 136.18 Withdrawn
9:00 E9 136.19 Integrated neuronal responses to
oxytocin signaling: simultaneous activation of ERK and
CaMK pathways. E. VAN DEN BURG*; B. JUREK; S.
MARTINETZ; G. WARNKE; S. KOSZINOWSKI; D.
SLATTERY; I. NEUMANN. Univ. of Regensburg.
10:00 E10 136.20 Defining the phosphodiesterase
families in brain microvessels of rats. Z. HE*; L. CUI; T. A.
PATTERSON; M. G. PAULE. Natl. Ctr. For Toxicology Res.,
UAMS Col. of Pharm.
11:00 E11 136.21 Insights to the Sigma-1 receptor
chaperone’s cellular functions: A microarray report. S. TSAI*;
T. HAYASHI; Y. ZHANG; K. BECKER; T. SU. NIDA/NIH, Natl.
Inst. of Aging, NIH.
8:00 E12 136.22 Sex-dependent expression of Beta-actin
gene in different tissue of rat. K. SHARIFI*; M. JORJANI;
K. SHARIFI; N. AHANGAR; L. SATTARIAN. Neurosci.
Res. Center, Shahid Beheshti Univ. of Med. Sci., Sch. of
Pharmacy, Mazandaran university of Med. Sciences,.
POSTER
137. Glycine and GABA B Receptors
Theme B: Neural Excitability, Synapses, and Glia:
Cellular Mechanisms
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 E13 137.1 The potentiation of glycine receptors by
low concentrations of ethanol requires several molecular
determinants. P. A. CASTRO*; G. E. YEVENES; G.
MORAGA; M. FIGUEROA; L. GUZMAN; L. G. AGUAYO.
Univ. Concepcion.
9:00 E14 137.2 Glycine supports excitatory
neurotransmitter release in developing mouse visual cortex.
P. A. MCCOY*; B. D. PHILPOT. UNC.
10:00 E15 137.3 A characterization of inhibitory
neurotransmission in the dorsal raphe. E. P. MAGUIRE*;
D. J. K. BALFOUR; J. J. LAMBERT; D. BELELLI. Univ. of
Dundee.
11:00 E16 137.4 Developmental differences in glycine
receptor subunit α1 and α2 expression in the brain of the
Wistar rat. S. JONSSON*; L. ADERMARK; M. ERICSON; B.
SÖDERPALM. Neurosci & Physiol.
8:00 E17 137.5 Endogenous and exogenous
cannabinoids potentiate glycine-activated current in spinal
neurons via a CB receptor independent mechanism. L.
ZHANG*; W. XIONG; D. M. LOVINGER. NIAAA, NIH.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
9:00 E18 137.6 Discovering novel drugs targeting glycine
receptor Cl- channels in pain sensory pathways. R. ISLAM;
W. BALANSA; F. FONTAINE; A. M. PIGGOTT; H. ZHANG; T.
I. WEBB; D. F. GILBERT; R. J. CAPON; J. W. LYNCH*. Univ.
of Queensland.
10:00 E19 137.7 Defective glycinergic synaptic
transmission in zebrafish motility mutants. V. M. JAMES*;
E. CARTA; L. R. GANSER; J. E. DALLMAN; M. TOPF; R. J.
HARVEY. The Sch. of Pharm., Univ. of Miami, Birkbeck.
11:00 E20 137.8 Morpholino knock-down of the zebrafish
glycine receptor a1 subunit yields phenotypes distinct from
the zebrafish glycine receptor b subunit mutant bandoneon.
L. R. GANSER; R. J. HARVEY; J. E. DALLMAN*. Univ. of
Miami, The Sch. of Pharm.
8:00 E21 137.9 Duplicated gephyrin genes mediate
glycine receptor clustering and escape behaviour in
zebrafish. S. RAMSDEN*; K. OGINO; R. J. HARVEY; H.
HIRATA. The Sch. of Pharm., Nagoya Univ.
9:00 E22 137.10 Volatile anaesthetics increase efficacy
of partial agonists on the glycine receptor. D. KIRSON*; J.
TODOROVIC; J. MIHIC. Univ. of Texas - Austin.
10:00 E23 137.11 Functional important domains within the
TM3-4 loop of the glycine receptor. B. UNTERER; C. M.
BECKER; C. VILLMANN*. Univ. Erlangen-Nurnberg.
11:00 E24 137.12 GABAB receptor activation leads to
changes in the activation voltage of calcium current. A. S.
KARLS*; M. MYNLIEFF. Marquette Univ.
8:00 E25 137.13 Anoxia-induced reduction of thalamic
gaba b currents: Pre- versus post-synaptic mechanisms. M.
P. BEENHAKKER*; J. R. HUGUENARD. Stanford Univ.
9:00 E26 137.14 Characterization of GABAergic inhibition
and interneuron number in GABAB1R knockout mice. E. C.
LOOKE-STEWART; S. C. BARABAN; J. Y. SEBE*. UCSF.
10:00 E27 137.15 Glutamate triggers lysosomal degradation
of endogenous GABAB receptors by reducing receptor
recycling. P. J. MAIER*; I. MARIN; T. GRAMPP; A.
SOMMER; D. BENKE. Univ. of Zurich, Inst. of Pharmacol.
and Toxicology.
11:00 E28 137.16 PKC but not PKA is involved in the
signal transduction mechanism of L-type calcium current
facilitation by GABAB receptor activation in the neonatal rat
hippocampus. J. G. BRAY*; M. MYNLIEFF. Marquette Univ.
8:00 E29 137.17 Growth hormone affects the GABAB
receptor levels in rat brain. A. GRÖNBLADH*; J.
JOHANSSON; F. NYBERG; M. HALLBERG. Uppsala
University, Dept Pharmaceut. Biosci.
9:00 E30 137.18  •  GABA(B) receptor activity dinamically
regulates expression of Kir3 channels. A. KULIK*; Y.
FUKAZAWA; R. SIGEMOTO; M. FROTSCHER; I. VIDA.
Insitute of Anat. and Cell Biol., Div. of Cerebral Structure,
NIPS, Neurosci. and Mol. Pharmacology, FBLS, Univ. of
Glasgow.
10:00 E31 137.19 Native GABAB receptors are
heteromultimers with a family of auxiliary subunits. M.
GASSMANN*; J. SCHWENK; M. METZ; G. ZOLLES; R.
TURECEK; T. FRITZIUS; W. BILDL; A. KULIK; A. UNGER;
K. IVANKOVA; R. SEDDIK; J. Y. TIAO; M. RAJALU; U.
SCHULTE; B. FAKLER; B. BETTLER. Univ. of Basel, Univ.
of Freiburg, Acad. of Sci. of the Czech Republic, Logopharm
GmbH, Ctr. for Biol. Signaling Studies (bioss).
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
11:00 E32 137.20 Sirna-mediated gabab receptor: Ethanol
and ptz effects on intracellular signaling and apoptotic
neurodegeneration. M. KIM*; M. I. NASEER; N. ULLAH; H.
Y. LEE; B. C. YANG. Gyeongsang Natl. Univ., Natl. Institue
of Animal Sci.
Sun. AM
POSTER
138. Muscarinic Receptors
Theme B: Neural Excitability, Synapses, and Glia:
Cellular Mechanisms
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 E33 138.1  •  Phosphorylation-dependent localization
of HSP27 and cytoskeletal reorganization in SH-SY5Y
neuroblastoma cells. L. A. DOKAS*; S. M. NAULI; F. E.
WILLIAMS; W. S. MESSER, Jr. The Univ. of Toledo.
9:00 E34 138.2 Allosteric-induced agonist-directed
trafficking at M1 muscarinic acetylcholine receptors. G. J.
DIGBY*; B. J. HANSON; Z. XIANG; E. P. LEBOIS; C. W.
LINDSLEY; P. J. CONN. Vanderbilt Univ., Invitrogen.
10:00 E35 138.3 The muscarinic allosteric ligand N-ethyl-
amiodarone exhibits positive homotropic cooperativity
in affecting muscarinic binding and response assays. E.
STAHL; J. ELLIS*. Penn State Univ.
11:00 E36 138.4 Identification and characterization of
a novel M1 selective muscarinic acetylcholine receptor
antagonist from an M1 allosteric agonist scaffold. T. J.
UTLEY*; E. P. LEBOIS; T. M. BRIDGES; B. J. MELANCON;
M. R. WOOD; C. M. NISWENDER; C. W. LINDSLEY; P. J.
CONN. Vanderbilt Univ.
8:00 E37 138.5 M1-like muscarinic acetylcholine
receptors regulate fast-spiking interneuron excitability in rat
dentate gyrus. P. CHIANG*; W. YEH; J. WENG; Y. HUANG;
C. LIEN. Inst. of Neurosci. and Brain Res. Center, Natl.
Yang-Ming Univ., Dept. of Anesthesiology, Cheng Hsin Gen.
Hosp.
9:00 E38 138.6 Acetylcholine (ACh) controls GABAergic
inhibition through M1 muscarinic acetylcholine receptor
(mAChR) activation of parvalbumin-positive (PV+)
hippocampal interneurons. V. C. SATPUTE*; J. T. VAN
LEUVAN; A. D. JOHNSTON; B. B. HOLLOWAY; D.
GERBER; S. TONEGAWA; J. J. LAWRENCE. The Univ. of
Montana, MIT.
10:00 E39 138.7 Depolarization induces a conformational
change in the m2 muscarinic receptor. N. DEKEL*; H.
PARNAS; I. PARNAS; F. BEZANILLA. The Hebrew Univ. of
Jerusalem, The Univ. of Chicago.
11:00 E40 138.8  •  M2-like muscarinic acetylcholine
receptors regulate perisomatic GABA release in rat dentate
gyrus. C. LEE*; C. LIEN. Inst. of Neuroscience, Natl. Yang-
Ming Univ.
8:00 E41 138.9 Localization of m1 and m2 muscarinic
cholinergic receptor immunoreactivity in the rat basolateral
amygdala. A. J. MCDONALD*; F. MASCAGNI; J. F.
MULLER. Univ. South Carolina Sch. Med.
9:00 E42 138.10  •  Multi-nutrient supplementation
enhances muscarinic receptor responses in vitro. P. J.
SAVELKOUL; M. M. MERKES; H. JANICKOVA; A. A.
KUIPERS; R. J. J. HAGEMAN; L. M. BROERSEN*; V.
DOLEZAL; P. J. KAMPHUIS. Danone Res., Acad. of Sci. of
the Czech Republic.
Neuroscience 2010  |  Sunday AM  |  13 
 POSTER
139. Calcium Channel Physiology I
Theme B: Neural Excitability, Synapses, and Glia:
Cellular Mechanisms
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 E43 139.1 Alternative-splicing of the singleton
invertebrate calcium channel beta subunit (LCavbeta)
governs alpha subunit specificity and kinetic differences. J.
SPAFFORD*; T. F. DAWSON; A. SENATORE; S. HAREL; A.
N. BOONE. Univ. of Waterloo.
9:00 E44 139.2 Splice variant selective regulation of
CaV1.2 channels by galectin-1. J. J. WANG; S. C. THIO;
S. H. YANG; C. Y. YU; D. J. YU; F. TSANG*; P. LIAO; T. W.
SOONG. Natl. Neurosci. Inst., Natl. Univ. of Singapore, Fai
Tsang.
10:00 E45 139.3 The neuronal splicing factor Fox-2
regulates an exon in Cav2.2 that controls the sensitivity of
N-type calcium channels to inhibition by Gs proteins. C. G.
PHILLIPS*; S. E. ALLEN; D. LIPSCOMBE. Brown Univ.
11:00 E46 139.4 Stathmin-2 regulates N-channel surface
expression through a direct protein-protein interaction. S.
MARANGOUDAKIS*; T. D. HELTON; D. LIPSCOMBE.
Brown Univ.
8:00 E47 139.5 The neuronal splicing factor Nova-2
controls the expression of Cav2.1 and 2.2 splice isoforms. S.
E. ALLEN*; D. LIPSCOMBE. Brown Univ.
9:00 E48 139.6 RNA editing of the IQ domain in Cav1.3
channels modulates their Ca2+-dependent inactivation.
M. ARIFFIN*; H. HUANG; B. Z. TAN; Y. SHEN; J. TAO;
F. JIANG; Y. Y. SUN; C. K. NG; M. RAIDA; G. KÖHR; M.
HIGUCHI; H. SHARIATPANAHI; D. YUE; T. W. SOONG.
Natl. Univ. Singapore, Exptl. Therapeut. Ctr., Max-Planck
Inst. for medical research, Johns Hopkins Univ. Sch. of Med.
10:00 E49 139.7 Effect of synthetic CaV2.2 peptides on
G protein modulation of Ca2+ channels. G. BUCCI*; S.
MOCHIDA; G. J. STEPHENS. Reading Univ., Tokyo Med.
Univ.
11:00 E50 139.8 Differential effect of migraine mutations
in the P/Q-type Ca2+ channel on cortical excitatory and
inhibitory synaptic transmission: Underlying mechanisms. D.
VECCHIA; A. TOTTENE; A. VAN DEN MAAGDENBERG; D.
PIETROBON*. Univ. Padova, Leiden Univ.
8:00 E51 139.9  Changes in steady-state expression
of CaV 1.2 and CaV 1.3 L-type calcium channels through
development in the postnatal rat hippocampus. N. E.
INGRAHAM*; M. MYNLIEFF. Marquette Univ.
9:00 E52 139.10 Localization of CaV1.2 and CaV1.3 L-type
calcium channels in the superior region of the neonatal Rat
hippocampus. A. KRAMER*; M. MYNLIEFF. Marquette Univ.
10:00 F1 139.11 Dwell time and turnover of L-type CaV1.2
calcium channels in the dendritic membrane of cultured
hippocampal neurons. V. DI BIASE*; G. J. OBERMAIR; M.
HEINE; B. E. FLUCHER. Innsbruck Med. Univ., Leibniz Inst.
for Neurobio.
11:00 F2 139.12 Properties of single voltage-dependent
calcium channels in somata of rat neocortical layer V
SLIDE
pyramidal neurons. C. O. SCHEPPACH*; M. E. LARKUM; H.
P. C. ROBINSON. Univ. of Cambridge, Univ. of Berne.
14  |  Society for Neuroscience
8:00 F3 139.13 Altered CaV1.2 channel properties
arising from deletion of exon 33 in mice contributes to
cardiac arrhythmia. P. BARTELS; G. LI; P. LIAO; J. WANG;
M. LIANG; D. YU; C. Y. YU; T. SOONG*. Natl. Univ. of
Singapore, Nat Univ. Singapore.
9:00 F4 139.14 Deletion of exon 11 in the regulator of G
protein signaling 7 (RGS7) gene reveals its selectivity for
specific Gi/o-coupled pathways. V. B. LU*; H. L. PUHL, III;
J. ZHANG; W. F. SIMONDS; S. R. IKEDA. NIH/NIAAA, NIH/
NIDDK.
10:00 F5 139.15 Stargazin modulation of CaV2.2
channel is dependent on G protein beta-gamma subunit. I.
TSELNIKER; V. TSEMAKHOVICH; C. W. DESSAUER; N.
DASCAL*. Sackler Sch. Med. Tel Aviv Univ., Univ. of Texas
Hlth. Sci. Ctr.
11:00 F6 139.16 Regulation of L-type Ca2+ channels by
the interaction between the auxiliary β subunit and RIM1. M.
A. GANDINI*; A. SANDOVAL; R. GONZÁLEZ-RAMÍREZ; R.
FELIX. Cinvestav IPN, Sch. of Med. FES Iztacala. UNAM,
Departament of Mol. Biol. and Histocompatibility, Dr. Manuel
Gea González Gen. Hospital, Ministry of Hlth.
8:00 F7 139.17 Spider venom toxins, Tx3-4 and Phα1β,
have different actions on calcium channel splice isoforms. C.
J. CASTRO-JUNIOR; A. S. ANDRADE*; M. V. GOMEZ; D.
LIPSCOMBE. Univ. Federal de Minas Gerais, Brown Univ.
9:00 F8 139.18 Inhibition of recombinant N-type voltage
dependent Ca2+ channels by AdGABA: Mechanism of action
studies. E. MARTÍNEZ-HERNÁNDEZ*; A. SANDOVAL;
R. GONZÁLEZ-RAMÍREZ; G. ZOIDIS; R. DELGADO; R.
FELIX. Cinvestav IPN, FES Iztacala UNAM, Dr. Manuel Gea
González Gen. Hospital, Ministry of Hlth., Univ. of Athens.
10:00 F9 139.19 Electrophysiological characterization of
a chromatographic fraction from the venom of marine snail
conus californicus over voltage-gated calcium channels.
O. LOPEZ*; E. SALCEDA; J. BERNALDEZ; A. LICEA;
E. SOTO. BUAP, Ctr. de Investigación Científica y de
Educación Superior de Ensenada.
11:00 F10 139.20  •  Role of spinal calcium channel subtypes
in modulation of intraplantar formalin evoked flinching and
substance P release. T. TAKASUSUKI; T. L. YAKSH*. UCSD,
Univ. California.
8:00 F11 139.21 G-protein coupled receptor regulation
of P/Q-type calcium channels in ataxia. J. L. WEISS*; R. L.
BRINDLEY. Univ. of Sheffield.
9:00 F12 139.22 Gating properties of a human disease-
causing mutation in Cav1.3 L-type calcium channels. A.
KOSCHAK; S. M. BAIG; M. GEBHART; C. DAFINGER;
G. NUERNBERG; N. BRANDT; J. ENGEL; A. ALI; I.
AHMAD; M. J. SINNEGGER-BRAUNS; M. E. MANGONI;
M. FAROOQ; H. U. KHAN; P. NUERNBERG; H. J. BOLZ;
J. STRIESSNIG*. Univ. of Innsbruck, Inst. for Biotech. and
Genet. Engin., Inst. of Human Genet., Cologne Ctr. for
Genomics and Inst. for Genet., Univ. of Tübingen, Saarland
Univ., Inst. de Génomique Fonctionnelle, Khyber Teaching
Hosp., Bioscientia.
10:00 F13 139.23 Mitochondrial ca2+ buffering limits
excitation-transcription coupling by n and p/q type (cav2)
ca2+ channels. H. MA*; S. F. OWEN; R. D. GROTH; D. G.
WHEELER; R. W. TSIEN. Stanford Univ., Dart Neurosci.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
11:00 F14 139.24  •  Cav1.2 and Cav1.3 channels are
equally affected by the opposing action of cAMP/PKA and
cGMP/PKG: a study using Cav1.3-/- mouse chromaffin
cells. S. MAHAPATRA*; A. MARCANTONI; V. CARABELLI;
J. STRIESSNIG; E. CARBONE. Univ. of Torino, Univ.of
Innsbruck.
8:00 F15 139.25 Regulation of the voltage-gated calcium
channel Cav1.2: Mass spectrometric identification and
functional charaterization of critical phosphorylation sites. S.
SHIN*; I. CHOI; Y. CHO; K. CHO; J. YOO; K. PARK. Kyung
Hee Univ. Sch. of Med., Korea Basic Sci. Inst.
9:00 F16 139.26 An alternative mechanism to modulate
Ca2+/calmodulin- independent inactivation of calcium
channels in schistosomes. V. SALVADOR-RECATALA*; R.
M. GREENBERG. Univ. of Pennsylvania.
POSTER
140. Synaptic Transmission: Modulation by Peptides and
Amines
Theme B: Neural Excitability, Synapses, and Glia:
Cellular Mechanisms
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 F17 140.1 Alzheimer’s amyloid beta peptide of
amyloid plaques contributes to synaptic plasticity changes
in aged APP transgenic mice. E. KEZLYA; K. KOZIREV; N.
KOUDINOVA; T. BEREZOV; A. R. KOUDINOV*. People’s
Friendship Univ., Severo-Osetinsky State Med. Acad.,
Berezov Academic Lab, RAMS, Russian Acad. of Med. Sci.
9:00 F18 140.2 Dopamine-dependent alteration of
synaptic responses in the entorhinal cortex associated with
exposure to food reward, and in response to rewarding
electrical brain stimulation. J. A. HUTTER; C. A. CHAPMAN*.
Concordia Univ.
10:00 F19 140.3 Profound conductance changes in the
neuronal plasma membrane induced by big dynorphin:
A novel non-receptor mechanism of cell signaling. O. A.
KRISHTAL*; O. MAXIMYUK; V. KHMYZ; T. YAKOVLEVA; F.
NYBERG; O. DYACHOK; G. BAKALKIN. Bogomoletz Inst.
Physiol., Uppsala Univ.
11:00 F20 140.4 Pyroglutamyl peptidase 2 controls
the analeptic effect of thyrotropin releasing hormone in
the medial septum in vivo. I. LAZCANO; R. URIBE; E.
MARTÍNEZ CHÁVEZ; M. VARGAS; P. JOSEPH-BRAVO; J.
CHARLI*. Univ. Natl. Autonoma Mexico (UNAM).
8:00 F21 140.5 Cathepsin L participates in dynorphin
and opioid neuropeptide production in brain, illustrated by
protease gene knockout and expression. C. MOSIER*;
A. MINOKADEH; L. FUNKELSTEIN; T. TONEFF; M.
BEINFELD; T. REINHECKEL; C. PETERS; J. ZADINA; V.
HOOK. Univ. of Calif., San Diego, Tulane Univ., Tufts Univ.,
Inst. fur Molekulare Medizin und Zellforschung, Albert-
Ludwigs Univ., SE Louisiana Veterans Hlth. Care Syst.
9:00 F22 140.6 β-Adrenoceptors differentially regulate
inhibitory synaptic transmission depending on presynaptic
interneuron subtype in rat cerebral cortex. Y. KOYANAGI; Y.
OI*; N. KOSHIKAWA; M. KOBAYASHI. Nihon Univ. Sch. of
Dentisitry, Nihon Univ. Sch. of Dent.
10:00 F23 140.7 Modulation of inhibitory synaptic
transmission in CA1area of rat hippocampus by novel
nootropic dipeptide Noopept. V. G. SKREBITSKY*; R. V.
KONDRATENKO; V. I. DEREVYAGIN. Ctr. of Neurol.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
11:00 F24 140.8 Changes of glutamatergic transmission
and dopamine receptor functions in the prelimbic cortex-
nucleus accumbens projection after 6-OHDA lesion. Q. CUI*;
W. YUNG. The Chinese Univ. of Hong Kong.
8:00 F25 140.9 Activation of postsynaptic D3 dopamine
receptors selectively inhibits IPSCs from Mu opioid-
containing GABAergic terminals in CA1 pyramidal cells. J. J.
Sun. AM
WAGNER*; M. STRAMIELLO. Univ. of Georgia.
9:00 F26 140.10 Opposing effects of depression and
antidepressants on serotonin mediated potentiation in area
CA1. A. J. KALLARACKAL*; K. GAYLOR; A. BAILEY; S.
THOMPSON; X. CAI. Univ. Maryland, Baltimore, St. Mary’s
Col. of Maryland.
10:00 F27 140.11 Reduced GABAergic transmission in
hippocampal neurons from oxytocin receptor null mice
with impaired spatial memory. M. PARENTI*; D. LENTINI;
F. GUZZI; S. RIPAMONTI; P. SPAIARDI; G. BIELLA; E.
BULGHERONI; K. NISHIMORI; M. SALA; B. CHINI; M.
TOSELLI. Univ. Milano-Bicocca, Dept. Physiol., Univ. Pavia,
CNR, Inst. Neurosci., Dept. Mol. Cell Biol., Grad. Sch. Agr.
Sci., Tohoku Univ., Dept Pharmacol., Chemother. Med.
Toxicol., Univ. Milano, Behav. Pharmacol. Drug Dependence
Ctr, Univ. Milano.
11:00 F28 140.12 Rescue of emotional and amygdalar
neurophysiological impairments with dietary copper. E. D.
GAIER*; R. M. RODRIGUIZ; W. C. WETSEL; B. A. EIPPER;
R. E. MAINS. UConn Hlth. Ctr., Duke Univ. Med. Ctr.
8:00 F29 140.13 Phasic and tonic patterns of locus
coeruleus output differentially modulate sensory network
function in the waking rat. B. D. WATERHOUSE*; D. M.
DEVILBISS. Drexel Univ. Col. Med., Univ. of Wisconsin.
9:00 F30 140.14 Bombesin modulation of neurons in the
central amygdala with specific projections to brain stem
nuclei. R. STOOP*; E. VAN DEN BURG; A. CHARLET. Univ.
Lausanne, Univ. Hosp. Ctr. and Univ. of Lausanne.
10:00 F31 140.15 Neuregulin-1 rescues the neurotoxicities
and impairment of long-term potentiation induced by amyloid
β. R. WOO; J. AN; P. KIM; S. HAN; C. KIM; J. IM; H. KIM; G.
SEOL; S. MIN*. Sch. of Medicine, Eulji Univeristiy, Sch. of
Medicine, Eulji Univ., Sch. of Humanities & Social Science,
Korea Advanced Inst. of Sci. and Technol., Wonkwang Univ.
Sch. of Med., Korea Univ. Sch. of Nursing.
11:00 F32 140.16 Aaa. A. BANERJEE*; M. LEE; S. RAO;
H. SALGADO; M. ATZORI. Univ. of Texas Dallas, Univ.
Autonoma de Yucatan.
8:00 F33 140.17 Distinctive properties of CXC chemokine
receptor 4 expressing Cajal-Retzius cells versus
GABAergic interneurons of the postnatal hippocampus. I.
MARCHIONNI*; G. MACCAFERRI. Northwestern Univ.
9:00 F34 140.18 Facilitation of the inhibitory transmission
by gastrin-releasing peptide receptors in the anterior
cingulate cortex. X. CAO*; V. MERCALDO; L. WU; P. LI; M.
ZHUO. Univ. of Toronto, Hosp. for Sick Children research
institute, Harvard Univ.
10:00 F35 140.19 D2-receptor activation in the VTA by tonic
and phasic actions of dopamine. C. FORD*; J. WILLIAMS.
OHSU.
Neuroscience 2010  |  Sunday AM  |  15 
 11:00 F36 140.20 Cathepsin L participates in dynorphin
and opioid neuropeptide production in brain, illustrated by
protease gene knockout and expression. A. MINOKADEH*;
L. FUNKELSTEIN; T. TONEFF; C. MOSIER; M. BEINFELD;
T. REINHECKEL; C. PETERS; J. ZADINA; V. HOOK.
Tulane Univ., Univ. of Calif., San Diego, Tufts Univ., Inst. fur
Molekulare Medizin und Zellforschung, Albert-Ludwigs Univ.,
SE Louisiana Veterans Hlth. Care Syst.
8:00 F37 140.21 Bidirectional regulation of NMDA receptor
signaling by type 7 serotonin receptors. M. A. BEAZELY*;
J. KRUK; M. VASEFI; K. YANG. Univ. of Waterloo, Univ. of
Toronto.
POSTER
141. LTD
Theme B: Neural Excitability, Synapses, and Glia:
Cellular Mechanisms
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 F38 141.1 Chronic adolescent methylphenidate
administration causes behavioral alterations and synaptic
changes in the striatum of C57BL/6J mice. N. CAPIK; D. M.
LOVINGER*; Y. MATEO. Natl. Inst. Alcohol Abuse & Alcohol.
9:00 F39 141.2 Involvement of actin-myosin interaction
in cerebellar long-term depression. T. TATSUKAWA*; S.
NAGAO; K. YAMAGUCHI. RIKEN BSI.
10:00 F40 141.3 Bistable induction of cerebellar long-term
depression in a stochastic model. G. ANTUNES*; E. DE
SCHUTTER. OIST, Univ. of Antwerp.
11:00 F41 141.4 Characterization of a novel form of long-
term depression at GABAergic synapses onto dopaminergic
neurons in the ventral tegmental area. M. DACHER*; F. S.
NUGENT. Uniformed Service Univ. Hlth. Sci.
8:00 F42 141.5 Insulin induces endocannabinoid-
mediated long-term depression of ventral tegmental area
dopaminergic neurons. G. LABOUEBE*; J. C. Y. WONG; S.
L. BORGLAND. Univ. of British Columbia.
9:00 F43 141.6 Purkinje cell NMDA receptors assume a
key role in synaptic gain control in the mature cerebellum.
C. PIOCHON; C. LEVENES; G. OHTSUKI; C. R. HANSEL*.
Univ. of Chicago, Univ. Pierre et Marie Curie, Univ. Chicago.
10:00 F44 141.7 Developmental plasticity of GABAergic
synapses in medial vestibular nucleus of rats. H. HU*; S.
K. LAI; C. H. LAI; D. K. Y. SHUM; Y. S. CHAN. The Univ.
of Hong Kong, Res. center of Heart, Brain, Hormone, Hlth.
Aging.
11:00 F45 141.8 State-dependent LTD of GABAergic
transmission onto striatal medium spiny neurons. B. N.
MATHUR*; D. M. LOVINGER. NIAAA/NIH.
8:00 F46 141.9 Acute ethanol exposure impairs long-term
depression in the CA1 but not the DG of the hippocampus in
vitro. J. L. HELFER*; J. D. SHIN; B. R. CHRISTIE. Univ. of
Victoria.
9:00 F47 141.10 Intracellular Ca2+ profiles and the roles of
individual Ca2+ sources in induction of LTD in visual cortex. I.
ISMAILOV*; D. KALIKULOV; M. J. FRIEDLANDER. Baylor
SLIDE
Coll Med.
10:00 F48 141.11 Corticosterone-induced regulation of
synaptic plasticity is related to dynamic changes of NMDA
receptors. Y. C. TSE*; R. C. BAGOT; T. P. WONG. Douglas
Mental Hlth. Univ., McGill Univ.
16  |  Society for Neuroscience
11:00 F49 141.12 A homosynaptic NMDAR-mediated
late-phase LTD in aged mice is kinase-independent, but
mediated by protein phosphatase 1 (PP1). T. AHMED; R.
D’HOOGE; D. K. BALSCHUN*. Katholieke Univ. Leuven.
8:00 F50 141.13 Agonist-induced silencing of ampa
receptor-mediated synaptic transmission at developing, but
not mature, ca3-ca1 synapses. P. T. WASLING*; E. HANSE.
Inst. Neurosc. and Physiol, Neurophysiol.
9:00 F51 141.14 TRPV3 is required for long-term
depression at synapses on hippocampal interneurons. T. E.
BROWN*; J. A. KAUER. Brown Univ.
10:00 F52 141.15 Burst firing-induced long-term
enhancement of CA1 pyramidal cell output due to
endocannabinoid-mediated disinhibition. T. J. YOUNTS*; P.
E. CASTILLO. Albert Einstein Col. of Med.
11:00 F53 141.16 Janus kinase 2 is involved in NMDA
receptor-dependent LTD in rat hippocampus. C. S.
NICOLAS; S. PEINEAU; Z. CSABA; G. SEATON; P.
DOURNAUD; S. M. FITZJOHN; Z. A. BORTOLOTTO; K.
CHO; G. L. COLLINGRIDGE*. Univ. of Bristol Sch. Med.
Sci., INSERM, U676, Univ. Paris 7, Henry Wellcome L.I.N.E.,
Dept. of Brain and Cognitive Sci., Brain Res. Center, Univ. of
British Columbia.
8:00 F54 141.17 Long-term depression caused by low
frequency stimulation revealed in paired recordings of
pyramidal cells of layer II/III of rat barrel cortex. L. LI; J.
CHOY; C. STRICKER*. Xi’an Jiaotong Univ., JCSMR, ANU,
ANUMS / JCSMR, ANU.
9:00 F55 141.18  •  Assessment of chemically-induced
long-term depression in mouse models of Down syndrome.
J. J. SCOTT-MCKEAN*; K. E. SMITH; M. L. DELL’ACQUA;
A. C. S. COSTA. Univ. Colorado Denver.
10:00 F56 141.19 Muscarinic modulation of the coupling of
NR2B-containing NMDARs to LTD induction. T. BARTLETT*;
Y. T. WANG. Univ. of British Columbia.
11:00 F57 141.20 Long term depression of nmda receptor-
mediated transmission in the ca1 region of the hippocampus.
P. FARROW; J. T. BROWN*; Z. BASHIR; S. FITZJOHN.
Univ. Bristol.
8:00 F58 141.21 Long-term depression at perforant
path-dentate gyrus synapses in vivo is observed in
lateral perforant path responses. J. GONZALEZ*; D. M.
VILLARREAL; J. B. BRISCOE; T. TROYER; B. E. DERRICK.
Univ. of Texas San Antonio, UTSA Cajal Neurosciences Inst.
9:00 G1 141.22 mGluR5 expression is required for NMDA
receptor-dependent long-term depression in layer IV of
mouse visual cortex. M. SIDOROV*; M. F. BEAR. MIT.
10:00 G2 141.23 Acetylcholine modulates activity-
dependent long-term synaptic depression in layer V neurons
in the medial prefrontal cortex. D. A. CARUANA*; E. C.
WARBURTON; Z. I. BASHIR. Univ. of Bristol.
11:00 G3 141.24 Role of constitutively cycling glur2
ampars in mglur- and nmdar- dependent ltd. T. M.
CASIMIRO*; K. G. SOSSA; R. C. CARROLL. AECOM, Col.
Of Notre Dame of Maryland, Albert Einstein Col. of Med.
8:00 G4 141.25 Selective manipulation of long-term
depression effectively modulates ocular dominance plasticity
in both juvenile and adult mice. K. YANG*; W. XIONG; L.
KOJIC; Y. WANG; M. S. CYNADER. Brain Res. Ctr.
9:00 G5 141.26 Cdk5 regulates the ubiquitination of PSD-
95 in neurons. M. A. MORABITO*; M. BIANCHETTA. Univ.
Massachusetts Med. Sch.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
POSTER
142. Spike Timing-Dependent Plasticity
Theme B: Neural Excitability, Synapses, and Glia:
Cellular Mechanisms
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 G6 142.1 When two is not enough: Functional
consequences of a triplet model of spike time-dependent
plasticity. J. GJORGJIEVA*; C. CLOPATH; J. AUDET; J.
PFISTER. Univ. of Cambridge, Univ. Paris Descartes, Ecole
Polytechnique Fédérale de Lausanne.
9:00 G7 142.2 Emergence of Bayesian computation in
generic motifs of cortical microcircuits. L. BUESING; J. BILL;
B. NESSLER; S. HABENSCHUSS; W. MAASS*. Graz Univ.
Technol.
10:00 G8 142.3 STDP can generate long-tail weight
distributions. M. GILSON*; T. FUKAI. Lab. For Neural Circuit
Theory, Riken BSI.
11:00 G9 142.4  •  A computational model of the two phase
theory of classical conditioning applied to an autonomous
behaving robot. M. P. INDERBITZIN*; I. HERREROS-
ALONSO; P. F. M. J. VERSCHURE. SPECS - UPF, Catalan
Inst. of Advanced Res. ICREA.
8:00 G10 142.5 Driving synaptic modifications in
prefrontal cortex: Role of d1/d2 synergism in separate
circuits. T. XU*; W. YAO. Harvard Med. Sch.
9:00 G11 142.6 The effect of cholinergic inputs on
STDP in hippocampal CA1 network. E. SUGISAKI*; Y.
FUKUSHIMA; H. HAYAKAWA; M. TSUKADA; T. AIHARA.
Tamagawa Univ. Grad. Sch. of Engin., Tagamawa Univ.
Brain Sci. Inst.
10:00 G12 142.7 Bidirectional modification of hippocampal
mossy fiber driven CA3 output via burst timing-dependent
NMDAR plasticity. D. L. HUNT; P. E. CASTILLO*. Albert
Einstein Col. of Med., Albert Einstein Coll Med.
11:00 G13 142.8 Synaptic plasticity of cortical neurons
in vitro induced by wake-like and sleep-like patterns of
stimulation. J. SEIGNEUR*; I. TIMOFEEV. Laval Univ.
8:00 G14 142.9 The efficiency of spike timing-dependent
plasticity in CA1 region of acute hippocampal slices
correlated with changes in excitability of pyramidal neurons.
E. EDELMANN*; V. LESSMANN. Otto-von-Guericke Univ.
9:00 G15 142.10 Alpha-1 adrenergic receptors habilitate
a stimulus-specific decrease in primary visual processing
of adult mice. M. TREVINO VILLEGAS*; S. FREY; G.
DOGBEVIA; R. SPRENGEL; M. T. HASAN; G. KÖHR. Max
Planck Inst.
10:00 G16 142.11  •  Interaction between temporal
information of dendritic inputs in hippocampal CA1 neurons.
M. KONDO; T. KITAJIMA; M. TSUKADA; T. AIHARA*.
Tamagawa Univ., Yamagata Univ.
11:00 G17 142.12 Calcium dynamics underlying the
induction of inhibitory synaptic plasticity. T. BALENA*; M.
WOODIN. Univ. of Toronto.
8:00 G18 142.13 Integration of glutamatergic inputs to
striatal medium spiny neurons as a function of dendritic
anatomy. J. L. PLOTKIN*; D. J. SURMEIER. Northwestern
Univ.
9:00 G19 142.14 Mechanism underlying the reversal of
spike timing-dependent long-term depression to potentiation
by external input during theta-frequency oscillation. J.
KWAG*; O. PAULSEN. Korea Univ., Univ. of Cambridge.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
10:00 G20 142.15 Neuromodulators control spike-timing-
dependent synaptic plasticity in excitatory inputs to fast-
spiking interneurons. S. HUANG*; A. KIRKWOOD. Johns
Hopkins Univ.
11:00 G21 142.16  •  Characterization of bilateral spike timing
dependent plasticity specifically appeared during the 2nd
postnatal week at L4-L2/3 synapses in the mouse barrel
Sun. AM
cortex. C. ITAMI*; F. KIMURA. Saitama Med. Univ., Osaka
Univ. Grad. Sch. Med.
8:00 G22 142.17 Pairing of dendritic excitation and
backpropagated spike results in LTP in CA1 in vivo. T. K.
FUNG; L. LEUNG*. Univ. Western Ontario.
POSTER
143. Homeostatic Plasticity
Theme B: Neural Excitability, Synapses, and Glia:
Cellular Mechanisms
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 G23 143.1  •  Metaplasticity of corticospinal and
inhibitory neurons in human motor cortex. T. MURAKAMI*;
F. MULLER-DAHLHAUS; M. LU; U. ZIEMANN. J.W. Goethe
Univ.
9:00 G24 143.2 The role of the AMPA receptor subunit
GluR2 and GRIP1 in synaptic scaling. M. A. GAINEY*; G. G.
TURRIGIANO. Brandeis Univ.
10:00 G25 143.3 Parallel homeostatic changes in evoked
and spontaneous activity in cortical organotypic slice
cultures. A. GOEL*; D. V. BUONOMANO. UCLA.
11:00 G26 143.4 Roles of CaV2.1 and Eph/Ephexin
signaling during synaptic homeostasis. C. A. FRANK*; G. W.
DAVIS. Univ. of Iowa, Univ. of California, San Francisco.
8:00 G27 143.5 Presynaptic scaling: a novel homeostatic
scaling plasticity. S. KARUNANITHI*; Y. LIN; J. M.
GONZALEZ; W. A. DAY. Charles Sturt Univ., Univ. of
Arizona.
9:00 G28 143.6 Molecular mechanisms of synaptic
homeostasis: Dysbindin, the BLOC-1 complex, and links to
neurological disease. D. K. DICKMAN*; G. W. DAVIS. UCSF.
10:00 G29 143.7 Rapid homeostatic modulation of intrinsic
excitability in hippocampal neurons. A. J. MCCARTNEY*; M.
A. SUTTON. Univ. of Michigan.
11:00 G30 143.8 PKM zeta inhibition prevents the
metaplastic change induced by conditioned taste aversion on
insular cortex long-term potentiation in vivo. S. ANGELES-
DURAN; L. F. RODRIGUEZ-DURAN; M. L. ESCOBAR*. Fac
Psicol, UNAM.
8:00 G31 143.9  •  Activity-dependent homeostatic
regulation of AMPA receptor localization at single synapses.
Q. HOU*; H. MAN. Boston Univ.
9:00 G32 143.10 Caclium-dependent but action potential-
independent BCM-like metaplasticity in the hippocampus. S.
HULME; O. JONES; W. C. ABRAHAM*. Univ. of Otago.
10:00 G33 143.11 Homeostatic processes stabilize hebbian
learning in the visual cortex. G. MATO*; R. ROSSI-POOL.
CNEA, CONICET.
11:00 G34 143.12 Neurotrophic modulation of subsequent
synaptic plasticity induced by high-frequency stimulation
on hippocampal mossy fiber. L. RAMOS-LANGUREN*; A.
GOMEZ-PALACIO-SCHJETNAN; M. L. ESCOBAR. Fac
Psicol,UNAM.
Neuroscience 2010  |  Sunday AM  |  17 
 8:00 G35 143.13 “State-dependent” homeostatic plasticity
gated by local presynaptic activity is dependent upon the
ubiquitin proteasome system. S. K. JAKAWICH*; M. J.
STRONG; M. A. SUTTON. Univ. of Michigan.
9:00 G36 143.14 Activity-regulated cytoskeletal protein
Arc translocation to the nucleus is increased with
prolonged BDNF application and functions in the nucleus
to regulate synaptic strength through decreasing levels of
AMPA receptor subunit GluR1. E. KORB*; C. PEEBLES;
R. DELGADO; K. LOVERO; S. FINKBEINER. Univ. of
California, San Francisco, Gladstone Inst. of Neurolog. Dis.
10:00 G37 143.15 Proteasome-dependent presynaptic
neuroprotection against hypoxic damage in hippocampal
neurons. J. HOGINS; D. CRAWFORD; S. J. MENNERICK*.
Washington Univ.
11:00 G38 143.16 Synaptic scaling and the development of
a motor network. L. D. KNOGLER*; M. LIAO; P. DRAPEAU.
Univ. of Montreal.
8:00 G39 143.17 Elevated postsynaptic spiking induces
homeostatic upregulation of inhibitorysynaptic transmission.
Y. PENG; S. ZENG; X. YU*. Inst. of Neurosci.
9:00 G40 143.18 Synaptic input frequency dependent
hippocampal synaptic strength compensation in vivo. D.
MIYAMOTO*; N. MATSUKI; H. NOMURA. The Univ. of
Tokyo.
10:00 G41 143.19 Unraveling presynaptic mechanisms
responsible for homeostatic modulation of synaptic
transmission. M. MUELLER*; E. PYM; A. TONG; G. W.
DAVIS. UCSF.
11:00 G42 143.20 Homeostatic regulation of presynaptic
function by dendritic mTORC1. F. E. HENRY*; A. S. PEREZ;
R. NEELY; K. INOKI; M. A. SUTTON. Univ. Michigan,
Harvard Univ.
8:00 G43 143.21 Homeostatic suppression of synaptic
transmission requires an active zone associated protein
kinase SRPK79D. G. W. DAVIS*; E. L. JOHNSON; A.
FRANK; D. K. DICKMAN. Univ. California-SF, UCSF.
9:00 G44 143.22 A hierarchy of cell intrinsic and target-
derived homeostatic signaling. S. B. BERGQUIST; D. K.
DICKMAN; D. BRASIER*; G. W. DAVIS. UCSF.
10:00 G45 143.23 Bi-directional regulation of calcineurin
and homeostatic plasticity. Y. FU; P. CAO; J. ZHAO; G. WU*.
Baylor Col. Med.
11:00 G46 143.24 Activity-dependent regulation of inhibition
via GAD67. C. G. LAU*; V. N. MURTHY. Harvard Univ.
POSTER
144. MicroRNAs in Plasticity
Theme B: Neural Excitability, Synapses, and Glia:
Cellular Mechanisms
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 G47 144.1  •  Role of MicroRNAs in experience-
dependent cortical plasticity. N. MELLIOS*; H. SUGIHARA;
J. CASTRO; A. KUMAR; R. GARCIA; B. KARKI; D.
TROPEA; S. LEVINE; D. EDBAUER; M. SUR. MIT/
SLIDE
Picower Inst. For Learning and Memory, Trinity Col. Dublin,
St James Hosp., Biomicro Ctr. - MIT, German Ctr. for
Neurodegenerative Dis. (DZNE).
18  |  Society for Neuroscience
9:00 G48 144.2 A study on the changes of microRNA
expression profile in rat hippocampal slices during long-
term potentiation (LTP) induction. K. LEE*; S. KIM; M.
CHOI; J. KIM; Y. SUH; H. KIM. #618, Dept. of Life Sciences,
POSTECH, Seoul Natl. Univ. Bundang Hosp.
10:00 G49 144.3 Micro RNA-Seq reveals cocaine-
regulated expression of striatal microRNAs. J. E. EIPPER-
MAINS*; D. D. KIRALY; D. PALAKODETI; R. E. MAINS; B.
A. EIPPER; B. R. GRAVELEY. Univ. of Connecticut Hlth. Ctr.
11:00 G50 144.4 miR-485 regulation of homeostatic
synaptic plasticity. J. E. COHEN*; P. R. LEE; R. D. FIELDS.
NIH, NICHD.
8:00 G51 144.5  •  Endogenous siRNAs and noncoding
RNA-derived small RNAs are expressed in adult mouse
hippocampus and are up-regulated in olfactory discrimination
training. N. R. SMALHEISER*. Univ. Illinois.
9:00 G52 144.6 Regulation of the microRNA RISC during
LTP in the adult rat brain. B. S. PAI; K. WIBRAND; C. R.
BRAMHAM*. Univ. of Bergen.
10:00 G53 144.7 Targeting of the ARPC3 actin nucleation
factor by microRNAs 29a and 29b: Role in neuronal
structural plasticity induced by synaptic activity. G. LIPPI*;
J. STEINERT; E. TAYLOR; R. FIORE; I. FORSYTHE; G.
SCHRATT; M. ZOLI; P. NICOTERA; K. W. YOUNG. UCSD,
MRC, Univ. of Heidelberg, Univ. of Modena and Reggio
Emilia, DZNE.
11:00 G54 144.8 Microrna regulation of nicotinic
acetylcholine receptor expression. E. M. HOGAN*; M.
D. SCOFIELD; Z. MOU; L. LIU; A. R. TAPPER; P. D.
GARDNER. Univ. of Massachusetts Med. Sch.
8:00 G55 144.9 MicroRNA expression in rat brain
exposed to repeated inescapable shock: Differential
alterations in learned helplessness vs. non-learned
helplessness. Y. DWIVEDI*; G. LUGLI; H. S. RIZAVI; H.
ZHANG; V. I. TORVIK; G. N. PANDEY; N. R. SMALHEISER.
Univ. Illinois.
9:00 G56 144.10 Group I metabotropic glutamate receptors
regulate microRNA expression in mouse brain. J. A.
SAUGSTAD*; T. A. LUSARDI; S. J. THOMPSON. RS Dow
Neurobio. Labs, Legacy Hlth.
10:00 G57 144.11 Profiling microRNA expression across
motor neuron injury and disease. K. L. BURGOS*; A. L.
COURTRIGHT; S. E. VILLA; W. S. LIANG; K. R. VAN
KEUREN-JENSEN. Translational Genomics Res. Inst.
11:00 G58 144.12 DGCR8-dependent microRNA biogenesis
and cortical neuron function. R. HSU; C. M. SCHOFIELD*;
C. DELA CRUZ; R. BLELLOCH; E. ULLIAN. UCSF.
8:00 H1 144.13 A novel pathway regulates memory and
plasticity via SIRT1 and miR-134. W. WANG*; J. GAO; Y.
MAO; J. GRÄFF; J. GUAN; G. MAK; D. KIM; S. SU; L. TSAI.
MIT, Howard Hughes Med. Inst., Broad Inst., Whitehead Inst.
for Biomed. Res.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
POSTER
145. Alzheimer’s Disease: Animal and Cellular Models
Theme C: Disorders of the Nervous System
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 H2 145.1 Phenotypic characterization of miR-29
family mouse knockout models. A. S. PAPADOPOULOU;
L. SERNEELS; W. MANDEMAKERS; S. HEBERT; P.
CALLAERTS*; B. DESTROOPER. Lab. for the research of
Neurodegenerative disease, Ctr. de Recherche de CHUQ,
Lab. of Developmental Genet.
9:00 H3 145.2 Differential amyloid distribution
suggesting an interaction between stroke and amyloid. B. E.
KUCZYNSKI*; F. SHARP; C. DECARLI. Univ. of California,
UC Davis.
10:00 H4 145.3  •  Developing an embryo/larval dosing
paradigm for medium-throughput screening of compounds
in Drosophila melanogaster models of neurodegenerative
diseases. L. DIGGINS*; M. B. MAHONEY; P. O’NEILL;
M. FOOS; M. FITZPATRICK; D. KEEFE; E. LUND; J.
MEDIATORE; J. SYMONDS; A. VILLALUZ; C. M. SINGH.
Vitruvean, LLC.
11:00 H5 145.4 Improvement of attention but not
spatial working memory by guanfacine in aged non-human
primates. E. DECAMP*; K. CLARK; J. S. SCHNEIDER.
Thomas Jefferson Univ.
8:00 H6 145.5 Decrease of Arc protein expression and
delay of memory acquisition by immunolesion. D. JEONG*;
D. LEE; J. CHANG. Yonsei Univ. Coll. of Med.
9:00 H7 145.6 Loss of forebrain, but not brainstem,
cholinergic nuclei correlate with cognitive impairment in a
rodent model of diencephalic amnesia. S. J. ANZALONE*; R.
P. VETRENO; L. M. SAVAGE. Binghamton univ.
10:00 H8 145.7 Mild reductions in a mitochondrial
enzyme impact cellular calcium regulation. G. E. GIBSON*;
H. CHEN; H. XU; T. DENTON; Q. SHI. Weill Cornell Med.
College/Burke Med. Res. Inst., Eastern Washington Univ.
11:00 H9 145.8 The ameoliorating effect of ethylacetate
fraction from angelica keiskei koid. on scopolamine-induced
memory impairment in mice. S. OH*; H. NAM; G. LEE; J.
JUNG; J. JANG. Col. of Oriental Medicine, Daegu Hanny
Univ.
8:00 H10 145.9 Melatonin has neuroprotective actions
in a cellular model of Alzheimer’s disease. G. O’NEAL-
MOFFITT*; A. PATEL; C. CAO; P. C. BRADSHAW; X. LIN;
J. OLCESE. Florida State Univ. Col. of Med., Univ. of South
Florida.
9:00 H11 145.10 Adult neurogenesis is increased in
hippocampus of rat with chronic cerebral hypoperfusion. B.
CHOI; D. CHOI*; S. HAN; H. KIM; J. HAN. Kon-Kuk Univ,
IBST, Konkuk Univ.
10:00 H12 145.11 Investigating cortical axonal transport
in Alzheimer’s disease with MR imaging. L. STRIZICH*;
S. MINOSHIMA; K. MARAVILLA; D. J. CROSS. Univ. of
Washington Sch. of Med.
11:00 H13 145.12 A species difference in hippocampal
astrocyte pathology: Rat vs. mouse. J. K. YOUNG*; K. F.
MANAYE. Howard Univ. Coll of Med.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
8:00 H14 145.13  •  Human neural stem cells genetically
modified to overexpress human nerve growth factor gene
improve memory in mouse model of dementia. H. LEE*; E.
KO; Y. KO; S. KIM. Chung-Ang Univ. Col. of Med., Div. of
Neurology, Dept. of Medicine, UBC Hospital, Univ. of British
Columbia, Col. of Life Sci. and Biotechnology, Korea Univ.
9:00 H15 145.14 MRI and histological evaluation of focal
Sun. AM
brain lesions in the Streptozotocin-treated rat. A. KRASKA*;
E. BOURRIN; M. SANTIN; F. PETIT; M. CHAIGNEAU; M.
GUILLERMIER; N. JOSEPH-MATHURIN; P. HANTRAYE; P.
LESTAGE; M. DHENAIN. CEA, Inst. de Recherches Servier,
URA CEA-CNRS 2210 MIRCen.
10:00 H16 145.15 A mouse model of cerebral hypoperfusion
displays Alzheimer’s disease-like neuropathology. R. LOVE-
KASISCHKE*; A. SAGARE; R. D. BELL; R. DEANE; B.
ZLOKOVIC. Univ. of Rochester Med. Ctr.
11:00 H17 145.16 Generation of disease-specific induced
pluripotent stem cells from Alzheimer’s disease patients. N.
YAHATA*; H. INOUE; S. KITAOKA; K. TSUKITA; T. KONDO;
E. NAOHIRO; I. ASAKA; K. TAKAHASHI; T. NAKAHATA; S.
KAWAKATSU; R. TAKAHASHI; T. ASADA; S. YAMANAKA.
Ctr. for iPS Cell Res. and Application, Kyoto Univ., Grad.
school of Med., Kyoto Univ., Dept. of Psychiatry, Yamagata
Univ. Sch. of Med., Dept. of Neuropsychiatry, Univ. of
Tsukuba.
8:00 H18 145.17  •  A c-terminal peptide derived from
acetylcholinesterase has novel behavioural, biochemical and
histological effects in vivo. L. C. JOHNSTON*; C. E. BOND;
S. A. GREENFIELD. Univ. of Oxford.
9:00 H19 145.18 Analyzing alterations in the
catecholamine neurotransmitters norepinephrine and
dopamine: Implications for development of Alzheimer’s
pathology in a non-human primate. K. B. DUFFY*; K.
HAGELIN; G. P. TINKLER; D. K. INGRAM; J. A. MATTISON;
M. OTTINGER. Dept. of Animal Science, Univ. of Maryland,
NIA/NIH, Univ. of Iowa, Louisiana State Univ.
10:00 H20 145.19 Forebrain neuron specific Atg7-deficient
mice display late-onset neurodegeneration and learning
impairment. K. INOUE*; J. RISPOLI; A. ABELIOVICH. Col. of
Physicians & Surgeons, Columbia Univ.
11:00 H21 145.20 Reduced voltage-gated sodium channels
in inhibitory interneurons - A potential mechanism of network
synchronization in Alzheimer’s disease. J. J. PALOP*; L.
VERRET; E. O. MANN; K. HO; M. T. THWIN; D. H. KIM; I.
COBOS; E. MASLIAH; I. MODY; L. MUCKE. Gladstone and
UCSF, UCLA, UCSD.
8:00 H22 145.21   The neuroprotective effect of
decreased luteinizing hormone on astrocytic pathology in an
Alzheimer’s disease model. T. SODERBORG; M. BURKE; J.
COHEN; J. E. THORNTON*. Oberlin Col.
POSTER
146. Motor Neuron Pathology Disease
Theme C: Disorders of the Nervous System
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 H23 146.1 Genetic analysis of SMN loss of function
defects in C. elegans. A. C. HART*; M. DIMITRIADI; G.
KALLOO. Brown Univ.
9:00 H24 146.2 Characterization of new mouse models
of SMA. M. A. OSBORNE; C. M. LUTZ*; M. WINBERG; D.
KOBAYASHI; T. ALLEY; K. HUEBSCH; D. LIU. The Jackson
Lab., SMA Fndn.
Neuroscience 2010  |  Sunday AM  |  19 
 10:00 H25 146.3 The effect of prolonged fluoxetine
treatment on an ALS mouse model. J. E. SCHUSTER*; R.
FU; C. J. HECKMAN. Northwestern Univ.
11:00 H26 146.4 Development and characterization of
inducible wild-type and mutant TDP-43 transgenic mice.
I. N. WEGORZEWSKA; S. BELL; D. MA; R. H. BALOH*.
Washington Univ.
8:00 H27 146.5 Phenotypic characterization of a new
mouse model (C/C line) of spinal muscular atrophy. Z.
FENG*; K. LING; M. LIN; C. KO. USC.
9:00 H28 146.6 Selective vulnerability of neuromuscular
junctions in the SMNΔ7 mouse model of spinal muscular
atrophy. K. LING*; R. GIBBS; M. LIN; Z. FENG; C. KO. Univ.
of Southern California.
10:00 H29 146.7 Cyclophilin D affects estrogen-dependent
regulation of brain mitochondrial Ca2+ handling in mutant-
SOD1 mice. H. KIM; A. STARKOV; G. MANFREDI*. Weill
Med. Col. Cornell Univ.
11:00 H30 146.8 Disruptions of spatacsin and/or spastizin
functions lead to motor neuron axonal outgrowth defects
in the Danio rerio. E. M. MARTIN*; C. YANICOSTAS;
A. MAOUEDJ; A. BRICE; G. STEVANIN; N. SOUSSI-
YANICOSTAS. CRICM, INSERM/UPMC Umr_s975, NEB.
8:00 H31 146.9 Modifier alleles in SMA mice. C. LUTZ;
M. OSBORNE; D. P. LIU*; K. HUEBSCH; T. ALLEY. The
Jackson Lab.
9:00 H32 146.10 Dysregulated expression of IGFBP-5
causes axonal degeneration and motoneuron cell death in
diabetic neuropathy. C. M. SIMON*; J. GUNNERSEN; B.
HOLTMANN; S. WIESE; S. JABLONKA; M. SENDTNER.
Clin. Inst. of Neurobio., Univ. of Melbourne, Ruhr-University
Bochum.
10:00 H33 146.11 RNA binding mediates neurotoxicity in
the Drosophila transgenic model of TDP-43 proteinopathy. R.
IHARA*; T. HASHIMOTO; Y. NAGATA; T. WAKABAYASHI; H.
TANAKA; Y. HORI; S. TSUJI; E. KURANAGA; M. MIURA; T.
IWATSUBO. Grad. Sch. of Medicine, Univ. of Tokyo, Grad.
Sch. of Pharmaceut. Sciences, Univ. of Tokyo.
11:00 H34 146.12 Motor nerve root pathology in canine
degenerative myelopathy with a mutation in the superoxide
dismutase 1 gene. B. R. MORGAN*.
8:00 H35 146.13 The role of the BH-3 only protein Bid
in the SOD1/G93A mouse model of amyotrophic lateral
sclerosis. B. BREEN*; I. WOODS; M. KING; D. KIERAN; J.
PREHN. Royal Col. of Surgeons In Ireland, AC Immune.
9:00 H36 146.14 Functional characterization of mouse
Tdp-43 point mutations generated by chemical mutagenesis.
T. RICKETTS*; P. FRATTA; P. JOYCE; P. MCGOLDRICK;
R. KENT; L. GREENSMITH; A. ACEVEDO-AROZENA; E.
FISHER. Med. Res. Council, Harwell, Univ. Col. London.
10:00 H37 146.15 Identification of a common critical
developmental time point between SMNΔ7 neonatal and
novel adult mouse models for spinal muscular atrophy. B. F.
EL-KHODOR*; S. RAMBOZ; D. KOBAYASHI; M. WINBERG.
Psychogenics, SMA Fndn.
11:00 H38 146.16 Dopamine D2 receptor function is
compromised in the brain of the methionine sulfoxide
reductase A knockout mouse. D. B. OIEN; A. N. ORTIZ;
SLIDE
R. T. DOBROWSKY; M. A. JOHNSON; B. LEVANT; S. C.
FOWLER; J. MOSKOVITZ*. Univ. Kansas.
20  |  Society for Neuroscience
8:00 H39 146.17 Generation and characterization
of transgenic mice expressing wild-type and mutant
human TDP-43. E. J. SUN*; M. HEFFERAN; C. LAGIER-
TOURENNE; M. POLYMENIDOU; S. LING; M. MARSALA;
D. W. CLEVELAND. Univ. of California San Diego, Ludwig
Inst. for Cancer Res.
9:00 H40 146.18 Attempted rescue of TDP-43 null mice
by wild-type or A315T TDP-43 transgenic mice. N. R.
STALLINGS*; K. PUTTAPARTHI; C. M. LUTHER; J. L.
ELLIOTT. UT Southwestern Med. Ctr.
10:00 H41 146.19 Absence of GluR2 RNA editing induces
slow death of motor neurons in conditional ADAR2 knockout
mice. T. HIDEYAMA; T. YAMASHITA; T. SUZUKI; S. TSUJI;
M. HIGUCHI; P. H. SEEBURG; R. TAKAHASHI; H. MISAWA;
S. KWAK*. Univ. Tokyo Grad Sch. Med., CREST, JST, Univ.
Tokyo Dev of Hlth. Promotion, Keio Univ., Max-Plunck Inst.,
Univ. Kyoto Grad Sch. Med.
11:00 H42 146.20 Elimination of CNS proliferating cells
exacerbates amyotrophic lateral sclerosis disease caused
by superoxide dismutase. J. AUDET*; G. GOWING; R.
PARADIS; G. SOUCY; J. JULIEN. Ctr. De Recherche Du
CHUL, Cedars-Sinai Regenerative Med. Inst.
POSTER
147. Autism: Genetic and Animal Models II
Theme C: Disorders of the Nervous System
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 H43 147.1 Impulsivity and interval timing in mice
lacking the NrCAM gene, a gene associated with autism
spectrum disorder. A. WOODELL*; R. HAMID; M. BUHUSI;
C. V. BUHUSI. Med. Univ. of South Carolina, Col. of
Charleston.
9:00 H44 147.2 The effects of fluoxetine on obsessive-
compulsive and anxiety-like behavior in BDNF over-
expressing mice. K. L. WEIDNER; K. K. CHADMAN*. Col. of
Staten Island, NYS Inst. Basic Res.
10:00 H45 147.3 ITGB3 gene variants double the risk
of autism. R. SACCO*; V. NAPOLIONI; F. LOMBARDI; P.
CURATOLO; B. MANZI; R. MILITERNI; C. BRAVACCIO;
C. LENTI; M. SACCANI; K. FONTAINE; F. ROUSSEAU; P.
LEWIN; A. PERSICO. Univ. Campus Bio-Medico, IRCCS
“Fondazione S. Lucia”, Univ. “Tor Vergata”, II Univ. of Naples,
Univ. “Federico II”, Univ. of Milan, IntegraGen SA Genopole.
11:00 H46 147.4  •  Activation of melanocortin receptors
enhances oxytocin-dependent social cognition in an animal
model relevant to autism. M. E. MODI*; L. J. YOUNG. Emory
Univ., Ctr. for Behavioral Neurosci., Yerkes Natl. Primate Ctr.
8:00 H47 147.5  •  Autistic-like deficits in the Fmr1
mouse model: The relevance of age, sex and the genetic
background. W. E. CRUSIO*; M. GAUDUCHEAU; S.
PIETROPAOLO. CNRS and Univ. Bordeaux I.
9:00 H48 147.6  •  Whole genome brain gene expression in
autism reveals signatures of multiple ongoing processes. M.
L. CHOW; H. LI; C. APRIL; M. WINN; A. WYNSHAW-BORIS;
X. FU; J. FAN; N. SCHORK; E. COURCHESNE*. Univ.
California San Diego, Illumina, Inc, Scripps Genomic Med.,
Univ. of California San Francisco.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
10:00 H49 147.7  •  Positive correlation of 5-HTTLPR
polymorphism of serotonin transporter gene (SLC6A4) with
platelet hyperserotoninemia in autism spectrum disorder has
implications in pharmacogenomics of autism. U. RAJAMMA*;
S. GUHATHAKURTA; S. SINHA; K. P. MOHANAKUMAR.
Manovikas Kendra Rehabil. and Res. Inst. For the
Handicapped, Indian Inst. of Chem. Biol.
11:00 H50 147.8 Impaired synaptic plasticity in
hippocampus of Pten mutant mice. K. TAKEUCHI*; L. F.
PARADA; R. S. ZUKIN. Albert Einstien Col. of Med., Univ. of
Texas Southwestern Med. Ctr.
8:00 H51 147.9 Synaptic proteins and social behavior are
regulated in a sex dependent manner in MTHFR deficient
mice treated with Vigabatrin. H. M. GOLAN*; E. BLUMKIN;
T. LEVAV-RABKIN; D. GALRON. Ben-Gurion Univ. of the
Negev, Soroka medical center.
9:00 H52 147.10  •  Rat models to study genetic disorders
of cognition and behavior. V. BROWN-KENNERLY*; J.
BOOKS; D. JI; L. LITTLE; Y. WU; E. WEINSTEIN; X. CUI.
Sigma Advance Genet. Engin. Lab.
10:00 H53 147.11 Neuroligin-3 R451C mutation affects
somatic and neurobehavioral development in mice. S.
YANG*; G. LONART. Eastern Virginia Med. Sch.
11:00 H54 147.12 A Dab1-lacZ reporter reveals CNS
lamination defects in a mouse model for autism. B. MULLEN;
E. KHIALEEVA; E. M. CARPENTER*. UCLA Sch. Med.
8:00 H55 147.13 Heavy metals and neuroimmune
modulation: Importance in autism? R. L. DAVIS; J. CURTIS;
D. BUCK; A. N. HOOD; D. R. WALLACE*. Oklahoma State
Univ. Ctr. for Hlth. Sci.
9:00 H56 147.14   Environmental enrichment does not
impact the emergence of repetitive behavior in the C58/J
inbred strain, a novel mouse model of autistic-like behavior.
H. WAHBY; M. COOL; C. HESS; A. JOHNSON; B. C.
RYAN*. Univ. of Redlands.
10:00 H57 147.15 Increased glutamatergic neuronal
differentiation in prenatal valproic acid model of autism is
mediated by activation of Pax6 in Sprague-Dawley rat. K.
KIM*; H. GO; S. LEE; C. CHOI; C. SHIN; K. KO. Seoul Natl.
Univ., Konkuk Univ.
11:00 H58 147.16 Altered social interactions, perseveration,
and enhanced fear conditioning in a Timothy Syndrome
mouse model of autism. P. L. BADER*; M. FAIZI; S. F.
OWEN; M. R. TADROSS; R. W. ALFA; G. C. L. BETT; R. W.
TSIEN; M. SHAMLOO; R. L. RASMUSSON. Stanford Univ.,
SINTN, Univ. at Buffalo.
POSTER
148. Rett Syndrome
Theme C: Disorders of the Nervous System
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 H59 148.1  •  Mecp2-regulated miR-137 governs
neuronal maturation. Z. TENG*; R. D. SMRT; K. E.
SZULWACH; R. L. PFEIFFER; X. LI; W. GUO; M.
PATHANIA; Y. LUO; M. C. WILSON; A. BORDEY; P. JIN; X.
ZHAO. Univ. of New Mexico, Emory Univ. Sch. of Med., Yale
Univ. Sch. of Med.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
9:00 H60 148.2 Alterations in dendritic morphology and
connectivity induced by overexpression of MeCP2: In vivo
imaging studies. S. MARSHAK; M. M. MEYNARD; Y. A.
DE VRIES; A. H. KIDANE; S. COHEN-CORY*. Univ. of
California Irvine.
10:00 H61 148.3 Altered morphology of layer 5
pyramidal neurons in a Rett Syndrome mouse model. K. R.
Sun. AM
DELANEY*; D. STUSS; L. RIETVELD. Univ. of victoria.
11:00 H62 148.4 The temporal course of development of
dendrite pathology in the MeCP2 A140V “knock-in” mutant
mouse. V. NARAYANAN*; G. M. JENTARRA; S. S. OLFERS;
S. G. RICE; S. NAIDU. Barrow Neurol Inst., Barrow
Neurolog. Inst., Kennedy Krieger Inst.
8:00 H63 148.5 Altered cardiac rhythm in a mouse
model of Rett syndrome. M. TATALOVIC; D. M. KATZ; D.
L. KUNZE*. MetroHealth Campus, Case Western Reserve
Univ.
9:00 H64 148.6 Gradual morphological and functional
alterations in the substantia nigra pars compacta of the
Mecp2-null mouse. N. PANAYOTIS*; M. PRATTE; A.
BORGES-CORREIA; A. GHATA; L. VILLARD; J. ROUX.
Inserm U.910 / Aix-Marseille Univ.
10:00 H65 148.7 Enhanced hypoxia susceptibility of
MeCP2-deficient mouse brainstem. M. MÜLLER; J. L.
ZIMMERMANN; M. KRON; F. FUNKE*. Univ. of Goettingen.
11:00 H66 148.8 Functional evaluation of MECP2 gene
therapy vectors in differentiated neurons. R. ZACHARIAH; C.
OLSON; M. RASTEGAR*. Univ. of Manitoba.
8:00 H67 148.9 Proteomic identification of co-factors for
the methyl-CpG binding protein, MeCP2. K. TSUJIMURA*; Y.
FUKAO; M. FUJIWARA; A. SUZUKI; K. NAKASHIMA. Nara
Inst. of Sci. and Technol.
9:00 H68 148.10 Disrupted synaptic scaling in an RNAi
model of Rett syndrome. M. P. BLACKMAN*; S. B. NELSON;
G. G. TURRIGIANO. Brandeis Univ.
10:00 H69 148.11 Characterization of the effects of MeCP2
on signaling pathways in Rett syndrome using Drosophila
and mammalian model systems. A. GAMLIEL*; T. R.
GROSSMAN; E. BIER; M. G. ROSENFELD. UCSD.
11:00 H70 148.12 Modulation of synaptic plasticity in
a mouse model of Rett syndrome. S. WENG*; M. E. S.
BAILEY; S. COBB. Fac. of Biomed. & Life Sciences, Univ. of
Glasgow.
8:00 I1 148.13 Loss of histone deacetylases 1 and 2
in postnatal neurons in forebrain is deleterious and leads
to abnormal behavior. M. ADACHI*; M. MAHGOUB; A. E.
AUTRY; L. M. MONTEGGIA. Univ. Texas Southwestern
Med. Ctr.
9:00 I2 148.14 Expression of MeCP2 in the hindbrain is
critical for autonomic function and survival. C. S. WARD*; E.
M. ARVIDE; H. Y. ZOGHBI; J. L. NEUL. Baylor Col. of Med.
POSTER
149. Angelman and Other Neurodevelopmental Disorders
Theme C: Disorders of the Nervous System
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 I3 149.1 Activation of the Rho/ROCK pathway via
lysophosphatidic acid (LPA) receptors in fetal hydrocephalus.
Y. C. YUNG*; J. CHUN. The Scripps Res. Inst., UC San
Diego Sch. of Med.
Neuroscience 2010  |  Sunday AM  |  21 
 9:00 I4 149.2 A small molecule screening approach for
identifying Angelman syndrome therapeutics. H. HUANG*;
J. A. ALLEN; J. MIRIYALA; M. J. ZYLKA; B. L. ROTH; B. D.
PHILPOT. UNC Chapel Hill.
10:00 I5 149.3 Disrupted thalamic physiology in
Angelman syndrome - The role of GABAergic signaling. C.
WEITLAUF; R. JAWA; L. L. HERRINGTON; M. D. GRIER; A.
H. LAGRANGE; K. F. HAAS*. Vanderbilt Univ.
11:00 I6 149.4 Heterotopia formation and aberrant
neuronal migration during cortical formation through
lysophosphatidic acid (LPA) signaling. K. E. PARK*; Y. C.
YUNG; M. LIN; J. CHUN. The Scripps Res. Inst., UC San
Diego.
8:00 I7 149.5  •  In vivo visual cortex plasticity in a mouse
model of Angelman syndrome. T. RIDAY*; B. PHILPOT. UNC
Chapel Hill.
9:00 I8 149.6 Alteration of intrinsic properties and
expression of related proteins in the CA1 pyramidal neurons
of the Angelman syndrome model mice. H. KAPHZAN*;
J. JUNG; S. BUFFINGTON; M. N. RASBAND; E. KLANN.
NYU, Baylor Col. of Med.
10:00 I9 149.7 Lack of LTP consolidation in a mouse
model of Angelman syndrome is associated with impaired
cytoskeletal reorganization. M. BAUDRY; E. KRAMAR;
Y. HSU; G. LIAO; X. XU; A. CLAUSEN; G. LYNCH; C. M.
GALL; X. BI*. USC, UCI, Western Univ. Hlth. Sci.
11:00 I10 149.8 Neocortical circuit dysfunction in a mouse
model of angelman syndrome. M. WALLACE*; B. PHILPOT.
Univ. of North Carolina.
8:00 I11 149.9 Efficacy of novel therapeutics in an
Angelman syndrome mouse model. J. L. DAILY*; K. NASH;
S. BENNETT; E. WEEBER. Univ. South Florida.
9:00 I12 149.10 Ube3a isoform #1, unlike #2 and #3, is
enzymatically inactive and fails to accumulate in the nucleus
of neurons. S. E. SMITH*; Z. JIN; M. P. ANDERSON.
Harvard Med. Sch. and BIDMC.
10:00 I13 149.11 Activity-dependent expression of the
UBE3A gene responsible for Angelman syndrome. I.
FILONOVA*; J. TROTTER; J. ROGERS; S. DINDOT; E.
J. WEEBER. Univ. of South Florida / Johnnie B Byrd Sr
Alzheimer’s Ctr. & Res. In, Texas A&M Univ.
POSTER
150. Epilepsy: Networks
Theme C: Disorders of the Nervous System
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 I14 150.1 Cell type-specific processes regulate
gating behavior in the dentate gyrus. E. M. GOLDBERG*; H.
TAKANO; D. A. COULTER. Children’s Hosp. of Philadelphia.
9:00 I15 150.2  •  Block of T-type calcium channels of
thalamocortical neurones by TTA-P2 does not suppress
absence seizures. G. ORBAN; F. DAVID; G. DI GIOVANNI;
D. W. COPE; K. BOWLES; V. N. UEBELE; J. J. RENGER;
R. C. LAMBERT; N. LERESCHE*; V. CRUNELLI. Sch. of
Biosci., UPMC-CNRS, Merck Res. Labs.
SLIDE
22  |  Society for Neuroscience
10:00 I16 150.3 Ictal neocortical slow rhythms and loss
of consciousness in temporal lobe epilepsy patients. D. J.
ENGLOT*; L. YANG; H. HAMID; N. DANIELSON; X. BAI;
A. MARFEO; L. YU; A. GORDON; M. J. PURCARO; J. E.
MOTELOW; R. AGARWAL; D. J. ELLENS; J. D. GOLOMB;
M. C. F. SHAMY; K. VIVES; D. D. SPENCER; S. S.
SPENCER; C. SHEVON; H. P. ZAVERI; H. BLUMENFELD.
Yale Univ., New York Univ.
11:00 I17 150.4 Spatiotemporal dynamics of epileptiform
thalamic oscillations. M. KLEIMAN-WEINER*; M. P.
BEENHAKKER; J. R. HUGUENARD. Univ. of Oxford,
Stanford Univ.
8:00 I18 150.5 Phase precession quality does not predict
short term memory performance in a spatial alternation task.
G. RICHARD*; P. LENCK-SANTINI; R. C. SCOTT; G. L.
HOLMES. Dartmouth Med. Sch., Univ. Col. London.
9:00 I19 150.6 Network level manipulation of neuronal
populations via microtechnology. L. A. CIRINELLI*; H. C.
ZERINGUE. Univ. of Pittsburgh, Ctr. for the Neural Basis of
Cognition.
10:00 I20 150.7 Neuromodulations of resting brain
networks by seizure precursors. C. STAMOULIS*; B. S.
CHANG. Harvard Med. School, Dept. of Neurol., Beth Israel
Deaconess Med. Ctr.
11:00 I21 150.8 Oxygen dynamics in the epileptic
hippocampus: From single microdomains to the larger
scale hippocampal formation. J. INGRAM*; C. ZHANG; R.
CRESSMAN; J. XU; S. SCHIFF. Pennsylvania State Univ.,
George Mason Univ.
8:00 I22 150.9 Interaction between hippocampal theta
rhythm and evoked seizures. I. BILANISHVILI*; N. A.
KHIZANISHVILI.; N. G. BUKIA; M. P. BUTSKHRIKIDZE; L.
I. MACHAVARIANI; Z. I. NANOBASHVILI. Inst. of Physiol.,
I.Beritashvili Inst. of Physiol.
9:00 I23 150.10 Analysis of cortical and hippocampal
network activity in Kv7-deficient mice. Q. LE*; A. NEU; R.
EICHLER; D. ISBRANDT. UMC Hamburg-Eppendorf.
10:00 I24 150.11 Multiple single neuron activity recorded
from CA3 hippocampus during spontaneous seizures in an
awake, freely moving rat model of temporal lobe epilepsy. D.
GRASSE*; K. A. MOXON. Drexel Univ.
11:00 I25 150.12 Functional organization of the developing
hippocampus in the absence of GABAergic transmission. T.
MARISSAL*; P. BONIFAZI; I. JORQUERA; G. J. FISHELL;
R. COSSART; Y. BEN-ARI. INMED, INSERM U901, NYU.
8:00 I26 150.13  •  Data assimilation into physiologically
based models of sleep dynamics for tracking and prediction
of rodent state of vigilance. M. SEDIGH-SARVESTANI*; B. J.
GLUCKMAN; S. J. SCHIFF. The Pennsylvania State Univ.
9:00 I27 150.14 Pharmacological modulation of network
activity in an in vitro epilepsy model studied with a perforated
multi-electrode array. A. GONZALEZ-SULSER*; J. WANG;
S. VICINI; G. K. MOTAMEDI; M. AVOLI; R. DZAKPASU.
Georgetown Univ., Montreal Neurolog. Inst.
10:00 I28 150.15 Short duration epileptic discharges show
a distinct phase preference during ongoing hippocampal
slow oscillations. P. H. DE GUZMAN*; F. NAZER; C. T.
DICKSON. Univ. of Alberta.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
11:00 I29 150.16 Flow of synchronized cortical neural
activity during spontaneous seizures in a rat model
of temporal lobe epilepsy. J. CHANG*; F. LUO; Z. LI;
D. WOODWARD. Neurosci Res. Inst. North Carolina,
Psychology Institute, Chinese Acad. of Sci., Stowers Inst. for
Med. Res.
8:00 I30 150.17 Elevated extracellular potassium
mediates pathological network synchronization. G.
FILATOV*; M. BAZHENOV. Univ. of California, Riverside.
9:00 I31 150.18 Interaction of sodium and potassium ion
dynamics mediates termination of seizure-like activity and
post-ictal depression. G. P. KRISHNAN*; M. BAZHENOV.
Univ. of California, Riverside.
10:00 I32 150.19 Computational model of the variability
of interictal spike propagation supports a GABAergic
etiology. W. B. SWIERCZ*; H. R. SABOLEK; K. J. STALEY.
Massachusetts Gen. Hosp., Harvard Med.
11:00 I33 150.20 GABAergic inhibition sculpts the
spread of interictal activity through neural networks. H. R.
SABOLEK*; W. B. SWIERCZ; S. S. CASH; G. HUBERFELD;
R. MILES; K. J. STALEY. Massachusetts Gen. Hosp.,
Harvard Med. Sch., INSERM, Pitié-Salpêtrière Hosp.
8:00 I34 150.21 Specific alterations in interictal activity
and information flow between temporal lobe structures
precede epilepsy onset. C. BERNARD*; L. CHAUVIERE; T.
DOUBLET; A. GHESTEM; F. BARTOLOMEI. INSERM U751.
9:00 I35 150.22 Spatiotemporal dynamics of epileptiform
propagations in human partial epilepsy in vitro. H.
KITAURA*; T. HIRAISHI; H. MURAKAMI; H. MASUDA; M.
FUKUDA; M. OISHI; M. RYUFUKU; Y. FU; H. TAKAHASHI;
S. KAMEYAMA; Y. FUJII; K. SHIBUKI; A. KAKITA. Dept.
Pathology, Brain Res. Institute, Univ.Niigata, Brain Res.
Institute, Univ. of Niigata, Neurosurgery, Nishi-Niigata Chuo
Hosp.
10:00 I36 150.23 Where do spontaneous seizures initiate
in a rat model of temporal lobe epilepsy? I. TOYODA*; M.
BOWER; F. LEYVA; P. S. BUCKMASTER. Stanford Univ.,
The Mayo Clin., Colorado State Univ.
11:00 I37 150.24 Is epileptiform activity initiated within
or adjacent to the developmental cortical malformation of
microgyria? A. BELL*; A. MCQUISTON; K. M. JACOBS.
Virginia Commonwealth Univ.
8:00 I38 150.25 Heterogeneous single-unit spiking
patterns during focal seizures in patients with intractable
epilepsy. J. A. DONOGHUE*; W. TRUCCOLO; L. R.
HOCHBERG; E. N. ESKANDAR; W. S. ANDERSON; J. R.
MADSEN; E. HALGREN; S. S. CASH. Massachusetts Gen.
Hosp., Brown Univ., Brigham & Women’s Hosp., U.C.S.D.
9:00 I39 150.26 Simultaneous optical imaging of cerebral
blood volume and voltage during the initiation, propagation
and termination of neocortical seizures reveals variability in
neurovascular coupling depending on seizure stage. H. MA*;
M. ZHAO; E. DE LA CRUZ; T. H. SCHWARTZ. Weill Med.
Sch. Cornell Univ., Weill-Cornell Med. Col.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
POSTER
151. Epilepsy: Seizure Mechanisms
Theme C: Disorders of the Nervous System
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 I40 151.1 Glutamate release by glioma cells
Sun. AM
induces peritumoral seizures. S. C. BUCKINGHAM*; S.
CAMPBELL; H. SONTHEIMER. Univ. AL - Birmingham.
9:00 J1 151.2 Changes in glial cell density and
phenotype underlie altered glutamate reuptake capacity and
contribute to local excitability in the freeze lesion model of
polymicrogyria. C. G. DULLA*; H. TANI; J. A. BRILL; R. J.
REIMER; J. R. HUGUENARD. Stanford Univ.
10:00 J2 151.3 Biphasic effects of endozepines on
synaptic integration in the thalamic reticular nucleus. C. A.
CHRISTIAN*; U. RUDOLPH; J. R. HUGUENARD. Stanford
Univ., McLean Hospital, Harvard Med. Sch.
11:00 J3 151.4  •  Comparison of acute electrographic
abnormalities in a rat model of hypoxia/hypoxia-ischemia. A.
ZAYACHKIVSKY; M. J. LEHMKUHLE; J. J. EKSTRAND; F.
DUDEK*. Univ. Utah Sch. Med.
8:00 J4 151.5 Combined hypoxia and hypoglycemia
induce seizures in rats. T. A. DWYER; B. L. BEHRLE; L.
GREENFIELD*, Jr. Univ. Toledo Coll Med.
9:00 J5 151.6 Specific alterations in hippocampal gene
expression in a putative mouse model for absence epilepsy.
S. W. HUPFER*; C. BECKER; K. BECKER. Univ. Erlangen-
Nuremberg.
10:00 J6 151.7 Agrin/α3 Na,K-ATPase interactions
regulate seizure sensitivity. L. G. HILGENBERG*; M. A.
NEMETALLA; M. A. SMITH. Univ. of California, Irvine.
11:00 J7 151.8 Characteristics of vesicular zinc release
in the rodent epileptic hippocampus. C. BASTIAN*; Y. V. LI.
Ohio Univ.
8:00 J8 151.9 Assesment of convulsion threshold
in adult rats after chronic mercury intoxication using
penthylenetetrazole: A preliminary study. G. O. PEKER*; A.
KESER; V. EVREN. Ege Univ. Fac. of Med.
9:00 J9 151.10 In vivo and in vitro study of the
cerebral vasomotion during epileptic seizures induced by
4- Aminopyridine in rat. V. TSYTSAREV*; A. VOLNOVA;
D. SIBAROV; D. LENKOV; A. CORDERO; M. INIUSHIN.
Washington Univ. in St. Louis, St. Petersburg State Univ.,
Sechenov Inst. of Evolutionary Physiol. and Biochemistry,
Russian Acad. of Sci., Univ. Central del Caribe.
10:00 J10 151.11 Why are seizures difficult to predict? D.
AUR*; M. R. BOWER. Stanford Univ., The Mayo Clin.
11:00 J11 151.12 Evoked potentials triggered by electrical
stimulation signal seizure onset: A new approach to seizure
prediction. D. C. MEDEIROS*; P. GUIDINE; F. MOURÃO; A.
MASSENSINI; M. MORAES. Federal Univ. of Minas Gerais.
8:00 J12 151.13 Dynamical and topographical
characterization of spike and wave discharges in
phospholipase C beta 4 knockout mice. M. LEE*; D. KIM; H.
SHIN; J. CHOI. Korea Inst. of Sci. and Technol., Univ. of Sci.
and Technol.
9:00 J13 151.14 Seizure tracking in the genetic absence
epilepsy rats from strasbourg (GAERS) model using
simultaneous fMRI / EEG recording. S. M. CAIN*; A. C.
YUNG; C. C. LAPISH; J. CHIEN-HSIN TSO; T. J. O’BRIEN;
P. KOZLOWSKI; T. P. SNUTCH. Univ. of British Columbia,
Univ. of Melbourne.
Neuroscience 2010  |  Sunday AM  |  23 
 POSTER
152. Ischemia: Cellular and Molecular Mechanisms:
Inflammation
Theme C: Disorders of the Nervous System
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 J14 152.1 Chemokine receptor-like 2 is involved in
ischemic cell death following middle cerebral artery occlusion
in mice. H. YAO; R. M. DOUGLAS*; A. CHEN; X. SUN; X.
GU; J. WANG; G. G. HADDAD. UCSD, The Rady Children’s
Hosp.
9:00 J15 152.2 Microglia and macrophage proliferative
response in the adult rat retina after optic nerve and retinal
lesion - A comparative study of cell proliferation potential
and nestin expression. S. G. WOHL*; C. SCHMEER; T.
FRIESE; O. W. WITTE; S. ISENMANN. Friedrich Schiller
Univ. of Jena, Univ. of Witten/Herdecke, HELIOS Klinikum
Wuppertal.
10:00 J16 152.3 The role of platelets and interleukin-1
in neutrophil infiltration in vivo. J. A. GILES*; A. D.
GREENHALGH; A. DENES; P. P. THORNTON; B. W.
MCCOLL; S. M. ALLAN. The Univ. of Manchester.
11:00 J17 152.4 Up-regulation of chemokine receptor-
like 2 in an in vitro model of cerebral ischemia. A. CHEN;
H. FELFLY; X. SUN; X. GU; J. WANG; G. G. HADDAD; H.
YAO*. UCSD, Rady Children’s Hosp.
8:00 J18 152.5 Capillary blood flow around microglial
somata determines microglial process dynamics in ischemic
conditions. T. MASUDA*; H. HIDA; S. A. KIROV. Med. Col. of
Georgia, Nagoya City Univ. Grad. Sch. of Med. Sci.
9:00 J19 152.6 TGFβ signaling increases in aging and
signals to innate immune cells in the weeks after stroke.
K. P. DOYLE*; E. CEKANAVICIUTE; L. E. MAMER; M. S.
BUCKWALTER. Stanford Univ.
10:00 J20 152.7  •  Hypoxia-induced oligodendrocyte death
is mediated by N-methyl D-aspartate receptors expressed in
amoeboid microglial cells via NF-ĸB signaling pathway. M.
MURUGAN*; C. KAUR. Natl. Univ. of Singapore.
11:00 K1 152.8 PARP-1 inhibition blocks ischemia-
induced microglial activation in male but not female rats. S.
WON*; S. SUH; T. KAUPPINEN; B. YOO; R. A. SWANSON.
UCSF and SFVAMC, Hallym Univ., Inje Univ. Sanggye Paik
Hosp.
8:00 K2 152.9  •  Immune cell characterisation of SAH
model. A. D. GREENHALGH; G. COUTTS; S. MAYSAMI*; S.
M. ALLAN; N. J. ROTHWELL. The Univ. of Manchester.
9:00 K3 152.10 Attenuated CCR2 expression in the
brain and spleen of the post-ischemic mice by antibacterial
treatment. Y. BAO*; S. BHOSLE; H. MEHTA; S. CHO. Burke
Med. Res. Inst., Weill Cornell Med. Colloage.
10:00 K4 152.11 Reduced innate immune response in Toll-
like receptor 2 deficient mice delays the brain response to
ischemic injury. S. GAJOVIC*; I. BOHACEK; D. GORUP; M.
LALANCETTE-HEBERT; Y. C. WENG; J. KRIZ. Sch. of Med.
Univ. of Zagreb, Fac. of Medicine, Laval Univ.
11:00 K5 152.12 Increased intracellular levels of reduced
glutathione in microglial cells worsen injury after neonatal
SLIDE
focal stroke. X. WANG; J. FAUSTINO; A. KLIBANOV; C.
JOHNSON; N. DERUGIN; M. WENDLAND; Z. S. VEXLER*.
UCSF, Xiangya hospital, Univ. of Virginia.
24  |  Society for Neuroscience
8:00 K6 152.13 Fas ligand plays an important role in cell
death after cerebral ischemia. M. AHMAD*; H. LIU; M. E.
ROSE; J. CHEN; S. H. GRAHAM. VA Pittsburgh Healthcare
System, Pittsburgh, Univ. of Pittsburgh.
9:00 K7 152.14 MyD88 regulation of haematopoietic
cells affects the outcome after stroke. P. J. CRACK*; C.
DOWNES; C. WONG; K. HENLEY; P. GUIO-AGUILAR; R.
ATES; B. KILE. Univ. of Melbourne, Walter and Eliza Hall
Inst.
10:00 K8 152.15 Notch pathway regulates innate activation
of microglia in a mouse model of focal ischemia. Z. WEI*; W.
TU; S. CHIGURUPATI; S. L. CHAN. Univ. of Central Florida.
11:00 K9 152.16 Astrocytic TGFbeta signaling modulates
the inflammatory response to stroke. E. CEKANAVICIUTE*;
K. P. DOYLE; M. S. BUCKWALTER. Stanford Univ.
8:00 K10 152.17 The role of inflammation in recovery from
perinatal brain injury. T. B. BEMISTER*; R. DYCK. Univ. of
Calgary.
9:00 K11 152.18 Inflammatory changes in obese mice
may mediate enhanced responses to experimental stroke.
C. B. LAWRENCE*; S. R. MURIKINATI; E. WHETTON; F.
ROBSON; B. W. MCCOLL. Univ. of Manchester.
10:00 K12 152.19 The effect of the electrovascular
streaming potential on endothelium. D. TRIVEDI*; P. R.
BERGETHON. Boston Univ. Sch. of Med.
POSTER
153. Ischemia: Neuroprotection I
Theme C: Disorders of the Nervous System
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 K13 153.1  •  Agmatine regulates endogenous
neurogenesis after ischemic injury. J. KIM*; S. SEO; K.
PARK; W. LEE; J. LEE. Yonsei University, Col. of Med.,
BK21 Project for Med. Science, Anatomy, Yonsei Univ., Col.
of Med.
9:00 K14 153.2 Regulation of GABAA receptor by PTEN
in ischemic stroke. Q. WAN*; B. LIU; Q. ZHANG; D. BRANN.
Univ. Nevada Sch. Med., Toronto Western Res. Inst., Med.
Col. of Georgia.
10:00 K15 153.3 Pituitary adrenal axis adaptation following
hypoxic preconditioning provide neuroprotection against
subsequent hypoxic-ischemic brain injury in newborn rats.
Y. FENG*; P. G. RHODES; A. J. BHATT. Dept. of Pediatrics,
Univ. of Mississippi Med. Ctr.
11:00 K16 153.4 Neurounina, a novel compound
that increases Na+/Ca2+ exchanger activity, effectively
protects against stroke damage. M. CANTILE; O. CUOMO;
P. MOLINARO; G. PIGNATARO; A. SECONDO; A.
PANNACCIONE; P. AMBROSINO; A. SCORZIELLO; B.
SEVERINO; F. FIORINO; G. CALIENDO; V. SANTAGADA;
L. A. RUOCCO*; A. SADILE; T. TAKAHIRO IWAMOTO; G.
DI RENZO; L. ANNUNZIATO. “Federico II” Univ. of Naples,
Second Univ. Naples, Univ. of Fukuoka.
8:00 K17 153.5 The protective effect of gelsolin and
alpha 1-anti trypsin in endothelin-induced middle cerebral
artery occlusion in rats. H. T. LE*; A. HIRKO; C. LEGLER; J.
THINSCHMIDT; M. KING; J. HUGHES; S. SONG. Univ. of
Florida, Roche Inc.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
9:00 K18 153.6  •  Role of progesterone in isoflurane
preconditioning neuroprotection in ischemic female mouse
brain. W. ZHU*; N. L. LIBAL; S. L. MADER; P. D. HURN;
S. J. MURPHY. Nanjing Benq Hosp., Oregon Hlth. and Sci.
Univ.
10:00 K19 153.7 Dynamic changes in expression levels
of the components of PcG/TrxG epigenetic regulatory
machinery during the induction of brain ischemic tolerance.
C. L. PIPER*; C. STOWELL; T. YANG; J. LAN; R. SIMON; A.
ZHOU. Legacy Hlth.
11:00 K20 153.8 Selective adenosine A2A receptor
antagonism reduces JNK activation in oligodendrocytes after
cerebral ischemia. F. PEDATA; A. MELANI; F. CORTI; S.
CIPRIANI; M. GIOVANNINI; G. PEPEU*. Univ. of Florence.
8:00 L1 153.9  •  The delta-opioid receptor agonist UFP-
512 up-regulates excitatory amino acid transporters in
astrocytes. J. LIANG*, SR; D. CHAO; S. CHEN; Y. XIA. Yale
Univ. Sch. of Med.
9:00 L2 153.10 Effect of peripheral and central AMP-
activated protein kinase activation on post-ischemic
hyperglycemia and on ischemic neuronal damage. S.
HARADA*; W. FUJITA; S. TOKUYAMA. Kobegakuin Univ.
10:00 L3 153.11 Lutein enhances survival and protects
against transient focal cerebral ischemia in mice. A. C. LO*;
S. LI; T. WOO; D. WONG. Eye Institute, The Univ. of Hong
Kong, Res. Ctr. of Heart, Brain, Hormone and Healthy Aging,
The Univ. of Hong Kong.
11:00 L4 153.12  •  A cell death-regulating chemical
compound ameliorates the functional impairments in the
animal stroke model. S. YOO; M. PARK; J. SUH; H. LEE; S.
KIM; Y. LEE; S. YOO; E. KIM; H. K. SUH-KIM*. Ajou Univ,
Sch. Med., Col. of Biol. Sci. and Biotechnology, Chungnam
Natl. Univ., Ctr. for Biol. Modulators of the 21st Century
Frontier Program, Korea Res. Inst. of Chem. Technol., Ctr.
for Cell Death Regulating Biodrug, Ajou Univ. Sch. of Med.,
BK21, Div. of Cell Transformation and Restoration, Ajou
Univ. Sch. of Med.
8:00 L5 153.13 The neuroprotective effect of alpha-
linolenic acid, an omega-3 fatty acid, against soman-
induced neuropathology. X. HU; H. PAN; C. CHEN; D. M.
JACOBOWITZ; J. MCDONOUGH; K. VAN SHURA; M.
LYMAN; A. M. MARINI*. USUHS, US Army Med. Res. Inst.
of Chem. Def.
9:00 L6 153.14 Autophagy deficiency protects males,
but not females, from neonatal hypoxia-ischemia. K.
BLOMGREN*; Q. LI; H. LI; X. WANG; Y. UCHIYAMA; C.
ZHU. Univ. Gothenburg, Queen Silvia Children’s Hosp.,
Zhengzhou Univ., Juntendo Univ.
10:00 L7 153.15 Modulation of indoleamine
2,3-dioxygenase reduces focal cerebral ischemic injury in
mice. C. WOO; H. LEE; C. KIM; W. LEE*. Pusan Natl. Univ.
Sch. of Med.
11:00 L8 153.16 Progranulin deficiency increases
susceptibility to cerebral ischemic injury. K. A. JACKMAN*;
T. ABE; K. HOCHRAINER; L. GARCIA BONILLA; P. ZHOU;
A. DING; J. ANRATHER; C. IADECOLA. Weill Cornell Med.
Col.
8:00 L9 153.17 The neuroprotective effect of
rosiglitazone in ischemic stroke injury involves c-Jun
N-terminal kinase. N. OKAMI*; H. YOSHIOKA; H. SAKATA;
P. H. CHAN. Stanford university.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
9:00 L10 153.18 Interrupting reperfusion using oxygen:
neuroprotection by intermittent normobaric hyperoxia after
transient focal cerebral ischemia in rats. C. LIU*; W. LIU; J.
WEAVER; K. J. LIU. Univ. of New Mexico Hlth. Sci. Ctr.
10:00 L11 153.19 Neural expression of G Protein-coupled
receptors GPR3 modulates survival of cerebellar granular
neurons under hypoxic conditions. S. TANAKA*; E. DOHI;
Sun. AM
T. MIYAGI; T. SEKI; I. HIDE; Y. SAEKI; E. CHIOCCA; M.
MATSUMOTO; N. SAKAI. Hiroshima Univ. Sch. of Biomed.
Sci., The Ohio State Univ.
11:00 L12 153.20 Modulation of acid sensing ion channels
by L-arginine. S. M. SWAIN; G. SAHU; A. K. BERA*. IIT
Madras.
8:00 M1 153.21  •  Simvastatin neuroprotection in a
clinically relevant rabbit embolic stroke model: Synergism
with a Rho-kinase (ROCK) inhibitor, but not the thrombolytic
tissue plasminogen activator. P. A. LAPCHAK*; M. K. HAN.
Cedars-Sinai Med. Ctr., Seoul Natl. Univ. Bundang Hosp.
9:00 M2 153.22 Silibinin reduces hippocampal neuronal
damage via matrix metalloproteinase-9 inhibition in transient
global cerebral ischemia. S. LEE*; J. HONG; E. PYO; J.
PARK. Keimyung university, Ulsan Univ. Hosp., Sch. of Med.
Keimyung Univ.
10:00 M3 153.23 SalB and minocycline promoting
neuronal proliferation may invole in the downregulation of
Robo1 protein expression on striatum in rats after cerebral
ischemia-reperfusion. M. TANG; W. FENG*. Beijing Univ. of
Chinese Med., Univ. Pittsburgh.
11:00 M4 153.24 Impact of apoptosis repressor with
caspase recruitment domain (ARC) protein delivery on
stroke outcome. S. L. L. LEE; G. LÄTTIG; K. GERTZ;
G. KRONENBERG; U. HARMS; M. BALKAYA; A.
DAETWYLER; J. AN; S. DONATH; M. ENDRES;
C. HARMS*. Ctr. for Stroke Research, Charité-
Universitätsmedizin, Dept. of Neurology, Charité-
Universitätsmedizin, Max-Delbrück-Center for Mol. Med.
8:00 M5 153.25 Mithramycin is a gene selective Sp1
inhibitor that identifies a biological intersection between
cancer and neurodegeneration. S. SLEIMAN*; B. LANGLEY;
G. COPPOLA; L. XIA; H. GUO; M. BASSO; J. ROHR; R.
RATAN. Cornell/Burke Res. Inst., Univ. of California Los
Angeles, Univ. of Kentucky.
9:00 M6 153.26  •  Proteolytic processing of single chain
protein C to heterodimer is not critical for biochemical
and biological characteristics of activated protein C. N.
CHOW*; H. GUO; I. SINGH; T. MEENAKSHISUNDARAM;
D. SCHWEIBERT; M. SPERBER; S. LAWRENCE; B.
ZLOKOVIC. ZZ Biotech, LLC, Univ. of Rochester.
10:00 M7 153.27 Neuroprotector effect of chlormethiazole,
a GABAA receptor agonist, on alterations induced by
intestinal ischemia in the contractile responses of the
guinea-pig ileum. R. VENTURA-MARTINEZ*; C. GOMEZ; R.
RODRIGUEZ. Fac Med, UNAM.
11:00 M8 153.28 Alteration of BDNF and TrkB in the
regions regulating glucose metabolism after cerebral
ischemic stress. S. TOKUYAMA*; S. HARADA; W. FUJITA.
Kobe Gakuin Univ. Library Yakugaku.
8:00 M9 153.29 Hsp 72 improves long term behavioral
recovery after focal ischemia in mice. L. XU*; G. BARRETO;
X. XIONG; Y. OUYANG; S. XIE; R. GIFFARD. Stanford Univ.,
AfaSci Res. Lab.
Neuroscience 2010  |  Sunday AM  |  25 
 9:00 M10 153.30 Novel neuroprotection pathways in
cerebral ischemia. M. PAPADAKIS*; L. HOYTE; S. NAGEL;
C. WRIGHT; Z. ZHAO; B. KESSLER; A. BUCHAN. Univ. of
Oxford, Univ. of Heidelberg, Univ. of Calgary.
POSTER
154. Spinal Cord Injury: Inflammation
Theme C: Disorders of the Nervous System
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 M11 154.1 High mobility group box-1 (HMGB1)
contributes to post-traumatic spinal cord inflammation. K. A.
KIGERL*; W. LAI; L. WALLACE; P. G. POPOVICH. The Ohio
State Univ.
9:00 M12 154.2 Hypoxia inducible factor 1 alpha
regulates divergent effects on CNS macrophage subsets
after traumatic spinal cord injury. D. J. DONNELLY*; K. A.
KIGERL; P. G. POPOVICH. The Ohio State Univ.
10:00 M13 154.3 Splenectomy influences the dynamics
of intraspinal macrophage activation after spinal cord injury.
A. L. HAWTHORNE*; Z. GUAN; D. J. DONNELLY; P. G.
POPOVICH. The Ohio State Univ.
11:00 M14 154.4 Prevention of both neutrophil and
macrophage recruitment promotes long-term functional
recovery after spinal cord injury in mice. S. LEE*; S.
ROSEN; L. J. NOBLE-HAEUSSLEIN. Univ. of California San
Francisco.
8:00 M15 154.5 Exploratory pathway analysis of
temporal gene changes in rat spinal cord injury: Long
lasting inflammatory response in chronic spinal cord injury.
E. EFTEKHARPOUR*; S. KARIMI-ABDOLREZAEE; P.
BOURTOS; M. FEHLINGS. Spinal Cord Res. Center, Univ.
of Manitoba, Regenerative Med. Program and Spinal Cord
Res. Center, Univ. of Manitoba, Ontario Inst. for Cancer
Res., Univ. of Toronto, Toronto Western Res. Institue,
Krembil Neurosci. Res. Ctr.
9:00 M16 154.6 Macrophage activation in DRG
contributes to enhanced regenerative capacity of sensory
neurons after conditioning injury. M. KWON*; B. G. KIM; S.
JOENG; D. HWANG. Ajou Univ. Sch. of Med. / Brain Dis.
Res. Ctr.
10:00 M17 154.7 The effect of immunizing with neural-
derived peptides on the expression of inflammatory genes
in spinal cord injured rats. E. E. GARCIA-VENCES*; S.
MARTIÑON; A. MURGUIA; P. CALDERON; R. SILVA; A.
IBARRA. Camina Res. Ctr., Anahuac Univ., CMN Siglo XXI.
H.P.
11:00 M18 154.8 Implantation of Th1 cells downregulates
IFN-Γ, IL-17 double positive lymphocytes and ameliorates
recovery after spinal cord injury. H. ISHII*; T. KUBO; T.
YAMASHITA. Grad. Sch. of Medicine, Osaka Univ., Grad.
Sch. of Medicine, Chiba Univ.
8:00 N1 154.9  •  Upregulation of the pro-inflammatory
cytokine macrophage migration inhibitory factor (MIF)
after spinal cord injury in lamprey. O. BLOOM*; A.
PAPATHEODOROU; K. CHENG; Y. AL-ABED; C. METZ; J.
MORGAN. Feinstein Inst., Univ. of Texas at Austin.
SLIDE
9:00 N2 154.10 Effects of cytokines on calcium extrusion
mechanisms in neurons. A. MEADE; A. RATNAYAKE; M. P.
KURNELLAS; A. K. FAKIRA; R. F. HEARY; S. ELKABES*.
New Jersey Med. Sch., Stanford Univ.
26  |  Society for Neuroscience
10:00 N3 154.11 Susceptibility of plasma membrane
calcium ATPase 2 (PMCA2)-heterozygous mice to
experimental autoimmune encephalomyelitis and spinal cord
injury. K. HOGNASON; M. P. KURNELLAS*; R. F. HEARY;
S. ELKABES. UMDNJ-NJMS, Stanford Univ.
11:00 N4 154.12 Role of lysophosphatidic acid in the
pathophysiology of spinal cord injury. E. S. NOGUEIRA*; K.
I. RATHORE; S. DAVID; X. NAVARRO; R. LÓPEZ-VALES.
Univ. Autònoma De Barcelona, McGill Univ.
8:00 N5 154.13  •  Inflammatory and neurotrophic signals
involved in hemidiaphragmatic paralysis. K. D. NANTWI*; P.
L. SINGH. Wayne State Univ. Sch. Med.
9:00 N6 154.14 Acid fibroblast growth factor and
peripheral nerve graft regulated Th2 cytokines expression,
macrophage activation, polyamines synthesis, and
neurotrophins expression in transected spinal cord of rats. H.
KUO*; C. CHIU; C. TSAI; H. CHANG. Taipei Veterans Gen
Hosp, Taipei Veterans Gen. Hosp., Natl. Yang-Ming Univ.
10:00 N7 154.15 Attenuated inflamatory response in gal-
3-/- mice after spinal cord injury. K. MOSTACADA*; F. M.
ALMEIDA; F. L. OLIVEIRA; D. M. S. VILLA-VERDE; A. M. B.
MARTINEZ. Univeridade Federal Do Rio De Janeiro, Univ.
Federal Do Rio De Janeiro, Fundação Osvaldo Cruz.
11:00 N8 154.16 Procoagulant effect of infiltrating
neutrophils after traumatic spinal cord injury. H. SAIWAI*; Y.
OHKAWA; H. KUMAMARU; K. KUBOTA; Y. IWAMOTO; S.
OKADA. Grad. Sch. of Med. Sciences, Kyushu Univ., Dept.
of Orthopedic Surgery, Grad. Sch. of Med. Sciences, Kyushu
Univ.
POSTER
155. Spinal Cord Injury: Therapeutic Strategies I
Theme C: Disorders of the Nervous System
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 N9 155.1 17beta-estradiol is protective in a
cervical hemicontusion spinal cord injury in rats. S.
CHOMPOOPONG*; A. SIRIPHORN; C. L. FLOYD. Fac. of
Med. Siriraj Hospital, Mahidol Univ., Ctr. of Glial Biol. in Med.
9:00 N10 155.2 Combination therapy of 17beta-
estradiol and Schwann cell transplantation in a cervical
hemicontusion spinal cord injury in rats. A. SIRIPHORN*;
S. CHOMPOOPONG; C. L. FLOYD. Fac. of Med. Siriraj
Hospital, Mahidol Univ., Univ. of Alabama at Birmingham.
10:00 N11 155.3 Light stimulated recovery of respiratory
rhythms in chronically C2 hemisected rats also reveals
dramatic plasticity of spinal cord circuitry. W. J. ALILAIN*;
X. LI; T. E. DICK; S. HERLITZE; J. SILVER. Case Western
Reserve Univ., Columbia Univ., Ruhr University-Bochum.
11:00 N12 155.4 Locomotor and sensory function
recovery after systemic administration of deoxyribozyme
to XT-1 mRNA after a moderate contusion of the adult rat
spinal cord. M. OUDEGA; R. BRONSON; D. AVISON; A.
MARCILLO; A. HURTADO; W. BUCHSER; B. GRIMPE*.
Univ. of Pittsburgh, Dana Faber/Harvard Cancer Ctr., Univ. of
Miami, Intl. Ctr. for Spinal Cord Injury, Hugo W. Moser Res.
Inst. at Kennedy Krieger, Heinrich Heine Univ. Düsseldorf.
8:00 N13 155.5 Treatment with DNA “decoy” that targets
Cox-2 gene promoter improves behavioral recovery after
spinal cord injury in rats. C. E. HULSEBOSCH*; G. XU; K.
M. JOHNSON; G. C. UNABIA; O. NESIC; J. PEREZ-POLO.
Univ. Texas Med. Br.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
9:00 N14 155.6 Neuroprotective effects of N-acetyl-
cysteine and acetyl-L-carnitine after spinal cord injury in
adult rats. L. N. NOVIKOVA*; A. KARALIJA; P. J. KINGHAM;
L. N. NOVIKOV; M. WIBERG. Umeå Univ.
10:00 N15 155.7 Amyloid precursor protein secreatases as
therapeutic targets for spinal cord injury. A. PAJOOHESH-
GANJI*; N. HOCKENBURY; Q. SHU; A. FADEN.
Georgetown university, Univ. of Maryland.
11:00 N16 155.8 The effect of hyperbaric oxygen on nerve
healing at acute thoracic spinal cord injury. T. DAGCI*; K.
DAYAN; M. ERTURK; G. SENGUL. Ege Univ. Sch. of Med.
Physiol. Dept., Izmir Bozyaka Training and Res. Hosp., Ege
University, Sch. of Med.
8:00 N17 155.9 The molecular mechanism of 1-deoxy-
nor-sominone (Denosomin) for repairing spinal cord
injury. A. NAGATA*; K. TESHIGAWARA; Y. MATSUYA; C.
TOHDA. Inst. of Natural Medicine, Univ. of Toyama, Fac. of
Pharmaceut. Science, Univ. of Toyama.
9:00 N18 155.10 Gene therapy for cervical spinal cord
injury with erythropoietin delivered using an HSV-based
vector. S. WANG*; P. CHIANG; D. J. FINK; M. MATA. Univ.
of Michigan.
10:00 O1 155.11 Tropism of adeno-associated virus 8
for large diameter sensory neurons of dorsal root ganglia
after direct injection or intrathecal delivery. S. J. JACQUES;
A. FORBES; M. DOUGLAS; Z. AHMED; M. BERRY; A.
LOGAN*. Univ. Birmingham.
11:00 O2 155.12 Delivery of decorin to acute dorsal
column lesion sites suppresses lesion size, inflammation,
angiogenesis and scar formation. D. MAHAY*; K. TIZZARD;
M. DOUGLAS; A. GONZALEZ; Z. AHMED; M. BERRY; A.
LOGAN. Univ. of Birmingham.
8:00 O3 155.13  •  Administration of a VEGF-A gene
therapy may have angiogenic and neuroprotective effects
when administered in a delayed fashion following spinal
cord injury. S. A. FIGLEY*; Y. LIU; K. SPRATT; D. ANDO; R.
SUROSKY; G. LEE; M. GIEDLIN; M. G. FEHLINGS. Univ. of
Toronto, Toronto Western Res. Inst., Sangamo Biosci.
9:00 O4 155.14  •  Stimulation of reactive astrocytes’
migration by specific inhibition of GSK-3 enhances locomotor
recovery after spinal cord injury. F. RENAULT-MIHARA*;
T. IKEGAMI; A. IWANAMI; H. KATOH; Y. TOYAMA; M.
NAKAMURA; H. OKANO. Keio Univ. Sch. of Med., the Henry
Singleton Brain Tumor Program at the David Geffen Univ. of
California at Los Angeles Sch. of Med.
10:00 O5 155.15 Therapeutic role of alpha b-crystallin in
acute spinal cord injury. A. J. KLOPSTEIN*; A. REDENSEK;
S. DAVID; X. NAVARRO; R. LÓPEZ VALES. Univ. Autonoma
De Barcelona, The Res. Inst. of the McGill Univ.
11:00 O6 155.16 Combination of trophic factors enhances
nestin expressing progenitors and neuroprotection after
spinal cord injury. W. KRITYAKIARANA*; A. ESPINOSA-
JEFFREY; P. M. ZHAO; F. GOMEZ-PINILLA; M.
YAMAGUCHI; N. KOTCHABHAKDI; J. DE VELLIS.
Srinakharinwirot Univ., UCLA, Univ. of Tokyo, Mahidol Univ.
8:00 O7 155.17 The Fat-1 gene and exogenous
docosahexaenoic acid protect adult mouse sensory neurons
against injury in vitro. S. J. GLADMAN*; M. M. KNIGHT;
J. X. KANG; J. V. PRIESTLEY; A. T. MICHAEL-TITUS.
Bart’s and the London Sch. of Medince and Dent., Bart’s
and the London Sch. of Medince and Dentistry, QMUL,
Massachusetts Gen. Hosp. and Harvard Med. Sch.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
9:00 O8 155.18   Neuroprotective effect of
Metallothionein II after spinal cord injury in rats. S.
ARELLANO-RUIZ; A. DIAZ-RUIZ*; H. SALGADO-
CEBALLOS; M. MENDEZ-ARMENTA; M. ALTAGRACIA; J.
KRAVZOV; K. JIMENEZ-GARCIA; C. RIOS. Univ. Autonoma
Metropolitana-Xochimilco, Natl. Inst. of Neurol Mexico, Inst.
Mexicano del Seguro Social.
Sun. AM
10:00 O9 155.19 An implantable immuno-modulatory
bioreactor for spinal cord injury repair. J. BARMINKO*; J.
H. KIM; S. OTSUKA; R. SCHLOSS; M. GRUMET; M. L.
YARMUSH. Rutgers Univ.
POSTER
156. Cell Death Mechanisms: Excitotoxicty and Calcium
Theme C: Disorders of the Nervous System
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 O10 156.1 Profiling MicroRNAs involved in
the neuroprotective effects of mood stabilizers. J. G.
HUNSBERGER*; Y. LENG; A. ELKAHLOUN; D. CHUANG.
NIH.
9:00 O11 156.2 Time-dependence of distal-to-proximal
hippocampal neurodegeneration produced by N-methyl-
D-aspartate receptor activation. J. N. BERRY*; L. J.
SHARRETT-FIELD; T. R. BUTLER; M. A. PRENDERGAST.
Univ. of Kentucky.
10:00 O12 156.3 An obligate role for astrocytic system
xc- in hypoglycemia-induced neuronal cell death. N.
A. JACKMAN*; S. E. MELCHIOR; J. A. HEWETT; S. J.
HEWETT. Univ. of Connecticut Hlth. Ctr.
11:00 O13 156.4 Neuropeptide Y inhibits rat retinal neural
cell death induced by glutamate. A. SANTOS-CARVALHO;
A. R. ALVARO; A. F. AMBROSIO; C. CAVADAS*. Univ. of
Coimbra, Cent Neurosci Cell Biol, Fac. of Pharm.
8:00 O14 156.5 Activation of Cdk5 by kainic acid
mediates loss of glutamatergic synapses and induction of
endoplasmic reticulum stress in rat hippocampal neurons.
N. J. PUTKONEN*; J. P. KUKKONEN; G. MUDO; N.
BELLUARDO; D. LINDHOLM; L. KORHONEN. Minerva Inst.
for Med. Res., Unit of Biochem. and Cell Biology, Univ. of
Helsinki, Div. of Human Physiology, Univ. of Palermo.
9:00 O15 156.6  •  Elevation of p-NR2AS1232 by Cdk5/p35
contributes to retinal ganglion cell apoptosis in rat chronic
ocular hypertension model. Z. WANG*; J. CHEN; Y. MIAO;
X. WANG; X. YANG. Fudan Univ.
10:00 O16 156.7 Intercellular communication through gap
junctions propagates cell death in the mammalian retina. A.
AKOPIAN*; Y. ZHANG; S. BLOOMFIELD. New York Univ.
Schl Med.
11:00 O17 156.8 Roles of activity-induced BRINP1 gene in
alteration of mouse behavior. I. MATSUOKA*; K. TAKAO; T.
MIYAKAWA; T. KODA; M. KOBAYASHI. Matsuyama Univ.,
Kyoto Univ., Fujita Hlth. Univ., Hokkaido Univ.
8:00 O18 156.9 p600 mediates neuronal survival by
regulating calcium signalling and microtubule stability. C.
A. BELZIL; M. CHANSARD; G. NEUMAYER; S. SHIM; A.
VASSILEV; K. YAP; M. IKURA; H. T. LI; Y. NAKATANI; M.
A. COLICOS; M. NGUYEN*. Univ. of Calgary, NIH, Univ. of
Toronto, Harvard Med. Sch., Univ. Calgary, HBI.
Neuroscience 2010  |  Sunday AM  |  27 
 9:00 P1 156.10 Fk506 binding protein 51 (fkbp51)
mediated neuroprotection during glutamate excitotoxicity in
661w neurons. D. R. DAUDT*; T. YORIO. Univ. North texas
Hlth.
10:00 P2 156.11 White matter damage in periventricular
leukomalacia is reversible with trophic factors interventions.
A. ESPINOSA MONTEROS*, Dr.; S. BARAJAS; K.
CLAUSEN; P. M. ZHAO; M. GEZALIAN; P. TOPALJEKIAN;
P. GRESSENS; A. FERIA-VELASCO; J. S. DE VELLIS.
UCLA, Univ. of Guadalajara, Hop. Robert Debre,.
11:00 P3 156.12 Effects of fingolimod, an oral active drug
for multiple sclerosis, on neurodegeneration/neuroprotection
mechanims. L. DI MENNA; G. MOLINARO; C. ZAPPULLA;
B. RIOZZI; F. FAZIO; S. NOTARTOMASO; P. SCARSELLI;
V. BRUNO*; G. BATTAGLIA; F. NICOLETTI. I.N.M.
Neuromed, Univ. La Sapienza, Univ. of Molise.
8:00 P4 156.13 Somatic injury precedes loss of nr2b
receptor protein following excitotoxic hippocampal insult.
L. SHARRETT-FIELD*; J. N. BERRY; T. R. BUTLER; M. A.
PRENDERGAST. Univ. of Kentucky.
9:00 P5 156.14 Cognitive impairment and glutamate
receptors modification in mice exposed to zidovudine during
intrauterine life. C. GIULI*; G. S. ALEMÀ; P. CASOLINI; A.
CATALANI; C. CINQUE; A. TRAMUTOLA; A. VENEROSI;
A. R. ZUENA; G. CALAMANDREI. Dept. of Physiol. and
Pharmacol., Sapienza Univ. of Rome, Catholic Univ. Sch. of
Med., Ist. Superiore di Sanità.
10:00 P6 156.15  •  Diarylheptanoids from Juglans sinensis
protect neuronal cells against glutamate-induced toxicity
in HT22 cells. H. YANG; E. JEONG; S. SUNG; Y. C. KIM*.
Seoul Natl. Univ.
11:00 P7 156.16 Neuroprotective effects of
pyrroloquinoline quinone against glutamate-induced
apoptosis in hippocampal neurons. F. DING*; Q. ZHANG; L.
GONG. Nantong University, China.
8:00 P8 156.17 Necrostain-1 indirectly inhibits PARP
activation induced by glutamate toxicity in HT-22 cells.
X. XU*; C. LIU; C. C. CHUA; J. HUANG; D. GENG; R. C.
HAMDY; B. H. L. CHUA. Inst. of Neuroscience, Soochow
Univ., East Tennessee State Univ., Xuzhou Med. Col.
Affiliated Hopspital.
9:00 P9 156.18 NMDA receptor modulation of HIV-
associated synapse loss and recovery. A. SHIN*; H. KIM; S.
A. THAYER. Univ. of Minnesota-Twin Cities.
10:00 P10 156.19 Urokinase plasminogen activator (uPA)
protects hippocampal neurons in the kainic acid-induced
animal model of epilepsy. E. CHO*; S. KIM; Y. KO; J. KOH;
J. S. KIM; J. LEE. Asan Med. Ctr., Univ. of Ulsan Col. of
Med.
11:00 P11 156.20 Developmentally modulated effect
of GluRAMPA receptor agonist on survival and dendritic
integrity of dopaminergic neurons. An organotypic ventral
mesencephalic culture model. H. M. BELALCAZAR*; B.
A. BENITEZ; D. G. HERRERA; G. A. DE ERAUSQUIN.
Brigham and Women’s Hospital, Dept. of Psychiatry, Harvard
Med. Sch.
8:00 P12 156.21 Astrocyte D-serine release influences
NMDA receptor-mediated cerebral vasodilation. J. L.
SLIDE
LEMAISTRE*; H. D. I. ANDERSON; C. M. ANDERSON. St
Boniface Res. Ctr., Univ. of Manitoba.
9:00 P13 156.22 Cofilin activity regulates neuronal calcium
overloading under pathological conditions. X. TANG; G.
CHEN*. Penn State Univ.
28  |  Society for Neuroscience
POSTER
157. Neurotoxicity and Neurodegeneration I
Theme C: Disorders of the Nervous System
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 P14 157.1 Copper nanoparticles induce
inflammation and increase permeability in porcine and
rat brain microvessel endothelial cells. W. J. TRICKLER*;
S. M. LANTZ; A. M. SCHRAND; R. C. MURDOCK; B. L.
ROBINSON; G. D. NEWPORT; J. J. SCHLAGER; M. G.
PAULE; S. M. HUSSAIN; S. F. ALI. Natl. Ctr. of Toxilogical
Research/FDA, U.S. Air Force Res. Lab.
9:00 Q1 157.2 Neuroprotective effects of galanthamine
against acetylcholinesterase inhibitor exposure. P.
WILLIAMS*; K. FINNERAN; C. J. HILMAS. USAMRICD,
George Washington Univ.
10:00 Q2 157.3 Interleukin-6 gene depletion enhances
neurotoxicity induced by trimethyltin. Y. CHUNG*; E. SHIN;
J. H. JEONG; K. SAITO; X. T. NGUYEN; T. L. NGUYEN;
J. BACH; K. YAMADA; Y. YONEDA; T. NABESHIMA; H.
KIM. Col. of Medicine, Chung-Ang Univ., Col. of Pharmacy,
Kangwon Natl. Univ., Grad. Sch. of Med. and Fac. of
Medicine, Kyoto Univ., Nagoya Univ. Grad. Sch. of Med.,
Kanazawa University, Grad. Sch. of Natural Sci. and
Technol., Grad. Sch. of Pharmaceut. Sciences, Meijo Univ.
11:00 Q3 157.4 Prolyl oligopeptidase inhibitors KYP-2047
and JTP-4819 are neuroprotective against glutamate and
oxygen glucose deprivation in vitro. N. E. VARTIAINEN*; M.
FORSBERG; A. NURMI; J. YRJÄNHEIKKI. Cerebricon Ltd /
Charles River Labs. Discovery and Imaging Services, Univ.
of Eastern Finland.
8:00 Q4 157.5 The changes of dorsal root ganglia
in pyridoxine induced neuropathy by subcutaneously
administration in dogs. J. CHUNG*; M. KIM; D. YOO;
J. CHOI; M. WON; I. HWANG; H. YOUN. Clin. Res.
Institute,Seoul Natl. Univ. Hosp., college of veterinary
medicine, seoul national university, Col. of Vet. Medicine,
Seoul Natl. Univ., Col. of Medicine, Hallym Univ.
9:00 Q5 157.6 Preconditioning with isoflurane prevents
prolonged exposure of isoflurane-induced apoptosis in
developing rat brains. J. PENG; S. INAN*; G. LIANG; H.
WEI. Univ. of Pennsylvania, Second Affiliated Hosp. of Sun
Yat-sen Univ.
10:00 Q6 157.7  •  Influence of sub-acute exposure to
nanoparticle-rich diesel exhaust on learning performance
in mice. Y. KUROKAWA; R. HOJO; T. WIN SHWE*; Y.
FUJITANI; S. HIRANO; S. YAMAMOTO. Natl. Inst. Envir,
Natl. Inst. Occup Safety Hlth.
11:00 Q7 157.8 Perinatal arsenic inhibits the binding of
glucocorticoid receptors to nuclear response elements. A. M.
ALLAN*; E. J. MARTINEZ-FINLEY. Univ. New Mexico Sch.
Med.
8:00 Q8 157.9 Damage to the hippocampal ca1 cell
population in rat offspring exposed to clembuterol during
gestation or lactation and its effect on learning and memory
process. M. ROSALES- CORTÉS*; A. FIGUEROA DAVID;
E. ALBARRAN RODRIGUEZ; M. M. OROZCO DELGADO;
C. VICTOR BARRAGÁN; G. NOLASCO RODRÍGUEZ;
X. R. AVILA DÁVILA; J. PEREGRINA SANDOVAL. Univ.
Guadalajara.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
9:00 Q9 157.10 Influence of sub-acute inhalation
exposure to nanoparticle-rich diesel exhaust on murine
brain. S. YAMAMOTO*; T. WIN SHWE; Y. KUROKAWA; Y.
FUJITANI; S. HIRANO; K. INOUE. Natl. Inst. For Envrn.
Studies.
10:00 Q10 157.11 Cyclooxygenase-2 in principal neurons
aggravates cognitive deficit after status epilepticus. G. E.
SERRANO*; J. R. LEVIN; R. DINGLEDINE. Emory Univ.
Sch. of Med.
11:00 Q11 157.12 Feeder-free derivation of patient-specific
human induced pluripotent stem cells for the study of
neurological disease. A. M. TIDBALL*; M. D. NEELY; K. C.
ESS; A. B. BOWMAN. Vanderbilt Univ.
8:00 Q12 157.13 Neurodevelopmental effects of the
pyrethroid pesticide deltamethrin. M. D. PINE*; T. WAGNER;
G. KO. Texas A&M Univ.
9:00 Q13 157.14 Effects of domoic acid on hippocampal
development in vitro. A. PEREZ*; R. A. TASKER. Univ. of
Prince Edward Island.
10:00 Q14 157.15 Long-term effects of postnatal
manganese exposure on the expression of D2S and D2L
receptor isoforms: Impact on PKA activity, p-ERK, and p-AKT
levels. T. DER-GHAZARIAN; C. E. BRITT; F. A. VARELA; C.
A. CRAWFORD*; S. A. MCDOUGALL. California State Univ.
11:00 Q15 157.16 Nitrosative stress induces aromatase
upregulation in astrocyte primary cultures from fetal sheep
brain. V. FARINA*; G. LEPORE; S. GADAU; A. MURA; E.
MURA; F. BALZANO; M. ZEDDA. Univ. of Sassari, Dept of
Animal Biol., Univ. of Padua.
8:00 Q16 157.17  •  Pathological tau contributes to
lactacystin induced fast axonal transport impairment
and neuroprotective effect of T-817MA. K. HIRATA*; M.
SUGIMORI; R. LLINAS. New York Univ. Med. Cntr, Toyama
Chem. Co. Ltd.
9:00 Q17 157.18  •  The effect of spatial exposure of
toxins on neurons and its impact on axonal degeneration.
N. SRIVASTAVA; F. A. AHMADI*; K. LONG; M. KUNIS; W.
SPECKMANN. Millipore Corp.
10:00 Q18 157.19 Central effect of tityustoxin on mean
arterial pressure, heart rate and survival of undernourished
rats. D. A. CHIANCA*; F. SILVA; M. RIBEIRO; M. SILVA; L.
CARDOSO; L. FERNANDES; P. GUIDINE. Federal Univ. of
Ouro Preto, Federal Univ. of Minas Gerais.
11:00 R1 157.20 Time- and dose-response of
6-hydroxydopamine on locus coeruleus noradrenegric
neurons in c57bl/6 mice. P. SZOT*; A. FRANKLIN; S.
WHITE; M. RASKIND. Univ. Washington, VA Puget Sound
Hlth. Care Syst.
POSTER
158. Sensory Disorders: Somatosensation and Pain: Animal
Models
Theme C: Disorders of the Nervous System
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 R2 158.1 Hyperexcitability of dorsal horn neurons
in a model of joint pain. F. J. GOLDER*; K. P. QUINN;
L. DONG; J. V. KRAS; B. A. WINKELSTEIN. Univ. of
Pennsylvania.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
9:00 R3 158.2 Persistent peripheral neuropathic pain
caused by spared nerve injury is associated with EEG
slowing in rat. E. SOKOLOVA*; S. LEE; R. LLINAS; K.
GINGRICH. NYU Sch. of Med., NYU Col. of Arts and Sci.
10:00 R4 158.3 Functional characterization of the
WNK1/HSN2 isoform causing HSAN type 2 in zebrafish.
V. BERCIER*; P. DION; G. A. ROULEAU; P. DRAPEAU.
Sun. AM
Univ. De Montréal, Ctr. D’excellence en Neuromique de
l’Université de Montréal.
11:00 R5 158.4   Characterization of BTBD9 homolog
knockout in C. elegans. A. DOROODCHI*; Y. YANG; M. P.
DEANDRADE; M. A. MILLER; Y. LI. Univ. of Alabama At
Birmingham.
8:00 R6 158.5 IL-6 neutralisation reduces inflammatory
pain in mouse models. P. THORNTON*; M. MORISSETTE; I.
ROBINSON; J. WHITWORTH; J. P. HATCHER; A. GILBERT;
F. MCINTOSH; I. CHESSELL; J. HUGHES. Medimmune,
AstraZeneca.
9:00 R7 158.6 Role of peripheral 5-HT7 receptors on
development and maintenance of secondary mechanical
allodynia and hyperalgesia. B. GODÍNEZ*; V. GRANADOS-
SOTO. Farmacobiologia, Cinvestav, Sede Sur.
10:00 R8 158.7 Decrease in neuroimmune activation by
HSV-mediated gene transfer of TNFsR alleviates pain in rats
with diabetic neuropathy. M. CHATTOPADHYAY*; K. MAIER;
M. MATA; D. FINK. Univ. Michigan.
11:00 R9 158.8 Effect of chronic undernutrition on the
primary afferent depolarization evoked by stimulation of
cutaneous nerves in the rat. S. QUIROZ-GONZALEZ; I.
JIMENEZ-ESTRADA*; J. GUADARRAMA; B. SEGURA.
CINVESTAV, IPN Ctr. Invst & Adv Studies, FES Iztacala,
UNAM.
8:00 R10 158.9 Pharmacological characterization of
lysophosphatidic acid-induced pain with clinically relevant
neuropathic pain drugs. K. OGAWA; K. TAKASU; S.
SHINOHARA; A. KATO*. Shionogi & Co Ltd.
9:00 R11 158.10 Chronic pre-treatment with topiramate
reduces the number of DC potentials and magnitude of CBF
events in cortical spreading depression model of migraine
in rats. R. O. PUSSINEN*; A. J. NURMI; J. PUOLIVÄLI; B.
VALASTRO; W. DANYSZ; J. YRJÄNHEIKKI. Cerebricon
Ltd/Charles River Discovery and Imaging Services, Merz
Pharmaceuticals GmbH.
10:00 R12 158.11 Is the Oprm1 knockout mouse a good
model of restless legs syndrome? M. DEANDRADE*; A.
DOROODCHI; A. WALTERS; Y. LI. Univ. of Alabama At
Birmingham, Vanderbilt Univ.
11:00 R13 158.12 A novel rat model of systemic chronic
itch. K. JEONG; S. BACK; C. LI; M. KIM; E. LIM; J. LEE; H.
S. NA*. Korea Univ. Med. Col., Neurosci. Res. Institute, Coll.
Med. Korea Univ.
8:00 R14 158.13 Extracellular matrix of sciatic nerve
from diabetic rats is less supportive for sensory nerve
regeneration: A role for chondroitin sulphate proteoglycans?
H. E. BROOKE*; S. ALI; N. GARDINER. Univ. of
Manchester.
9:00 R15 158.14 Excess TRPV1 stimulation leads to
the induction of autophagy. M. SHIBATA*; T. SHIMIZU; M.
FUNAKUBO; T. IWASHITA; H. TORIUMI; K. KOIZUMI; Y.
ITOH; N. SUZUKI. Dept. of Neurology, Sch. of Medicine,
Keio Univ.
Neuroscience 2010  |  Sunday AM  |  29 
 10:00 R16 158.15 Pressure hyperalgesia in hind-limb
suspended rats. M. DOBRETSOV*; M. E. SOULSBY; E.
JOHNSON; D. MCKAY; P. CHOWDHURY. Univ. Arkansas
Med. Sci.
11:00 R17 158.16 Swim training reduces neuropathic pain
induced by chronic constriction injury in rats. J. SHEN; L.
FOX; J. CHENG*. Cleveland Clin.
8:00 R18 158.17 A possible involvement of cathepsin B in
nociceptive processing through the processing and secretion
of interleukin-1 family from microglia. L. SUN; Z. WU; Y.
HAYASHI; H. NAKANISHI*. Kyushu Univ. Fac Dent. Sci.
9:00 S1 158.18 S-ketamine preferentially inhibits
neuropatic pain through the neuronal-based and microglia-
related mechanis. K. KAWAJI*; Y. HAYASHI; H. NAKANISHI.
Faculy of Dent. Science, Kyushu Univ.
POSTER
159. Psychotropic Drug Effects in Animal Model Systems
Theme C: Disorders of the Nervous System
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 S2 159.1 The mGluR7 allosteric agonist AMN-082
produces antidepressant-like effects that are reversed by
AMPA receptor antagonism. A. LEE*; K. GROOVER; R.
FLICK; S. BRADLEY; P. HUTSON; J. USLANER. Merck &
Co.
9:00 S3 159.2   The effect of monosodium glutamate on
amphetamine-induced psychosis in the rat: Integration of the
dopamine and glutamate hypotheses of schizophrenia. T.
O’CONNELL*; J. R. YATES. Ohio Wesleyan Univ.
10:00 S4 159.3  •  Effects of the alpha7 nicotinic agonist
TC-7020 on striatal dopamine release correlate with
changes in prepulse inhibition in an FGF/Dopamine
mouse developmental model of schizophrenia. M. K.
STACHOWIAK*; A. KUCINSKI; M. BENCHERIFF; S.
WERSINGER. State Univ. New York Buffalo, Targacept Inc.
11:00 S5 159.4 Actions on Beta-Arrestin 2 signaling
pathways define pharmacological profiles of diverse mood
stabilizers. T. M. DEL’GUIDICE*; J. BEAULIEU. Ctr. De
Recherche Universitaire Laval Robert-Giffard.
8:00 S6 159.5 Effects of repeated treatment with
lithium or carbamazepine in animal models of mania
and anhedonia. C. GAMBARANA*; S. SCHEGGI; G.
MARCHESE; M. SECCI; J. IBETTI; M. DE MONTIS; A.
TAGLIAMONTE. Univ. of Siena.
9:00 S7 159.6 Quetiapine blocks high-dose
methamphetamine-induced apoptosis in the medial
prefrontal cortex and the accompanying PPI deficit. K. ITO*;
T. ABEKAWA; Y. NAKATO; T. KOYAMA. Hokkaido Univ., Aiko
Hosp.
10:00 S8 159.7  •  Comparison of established mood
stabilizers with selective PKC and GSK-3β inhibitors in a rat
model of euphoric mania. G. T. PANAGIS*; M. MAVRIKAKI;
G. G. NOMIKOS. Univ. of Crete, Sch. of Social Sci., Takeda
Global Res. & Develop. Ctr.
11:00 S9 159.8 Schizophrenia-like white and gray matter
SLIDE
pathology following prenatal maternal immune activation
is prevented by clozapine treatment in adolescence. Y.
PIONTKEWITZ*; L. LEVIN; Y. ASSAF; I. WEINER. Dept. of
Psychology Tel-Aviv Univ., Dept. of Neurobio. Tel-Aviv Univ.
30  |  Society for Neuroscience
8:00 S10 159.9 Effect of aripiprazole on
methamphetamine-induced disruption of latent inhibition
in rats. H. MATSUO; H. ABE; K. EBIHARA; R. TAKEDA; T.
NISHIMORI; Y. ISHIDA*. Fac of Med, Univ. Miyazaki.
9:00 S11 159.10 Regulation of netrin-1 receptors by
chronic oral administration of haloperidol. A. D. GRANT*; C.
FLORES. McGill Univ.
10:00 S12 159.11 Clomipramine inhibits contrafreeloading
for water induced by repeated administration of the
dopaminergic D2/D3 agonist quinpirole in the rat. L. DE
CAROLIS*; C. SCHEPISI; M. MILELLA; P. NENCINI.
Sapienza Unversity of Rome, Sapienza Univ. of Rome.
11:00 T1 159.12 Effects of chronic clozapine on markers
of the arachidonic acid cascade and synaptic integrity in rat
brain. H. KIM*; Y. CHEON; S. I. RAPOPORT; J. S. RAO. Nat
Inst. Hlth.
8:00 T2 159.13  •  Group II mGluR agonist partially
rescues disrupted inhibitory synaptic transmission in MK801
schizophrenia model. H. WANG*; W. GAO. Drexel Univ. Coll
Med.
9:00 T3 159.14 Enhanced antidepressant-like effect of
Lithium in serotonin transporter (SERT) knockout mice. J.
A. SALEMME; P. R. MOYA; D. CHUANG; D. L. MURPHY*.
NIMH, NIH.
10:00 T4 159.15 Repeated quinpirole treatment induces
recovery of prepulse inhibition and delta FosB labeling in
rat nucleus accumbens. A. M. MAPLE*; M. BRITTON; E. M.
NIKULINA; R. P. HAMMER, Jr. Arizona State Univ., Univ. of
Arizona.
11:00 T5 159.16  •  Targeting the alpha7 nicotinic receptor
subtype to restore working memory deficits in rats following
sub-chronic ketamine exposure. S. L. RUSHFORTH*;
E. L. MALCOLM; A. S. J. LESAGE; F. E. N. LEBEAU; T.
STECKLER; M. SHOAIB. Newcastle Univ., Johnson and
Johnson.
8:00 T6 159.17  •  Risperidone and paliperidone reduce
extracellular glutamate in the prefrontal cortex of rats
treated with MK-801 or in rats exposed prenatally to immune
activation. N. ROENKER; R. AHLBRAND; D. LINDQUIST;
N. RICHTAND; G. A. GUDELSKY*. James Winkle Col.
of Pharm., Univ. of Cincinnati, Veterans Affairs Med. Ctr.,
Children’s Hosp. Med. Ctr.
9:00 T7 159.18 Mechanistic action of L-prolyl-L-leucyl-
glycinamide (PLG) in modulating dopamine D2 receptor
neurotransmission: Implications in the treatment of
Parkinson’s disease and schizophrenia. D. BASU; M. G. R.
BEYAERT; N. ARGINTARU; R. DAYA; R. L. JOHNSON; R.
K. MISHRA*. McMaster Univ., Univ. of Minnesota, McMaster
Univ. HSC-4N52.
10:00 T8 159.19 MDL11939-dependent and independent
coupling of 5-HT2 receptors to G proteins induced by the
agonist TCB-2. E. M. VALDIZAN*; E. CASTRO; A. DÍAZ; A.
MARTÍN; B. ROMERO; A. PAZOS. Inst. De Biomedicina Y
Biotecnologia (IBBTEC, UC-CSIC-IDCAN), CIBER-SAM,
Inst. de Salud Carlos III.
11:00 T9 159.20 In vitro involvement of Akt/GSK-3
signaling pathway in antipsychotic-induced dopamine D2
receptor up-regulation. J. DESLAURIERS*; P. SARRET; S.
GRIGNON. Univ. de Sherbrooke.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
8:00 T10 159.21  •  Identification of neurons in the rat
prefrontal and signalling pathways activated by different α7
nAChR agonists. D. B. TIMMERMANN*; M. S. THOMSEN;
M. M. JENSEN; S. C. LANGE; M. EL-SAYED; A. HAY-
SCHMIDT; D. PETERS; H. H. HANSEN; J. D. MIKKELSEN.
Neurosearch, Univ. Hosp. Rigshospitalet, Univ. of
Copenhagen.
9:00 T11 159.22  •  The effects of uridine treatment on
synaptic efficacy and plasticity in acute hippocampal brain
slices from mice. E. H. CHANG*; S. W. JONES; S. P.
MILLER; S. T. CARREIRO; P. T. HUERTA; J. R. RUSCHE.
Cornell Univ, Weill Med. Coll, Burke Med. Res. Inst.,
Repligen Corp.
10:00 T12 159.23 Characterization of AMN082: A
rich pharmacology which does not appear to include a
measurable stimulation of the mGlu7 receptor. R. M.
BRODBECK*; F. SOTTY; X. PU; M. UBERTI; L. K. ISAAC; T.
SCHULENBURG; B. CHEN; M. DIDRIKSEN. Lundbeck Res.
USA, Inc, H. Lundbeck A/S.
11:00 T13 159.24 Effects of clozapine on the enteric
system: Implications for antipsychotic-induced weight gain.
C. B. PALAVICINO-MAGGIO; K. TOBON; V. DOUARD; R.
FERRARIS; E. V. KUZHIKANDATHIL*. UMDNJ-New Jersey
Med. Sch., UMDNJ -New Jersey Med. Sch.
8:00 T14 159.25 Lithium modulates L-type calcium
channel in olfactory sensory neurons. J. XU; J. REISERT; K.
BORGMANN-WINTER; R. RAY*; C. HAHN. Monell Chem.
Senses Ctr., Univ. of Pennsylvania Sch. of Med.
9:00 T15 159.26 Serotonin 5-HT2A and dopamine D2
receptors, both antipsychotic drug targets, present a
functional crosstalk involving their heteromerization. L.
ALBIZU*; J. GONZÁLEZ-MAESO; S. SEALFON. Mount
Sinai Sch. of Med.
10:00 T16 159.27 Transcriptional repression of the α7
nicotinic acetylcholine receptor subunit gene (CHRNA7) by
AP-2 alpha. J. A. FINLAY SCHULTZ*; A. CANASTAR; M.
SHORT; S. LEONARD. Univ. of Colorado, Denver.
POSTER
160. Anxiety Disorders: Human Biomarkers and Treatment
Studies
Theme C: Disorders of the Nervous System
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 T17 160.1 Serum hepatocyte growth factor levels
and the effects of antidepressants in panic disorder. J.
AKIYOSHI*; M. KANEHISA; Y. ISHITOBI; J. TSURU; Y.
TANAKA. Oita Univ. Fac. of Med.
9:00 T18 160.2  •  Modulation of functional activation
patterns by disorder-specific stimuli before and after
cbt in patients with agoraphobia and panic disorder. A.
WITTMANN*; A. GUHN; F. SCHLAGENHAUF; T. FYDRICH;
A. SIEGMUND; M. STOY; B. PFLEIDERER; U. LUEKEN;
H. BRUHN; H. REHBEIN; L. FEHM; T. KIRCHER; I.
REINHARDT; H. WITTCHEN; A. STRÖHLE. Charité -
Universitätsmedizin Berlin, Humboldt-Universität Berlin,
Westfälische-Wilhelms-Universität Münster, Technische
Univ. Dresden, Campus Virchow Klinikum, Charité
Universitätsmedizin Berlin, Philipps-Universität Marburg,
Universitätsklinikum Aachen.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
10:00 U1 160.3 Worry modulation in late-life generalized
anxiety disorder. C. ANDREESCU; M. WU; G. SIEGLE; W.
THOMPSON; H. J. AIZENSTEIN*. Univ. of Pittsburgh, Univ.
of California at San Diego, Univ. Pittsburgh.
11:00 U2 160.4 BDNF polymorphism contributes to
altered structural connectivity in generalized anxiety disorder.
D. W. GRUPE; D. TROMP; D. J. OATHES; T. KRAL; M.
Sun. AM
ADAMS; J. B. NITSCHKE*. Univ. Wisconsin-Madison,
Stanford Univ.
8:00 U3 160.5 Generalized anxiety disorder, social
anxiety disorder, and panic disorder: Common and unique
neural substrates of anticipation. R. L. AUPPERLE*; H.
RAMSAWH; T. FLAGAN; S. SULLIVAN; G. FONZO; A.
LETAMENDI; A. SIMMONS; M. PAULUS; M. STEIN. San
Diego VA Healthcare Syst., UCSD.
9:00 U4 160.6 Mutations in SLITRK1 associated
with the obsessive-compulsive disorder spectrum alter
neuronal branch length in rat embryonic hippocampal
neurons. U. OZOMARO*; A. PICKRELL; J. HUANG; D.
MCCORQUODALE, III; J. PRICE; G. MONTENEGRO;
G. FENG; M. WAGNER; D. MURPHY; J. WENDLAND; V.
LEMMON; S. ZUCHNER. John P. Hussman Inst. for Human
Genomics, Univ. of Miami Sch. of Med., Duke Univ., Univ. of
Bonn, Natl. Inst. of Mental Hlth.
10:00 U5 160.7 Sensory evoked fields in children with
obsessive compulsive disorder (OCD) reveal a longer
latency compared with healthy controls. E. HARRIS*; C.
MEYER; Y. WANG; J. XIANG; M. KOROSTENSKAJA.
Cincinnati Children’s Hosp. Med. Ctr.
11:00 U6 160.8 Changes in regional cerebral blood flow
after repetitive transcranial magnetic stimulation on the right
dorsolateral prefrontal cortex of the patients with obsessive
compulsive disorder. J. MIN*; H. LIM; J. CHAE; Y. CHUNG.
Seoul St. Mary’s Hosp.
8:00 U7 160.9  •  Fractional anisotropy differences of
the inferior fronto-occipital fasciculus in body dysmorphic
disorder. W. LI*; L. ZHAN; D. ARIENZO; A. LEOW; J.
FEUSNER. UCLA, Univ. of Illinois at Chicago.
9:00 U8 160.10 Neural substrate evidence for disorder-
specific dysfunction of emotion regulation in anxiety
disorders. T. M. BALL*; H. RAMSAWH; A. M. LETAMENDI;
S. SULLIVAN; T. FLAGAN; G. FONZO; L. CAMPBELL-
SILLS; M. P. PAULUS; M. B. STEIN. UCSD.
10:00 U9 160.11 Predicting cognitive-behavioral
therapy outcomes for pediatric anxiety disorders using
fMRI. S. RICH*; D. PINE; M. ERNST; J. CAMERON;
D. LUCKENBAUGH; A. ZAMETKIN; E. NELSON; B.
JUSTEMENT. Georgetown Univ. Sch. of Med., Natl. Inst. of
Mental Hlth., NIH.
11:00 U10 160.12 Effects of trauma exposures on cortical
thickness of veterans with and without Post traumatic stress
disorder. X. WANG*; S. N. GARFINKEL; A. P. KING; R. E.
KAUFMAN; I. LIBERZON. Univ. of Toledo, Univ. of Michigan.
Neuroscience 2010  |  Sunday AM  |  31 
 POSTER
161. Anxiety Disorders: Animal Models of Medial Temporal
Lobe/mPFC Systems
Theme C: Disorders of the Nervous System
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 U11 161.1 Activation of amygdala and
medial prefrontal cortex in lever-press avoidance: An
immunohistochemistry study. X. JIAO*; K. C. H. PANG; K.
D. BECK; A. AGLEY; S. FAZELINIK; R. J. SERVATIUS.
SMBI, Univ. Med. Dent. New Jersey, Grad. Sch. of Biomed.
Sciences, NJMS-UMDNJ, DVA Med. Center, NJHCS,
Honor’s College, Rutgers Univ.
9:00 U12 161.2 Lesions to ventral medial prefrontal cortex
affect extinction of active avoidance behavior. K. D. BECK*;
X. JIAO; S. J. FURST; K. C. H. PANG; R. J. SERVATIUS.
East Orange VAMC/NJ Med. Sch., UMDNJ - New Jersey
Med. Sch., UMDNJ - Grad. Sch. of Biomed. Sci.
10:00 U13 161.3 Neural mechanisms for active-avoidance
behavior. L. I. PERROTTI*; T. S. DENNIS; X. JIAO; R. J.
SERVATIUS; K. C. H. PANG; K. D. BECK. Univ. of Texas at
Arlington, East Orange VAMC/New Jersey Med. Sch.
11:00 U14 161.4 Selective amygdala lesions facilitate
acquisition of signaled lever-press avoidance in Wistar
Kyoto and Sprague Dawley rats. D. P. MILLER*; D. S. REIS;
X. JIAO; K. D. BECK; K. C. H. PANG; R. J. SERVATIUS.
Carthage Col., UMDNJ, VA New Jersey Hlth. Care Syst.
8:00 U15 161.5 The expression of escape deficits
produced by uncontrollable stress are mediated by 5-HT2C
receptors in the dorsal striatum. P. V. STRONG*; A. B.
LOUGHRIDGE; J. P. CHRISTIANSON; T. RAGOLE; J.
AMAT; S. F. MAIER; M. FLESHNER; B. N. GREENWOOD.
Univ. Colorado Boul, Univ. of Colorado.
9:00 U16 161.6 Behavioral profile, corticosterone levels
and hippocampal neurogenesis in carioca high-conditioned
freezing rats. G. P. DIAS*; M. BEVILAQUA; A. SILVEIRA;
F. MOUSOVICH; V. COSTA; M. ROCHA; J. LANDEIRA-
FERNANDEZ; P. GARDINO. Gisele Pereira Dias, Univ.
Federal do Rio de Janeiro (UFRJ), Pontifícia Univ. Católica
do Rio de Janeiro (PUC-Rio).
10:00 U17 161.7 PET imaging of rhesus monkeys with
OCD-like behaviors. M. CAMPOS*; J. N. CAMACHO; A.
M. DUFFY; J. GALE; S. M. NIEMI; D. D. DOUGHERTY; E.
ESKANDAR. MGH / Harvard, MGH / Ctr. for Comparative
Med.
11:00 U18 161.8 Bed nucleus of the stria terminalis is
required for uncontrollable stress induced anxiety. T. E.
RAGOLE*; J. P. CHRISTIANSON; J. N. FLYER; L. R.
WATKINS; S. F. MAIER. Univ. of Colorado.
8:00 V1 161.9 Juvenile stress alters anxiety behaviors
and neural activities in the medial prefrontal cortex and
amygdala in adult rats. A. ISHIKAWA*; J. ISHIKAWA; R.
NISHIMURA; S. NAKAMURA. Yamaguchi Univ. Grad Sch.
Med.
9:00 V2 161.10 The role of the medial prefrontal
cortex in the protective effect of exercise against learned
helplessness. A. B. LOUGHRIDGE*; B. N. GREENWOOD;
P. V. STRONG; J. P. CHRISTIANSON; T. RAGOLE; S. F.
SLIDE
MAIER; M. FLESHNER. Univ. of Colorado, Boulder.
10:00 V3 161.11 Cortical and subcortical patterns of
neuronal activation in a predator-odor model of post-
traumatic stress disorder. D. F. SCUTELLA; M. T.
KERCHNER*. Washington Col.
32  |  Society for Neuroscience
11:00 V4 161.12 Resting functional connectivity between
amygdala and dlPFC predicts anxious temperament in
the rhesus monkey. R. M. BIRN*; S. E. SHELTON; J. A.
OLER; A. S. FOX; R. J. DAVIDSON; N. H. KALIN. Univ. of
Wisconsin - Madison.
8:00 V5 161.13 The effects of withdrawal of enriched
environment on emotional behavior and adult hippocampal
neurogenesis in mice. T. NISHIJIMA*; T. HAYAKAWA; S.
AMEMIYA; N. KUBOTA; I. KITA. Tokyo Metropolitan Univ.
9:00 V6 161.14 Through the gates of the amygdala: A
multi-node circuitry study of anxiety. Y. T. CHO*; M. ERNST;
J. L. FUDGE. Univ. of Rochester Sch. of Med. and Dent.,
Natl. Inst. of Mental Hlth.
10:00 V7 161.15 Prior exposure to glucocorticoids protects
from the delayed effects of acute stress in an animal model
of PTSD. R. P. RAO*; S. ANILKUMAR; B. S. MCEWEN; S.
CHATTARJI. Natl. Ctr. for Biol Sci., Rockefeller Univ.
11:00 V8 161.16 Effects of stressor controllability
on cardiovascular responses. R. S. THOMPSON*; J.
P. CHRISTIANSON; T. MASLANIK; S. F. MAIER; M.
FLESHNER. Univ. Colorado Boul.
POSTER
162. Anxiety Disorders: Experimental Therapeutics
Theme C: Disorders of the Nervous System
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 V9 162.1 The involvement of synaptic degeneration
in major depressive disorder and antidepressant mechanism
of action. S. WUWONGSE*; C. H. HUNG; R. C. C. CHANG;
A. C. K. LAW. The Univ. of Hong Kong.
9:00 V10 162.2  •  The aqueous extract of roots of
Terminalia macroptera possess anxiolytic and antipyretic
activities in mice. E. NGO BUM*; G. DJAFSIA; G. S. TAIWE;
C. O. MOTO; S. V. RAKOTONIRINA; A. RAKOTONIRINA.
Univ. Ngaoundere, Cameroon, Univ. of Yaoundé1.
10:00 V11 162.3 A diet rich in the milk protein Calcium
casienate throughout pregnancy prevents postpartum
anxiety in mice. C. M. LARSEN*; D. R. GRATTAN. Univ.
Otago.
11:00 V12 162.4 Anxiolytic effects of Cinnamomum cassia.
M. A. BIRKETT*; E. BLAKE; K. SHELTON; S. GRENALD.
Northern Arizona Univ., Columbia Univ.
8:00 V13 162.5 Potentiated startle induced by anticipation
of aversive images is not affected by anxiolytic treatment.
D. T. ACHESON; L. RAVINDRAN; C. WALLACE; M.
STEIN; M. PAULUS; A. SIMMONS; A. DER-AVAKIAN*; V.
RISBROUGH. VA San Diego Healthcare Syst., UCSD.
9:00 V14 162.6  •  Silexan, an essential oil from flowers of
Lavandula angustifolia, increases the extracellular levels
of noradrenaline, dopamine and serotonin in the prefrontal
cortex of freely moving rats. J. KEHR*; S. YOSHITAKE;
T. YOSHITAKE; E. KOCH; M. NOELDNER. Pronexus
Analytical AB, Karolinska Institutet, Dr. Willmar Schwabe
GmbH & Co. KG.
10:00 V15 162.7  •  The antidepressant tianeptine prevents a
stress-induced sensitization of the startle reflex in the rat. B.
P. GODSIL*; M. SPEDDING; T. M. JAY. INSERM U894, Univ.
Paris Descartes, Servier.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
11:00 V16 162.8  •  A potent and novel anxiolytic-like
action of tipepidine possessing GIRK channel inhibiting
action in mice. S. HONDA*; F. SOEDA; T. SHIRASAKI;
K. TAKAHAMA. Grad. Sch. of Pharmaceut. Sciences,
Kumamoto Univ.
8:00 V17 162.9 Novel triazinedione derivatives as
GABAB receptor positive allosteric modulators: Synthesis,
in vitro pharmacological characterization, pharmacokinetic
profile and in vivo activity in rodent model of anxiety. E.
RIGUET; F. GIRARD; S. POLI; A. GIBELIN; K. MALLAH; M.
GALBY; E. LE POUL; J. ROCHER; V. MUTEL*; B. CAMPO.
Addex Pharma S.A, Addex Pharmaceuticals SAS.
9:00 V18 162.10 Novel beta-subunit selective GABAA
receptor allosteric modulators have reduced side effect
liability when compared to benzodiazepines. R. F.
YOSHIMURA*; M. B. TRAN; D. J. HOGENKAMP; T. B.
JOHNSTONE; K. W. GEE. Univ. of California, Irvine.
10:00 W1 162.11  •  Opposing roles of mGluR8 in measures
of anxiety and social interaction. J. RABER*; L. VILLASANA;
T. PFANKUCH; H. B. GOSSNEL; D. WINDER; R. M.
DUVOISIN. OHSU, Vanderbilt Univ.
11:00 W2 162.12   The anxiolytic effect of hyperbaric
oxygen (HBO2) in mice is mediated by the benzodiazepine
(BZ) binding site and involves nitric oxide (NO). E.
CARLILE; L. K. VAUGHN*; D. Y. SHIRACHI; R. M. QUOCK.
Washington State Univ., Marquette Univ., Chico Hyperbaric
Ctr.
8:00 W3 162.13 High frequency unilateral deep brain
stimulation of the nucleus accumbens induces alterations in
local field potential oscillations in regions both ipsilateral and
contralateral to stimulation in awake, freely moving rats. S.
G. EWING*; A. A. GRACE. The Univ. of Pittsburgh.
9:00 W4 162.14  •  Silexan® - Anxiolytic properties by
inhibition of voltage-operated calcium channels. A. M.
SCHUWALD*; M. NÖLDNER; K. LEUNER; W. E. MÜLLER.
Goethe Univ., Dr. Willmar Schwabe Pharmaceuticals.
10:00 W5 162.15 Altered substance P signaling in an
animal model of post-traumatic stress disorder. K. L.
MITTELSTEADT; V. OLSON; P. SZOT; T. A. KNIGHT; M.
RASKIND; L. S. KNIGHT*. Whitman Col., VA Puget Sound
Hlth. Care Syst., Univ. of Washington.
11:00 W6 162.16 The neurotensin analog PD149163
decreases 22 kHz vocalizations in adult rats: Evidence
for putative anxiolytic effects. A. L. LACROSSE*; T. M.
HILLHOUSE; A. J. PRUS. Northern Michigan Univ.
8:00 W7 162.17  •  WYE-198232 is a selective positive
allosteric modulator of the Neuropeptide S Receptor. S. K.
LEONARD*; P. DOLLINGS; M. A. OLSEN; C. N. BENDER;
A. M. GILBERT; E. MCKILLIP; V. SOLOVEVA; A. PERIHAR;
J. LAROCQUE; J. DUNLOP; J. PASLAY; R. H. RING. Pfizer
Neurosci., Pfizer Screening Sci.
9:00 W8 162.18 Characterization of a novel selective
Vasopressin V1b receptor antagonist, SCH 740935 in animal
models of anxiety-like and depression-like behavior. S. X.
LU*; D. MULLINS; D. GUTHRIE; M. GUZZI; X. ZHANG;
J. SCOTT; M. MILLER; A. STAMFORD; E. PARKER; G.
VARTY; R. HODGSON. Merck Res. Labs., Sanofi-Aventis.
10:00 W9 162.19 Anxiolytic effect of a novel adaptogenic
treatment. K. LAVI; L. BENATAV; G. M. YADID*; N.
KATAELY; R. DORON. The Open Univ., Bar-Ilan Univ., Tel-
Aviv Univ.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
POSTER
163. Learning, Memory, and Addiction
Theme C: Disorders of the Nervous System
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 W10 163.1 Blockade of cyclin-dependent kinase 5
Sun. AM
in the nucleus accumbens during amphetamine exposure
reduces conditioned locomotor responding to drug-paired
cues. B. F. SINGER*; P. VEZINA. Univ. of Chicago.
9:00 W11 163.2 Retrieval of context-drug memories
increases the number of recently activated synapses in the
basolateral amygdala. D. J. RADEMACHER*; D. A. FIGGE;
I. RAHMAN. Rosalind Franklin Univ. Med. & Sci.
10:00 W12 163.3 dmPFC infusion of D1R antagonist
SCH eliminates impulsivity and restores proper timing in
rats chronically exposed to cocaine self-administration.
C. V. BUHUSI*; M. B. REYES; J. E. SWEARINGEN; A. S.
WOODELL. Med. Univ. South Carolina.
11:00 W13 163.4 Repeated amphetamine exposure
in adolescence impairs impulse control in adulthood.
E. R. VENHEIM*; B. A. MARCUS; C. M. VIDAS; P. J.
SYLVESTER; C. M. LAM; J. M. GULLEY. Univ. of Illinois.
8:00 W14 163.5 Methamphetamine exposure produces
persistent memory: Possible role of epigenetic changes
in the pond snail, Lymnaea stagnalis. B. A. SORG; T. E.
BENNETT; L. K. CURTIS; G. STARK; K. D. LUKOWIAK*.
Washington State Univ., Univ. Calgary.
9:00 X1 163.6 Addiction and the question of
inconsistency between cognitive plans and motor-level
actions: A neurocomputational explanation. M. KERAMATI*;
B. GUTKIN. Ecole Normale Superieure.
10:00 X2 163.7 Cocaine exposure results in transient
cognitive deficits in adult male and female rats. K. Y. SALAS-
RAMIREZ*; L. STAHL; M. FRANKFURT; E. FRIEDMAN;
V. LUINE. CUNY Med. Sch., Hunter Col. , CUNY, Hunter
College, CUNY.
11:00 X3 163.8 Cocaine induced deficits in cognitive
performance in nonhuman primates are reduced by
prior injection of the GABA agonist Baclofen. S. A.
DEADWYLER*; L. J. PORRINO; M. A. NADER; P. W.
CZOTY; D. C. S. ROBERTS; M. D. MILLER; J. L. LONG; J.
V. NOTO; B. C. PARRISH; R. E. HAMPSON. Wake Forest
Univ. Sch. Med.
8:00 X4 163.9  •  Low frequency stimulation of the
hippocampus facilitates reinstatement of cocaine seeking
behavior in rats. G. F. KOOB*; O. DESCHAUX. The Scripps
Rsrch Inst., The Scripps Res. Inst.
9:00 X5 163.10 Preventive role of social interaction for
cocaine-induced place preference and Zif268 expression
in mesocorticolimbic areas. G. ZERNIG*; M. FRITZ; R.
EL RAWAS; A. SALTI; S. KLEMENT; G. DECHANT; M. T.
BARDO; A. SARIA. Med. Univ. Innsbruck, Univ. of Kentucky.
10:00 X6 163.11 Sleep is required for the formation of
locomotor sensitization, a non-associative learning process
implicated in drug addiction. T. SHUMAN*; D. J. CAI; S. G.
ANAGNOSTARAS. Univ. of California, San Diego, UCSD.
11:00 X7 163.12 Incentive learning and the psychomotor
activating effects of cocaine are controlled by mGluR5
in dopaminoceptive neurons. E. C. O’CONNOR*; H. S.
CROMBAG; A. N. MEAD; D. ENGBLOM; D. N. STEPHENS.
Univ. of Sussex, Pfizer Global Res. and Develop., Linköping
Univ.
Neuroscience 2010  |  Sunday AM  |  33 
 8:00 X8 163.13 High cocaine dosage decreases
neurogenesis in the hippocampus and impairs working
memory. E. SUDAI*; O. CROITORU; A. SHALDUBINA; L.
ABRAHAM; I. GISPAN; Y. FLAUMENHAFT; I. ROTH-DERI;
N. KINOR; S. AHARONI; M. BEN-TZION; G. YADID. The
Mina & Evarerd Fac. of Life Sciences, Bar-Ilan Univ., The
Leslie and Susan Gonda (Goldschmied) Multidisciplinary
Brain Res. Ctr., Dept of Chemistry, Bar-Ilan Universit.
9:00 X9 163.14 NMDA receptor antagonists interfere
with the consolidation and reconsolidation of cocaine-cue
memories. Y. ALAGHBAND*; J. F. MARSHALL. Univ. of
California, Irvine.
10:00 X10 163.15 Dopamine D1 receptor antagonism
impairs consolidation of extinction of cocaine-cue memories.
A. J. KHALAJ*; A. N. FRICKS-GLEASON; J. F. MARSHALL.
Univ. of California, Irvine.
11:00 X11 163.16 Post-training cocaine facilitates spatial
memory performance and increases extracellular signal-
regulated kinase-2 within the hippocampus in C57BL/6 mice.
S. D. INIGUEZ; S. CHARNTIKOV; S. A. BAELLA; M. S.
HERBERT; C. A. BOLANOS-GUZMAN*; C. A. CRAWFORD.
Florida State Univ., California State Univ. San Bernardino.
8:00 X12 163.17 Role of environmental conditioning in one
injection-induced behavioral sensitization. T. F. TROMBIN*;
D. F. FUKUSHIRO; R. G. BELLOT; G. D. MAHANA; R.
PROCOPIO-SOUZA; S. R. KAMEDA; B. R. DOS SANTOS;
R. FRUSSA-FILHO. UNIFESP - Univ. Federal De Sao Paulo,
Univ. Metodista de Sao Paulo, UFU.
9:00 X13 163.18 NMDA inputs on noradrenergic neurons
are essential in morphine psychomotor sensitization and
incetive learning in mice. W. SOLECKI; J. RODRIGUEZ
PARKITNA; M. SIKORA; S. GOLDA; J. KUBIK; R.
SPRENGEL; R. A. PRZEWLOCKI*. Inst. Pharmacol PAS,
Max Planck Inst. for Med. Res.
10:00 X14 163.19 I remember µ: The effects of methadone
and heroin on memory retrieval in rats. E. L. CUMMINS*; M.
HAINES; L. PARKER; F. LERI. Univ. Guelph.
11:00 X15 163.20 The addictive properties of soft drink
consumption using a CTA animal model for addiction. C. N.
FREEMAN; E. CUMMINS; K. C. MILLER; A. L. HUGHES; J.
OSTLAND; C. TUCKER; B. J. HOCK*, Jr. Austin Peay State
Univ.
8:00 X16 163.21   Measuring alcohol consumption using
a CTA animal model for addiction. C. J. TUCKER, Jr.; B. J.
HOCK, Jr.; R. W. FLINT*. Austin Peay State Univ., Col. St
Rose.
9:00 X17 163.22   Caffeine dose-dependently increases
the motivation to obtain non-drug reinforcers. S. A.
PAVELKA*; M. J. HALL; K. S. FREEMAN; M. I. PALMATIER.
Kansas State Univ.
10:00 X18 163.23 Neuroprotective effects of vitamin E
against fetal alcohol-induced hippocampal-dependent
associative learning deficits in rats. T. D. TRAN*; E. M.
SHEFFER; R. J. CRAFT. East Carolina Univ.
11:00 Y1 163.24 Functionally disconnecting the basolateral
amygdala and nucleus accumbens core: Effects on context-
induced renewal of alcohol seeking in rats. N. CHAUDHRI;
L. L. SAHUQUE; C. WOODS; T. M. GILL; P. H. JANAK*.
SLIDE
Concordia Univ., UCSF.
8:00 Y2 163.25 Effect of toluene on the process of
learning in rats. L. GELAZONIA*; T. BIKASHVILI; L.
CHILACHAVA; N. JAPARIDZE; M. ZHVANIA. I.Beritashvili
Inst. of Physiol.
34  |  Society for Neuroscience
POSTER
164. Cocaine: Brain Mechanisms
Theme C: Disorders of the Nervous System
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 Y3 164.1 Intra-dorsomedial prefrontal cortical
infusion of BDNF reverses cocaine self-administration-
induced decrease in Synapsin I mRNA locally and Synapsin
I protein distally in the nucleus accumbens of rats. S. A.
EISENSTEIN*; T. W. WHITFIELD; T. L. SCHOCHET; J. F.
MCGINTY. Med. Univ. of South Carolina.
9:00 Y4 164.2 Intra-dorsomedial prefrontal cortical
BDNF infusion after cocaine self-administration differentially
regulates TrkB-related intracellular signaling in the nucleus
accumbens. W. SUN*; T. W. WHITFIELD, Jr; J. F. MCGINTY.
Med. Univ. of South Carolina.
10:00 Y5 164.3 The effects of acute cocaine and
amphetamine on gamma frequency (20-80Hz) oscillations in
the prefrontal cortex in vitro. B. O’DONOVAN*; M. SHOAIB;
F. E. N. LEBEAU. Newcastle Univ.
11:00 Y6 164.4 Reversible lidocaine inactivation of the
bed nucleus of the stria terminalis blocks the negative/
anxiogenic effects of cocaine in a runway model of self-
administration. J. M. WENZEL*; Z. SU; Z. M. HABER; A.
ETTENBERG. Univ. Calif.
8:00 Y7 164.5 Endocannabinoids and CRF interact
to mediate the expression of anxiety and reinstatement of
cocaine seeking. D. A. KUPFERSCHMIDT*; T. WANG; S.
ERB. Univ. of Toronto Scarborough.
9:00 Y8 164.6 Corticotropin releasing factor receptor
1 in the rat ventral tegmental area: A critical site for social
stress and intravenous cocaine taking. C. O. BOYSON*; T. T.
MIGUEL; J. F. DEBOLD; K. A. MICZEK. Tufts Univ., UFSCar/
UNESP-Araraquara.
10:00 Y9 164.7  •  Targeting cholinergic dysregulation
in cocaine addiction. D. C. MASH*; J. PABLO; X. XIE; J.
FFRENCH-MULLEN. Univ. Miami Miller Sch. Med., Ocimum
Biosolutions.
11:00 Y10 164.8 Alpha-1 adrenergic receptors modulate
the development and expression of cocaine sensitization in
rats. J. R. NIEVES-MELÉNDEZ; R. VÁZQUEZ-TORRES; M.
E. VÉLEZ-HERNÁNDEZ; M. C. VELÁSQUEZ-MARTÍNEZ;
N. G. SÁNCHEZ-DÍAZ; C. A. JIMENEZ-RIVERA*. Univ. of
Puerto Rico, Univ. Puerto Rico, Sch. Med.
8:00 Y11 164.9 Role of Elk-1 phosphorylation in
molecular, cellular and behavioural adaptations to cocaine.
A. BESNARD*; N. HECK; N. BOUVEYRON; V. KAPPÈS;
C. PAGÈS; P. VANHOUTTE; J. CABOCHE. Umrs952 -
Umr7224.
9:00 Y12 164.10 Prior motherhood affects drug-taking
behavior in the female rat. J. A. CUMMINGS*; J. B.
BECKER. Univ. of Michigan.
10:00 Y13 164.11 Pair-housing differentially affects
motivation for cocaine intake in male and female rats. C.
WESTENBROEK*; A. N. PERRY; J. B. BECKER. Univ. of
Michigan.
11:00 Y14 164.12 Variation in the propensity to attribute
incentive salience to a food cue predicts the attractiveness
of a cocaine cue. L. M. YAGER*; T. E. ROBINSON. Univ. of
Michigan.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
8:00 Y15 164.13 Neural response to drug-associated
odor cues in rats exposed to long-access cocaine self-
administration. H. LIU; S. CHEFER; H. LU; K. GUILLEM; W.
REA; P. KURUP; Y. YANG; L. PEOPLES; E. A. STEIN*. Nat’l
Inst. Drug Abuse-IRP, Univ. of Pennsylvania Med. Sch.
9:00 Y16 164.14 Analysis of altered mesolimbic dopamine
neurotransmission following “speedball” self-administration
using in vivo microdialysis and fast-scan cyclic voltammetry.
L. P. PATTISON*; S. MCINTOSH; B. M. HORMAN; E. A.
BUDYGIN; S. E. HEMBY. Wake Forest Univ.
10:00 Y17 164.15 Motivational processes alter A2A
receptor density, but not D2-like receptor density in ventral
striatum in a rat model of cocaine self-administration.
M. FRANKOWSKA*; D. MARCELLINO; K. WYDRA; E.
NOWAK; M. ZANIEWSKA; P. ADAMCZYK; L. AGNATI; M.
FILIP; K. FUXE. Karolinska Institutet, Inst. of Pharmacol.
Polish Acad. of Sci., Univ. of Modena, Reggio Emilia and
IRCCS Lido.
11:00 Y18 164.16 The effect of sv series compounds on
spontaneous and psychostimulant-dependent locomotor
activity. R. R. LUEDTKE*, Ph.D.; C. S. ELSKEN; S.
VANGVERVONG; R. H. MACH; M. J. FORSTER. Univ.
North Texas Hlth. Sci. Cter, Univ. of North Texas Hlth. Sci.
Ctr., Washington Univ. Sch. of Med.
8:00 Z1 164.17 Modulation of beta integrin function
upregulates GluR2 surface expression and MMP activity in
the nucleus accumbens after cocaine self-administration and
extinction. A. T. WIGGINS*; P. W. KALIVAS. Med. Univ. SC.
9:00 Z2 164.18 Variation in attributing incentive salience
to a food-related cue predicts motivation for cocaine and
cocaine-induced drug seeking. B. T. SAUNDERS*; T. E.
ROBINSON. Univ. of Michigan.
10:00 Z3 164.19 Long-term blockade of cocaine seeking in
rats treated with a viral vector encoding cocaine hydrolase.
J. J. ANKER*; S. BRIMIJOIN; Y. GAO; R. PARKS; N.
ZLEBNIK; P. REGIER; M. E. CARROLL. Univ. of Minnesota,
Mayo Clin., Ottawa Hlth. Res. Inst.
11:00 Z4 164.20 Combining cocaine hydrolase and anti-
cocaine antibody for interception of drug delivery to brain
and suppression of drug-induced locomotor behavior in
mice. Y. GAO; F. ORSON; T. KOSTEN; B. KINSEY; W.
BRIMIJOIN*. Mayo Clin., VAMC, Baylor Col. of Med.
8:00 Z5 164.21 Cocaine hydrolase alters iv cocaine self-
administration under progressive ratio (PR) and long access
(escalation). N. E. ZLEBNIK*; M. E. CARROLL; Y. GAO; S.
BRIMIJOIN; J. J. ANKER. Univ. of Minnesota, Mayo Clin.
9:00 Z6 164.22 Sirt1 regulates reward-related behaviors
within the nucleus accumbens. D. FERGUSON*; D. M.
DIETZ; I. MAZE; W. RENTHAL; P. KENNEDY; J. KOO; R.
NEVE; V. SARTORELLI; E. J. NESTLER. Mount Sinai Sch.
of Med., Univ. of Texas Southwestern Med. Ctr., MIT, Natl.
Inst. of Arthritis.
10:00 Z7 164.23 Hormone manipulations at puberty and
the effect of estradiol on cocaine self-administration in male
and female rats. A. N. PERRY*; C. WESTENBROEK; J. B.
BECKER. Univ. of Michigan.
11:00 Z8 164.24 Sex-specific sensitization of addiction-like
behaviors induced by prenatal stress. M. B. THOMAS*; M.
T. DASSANAYAKE; S. BHATNAGAR; J. B. BECKER. Univ.
Michigan, Univ. Pennsylvania.
8:00 Z9 164.25 Sex-specific effects of prenatal stress on
basal extracellular dopamine in the nucleus accumbens and
dorsal striatum. H. YANG*; M. B. THOMAS; J. B. BECKER.
Univ. Michigan, Univ. Michigan.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
9:00 Z10 164.26 Effect of estradiol on motivation for
cocaine and sucrose reward. C. P. RAMÔA*; S. E. DOYLE;
W. J. LYNCH. Univ. of Virginia.
10:00 Z11 164.27 Fos expression by systemic
administration of D3 receptor ligands. B. C. NOLAN*; S.
LIU; L. M. ROBERTSON; R. H. MACH; R. R. LUEDTKE; J.
L. NEISEWANDER. Arizona State Univ., Washington Univ.
Sun. AM
Sch. of Med., Univ. of North Texas Hlth. Sci. Ctr.
POSTER
165. Cannabinoids: Developmental Effects
Theme C: Disorders of the Nervous System
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 Z12 165.1  •  CB1R proximal signaling in CNS
neurons. N. N. SAKELLARIDIS*; O. ASIMAKI; D.
MANGOURA. Univ. Thessaly Sch. Med., Biomed. Res.
Fndn. of the Acad. of Athens.
9:00 Z13 165.2 Chronic treatment with cannabinoid
receptor agonist, CP 55,940, alters GLT1 expression
in adolescent rats. S. LEE*; G. V. REBEC. Program In
Neuroscience, Indiana Univ.
10:00 Z14 165.3 Repeated cannabidiol administration
decreases lymphocyte number in the spleen - Possible
involvement of CB2 receptors. B. M. IGNATOWSKA-
JANKOWSKA*; M. M. JANKOWSKI; W. GLAC; A. H.
SWIERGIEL. Dept. of Animal Physiology, Univ. of Gdansk.
11:00 AA1 165.4 Increased sensitivity to phencyclidine
after adolescent exposure to THC. T. RUBINO*; N. REALINI;
E. ZAMBERLETTI; P. PRINI; D. VIGANO’; D. PAROLARO.
Univ. of Insubria.
8:00 AA2 165.5 Chronic exposure to cannabinoids during
adolescence: Anxiety and depression in rats. A. L. MEDINA;
A. L. FURROW; P. A. JACKSON*. Radford Univ.
9:00 AA3 165.6 Proenkephalin in the nucleus accumbens
shell maintains the long-term effects of adolescent cannabis
exposure underlying subsequent addiction vulnerability. H.
C. TOMASIEWICZ*; M. B. WILKINSON; S. P. WILSON; E. J.
NESTLER; Y. L. HURD. Mount Sinai Sch. of Med., Univ. of
South Carolina Sch. of Med.
10:00 AA4 165.7 Prenatal cannabis exposure alters
the epigenetic regulation of dopamine receptor D2 gene
in the nucleus accumbens leading to persistent D2
receptor impairment in adulthood. J. DINIERI*; X. WANG;
H. SZUTORISZ; S. SPANO; P. CASACCIA; D. DOW-
EDWARDS; Y. HURD. Mount Sinai Sch. of Med., Karolinska
Inst., State Univ. of New York, Downstate Med. Ctr.
11:00 AA5 165.8 Early cannabis exposure: Genetic
contributions and epistatic interactions relevant to addiction
risk. M. M. JACOBS*; X. WANG; E. KELLER; D. DOW-
EDWARDS; Y. L. HURD. Mount Sinai Sch. of Med.,
Karolinska Inst., Semmelweis Univ., State Univ. of New York,
Downstate Med. Ctr.
8:00 AA6 165.9 Marijuana use and age of onset impacts
performance on the Wisconsin Card Sorting Task. M. K.
DAHLGREN*; M. T. RACINE; K. A. SAGAR; S. A. GRUBER.
McLean Hosp, McLean Hospital/Harvard Med. Sch.
9:00 AA7 165.10 Age of onset of marijuana use is
correlated with altered inhibitory function. S. A. GRUBER*;
M. DAHLGREN; K. SAGAR; M. RACINE. McLean Hospital/
Harvard Med. Sch., McLean Hospital,NeuroImaging Ctr.
Neuroscience 2010  |  Sunday AM  |  35 
 POSTER
166. Regulation of Behavior by Peptide Signaling
Theme C: Disorders of the Nervous System
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 AA8 166.1 Environmental enrichment induced
changes in CRF-R1 and NPY-R1 in the amygdala may be
instrumental in alleviating anxiety in an animal model for
PTSD. E. HENDRIKSEN*; R. PANDIT; R. SLIEKER; B.
OLIVIER; R. S. OOSTING. Utrecht Univ., Utrecht Inst. for
Pharmaceut. Sci.
9:00 AA9 166.2 Behavioral phenotype of rats knockout
for the nociceptin/orphanin FQ receptor gene. A. RIZZI*;
S. MOLINARI; M. MARTI; G. MARZOLA; M. MORARI; G.
CALO’. Univ. Ferrara.
10:00 AA10 166.3 Orexin-A changes the characteristics of
masticatory muscle activities in feeding behavior. T. TSUJI;
S. TANAKA*; T. INUI; S. BAKHSHISHAYAN; T. YAMAMOTO;
M. KOGO. Grad. Sch. of Dentistry, Osaka Univ., Osaka
Police Hosp., Grad. Sch. of Human Science, Osaka Univ.,
Grad. Sch. of Hlth. Science, Kio Univ.
11:00 AA11 166.4 Intracerebroventricular injection of
orexin-A induces an antidepressive-like effect through
hippocampal cell proliferation. N. ITO; T. YABE*; Y. GAMO;
T. NAGAI; T. OIKAWA; H. YAMADA; T. HANAWA. Kitasato
Univ.
8:00 AA12 166.5 Blockade of orexin-A receptor in the
ventral tegmental area suppressed the development
of conditioned place preference induced by chemical
stimulation of the lateral hypothalamus in the rats. Z.
TASLIMI*; M. HASSANPOUR-EZATTI; M. SAFARI; P. AZIZI;
A. HAGHPARAST. Neurosci. Res. Center, Shahid Beheshti
Univ. of Med. Sci., Fac. of Basic Sciences, Shahed Univ.
9:00 AA13 166.6  •  Influence of gamma- and beta-MSH
peptides on ethanol-induced antidepressant effect in
forced swim test in mice. B. JANSONE*; J. PUPURE; J.
RUMAKS; Z. DZIRKALE; S. SVIRSKIS; R. MUCENIECE; L.
KLIMAVICIUSA; V. MATTO; V. KLUSA. Univ. of Latvia.
10:00 AA14 166.7  •  Histone deacetylase inhibitors induce
partner preference in prairie voles. M. KABBAJ*; H. WANG;
Y. LIU; Z. WANG. Florida State Univ.
11:00 AA15 166.8 Treatment with dizocilpine (MK-801)
disrupts prepulse inhibition of the acoustic startle reflex
in male vasopressin 1b receptor knockout mice. M. B.
DHAKAR*; H. K. CALDWELL. Kent State Univ.
8:00 AA16 166.9 Adenoviral-mediated CRF hyper-
expression: Implications for a novel preclinical model of
depression. C. F. BORNA FARROKHI*; J. VIT; L. LACAYO;
M. G. CASTRO; C. MANALO; P. R. LOWENSTEIN;
M. PUNTEL; A. G. MUHAMMAD; K. C. REYES; R. N.
PECHNICK. Cedars Sinai Med. Ctr., Cedars-Sinai Med. Ctr.,
UCLA.
9:00 AA17 166.10  •  Individual differences in response
to social stress may predict susceptibility and resilience
to depression and cardiovascular co-morbidity: Role
of corticotropin-releasing factor. S. K. WOOD*; K. V.
MCFADDEN; D. E. GRIGORIADIS; S. BHATNAGAR; R. J.
VALENTINO. Children’s Hosp. of Philadelphia, Neurocrine
SLIDE
Biosciences, Inc.
10:00 AA18 166.11  •  Glutamate-vasopressin interactions and
AAS-induced aggression. M. C. CARRILLO*; L. RICCI; R.
MELLONI. Northeastern Univ.
36  |  Society for Neuroscience
11:00 BB1 166.12 Impaired prepulse inhibition of the
acoustic startle reflex in oxytocin receptor mice treated with
phencyclidine, but not dizocilpine (MK-801). M. E. RICH; O.
E. DIKE; H. LEE; W. S. YOUNG, III; H. K. CALDWELL*. Kent
State Univ., Kyungpook Natl. University/ Sch. of Dent., NIH.
8:00 BB2 166.13 Role of oxytocin/vasopressin system on
social behavior and fear response to predator in zebrafish.
D. BRAIDA; A. FINARDI; A. DONZELLI; V. CAPURRO; B.
CHINI; M. SALA*. Univ. Milan, CNR.
9:00 BB3 166.14 Neuropeptide S system on cue induced
reinstatement of cocaine seeking behavior. An effect
mediated by Hypocretin-1/Orexin-A activation on the lateral
hypothalamus. M. KALLUPI; G. DE GUGLIELMO; B.
RUGGERI; N. CANNELLA; L. SOVERCHIA; M. UBALDI;
S. STOPPONI; A. CIPPITELLI; R. CICCOCIOPPO*. Univ.
Camerino.
10:00 BB4 166.15  •  Analgesic effect of intranasal oxytocin in
chronic daily headache. J. A. MECHANIC*; D. R. JACOBS;
C. PASCUAL; M. S. ANGST; G. SPIERINGS; D. C.
YEOMANS. Trigemina, Inc, Stanford Univ., Medvadis Res.
Corp.
11:00 BB5 166.16 Contribution of CRF1 and CRF2
receptors to acute psychostimulant-induced hyperactivity
in mice. A. L. HALBERSTADT*; C. SCOTT; E. TSAN; M. A.
GEYER; V. B. RISBROUGH. UCSD.
8:00 BB6 166.17 Antidepressant-like effect of AMPA and
ketamine combination is associated with an increase in
hippocampal BDNF. L. AKINFIRESOYE*; B. H. BHATTI; J.
R. DAS; A. LOTFI; Y. TIZABI. Howard Univ. Col. of Med.
9:00 BB7 166.18 Repeated Forced swim Stress-induced
behavioral changes are associated with changes in GRK3
in rat Locus Coeruleus. K. SAHA; M. TANEJA; S. SALIM;
J. ZIBURKUS*; D. C. EIKENBURG. Univ. of Houston, Univ.
Houston.
10:00 BB8 166.19  •  Stimulation of the RXFP3 receptor
increases locomotor activity via the orexin system. S.
SUTTON*; J. SHELTON; R. GALICI; J. R. SHOBLOCK; B.
LORD; C. DUGOVIC; P. BONAVENTURE; T. LOVENBERG.
Johnson & Johnson, PRD, Johnson & Johnson PR&D.
POSTER
167. Peptide Regulation and Action
Theme C: Disorders of the Nervous System
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 BB9 167.1  •  Functional characterization of the
action of orexins in different CNS tissue models. O. H.
SCHROEDER*; J. SCHIMMEL; K. JÜGELT; L. WEBER; A.
GRAMOWSKI. NeuroProof GmbH, OntoChem GmbH, Univ.
of Rostock.
9:00 BB10 167.2 Regulation of different protein isoforms
of NFAT family by neuronal activity. H. VIHMA*; M.
LUHAKOODER; P. PRUUNSILD; T. TIMMUSK. Tallinn Univ.
of Technol.
10:00 BB11 167.3 Molecular cloning of neuropeptide F
(NPF)-encoding precursors from the shrimp Litopenaeus
vannamei and Melicertus marginatus. A. E. CHRISTIE*; J.
M. JACKSON; M. C. CHAPLINE; P. H. LENZ. MDI Biol. Lab.,
Univ. of Hawaii at Manoa.
11:00 BB12 167.4 Distinct regulation of NFATc3 and NFATc4
in central and peripheral neurons. J. D. ULRICH*; M. KIM; Y.
M. USACHEV. Univ. of Iowa.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
8:00 BB13 167.5 Regulation of human prodynorphin gene
(PDYN) expression by REST and miR-9. R. HENRIKSSON;
C. M. BÄCKMAN; B. K. HARVEY; G. BAKALKIN; T. S.
SHIPPENBERG*. NIDA-IRP/NIH/DHHS, Cell. Neurobio.
Res. Branch/NIDA-IRP/NIH/DHHS, Neural Protection and
Regeneration Section/NIDA-IRP/NIH/DHHS, Biol. Res. on
Drug Dependence/Pharmaceutical Biosciences/Uppsala
Univ.
9:00 BB14 167.6 The distribution of neuropeptides in the
CNS of Mantophasmatodea. D. M. LANG*; S. KREISSL.
Univ. Cape Town, Univ. of Konstanz.
10:00 BB15 167.7 The opioid growth factor receptor
(OGFr) is dependent on karyopherin β and Ran for
nucleocytoplasmic transport. I. S. ZAGON*; F. CHENG; P. J.
MCLAUGHLIN. Penn State Univ. Coll Med.
11:00 BB16 167.8  •  DREAM mediates prodynorphin and
dynorphin expression in astrocyte. F. SUN; J. WANG; X.
YUE; J. TENG; J. CHEN; A. C. YU*. Peking Univ., Col. of
Life Sciences, Peking Univ.
8:00 BB17 167.9 Genome-wide characterization of
signaling peptides in Aplysia and related molluscs: Insights
into memory mechanisms and neuronal evolution. A.
KOHN; M. CITTARELLA; E. BOBKOVA; F. XIE; X. HOU; E.
ROMANOVA; J. V. SWEEDLER; L. L. MOROZ*, Prof. Univ.
Florida, Univ. of Illinois, Univ. of Florida.
9:00 BB18 167.10 Biological effects of urease-related
peptides on the central nervous system of a disease
vector insect. B. P. SETTEMBRINI*; A. GONZALEZ; M. F.
CORONEL; S. NOWICKI; L. E. CANAVOSO; M. POSTAL;
M. S. DEFFERRARI; C. R. CARLINI. Museo Argentino De
Ciencias Naturales, IBYME-Conicet, CEDIE-Conicet, Univ.
Nac. Córdoba, CIBICI-CONICET., Dept. de Biotecnología,
Univ. Federal de Rio Grande do Sul.
10:00 CC1 167.11 Internalization of the opioid growth factor
([Met5]-enkephalin) is dependent on clathrin-mediated
endocytosis. P. J. MCLAUGHLIN*; F. CHENG; I. S. ZAGON.
Penn State Univ. Coll Med.
11:00 CC2 167.12 A novel role for GDNF receptor, GFR
alpha-1, in dopamine regulation in vivo. B. S. PRUETT*; M.
F. SALVATORE. Louisiana State Univ. HSC.
8:00 CC3 167.13 Intracellular pathways activated by
Insulin-like growth factor 1 and its derivates. D. TROPEA*;
I. MOLINOS; G. LITTLE; K. J. MITCHELL; A. P. CORVIN.
Trinity Col. Dublin.
9:00 CC4 167.14 In vitro study of motilin action on
the medial vestibular nuclear neurons. H. TODAKA*; T.
TATSUKAWA; T. YAMAZAKI; Y. YANAGAWA; K. SHIBUKI;
S. NAGAO. RIKEN Brain Sci. Inst., Niigata Univ. Brain Res.
Inst., RIKEN BSI, Gunma Univ.
10:00 CC5 167.15 Hypoxia-inducible expression of vascular
endothelial growth factor stimulates neuroprotection and
neurogenesis in organotypic spinal cord slice culture. S. AN*.
younsei university.
11:00 CC6 167.16 Methylation of the enkephalin-encoding
sequences in the human prodynorphin gene: Specific
patterns in brain and peripheral tissues. G. Y. BAKALKIN*;
O. KONONENKO; M. TAQI; H. WATANABE; O. KRISHTAL;
F. NYBERG; T. YAKOVLEVA; I. BAZOV. Dept. of
Pharmaceut. Biosciences, Uppsala Univ., Bogomoletz Inst.
of Physiol.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
8:00 CC7 167.17 In vivo neurochemical characterization of
a selective orexin-2 receptor antagonist. I. FRASER*; L. E.
ALUISIO; C. DUGOVIC; J. E. SHELTON; S. W. SUTTON; P.
BONAVENTURE; C. A. DVORAK; N. I. CARRUTHERS; T.
W. LOVENBERG. Johnson & Johnson.
Sun. AM
POSTER
168. Regulation of Behavior by Aminergic Signaling
Theme C: Disorders of the Nervous System
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 CC8 168.1 Role of dopamine and serotonin
receptors in orbitofrontal cortex on impulsive choice in rats.
C. D. GIPSON*; J. L. PERRY; A. C. MEYER; J. YATES; J. S.
BECKMANN; M. T. BARDO. Univ. of Kentucky, Kalamazoo
Col.
9:00 CC9 168.2 Individual differences in reward seeking
and inhibition: Role of cortical monoamine transporters. M.
DARNA*; J. A. MARUSICH; M. T. BARDO; L. P. DWOSKIN.
Univ. of Kentucky.
10:00 CC10 168.3  •    A novel, non-imidazole-containing
H3 antagonist alleviates delayed spatial alternation
deficits in a rat model of NMDA receptor hypofunction. M.
BLANKENSHIP; M. S. GRIFFITH; M. E. BARDGETT*.
Northern Kentucky Univ.
11:00 CC11 168.4 Effects of norepinephrine transporter
overexpression in the locus ceruleus on depressive-like
behaviors. H. KIM*; H. KIM; S. KANG; S. CHOI; S. SHIN; K.
SHIN. Korea Univ., Coll. of Med.
8:00 CC12 168.5 A selective dopaminergic agonist for
D3 receptors, PD 128907, induced place preference as
cocaine, whatever animal models tested. Y. ZENGIN*; H.
DENIZOT; N. AUTHIER; P. M. LLORCA; F. DURIF. CHU
Gabriel Montpied - CMPB Service Pr PM LLORCA, Clermont
Université, EA3845, Clermont Université, UMR INSERM
766, CHU Gabriel Montpied - Service de Neurologie A.
9:00 CC13 168.6 Differential effects of NGB 2904 and
nafadotride on acquisition and expression of conditioned
catalepsy in rats. T. J. BANASIKOWSKI*; R. J. BENINGER.
Queen’s Univ.
10:00 CC14 168.7 The 5-HT2C receptor agonist Ro60-
0175 and the 5-HT2A receptor antagonist M100907 reduce
impulsive action induced by amphetamine, cocaine and
MK801. P. J. FLETCHER*; Z. RIZOS; K. NOBLE; G. A.
HIGGINS. Ctr. For Addiction & Mental Hlth., Univ. of Toronto,
CanCog Technologies.
11:00 DD1 168.8 Receptor-specific serotonergic
modulation of PPI in the acoustic startle pathway in goldfish.
H. NEUMEISTER; V. MEDAN; J. FICEK; N. JOSEPH; T.
PREUSS*. CUNY, Hunter Col.
8:00 DD2 168.9 Participation of the serotonergic system in
the antidepressant-like effects induced by mineralocorticoid
and glucocorticoid antagonists in the lateral septum and
amygdala. C. LOPEZ-RUBALCAVA*; C. R. MOSTALAC-
PRECIADO; P. DE GORTARI. CINVESTAV-IPN, Inst.
Nacional de Psiquiatría.
9:00 DD3 168.10  •  Behavioral and electrophysiological
studies of the ventral tegmental area after traumatic
stress. N. S. CORRAL-FRIAS*; S. W. BROOKSHIRE; K.
EDELMAN-VOGELSANG; J. L. VALDÉS; E. D. FRENCH; J.
FELLOUS. Univ. Arizona, Univ. of Arizona, Univ. de Chile.
Neuroscience 2010  |  Sunday AM  |  37 
 10:00 DD4 168.11 Adolescent rats are less sensitive to the
anxiogenic and serotonin releasing effects of fenfluramine.
A. E. ARRANT*; H. JEMAL; C. M. KUHN. Duke Univ., Texas
A&M University-Commerce.
11:00 DD5 168.12 Long-term neurodevelopmental sequelae
of adolescent olanzapine exposure: Behavioral effects. J. A.
MILSTEIN*; M. VINISH; J. K. ENOS; T. ADLE; S. ROBSON;
B. E. KOLB; D. O. FROST. Univ. of Maryland, Baltimore,
Univ. of Lethbridge.
8:00 DD6 168.13 Integrating dopamine, serotonin, and
GABA neural systems in the lateral anterior hypothalamus
of aggressive adolescent AAS-treated Syrian hamsters. J. J.
SCHWARTZER*; R. H. MELLONI, Jr. Northeastern Univ.
9:00 DD7 168.14 Behavioral outcomes of mice prenatally
exposed to Fluoxetine. V. KIRYANOVA*; R. DYCK. Univ. of
Calgary.
10:00 DD8 168.15 Adolescent olanzapine treatment induces
long-lasting changes in dopamine receptor binding. A.
ELNABAWI; J. A. MILSTEIN; M. VINISH*; J. K. ENOS; I.
MERCHENTHALER; B. E. KOLB; D. O. FROST. Univ. of
Maryland,, Univ. Maryland, Neurosci. Program, Univ. of
Lethbridge.
11:00 DD9 168.16  •  Age differences in methylphenidate
dose-response in rats in a test of activity and response
to spatial novelty. B. LEVANT*; T. J. ZARCONE; S. C.
FOWLER. Univ. Kansas Med. Ctr., Univ. Rochester Sch.
Med.
8:00 DD10 168.17 Zolmitriptan, a serotonin 1B/D agonist,
reduces human aggression. J. L. GOWIN*; S. LANE; A.
SWANN; F. G. MOELLER. Univ. of Texas Hlth.
9:00 DD11 168.18  •  Characterization of the 5-HT6 receptor
antagonist, SB-742457, on cognitive test performance
in the rat. G. A. HIGGINS; L. SILENIEKS; W. LAU; S.
THEVARKUNNEL*; A. HENDERSON; N. MOORE. CanCog
Technologies, Univ. of Toronto, AMRI.
10:00 DD12 168.19  •  The selective 5-HT2C receptor agonist,
lorcaserin, reduces indices of nicotine reward as well as food
intake in the rat. G. A. HIGGINS*; L. SILENIEKS; Z. RIZOS;
K. NOBLE; P. J. FLETCHER. Cancog Technologies, U.
Toronto, CAMH.
11:00 DD13 168.20 Intrapallidal injection of histamine H 3 geniculate body modulated by thalamic reticular nucleus. G.
receptor agonist (immepip) decrease turning behavior in
hemiparkinsonian rats. M. GARCIA-RAMIREZ*; A. DE
LA PEÑA-OROZCO; L. VARGAS. Escuela Nacional De
Ciencias Biologicas.
8:00 DD14 168.21 The effects of eltoprazine, a 5-HT1A/1B
receptor agonist, on monoamine release in the prefrontal
cortex, on brain reward and impulsivity. J. PRINS*; R. S.
OOSTING; R. DUPREE; G. A. H. KORTE-BOUWS; P. J.
KENNY; B. OLIVIER; S. M. KORTE. Utrecht Univ., Rudolf
Magnus Inst. of Neurosci., Utrecht Inst. for Pharmaceut. Sci.,
The Scripps Res. Inst.
9:00 EE1 168.22 Distinct arousal states are induced
by monoaminergic and cholinergic stimulation during
isoflurane general anesthesia. K. SOLT*; J. F. COTTEN; A.
CIMENSER; E. N. BROWN. Massachusetts Gen. Hosp.,
Harvard Med. Sch., MIT, Harvard - MIT Div. of Hlth. Sci. and
Technol.
SLIDE
10:00 EE2 168.23 A re-evaluation and extension
of the behavioral and neurochemical phenotype of
dopamine transporter (DAT)-deficient mice; a model for
neuropsychiatric disorders. M. A. FOX*; M. G. PANESSITI; F.
S. HALL; G. R. UHL; D. L. MURPHY. NIMH, NIDA.
38  |  Society for Neuroscience
11:00 EE3 168.24  •  Preclinical investigations into the
neurochemical profile of SUVN-G1031, a novel histamine H3
receptor antagonist. V. KANDIKERE*; N. R. MUDDANA; R.
S. SARALAYA; V. S. BENADE; R. K. PONNAMANENI; S. M.
IRAPPANAVAR; G. BHYRAPUNENI; V. PALANI; A. SHINDE;
A. R. DWARAMPUDI; A. DESHPANDE; R. KAMBHAMPATI;
R. NIROGI. Suven Life Sci.
8:00 EE4 168.25  •  Procognitive properties of
SUVN-G1031, a novel selective H3 receptor antagonist in rat
models of cognitive deficits. D. SHANMUGANATHAN*; M.
R. BABU; K. BABURAO; R. ABRAHAM; P. JAYARAJAN; S.
L. JABARIS; V. GOURA; R. YARAMASU; K. MARIMUTHU;
V. KANDIKERE; N. R. MUDDANA; A. SHINDE; A.
DESHPANDE; A. R. DWARAMPUDI; R. KAMBHAMPATI; R.
SUBRAMANIAN; V. R. MEKALA; R. NIROGI. Suven Life Sci.
9:00 EE5 168.26 Involvement of the endocannabinoid
system in the development of quinpirole sensitization.
D. JACKLIN*; M. TUCCI; R. SHARMA; B. GREENE; A.
ALKHATIB; D. GRAHAM; H. SZECHTMAN. McMaster Univ.
10:00 EE6 168.27 LSD- and DOM-induced head twitch
response is not blocked by inhibition of presynaptic
glutamate release in the medial prefrontal cortex of rats. C.
L. FEENEY; D. J. LEE; J. C. WINTER; R. A. RABIN; A. C.
THOMPSON*. Univ. Buffalo.
11:00 EE7 168.28 Model of sexual side effects of
antidepressant medication: Imipramine-induced rapid
ejaculation in rats. I. V. BELOZERTSEVA*. Pavlov State
Med. Univ., Almazov Federal Heart, Blood and Endrocrinol.
Ctr.
POSTER
169. Auditory Processing: Adaptation, Learning, and Memory
Theme D: Sensory and Motor Systems
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 EE8 169.1 Habituation and stimulus specific
adaptation in the optic tectum of the barn owl. Y.
GUTFREUND*; S. NETZER. The Technion.
9:00 EE9 169.2  •  Stimulus specific adaptation in medial
LIXIA*. Hongkong Polytechnic Univ.
10:00 EE10 169.3 Responses to sound sequences in
auditory cortex: Beyond the oddball paradigm. I. NELKEN*;
A. YARON; N. TAASEH; I. HERSHENHOREN. Hebrew Univ.
11:00 EE11 169.4 Frequency and duration oddball effects
in the auditory cortex of the mouse characterized with ERP
recordings. J. GARCIA-LAZARO; J. W. SCHNUPP*. Oxford
Univ.
8:00 EE12 169.5  •  Long-term potentiation induced by
combined electrical and acoustic stimulation in rat auditory
cortex. X. LI*; J. HE. The Hong Kong Polytechnic Univ., Inst.
of Biophysics, Chinese Acad. of Sci.
9:00 EE13 169.6  •  Is a profession-specific acoustic signal
important for auditory processing? - Observations in hearing
impaired professional musicians and industrial workers. E.
EMMERICH*; M. ENGELMANN; F. RICHTER. Friedrich
Schiller Univ. Jena.
10:00 EE14 169.7 Sound-guided plasticity of auditory
thalamus by cholinergic pedunculopotine tegmental nucleus.
F. LUO*; X. LIU; J. YAN. Hotchkiss Brain Institute, Univ. of
Calgary.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
11:00 EE15 169.8 Speech motor learning results in specific
changes in speech perception. A. ROCHET-CAPELLAN*; W.
CHEN; D. J. OSTRY. McGill.
8:00 EE16 169.9 Optical imaging of plastic changes
induced by fear conditioning in the auditory cortex. Y. IDE*;
M. TSUKADA; T. AIHARA. Tamagawa Univ. Brain Sci. Inst.,
Fac. of Engineering, Tamagawa Univ.
9:00 EE17 169.10 Correlating auditory cortical expression
of Arc/Arg 3.1 mRNA to communicative significance. T.
IVANOVA; C. GROSS; G. J. BASSELL; R. C. LIU*. Emory
Univ.
10:00 EE18 169.11 Pharmacological evaluation of dynamic
causal models for event-related responses. F. JUNG*; R.
J. MORAN; M. TITTGEMEYER; H. ENDEPOLS; R. GRAF;
R. J. DOLAN; K. J. FRISTON; K. E. STEPHAN. Max
Planck Inst. For Neurolog. Res., Wellcome Trust Ctr. for
Neuroimaging, Lab. for Social and Neural Systems Res.
11:00 FF1 169.12 Auditory n1 and change-evoked n1. M.
NISHIHARA*; K. INUI; T. USHIDA; R. KAKIGI. Aichi Med.
Univ., Natl. Insutitute for Physiological Sci.
8:00 FF2 169.13  •  Neural correlates of non-native accent
perception. P. E. BESTELMEYER*; D. R. LADD; P. BELIN.
Univ. of Glasgow, Univ. of Edinburgh, BRAMS.
9:00 FF3 169.14 A prototype-based multidimensional
voice space: behavioural and fMRI evidence. M. LATINUS*;
P. BELIN. Univ. of Glasgow, Intl. Lab. for Brain, Music and
Sound Research, Univ. de Montreal & McGill Univ.
10:00 FF4 169.15  •  Cortical auditory adaptation in the
awake rat and the role of potassium currents. M. V.
SANCHEZ-VIVES*; J. ABOLAFIA; M. M. ARNOLD; R.
VERGARA; R. REIG. IDIBAPS (Institut D’Investigacions
Biomediques August Pi I Sunyer), ICREA.
POSTER
170. Auditory Processing: Perception, Action, and Behavior
Theme D: Sensory and Motor Systems
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 FF5 170.1 Leftward lateralization of auditory cortex
underlies holistic sound perception in Williams syndrome.
M. WENGENROTH; M. BLATOW*; M. BENDSZUS; P.
SCHNEIDER. Univ. of Heidelberg.
9:00 FF6 170.2 Music and mu rhythms. M. D.
SCHALLES*; N. B. BRESLER; J. A. PINEDA. Univ.
California San Diego.
10:00 FF7 170.3 In vivo pH imaging of auditory stimulation-
induced neural activity in female zebra finch. F. TAKAYAMA*;
H. HARUHITO; K. HOTTA; K. OKA. Keio Univ., Hokkaido
university.
11:00 FF8 170.4 Effects of noise on the behavioral
detection of tones by nonhuman primates. M. E. DYLLA; C.
W. RICE; R. RAMACHANDRAN*. Wake Forest Univ. Hlth.
Sci.
8:00 FF9 170.5 Judgment of perceptual synchrony
between two pulses and its relation to the auditory brainstem
response. E. AIBA; T. SHIMOTOMAI*; K. KAZAI; N.
NAGATA; M. TSUZAKI. Kwansei-Gakuin Univ., Tamagawa
Univ., Kyoto City Univ. of Arts.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
9:00 FF10 170.6 Premotor activity in auditory-motor
integration during music performance. R. BROWN*; J.
CHEN; A. HOLLINGER; V. PENHUNE; C. PALMER; R.
ZATORRE. McGill Univ., Univ. of Oxford, Concordia Univ.
10:00 FF11 170.7 Brain activities for audiomotor integration
in pitch regulation using simplified musical instrument. R.
TACHIBANA*; M. YANAGIDA; H. RIQUIMAROUX. Doshisha
Sun. AM
Univ.
11:00 FF12 170.8 Primary auditory cortex is necessary
for fine-grained loudness discrimination in humans. A. R.
DYKSTRA*; C. K. KOH; L. D. BRAIDA; M. J. TRAMO.
Harvard-MIT Div. of Hlth. Sci. and Technol., Massachusetts
Gen. Hosp. and Harvard Med. Sch., David Geffen Sch. of
Med. at UCLA.
8:00 FF13 170.9 Effector-specific effect of self-articulatory
movement on speech perception. T. MOCHIDA*; T. KIMURA;
S. HIROYA; N. KITAGAWA; H. GOMI; T. KONDO. NTT
Communication Sci. Labs.
9:00 FF14 170.10 Song recognition is invariant to absolute
pitch shifts in the European Starling. M. R. BREGMAN; A. D.
PATEL*; T. Q. GENTNER. UCSD, Neurosci Inst.
10:00 FF15 170.11 Tinnitus-associated plasticity in auditory
cortex of Mongolian gerbils. S. AHLF*; K. TZIRIDIS; H.
SCHULZE. Univ. of Erlangen-Nuremberg.
11:00 FF16 170.12 Neural correlates of interaural temporal
integration in duplex speech perception. M. SABRI*; E.
LIEBENTHAL; A. DESAI; J. MANGALATHU. Med. Col.
Wisconsin, Natl. Res. Council Inst. for Biodiagnostics.
8:00 FF17 170.13 Effects of hearing aid use on sound
processing in primary auditory cortex of Mongolian gerbils.
K. TZIRIDIS*; S. AHLF; H. SCHULZE. Univ. of Erlangen-
Nuremberg.
9:00 FF18 170.14 Comprehension of modulation filtered
phonemes. W. DE HEER*; F. THEUNISSEN. Dept. of
Psychology, Univ. of California.
10:00 FF19 170.15 Simultaneous neural and behavioural
assessment of pitch discrimination in freely moving ferrets. J.
K. BIZLEY*; K. M. WALKER; F. R. NODAL; A. J. KING; J. W.
SCHNUPP. Univ. Oxford.
11:00 FF20 170.16 Tone-sequence sensitivity of neurons in
the primary auditory cortex of adult rats induced by training.
X. ZHOU*; M. M. MERZENICH. East China Normal Univ.,
Univ. of California.
8:00 GG1 170.17 Effects of speech sound naturalness
on the neural basis of formant frequency discrimination. S.
HIROYA*; F. H. GUENTHER. NTT Corp., Boston Univ.
9:00 GG2 170.18 Acoustic structure of the five perceptual
dimensions of timbre in orchestral instruments. T. M.
ELLIOTT*; L. S. HAMILTON; F. E. THEUNISSEN. UC
Berkeley.
10:00 GG3 170.19 Connectivity of the planum temporale: A
DTI study. A. ISENBERG*; L. MUFTULER; G. HICKOK. UC
Irvine.
11:00 GG4 170.20 High-dimensional anatomical
normalization is more effective at compensating for inter-
subject variability in the location of fMRI activation in sensory
than in higher-level association areas. A. TAHMASEBI;
H. HAKYEMEZ; C. WILD; J. RODD; M. DAVIS; I. S.
JOHNSRUDE*. Univ. of Toronto, Queen’s Univ., Univ. Col.
London, MRC Cognition and Brain Sci. Unit.
Neuroscience 2010  |  Sunday AM  |  39 
 8:00 GG5 170.21 Peripheral auditory dysfunction in tinnitus
subjects with clinically normal hearing. I. KNUDSON*; J.
GU; C. A. SHERA; B. HERRMANN; R. A. LEVINE; J. R.
MELCHER. Massachusetts Eye & Ear Infirmary/Harvard
Med. Sch., MIT, Massachusetts Gen. Hosp.
9:00 GG6 170.22 Evidence for depression of auditory
cortical synapses in tinnitus and its reversal in residual
inhibition. L. E. ROBERTS*; D. J. BOSNYAK. McMaster
Univ.
10:00 GG7 170.23 Limbic and auditory contributions to
tinnitus. A. M. LEAVER*; L. RENIER; A. SEYDELL; M. A.
CHEVILLET; S. MORGAN; H. J. KIM; J. P. RAUSCHECKER.
Georgetown Univ. Med. Ctr., Univ. Catholique de Louvain.
11:00 GG8 170.24  •  Treating tinnitus with targeted neural
plasticity. M. P. KILGARD*; N. D. ENGINEER; J. RILEY; J.
SEALE; W. VRANA; J. SHETAKE; S. SUDANAGUNTA; M.
BORLAND. Univ. of Texas At Dallas, MicroTransponder. Inc.
8:00 GG9 170.25 A cerebellar contribution to chronic
tinnitus in an animal model. T. J. BROZOSKI*; C. A. BAUER.
SIU Sch. of Med.
9:00 GG10 170.26 Effects of narrow-band noise exposure
on auditory and somatosensory inputs of the dorsal cochlear
nucleus in guinea pigs. S. DEHMEL; K. ANDERSON; M.
PARIKH; S. E. SHORE*. Univ. Michigan.
10:00 GG11 170.27 Body color regulates the decision
to startle in fish. K. W. WHITAKER*; M. I. ALVAREZ; T.
PREUSS; H. A. HOFMANN. The Univ. of Texas At Austin,
Army Res. Lab., Crockett High Sch., Hunter Col. of CUNY,
The Univ. of Texas at Austin.
POSTER
171. Retina: Photoreceptors
Theme D: Sensory and Motor Systems
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 GG12 171.1 Cone arrestin regulates cone response
inactivation to confer vision of high temporal resolution. S.
L. RENNINGER*; M. GESEMANN; O. BIEHLMAIER; S. C.
NEUHAUSS. Inst. of Mol. Life Sciences, Univ. of Zurich, Inst.
for Biochemistry, ETH Zurich.
9:00 GG13 171.2 Structural & functional changes in the
hibernating ground squirrel photoreceptor ribbon synapse. J.
G. POPE*; S. CHEN; C. GRAYDON; F. QIAO; B. KACHAR;
W. LI. Natl. Eye Inst., Natl. Inst. on Deafness and Other
Communication Disorders.
10:00 GG14 171.3 Mutations in an L-type voltage-dependent
calcium channel disrupt cone photoreceptor synaptic ribbon
formation in zebrafish. S. JIA*; M. R. TAYLOR. St Jude
Children’s Res. Hosp.
11:00 GG15 171.4 Colour blind sharks: Embryogenesis and
development of a single class of long wavelength sensitive
cone photoreceptor. N. S. HART; B. K. HARAHUSH; S. P.
COLLIN*. Univ. of Western Australia, Univ. of Queensland.
8:00 GG16 171.5 Matrix metalloproteinase-9 enhances the
ligand sensitivity of cone photoreceptor cyclic nucleotide-
gated channels. P. C. MEIGHAN; S. E. MEIGHAN; E. D.
SLIDE
RICH; M. D. VARNUM*. Washington State Univ.
9:00 HH1 171.6 Thyroid hormone receptors beta action
during mouse retinal development is required for normal
chromatic discrimination. P. F. GARDINO*; C. N. PESSÔA;
C. C. PAZOS-MOURA; T. M. ORTIGA-CARVALHO. Inst. de
Biofísica Carlos Chagas Filho / UFRJ.
40  |  Society for Neuroscience
10:00 HH2 171.7  •  Rod and cone photoreceptor
contributions to scotopic, mesopic and photopic vision in
mice. N. M. ALAM*; C. M. ALTIMUS; R. M. DOUGLAS; S.
HATTAR; G. T. PRUSKY. Burke-Cornell Med. Res. Inst.,
Johns Hopkins Univ., Univ. of British Columbia.
11:00 HH3 171.8 The scotopic action spectra of intrinsic
signals of the retina reveal a rod-driven mechanism. J. B.
SCHALLEK*; D. Y. TS’O. SUNY Upstate Med. Univ.
8:00 HH4 171.9 Rod single photon responses are
stabilized by calcium feedback to cGMP synthesis. O.
GROSS*; E. N. PUGH, Jr; M. E. BURNS. Univ. of California,
Davis.
9:00 HH5 171.10 Experimental protocols alter
phototransduction: The implications for retinal processing
at visual threshold. A. W. AZEVEDO*; F. RIEKE. Univ. of
Washington, HHMI.
10:00 HH6 171.11 Palmitoylation stabilizes unliganded rod
opsin. A. MAEDA*; K. OKANO; P. S. PARK; J. LEM; R. K.
CROUCH; T. MAEDA; K. PALCZEWSKI. Case Western
Reserve Univ., Tufts Med. Ctr., Med. Univ. of South Carolina.
11:00 HH7 171.12 Analysis of noise and response variability
in rabbit rod photoreceptors. A. R. CASTI*; B. TREXLER.
Mount Sinai Sch. of Med.
8:00 HH8 171.13 Assessing the temporal contrast
sensitivity function (TCSF) in a young healthy population. J.
C. WONG*; B. R. HAMMOND, JR. Univ. of Georgia.
9:00 HH9 171.14 The association between retinitis
pigmentosa related gene SEMA4A and endoplasmic
reticulum stress. K. TSURUMA; M. SHIMAZAWA*; H. HARA.
Mol. Pharmacology, Dept Biofunctional Evaluation, Gifu
Pharmaceut. Univ.
10:00 HH10 171.15 In vitro modeling of retinal degeneration
using patient-specific induced pluripotent stem cells.
Z. JIN*; S. OKAMOTO; F. OSAKADA; K. HOMMA; J.
ASSAWACHANANONT; T. IWATA; M. TAKAHASHI. RIKEN
Ctr. for Developmental Biol., Salk Inst. for Biol. Studies, Natl.
Inst. of Sensory Organs, Ctr. for iPS Res. and Application,
Kyoto Univ.
11:00 HH11 171.16 The oxysterol 27-hydroxycholesterol
increases β-amyloid and oxidative stress in retinal pigment
epithelial cells. B. C. DASARI*; O. GHRIBI. Univ. of North
Dakota.
8:00 HH12 171.17 Curcumin protects against hydrogen
peroxide-induced apoptotic cell death in ARPE-19 by
reducing oxidative stress and stabilizing Bcl-2/BAX ratio.
K. KHANOBDEE*; N. WANNASILP; Y. KITIYANANT; K.
WONGPRASERT. Inst. of Science, Suranaree Univ. of
Technol., Fac. of Science, Mahidol Univ.
9:00 HH13 171.18 Mutation in dSans, a Drosophila homolog
of human Usher syndrome type 1G, affects the ERG
phenotype. S. SHINO*; E. KIM; H. LEUNG; W. L. PAK.
Purdue Univ.
10:00 HH14 171.19  •  Intrinsic signals in different layers of
macaque retina revealed by optical coherence tomography
(OCT). W. SUZUKI*; G. HANAZONO; T. NANJO; K. ITO; J.
NISHIYAMA; M. TANIFUJI; K. TSUNODA. RIKEN BSI, Natl.
Inst. of Sensory Organs, Nidek Co., LTD.
11:00 HH15 171.20 Light-induced photoreceptor
neurodegeneration involves Zn2+ toxicity: protection by
pyruvate or nicotinamide in vitro and in vivo. C. T. SHELINE*;
S. BAI. LSU Hlth. Sci. Ctr.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
8:00 HH16 171.21 Topical ocular administration of BDNF
protects photoreceptors from light-induced degeneration.
L. DOMENICI*; N. ORIGLIA; E. CERRI; M. SANSÒ; L.
GIOVANNINI. CNR, Univ. of L’Aquila, Farmigea SpA, Univ. of
Pisa.
9:00 HH17 171.22 Macular pigment and its relation to body
composition. E. R. BOVIER*; R. LEWIS; M. N. ASEF; J. K.
CRABBE; B. R. HAMMOND, Jr. The Univ. of Georgia.
10:00 HH18 171.23 Ultra-high photosensitivity vertical
nanowire arrays for retinal prosthesis. M. L. KHRAICHE*;
G. SILVA; G. CAUWENBERGHS; Y. LO; D. WANG; W.
FREEMAN. UCSD, Jacobs Retina Center,.
11:00 HH19 171.24 Developmental loss of ipRGCs causes a
lengthened free-running circadian period. K. S. CHEW*; D.
S. MCNEILL; J. L. ECKER; S. HATTAR. Johns Hopkins Univ.
8:00 HH20 171.25 Circadian phase-dependent modulation
of L-type voltage-gated calcium channels by calcineurin in
chick retinal photoreceptors. C. C. HUANG; M. L. KO; G. Y.
KO*. Texas A&M Univ.
9:00 II1 171.26 Comprehensive map of melanopsin-
expressing retinal ganglion cells in mouse. S. PANDA*; S. R.
KEDING; M. HATORI. Salk Inst.
10:00 II2 171.27 Developing tools to understand zebrafish
melanopsin gene function. V. MATOS-CRUZ*; S. HATTAR;
M. E. HALPERN. Carnegie Inst. For Sci., Johns Hopkins
Univ.
11:00 II3 171.28 Light adaptation and sustained signaling
by melanopsin retinal ganglion cells. M. H. DO*; K. YAU.
Johns Hopkins Univ. Sch. of Med.
8:00 II4 171.29 Characteristics of light elicited currents of
crayfish photoreceptors and their dependence on circadian
time. B. FUENTES-PARDO*; C. BARRIGA-MONTOYA; F.
GÓMEZ-LAGUNAS. Univ. Nacional Autónoma de México.
9:00 II5 171.30 Identification of a pkc-dependent
mechanism of modulation of the dim light response in retinal
rod bipolar cells. M. F. RAMPINO*; S. NAWY. Albert Einstein
Col. of Med.
POSTER
172. Visual Cognition: Attention and Decision Making I
Theme D: Sensory and Motor Systems
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 II6 172.1 Context-dependent gating of sensory
signals for decision making. V. MANTE*; W. T. NEWSOME.
Stanford/HHMI.
9:00 II7 172.2 Neural correlates of perceptual decisions
by population activity in primate V1. C. A. MICHELSON;
W. S. GEISLER*; Y. CHEN; E. SEIDEMANN. Univ. Texas
Austin.
10:00 II8 172.3 Scalar timing law for interval timing in a
plastic network of spiking neurons. H. Z. SHOUVAL*; J. P.
GAVORNIK. Univ. Tex Medl Schl Houston, MIT.
11:00 II9 172.4 Trial-to-trial variability of the putative
pyramidal prefrontal neurons reveals the nature of their
engagement in a motion discrimination task. C. R. HUSSAR;
T. PASTERNAK*. Univ. Rochester.
8:00 II10 172.5 Effects of stimulus conditions on cortical
readout from three areas in the dorsal visual pathway. I.
KANG*; J. H. R. MAUNSELL. Harvard Med. Sch., HHMI.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
9:00 II11 172.6 Motion discrimination under uncertainty
and ambiguity. J. P. KALISVAART*; I. KLAVER; J.
GOOSSENS. Radboud Univ. Med. Centre, Donders Inst. For
Brain, Cognitition & Behavior.
10:00 II12 172.7 The development of other race effect in
face recognition: Evidences in a cross-cultural study. A. M.
FIORAVANTI-BASTOS*; A. FILGUEIRAS; J. LANDEIRA-
Sun. AM
FERNANDEZ. PUC-Rio, UNESA.
11:00 II13 172.8 A new measure of firing rate correlations
across time reveals a signature of bounded evidence
accumulation in LIP firing rates. A. K. CHURCHLAND*; M. N.
SHADLEN; E. SHEA-BROWN; R. KIANI. Univ. Washington,
Sch. Med., HHMI, Univ. of Washington, Stanford Univ.
8:00 II14 172.9 Occipital reflections of perceptual
decisions revealed by subdural electrode recordings in
human. M. C. DE JONG*; M. J. VAN STEENSEL; R. J. M.
HENDRIKS; M. A. H. L. RAEMAEKERS; F. S. S. LEIJTEN;
N. F. RAMSEY; R. VAN EE. Utrecht Univ., Univ. Med. Ctr.
Utrecht.
9:00 II15 172.10 Limits on the integration of spatially
distributed signals in cortex. K. GHOSE*; J. H. R.
MAUNSELL. Harvard Med. Sch., HHMI.
10:00 II16 172.11 An executive function deficit in amblyopia:
Evidence from the Eriksen flanker task. F. FARZIN*; A. M.
NORCIA. Stanford Univ.
11:00 II17 172.12 The effect of attentional modulation on
adaptation to transparent expanding/contracting motion. S.
RAPHAEL*; B. DILLENBURGER; M. J. MORGAN. Max-
Planck-Institute for Neurolog. Res.
8:00 II18 172.13 Area V1 “point set” as the unit of object-
based selection. G. R. STONER*. The Salk Inst. Biol
Studies.
9:00 II19 172.14 Feature and spatial attention interact
differently with normalization. A. M. NI*; J. H. R. MAUNSELL.
Harvard Med. Sch.
10:00 II20 172.15 Neural responses in V4 and FEF
modulated by salience during visual search. H. ZHOU*; R.
DESIMONE. MIT.
11:00 JJ1 172.16 Single trial measures of neuronal
population activity reveal cross-hemispheric coordination of
feature, but not spatial attention. M. R. COHEN*; J. H. R.
MAUNSELL. Harvard Med. Sch.
8:00 JJ2 172.17 Feature-based attentional modulation in
the hemodynamic responses of macaque V4. S. R. YANG*;
H. TANIGAWA; A. W. ROE. Vanderbilt Univ.
9:00 JJ3 172.18 Feature relevance or similarity:
Dissociating mechanisms of global feature-based selection
with electromagnetic brain recordings. R. BONDARENKO;
H. STRUMPF; C. M. STOPPEL; M. A. SCHOENFELD; C.
N. BOEHLER; J. M. HOPF*. Leibniz-Institute for Neurobio.,
Otto-von-Guericke-Universität, Duke Univ., Otto-von_
guericke-University.
10:00 JJ4 172.19 Magnitude of spatial but not feature-
based attentional modulation in MSTd cells of Macaque
visual cortex depends on a cell’s preferred spiral motion
direction. S. BALONI; D. KAPING; S. TREUE*. German
Primate Ctr., Bernstein Ctr. for Computat. Neurosci.
11:00 JJ5 172.20 Feature-directed attention to color and
motion: A human fMRI study. D. GALASHAN; A. THÜNS; R.
ROESE; T. REESS; D. WEGENER*; M. H. HERRMANN.
Univ. of Bremen.
Neuroscience 2010  |  Sunday AM  |  41 
 8:00 JJ6 172.21 Is there an inter-hemispheric difference
of implicit deviance detection processes in the human brain?
Y. LIN; K. CHANG; H. LIU; M. HSIEH; W. LAI*; Y. HSU. Natl.
Taiwan Univ., Natl. Taiwan Univ. Hosp.
POSTER
173. Vision: Spatial Attention
Theme D: Sensory and Motor Systems
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 JJ7 173.1 Neuronal responses in macaque area
V4 are modulated by spatiotemporal predictions of moving
attended items. J. F. MITCHELL*; J. C. CURTIS; J. H.
REYNOLDS. Salk Inst.
9:00 JJ8 173.2 Attentional modulation of neural
responses specific to cortical layer and neuron-type in visual
area V4 of the macaque. J. C. CURTIS*; J. MITCHEL; J.
REYNOLDS. Salk Inst.
10:00 JJ9 173.3 Among putative pyramidal neurons in
macaque V4, attentional modulation is largely restricted to
bursting cells. E. B. ANDERSON*; J. F. MITCHELL; J. H.
REYNOLDS. Systems Neurobio. Laboratory, Salk Inst. of
Biol. Sci., UCSD.
11:00 JJ10 173.4 Visual change detection behavior in the
mouse. M. H. HISTED*; J. H. R. MAUNSELL. Harvard Med.
Sch.
8:00 JJ11 173.5 Spatial attention enhances perception
by suppression of activity in portions of visual cortex that
represent unattended locations. D. W. BRESSLER*; M.
A. SILVER. Sch. of Optometry, UC Berkeley, Helen Wills
Neurosci. Institute, UC Berkeley.
9:00 JJ12 173.6 Attention-dependent changes in response
latency following behaviorally relevant speed changes in
macaque area MT. F. O. GALASHAN*; H. C. REMPEL; A. K.
KREITER; D. WEGENER. Univ. of Bremen.
10:00 JJ13 173.7 Electrophysiological correlates of near-
hand spatial attention. M. FALLAH*; C. J. PERRY; A. OWLIA;
H. JORDAN. York Univ., Canadian Action and Perception
Network.
11:00 JJ14 173.8 Enhanced activation of macaque areas
frontal eye fields and LIP during distributed spatial attention
irrespective of motor output. W. VANDUFFEL*; P. JANSSEN;
H. KOLSTER; E. PREMEREUR. Harvard Med. Sch.,
K.U.Leuven, Massachusetts Gen. Hosp.
8:00 JJ15 173.9 Encoding of salient stimuli by gamma
oscillations in the barn owl optic tectum. S. DEVARAJAN*; S.
MYSORE; E. KNUDSEN. Stanford Univ.
9:00 JJ16 173.10 Simultaneous onset of attentional
modulation in primary visual cortex and frontal eye fields.
J. POORT*; A. POORESMAEILI; P. R. ROELFSEMA.
Netherlands Inst. For Neurosci., CNR, Ctr. for
Neurogenomics and Cognitive Res.
10:00 KK1 173.11 Graded improvement in human contrast
discrimination by limiting the number of irrelevant locations
cued. Y. HARA; K. CHENG*; J. L. GARDNER. Gardner Res.
Unit, RIKEN Brain Sci. Inst.
SLIDE
11:00 KK2 173.12 Top-down attentional modulations in
primate V1 measured with voltage-sensitive dye imaging. Y.
Y. CHEN*; E. SEIDEMANN. Univ. of Texas at Austin.
42  |  Society for Neuroscience
8:00 KK3 173.13 Expansion of spatiotemporal receptive
field profiles of macaque MT neurons during attentive
tracking. R. NIEBERGALL*; P. S. KHAYAT; S. TREUE; J. C.
MARTINEZ-TRUJILLO. McGill Univ., German Primate Ctr.,
Bernstein Ctr. for Computat. Neurosci., Univ. of Montreal.
9:00 KK4 173.14 Recurrent antitopographic inhibition
mediates competitive stimulus selection in an attention
network. D. LAI*; S. BRANDT; H. LUKSCH; R. WESSEL.
Washington Univ., Technischen Univ. München.
10:00 KK5 173.15 Using fMRI to localize the cortical
substrates of covert serial visual search in rhesus monkeys.
A. ATABAKI*; P. DICKE; H. KARNATH; P. THIER. Hertie Inst.
For Clin. Brain Res., Hertie-Institute for Clin. Brain Res.
11:00 KK6 173.16 Contribution of cholinergic mechanisms
to attentional modulation of LFP gamma oscillatory
activity in V1. J. L. HERRERO*; S. GOTTHARDT; M. A.
GIESELMANN; L. DELICATO; A. THIELE. Newcastle Univ.,
Sunderland Univ.
8:00 KK7 173.17 Retinotopic maps in human cortex:
Effects of stimulus structure, attentional load and top down
attention. A. P. SAYGIN*; B. A. URGEN; D. J. HAGLER, Jr;
J. DRIVER. Univ. of California San Diego, Univ. Col. London.
POSTER
174. Nociceptive Transduction Mechanisms: Ion Channels
and Receptors
Theme D: Sensory and Motor Systems
Sun. 8:00 AM – San Diego Convention Center, Halls B-H
8:00 KK8 174.1 Anti-nociceptive actions of Gi-coupled
Ρ2Y receptors: inhibition of adenylate cyclase. H. O.
VONGTAU; D. C. MOLLIVER*. Univ. Pittsburgh.
9:00 KK9 174.2 Air-mediated ATP release from
keratinocytes: Analysis of the mechanism and its potential
contribution to chronic pain and keratinocyte differentiation.
T. P. BARR*; P. J. ALBRECHT; F. L. RICE. Albany Med. Coll,
Integrated Tissue Dynamics LLC.
10:00 KK10 174.3 Mechanical and chemical sensitivity of
cultured rat merkel cells. M. CHA*; J. LING; J. GU. Univ. of
Cincinnati.
11:00 KK11 174.4 The acute nociceptive signals induced by
bradykinin in rat sensory neurons are mediated by inhibition
of M-type K+ channels and activation of Ca2+ activated
Cl- channels. B. LIU*; J. E. LINLEY; X. DU; X. ZHANG; L.
OOI; H. ZHANG; N. GAMPER. Hebei Med. Univ., Inst. of
Membrane and Systems Biology, Fac. of Biol. Sci.
8:00 KK12 174.5 Implication of anoctamin 1, a ca2+-
activated cl- channel in nociception. B. LEE; H. CHO; Y.
YANG; M. TAK; Y. JANG; Y. CHO; J. LEE; K. KWAK; H.
CHUN; U. OH*. Seoul Natl. Univ. Col. Pharm, Grad. Sch. of
Convergence Sci. and Technology, Seoul Natl. Univ.
9:00 KK13 174.6  •  Differential modulation of trek-1, task-
3 and tresk k2p ion channels by bl-1249. L. CAO*; E. L.
VEALE; A. A. MATHIE; E. STEVENS. Pfizer Global Res. &
Develop., Univ. of Kent.
10:00 KK14 174.7 Inhibition of acid-sensing ion channel 3
by zinc. X. CHU*; Q. JIANG; C. J. PAPASIAN; J. Q. WANG;
Z. XIONG. Univ. Missouri-Kansas City, Legacy Res.
11:00 KK15 174.8 Novel PKC-dependent modulation
of Kv3.4 channel inactivation in dorsal root ganglion
nociceptors. D. RITTER*; C. HO; M. O’LEARY; M.
COVARRUBIAS. Thomas Jefferson Univ.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
8:00 KK16 174.9 N-type calcium current is augmented in
small diameter sensory neurons isolated from Nf1+/- mice. J.
DUAN; C. M. HINGTGEN*; G. D. NICOL. Indiana Univ. Sch.
Med.
9:00 KK17 174.10 The effects of voltage-gated calcium
channel mutations on trigeminal ganglion neurons
innervating the dura. Z. XIAO*; J. TAO; G. XIE; E. GUHL;
D. HUANG; P. LIU; J. C. RODER; Y. CAO. Washington
Univ. In St Louis, Sch. of Med., Washington Univ. Pain
Center, Washington Univ. Sch. of Med., Samuel Lunenfeld
Res. Institute, Mount Sinai Hospital, Dept. of Mol. and Med.
Genetics, Univ. of Toronto.
10:00 KK18 174.11  •  Evaluation of CLR and RAMP1
antibodies for the use of determining distribution of CGRP
receptor components in the trigeminal ganglia. A. S.
CALAMARI*; E. CROWN; S. EFTEKHARI; L. EDVINSSON;
S. KANE; C. SALVATORE. Merck, Lund Univ.
11:00 LL1 174.12 Peripheral glutamate receptors sensitize
facial skin and tongue nociception in rats. K. HONDA*; N.
NOMA; M. SHINODA; K. IWATA. Nihon Univ. Sch. of Dent.
8:00 LL2 174.13 Activation and sensitization of nociceptors
by complement C5a in incised mouse skin. J. H. JANG*; K.
KIDO; T. J. BRENNAN. Univ. of Iowa.
POSTER
175. Neuropathic Pain: Neurotrophins, Neurotransmitters,
and Inflammatory Mediators
Theme D: Sensory and Motor Systems
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 LL3 175.1 Pain-induced cytokine expression in the
rat hippocampus. H. YAU*; A. RANDOLF; J. WILDMANN; M.
V. CENTENO; M. MARTINA; H. O. BESEDOVSKY; A. DEL
REY; A. V. APKARIAN. Northwestern Univ., Inst. of Normal
and Pathological Physiology, Univ. of Marburg.
9:00 LL4 175.2 Long-term interleukin-1beta exposure
increases excitability of small IB4-postive and medium
sensory neuron by differential actions on ionic conductances.
P. L. STEMKOWSKI; P. A. SMITH*. Univ. Alberta.
10:00 LL5 175.3 Chemotactic cytokine ligand-1 (CCL-
1) contributes to neuropathic pain in mice. N. AKIMOTO*;
K. HONDA; Y. USHIJIMA; S. NAKASHIMA; M. NODA; Y.
TAKANO. Pathophysiology, Grad. Sch. of Pharmaceut.
Sciences, Kyushu Univ., Physiol. and Pharmacology,
Pharmaceut. Sciences, Fukuoka Univ.
11:00 LL6 175.4 Noxious tail-shock following contusion
spinal cord injury increases the expression of TNF alpha in
the spinal cord dorsal horn. S. M. GARRAWAY*; J. R. HUIE;
K. H. LEE; J. D. TURTLE; M. A. HOOK; S. A. WOLLER;
A. R. FERGUSON; M. BEATTIE; J. BRESNAHAN; J. W.
GRAU. Texas A&M Univ., Univ. of California, San Francisco.
8:00 LL7 175.5 RAP-103, a potent, orally active, and
short peptide chemokine receptors CCR2/CCR5 antagonist,
ameliorates peripheral neuropathic pain in rats. S. S.
PADI*; X. Q. SHI; Y. Q. ZHAO; M. R. RUFF; C. B. PERT; N.
BAICHOO; J. ZHANG. The Alan Edwards Ctr. For Res. On
Pain, McGill Univ., RAPID Laboratories, Inc.,.
9:00 LL8 175.6 Inflammation mediated changes in blood
spinal-cord barrier (BSCB) permeability following sciatic
nerve injury. S. ECHEVERRY*; Y. WU; J. ZHANG. McGill
Univ.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
10:00 LL9 175.7 Neuropathic pain mechanisms
produced by TNF-α in disc hernia patients. P. ANDRADE*;
M. A. DAEMEN; V. VISSER-VANDEWALLE; H. W. M.
STEINBUSCH; G. HOOGLAND. Maastricht Univ., Maastricht
Univ. Med. Ctr., European Grad. Sch. of Neurosci. (EURON),
Maastricht Inst. of Neuromodulative Develop. (MIND).
11:00 LL10 175.8 Peptidergic intraepidermal nerve fiber
Sun. AM
mediates mechanical allodynia in type 2 diabetes. J.
DAUCH*; H. T. CHENG; S. S. OH; J. M. HAYES; E. L.
FELDMAN. Univ. of Michigan.
8:00 LL11 175.9 Local inflammation is essential for
triggering neuroplastic changes which lead to hyperalgesia
induced by sciatic nerve constriction in rats. M. F. MORAES*;
L. F. S. BASTOS; D. C. MEDEIROS; R. P. VIEIRA; M. M.
COELHO. Univ. Federal De Minas Gerais, Univ. Federal de
Minas Gerais.
9:00 LL12 175.10  •  Lysophosphatidic acid receptor 5
(LPA5) signaling in the initiation of neuropathic pain. M. LIN*;
R. R. RIVERA; J. CHUN. Scripps Res. Inst.
10:00 MM1 175.11 Macrophage inflammatory protein-
1α mediates the pathogenesis of neuropathic pain. N.
KIGUCHI*; T. MAEDA; Y. KOBAYASHI; Y. FUKAZAWA; S.
KISHIOKA. Wakayama Med. Univ.
11:00 MM2 175.12 Contribution of injured nerve-derived
COX2/PGE2 to the up-regulation of brain derived
neurotrophic factor in dorsal root ganglion neurons of
neuropathic rats. P. CRUZ DUARTE; B. ST-JACQUES; W.
MA*. McGill Univ.
8:00 MM3 175.13 Nuclear localization of metabotropic
glutamate receptor mGluR5, in spinal cord dorsal horn
neurons and its possible role in neuropathic pain: An electron
microscopic study. V. CORNEA-HEBERT*; A. RIBEIRO-DA-
SILVA; T. J. CODERRE. McGill Univ.
9:00 MM4 175.14  •  The expression level of serotonin
type 3 receptors is increased in excitatory neurons in the
mouse spinal dorsal horn by peripheral nerve injury. T.
FUKUSHIMA*; T. TERASHIMA; S. TANAKA; Y. HORI.
Dokkyo Univ. Schl Med.
10:00 MM5 175.15 Brain-derived neurotrophic factor
modulates antiretroviral-induced mechanical allodynia in the
mouse. C. L. RENN*; P. RHEE; S. LESSANS; B. SMITH;
R. TRAUB; S. DORSEY. Univ. of Maryland Sch. of Nursing,
Univ. of Maryland Dent. Sch.
11:00 MM6 175.16  •  Neural mobilization as neuropathic
pain control: Involvement of nerve growth factor (ngf). M.
CHACUR*; F. M. SANTOS; A. C. GIARDINI; J. T. SILVA.
Univ. of São Paulo.
8:00 MM7 175.17 Substance P release mediated by
synchronized activation of PKA and PKC serves as a cellular
mechanism of paclitaxel-induced persistent pain. Y. HE; Z. J.
WANG*. Univ. Illinois.
9:00 MM8 175.18 P2x4receptor (p2x4r)-mediated aspartate
release in spinal cord. R. STEINBERG*; S. TEIXEIRA;
M. LEONETTI; P. ROUX; I. LEFEVRE; F. OURY-DONAT.
Sanofi-Aventis Recherche.
10:00 MM9 175.19 Phenotypic changes in spinal lamina I
pyramidal neurons in an animal model of neuropathic pain.
A. W. SAEED*; A. RIBEIRO-DA-SILVA. McGill Univ.
Neuroscience 2010  |  Sunday AM  |  43 
 11:00 MM10 175.20 Antibody to varicella-zoster virus protein
IE62 augments neuropathic allodynia via BDNF activity in
mice. I. TAKASAKI*; Y. HAMA; Y. YOSHIDA; T. DAIKOKU;
M. TSUDA; T. TSUMOTO; K. SHIRAKI. Life Sci. Res. Ctr,
Univ. of Toyama, Dept of Virol, Univ. of Toyama, Dept of Mol
Neurobiol, Univ. of Toyama, Brain Sci. Institute, Riken.
8:00 MM11 175.21 In vitro and in vivo profiling of CE-
245677, a pan-Trk inhibitor with antinociceptive effects in
rodent models of inflammatory pain. S. TANIMOTO; C.
HOLLINS; M. CLARK; J. STROVER; J. NICHOLSON; P.
STUPPLE; T. RYCKMANS; K. GIBSON; S. C. PHILLIPS; J.
G. BILSLAND*. Pfizer PGRD.
9:00 MM12 175.22  •  Decreasing abnormal nocifensive
responses in the bilateral chronic constriction injury (bCCI)
model of neuropathic pain: Effects of lumbar intrathecal
CCK-saporin. S. DATTA*; K. CHATTERJEE; R. WILEY.
Middle Tennessee Res. Inst., VA TN Valley Healthcare Sys.
POSTER
176. Neuropathic Pain: Signaling Mechanisms and Models
Theme D: Sensory and Motor Systems
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 MM13 176.1 Cutaneous GABAB receptors modulate
prostaglandin-induced allodynia. R. A. WHITEHEAD; J. E.
COOKE; C. ROSSE; E. PUIL*; B. A. MACLEOD. Univ. of
British Columbia, Univ. British Columbia Fac Med.
9:00 MM14 176.2 Identification of suitable normalization
genes for transcript expression analysis in injured
sensory neurons. M. L. BANGARU*; V. ZOGA; H. WU;
B. MCCALLUM; F. PARK; Q. H. HOGAN. Med. Col. of
Wisconsin.
10:00 NN1 176.3 Losing touch: A mouse model of diabetic
neuropathy. R. C. LENNERTZ*, III; D. E. WRIGHT; C. L.
STUCKY. Med. Col. of Wisconsin, The Univ. of Kansas Med.
Ctr.
11:00 NN2 176.4 Influences of experimental dyslipidemia
on murine diabetic neuropathy. B. L. GUILFORD*; J. M.
RYALS; D. E. WRIGHT. Univ. of Kansas Med. Ctr.
8:00 NN3 176.5 Voluntary exercise reduces mechanical
allodynia by increasing glial cell line-derived neurotrophic
factor levels and axonal transport in diabetic A/J mice. K. L.
FARMER*; J. M. RYALS; I. V. SMIRNOVA; D. E. WRIGHT.
Univ. of Kansas Med. Ctr.
9:00 NN4 176.6 Genetic variability of mice in response to
intramuscular acid injection: Modeling widespread pain in a
model of fibromyalgia. A. GROOVER*; J. M. RYALS; D. E.
WRIGHT. Univ. of Kansas Med. Ctr.
10:00 NN5 176.7 Advanced glycation endproducts in
diabetic sensory neuropathy: A role for glyoxalase I in
population-specific sensory neurons. M. M. DUNN*; J. M.
RYALS; D. E. WRIGHT. Univ. of Kansas Med. Ctr.
11:00 NN6 176.8 Insulin signaling and insulin receptor
substrates in murine diabetic neuropathy. C. W. GROTE; J.
K. MORRIS; J. M. RYALS; P. C. GEIGER; D. E. WRIGHT*.
Univ. Kansas Med. Ctr.
8:00 NN7 176.9 Erk1/2 and p38 mitogen-activated protein
SLIDE
kinase signaling in the rat monoiodoacetate osteoarthritis
and spinal nerve ligation chronic pain models. Y. LEE; D.
WILCOX; A. L. NIKKEL; M. F. JARVIS; R. BITNER*. Abbott
Lab.
44  |  Society for Neuroscience
9:00 NN8 176.10 Integrative silencing of Cav1.2 calcium
channel subunits by microRNA miR-103: Involvement in
chronic pain sensitization. A. FAVEREAUX; O. THOUMINE;
R. BOUALI-BENAZZOUZ; V. ROQUES; M. PAPON; G.
DRUTEL; C. LÉGER; A. CALAS; F. NAGY; M. LANDRY*.
Univ. Bordeaux 2, INSERM U862, CNRS UMR 5091.
10:00 NN9 176.11 Nerve-injury induced spontaneous pain
is driven by injured trpv1 sensitive afferents. A. OKUN*; T.
KING; C. QU; J. LAI; F. PORRECA. Univ. of Arizona.
11:00 NN10 176.12 Alteration in the phosphorylation
of MAPKs in cisplatin-induced neuropathy. T.
WONGTAWATCHAI*; S. AGTHONG; V. CHENTANEZ.
Fac. of Grad. Study Chulalongkorn Univ., Fac. of Med.
Chulalongkorn university.
8:00 NN11 176.13  •  Neuronal & inflammatory responses in
an adolescent rat model of painful joint injury in the neck.
C. WEISSHAAR; L. DONG; A. BOWMAN; F. PEREZ; B.
GUARINO; S. SWEITZER; B. A. WINKELSTEIN*. Univ.
Pennsylvania, Univ. of South Carolina.
9:00 NN12 176.14 Chronic spontaneous activity generated
in the somata of presumptive nociceptors is associated
with allodynia and hyperalgesia following spinal cord injury.
Q. YANG; R. J. CROOK; S. S. BEDI; J. DU; Z. WU; R. J.
GRILL; S. M. CARLTON; E. T. WALTERS*. Univ. Texas Med.
Sch. At Houston, Univ. of Texas Med. Br.
10:00 NN13 176.15 Disinhibition replicates changes in
encoding properties of deep spinothalamic tract neurons
associated with peripheral nerve injury. G. LAVERTU*; S. L.
CÔTÉ; Y. DE KONINCK. CRULRG.
11:00 NN14 176.16 Role of the rostral anterior cingulate
cortex (racc) in spontaneous neuropathic pain in rats. T.
E. KING*; C. QU; A. OKUN; J. REN; F. PORRECA. Univ.
Arizona.
8:00 OO1 176.17 Lost of µ-opioid receptor inhibition of
substance P release in a rat model of neuropathic pain. J. G.
MARVIZON*; W. CHEN; G. ZHANG. UCLA, VA Greater Los
Angeles Healthcare Syst.
9:00 OO2 176.18 Reduced nerve injury induced
neuropathic pain in NTS2 agonist treated rats. P. G.
TÉTREAULT*; K. BELLEVILLE; J. MARTINEZ; N.
BEAUDET; P. SARRET. Univ. De Sherbrooke, Universités
Montpellier 1 & 2.
10:00 OO3 176.19 The role of mTORC1 and mTORC2 in
neuropathic pain. O. K. MELEMEDJIAN*; M. ASIEDU; R.
SANOJA; J. JOHNSON; T. PRICE. Univ. Arizona, Univ. of
Arizona, Univ. of British Columbia.
11:00 OO4 176.20 Gastrin-releasing peptide receptor in the
spinal cord mediates mechanical allodynia following nerve
injury. C. LI; S. BACK*; J. LEE; S. K. BAEK; H. NA. Korea
Univ. Coll Med., Neurosci. Res. Institute, Coll. Med. Korea
Univ.
8:00 OO5 176.21 Analgesic effects of Rolipram, a
selective phosphodiesterase 4 inhibitor, on rat model of
chemotherapy-induced neuropathic pain. H. KIM*; S. ABDI.
Univ. Miami.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
POSTER
177. Receptors and Mechanisms of Transduction
Theme D: Sensory and Motor Systems
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 OO6 177.1 Structure and dynamics of the mouse
follicle sinus complex. D. MATTHEWS*; K. SAKURAI; F.
WANG; H. J. KARTEN; D. KLEINFELD. Univ. California San
Diego, Duke Univ.
9:00 OO7 177.2  •  Multiple neurotrophins involve
regeneration of the periodontal Ruffini endings after
transection of rat inferior alveolar nerve. M. OHISHI; F.
HARADA; T. MAEDA*. Niigata Univ. Grad Sch. Med. Dent.
10:00 OO8 177.3 Glutamatergic modulation of synaptic-
like vesicle recycling in primary mechanosensory nerve
terminals. A. B. GRACA; P. SINGH; A. SIMON; R. W.
BANKS; G. S. BEWICK*. Univ. of Aberdeen, Univ. of
Durham.
11:00 OO9 177.4 Ecm-tethering stretch-activated currents
in neurosensory mechanotransduction. Y. R. CHENG*; Y.
LIN; C. CHEN. Inst. of Biomed. Sciences, Academia Sinica,
Inst. of Zoology, Natl. Taiwan University, Col. of Life Sci.,
Grad. Inst. of Acupuncture Science, China Med. Univ.
8:00 OO10 177.5 The central organization of trigeminal
afferents in the mouse. H. J. KARTEN*; D. W. MATTHEWS;
K. SAKURAI; F. WANG; D. KLEINFELD. UCSD, Duke Univ.
9:00 OO11 177.6 Dissecting the molecular mechanism
of TRPA1 activation. H. WANG*; P. A. HEPPENSTALL.
European Mol. Biol. Lab.
10:00 OO12 177.7 Determining optimal stimuli from neuronal
anatomy. J. MULDER-ROSI*; G. I. CUMMINS; J. P. MILLER.
Montana State Univ.
11:00 OO13 177.8 Synapsin I/II knock out disrupts
mechanosensory terminal firing and motor behaviour. A.
SIMON; A. NJÅ; I. WALAAS; R. W. BANKS*; G. S. BEWICK.
Univ. of Aberdeen, Univ. of Oslo, Univ. of Durham.
POSTER
178. Tactile/Somatosensory: Functional Studies
Theme D: Sensory and Motor Systems
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 OO14 178.1 Characterization of the BOLD impulse
response function in somatosensory cortex in awake
marmosets. Y. HIRANO*; A. C. SILVA. CMU, LFMI, NINDS,
NIH.
9:00 OO15 178.2 Differential modulation of corticospinal
excitability for spatial vs. texture surface attributes in the
context of haptic sensing. S. R. MASTER*; F. TREMBLAY.
Univ. Ottawa, Univ. of Ottawa.
10:00 OO16 178.3 Processing in prefrontal cortex underlies
accurate tactile direction discrimination: An fMRI study
of a patient with a traumatic spinal cord lesion. L. C.
LUNDBLAD*; H. W. OLAUSSON; C. MALMESTRÖM; H.
BACKLUND WASLING. Sahlgrenska Univ. Hosp., Neurosci.
and Physiol.
11:00 OO17 178.4 The influence of body-ownership cues on
tactile sensitivity. R. ZOPF*; J. A. HARRIS; M. A. WILLIAMS.
Macquarie Univ., Univ. of Sydney.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
8:00 OO18 178.5 Influence of age and expertise on
tactile perception. B. GODDE*; E. REUTER; S. VIELUF;
C. VOELCKER-REHAGE. Jacobs Univ. Bremen, Univ.
Bielefeld.
9:00 PP1 178.6 The effect of short-term peripheral
nerve stimulation (PNS) on sensitivity and hand motor
performance in healthy aging. R. MEESEN*; L. VRANCKEN;
Sun. AM
K. CUYPERS. PHL Univ. Col., Hasselt Univ.
10:00 PP2 178.7 Feedback after touch modifies rat’s
whisking. D. DEUTSCH*; M. PIETR; P. M. KNUTSEN; E.
AHISSAR; E. SCHNEIDMAN. Weizmann Institude of Sci.,
Univ. of California.
11:00 PP3 178.8 Simulation of the vibrissal brainstem
loop reveals effects of sensory feedback on whisking and
active touch. E. SIMONY*; E. AHISSAR; D. GOLOMB. The
Weizmann Inst. of Sci., Ben-Gurion Univ.
8:00 PP4 178.9 Improving perceptual accuracy via motor
and not sensory modifications. A. SAIG*; A. ARIELI; E.
AHISSAR. Weizmann Inst. of Sci.
9:00 PP5 178.10 The curious rat: hierarchical autonomous
active learning loops. G. GORDON*; E. AHISSAR.
Weizmann Inst. of Sci.
10:00 PP6 178.11 Cutaneous tactile inputs to human
hand and lip induces short-term adaptation of the primary
somatosensory cortex. L. VENKATESAN*; S. M. BARLOW;
M. POPESCU; A. POPESCU. Univ. of Kansas, KU Med. Ctr.
11:00 PP7 178.12 BOLD signal differences in the structures
of whisker and visual pathways. D. P. AKSENOV*; L. LI; G.
IORDANESCU; X. SONG; A. WYRWICZ. Northshore Univ.
RI, Univ. of Chicago Pritzker Sch. of Med.
8:00 PP8 178.13 A novel class of unmyelinated (C)
tactile afferents in human glabrous skin. S. S. NAGI*; D. A.
MAHNS. Univ. of Western Sydney.
9:00 PP9 178.14   Do afferent properties recover following
6 weeks of uncontrolled diabetes? J. JONES; C. DARLING;
T. DEAN; B. SOWELL; V. K. HAFTEL*. Morehouse Col.
10:00 PP10 178.15 Profound activity of somatosensory
responsive neurons in high subdivisions of SI cortex during
simple locomotion. O. V. FAVOROV*; W. U. NILAWEERA; A.
A. MIASNIKOV; I. N. BELOOZEROVA. Univ. North Carolina,
Barrow Neurolog. Inst., Univ. of California Irvine.
11:00 PP11 178.16 Effect of fluctuations in BOLD signal on
trial-to-trial variability of BOLD responses. P. HERMAN*; B.
G. SANGANAHALLI; R. N. S. SACHDEV; D. MCCORMICK;
F. HYDER. Yale Univ. Sch. of Med., Yale Univ. and Kavli Inst.
of Neurosci.
8:00 PP12 178.17 Tactile stimulus localization ability linked
to genetic deletion in people with Williams Syndrome. B.
LANDAU*; M. CHEN; G. C. BECK; B. RAPP; T. YOSHIOKA.
Johns Hopkins Univ.
9:00 PP13 178.18 The differentations of brain activity for
the stimuli on LI4 acupuncture points. Y. RYU*; K. CHOI; S.
JEONG; S. LEE; S. CHOI. Korea Inst. Oriental Med.
10:00 PP14 178.19 Improved tactile and limb position
sense in adults with cerebral palsy following upper limb
sensorimotor training. J. LANGAN*; K. L. KERN; E. A.
HURVITZ; S. H. BROWN. Univ. Michigan, Univ. of Michigan.
Neuroscience 2010  |  Sunday AM  |  45 
 11:00 PP15 178.20 Frequency-dependent fMRI-BOLD 10:00 QQ9 179.11 Dynamic human motor control tasks are
responses to high intensity peripheral somato-sensory dominated by proprioceptive feedback. W. MUGGE*; D. A.
stimulation. B. TASKIN; S. HOLTZE; A. VILLRINGER*. ABBINK; A. C. SCHOUTEN; F. C. T. VAN DER HELM; J. H.
Charité’Universitätsmedizin Berlin, Max-Planck-Institute for ARENDZEN; C. G. M. MESKERS. Delft Univ. of Technol.,
Cognitive and Brain Res., Humboldt Univ. Berlin, Charite, Leiden Univ. Med. Ctr.
Humbold Univ.
11:00 QQ10 179.12 Time variant system identification of
8:00 PP16 178.21 Validation of an automated system to human limb dynamics using wavelets. A. C. SCHOUTEN*;
measure histamine-induced itch-scratch behavior in mouse. W. MUGGE; E. DE VLUGT; F. C. T. VAN DER HELM. Delft
P. P. HUANG*; E. A. MAC; T. L. YAKSH. UC San Diego. Univ. Tech., Univ. of Twente.
8:00 QQ11 179.13 Modulation of the flexor carpi radialis
H-reflex during constrained treadmill walking. A. DOMINGO*;
POSTER M. KLIMSTRA; T. NAKAJIMA; T. LAM; S. R. HUNDZA. Univ.
British Columbia, Intl. Collaboration on Repair Discoveries
179. Reflexes and Reflex Modulation
(ICORD), Univ. of Victoria.
Theme D: Sensory and Motor Systems 9:00 QQ12 179.14  •  Difference of the responsiveness of
Sun. 8:00 AM — San Diego Convention Center, Halls B-H the swallowing central pattern generator to the peripheral
stimulation between wakefulness and sleep in man. S.
8:00 PP17 179.1 Rhythmic arm cycling differentially
SUGINO*; M. KUROSE; J. KITAGAWA; M. RAHMAN;
modulates stretch and H-reflex amplitudes in soleus muscle.
Z. HOSSAIN; T. HANAKO; Y. YAMADA; Y. MASUDA; K.
A. PALOMINO; E. GILES; R. MEZZARANE; T. NAKAJIMA;
TERADA; K. YAMAMURA. Dept. of Orthodontics, The
E. ZEHR*; S. R. HUNDZA. Univ. of Victoria, Rehab Neurosci.
Nippon Dent. Univ. Sch. of Life Dentistr, Niigata University,
Lab.
Grad. Sch. of Med. and Dent. Sci., Grad. Sch. of Oral
9:00 PP18 179.2 Effect of assistive device use on Medicine, Matsumoto dental Univ.
interlimb cutaneous reflex modulation during walking. S. R.
10:00 QQ13 179.15 The effects of ankle bracing during a
HUNDZA*; A. LEWIS; E. P. ZEHR. Univ. Victoria.
6-week rehabilitation protocol on spinal reflex modulation
10:00 QQ1 179.3 Excitability of common interneurons in during double and single legged stance. C. YARAR*; M.
reflex pathways from cutaneous inputs innervating different PLUEGER; J. M. SEFTON. Auburn Univ.
foot regions during remote rhythmic limb movements.
11:00 QQ14 179.16   Dependence of tail movement on
T. NAKAJIMA*; R. A. MEZZARANE; S. R. HUNDZA; E.
stimulus location in the nociceptive withdrawal response of
P. ZEHR. Univ. of Victoria, Rehabil. Neurosci. Lab., Intl.
spinalized rats. N. BENCE*; G. S. YOUNG; A. L. TONGEN;
Collaboration on Repair Discoveries, Ctr. for Biomed.
C. L. CLELAND. James Madison Univ.
Research, Univ. of Victoria.
8:00 QQ15 179.17 Dependence of foot movement on
11:00 QQ2 179.4 Training the less affected side can
stimulus location in the nociceptive withdrawal response
improve strength and muscle activation on the more affected
of spinalized and intact, unanaesthetized rats. C. L.
side after stroke. K. L. DRAGERT*; E. P. ZEHR. Univ. of
CLELAND*; L. A. WYATT; C. E. ESQUIVEL; H. T. DAVIS.
Victoria, Intl. Collaboration on Repair Discoveries (ICORD).
James Madison Univ.
8:00 QQ3 179.5 Effects of locomotor-related signals from
9:00 QQ16 179.18 Conditioning of the H-reflex to
the legs and voluntary activity in the arms on modulation
demonstrate short latency crossed connections between
of bilateral H-reflex in forearm flexor muscles. R. A.
human soleus muscles. P. W. STUBBS*; J. F. NIELSEN; N.
MEZZARANE*; E. ZEHR. Univ. of Victoria.
MRACHACZ-KERSTING. Hammel Neurocenter, Univ. of
9:00 QQ4 179.6 Investigating dimensionality reduction Aalborg.
using single joint movements: On the definition of muscle
10:00 QQ17 179.19 Serial assessment of postural and
synergy. E. CHIOVETTO*; B. BERRET; S. PANZERI; I.
dynamic activities of masticatory muscles - validity and
DELIS; T. POZZO. Inst. Italiano di Tecnologia, Univ. Clin.
reliability of emg parameters. P. S. KEMPPAINEN*; A.
Tübingen, Section for Computat. Sensomotorics, Univ. of
COHEN; T. NORDLUND; T. SUVINEN. Univ. Turku.
Genova, Univ. de Bourgogne, INSERM.
11:00 QQ18 179.20  •  Inhibition of the startle response
10:00 QQ5 179.7 H-reflex modulation during forward and
triggered by whiplash collisions. D. W. H. MANG*; G. P.
backward walking on a split-belt treadmill. F. MASSAAD;
SIEGMUND; J. T. INGLIS; J. BLOUIN. Univ. of British
K. JANSEN; P. MEYNS; D. DRIJKONINGEN; O. LEVIN; I.
Columbia, MEA Forensic Engineers & Scientists, Brain Res.
JONKERS; J. E. DUYSENS*. Dept of Biomed. Kinesiology
Ctr.
(FaBeR).
8:00 QQ19 179.21 Identification of interneurons that secure
11:00 QQ6 179.8 Amplification of background EMG activity
flexor-extensor alternation in the spinal cord. J. ZHANG*; G.
affects the interpretation of H-reflex gain. D. M. KOCEJA*; B.
LANUZA; Z. WANG; Y. ZHANG; T. VELASQUEZ; E. FRANK;
TAHAYORI; K. KITANO. Indiana Univ.
M. GOULDING. The Salk Inst. for Biol. Studies, Fundación
8:00 QQ7 179.9 Effects of conditioning stimulation on Inst. Leloir, Tuffs Univ. Sch. of Medchine.
post-activation depression in human soleus H-reflex. K.
9:00 QQ20 179.22 Responsiveness of the tibialis anterior
KITANO*; B. TAHAYORI; M. TSURUIKE; D. M. KOCEJA.
Ia-afferent pathway, as assessed by the H-reflex, is not
Indiana Univ., Osaka Univ. of Hlth. and Sport Sci.
altered by small cyclic changes in muscle length. A. G.
9:00 QQ8 179.10 Effect of femoral nerve input on
SLIDE

CRESSWELL*; G. A. LICHTWARK; L. A. HANSSON; E.

homosynaptic depression in soleus H-reflex. M. TSURUIKE*; WIKLUND. The Univ. of Queensland, Umeå Univ.
K. KITANO; D. M. KOCEJA. Osaka Univ. of Hlth. and Sport
Sci., Indiana Univ.

46  |  Society for Neuroscience • Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
10:00 RR1 179.23 Quantification of reflex response through
an iPhone wireless accelerometer application. R. C.
LEMOYNE*; C. COROIAN; T. MASTROIANNI; M. COZZA;
W. S. GRUNDFEST. UCLA, Cognition Engin. Inc., Converge
Robotics Corp.
11:00 RR2 179.24 Angle-dependent modulation of the long-
latency stretch reflex responses in elbow flexor muscles
induced by a mirror. K. YAMANAKA*; N. KAWASHIMA.
Showa Women’s Univ., Res. Inst., Natl. Rehab. Ctr.
8:00 RR3 179.25 A neuromuscular probe to evaluate
hormonally-mediated changes in soft tissue properties. Y. Y.
DHAHER*; M. L. CAMMARATA. Northwestern Univ.
9:00 RR4 179.26 A comparison group kinematic and kinetic
investigation of the asymmetric tonic neck reflex in chronic
stroke survivors and individuals without stroke. M. D. ELLIS;
A. BUCHLER; K. BURKE; V. FRANIAK; N. RATAJCZAK; J.
P. DEWALD*. Northwestern Univ.
10:00 RR5 179.27 Altered control of muscle activation
and deactivation in the hemiparetic elbow post-stroke. P.
KANADE*; C. GHEZ; J. WIESER; L. BOTZER; L. SIMO;
R. A. SCHEIDT. Marquette Univ., Columbia Univ. Col. of
Physicians, Rehabil. Inst. of Chicago, Feinberg Sch. of Med.,
Northwestern Univ., Med. Col. of Wisconsin.
11:00 RR6 179.28 The relationship between velocity and
shoulder abduction loading in post-stroke upper limb stretch
reflexes. J. G. MCPHERSON*; A. H. A. STIENEN; J. M.
DROGOS; J. P. A. DEWALD. Northwestern Univ.
8:00 RR7 179.29 The effects of abnormal shoulder-elbow
torque coupling on spasticity in chronic hemiparetic stroke.
A. STIENEN*; J. G. MCPHERSON; J. M. DROGOS; J. P. A.
DEWALD. Univ. of Twente, Northwestern Univ.
POSTER
180. Motor Unit Recordings
Theme D: Sensory and Motor Systems
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 RR8 180.1 Sampling large populations of motor
units in humans with multichannel thin-film electrodes.
S. MUCELI*; F. NEGRO; W. JENSEN; K. YOSHIDA; W.
POPPENDIECK; T. DOERGE; D. FARINA. Ctr. For Sensory-
Motor Interaction, Aalborg Univ., Dept. of Biomed. Engin.,
Indiana University-Purdue Univ., Fraunhofer Inst. for Biomed.
Engin.
9:00 RR9 180.2   A new method to improve the accuracy
of motor unit number estimation in the ulnar nerve innervated
hypothenar muscles. A. CHEEMA; M. MACKIE; G. SMILEY-
WIENS; A. LO; K. CHAN*. Univ. Alberta.
10:00 RR10 180.3 Accurate measure of motor unit twitch
force in humans. F. NEGRO*; D. FARINA. Aalborg Univ.
11:00 RR11 180.4 Motor unit discharge patterns of the
anconeus during maximal velocity elbow extensions. B.
HARWOOD*; C. L. RICE. The Univ. of Western Ontario.
8:00 RR12 180.5 Motor unit properties of the triceps surae.
B. H. DALTON*; B. HARWOOD; G. A. POWER; C. L. RICE.
The Univ. of Western Ontario.
9:00 RR13 180.6 Phase-locking of motor unit discharges to
beta band EEG in sustained isometric muscle contraction. T.
WATANABE*; M. HYODO; J. USHIBA; Y. MASAKADO. Keio
Univ., Tokai Univ.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
10:00 RR14 180.7 Comodulation but not short-term
synchrony in human hypoglossal motor unit pairs. C.
LAINE*; E. BAILEY. Univ. Arizona.
11:00 RR15 180.8  •  Changes in human genioglossus single
motor units discharge properties in quiet breathing, CO2 and
CPAP. J. SABOISKY*; D. J. ECKERT; A. S. JORDAN; J. A.
TRINDER; C. L. NICHOLAS; D. P. WHITE; A. MALHOTRA.
Sun. AM
Brigham & Women’s Hosp. and Harvard Med. Sch., The
Univ. of Melbourne.
8:00 RR16 180.9 Evaluation of persistent inward currents
using paired motor-unit recordings in human genioglossus
muscle. A. L. REVILL*; E. F. BAILEY; A. J. FUGLEVAND.
Univ. of Arizona.
9:00 RR17 180.10 Motor unit recruitment thresholds of
potentiated muscle in humans. C. B. SMITH; B. HARWOOD;
C. L. RICE*. The Univ. of Western Ontario, The Univ.
Western Ontario.
10:00 RR18 180.11 Fatigue-related increases in motor-unit
synchronization between knee extensor synergists during
stepping exercise. C. CHOU; Y. HUANG; Y. CHANG*; H.
CHAN. Chang Gung Univ.
11:00 RR19 180.12 Adaptations in motor unit activity with
aging. F. ZAHEER*; S. H. ROY; H. S. NAWAB; C. J. D.
LUCA. NeuroMuscular Res. Ctr., Boston Univ.
8:00 RR20 180.13 Motor unit number estimates in a
proximal human upper limb muscle: An age-related
reduction. G. A. POWER*; B. H. DALTON; A. A.
VANDERVOORT; C. L. RICE; T. J. DOHERTY. The Univ. of
Western Ontario.
9:00 SS1 180.14 Motoneuron afterhyperpolarization time
course after chronic stroke. S. J. GARLAND*; S. KNORR;
C. L. POLLOCK; C. W. MACDONELL; T. D. IVANOVA.
Univ. British Columbia, Univ. of Western Ontario, Univ. of
Manitoba.
10:00 SS2 180.15 Properties of mouse motor units
investigated in vivo: Implication for ALS. M. MANUEL*; C. J.
HECKMAN. Northwestern Univ. Feinberg Sch. of Med.
POSTER
181. EMG, Stimulation, and Kinematics
Theme D: Sensory and Motor Systems
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 SS3 181.1 Activity and timing of leg muscles in the
forward and backward walking stick insect. A. BUSCHGES*;
P. ROSENBAUM; A. WOSNITZA; M. GRUHN. Univ. Koln.
9:00 SS4 181.2 Identical motor patterns but different body
mechanics result in different behaviors in a computational
model of lamprey swimming. E. D. TYTELL*; C. HSU; L. J.
FAUCI; A. H. COHEN. Univ. of Maryland, Tulane Univ.
10:00 SS5 181.3 Identifying oscillations from surface
EMG signals. O. PINTO NETO*; E. A. CHRISTOU. Univ. of
Florida, Univ. Camilo Castelo Branco (Unicastelo).
11:00 SS6 181.4 Coherence between surface EMGs is
influenced by electrode placement in hand muscles. K. G.
KEENAN*; J. COLLINS; W. MASSEY; T. WALTERS; H.
GRUSZKA. Univ. of Wisconsin-Milwaukee.
8:00 SS7 181.5 Explaining EMGs based on gamma noise
models. M. C. TRESCH*; A. M. JARC; B. A. RELLINGER;
V. C. K. CHEUNG. Northwestern Univ., McGovern Inst. for
Brain Res.
Neuroscience 2010  |  Sunday AM  |  47 
 9:00 SS8 181.6 Short-range stiffness in huxley cross- 10:00 TT2 182.3 Coordination of foot dynamics in upright
bridge muscle models. A. N. VARDY*; E. DE VLUGT; F. C. T. standing. Z. WANG*; K. JORDAN; K. NEWELL. The
VAN DER HELM. Delft Univ. of Technol. Pennsylvania State Univ.
10:00 SS9 181.7 Task-related variations in the surface 11:00 TT3 182.4 Convergence of effects from arm and leg
EMG of human first dorsal interosseous muscle. M. pedaling on cutaneous reflex in arm muscles. S. SASADA;
WHITFORD*; C. G. KUKULKA. Univ. Minnesota. T. TAZOE; T. NAKAJIMA; T. KOMIYAMA*. Tokyo Gakugei
Univ., Res. instituteNational Rehabil. Ctr. for Persons with
11:00 SS10 181.8 Hand movements and muscle activation
Disabilities, Natl. Rehabil. Ctr. for Persons with Disabilities,
evoked by intracortical microstimulation. S. A. OVERDUIN*;
Chiba Univ.
A. D’AVELLA; J. M. CARMENA; E. BIZZI. UC Berkeley,
Santa Lucia Fndn., MIT. 8:00 TT4 182.5 Sensory reweighting in control subject
and in stroke patients. P. VIDAL*; S. ESKIIZMIRLILER;
8:00 SS11 181.9 Proximal to distal sequencing behavior
A. MARQUER; A. YELNIK; I. BONAN. UMR 8194, Univ.
and spatiotemporal dynamics of beta oscillations in primary
Paris Descartes - CNRS, AP-HP, Univ. René Diderot, CHU
motor cortex during self-paced simulated climbing. L.
Rennes.
OLMEDO*; K. TAKAHASHI; A. RAJAN; N. HATSOPOULOS.
Univ. of Chicago. 9:00 TT5 182.6 Visual reweighting in locomotion. D. M.
LOGAN*; T. KIEMEL; G. CAPPELLINI; F. SYLOS LABINI;
9:00 SS12 181.10 Aging does not affect voluntary activation
Y. IVANENKO; F. LACQUANITI; J. JEKA. Univ. Maryland,
of the quadriceps muscle during isometric contractions. M.
Santa Lucia Fndn.
BEHRENS*; A. MAU-MÖLLER; D. WERNER; S. BRUHN.
Univ. of Rostock. 10:00 TT6 182.7 Activity of red nucleus neurons in the cat
during postural corrections. T. DELIAGINA*; P. V. ZELENIN;
10:00 SS13 181.11 Contractile changes in the quadriceps
M. G. SIROTA; G. N. ORLOVSKY; I. N. BELOOZEROVA.
muscle with aging. A. MAU-MÖLLER*; M. BEHRENS; D.
Karolinska Inst., Barrow Neurolog. Inst.
WERNER; R. BADER; S. BRUHN. Univ. of Rostock.
11:00 TT7 182.8 Interpersonal light touch and balance.
11:00 SS14 181.12 Alteration in muscle electrical anisotropy
A. M. WING*; L. JOHANNSEN; V. HATZITAKI. Univ.
after sciatic nerve crush in the rat. J. LI*; L. L. WANG; S. B.
Birmingham, Aristotle Univ. of Thessaloniki.
RUTKOVE. Harvard Med. School, Beth Israel Deaconess
Med. Ctr. 8:00 TT8 182.9 The effect of the anti-spastic drug
Tizanadine on the contribution of afferent feedback to the
8:00 SS15 181.13 Scapular instability and overuse injury in
soleus muscle activation during walking in stroke patients.
pianists. E. S. REID*, JR; A. BHATT; J. SIEFFERMAN; D.
N. MRACHACZ-KERSTING; J. FELDBÆK NIELSEN;
WEISZ; P. RAGHAVAN. Mount Sinai Sch. of Med., New York
P. STUBBS; T. SINKJAER*. Aalborg Univ., 2Hammel
Univ. Sch. of Med.
Neurorehabilitation and Res. Ctr. Hosp.
9:00 SS16 181.14 Dynamic spinal segmental organization
9:00 TT9 182.10 Reduced antagonist activity changes
in pianists with overuse injury. A. BHATT*; E. REID; J.
the soleus H reflex modulation significantly during
SIEFFERMAN; D. WEISZ; P. RAGHAVAN. Mt. Sinai Sch. of
human walking. T. ALKJAER*; E. B. SIMONSEN. Univ. of
Med., NYU Sch. of Med.
Copenhagen.
10:00 SS17 181.15 Surface EMG assessment of muscle fiber
10:00 TT10 182.11 Stretch reflexes and reciprocal inhibition
reinnervation in hemiparetic muscles. P. ZHOU; X. LI; N. L.
in forearm extensors and flexors in humans. C. D.
SURESH; W. Z. RYMER*. Rehab Inst. Chicago.
MANNING*; P. BAWA. Simon Fraser Univ.
11:00 SS18 181.16 Upper limb synergy structure in chronic
11:00 TT11 182.12 The use of proprioceptive and visual
stroke survivors with moderate to severe impairment. J.
feedback for gait retraining post-stroke. M. D. LEWEK*; J.
ROH*; R. F. BEER; E. J. PERREAULT; W. Z. RYMER.
FEASEL; L. KASSLER; F. BROOKS, Jr; M. WHITTON. Univ.
Northwestern Univ., Rehabil. Inst. of Chicago.
of North Carolina At Chapel Hill, Univ. of North Carolina at
8:00 SS19 181.17 Monoamine contributions to the stretch Chapel Hill.
reflex response threshold in hemispheric stroke and control
8:00 TT12 182.13 Proprioceptive reweighting depends on
subjects. N. L. SURESH*; K. E. MORRIS; R. D. THEISS;
postural task complexity. S. BRUMAGNE*; L. JANSSENS.
M. K. CHARDON; W. Z. RYMER. Rehabil. of Chicago,
K.U.Leuven.
Northwestern Univ.
9:00 TT13 182.14 Ephrin-B2 in the spinal cord
proprioceptive sensory system. M. D. BENSON*; M. I.
POSTER ROMERO-ORTEGA; M. HENKEMEYER; L. F. PARADA.
Baylor Col. of Dent., Univ. of Texas at Arlington, Univ. of
182. Posture and Gait: Afferent Control Texas Southwestern Med. Ctr.

Theme D: Sensory and Motor Systems
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 SS20 182.1  •  Effects of thrust displacements simulating
a spinal manipulation on the response of lumbar paraspinal
muscle spindles to ramp & hold movement. D. CAO*; W.
R. REED; G. N. KAWCHUK; J. G. PICKAR. Palmer Col. of
SLIDE
10:00 TT14 182.15 Role of RORalpha expressing
interneurons in the spinal cord. K. S. GROSSMANN*; O.
BRITZ; M. DEL BARRIO; C. BIRCHMEIER; D. O´LEARY; M.
GOULDING. Salk Inst. For Mol. Studies, Max Delbrueck Ctr.
for Mol. Med., Salk Inst. for Mol. Studies.
11:00 TT15 182.16 Psychophysical detection thresholds
to anterior horizontal translations in restrained seated vs.

Chiropractic, Univ. of Alberta.

harnessed standing conditions. C. J. ROBINSON*; X.
9:00 TT1 182.2 Models of neuropathy syndromes and DONG; G. D. FULK. Clarkson Univ., VA Med. Ctr.
their effects on shoulder posture. R. E. MELTZER*; W. E.
JANES; J. IMBS; J. M. ESSENBERG; J. ENGSBERG; J. M.
BROWN. Washington Univ. in St. Louis.

48  |  Society for Neuroscience • Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
8:00 TT16 182.17 Effects of spinal manipulation’s
mechanical characteristics (magnitude and duration) on
paraspinal muscle spindle discharge. W. R. REED*; D.
CAO; G. N. KAWCHUK; J. G. PICKAR. Palmer Col. of
Chiropractic, Univ. of Alberta.
9:00 TT17 182.18 Afferent feedback from the distal tibial
nerve regulates hip muscle activity in the decerebrate
walking cat. J. E. MISIASZEK*; D. A. E. BOLTON. Univ.
Alberta, Univ. of Waterloo.
10:00 TT18 182.19 The impact of light hand touch on haptic
cortical processing during a standing balance task. D. A.
BOLTON*; W. MCILROY; J. THAKER; W. R. STAINES. Univ.
Waterloo.
11:00 TT19 182.20 Task dependent vestibular-evoked
muscle responses to galvanic stimulation in humans. B. L.
LUU*; J. T. INGLIS; T. P. HURYN; H. F. M. VAN DER LOOS;
J. BLOUIN. UBC, Intl. Collaboration On Repair Discoveries.
8:00 TT20 182.21 The contribution of light touch sensory
cues to balance reactions during treadmill walking. J.
FORERO*; J. E. MISIASZEK. Univ. Alberta.
9:00 UU1 182.22 Variations in loading type cause timing
changes in paretic leg extensor muscles during pedaling. J.
K. BURGESS*; D. A. BROWN. Northwestern Univ.
10:00 UU2 182.23 Increased afferent input in multi-level
compression neuropathy produces changes in 3-dimensional
scapular dynamics and posture. J. GODZIK*; W. JANES; J.
M. BROWN. Washington Univ. Sch. of Med.
11:00 UU3 182.24 Objective quantification of kinematics in
multi-level nerve compression syndrome. W. E. JANES*; J.
M. BROWN; J. R. ENGSBERG. Washington Univ. Sch. of
Med.
POSTER
183. Posture and Gait: Control and Integration
Theme D: Sensory and Motor Systems
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 UU4 183.1 Navigation in a virtual reality environment
for Parkinson’s disease. A. R. SOUTH*; H. KUMAR; G.
KAPP; V. VUJCIC; R. JOG; M. KATCHABAW; M. JOG.
Univ. of Western Ontario, London Hlth. Sci. Ctr., Central
Secondary Sch.
9:00 UU5 183.2 Single-unit activity in primary motor cortex
of an unrestrained Japanese monkey during quadrupedal
v.s. bipedal locomotion on the treadmill. K. NAKAJIMA*;
F. MORI; A. MURATA; M. INASE. Kinki Univ, Facult Med.,
Yamaguchi Univ, Facult Agr.
10:00 UU6 183.3 How does the bipedal locomotor system
steer itself round a curved path? E. W. BLOCK; G. MELVILL-
JONES*; W. A. FLETCHER; C. PAQUETTE; F. B. HORAK.
Univ. Calgary, Neurolog. Institute, Oregon Hlth. & Sci. Univ.
11:00 UU7 183.4 Postural response to consistent &
inconsistent visual and motion stimuli. J. E. BARTON*; E.
KESHNER. Joseph Barton, Temple Univ.
8:00 UU8 183.5 Determining the contribution of the
ankle and hip joint to human balance control using system
identification techniques. T. A. BOONSTRA*; H. VAN DER
KOOIJ. Univ. of Twente.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
9:00 VV1 183.6 Size-dependant changes in gait
awareness when walking towards your mirror reflection.
T. TADI*; S. DIEGUEZ; O. BLANKE. Brain Mind
Institute(EPFL), Dept. of Neurology, Univ. Hosp.
10:00 VV2 183.7 Amplitudes of electroencephalographic
contingent negative variation are related to the magnitude
of anticipated postural perturbations. B. A. SMITH*; J. V.
Sun. AM
JACOBS; F. B. HORAK. Oregon Hlth. and Sci. Univ., Univ. of
Vermont.
11:00 VV3 183.8 Gait characteristics and skilled locomotor
tasks in normally developing children. C. W. CHAU*; S.
GOMBATTO; S. DEY; D. GRAVETT; E. SMITH. Nazareth
Col.
8:00 VV4 183.9 Visuospatial interference between an
arithmetic task & sensory organization for stance balance
control. R. K. CHONG*; L. DAILEY; E. LANE; B. MILLS; S.
SMITH; K. LEE. Med. Col. of Georgia.
9:00 VV5 183.10 Conscious gait monitoring in
virtual environments: Spatial, temporal, and cognitive
characteristics. O. A. KANNAPE*; O. BLANKE. Ecole
Polytechnique Federale De Lausanne, Univ. Hosp.
10:00 VV6 183.11 What factors are prioritized for planning
actions that require goal-directed positioning? C. B.
CHARALAMBOUS*; Y. LAI; E. WADE; C. WINSTEIN. USC.
11:00 VV7 183.12 Repeated exposure to split-belt treadmill
walking reveals differences in learning between stroke
survivors and healthy human adults. C. L. MALECKA*; D.
REISMAN. Univ. Delaware.
8:00 VV8 183.13 Human walking stabilized by foot force
direction control. K. G. GRUBEN*; W. L. BOEHM; A. R.
GUTIERREZ. Univ. Wisconsin.
9:00 VV9 183.14 Attentional demands associated with
obstacle crossing while carrying a load. J. B. KIRIELLA*; C.
J. PERRY; K. M. HAWKINS; C. J. SHANAHAN; A. MOORE;
W. GAGE. York Univ.
10:00 VV10 183.15  •  Muscle synergy variance is structured
to stabilize whole body center of mass during walking.
V. KRISHNAMOORTHY*; S. A. CHVATAL. Emory Univ.,
Georgia Inst. of Technology, Emory Univ.
11:00 VV11 183.16 Effects of allocation of visuo-spatial
attention on anticipatory postural control and event-related
potentials during unilateral arm abduction while standing. C.
YAGUCHI*; K. FUJIWARA. Kanazawa Univ.
8:00 VV12 183.17 A stability-maneuverability tradeoff during
whole-body movements: biomechanical and muscular
control. H. J. HUANG*; A. A. AHMED. Univ. Colorado at
Boulder.
9:00 VV13 183.18 Imaging the mobile brain. J. T. GWIN*;
D. P. FERRIS; N. BIGDELY-SHAMLO; S. MAKEIG; K.
GRAMANN. Univ. of Michigan, Univ. of California.
10:00 VV14 183.19  •  Paw trajectories of cat fore- and
hindlimbs are stabilized during swing of walking on a flat
surface and horizontal ladder. A. KLISHKO*; B. J. FARRELL;
M. L. LATASH; B. I. PRILUTSKY. Georgia Inst. Tech., Penn
State Univ.
11:00 VV15 183.20 Individual differences in sensorimotor
performance and motor sequence learning. N. B. BOYDEN*;
Y. KWAK; J. HUMFLEET; M. L. T. M. MULLER; D. T. BURKE;
N. BOHNEN; R. D. SEIDLER. Univ. of Michigan.
Neuroscience 2010  |  Sunday AM  |  49 
8:00 VV16 183.21 Modification of gaze and steering
behaviours by changing optic flow. A. GARCIA POPOV*;
A. LAMONTAGNE. Jewish Rehabil. Hosp. (Feil & Oberfeld/
CRIR) Res. Ctr., McGill Univ.
9:00 VV17 183.22 Pre-motor event-related potential related
to toe-off during human walking. J. E. KLINE; A. SIPP*; K.
GRAMANN; S. MAKEIG; D. P. FERRIS. Univ. of Michigan,
Univ. of California.
POSTER
184. Voluntary Reaching: Action and Perception
Theme D: Sensory and Motor Systems
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 VV18 184.1 Proprioceptive pathways to posterior
parietal areas MIP and LIPv from the dorsal column nuclei
and areas 3a and 2, revealed by retrograde transneuronal
transfer of rabies virus combined with a conventional tracer.
V. PREVOSTO*; W. GRAF; G. UGOLINI. CNRS, Howard
Univ.
9:00 VV19 184.2 Directional bias of proprioceptive hand
position information - Evidence from a patient with unilateral
damage of the postcentral gyrus. S. BORCHERS*; M.
HIMMELBACH. Univ. Hosp. Tuebingen, Hertie-Institute for
Clin. Brain Res.
10:00 VV20 184.3 Perception and action in simulated needle
insertion task. I. NISKY*; A. PRESSMAN; C. M. PUGH; F.
A. MUSSA-IVALDI; A. KARNIEL. Ben-Gurion Univ., Rehabil.
Inst. of Chicago, Northwestern Univ.
11:00 WW1 184.4 How seeing improves haptic perception.
N. B. DEBATS*; I. KINGMA; P. J. BEEK; J. B. J. SMEETS.
Fac. of Human Movement Sciences, VU Univ.
8:00 WW2 184.5 Virtual lesion of posterior parietal cortex
via theta burst stimulation disrupts visual-proprioceptive
realignment. H. J. BLOCK*; P. CELNIK; A. J. BASTIAN.
Johns Hopkins Univ, Sch. Med., Kennedy Krieger Inst.
9:00 WW3 184.6 Functional organization and behavioral
significance of the rostral spinocerebellar system in behaving
primates. O. COEHN; R. HAREL; T. AUMANN; Y. PRUT*.
Hebrew Univ, Hadassah Med. Sch., Sheba Med. Ctr., The
Univ. of Melbourne.
10:00 WW4 184.7 Thalamocortical input produces
feedforward inhibition on motor cortical neurons of behaving
primates. O. COHEN*; Z. ISRAEL; Y. PRUT. The Hebrew
Univ. - Hadassah Med. Sch., Hadassah Hosp.
11:00 WW5 184.8 The effect of length of the end-effector
on arm synergies during pointing movements. R. M.
BONGERS*; M. C. VAN DER STEEN. Univ. of Groningen,
Univ. Med. Ctr. Groningen.
8:00 WW6 184.9 Muscle activity and force field adaptation
effects on visuomotor reflex gain. S. M. FRANKLIN*; D. W.
FRANKLIN; D. M. WOLPERT. Univ. of Cambridge.
9:00 WW7 184.10 State dependence of reflex adaptation. D.
W. FRANKLIN*; S. M. FRANKLIN; D. M. WOLPERT. Univ.
Cambridge.
10:00 WW8 184.11 Frontal lobe inputs to the shoulder
region of the dorsal premotor area in macaque monkeys.
Y. HIRATA*; K. INOUE; D. TAKAHARA; M. TAKADA; E.
HOSHI. Systems Neurosci., Primate Res. Inst., Kyoto Univ.,
Brain Sci. Inst., Tamagawa Univ.
50  |  Society for Neuroscience
POSTER
185. HPG Axis: Gonadotropin Release
Theme E: Homeostatic and Neuroendocrine Systems
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 WW9 185.1 Targeted pituitary over-expression of
PACAP modifies the regulation of the pituitary-gonadal axis
in male mice. R. Q. YANG; J. P. MOORE*; S. J. WINTERS.
Univ. of Louisville, Univ. Louisville.
9:00 WW10 185.2 Transection of parasympathetic
innervation forestalls cervical ripening and parturition in rats.
L. A. CLYDE; T. J. LECHUGA; C. A. EBNER; A. E. BURNS;
M. A. KIRBY; S. M. YELLON*. Loma Linda Univ. Sch. Med.
10:00 WW11 185.3 Differential roles of corticotropin-releasing
hormone receptor types 1 and 2 on gonadotropins secretion
from rat under restraint stress during proestrus. G. A.
TRASLAVIÑA*; C. R. FRANCI. Univ. of São Paulo.
11:00 WW12 185.4 Persistent cytoarchitectural changes in
the adult male rat pituitary after discontinuing treatment with
the GnRH agonist deslorelin. A. W. SMITH*; C. S. ASA; B.
S. EDWARDS; W. J. MURDOCH; D. C. SKINNER. Univ.
Wyoming, St. Louis Zoo.
8:00 WW13 185.5   The impact of compound FGFR1 and
FGF8 signaling deficiencies on the murine reproductive
system. B. K. TATA; P. TSAI; W. C. CHUNG*. Univ. Colorado
Boulder.
9:00 WW14 185.6 Is increased running activity essential for
novel wheel-induced blockade of the preovulatory luteinizing
hormone (LH) surge and circadian phase advances? S. J.
LEGAN*; X. PENG; K. M. FRANKLIN; M. J. DUNCAN. Univ.
Kentucky.
10:00 WW15 185.7 The effects of unilateral section of the
superior ovarian nerve (SON) on spontaneous ovulation
vary during the estrous cycle and time of the day when it
is performed and presents asymmetry. J. VELASCO; A.
FLORES; R. DOMINGUEZ*. FES Zaragoza UNAM.
11:00 WW16 185.8 Intracerebroventricular injection of
vasoactive intestinal peptide restores the luteinizing hormone
surge in middle-aged female rats. Y. SUN; J. SHU; A. M.
ETGEN; G. NEAL-PERRY*. Albert Einstein Col. of Med.,
Montefior Med. Ctr, Albert Einstein Col. Med.
8:00 WW17 185.9 Changes in the estrous cycle and
ovulation induced by microinjection of haloperidol in anterior
hypothalamus of the rat. A. PATRICIO*; J. L. MORÁN;
C. MORÁN; M. HERNÁNDEZ; A. HANDAL; I. D. LIMÓN.
Benemerita Univ. Autonoma De Puebla, Benemérita Univ.
Autónoma de Puebla.
9:00 WW18 185.10  •  The cholinergic blockade during the rat
estrous cycle results in opposite effects on gonadotropins
and estradiol surge at proestrus. M. B. CRUZ*; A.
DOMINGUEZ-GONZÁLEZ; A. FLORES; M. CÁRDENAS;
R. CHAVIRA; R. DOMÍNGUEZ. Univ. Autonoma De Mexico,
Westhill Univ., Facultad de Estudios Superiores Zaragoza,
UNAM, Inst. Nacional de la Nutrición Salvador Zubirán,
Facultad de Estudios Superiores Zaragoza. UNAM.
10:00 WW19 185.11 The neural activity in the rat celiac-
superior mesenteric ganglia related with the ovary via the
superior ovarian nerve during the estrus cycle. C. MORAN*;
B. ROBLEDO; H. E. SCOTT; J. L. MORAN; A. HANDAL; R.
DOMINGUEZ. Univ. Autonoma de Puebla, Univ. Nacional
Autonoma de Mexico.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
POSTER
186. Steroids and Plasticity: Cortex, Hippocampus, and Basal
Ganglia
Theme E: Homeostatic and Neuroendocrine Systems
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 WW20 186.1 Some of testosterone’s effects to protect
against scopolamine-induced memory impairment in male
mice may involve 5alpha-reduction. D. M. OSBORNE*; C. A.
FRYE. Univ. Albany, Univ. at Albany.
9:00 XX1 186.2   Phenytoin reduced sexual behavior, and
increased latencies to chemoconvulsant-induced mortality,
among 5alpha-reductase replete, but not 5alpha-reductase
knockout, male mice. J. A. FRIEDMAN*; D. M. OSBORNE;
C. A. FRYE. SUNY Albany, Univ. at Albany.
10:00 XX2 186.3 Progesterone and fluoxetine have
antidepressant effects among wildtype, but not 5alpha-
reductase deficient, mice. C. J. KOONCE*; E. D.
BASTARACHE; A. A. WALF; C. A. FRYE. Univ. Albany,
Berkshire Sch., Univ. at Albany.
11:00 XX3 186.4 Infusions of anti-sense oligonucleotides
targeted against pregnane xenobiotic receptor attenuate
anti-anxiety, pro-social, and reproductive behavior of
ovariectomized, estrogen-primed rats co-administered
3alpha,5alpha-THP. D. J. DACOSTA*; C. J. KOONCE; J.
TORGERSEN; A. A. WALF; C. A. FRYE. UAlbany, Univ. at
Albany.
8:00 XX4 186.5 The effects of long term treatment with 17
β-estradiol in combination with progesterone on the number
of synaptophysin labeled boutons in the medial prefrontal
cortex of aged female rats. N. C. LOWRY*; M. A. YATES; J.
M. JURASKA. Univ. Illinois.
9:00 XX5 186.6 Blockade of androgen receptors inhibits
treadmill running-induced adult hippocampal neurogenesis.
M. OKAMOTO*; K. INOUE; T. MATSUI; M. LEE; H. SOYA.
Univ. of Tsukuba.
10:00 XX6 186.7 Hippocampal aromatase expression in
Alzheimer’s disease. J. PRANGE-KIEL*; D. DUDZINSKI;
G. M. RUNE. UT Southwestern, Univ. Med. Ctr. Hamburg-
Eppendorf.
11:00 XX7 186.8 Mossy fibers plasticity and activity of nitric
oxide synthase in rat hippocampus through out the estrous
cycle. E. PADILLA*; F. SEVERIANO; V. BELTRÁN; J.
PINEDA; V. PINEDA; A. AGUILAR; C. RÍOS; S. DÍAZ. Inst.
Neurobiol, Inst. Nacional de Neurología y Neurocirugía.
8:00 XX8 186.9 Estrogen targets LIM Kinase via non-
nuclear receptor activity. K. T. AKAMA*; G. S. YUEN; B. S.
MCEWEN. The Rockefeller Univ.
9:00 XX9 186.10 Delta-opioid receptor colocalization with
the corticotropin releasing factor receptor in CA1 of the male
and female hippocampus. T. J. WILLIAMS*; T. A. MILNER.
Weill Cornell Med. Coll, Weill Cornell/Rockefeller/Sloan-
Kettering Tri-Institutional MD-PhD Program, The Rockefeller
Univ.
10:00 XX10 186.11   Acute immobilization stress
alters the subcellular distribution of mu opioid receptor
immunoreactivity in hippocampal parvalbumin-containing
interneurons of female rats. S. KHALID; J. D. CHAPLEAU;
T. J. WILLIAMS; K. SCHIERBERL; H. M. GUARJARDO;
E. M. WATERS; T. A. MILNER*. Weill Cornell Med. Coll,
Rockefeller Univ.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
11:00 XX11 186.12 Interactions between sex and acute
stress on levels of phosphorylated mu opioid receptor-
immunoreactivity in the rat hippocampus. J. D. CHAPLEAU*;
T. J. WILLIAMS; E. M. WATERS; L. I. THOMPSON; T. A.
MILNER. Weill Cornell Med. Coll, Rockefeller Univ.
8:00 XX12 186.13  •  Neuroinflammation and
neurodegeneration in Accelerated Ovarian Failure: A novel
Sun. AM
mouse model of menopause. T. A. VAN KEMPEN*; T. A.
MILNER; E. M. WATERS. Weill Cornell Med. Col., Weill
Cornell Grad. Sch. of Med. Sci., Rockefeller Univ.
9:00 XX13 186.14 17Β-Estradiol reverses oxidative stress
and improves spine plasticity of hippocampal CA1 pyramidal
neurons. A. AGUILAR VAZQUEZ*; V. BELTRÁN CAMPOS;
E. PADILLA GÓMEZ; M. ALCARAZ ZUBELDIA; V. PINEDA
MARTÍNEZ; A. DÍAZ RUIZ; C. RIOS; S. DÍAZ CINTRA.
Inst. de Neurobiologia, Inst. Nacional de Neurología y
Neurocirugía Manuel Velazquez Súarez.
10:00 XX14 186.15 Synthesis of estrogen and androgen
which rapidly modulate spines and LTD/LTP in the
hippocampus. S. KAWATO*; Y. HOJO; S. HIGO; R. SATO;
H. MUKAI; G. MURAKAMI. Univ. of Tokyo, Rockefeller Univ.
11:00 XX15 186.16 Diferential glial response to excitotoxicity
in the hippocampus of nulliparous and lactating rats. V.
CABRERA; E. RAMOS; M. CERBON; T. MORALES*. Inst.
de Neurobiologia, UNAM, Facultad de Quimica, UNAM.
8:00 XX16 186.17 Thyroid hormone (T3) changes
neuroglobin and cytoglobin gene expression in the cortex,
hippocampus and cerebellum in rats. M. A. SATO*; K. O.
CARNEIRO; R. M. B. MACIEL; G. GIANNOCCO. Fac Med.
do ABC, Faculdade de Medicina do ABC, UNIFESP.
9:00 XX17 186.18 Androgens decrease cell viability in
oxidative stressed dopamine neurons: Implications for
Parkinson’s disease. R. L. CUNNINGHAM*; M. SINGH. Univ.
North Texas Hlth. Sci. Ctr.
10:00 XX18 186.19 Intra-striatal estradiol rapidly increases
dopamine release in female rats. M. G. QUINLAN*; M.
COSSETTE; T. MCPEAK; W. G. BRAKE. California State
University, San Bernardino, Concordia Univ.
11:00 XX19 186.20 Midbrain dopamine neuron number and
cocaine-stimulated locomotion decrease after estrogen
removal in mice. A. E. DAY*; M. L. JOHNSON; C. C. HO; C.
M. KUHN. Duke Univ.
8:00 XX20 186.21 Acute effects of 17-beta estradiol on the
nucleus accumbens in young rats. E. PENICK*; M. IKEDA.
knox college.
POSTER
187. Parental Behavior
Theme E: Homeostatic and Neuroendocrine Systems
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 YY1 187.1  •  Insecure attachment, but not difficult
temperament, is related to HPA axis suppression to
challenging and positive emotional contexts, in children
but not in mothers. L. ROQUE*; M. VERÍSSIMO; T. F.
OLIVEIRA; M. FERNANDES; R. F. OLIVEIRA. Inst.
Superior De Psicologia Aplicada, UICPDE, Inst. Superior
de Psicologia Aplicada, UIE-E, Inst. Superior de Psicologia
Aplicada, Inst. de Medicina Mol. da Faculdade de Medicina
da Univ. de Lisboa, Champalimaud Neurosci. Programme,
Inst. Gulbenkian de Ciência.
Neuroscience 2010  |  Sunday AM  |  51 
9:00 YY2 187.2 GABAA receptor α2, α4, and Γ2 subunit
expression in the neural anxiety network in postpartum,
virgin, pregnant, and male rats. S. M. MILLER*; J. S.
LONSTEIN. Michigan State Univ.
10:00 YY3 187.3 The effect of genitosensory stimulation
and hormone treatment on the induction of maternal
behavior in female prairie voles. A. VELEZ*; U. L. HAYES.
Univ. of Massachusetts.
11:00 YY4 187.4 Gene expression profiling in the brain of
pregnant and lactating rats. P. E. MANN*; J. LEE. Tufts Univ.
8:00 YY5 187.5 Effect of isolation rearing and
reproductive experience on dendritic morphology in the
medial preoptic area, nuclues accumbens and caudate
nucleus, in female Sprague-Dawley rats. S. SHAMS*; M.
CHATTERJEE-CHAKRABORTY; H. OATLEY; J. PAWLUSKI;
A. S. FLEMING. Univ. of Toronto, Maastricht Univ.
9:00 YY6 187.6 Parental transmission of social
experiences in Balb/c mice. R. MASHOODH*; J. Y. WANG;
B. FRANKS; J. P. CURLEY; F. A. CHAMPAGNE. Columbia
Univ.
10:00 YY7 187.7 Variations in maternal care program
development of site-specific hormone receptor differences.
C. L. JENSEN*; F. A. CHAMPAGNE. Columbia Univ.
11:00 YY8 187.8 Developmental origins of variation in
estrogen receptor α levels in the brain. S. GRENALD;
C. L. JENSEN; J. P. CURLEY; S. BRUNELLI; F. A.
CHAMPAGNE*. Columbia Univ., New York State Psychiatric
Inst.
8:00 YY9 187.9 Dopamine receptor gene expression
associated with maternal behavior and memory in the
parturient rat. J. J. BYRNES; D. F. LOVELOCK; R. S.
BRIDGES*. Tufts Univ. - Cummings Sch. of Vet. Med.
9:00 YY10 187.10 Social experience affects paternal
behavior and dopamine turnover in the nucleus accumbens
of male prairie voles. K. LEI*; Y. LIU; H. WANG; Z. WANG.
Florida State Univ.
10:00 ZZ1 187.11 Brief pup exposure induces Fos
expression in the lateral habenula and serotonergic
caudal dorsal raphe nucleus of paternally experienced
male California mice (Peromyscus californicus). T. R. DE
JONG*; K. R. MEASOR; M. CHAUKE; B. N. HARRIS; W.
SALTZMAN. UC Riverside.
11:00 ZZ2 187.12 Affective and neuroendocrine correlates
of fatherhood in a biparental mammal, the California mouse
(Peromyscus californicus). M. CHAUKE*; T. R. DE JONG;
K. R. MEASOR; B. N. HARRIS; M. ANTONIOUS; W.
SALTZMAN. UC Riverside.
8:00 ZZ3 187.13 Vasopressin influences olfactory
processing in maternal Peromyscus californicus. J. K.
BESTER-MEREDITH*; E. COLE; J. M. HINTON. Seattle
Pacific Univ.
9:00 ZZ4 187.14 Expression of oxytocin receptor gene in
the MPOA and the hypothalamic SON in mice, when they
exhibited parental behaviors. K. SATO*; A. YAMASHITA; M.
YOSHIDA; K. NISHIMORI. Tohoku Univ.
10:00 ZZ5 187.15 Maternal behaviors in dominant
negative fibroblast growth factor receptor mutant mice. L.
R. BROOKS*; D. LE; W. C. J. CHUNG; P. TSAI. Univ. of
Colorado.
52  |  Society for Neuroscience
11:00 ZZ6 187.16 Gestational cocaine exposure disrupts
stress-related oxytocin and corticosterone plasma levels
in postpartum rat mothers. S. WILLIAMS*; A. JAMIESON-
DRAKE; B. W. THOMPSON; J. A. ENNS; J. S. BARBER;
B. ROSS; C. S. WALKER; J. M. JOHNS. UNC-Chapel Hill,
Univ. of North Carolina.
8:00 ZZ7 187.17 Cocaine exposure alters maternal
sensitivity to infant behavior predicting infant developmental
outcome. E. T. COX*; P. S. ZESKIND; M. E. PIMENTEL;
A. D. BAXLEY; M. J. DEBURKARTE; M. C. ELAM; J.
M. JOHNS; K. M. GREWEN. UNC-Chapel Hill, Levine
Children’s Hosp. at Carolinas Med. Ctr.
POSTER
188. Central Respiratory Chemoreception
Theme E: Homeostatic and Neuroendocrine Systems
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 ZZ8 188.1 Characterization of the signaling
cascades underlying the effects of ATP on glia cultured
from preBötzinger Complex inspiratory rhythm generating
networks. J. D. ZWICKER*; L. B. HAHN; E. POSSE DE
CHAVES; G. D. FUNK. Univ. of Alberta.
9:00 ZZ9 188.2  •  Development of chemosensitivity to CO2
and O2 in mice with absence of central serotonin neurons in
vivo. V. CERPA*; G. B. RICHERSON. Yale Univ., VAMC.
10:00 ZZ10 188.3  •  Cholinergic mechanisms involved in
chemosensitivity of cultured 5-HT neurons. J. AVRAAM; Y.
WU*; G. B. RICHERSON. Yale Univ. Sch. Med.
11:00 AAA1 188.4 Identification of chemosensitive and
insensitive serotonergic and GABAergic neurons in rat
medullary raphé nuclei. K. E. ICEMAN*; G. B. RICHERSON;
M. B. HARRIS. Univ. of Alaska Fairbanks, Yale Univ.
8:00 AAA2 188.5 Serotonergic mechanisms are implicated
in nicotine- and ethanol-induced impairments of respiratory
chemosensitivity. B. E. TAYLOR*; C. M. BRUNDAGE; E.
VAYNDORF. Univ. of Alaska Fairbanks.
9:00 AAA3 188.6 Ethanol-induced loss and return of
central CO2 chemosensitivity is coincident with GABAergic
desensitization and resensitization. C. M. BRUNDAGE*; K.
E. ICEMAN; C. M. CARTAGENA DE JESUS; B. E. TAYLOR.
Univ. Alaska Fairban, Inst. of Arctic Biol.
10:00 AAA4 188.7 Implementation of dynamical systems
analysis in development of an excitable cell model of
a respiratory CO2 sensing neuron based on the GHK
equation. J. M. CORDOVEZ*; I. C. SOLOMON. Univ. De Los
Andes, State Univ. of New York at Stony Brook.
11:00 AAA5 188.8 Astrocytic calcium signals in pre-
Bötzinger complex induced by norepinephrine. S.
HÜLSMANN*; M. NEGM; C. SCHNELL. Georg August Univ.
Goettingen.
8:00 AAA6 188.9  •  Postsynaptic mechanisms of CO2
responses in parafacial pre-inspiratory neurons of newborn
rats. H. ONIMARU*; K. IKEDA; K. KAWAKAMI. Showa Univ.
Sch. of Med., Jichi Med. Univ.
9:00 AAA7 188.10 Immunohistochemical evidence for
expression of α-gustducin at brainstem sites of CO2/H+
respiratory chemoreception. A. J. TROUTH*; O. DEHKORDI;
J. E. ROSE; K. V. BALAN; S. FATIMA; R. M. MILLIS. Howard
Univ. Hosp., Duke Univ. Med. Ctr., Case Western Reserve
Univ.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
10:00 AAA8 188.11 Acute and specific silencing of Phox2b-
expressing neurons in the region of retrotrapezoid nucleus
attenuates respiratory and blood pressure responses to
hypercapnia in unanesthetized rats. A. LI*; A. P. ABDALA; J.
F. R. PATON; E. E. NATTIE. Dartmouth Med. Sch., Univ. of
Bristol.
11:00 AAA9 188.12 Focal acidification in the perifornical
hypothalamic area by high CO2 microdialysis increases
ventilation in wakefulness. N. LI*; A. LI; E. NATTIE.
Dartmouth Med. Sch.
8:00 AAA10 188.13 Astrocytes in the retrotrapezoid nucleus
(RTN) sense H+ by inhibition of a Kir4.1-Kir5.1-like current
and contribute to chemoreception by a purinergic-dependent
mechanism. I. C. WENKER*; A. NISHIYAMA; D. K. MULKEY.
Univ. of Connecticut.
9:00 AAA11 188.14 Localized corpus callosum fiber injury in
patients with congenital central hypoventilation syndrome. R.
KUMAR*; P. M. MACEY; M. A. WOO; R. M. HARPER. Univ.
of California at Los Angeles.
10:00 AAA12 188.15 The role of calcium in the chemosensitive
response of neurons from neonatal rat locus coeruleus (LC).
A. N. IMBER; R. W. PUTNAM*. Wright State Univ. Boonshoft
Sch. Med.
11:00 AAA13 188.16 Mapping chemosensitivity onto
genetically-defined serotonergic neuron subtypes. R. D.
BRUST*; G. B. RICHERSON; Y. WU; S. M. DYMECKI.
Harvard Med. Sch., Yale Univ. Sch. of Med.
8:00 AAA14 188.17 Impaired neural, cardiovascular, and
respiratory responses to isometric handgrip challenge in
congenital central hypoventilation syndrome. J. A. OGREN*;
P. M. MACEY; R. KUMAR; M. A. WOO; R. M. HARPER.
UCLA, David Geffen Sch. of Med. at UCLA.
9:00 AAA15 188.18 Estrogen modulation of hypercapnia-
induced c-Fos expression in norepinephrine neurons of
the female rat locus coeruleus. D. DE CARVALHO*; K. C.
BÍCEGO; M. P. BERNUCI; F. B. LIMA; D. MARQUES; R. E.
SZAWKA; J. A. ANSELMO-FRANCI; L. H. GARGAGLIONI*.
Univ. Federal de São Carlos, UNESP, Faculdade de
Odontologia de Ribeirão Preto-USP, Inst. de Ciências
Biológicas - UFMG.
10:00 AAA16 188.19 Does neonatal stress affect purinergic
modulation of cardiorespiratory responses to hypercapnia in
adult rats? V. BIANCARDI*; F. DUMONT; D. DE CARVALHO;
L. H. GARGAGLIONI; R. KINKEAD. Sao Paulo State Univ.,
Federal Univ. of Sao Carlos, Laval Univ.
11:00 AAA17 188.20 Hypercapnia inhibits a transient K+
current in chemosensitive neurons from the nucleus tractus
solitarius (NTS) of neonatal rats. K. LI*; R. W. PUTNAM.
Wright State Univ., Wright State Univ. Boonshoft Sch. of
Med.
8:00 AAA18 188.21 The three dimensional morphology and
immunostaining for Kv1.4 channel subunit of chemosensitive
and nonchemosensitive neurons from the locus coeruleus
(LC). C. GRAHAM*; R. W. PUTNAM. Wright State Univ.
9:00 AAA19 188.22 Congenital central hypoventilation
syndrome neural alterations; overlap with phox2b expression
in murine models. R. M. HARPER*; R. KUMAR; P. M.
MACEY; M. A. WOO; J. A. OGREN; H. DONG. UCLA,
Neurobio., UCLA, Brain Res. Inst., UCLA Sch. of Nursing,
UCLA, Neurol.
10:00 AAA20 188.23 Serotonergic raphe neurons are required
for normal burst rate and chemosensitivity in medullary
slices. R. T. R. HUCKSTEPP; A. E. CORCORAN; G. B.
RICHERSON*. Yale Univ.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
POSTER
189. Early Life Experience: Postnatal Maternal Factors
Theme E: Homeostatic and Neuroendocrine Systems
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 AAA21 189.1 Effects of early life stress on CRF
Sun. AM
systems and behavior in adolescent rats. K. TSCHETTER;
L. B. CALLAHAN*; P. J. RONAN. USD Sch. of Medicine/VA
Res., Avera McKennan.
9:00 AAA22 189.2 Early life stress enhances behavioral
vulnerability to stress through the activation of REST4-
mediated gene transcription in the medial prefrontal cortex
of rodents. S. UCHIDA*; K. HARA; A. KOBAYASHI; Y.
WATANABE. Yamaguchi Univ. Sch. Med.
10:00 BBB1 189.3 The effects of early postnatal separation
and sex on methamphetamine reward. E. HENSLEIGH*; S.
LYNCH; M. SEMMEL; M. PIERCE; L. M. PRITCHARD. Univ.
of Nevada Las Vegas.
11:00 BBB2 189.4 Adverse early life history leads
to maladaptive responses to adult stressors: Role of
the serotonin2A/C receptor. M. B. REDDY*; A. NAIR; K.
VADODARIA; V. A. VAIDYA. Tata Inst. Fundamental Res.
8:00 BBB3 189.5 Blunted feeding response to leptin
in adolescent rats that experienced neonatal maternal
separation. S. YOO*; J. Y. KIM; E. Y. PARK; J. -. LEE; J. W.
JAHNG. Seoul Natl. Univ. Sch. of Dent.
9:00 BBB4 189.6 Within-litter variance in maternal behavior
predicts adult sibling variance in anxiety-related behaviors in
inbred mice. C. M. RAGAN*; J. GYEKIS; S. A. CAVIGELLI;
D. J. VANDENBERGH. Pennsyl State Univ.
10:00 BBB5 189.7 Early stress and subsequent adult
chronic stress potentiates anxiety and blunts hippocampal
apical dendritic remodeling. L. R. EILAND*; B. S. MCEWEN.
Weill Cornell Med. Col., Rockefeller Univ.
11:00 BBB6 189.8 Maternal separation affects functional
and structural neuroplasticity in the medial prefrontal cortex
of adolescent rats. A. CHOCYK*; D. DUDYS; B. BOBULA;
A. PRZYBOROWSKA; M. MACKOWIAK; G. HESS; K.
WEDZONY. Inst. of Pharmacol. PAN.
8:00 BBB7 189.9 Genome-wide analysis of the impact of
early life stress across generations in mice. J. BOHACEK*;
T. F. FRANKLIN; A. SEE; A. L. INIGUEZ; I. M. MANSUY.
Brain Res. Institute, Univ. Zurich | ETH Zurich, Roche
NimbleGen, Inc.
9:00 BBB8 189.10 Effects of early life stress on an animal
model of ADHD and an animal model of depression/anxiety
disorder. T. STERLEY*; F. M. HOWELLS; V. A. RUSSELL.
Univ. of Cape Town.
10:00 BBB9 189.11 Maternal care behavior modulates brain
development in neonatally stressed and litter mate control
mice. C. F. HOHMANN*; T. AKINTOLA; I. BONNEY; J.
CHUCKWUKA; A. HODGES. Morgan State Univ.
11:00 BBB10 189.12 Decrease of hippocampal neurogenesis
at early postnatal life induced by periodic maternal
separation is independent of postnatal HPA activity. N.
LAJUD*; A. ROQUE; L. TORNER. IMSS.
Neuroscience 2010  |  Sunday AM  |  53 
8:00 BBB11 189.13 Maternal exposure to moderate doses
of corticosterone during lactation induces behavioral
and neuroendocrine effects across generations. A.
ZUENA*; G. S. ALEMÀ; P. CASOLINI; C. CINQUE; A. DI
MEGLIO; C. GIULI; S. SCACCIANOCE; M. L. SPARAGO;
A. TRAMUTOLA; A. CATALANI. Dept. of Physiol. and
Pharmacol, Sapienza Univ. of Rome, Catholic Univ. Sch. of
Med.
9:00 BBB12 189.14 Effects of maternal exposure to low
levels of corticosterone during lactation on sleep/wake
cycle and hippocampal neurogenesis in the adult progeny.
A. TRAMUTOLA*; G. ALEMÀ; P. CASOLINI; A. CATALANI;
C. CINQUE; C. GIULI; G. MENNUNI; V. SILLETTI; M.
SPARAGO; A. ZUENA; J. MAIRESSE. Catholic Univ. Sch. of
Med., Dept. of Human Physiol. and Pharmacology, Sapienza
Univ. of Rome, Dept. of Neurology, Catholic Univ. Sch. of
Med., Neuroplasticity team, UMR 8576 CNRS, Univ. Lille
North of France.
10:00 BBB13 189.15 Chronic maternal adversity modifies
activity and attention behaviours in juvenile guinea pig
offspring: Dopaminergic modulation. J. EMACK*, Mr.; S. G.
MATTHEWS. Univ. of Toronto.
11:00 BBB14 189.16 Maternal corticosterone exposure
during the postpartum and adolescent stress affect adult
behaviour and neurogenesis in a sex-dependent manner. S.
BRUMMELTE*; J. H. K. WONG; S. E. LIEBLICH; C. CHOW;
L. A. M. GALEA. Univ. of British Columbia, Brain Res. Inst.
POSTER
190. Stress-Modulated Pathways: Brainstem, Hypothalamus,
and Endocrine
Theme E: Homeostatic and Neuroendocrine Systems
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 BBB15 190.1 Resilience to stress-related disorders
resulting from increased maternal stimuli involves reduced
excitatory input onto CRH expressing neurons in the
hypothalamus. A. KOROSI*; J. L. COPE; S. MCCLELLAND;
T. Z. BARAM. Univ. California Irvine.
9:00 BBB16 190.2 Corticotropin-releasing hormone
expression in the hypothalamus is governed by CREB-CBP
interaction. J. L. COPE*; A. KOROSI; C. J. RICE; M. A.
WOOD; T. Z. BARAM. Univ. of California, Irvine.
10:00 BBB17 190.3  •  Blood-borne angiotensin II acts in the
subfornical organ to promote anxiety-like behavior and
initiate endocrine responses to psychological stress. E. G.
KRAUSE*; A. D. DE KLOET; K. A. SCOTT; J. N. FLAK; R.
JANKORD; K. JONES; Y. M. ULRICH-LAI; S. C. WOODS;
S. P. WILSON; L. P. REAGAN; J. P. HERMAN; R. R. SAKAI.
Univ. Cincinnati, Univ. of South Carolina, Sch. of Med.
11:00 BBB18 190.4 Active behavioral coping by rats dampens
the behavioral response to stress, but not the corticosterone
response. D. L. HELMREICH*; D. TYLEE; W. E. O’NEILL; S.
T. GOVINDARAJAN. Univ. Rochester, Univ. of Rochester.
8:00 BBB19 190.5 Audiogenic stress activation of regions
projecting to both the raphe pallidus and paraventricular
hypothalamic nucleus. T. J. NYHUIS*; H. E. W. DAY; S.
CAMPEAU. Univ. Colorado Boulder.
9:00 BBB20 190.6 Candidate protein stress markers in
human plasma with induced hyperglucocorticoid state. Z. A.
ZIMOLO*; K. STONE; T. WU; C. BRUCE; C. COLANGELO;
S. M. SOUTHWICK; D. VOJVODA. Yale Univ., VA-CT, Natl.
Ctr. for PTSD.
54  |  Society for Neuroscience
10:00 BBB21 190.7  •  Oxytocin alters the behavioral,
cardiovascular, and hormonal responses to a mild
daily stressor. J. R. YEE*; J. FRIJLING; M. SABER; A.
STERLINSKI; S. TOVAR; L. BARLAS; H. POURNAJAFI-
NAZARLOO; G. LEWIS; J. STEVENSON; W. KENKEL; S.
W. PORGES; C. S. CARTER. Univ. of Illinois At Chicago.
11:00 BBB22 190.8 Endocannabinoid receptor antagonism
increases hypothalamic-pituitary-adrenal axis activity
basally and to loud noise stress in male sprague dawley
rat. R. J. NEWSOM*; C. OSTERLUND; R. L. SPENCER; S.
CAMPEAU. Univ. of Colorado Boulder.
8:00 CCC1 190.9 FDG-PET imaging of the rat
hypothalamus during stress-coping. Y. ONO*; H. LIN;
H. CHEN; K. TZEN; M. ONOZUKA; C. YEN. Kanagawa
Dent. Col., Col. of Life Science, Natl. Taiwan Univ., Col. of
Medicine, Natl. Taiwan Univ.
9:00 CCC2 190.10  •    Role of the serotonin 5-HT7
receptor in the neuroendocrine response induced by acute
restraint stress in rats. B. B. GARCIA-IGLESIAS*; J. A.
TERRÓN. CINVESTAV.
10:00 CCC3 190.11 Paradoxical neuroendocrine and
neurochemical outcomes associated with enriched
environmental housing in mice. R. J. MCQUAID*; M. AUDET;
H. ANISMAN. Carleton Univ.
11:00 CCC4 190.12 Sex differences in 5-HT 1A receptor
regulation of the stress induced activation of the
paraventricular nucleus of the hypothalamus. N. GOEL*; L.
INNALA; V. VIAU. Univ. of British Columbia.
8:00 CCC5 190.13 Glucocorticoid receptor expression in
dopamine neurons of the rat midbrain. L. M. PRITCHARD*;
E. HENSLEIGH; S. ENGEL; A. FOWLER; M. SEMMEL;
M. ZIZZO; N. RIDOLFI; S. THOMASON. Univ. Nevada Las
Vegas.
9:00 CCC6 190.14 Contributions of hypocretins in the stress
response: Requirement of a specific discharge pattern. P.
BONNAVION*; M. E. CARTER; A. ADAMANTIDIS; L. DE
LECEA. Stanford Univ. Sch. of Medecine.
10:00 CCC7 190.15 Corticotropin-releasing hormone
and catecholamines. V. OKUNEVA*; T. BIKASHVILI; T.
LORDKIPANIDZE; N. JAPARIDZE; M. ZHVANIA. Inst. Of
Physiol., Inst. of Physiol.
11:00 CCC8 190.16 Chronic corticosterone exposure
modulates the effects of a high-fat diet on the brain and
physiology. I. N. KARATSOREOS*; N. P. BOWLES; C.
BELLANDER; A. LARSSON; B. S. MCEWEN. Rockefeller
Univ.
8:00 CCC9 190.17 Pubertal- and experience-dependent
changes in stress reactivity. R. D. ROMEO*; V. A. PADOW;
Z. A. KLEIN; P. LUI. Barnard Col. of Columbia Univ.
9:00 CCC10 190.18 A comparison of the effects of tmt
exposure and restraint stress on hpa axis function and
noradrenergic systems. D. K. KNOX*; I. LIBERZON. Univ. of
Michigan.
10:00 CCC11 190.19 Immunohistochemical localization of
corticotropin-releasing factor receptors in the rat dorsal
raphe nucleus. E. J. VAN BOCKSTAELE*; M. WASELUS; R.
J. VALENTINO. Thomas Jefferson Univ., Univ. of Michigan,
The Children’s Hosp. of Philadelphia.
11:00 CCC12 190.20 Repeated social defeat increases
passive-submissive coping behavior in the male rat: A
potential role for the dorsal raphe nucleus. E. D. PAUL*;
M. W. HALE; M. J. VALENTINE; D. M. SARCHET; C. A.
LOWRY. Univ. of Colorado.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
8:00 CCC13 190.21 Sex differences in locus coeruleus
dendritic morphology. D. A. BANGASSER*; X. ZHANG; R.
VALENTINO. Children’s Hosp Philadel.
9:00 CCC14 190.22 Adeno-associated viral transduction of
the corticotropin-releasing factor gene into rat Barrington’s
nucleus neurons increases bladder weight. R. J.
VALENTINO*; T. A. GRIFFIN; K. MCFADDEN; J. H. WOLFE.
Children’s Hosp Philadelphia, The Univ. of Pennsylvania.
10:00 CCC15 190.23 Different effects of two stressors in
the activation of catecholamines in the rat brain. A. K.
GOODCHILD*; H. A. DAMANHURI; L. BOBROVSKAYA; P.
R. DUNKLEY. The Australian Sch. of Advanced Medicine,
Macquarie Univ., Univ. of Newcastle.
11:00 CCC16 190.24  •  Corticotropin-releasing factor 1 receptor
antagonist inhibits regional activation in an emotional-
arousal circuit in patients with irritable bowel syndrome. C.
S. HUBBARD*; J. S. LABUS; J. BUELLER; K. TILLISCH; J.
STAIN; B. SUYENOBU; G. E. DUKES; D. L. KELLEHER; B.
NALIBOFF; E. MAYER. UCLA, GlaxoSmithKline.
POSTER
191. Food Intake and Energy Balance: Neuropeptides I
Theme E: Homeostatic and Neuroendocrine Systems
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 CCC17 191.1 Homeostatic and hedonic gene
expression signatures in rats bred for divergent intrinsic
aerobic capacity. P. R. BURGHARDT*; K. E. DYKHUIS; L.
GERARD-KOCH; S. L. BRITTON; S. J. WATSON; H. AKIL.
Univ. Michigan, Mol. & Behavioral Neurosci. Institute, The
Univ. of Michigan.
9:00 CCC18 191.2   Novelty suppressed feeding in rats bred
for divergent intrinsic aerobic capacity. K. E. DYKHUIS*; P.
R. BURGHARDT; L. GERARD-KOCH; S. L. BRITTON; S.
J. WATSON; H. AKIL. Mol. & Behavioral Neurosci. Institute,
The Univ. of Michigan.
10:00 CCC19 191.3   Endoncannabinoid signaling in the
hypothalamic paraventricular nucleus (PVN) induces
alterations in eating and carbohydrate oxidation. C. D.
CHAPMAN; P. J. CURRIE*. Dept. Psychology, Reed Col.
11:00 CCC20 191.4 Hemopressin is a novel peptide ligand at
CB1 cannabinoid receptors that reduces appetite in rodents.
G. T. DODD*; G. MANCINI; B. LUTZ; S. M. LUCKMAN. The
Univ. of Manchester, Univ. of Mainz.
8:00 CCC21 191.5 Ghrelin mediates vulnerability to stress
induced metabolic and hormonal dysfunctions. Z. R.
PATTERSON*; R. KHAZALL; M. SLEEMAN; A. ABIZAID.
Carleton Univ., Regeneron Pharmaceuticals.
9:00 CCC22 191.6  •  Role of ghrelin in sugar reward: Effects
of GHS-R1A stimulation and antagonism on sucrose self-
administration and conditioned place preference in rats.
K. P. SKIBICKA*; E. EGECIOGLU; S. L. DICKSON. The
Sahlgrenska Acad. At Univ. of Gothenburg.
10:00 DDD1 191.7 The motivation to obtain highly palatable
food is enhanced by ghrelin in the ventral tegmental area. S.
J. KING*; A. M. ISAACS; A. ABIZAID. Carleton Univ.
11:00 DDD2 191.8 Site-specific expression of hypocretin
receptor type 1 in the gastrointestinal tract of mice. J.
ZHANG; S. J. FUNG; M. XI; S. SAMPOGNA; M. H. CHASE*.
Websciences Intl., VA Greater Los Angeles Healthcare Syst.,
UCLA Sch. of Med.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
8:00 DDD3 191.9 Effect of high-fat consumption on
activity of the orexin peptides and receptors. C. E. PEREZ-
LEIGHTON*; C. BILLINGTON; C. M. KOTZ. Univ. of
Minnesota, Veterans Affairs Med. Ctr.
9:00 DDD4 191.10 Evaluation of orexin siRNA effects on
food intake, body weight and activity in rats. J. P. NIXON*;
C. E. PEREZ-LEIGHTON; C. M. KOTZ. Univ. Minnesota,
Sun. AM
Veterans Affairs Med. Ctr.
10:00 DDD5 191.11 Distribution of neurons expressing nitric
oxide synthase, acetylcholinesterase, and hypocretin/orexin
in the rat hypothalamus: relation to basal and stimulated
levels of Fos and phospho-ERK1/2. L. J. AGOSTINELLI*; T.
A. NHAM; M. ZOBEL; J. MICHAELS; A. M. KHAN. USC.
11:00 DDD6 191.12 Distinctive characteristics of synaptic
transmission onto MCH and hypocretin/orexin neurons
underlie the role of the LH area in regulating appetite and
energy homeostasis. G. GAN; X. GAO*. Yale Univ. Sch.
Med.
8:00 DDD7 191.13 Increased orexin and melanin-
concentrating hormone expression in the perifornical lateral
hypothalamus of rats prone to overconsuming a fat-rich
diet. S. F. LEIBOWITZ*; G. CHANG; O. KARATAYEV; I.
MORGANSTERN. Rockefeller Univ.
9:00 DDD8 191.14 The role of melanin concentrating
hormone in the pathology of anorexia nervosa. A. C.
ADAMS*; N. DOURIS; K. E. KURGANSKY; E. MARATOS-
FLIER. BIDMC.
10:00 DDD9 191.15 Regulation of central glucagon-like
peptide-1 system. K. W. WILLIAMS*; M. M. SCOTT;
C. E. LEE; C. F. ELIAS; J. K. ELMQUIST. Univ. Texas
Southwestern.
11:00 DDD10 191.16 Prolonged intake of high fat diets alters
differentially the effects of GLP-1 on sucrose and fructose
intake in rats. C. E. PRITCHETT*; A. HAJNAL. Penn State
Univ.
8:00 EEE1 191.17 Comparative effects of the DPP-IV-
resistant GLP-1 receptor ligands, liraglutide and exendin-4,
on food intake and body weight suppression in rats. S. E.
KANOSKI*; A. L. ALHADEFF; A. M. SPAETH; H. J. GRILL;
M. R. HAYES. Univ. of Pennsylvania.
9:00 EEE2 191.18 Corticotrophin releasing hormone
receptor (CRHR) signaling may mediate BDNF-induced
reduction of feeding and body weight gain in the
paraventricular nucleus of hypothalamus (PVN). Y. DAI; R.
GODAR; C. BILLINGTON; C. KOTZ; C. WANG*. Univ. of
Minnesota, VA Med. Ctr., Minnesota Obesity Ctr., VA medical
Ctr. at Minneapolis.
10:00 EEE3 191.19 Melanocortin signaling in central nucleus
of the amygdala regulates alcohol intake in alcohol preferring
rats. D. A. YORK*; S. BOGHOSSIAN; M. PARK-YORK. Utah
State Univ.
11:00 EEE4 191.20 Increased central renin angiotensin
system activity promotes negative energy balance. A. D. DE
KLOET*; E. G. KRAUSE; K. A. SCOTT; M. T. FOSTER; R. R.
SAKAI; R. J. SEELEY; S. C. WOODS. Univ. of Cincinnati.
8:00 EEE5 191.21 Effects of acute or prolonged rimonabant
administration on hypothalamic mRNA gene expression and
neuronal activation of neuropeptides involved with energy
homeostasis. R. C. RORATO*; C. B. MIYAHARA; L. E. C. M.
SILVA; J. ANTUNES-RODRIGUES; L. L. K. ELIAS. Sch. of
Med. of Ribeirao Preto - Univ. of São Paulo.
Neuroscience 2010  |  Sunday AM  |  55 
9:00 EEE6 191.22 Establishing the hypothalamic
ventromedial nucleus as a target of pituitary adenylate
cyclase-activating polypeptide signaling and its potential
role in regulating metabolic phenotypes. J. M. RESCH*; A.
HOURIGAN; J. P. BOISVERT; S. CHOI. Marquette Univ.
10:00 EEE7 191.23 Rats prone to overconsuming a fat-rich
diet have elevated enkephalin in the hypothalamus and
extra-hypothalamic regions. J. R. BARSON*; G. CHANG; O.
KARATAYEV; S. CHANG; S. F. LEIBOWITZ. The Rockefeller
Univ.
11:00 EEE8 191.24 Selective antagonism of hindbrain
NMDA-type glutamate receptors reverses reduction of food
intake by cholecystokinin. J. S. WRIGHT*; T. HERZOG; M.
COVASA; K. CZAJA; R. C. RITTER. Washington State Univ.,
INRA, Ctr. de Recherche de Jouy-en-Josas.
8:00 EEE9 191.25 Meal pattern and neuropeptide analyses
in cafeteria diet fed obese and chow fed lean rats. S. I.
MARTIRE*; F. WESTBROOK; M. J. MORRIS. Univ. of New
South Wales.
9:00 EEE10 191.26 alpha-MSH influences the excitability of
neurons in the nucleus of the solitary tract. A. V. MIMEE; A.
V. FERGUSON*. Queen’s Univ.
10:00 FFF1 191.27 Characterization of glucose-inhibited
neurons in the lateral hypothalamic area expressing
neuropeptide Y. O. J. MARSTON; R. D. MURRELL-
LAGNADO*; D. I. BURDAKOV; L. K. HEISLER. Univ.
Cambridge.
11:00 FFF2 191.28 Distribution and regulation by fasting
and hypoglycemia of FKBP51 in rat brain. A. A. DUNN-
MEYNELL*; R. SHERWIN; C. MOBBS; V. ROUTH; S.
MUSATOV; R. MCCRIMMON; B. E. LEVIN. VA Med.
Ctr., Yale Univ., Mount Sinai Sch. of Med., NJ Med. Sch.
(UMDNJ), Neurologix, Inc.
8:00 FFF3 191.29 The novel cannabinoid CB1 antagonist
AM6545 suppresses food intake and food-reinforced
behavior. P. A. RANDALL*; V. K. VEMURI; K. N. SEGOVIA;
E. FERRERIS-TORRES; S. HOSMER; E. J. NUNES; J. L.
SANTERRE; A. MAKRIYANNIS; J. D. SALAMONE. Univ. of
Connecticut, Northeastern Univ.
9:00 FFF4 191.30 Effects of cannabinoid agonists on
sucrose solution preference. N. CENDEJAS-TREJO; J.
TEJAS-JUÁREZ; A. M. CRUZ MARTÍNEZ; B. GONZÁLEZ-
HERNÁNDEZ; B. FLORÁN-GARDUÑO; J. MANCILLA-DÍAZ;
R. ESCARTIN-PEREZ*. Univ. Natl. Autonoma Mexico,
CIVESTAV IPN, Univ. Autónoma de Nuevo León.
POSTER
192. Brain Blood Flow Functional Imaging
Theme E: Homeostatic and Neuroendocrine Systems
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 FFF5 192.1 Neuronal mechanisms underlying resting
state functional connectivity between regions of S1 of the
left and right hemisphere. S. NAAMAN*; A. BORTEL; S.
THOMAS; P. O’CONNOR; S. NEUPANE; A. SHMUEL.
McGill University/Montreal Neurolog. Inst., MNI.
9:00 FFF6 192.2  •  Functional imaging of cerebral
hemodynamics using high-frequency contrast-enhanced
ultrasound. M. E. VAN RAAIJ; L. LINDVERE; J. SUN; A.
DORR; J. HE; C. CESTA; F. FOSTER; B. STEFANOVIC*.
Sunnybrook Hlth. Sci. Ctr.
56  |  Society for Neuroscience
10:00 FFF7 192.3 Synaptic inhibition modulates Ca2+-
dependent variations in neurovascular and neurometabolic
coupling in mouse cerebellum. C. MATHIESEN*; K.
CAESAR; T. M. HOOGLAND; A. R. BRAZHE; B. M.
WITGEN; C. I. DE ZEEUW; D. A. BOAS; M. LAURITZEN.
Panum Inst., Erasmus Med. Ctr., State Univ., Harvard Med.
Sch.
11:00 FFF8 192.4 Spatiotemporal wavelet analysis of low
frequency fluctuations in BOLD fMRI signals. M. BRUYNS-
HAYLETT*; A. J. KENNERLEY; J. BERWICK; M. JONES.
Univ. of Sheffield.
8:00 FFF9 192.5 Orbitofrontal sulcogyral folding associated
with different brain activation patterns. G. CHAKIROVA*; H.
WHALLEY; T. W. J. MOORHEAD; P. MUKHERJEE; J. E.
SUSSMANN; K. A. WELCH; S. GILES; A. C. STANFIELD;
V. J. BROWN; E. C. JOHNSTONE; D. G. CUNNINGHAM
OWENS; S. M. LAWRIE; A. M. MCINTOSH. The Univ. of
Edinburgh, Univ. of St Andrews.
9:00 FFF10 192.6 Direct and simultaneous 2-photon
imaging of intravascular and tissue oxygenation during
the response to sensory stimulation in vivo. A. DEVOR*;
S. SAKADZIC; M. A. YASEEN; E. ROUSSAKIS; V. J.
SRINIVASAN; A. M. DALE; S. A. VINOGRADOV; D. A.
BOAS. Univ. of California San Diego, MGH, Harvard Med.
Sch., Univ. of Pennsylvania.
10:00 FFF11 192.7 Two-photon microscopic measurement
of distribution and cerebral metabolic rate of oxygen in
cortical tissue. S. SAKADZIC; A. DEVOR; M. A. YASEEN; E.
ROUSSAKIS; V. J. SRINIVASAN; S. A. VINOGRADOV; D. A.
BOAS*. Photon Migration Imaging Laboratory, Martinos Ctr.
for Biomed. Imaging/Massachusetts Gen. Hospital/Harvard
Med. Sch., Univ. of Pennsylvania, MGH, Harvard Med. Sch.
11:00 FFF12 192.8  •  Functional connectivity and obesity:
Changes after a behavioral weight loss intervention. L. E.
MARTIN; J. M. BRUCE; R. J. CHAMBERS; A. S. BRUCE; T.
M. HAY; F. J. BRESLIN*; W. K. SIMMONS; J. E. DONNELLY;
C. R. SAVAGE. Univ. Kansas Med. Ctr., Univ. of Missouri
Kansas City, Univ. of Kansas, Laureate Inst. for Brain Res.
8:00 FFF13 192.9 Unreliable and delayed astrocytic calcium
response does not support the hypothesis of calcium-
dependent astrocytic regulation of blood flow. K. W. NIZAR*;
L. REZNICHENKO; Q. CHENG; S. SAKADZIC; D. A. BOAS;
E. MASLIAH; A. M. DALE; G. A. SILVA; A. DEVOR. UC San
Diego, MGH, Harvard Med. Sch.
9:00 FFF14 192.10 Frequency dependent rises in cerebral
blood flow and oxygen use predicted by Ca2+ signals in
astrocytes and neurons in primary somatosensory cortex
in mice. B. L. LIND*; A. BRAZHE; S. B. JESSEN; M.
LAURITZEN. Univ. Copenhagen, State Univ. of Moscow,
Univ. of Copenhagen.
10:00 FFF15 192.11 Functional connectivity based model for
regional specialization of the insula. M. A. FERGUSON*;
J. S. ANDERSON; M. LOPEZ-LARSON; D. YURGELUN-
TODD. Univ. of Utah.
11:00 FFF16 192.12  •  Fast arterial and slow venous blood
volume changes during visual stimulation. T. KIM*; S. KIM.
Univ. Pittsburgh.
8:00 FFF17 192.13 Probing the temporal properties of the
hemodynamic response as function of cortical depth for
increased BOLD specificity. J. C. W. SIERO*; N. PETRIDOU;
J. M. HOOGDUIN; N. F. RAMSEY. Univ. Med. Ctr. Utrecht,
Univ. of Nottingham.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
9:00 FFF18 192.14 Towards quantitative pharmacological
MRI. J. K. HUTTUNEN*; K. LEHTIMÄKI; A. M. M.
AIRAKSINEN; J. NISKANEN; A. SHATILLO; P. TUUNANEN;
J. PUOLIVÄLI; A. NURMI; J. YRJÄNHEIKKI; O. GRÖHN.
Univ. of Eastern Finland, Cerebricon Ltd / Charles River
Labs. Discovery and Imaging Services.
10:00 FFF19 192.15 In vivo study of abnormal neuronal Ca2+
activity in α-synuclein transgenic mice model of Parkinson’s
disease using 2-photon microscopy. L. REZNICHENKO*;
K. NIZAR; Q. CHENG; A. DEVOR; E. MASLIAH. UCSD,
Harvard Med. Sch.
11:00 FFF20 192.16 Topographical maps of multisensory
attention. J. S. ANDERSON*; M. A. FERGUSON; M. LOPEZ-
LARSON; D. YURGELUN-TODD. Univ. of Utah.
8:00 FFF21 192.17 Relationship between changes in
emerging vein oxygen tension and the presence of early dip
in intrinsic signal imaging. H. FUKUDA*; A. VAZQUEZ; S.
KIM. Univ. Pittsburgh.
9:00 FFF22 192.18 Investigating neurovascular coupling
using simultaneous optical coherence tomography
and electrophysiology measurements in rats. H.
RADHAKRISHNAN*; V. J. SRINIVASAN; M. A. YASEEN; W.
WU; M. A. FRANCESCHINI. Massachusetts Gen. Hosp.
10:00 GGG1 192.19 Validating fMRI maps of
complex(language) and simple(motor) processes using
lesion-deficit data. T. A. GALLAGHER*; J. WOOD; B.
KUNDU; A. UTTER; J. VOSS; S. SANAMANDRA; V.
A. NAIR; S. VYSOTSKI; D. HUSS; N. KORNDER; D.
BANIULIS; N. HTET; A. ATASSI; C. MADURA; J. KUO; A. S.
FIELD; C. MORITZ; B. MEYERAND; V. PRABHAKARAN.
Univ. of Wisconsin-Madison Hosp. and Clinics.
11:00 GGG2 192.20 Differential role of cyclooxygenase
in mediating whisker evoked BOLD fMRI responses in
somatosensory structures in rat. L. W. BOORMAN*; J.
BERWICK; M. JONES; A. KENNERLEY; M. PORT; P.
OVERTON. Univ. Sheffield.
8:00 GGG3 192.21  •  Contrast of activation pattern for
deoxyhemoglobin concentration maps is predictive of
measurement reliability using transcranial functional near-
infrared spectroscopy. M. KATO*; S. MIYAUCHI; T. MURATA.
Kobe Adv. ICT Res. Ctr., NICT, CREST, JST.
POSTER
193. Long-Term Memory: Space and Navigation
Theme F: Cognition and Behavior
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 GGG4 193.1 Virtual navigation investigation of
hippocampus- and caudate nucleus-dependent strategies
from childhood to senescence in 475 healthy participants:
Evidence for changes across the life span. V. D. BOHBOT*;
R. SCHACHAR; M. BOIVIN; P. ROBAEY. Douglas, Hosp. for
Sick Children, Laval Univ., Ste-Justine Res. Ctr.
9:00 GGG5 193.2 Grey matter in the hippocampus
correlates with spatial memory strategies in human older
adults tested on a virtual navigation task. K. KONISHI*; V. D.
BOHBOT. Douglas, McGill Univ.
10:00 GGG6 193.3 Reduction of hippocampal-dependent
spatial navigational strategies in favor of caudate nucleus-
dependent responses strategies in aging: An fMRI study
of virtual navigation. R. SHAM*; K. KONISHI; S. ROY; N.
ETCHAMENDY; N. RAJAH; V. D. BOHBOT. Douglas, McGill
Univ.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
11:00 GGG7 193.4   The use of hippocampal-dependent
spatial memory strategies in aging are associated
with reduced risks for dementia assessed with the
MoCA in healthy older adults. F. DOSSA; M. TAU*; N.
ETCHAMENDY; V. D. BOHBOT. Douglas, McGill Univ.
8:00 GGG8 193.5 The BDNF val66met polymorphism is
associated with reduced fMRI activity in the hippocampus
Sun. AM
and increased use of caudate nucleus-dependent strategies
in a human virtual navigation task. H. BANNER*; V. BHAT;
N. ETCHAMENDY; R. JOOBER; V. D. BOHBOT. Douglas,
McGill Univ.
9:00 GGG9 193.6 Apolipoprotein E2 allele promotes
hippocampal-dependent spatial strategies in a human virtual
navigation task. V. BHAT*; H. BANNER; R. JOOBER; V. D.
BOHBOT. Douglas, McGill Univ.
10:00 GGG10 193.7 Genetic contributions to virtual navigation
strategies dependent on the hippocampus and caudate
nucleus in monozygotic and dizygotic twin children. S. A.
MCKENZIE*; V. KURDI; P. ROBAEY; R. SCHACHAR; V. D.
BOHBOT. Boston Univ., Douglas, McGill Univ., Ste-Justine
Res. Ctr., Hosp. for Sick Children.
11:00 GGG11 193.8   Substance abuse is associated with
response strategies in a human virtual navigation task. D.
DEL BALSO*; K. F. CASEY; K. CONRAD; M. LEYTON; V. D.
BOHBOT. Douglas, McGill Univ.
8:00 GGG12 193.9 Wayfinding in a virtual town: the effects
of large displays, 3D perception and correlation with human
virtual navigation analogues of rodent radial maze tasks. L.
DAHMANI*; A. LEDOUX; P. BOYER; N. ETCHAMENDY;
V. D. BOHBOT. Douglas Hosp. Res. Ctr., Univ. of Ottawa,
European Initiative for Res. Networks.
9:00 GGG13 193.10   Cultural differences in spontaneous
virtual navigation strategies in aging: A higher proportion
of Japanese people use spatial strategies compared to
North Americans. B. BALRAM*; N. ETCHAMENDY; V. D.
BOHBOT. Douglas, McGill Univ.
10:00 GGG14 193.11   Endogenous cortisol circadian rhythms
differ in people who use hippocampal- and caudate nucleus-
dependent strategies in a human virtual navigation task. M.
GUPTA*; H. BANNER; V. D. BOHBOT. Douglas, McGill Univ.
11:00 GGG15 193.12 Decreased fMRI activity in the
hippocampus of patients with Schizophrenia during
performance on a virtual navigation task. A. LEDOUX*; J. L.
PHILLIPS; V. D. BOHBOT; A. SMITH; P. BOYER. Univ. of
Ottawa Inst. of Mental Hlth. Res., Sch. of Psychology, Univ.
of Ottawa, Douglas, McGill Univ., Univ. Paris.
8:00 GGG16 193.13 Stop and Look! Evidence for a bias
towards caudate nucleus-dependent response strategies
in children with ADHD tested in a virtual navigation task. P.
ROBAEY*; S. MCKENZIE; R. SCHACHAR; M. BOIVIN; V. D.
BOHBOT. Res. Ctr. of Ste-Justine Hosp., Douglas Hospital,
Dept. of Psychiatry, McGill Univ., Hosp. for Sick Children,
Dept. of Psychiatry, Univ. of Toronto, Dept. of Psychology,
Laval Univ.
9:00 GGG17 193.14   Performance of hippocampus-
dependent spatial learners and caudate nucleus-dependent
response learners in the virtual water maze. S. CAUMAN*;
K. CONRAD; O. HARDT; V. D. BOHBOT. Douglas Hosp.,
McGill Univ.
Neuroscience 2010  |  Sunday AM  |  57 
POSTER
194. Long-Term Memory: Encoding
Theme F: Cognition and Behavior
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 GGG18 194.1 The development of automaticity
during information-integration categorization. J. G.
WALDSCHMIDT*; F. G. ASHBY; M. SCHELLENBERGER.
Univ. of California, Santa Barbara.
9:00 GGG19 194.2 Linking human theta oscillations to
navigation and environmental novelty. R. KAPLAN*; C.
DOELLER; E. DUZEL; P. BANDETTINI; N. BURGESS. Univ.
Col. London, Natl. Inst. of Mental Hlth., NIMH-UCL Grad.
Partnership Program, Otto von Guericke Univ.
10:00 GGG20 194.3 Functional dissociation of upper and
lower-band oscillations in human scalp EEG during episodic
memory encoding. N. SATO*. Future Univ. Hakodate, RIKEN
Brain Sci. Inst.
11:00 GGG21 194.4 Confidence, Encoding and Emotion:
A parametric analysis of the encoding of short and long
term retention of emotional information. K. R. MICKLEY
STEINMETZ*; K. SCHMIDT; E. A. KENSINGER. Boston Col.
8:00 GGG22 194.5 A meta-analysis of fMRI studies of
successful emotional memory encoding. M. RITCHEY*; V. P.
MURTY; R. A. ADCOCK; K. S. LABAR. Duke Univ.
9:00 HHH1 194.6 Distinguishing association formation from
item encoding using ERPs. A. S. N. KIM*; M. A. BINNS; C.
ALAIN; E. TULVING. Rotman Res. Inst. of Baycrest, Univ. of
Toronto.
10:00 HHH2 194.7 Motivation during associative encoding
influences subsequent recall responses in medial temporal
subregions. S. M. WOLOSIN*; D. ZEITHAMOVA; A. R.
PRESTON. The Univ. of Texas At Austin.
11:00 HHH3 194.8 The impact of perceptual richness and
study-test overlap on neural correlates of memory formation.
E. M. BAUCH*; L. J. OTTEN. Inst. of Cognitive Neurosci.
8:00 HHH4 194.9 Functional activation patterns in the
episodic memory network during intentional encoding,
recognition, and incidental encoding in young adults. M. A.
TRIVEDI*; V. T. DINH; G. T. STEBBINS. Rush Univ. Med.
Cntr.
9:00 HHH5 194.10 Event-related potentials in a time-based
prospective memory task. A. GARCIA-ANACLETO; B.
TELLEZ-ALANIS*. Fac Psy, UAEM.
10:00 HHH6 194.11 The neural correlates of auditory episodic
encoding: Convergence and divergence across experiments.
L. J. GOTTLIEB*; M. D. RUGG. Univ. of California, Irvine.
11:00 HHH7 194.12 The relationship between reversed
subsequent memory effects and task-induced deactivations.
M. A. DE CHASTELAINE*; M. D. RUGG. Univ. of California,
Irvine.
8:00 HHH8 194.13 Investigation of the neural correlates
of the successful encoding of inter-item and temporal
associations. M. ABDELLATEEF*; M. RUGG; M. SUZUKI.
UCI: Ctr. For the Neurobio. of Learning and Memory.
9:00 HHH9 194.14 Acquiring new memories in the face
of competition from prior learning. B. A. KUHL*; W. A.
BAINBRIDGE; M. M. CHUN. Yale Univ.
58  |  Society for Neuroscience
10:00 HHH10 194.15 Repetition enhancement in the default
network is associated with successful memory encoding:
An fMRI study investigating face-name associations in
young individuals. P. VANNINI*; T. HEDDEN; C. SULLIVAN;
D. PUTCHA; A. SCHULTZ; R. SPERLING. Brigham and
Womens Hospital, Harvard Med. Sch., Karolinska Institutet,
Massachusetts Gen. Hospital, Harvard Med. Sch.
11:00 HHH11 194.16 Behavioural and neural differences
for memory formation of pictures of animals and tools. P.
KLAVER*; S. LANG; E. MARTIN. Univ. Children’s Hosp.,
Univ. of Zurich.
8:00 HHH12 194.17  •  Analysing the representational content
of object representations using magnetoencephalography:
Testing category-specific and feature-based accounts of
semantic knowledge. A. CLARKE; K. I. TAYLOR*; L. K.
TYLER. Univ. of Cambridge, Univ. Hosp. Basel.
POSTER
195. Disorders of Attention and Cognition
Theme F: Cognition and Behavior
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 HHH13 195.1 Prefrontal lesion impairs visual attention
mechanisms. Y. LIU*; B. VOYTEK; R. KNIGHT; M. DING.
Univ. of Florida, Univ. of California at Berkeley.
9:00 HHH14 195.2 A comparison of cognitive deficits in
chronic methamphetamine users and schizophrenia patients.
R. SALO*; S. RAVIZZA; C. FASSBENDER; M. H. LEAMON.
UC Davis, Michigan State Univ.
10:00 HHH15 195.3 Dissociation of facilitatory and inhibitory
auditory attention mechanisms after lateral prefrontal
lesions in humans. A. BIDET-CAULET*; K. G. BUCHANAN;
H. VISWANATH; J. BLACK; D. SCABINI; F. BONNET-
BRILHAULT; R. T. KNIGHT. Univ. Calif Berkeley, UMR
INSERM U930, CNRS ERL 3106, Univ. François-Rabelais
de Tours, CHRU de Tours.
11:00 HHH16 195.4 Inter-regional gamma-band phase
synchronization during visual oddball task in patients with
restless legs syndrome. J. CHOI*; G. LEE; D. KO; K. JUNG;
K. KIM. Yonsei Univ., Korea Univ.
8:00 HHH17 195.5 Top-down cognitive demands modulate
spatial attention bias in patients with right hemisphere
damage. M. SARRI*; T. HABEKOST; J. DUNCAN. Univ. of
Copenhagen, MRC Cognition and Brain Sci. Unit.
9:00 HHH18 195.6   The neural basis of visual neglect:
Insights from a SPECT study in posterior cortical atrophy.
K. ANDRADE*; A. KAS; D. SAMRI; M. SARAZIN; B.
DUBOIS; M. HABERT; P. BARTOLOMEO. Inserm_u975,
Inserm UMR S 975, CRICM, UPMC, Paris 6, Service de
Médecine Nucléaire- Hôpital Pitié-Salpêtrière, Fédération de
Neurologie, Hôpital Pitié-Salpêtrière, Dept. of Psychology,
Catholic Univ.
10:00 HHH19 195.7 Brain activation during task-switching
following traumatic brain injury. P. VAN DONKELAAR*; C.
LAROUX; L. OSTERNIG; L. CHOU; U. MAYR. Univ. of
Oregon.
11:00 HHH20 195.8  •  Cerebellar decrements in adolescents
with bipolar disorder. M. R. MADORE*; D. E. FLECK; M. D.
DELBELLO; N. P. MILLS; C. ADLER; P. K. SHEAR; S. M.
STRAKOWSKI. Univ. of Cincinnati.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
8:00 HHH21 195.9 Mismatch negativity in clinically
unaffected family members of schizophrenia patients. R.
MALAGUTI; A. RISSLING; N. SWERDLOW; D. BRAFF; G.
A. LIGHT*. Univ. Calif San.
9:00 HHH22 195.10 Parsing prefrontal contributions to
response inhibition: A trial-by-trial analysis of stop signal
task performance in patients with frontal lobe damage. A.
TSUCHIDA*; L. FELLOWS. McGill Univ.
10:00 HHH23 195.11 The effects of task complexity and time
manipulations on frontal lobe performance monitoring. S.
GILLINGHAM; T. SHALLICE; M. P. ALEXANDER; T. W.
PICTON; D. T. STUSS*. Rotman Res. Inst., SISSA, Univ.
Col. London, Harvard Med. Sch., Beth Israel Deaconess
Med. Ctr., Univ. of Toronto.
11:00 HHH24 195.12 ADHD symptoms affect neural
correlates of performance preparation and evaluation. C.
FASSBENDER*; S. COFFEY-CORINA; J. F. DIXON; D.
MIZUIRI; T. YIP; K. J. RUTLEDGE; C. S. CARTER; G. R.
MANGUN; J. B. SCHWEITZER. Univ. of California Davis,
MIND Inst., Ctr. for Mind and Brain, Imaging Res. Ctr.
8:00 HHH25 195.13 Contingent negative variation in patients
with orbitofrontal and lateral lesions in the prefrontal cortex. I.
FUNDERUD; M. LØVSTAD; M. LINDGREN; T. ENDESTAD;
P. DUE-TØNNESSEN; T. MELING; B. VOYTEK; R. T.
KNIGHT*; A. SOLBAKK. Oslo Univ. Hosp., Sunnaas Rehabil.
Hosp., Lund Univ., Univ. of Oslo, Univ. California Berkeley.
9:00 HHH26 195.14 Evidence of frontal dysregulation
associated with heightened attention to task-irrelevant stimuli
in police officers with high PTSD symptomatology: A dense
electrode array ERP study. J. L. SHUCARD*; J. LEE; T.
COVEY; J. VIOLANTI; D. W. SHUCARD. Univ. At Buffalo.
10:00 HHH27 195.15 Single-trial variability of P3b visual
target erp: A twin study of ADHD. J. A. PALMER*; G.
MCLOUGHLIN; S. MAKEIG. Univ. of California San Diego,
King’s Col. London.
11:00 HHH28 195.16 Differentiating patients (ADHD, FASD,
Parkinson’s Disease) from controls by gazing patterns. P.
TSENG*; I. G. M. CAMERON; D. P. MUNOZ; L. ITTI. USC,
Queen’s Univ.
POSTER
196. Syntax and Semantics
Theme F: Cognition and Behavior
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 HHH29 196.1 Hierarchical model comparisons on
effective connectivity in semantic judgments of Chinese
characters. L. FAN*; T. CHOU; T. BITAN; J. BOOTH. Natl.
Taiwan Univ., Haifa Univ., Northwestern Univ.
9:00 HHH30 196.2 An event related synchronization study
of verbal mode information in a lexical decision task. C.
IMPERIOSO; V. JAICHENCO; S. LEW; S. ZANUTTO; A. J.
WAINSELBOIM*. IBYME-CONICET, Inst. de Lingüística,
Inst. de Ingeniería Biomédica.
10:00 HHH31 196.3 Left hemisphere knows more about verbs
than right hemisphere does . Z. QI*; S. R. JACKSON; S. M.
GARNSEY. Univ. of Illinois, Urbana-Champaign, Univ. of
Maryland.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
11:00 HHH32 196.4 Intersubject correlations during
comprehension of narratives, sentences and words . L.
MENENTI*; N. HOOGENBOOM; E. J. HERMANS; P. BELIN;
S. C. GARROD. Univ. of Glasgow, Radboud Univ. Nijmegen,
Donders Inst. for Brain, Cognition and Behaviour, Radboud
Univ. Med. Centre, Dept. of Neurol.
8:00 HHH33 196.5  •  Sound, sight and action in meaning:
Sun. AM
fMRI evidence of word representations in perceptual and
motor cortices. M. F. BONNER*; M. GROSSMAN. Univ. of
Pennsylvania.
9:00 HHH34 196.6  •  Neural representation of word meaning:
an fmri study. M. DREYFUSS*; E. E. SMITH; C. MCMILLAN;
D. GUNAWARDENA; L. RICHMOND; M. BONNER; M.
GROSSMAN. Univerity of Pennsylvania Sch. of Med.,
Columbia Univ.
10:00 HHH35 196.7  •  Prefrontal cortex supports the
coordination of a pronoun’s referent during discourse.
C. MCMILLAN*; R. CLARK; D. GUNAWARDENA; M.
DREYFUSS; M. GROSSMAN. Hosp. of the Univ. of
Pennsylvania.
11:00 HHH36 196.8  •  Logical quantifier comprehension in
frontotemporal degeneration. B. MORGAN*; A. BOLLER;
E. CAMP; P. MOORE; R. G. GROSS; C. MCMILLAN; R.
CLARK; M. GROSSMAN. Universit of Pennsylvania Sch. of
Med., Univ. of Pennsylvania Sch. of Med.
8:00 HHH37 196.9  •  Executive resources and pronoun
resolution in behavioral-variant frontotemporal dementia
(bvFTD). M. REILLY*; C. MCMILLAN; R. CLARK; M.
GROSSMAN. Univ. of Pennsylvania.
9:00 HHH38 196.10  •  Neural representation of word meaning
in healthy seniors: An fMRI study. M. GROSSMAN*; E.
E. SMITH; D. E. GUNAWARDENA; M. DREYFUSS;
L. RICHMOND; M. BONNER; C. MCMILLAN. Univ.
Pennsylvania Sch. Med., Columbia Univ.
10:00 HHH39 196.11 Functional fronto-temporal connectivity
for syntax: The effect of left hemisphere damage. M.
PAPOUTSI; E. A. STAMATAKIS; J. ZHUANG; B. J.
DEVEREUX; B. RANDALL; P. WRIGHT; L. K. TYLER*. Univ.
Cambridge.
11:00 HHH40 196.12 Left inferior frontal cortex and syntax:
Analysis of structure, function and behaviour in LH damaged
patients. P. WRIGHT*; B. RANDALL; B. J. DEVEREUX; J.
ZHUANG; W. D. MARSLEN-WILSON; M. PAPOUTSI; E. A.
STAMATAKIS; L. K. TYLER. Ctr. For Speech, Language and
the Brain, MRC Cognition and Brain Sci. Unit.
8:00 HHH41 196.13 Adaptive significance of right hemisphere
activation in aphasic language comprehension. J. A.
MELTZER*; S. WAGAGE; A. R. BRAUN. NIH.
9:00 HHH42 196.14 Meta-analysis reveals consistent
activation patterns in aphasic patients. P. E. TURKELTAUB;
S. MESSING; C. NORISE; R. H. HAMILTON*. Univ.
Pennsylvania, Haverford Col.
10:00 HHH43 196.15 Probing language networks with electrical
intracranial stimulation, task based fmri and resting state
functional connectivity analysis. S. BICKEL*; L. ENTZ; C.
KELLY; M. ARGYELAN; P. KINGSLEY; S. JAIN; S. HWANG;
A. D. MEHTA. Comprehensive Epilepsy Center, North Shore
Long Island Jewish Med. Ctr., New York Univ. Child Study
Ctr., The Feinstein Inst. for Med. Res.
Neuroscience 2010  |  Sunday AM  |  59 
11:00 HHH44 196.16 Shared syntactic processing in language
comprehension and language production. K. SEGAERT*; L.
MENENTI; K. WEBER; K. M. PETERSSON; P. HAGOORT.
Max Planck Inst. for Psycholinguistics, Radboud Univ.
Nijmegen, Dept. of Psychology & Ctr. for Cognitive
Neuroimaging.
8:00 HHH45 196.17 Effects of task and narrative context on
syntactic processing: An ERP-fMRI study. E. PAKULAK*; M.
DOW; H. J. NEVILLE. Univ. of Oregon.
POSTER
197. Human Memory Behavior
Theme F: Cognition and Behavior
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 HHH46 197.1 Working memory capacity reflects
precision of storage not the number of items stored. M.
HUSAIN*; E. Y. WU; P. M. BAYS. Univ. Col. London.
9:00 HHH47 197.2 Neurophysiological correlates of mental
calculation. M. VANSTEENSEL*; M. BLEICHNER; D.
HERMES; E. AARNOUTSE; F. LEIJTEN; N. RAMSEY. UMC
Utrecht-Rudolf Magnus Inst.
10:00 HHH48 197.3  •  A computational model of the working
memory control based on EEG theta-alpha 1:2 cross-
frequency synchronization. D. T. CHIK*; M. KAWASAKI; Y.
YAMAGUCHI. RIKEN Brain Sci. Inst., RIKEN BSI-Toyota
Collaboration Ctr.
11:00 III1 197.4  •  The neurotensin receptor 1 gene
(NTSR1) polymorphism is associated with working memory.
J. LI; C. CHEN; Q. HE; H. LI; R. MOYZIS; G. XUE; Q.
DONG; C. CHEN*. Beijing Normal Univ., Psychology and
Social Behavior, USC, UCI.
8:00 III2 197.5  •  Visual working memory capacity and
stimulus categories: A behavioral and electrophysiological
investigation. D. TALSMA*; P. KLAVER; L. POOM; S.
DIAMANTOUPOULOU. Univ. of Twente, Univ. of Zurich,
Univ. of Uppsala, Vrije Univeristeit Amsterdam.
9:00 III3 197.6 Evidence of individual differences in
working memory capacity using event-related potentials:
Influence of distractors on visual working memory. A.
BECKE*; A. VELLAGE; H. STRUMPF; J. HOPF; N. G.
MÜLLER. Otto-von-Guericke-University, Leibniz-Institue for
Neurobio., German Ctr. for Neurodegenerative Dis.
10:00 III4 197.7 A working memory model based on
excitatory-inhibitory interactions and calcium dynamics. D.
H. TERMAN*; K. LYMAN; R. MCDOUGAL; B. MYERS; M.
ZEKI; J. TIEN; C. FALL. Ohio State Univ., Univ. of Illinois,
Chicago.
11:00 III5 197.8 Intact working memory for objects-
in-scene information after hippocampal damage. A.
JENESON*; K. N. MAULDIN; R. O. HOPKINS; L. R.
SQUIRE. UCSD, Brigham Young Univ., Intermountain Med.
Ctr., VAMC.
8:00 III6 197.9 Response selection versus feedback
analysis in visuo-motor conditional learning. C. AMIEZ*; F.
HADJ-BOUZIANE; M. PETRIDES. Montreal Neurolog. Inst.,
Lab. of Brain and Cognition, Natl. Inst. of Mental Health,
Natl. Inst. of Hlth.
9:00 III7 197.10 Top-down control modulates content-
specific EEG correlates of somatosensory working memory
processing in humans. B. SPITZER*; F. BLANKENBURG.
Charité.
60  |  Society for Neuroscience
10:00 III8 197.11 Effects of college students’ sleep habits
on self-reported sleep quality and short-term memory.
R. WILLIAMSMORRIS*; K. C. MORRIS; C. JEWELL; H.
MAYER. Southern Adventist Univ., Univ. of Miami, Univ. of
Tennessee at Chattanooga.
11:00 III9 197.12 EEG alpha is reduced during short-term
memory retention by the requirement to attend a visual
display. L. PAYNE*; J. KOUNIOS. Brandeis Univ., Drexel
Univ.
8:00 III10 197.13 Cross-frequency phase interactions
during visual working memory. S. PALVA*; M. PALVA.
Neurosci. Ctr.
9:00 III11 197.14 An extensive memory lifetime is achieved
by coupled nonlinear neurons. T. TOYOIZUMI*. RIKEN.
10:00 III12 197.15 Human frontal beta activity for monetary-
reward motivation facilitates the visual working memory
system. M. KAWASAKI*; Y. YAMAGUCHI. Rhythm-Based
Brain Computation Unit, RIKEN BSI-TOYOTA Collaboration
Ctr., Lab. for Dynamics of Emergent Intelligence, BSI,
RIKEN.
11:00 III13 197.16 Using the delayed match to sample
procedure to classify short-term and working memory
deficits. C. D. HUDGINS*; M. VAIDYA. Univ. of North Texas.
8:00 III14 197.17  •  Influences of encoding and
maintenance in neural circuitry underlying visual spatial
working memory over development. A. PADMANABHAN*; D.
F. MONTEZ; B. LUNA. Univ. of Pittsburgh, Univ. of Pittsburgh
Med. Ctr.
9:00 III15 197.18 The effect of the temporal predictability
of an exogenous cue on visual perception and memory. J.
OHYAMA*; K. WATANABE. The Univ. of Tokyo, Natl. Inst.
of Advanced Industrial Sci. and Technol., Japan Sci. and
Technol. Agency.
10:00 III16 197.19 Precision in visual working memory
reaches asymptote when individual item limits are exceeded.
D. E. ANDERSON*; E. K. VOGEL; E. AWH. Univ. of Oregon.
11:00 III17 197.20 Topographic organization of touch
localization and its short-term retrieval. J. PARK*; S. DULAI;
M. HALYKO; V. SURESH; L. KLOSINSKI; Y. LI; W. LE; B.
TJAN; T. CELIKEL. USC.
8:00 III18 197.21 Visual short term memory serves as a
gateway to long term memory. K. FUKUDA*; E. K. VOGEL.
Univ. of Oregon.
9:00 III19 197.22 Alpha and theta oscillations in working
memory: Functional connectivity and time-frequency
analysis. C. WANG*; S. HAN; M. DING. Univ. of Florida.
10:00 III20 197.23 Selecting and ignoring representations
in spatial working memory: An event-related potential (ERP)
study. C. HAU*; H. LEUNG. SUNY At Stony Brook, SUNY at
Stony Brook.
11:00 III21 197.24 Network mechanisms of visuo-spatial
working memory. O. HARISH; D. HANSEL*. Neurophysics
and Physiol. - UMR8119 - CNRS - Univ. Paris Descartes,
Neurophysics and Physiol. - UMR 8119 CNRS - Univ. Paris
Descartes.
8:00 III22 197.25 Event-related EEG spectral dynamics
associated with situational context. J. A. ONTON*; S.
MAKEIG. Naval Hlth. Res. Ctr., UCSD.
9:00 III23 197.26 Alterations in human gamma network
topology during successful and unsuccessful memory
encoding. J. F. BURKE; J. JACOBS; M. J. KAHANA; K. A.
ZAGHLOUL*. Univ. of Pennsylvania, Hosp. Univ. of Penn.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
10:00 III24 197.27 Enhancement and suppression in
reflective attention: Separate processes, or different
manifestations of one process? M. R. JOHNSON*; M. K.
JOHNSON. Yale Univ.
POSTER
198. Decision Making: Gaming, Gambling, Risk, and Reward
Theme F: Cognition and Behavior
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 III25 198.1 Evidence-seeking and reward prediction
in the beads task. N. FURL; J. ARIZPE; B. B. AVERBECK*.
NIMH-NIH, NIMH/NIH.
9:00 III26 198.2 Neural bases of intuitive best next-move
generation in board game experts. X. WAN*; H. NAKATANI;
K. UENO; T. ASAMIZUYA; K. CHENG; K. TANAKA. RIKEN
Brain Sci. Inst.
10:00 III27 198.3 Past and future decisions: A positive
component of the feedback event-related potential predicts
subsequent choice in a gambling task. R. BHATIA; D. WICK;
N. HAMMACK; M. D. LOOSE*. Oberlin Coll.
11:00 III28 198.4 The neural mechanisms of the gambler’s
fallacy. G. XUE*; X. LEI; Z. LU; I. P. LEVIN; E. BOSSARD; Q.
DONG; A. BECHARA. Univ. of Southern California, Beijing
Normal Univ., Univ. of Iowa.
8:00 III29 198.5 Making economic decisions for other
people: An exception to loss aversion law. L. MORETTI*; V.
FARALLA; P. VINDRAS; A. SIRIGU. CNRS Ctr. De Neurosci.
Cognitive.
9:00 III30 198.6 Endogenous testosterone has an
inverted-U relationship with financial risk preferences in
both men and women. S. STANTON*; O. MULLETTE-
GILLMAN; E. MCLAURIN; C. KUHN; K. LABAR; M. PLATT;
S. HUETTEL. Duke Univ.
10:00 III31 198.7 Neural pattern classification reveals trial-
specific outcomes in a simple game. T. J. VICKERY*; M. R.
KLEINMAN; D. LEE; M. M. CHUN. Yale Univ.
11:00 III32 198.8 Dissecting the neural architecture of
reversal learning: Overcoming avoidance versus inhibiting
responding. S. G. GREENING*; E. C. FINGER; D. G. V.
MITCHELL. Univ. of Western Ontario.
8:00 III33 198.9 Modulation of conflict monitoring
processes by stimulus ambiguity in an Eriksen flanker task:
An event-related potential study. J. R. FEDOTA*; C. G.
MCDONALD; R. PARASURAMAN. George Mason Univ.
9:00 III34 198.10 Frontal oscillatory activity changes in a
visual go/no-go task. M. TAKAYOSE*; A. MORI; T. OZAWA;
Y. KITA. Nihon Univ., Col. of Art, Nihon Univ., Fac. of Human
and Social Studies, Keisen Univ.
10:00 III35 198.11 Intensive preparation for a standardized
test changes brain function and structural connections. A.
MACKEY*; K. J. WHITAKER; A. T. MILLER-SINGLEY; C.
WENDELKEN; S. A. BUNGE. Helen Wills Neurosci. Institute,
Univ. of California, Berkeley.
11:00 III36 198.12  •  Dysfunctional learning: What happens
in the lateral and medial ansiform cerebellum when one gets
the answer wrong? C. D. WOODY*. UCLA Med. Cntr. NPI
58-258.
8:00 III37 198.13 Resolving the puzzle of unrealistic
optimism. T. SHAROT*; C. W. KORN; R. J. DOLAN. Univ.
Col. London, Freie Univ. Berlin.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
9:00 III38 198.14 Examining the relationship between
resting state functional connectivity and behavioral
performance on the stop signal task in people with
schizophrenia and healthy controls. S. NAIR*; C. J. MAURO;
K. A. NOLAN; D. JAVITT; M. J. HOPTMAN. Nathan Kline
Inst. for Psychiatric Res., The Grad. Center, CUNY, Yeshiva
Univ., New York Univ. Sch. of Med.
Sun. AM
10:00 III39 198.15 Older adults with trait negative affect do
not display classic ambiguity aversion during the Ellsberg
task. G. L. MORENO*; J. WELLER; S. SHIVAPOUR; D.
TRANEL; N. DENBURG. Univ. of Iowa, Decision Res.
11:00 III40 198.16 The neural basis of time discounting
and intertemporal economic decisions: An EEG study.
A. HORTACSU; B. GUCLU; S. ERTAC*; J. LIST. Univ. of
Chicago, Bogazici Univ., Koc Univ.
8:00 III41 198.17 Effects of red wine on performance of
the Tower of Hanoi task and prefrontal-parietal electrical
activity in young men. A. SANZ MARTIN*; M. GUEVARA;
M. HERNÁNDEZ- GONZALEZ; C. AMEZCUA. Inst. De
Neurociencias, Univ. De Guadalajara.
POSTER
199. Social Cognition: Attention, Imitation, and Perception of
Self versus Others
Theme F: Cognition and Behavior
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 III42 199.1 The neurobiological basis of socially-
induced memory errors. M. EDELSON*; T. SHAROT; R.
DOLAN; Y. DUDAI. Weizmann Inst., Functional imaging
laboratory.
9:00 III43 199.2 Decreased precuneus activity during
personality appraisals in eating disorder patients. C.
J. MCADAMS*; D. C. KRAWCZYK. Univ. of Texas at
Southwestern Med. Ctr., Ctr. for Brain Health, Univ. of Texas
at Dallas.
10:00 III44 199.3 Sensory suppression of self- versus
other-generated action effects and the sense of agency:
An event-related potential study. A. GENTSCH*; N.
KATHMANN; S. SCHUETZ-BOSBACH. Max Planck Inst.
For Human Cognitive and Brain Sci., Berlin Sch. of Mind and
Brain, Inst. of Psychology, Humboldt-University Berlin.
11:00 III45 199.4 Difficult to look at: ERPs and fMRI
activation to personally familiar disliked faces pre- and
post-compassion meditation training. J. A. BREFCZYNSKI-
LEWIS*; S. DONLEY; A. PORTURICA; A. PUCE. West
Virginia Univ., Indiana Univ.
8:00 III46 199.5 Cultural experiences shape the
neural representation of self-face perception. J. SUI*; G.
HUMPHREYS. Univ. of Brimingham, Univ. of Birmingham.
9:00 III47 199.6 This is your brain on pretense: Merged
behavioral and fMRI techniques reveal neural correlates
of pretense observation. E. SMITH*; Z. ENGLANDER; A.
LILLARD; J. MORRIS. Univ. of Virginia.
10:00 III48 199.7 Own-gender imitation activates the
brain’s reward circuitry. E. A. REYNOLDS LOSIN*; M.
IACOBONI; A. MARTIN; M. DAPRETTO. Univ. of California.
11:00 III49 199.8  •  Differential brain responses to polite and
impolite actions: A NIRS study. K. TAGAI; T. KUMADA*; M.
NAGAI; K. WATANABE; S. TAKATA. SHISEIDO CO. LTD.,
Univ. of Tokyo, Nat Inst. of Adv Indust Sci. and Tech.
Neuroscience 2010  |  Sunday AM  |  61 
8:00 III50 199.9 The neural signature of social pain. I.
CRISTOFORI*; L. MORETTI; S. HARQUEL; A. POSADA; G.
DEIANA; J. ISNARD; F. MAUGUIÈRE; A. SIRIGU. Ctr. De
Neurosciences Cognitives-Cnrs, Dept. of Functional Neurol.
and Epileptology,Hôpital Neurologique.
9:00 JJJ1 199.10  •  Reduced gray matter volume of pars
opercularis and impaired social communication in high-
functioning autism spectrum disorders. H. YAMASUE*; S.
YAMASAKI; O. ABE; M. SUGA; H. YAMADA; H. INOUE;
H. KUWABARA; Y. KAWAKUBO; S. AOKI; N. YAHATA; Y.
KANO; N. KATO; K. KASAI. Univ. of Tokyo, JST, Showa
Univ.
10:00 JJJ2 199.11 The processing of emotion and identity
in avatar faces - An EEG/EMG study. S. KORB*; D.
GRANDJEAN; K. R. SCHERER. Swiss Ctr. For Affective
Sciences, Geneva Univ.
11:00 JJJ3 199.12  A fresh look on mu rhythms: individual
and social behaviors. B. S. SUUTARI; S. A. WEISBERG; E.
TOGNOLI*; S. KELSO. Ctr. for Complex Systems & Brai,
Univ. of Ulster.
8:00 JJJ4 199.13 Self-face evaluation and self-esteem
in young females : An fMRI study using contrast effect. H.
OIKAWA*; M. SUGIURA; A. SEKIGUCHI; T. TSUKIURA; C.
M. MIYAUCHI; T. HASHIMOTO; T. TAKANO-YAMAMOTO;
R. KAWASHIMA. Tohoku Univ. Grad. Sch. of Dent., Dept. of
Functional Brain Imaging, IDAC, Tohoku Univ., Smart Ageing
Intl. Res. Ctr.
9:00 JJJ5 199.14 Relationship between puberty status and
neural activity during social emotion processing in female
adolescents. A. GODDINGS; S. BURNETT; G. BIRD; R.
VINER; S. BLAKEMORE*. Univ. Col. London, Birkbeck Col.
10:00 JJJ6 199.15 Brain mechanisms with social interaction
in usual situation by the different interactive manners. H.
LEE*; J. KU; W. LEE; K. YOON; I. KIM; S. KIM. Hanyang
Univ., St. Peter’s Hosp.
11:00 JJJ7 199.16 Trusting and recognizing trust in autism.
E. ANDARI*; G. CORICELLI; N. GEORGIEFF; A. SIRIGU.
CNRS, Ctr. De Neurosci. Cognitive.
8:00 JJJ8 199.17 Do alternation or restriction of
grammatical constructions affect sentence comprehension
by patients with autistic spectrum disorders? M. D.
STOCKBRIDGE*; S. WHITE; F. HAPPÉ. Univ. Col. London,
King’s Col. London.
9:00 JJJ9 199.18 Altered social reward and attention
in anorexia nervosa. K. K. WATSON*; N. ZUCKER; D.
WERLING; M. L. PLATT. Duke Univ., UCLA.
10:00 JJJ10 199.19 Support for the existence of an eye
detector within the face processing neural network. T. M.
BROWN*; R. J. ITIER; A. R. MCINTOSH. Baycrest Ctr. For
Geriatric Care, Univ. of Waterloo, Univ. of Toronto.
11:00 JJJ11 199.20 Neural signature of extended self: Self-
object association through mere ownership. K. KIM; G.
MCCARTHY; M. K. JOHNSON*. Yale Univ.
62  |  Society for Neuroscience
POSTER
200. Learning and Memory: Cognitive Flexibility
Theme F: Cognition and Behavior
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 JJJ12 200.1 Differential effects of lesions to the dorsal
and ventral medial prefrontal cortex on the context specificity
of latent inhibition. D. N. GEORGE*; S. KILLCROSS; J. E.
HADDON. Cardiff Univ., Univ. of New South Wales.
9:00 JJJ13 200.2 Mechanisms of visual working memory
capacity limit in prefrontal cortex. A. H. LARA*; J. D.
WALLIS. Univ. California Berkeley.
10:00 JJJ14 200.3 Role of prefrontal local field potential in
holding action-outcome information in working memory. J. D.
WALLIS*; C. LUK. Univ. California-Berkeley.
11:00 JJJ15 200.4 Differential roles of prefrontal neurons
in encoding stimulus-outcome and action-outcome
associations. C. LUK*; J. D. WALLIS. Helen Wills Neurosci.
Institute, UC Berkeley, Dept. of Psychology, UC Berkeley.
8:00 JJJ16 200.5 Prefrontal and hippocampal coding during
long-term memory formation in monkeys. S. L. BRINCAT*; E.
K. MILLER. MIT.
9:00 JJJ17 200.6 Neural correlates of abstract category
learning and insight in the monkey prefrontal cortex. E. G.
ANTZOULATOS*; E. K. MILLER. Picower Inst. For Learning
and Memory, MIT.
10:00 JJJ18 200.7 Role of dopamine D1 receptors in the
monkey prefrontal cortex during learning and memory. M. V.
PUIG*; E. K. MILLER. MIT.
11:00 JJJ19 200.8 Neural correlates of working memory
capacity limitation in primate prefrontal and parietal cortices.
T. BUSCHMAN*; V. R. YORGAN; M. SIEGEL; E. K. MILLER.
MIT, Brown Univ.
8:00 JJJ20 200.9 Time-frequency classification of
oscillatory neuronal activity in the frontoparietal system in
working memory. T. A. ROMANO*; S. L. BRESSLER; R. F.
SALAZAR; N. M. DOTSON; C. M. GRAY. Florida Atlantic
Univ., Montana State Univ.
9:00 JJJ21 200.10 Abstract rule learning in rhesus monkeys.
J. D. KRALIK*; S. A. KHAN; W. W. L. SAMPSON; M. K.
DOYLE. Dartmouth Col.
10:00 JJJ22 200.11 A comparison of reward-related activity in
different frontal cortical and limbic structures in primates. E.
R. XU*; J. D. KRALIK. Dartmouth Col.
11:00 JJJ23 200.12 Comparison of the timing of spatial
category representation in parietal and prefrontal cortices.
D. A. CROWE*; M. S. ROBERTSON; J. W. KLEASON;
H. MERCHANT; A. F. FORTES; A. P. GEORGOPOULOS.
Augsburg Col., Univ. Nacional Autonoma de Mexico, Univ. of
Minnesota.
8:00 JJJ24 200.13  •  Effects of chronic delta-9-
tetrahydrocannabinol administration on working memory
performance in adolescent rhesus monkeys. C. D.
VERRICO*; M. L. PETERSON; D. A. LEWIS. Univ. of
Pittsburgh.
9:00 JJJ25 200.14 Sensitivity to feedback in discrimination
learning is related to D2-like receptor availability in monkeys.
S. M. GROMAN*; B. LEE; M. A. MANDELKERN; M.
DALBHOUM; K. FEILER; R. RIVERA; E. D. LONDON; J.
JENTSCH. UCLA, UCI.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
10:00 JJJ26 200.15 Silencing calcyon over-expression
during adolescence preempts adult deficits in contextual
fear extinction and working memory. C. M. BERGSON*; N.
MUTHUSAMY; K. BUNTING; A. VAZDARJANOVA. Med.
Col. Georgia.
11:00 JJJ27 200.16 Role of PFC in response matching to
dynamically changing reward contingencies. C. P. ALLEN*;
F. LERI. Univ. Guelph.
8:00 JJJ28 200.17 Age-related changes in neural ensemble
activity in the medial prefrontal cortex. M. S. CAETANO*; N.
K. HORST; M. LAUBACH. The John B. Pierce Lab.
9:00 JJJ29 200.18 Neural circuits for persistent activity in
medial prefrontal cortex. M. LAUBACH*; M. S. CAETANO; B.
LIU; N. S. NARAYANAN; C. ELIASMITH. The John B. Pierce
Lab., Yale Univ., Yale Univ. Sch. of Med., Univ. of Waterloo.
10:00 JJJ30 200.19 Serotonergic neuromodulation of
prefrontal cortical circuits implicated in working memory:
A modeling study. M. CANO-COLINO; R. ALMEIDA; D.
GOMEZ-CABRERO; A. COMPTE*. IDIBAPS.
11:00 JJJ31 200.20 Corticostriatal and glutamatergic
mediation of cognitive flexibility and habit. J. L. BRIGMAN*;
T. WRIGHT; L. M. SAKSIDA; T. J. BUSSEY; S. JINDE; K.
NAKAZAWA; E. DELPIRE; D. M. LOVINGER; A. HOLMES.
NIAAA/NIH, Univ. of Cambridge, NIMH/NIH, Vanderbilt Univ.
8:00 JJJ32 200.21 Role of BDNF in modulating stress-
induced changes in cognitive flexibility. C. GRAYBEAL*;
L. M. SAKSIDA; T. J. BUSSEY; A. HOLMES. Natl. Inst. on
Alcohol Abuse and Alcoholism, NIH, Univ. of Cambridge.
9:00 JJJ33 200.22 Primate orbitofrontal neurons represent
a degree of liking of visual stimuli. M. TAKEBAYASHI*; S.
FUNAHASHI. Kyoto Univ., JSPS, Kokoro Res. Ctr., Kyoto
Univ.
10:00 JJJ34 200.23 Electrical stimulation of the ventral
tegmental area inhibits cell firing in pyramidal neurons of
the orbitofrontal cortex via a non-dopaminergic mechanism.
R. KARLSSON*; E. SULLIVAN; P. O’DONNELL. Univ. of
Maryland Sch. of Med.
11:00 JJJ35 200.24 Learning induced plasticity in the
primate lateral prefrontal cortex (lPFC) in auditory and
visual working memory tasks. H. KANG*; E. SPINGATH;
C. CONSTANTINIDIS; T. K. PLUMMER; J. ISAAC; J. M.
CRAWFORD; D. T. BLAKE. Med. Coll Georiga, Wake Forest
Univ. Sch. of Med.
8:00 JJJ36 200.25 Neural correlates of category-based
behavior control in the prefrontal cortex. K. TSUTSUI*; M.
YAMADA; Y. OHNO; T. IIJIMA. Tohoku Univ. Grad Schl Life
Sci.
9:00 JJJ37 200.26 A Quantitative trait locus for behavioral
flexibility: A genome-wide linkage study of reversal learning
in recombinant inbred mice. R. E. LAUGHLIN; T. L. GRANT;
R. W. WILLIAMS; J. D. JENTSCH*. Univ. of Calif, Los
Angeles, Univ. of Tenn, Hlth. Sci. Ctr., Univ. Calif, Los
Angeles.
10:00 JJJ38 200.27 Encoding of auditory recognition memory
within the primate lateral prefrontal cortex. B. PLAKKE*; C.
NG; R. OPHEIM; A. POREMBA. Univ. Iowa.
11:00 JJJ39 200.28 Effects of age and diet on performance
on the object recognition with detours task in common
marmosets. Z. L. SULKOWSKI*; L. M. WACHTMAN; J. A.
KRAMER; K. G. MANSFIELD; J. K. ROWLETT. Harvard
Med. School, New England Primate Res. Ctr.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
8:00 JJJ40 200.29 Contribution of orbitofrontal and
ventrolateral prefrontal cortex to mild aversive discrimination
and reversal learning in marmoset monkeys. C. AGUSTÍN-
PAVÓN; K. BRAESICKE; Y. SHIBA; Y. P. MIKHEENKO; F.
ASMA; G. HILL; M. MAN; S. C. WALKER*; A. C. ROBERTS.
Univ. of Cambridge, Behavioural and Clin. Neurosci. Inst.,
Unilever R&D.
Sun. AM
POSTER
201. Network Activity: Attention
Theme F: Cognition and Behavior
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 JJJ41 201.1 Mapping the functional connectivity
of anterior cingulate cortex in the nonhuman primate. R.
HUTCHISON; J. S. GATI; L. LEUNG; R. S. MENON; S.
EVERLING*. Robarts Res. Inst., Univ. Western Ontario.
9:00 JJJ42 201.2 Parallel prefrontal pathways target distinct
memory-related medial temporal cortices. J. G. BUNCE*; B.
ZIKOPOULOS; H. BARBAS. Boston Univ.
10:00 JJJ43 201.3 Convergence of posterior orbitofrontal
and amygdalar pathways for emotions onto the thalamic
reticular nucleus in primates. B. ZIKOPOULOS*; A. PATEL;
H. BARBAS. Boston Univ.
11:00 JJJ44 201.4 Differential synaptic localization of m2
cholinergic receptors in anterior cingulate and dorsolateral
prefrontal pathways. M. L. MEDALLA*; H. BARBAS. Boston
Univ.
8:00 JJJ45 201.5 Cortical connections of the ventrolateral
prefrontal area 12r of the macaque monkey. E. BORRA; M.
GERBELLA; S. ROZZI; G. LUPPINO*. Univ. of Parma and
Italian Inst. of Tecnology (Parma Unit).
9:00 JJJ46 201.6 Demixing population activity in higher
cortical areas. C. K. MACHENS*. Ecole Normale Superieure.
10:00 JJJ47 201.7 Identification and neural correlates of
somatostatin interneurons in medial prefrontal cortex of
behaving mice. D. KVITSIANI*; S. RANADE; J. Z. HUANG;
A. KEPECS. Cold Spring Harbor Laboratory.
11:00 JJJ48 201.8 Optogenetic control of serotonergic
neurons in rats. G. P. DUGUÉ*; M. L. LORINCZ; S.
MATIAS; M. VINHAS; P. GARCIA DA SILVA; S. Q. LIMA;
Z. F. MAINEN. Champalimaud Neurosci. Prog. at the Inst.
Gulbenkian De Ciência.
8:00 JJJ49 201.9 Bidirectional coupling between
prefrontal and dopamine neurons: Paired-cell recording
and causality analysis. W. SHI*; M. GAO; C. LIU; D. XU; E.
A. HERNANDEZ; P. A. WILLIAMS. Loma Linda Univ. Sch.
Pharm., Loma Linda Univ. Sch. Med., Shanghai Inst. of Mat
Med, Chinese Acad of Sci., Loma Linda Univ. Sch. of Med.
9:00 JJJ50 201.10 Task-relevant coherence across the
fronto-parietal network during visual working memory. R. F.
SALAZAR*; N. M. DOTSON; S. BRESSLER; C. M. GRAY.
Montana State Univ., Florida Atlantic Univ.
10:00 KKK1 201.11  •  Joint and independent contributions of
the frontal cortex and central thalamus to visual sustained
attention. J. L. BAKER*; S. A. SHAH; J. RYOU; N. D.
SCHIFF; K. P. PURPURA. Weill Cornell Med. Col.
11:00 KKK2 201.12  •  Distributed feed-forward network activity
may underlie the contextual flexibility of neurons within
the frontal cortex and central thalamus. S. A. SHAH*; J. D.
DROVER; N. D. SCHIFF; K. P. PURPURA. Cornell Univ.
-Weill Med. Coll.
Neuroscience 2010  |  Sunday AM  |  63 
8:00 KKK3 201.13  •  Modeling the contextual flexibility of
neurons across executive tasks within the frontal cortex
and central thalamus via a distributed feed-forward network
mechanism. J. D. DROVER*; S. A. SHAH; N. D. SCHIFF; K.
P. PURPURA. Weill Cornell Med. Col.
9:00 KKK4 201.14 Cognitive modulation and long term
stability of beta event-related synchronization in macaque
monkeys. C. R. WILSON*; F. STOLL; J. VEZOLI; E.
PROCYK. Inserm U846, Univeristé de Lyon, UCBL.
10:00 KKK5 201.15 Single neurons differentially phase
synchronize to beta oscillations in macaque prefrontal cortex
during selective attentional control. T. WOMELSDORF*; I.
JANEMI; M. BALE; S. EVERLING. Univ. of Western Ontario,
Robarts Res. Inst.
11:00 KKK6 201.16  •  pH sensitive NMDA inhibitors improve
outcome in a murine model of SAH. H. WANG; B. LEI; S.
MYERS; P. LYUBOSLAVSKY; L. WILSON; C. D. LASCOLA;
M. L. JAMES; D. T. LASKOWITZ*. Duke Univ. Med. Ctr.,
NeurOp Inc.
8:00 KKK7 201.17 Columnar organization of spatial
attention and spatial working memory in the frontal cortex of
primates. D. MULDREW*; M. A. LEBEDEV; J. D. KRALIK; A.
MESSINGER. Dartmouth Col., NIMH, Duke Univ.
9:00 KKK8 201.18 Involvement of the lateral prefrontal
cortex in monitoring the phase of behavior based on sensory
signals of three sensory modalities. Y. SAGA*; M. IBA; E.
HOSHI; J. TANJI. Tamagawa Univ.
10:00 KKK9 201.19 Saccade countermanding with
asymmetric reward. D. C. GODLOVE*; J. D. SCHALL.
Vanderbilt Univ.
11:00 KKK10 201.20 Spatial tuning of movement inhibition:
A saccade countermanding study in human and non-
human primates. M. J. NELSON; T. POITOU; N. WATTIEZ;
S. RIVAUD-PÉCHOUX; B. GAYMARD; P. POUGET*.
CRICM,INSERM UMRS 975, CNRS UMR 7225, UPMC,
Caltech.
8:00 KKK11 201.21 Cell-type specific optogenetic activation
of the locus coeruleus modulates electroencephalographic
activity in the hippocampus and forebrain. E. M. VAZEY*; D.
E. MOORMAN; G. ASTON-JONES. MUSC.
9:00 KKK12 201.22  •  Role of the locus coeruleus
norepinephrine system in behavioral response inhibition.
M. D. RIEDY*; D. E. MOORMAN; Z. A. COPE; G. ASTON-
JONES. Med. Univ. of South Carolina.
10:00 KKK13 201.23 Optogenetic manipulation of locus
coeruleus norepinephrine neurons: Effects on set-shifting. Z.
A. COPE*; E. VAZEY; D. E. MOORMAN; S. B. FLORESCO;
G. A. ASTON-JONES. Med. Univ. of South Carolina, Univ. of
British Columbia.
POSTER
202. Learning and Memory Systems: Hippocampus II
Theme F: Cognition and Behavior
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 KKK14 202.1 Reelin supplementation enhances
cognitive ability, synaptic plasticity and dendritic spine
density. J. T. ROGERS*; I. RUSIANA; J. TROTTER; M.
PETERS; L. ZHAO; D. PAK; L. BABUS; J. BANKO; H.
HOE; E. WEEBER. Univ. of South Florida, Vanderbilt Univ.,
Georgetown Univ.
64  |  Society for Neuroscience
9:00 KKK15 202.2 Oscillation coherencies between CA3-
CA1 and CA1-prefrontal cortex during the delayed-non-
match-to-sample task are altered in rats with early-life
seizures. J. K. KLEEN*; E. X. WU; R. C. SCOTT; G. L.
HOLMES; P. LENCK-SANTINI. Dartmouth Med. Sch., UCL,
Inst. of Child Hlth.
10:00 KKK16 202.3 Early postnatal maternal deprivation
in rats induces memory deficits in adult life that can be
mediated by modification of the cholinergic system and the
CREB and ERK1/2 phosphorylation. F. BENETTI*; P. B.
MELLO; S. MONTEIRO, Ph.D,; J. S. BONINI; W. C. F. N. DA
SILVA; J. I. ROSSATO; M. CAMMAROTA; I. IZQUIERDO.
Pontifical Catolic Univ.
11:00 KKK17 202.4 Object recognition memory and electrical
stimulation of the amygdala. D. I. BASS; K. N. PARTAIN; H.
B. DALKE; R. A. STEFANESCU; J. R. MANNS*. Emory Univ.
8:00 KKK18 202.5 Hippocampal contributions to spatial
reference memory: A sub-regional analysis. A. M.
BRUSHFIELD*; C. S. S. WEEDEN; P. E. GILBERT; R. P.
KESNER. Univ. of Utah, San Diego State Univ.
9:00 KKK19 202.6 Differential influence of environmental
enrichment and exercise on learning and memory, synaptic
plasticity, and neuronal excitability during senescence. A.
KUMAR*; A. RANI; J. HERRERA; T. C. FOSTER. Univ.
Florida.
10:00 KKK20 202.7 Transcriptional control in memory
consolidation: A role for REST/NRSF. K. J. MURPHY*; D. C.
CORBETT. Univ. Col. Dublin.
11:00 KKK21 202.8  •  Effects of cyclic 17β-estradiol injections
on chronic stress induced CA3 dendritic retraction and
CA1 dendritic spines in ovariectomized female rats. K. J.
MCLAUGHLIN*; M. SPARKS; M. EL-ASHMAWY; T. N.
HUYNH; J. J. HANNA; C. D. CONRAD. Loras Col., Arizona
State, Univ. of Texas Southwestern Med. Ctr.
8:00 KKK22 202.9 Kinematic analysis of rats with
hippocampal or dorsolateral striatal lesions during navigation
controlled by distal and proximal cues in the Morris water
task. J. P. RICE*; D. G. WALLACE; D. A. HAMILTON. Univ.
New Mexico, Northern Illinois Univ.
9:00 KKK23 202.10 Hippocampal neurons represent odor
identity and context in an overlapping odor sequence
learning task. S. J. RAMUS*; D. F. WALSH; M. R. GINTHER;
S. M. SHETH. Bowdoin Col.
10:00 KKK24 202.11  •  Blockade of TrkB receptor signaling
impairs learning in physically active but not sedentary male
Sprague Dawley rats. C. J. SCAVUZZO*; S. L. PARK; R. L.
COLLIER; D. L. KOROL. Univ. of Illinois.
11:00 KKK25 202.12 Lentivirus overexpression of CREB in the
dorsolateral striatum impairs long-term memory for place
learning: Evidence for a competitive interaction between
the striatum and the hippocampus. P. J. COLOMBO*;
B. KATHIRVELU; G. S. HILL; B. S. EAST, Jr.; M. A.
MUSSELMAN. Tulane Univ.
8:00 KKK26 202.13 Behavioral differences in two inbred
strains of mice to shift learning strategy and differences
of phosphorylated CREB expression in hippocampus and
striatum. W. CHO; S. KIM; W. JEON; S. HAN*; J. HAN.
Konkuk Univ., Korea Inst. of Oriental Med., Konkuk Univ.
Med. Ctr.
9:00 KKK27 202.14 Neuronal mechanisms of sequential
information processing in rats. S. ISHINO*; S. TAKAHASHI;
Y. SAKURAI. Kyoto Univ., Kyoto Sangyo Univ.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
10:00 KKK28 202.15 Systemic dizocilpine (MK-801) impairs
rats’ ability to segregate information from dissociated spatial
reference frames. S. KUBIK*; A. STUCHLIK; K. VALES; V.
BUBENIKOVA-VALESOVA. Inst. of Physiol. Acad. of Sci. of
the Czech Republic, v.v.i., Prague Psychiatric Ctr.
11:00 KKK29 202.16 Temporal dynamics of epigenetic
modifications induced by water maze training. A. S. SEWAL*;
B. KELLEY-BELL; S. BHAMIDIPATY; J. F. CASTELLANO; D.
H. KIM; E. J. PEREZ; B. R. FLETCHER; P. R. RAPP. Natl.
Institue On Aging, Mount Sinai Sch. Med.
8:00 KKK30 202.17 The histone deacetylase inhibitor
sodium butyrate facilitates long-term memory for a striatum-
dependent response task. M. E. CRAWLEY*; M. A.
MUSSELMAN; B. T. WOJTOWICZ; P. J. COLOMBO. Tulane
Univ.
9:00 KKK31 202.18 Lentivirus overexpression of mutant
CREB in the dorsal hippocampus impairs long-term memory
retention of place learning and contextual fear conditioning.
B. KATHIRVELU*; B. S. EAST, Jr.; A. R. HILL; C. A. SMITH;
P. J. COLOMBO. Tulane Univ.
10:00 KKK32 202.19 The hippocampus as a cognitive map:
A self-organizing map hierarchy for learning entorhinal
grid cells and hippocampal place cells. P. K. PILLY*; S.
GROSSBERG. Boston Univ.
11:00 KKK33 202.20 Effects of selective hippocampal damage
on tests of oddity in rhesus macaques. M. C. ALVARADO*;
A. KAZAMA; A. ZEAMER; J. BACHEVALIER. Yerkes Natl.
Primate Res. Center/Emory Univ., Thomas Jefferson Univ.
8:00 KKK34 202.21 Water maze training during the juvenile
period enhances later learning and pre- and post-synaptic
hippocampal morphological attributes in an NMDAr-
independent fashion. B. C. WARTMAN*; C. SMITH; M. R.
HOLAHAN. Carleton Univ.
9:00 KKK35 202.22 Increased expression of the GluN2B
(NR2B) subunit of the NMDA receptor in the hippocampus
improves flexibility in aged mice. B. L. BRIM*; R. HASKELL;
R. AWEDIKIAN; M. ELLINWOOD; L. JIN; K. MAGNUSSON.
Oregon State Univ., Viraquest, Inc., Iowa State Univ.
10:00 KKK36 202.23 Representation of identity through voices
and faces in macaque hippocampus. J. SLIWA; A. PLANTÉ;
J. DUHAMEL; S. C. WIRTH*. CNRS - Ctr. de Neurosci.
Cognitive.
11:00 KKK37 202.24 BDNF and pattern separation in the
hippocampus. P. BEKINSCHTEIN*; L. M. SAKSIDA; T. J.
BUSSEY. Univ. of Cambridge.
8:00 KKK38 202.25 The dorsal hippocampus is necessary
for non-spatial object memory in male C57BL/6J mice.
L. SIGNORELLI*; C. R. CHRISTAKIS; M. GUIDI; R. W.
STACKMAN. Florida Atlantic Univ.
9:00 KKK39 202.26 Investigating the role of the hippocampus
in the mouse touchscreen object-in-place Paired Associate
Learning (PAL) task. A. HORNER*; C. ROMBERG; T. J.
BUSSEY; L. M. SAKSIDA. Univ. of Cambridge, Max-Planck
Inst. for Psychiatry, MRC and Wellcome Trust Behavioural
and Clin. Neurosciences Inst.
10:00 KKK40 202.27  •  Dissociation of the effects of subchronic
phencyclidine on rodent tasks relevant to schizophrenia. K.
A. L. MCALLISTER*; L. M. SAKSIDA; T. J. BUSSEY. The
Univ. of Cambridge.
11:00 KKK41 202.28 Norepinephrine effects on hippocampal
activity patterns in the freely behaving rat. A. SERGEEVA; B.
GROSS; D. BAUER; G. R. POE*. Univ. Michigan.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
8:00 KKK42 202.29 Extent of preservation of hippocampal
Reelin+ interneurons predicts the ability for spatial learning
& memory function in chronic temporal lobe epilepsy. R. R.
GRIER*; B. HATTIANGADY; R. KURUBA; V. K. PARIHAR;
B. SHUAI; A. K. SHETTY. Duke Univ. Med. Ctr. and VA Med.
Ctr., Duke Univ. Med. Ctr. & VA Med. Ctr.
9:00 KKK43 202.30 Dual modulators of ligand-gated ion
Sun. AM
channels synergistically induce LTP in the hippocampus and
enhance cognition. P. HORVATH*; T. B. JOHNSTONE; R. F.
YOSHIMURA; E. R. WHITTEMORE; D. J. HOGENKAMP;
J. L. YAKEL; Z. GU; K. W. GEE. Univ. of California, Irvine,
NATIONAL INSTITUTES OF HEALTH.
POSTER
203. Learning and Memory: Gamma and Theta Activity
Theme F: Cognition and Behavior
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 KKK44 203.1 Theta/gamma cross frequency coupling
across the septotemporal axis of the hippocampus and
the effects of ketamine. L. LONG*; J. R. HINMAN; S.
C. PENLEY; M. A. ESCABI; J. J. CHROBAK. Univ. of
Connecticut.
9:00 KKK45 203.2 Septotemporal variation in the effects
of speed on the theta rhythm. J. R. HINMAN*; S. C.
PENLEY; L. L. LONG; M. A. ESCABI; J. J. CHROBAK. Univ.
Connecticut.
10:00 KKK46 203.3 Gamma-band activity in monkey
hippocampus signals temporal-order information of two
visual items. Y. NAYA*; W. A. SUZUKI. New York Univ.
11:00 KKK47 203.4 Theta-band phase reset in the primate
hippocampus influences recognition memory performance.
M. J. JUTRAS*; E. A. BUFFALO. Yerkes Natl. Primate Res.
Ctr., Emory Univ., Emory Univ. Sch. of Med.
8:00 KKK48 203.5 The time-course of gamma-band
synchronization across layers of the macaque entorhinal
cortex predicts the strength of memory formation. N. J.
KILLIAN*; E. A. BUFFALO. Georgia Tech. and Emory Univ.,
Yerkes Natl. Primate Res. Ctr., Emory Univ. Sch. of Med.
9:00 KKK49 203.6 Face-preferring neurons in the monkey
hippocampus. J. A. SOLYST*; M. J. JUTRAS; M. L.
TOMPKINS; E. A. BUFFALO. Emory University, Neurosci.
Program, Yerkes Natl. Primate Res. Ctr., Emory Univ. Sch. of
Med.
10:00 KKK50 203.7 Unstable place cell coding in an
Alzheimer’s disease transgenic rat model. H. M. JARRELL*;
J. KOENIG; K. E. DELOACH; A. C. CUELLO; S. LEUTGEB.
UCSD, McGill Univ.
11:00 KKK51 203.8 Hippocampal activation during the recall
of recent as well as remote spatial memories in the radial
maze. M. I. SCHLESIGER*; J. C. CRESSEY; J. KOENIG; S.
LEUTGEB. Univ. of St Andrews, Ruprecht-Karls-Universität
Heidelberg, UCSD.
8:00 KKK52 203.9 Coding of temporal context in the
hippocampus: Do rate codes offer insight into a time-of-day
signature? F. T. SPARKS*; E. A. MANKIN*; B. SLAYYEH;
R. J. SUTHERLAND; J. K. LEUTGEB*. Univ. of Lethbridge,
UCSD.
9:00 KKK53 203.10 Grid-like firing of entorhinal cells does
not persist during reduced theta activity. J. KOENIG*; A.
LINDER; S. LEUTGEB. UCSD.
Neuroscience 2010  |  Sunday AM  |  65 
10:00 KKK54 203.11 Relative changes of intrinsic excitability
are sufficient for preferential recruitment of neurons into
a fear memory trace. A. P. YIU*; V. MERCALDO; S. A.
KUSHNER; S. A. JOSSELYN. Hosp. For Sick Children, Univ.
of Toronto, Eramus MC.
11:00 KKK55 203.12 Time-dependent brain-wide
reorganization of functional networks supporting contextual
fear memory. A. L. WHEELER*; C. M. TEIXEIRA; A. R.
MCINTOSH; N. KOVACEVIC; P. W. FRANKLAND. Hosp
Sick Children, Univ. of Toronto, Rotman Res. Inst.
8:00 KKK56 203.13 Hippocampal theta activity in young
and aged rats: Effects of a modified environment and
physostigmine. T. K. JACOBSON*; M. D. HOWE; S.
BOHANNON; E. J. MARKUS. Univ. Connecticut.
9:00 KKK57 203.14 Theta and gamma oscillations in the
hippocampus, striatum, and prefrontal cortex during a
place and response task. B. SCHMIDT*; L. FORGETTE; M.
ESCABI; E. MARKUS. Univ. Connecticut.
10:00 KKK58 203.15 Spatial maps in the medial entorhinal
cortex of the egyptian fruit bat. M. M. YARTSEV*; M.
WITTER; N. ULANOVSKY. Weizmann Inst. of Sci., Kavli
Inst. for Systems Neurosci. and Ctr. for the Biol. of Memory,
Norwegian Univ. of Sci. and Technol.
11:00 KKK59 203.16 FMRP is critical for late-phase long-term
potentiation in the anterior cingulate cortex. S. J. KANG*; T.
CHEN; H. LEE; B. KAANG; M. ZHUO. Dept. of Brain and
Cognitive Science, Seoul Natl. Univ., Dept. of Physiology,
Fac. of Medicine, Univ. of Toronto, Dept. of Biol. Sciences,
Seoul Natl. Univ.
8:00 KKK60 203.17 Theta-burst stimulation induces long-
term potentiation during beta oscillation but not induce it
during the epileptic discharges in rat hippocampal slices. K.
NATSUME*; M. NISHIMURA. Kyushu Inst. Technol.
9:00 KKK61 203.18 Functional imaging of hippocampal place
cells at cellular resolution during virtual navigation. D. A.
DOMBECK*; C. D. HARVEY; L. TIAN; L. L. LOOGER; D. W.
TANK. Princeton Univ., Janelia Farm Res. Campus.
10:00 KKK62 203.19 Voltage-sensitive dye imaging alterations
in the hippocampal CA1 region in a mouse model of an
OPRM1 SNP (A118G). S. MAGUE*; G. C. CARLSON; J. A.
BLENDY. Univ. Pennsylvania.
11:00 KKK63 203.20 Cosine directional tuning of theta cell
burst frequencies in anterior thalamus: Evidence for an
oscillatory path integration circuit in the rat brain. A. C.
WELDAY; I. G. SHLIFER; M. L. BLOOM; H. T. BLAIR*, IV; K.
ZHANG. UCLA, Johns Hopkins Univ.
POSTER
204. Learning and Memory: Genes and Aging
Theme F: Cognition and Behavior
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 KKK64 204.1 Aging and correlations across visual,
auditory and cognitive processing in F344 rats. B. J.
SWETTER*; R. FITCH; E. J. MARKUS. UConn, Univ. of
Connecticut.
9:00 KKK65 204.2  •  Electrophysiological indication of
hippocampal deficits in early-aged rats. J. A. MIRANDA*; R.
DIAS; J. R. HUXTER. Pfizer Regenerative Med.
66  |  Society for Neuroscience
10:00 KKK66 204.3 Age-related changes in cortical thinning.
T. R. STOUB*; R. C. SHAH; C. A. BARNES; L. DETOLEDO-
MORRELL. Rush Univ., Rush Univ. Med. Ctr., Univ. of
Arizona.
11:00 KKK67 204.4 Use of lego objects to create perceptual
ambiguity on the object discrimination task: Testing
for perceptual changes across the life span of bonnet
macaques. K. PLANGE*; S. N. BURKE; S. NEMATOLLAHI;
D. HUERTA; K. LIND; C. A. BARNES. Univ. Arizona, Univ. of
Arizona.
8:00 KKK68 204.5   The effect of perceptual difficulty and
age on spontaneous object recognition. A. L. HARTZELL*;
J. L. WALLACE; S. NEMATOLLAHI; S. N. BURKE; C. A.
BARNES. Univ. of Arizona.
9:00 KKK69 204.6 Hippocampal CA1 firing rates vary with
spatial training and place field stability in young and old
rats. L. A. SCHIMANSKI*; B. M. BROERSMA; P. LIPA; C. A.
BARNES. Univ. Arizona, Univ. of Arizona.
10:00 KKK70 204.7 Weakening of slow gamma/theta coupling
strength in CA1 of senescent rats. A. THOME*; L. A.
SCHIMANSKI; P. LIPA; C. A. BARNES. Univ. Arizona, Univ.
of Arizona.
11:00 LLL1 204.8 Micro-scale coupling, macro-scale
antagonism between excitation and inhibition during a
decision-making task. N. INSEL*; L. PATRON; Z. WAGNER;
J. N. VEGA; C. A. BARNES. Univ. Arizona, Univ. of Arizona.
8:00 LLL2 204.9 A characterization of perirhinal cortical
interneurons in quiet rest and active exploration. A. P.
MAURER*; S. N. BURKE; J. L. WALLACE; C. A. BARNES.
Univ. of Arizona.
9:00 LLL3 204.10 Transcription of the immediate-early
gene Arc in the perirhinal cortex does not show a response
decrement following repeated exposures to novel objects. S.
BURKE*; A. L. HARTZELL; L. T. HOANG; J. L. WALLACE;
A. P. MAURER; M. K. CHAWLA; C. A. BARNES. Univ.
Arizona, Univ. of Arizona.
10:00 LLL4 204.11 Changing objects encountered during
track running alters expression patterns of the immediate
early gene Arc in the lateral entorhinal cortex of the rat. J. P.
LISTER*; S. J. CLASEN; C. A. BARNES. Univ. Arizona, Univ.
of Arizona.
11:00 LLL5 204.12 Quantification of microcolumn structure in
the frontal, parietal, and occipital cortices of the Fischer 344
rat. A. INGLIS*; J. P. LISTER; K. ANAND; C. RICHARDS;
L. R. CRUZ; C. A. BARNES; D. L. ROSENE. Boston Univ.,
Univ. of Arizona, Drexel Univ.
8:00 LLL6 204.13 Age-related changes in the plasticity
of the Arc transcriptional response. M. R. PENNER*; L.
T. HOANG; A. THOME; J. P. LISTER; E. G. WANN; C. A.
BARNES. Univ. of Washington, Univ. of Arizona.
9:00 LLL7 204.14 Characterization of Arc-expression in
GABAergic neurons of the ventral tegmental area during
aging. L. T. HOANG*; A. M. EGURROLA; E. G. WANN; A. R.
UPRETY; J. FELLOUS; C. A. BARNES. Univ. Arizona, Univ.
of Arizona.
10:00 LLL8 204.15 Location of Arc mRNA expressing granule
cells following spatial exploration in the rat dentate gyrus.
M. K. CHAWLA*; P. C. BELLO MEDINA; C. J. SANDOVAL;
V. RAMIREZ-AMAYA; C. A. BARNES. Univ. of Arizona,
Unversidad Nacional Autonoma de Mexico.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
11:00 LLL9 204.16 Functional neurogenesis in the senescent
fascia dentata. D. F. MARRONE*; C. J. SANDOVAL; M.
J. SCHANER; V. RAMIREZ-AMAYA; C. A. BARNES.
Wilfrid Laurier Univ., Univ. of Arizona, Unversidad Nacional
Autonoma de Mexico.
8:00 LLL10 204.17 A virtual place cell? Virtual place
related responses in primate hippocampal complex spike
cells. J. L. GERRARD*; S. R. PATEL; E. N. ESKANDAR.
Massachusetts Gen. Hosp.
9:00 LLL11 204.18 Modulation of primate hippocampal
local-field potential during learning. S. R. PATEL*; J. L.
GERRARD; E. N. ESKANDAR. Massachusetts Gen. Hosp.
10:00 LLL12 204.19 The discrete nature of place cell silencing
due to seizure activity. H. LIN*; S. FOX; R. MULLER. SUNY
Downstate Med. Ctr.
11:00 LLL13 204.20 Enhanced pattern separation in dentate
gyrus granule cells in infant (P17-19) rats. J. Y. XIE*; D. F.
MARRONE; R. J. SUTHERLAND; B. L. MCNAUGHTON.
Univ. of Lethbridge, Wilfrid Laurier Univ.
8:00 LLL14 204.21 Towards large scale image acquisition
and fully automated quantification of activity induced
IEG expression in central nervous system. Q. LU*; B. L.
MCNAUGHTON. Univ. of Lethbridge.
9:00 LLL15 204.22 Confirmation by immediate-early gene
activation analysis of non-sparse coding in subiculum during
spatial behavior. W. K. LI*; B. L. MCNAUGHTON. Univ. of
Lethbridge.
10:00 LLL16 204.23 Monosynaptic interactions between
excitatory neurons in medial prefrontal cortex. C. D.
SCHWINDEL*; M. TATSUNO; B. L. MCNAUGHTON. Univ. of
Lethbridge.
11:00 LLL17 204.24 CA1 place cells show a gradual firing
rate remapping in opposite running directions with repeated
traversals of a track, leading to increased directional
asymmetry of place fields. Z. NAVRATILOVA*; L. T. HOANG;
J. L. VALDES; M. TATSUNO; B. L. MCNAUGHTON. Univ. of
Lethbridge, Univ. of Arizona.
POSTER
205. Aging: Dementia, Animals, and People
Theme F: Cognition and Behavior
Sun. 8:00 AM— San Diego Convention Center, Halls B-H
8:00 LLL18 205.1 Sexual experience enhances adult
neurogenesis in the dentate gyrus and affects cognitive and
anxiety-like behavior in the aging rat. E. R. GLASPER*; E.
GOULD. Princeton Univ.
9:00 LLL19 205.2 Beta amyloid deposition and default
mode network activity in nondemented older adults. J.
SOJKOVA*; L. L. BEASON-HELD; Y. ZHOU; M. A. KRAUT;
D. F. WONG; S. M. RESNICK. Natl. Inst. on Aging/NIH,
Johns Hopkins Univ.
10:00 LLL20 205.3 Increased generalization of fear in aged
mice. P. J. HERNANDEZ*; M. E. WIMMER; T. ABEL. Univ.
Pennsylvania.
11:00 LLL21 205.4 Aging and context: Older mice are
impaired in their ability to acquire, and then reverse, a
contextual discrimination in Pavlovian fear conditioning. M. J.
SANDERS*; H. BOEH; S. STEVENS. Marquette Univ.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
8:00 LLL22 205.5 Hippocampal synaptoproteomic
dysregulation with age-related cognitive decline. H. D.
VANGUILDER; J. A. FARLEY; H. YAN; C. A. VAN KIRK; W.
E. SONNTAG; W. M. FREEMAN*. Penn State Coll Med.,
Univ. of Oklahoma Hlth. Sci. Ctr.
9:00 LLL23 205.6 Levetiracetam improves spatial memory
in aged-impaired Fischer 344 rats. G. M. ROSE*; A. E.
Sun. AM
CORBIN. Southern Illinois Univ.
10:00 LLL24 205.7 Oligodendroglial myelinogenic programs
in aging rat hippocampus are linked to activation of
astrocytic lysosomal and protein translation pathways. E.
M. BLALOCK*; I. KADISH; V. THIBAULT; K. C. CHEN; N.
M. PORTER; P. W. LANDFIELD. Univ. Kentucky Coll Med.,
Univ. of Alabama, Birmingham.
11:00 LLL25 205.8 Age-dependent alterations in adult-
born neurons within subdivisions of the rostral migratory
stream. A. S. MOBLEY*; J. H. BRANN; S. FIRESTEIN; C. A.
GREER. Yale Univ., Columbia Univ.
8:00 LLL26 205.9 Regional FDG uptake in AD, MCI, and
normal aging. C. BAUER*; R. KILLIANY. Boston Univ.
9:00 LLL27 205.10 Aging impact on proteasome activity
and mitochondrial function in the CNS of Drosophila
melanogaster. J. GAO*; M. FIGUEIREDO-PEREIRA; T.
SCHMIDT-GLENEWINKEL. Hunter Col. and Grad. Ctr. of
CUNY.
10:00 LLL28 205.11 Characterization of the neuroprotective
mechanism of selenoprotein M. M. A. REEVES*; A. S.
TAKEMOTO; F. P. BELLINGER; M. J. BERRY. Univ. Hawaii
Manoa, JABSOM.
11:00 LLL29 205.12 Patterns of fibroblast networks screen
for Alzheimer’s disease. F. V. CHIRILA; T. K. KHAN*; D. L.
ALKON. Blanchette Rockefeller Neurosciences Inst.
8:00 LLL30 205.13 Systematic inflammation and central
nervous system dysfunction. E. G. INUI*; J. LUCERO; G.
A. SHEKHTMAN; J. D. WALSTON; L. L. DUGAN. Univ. of
California San Diego, Johns Hopkins Univ. Sch. of Med.
9:00 LLL31 205.14 Increased hippocampal acetate
incorporation is associated with the preservation of cognitive
status in aged Fischer 344 rats. J. M. EBERSOLE*; T. EID;
G. ROSE; P. PATRYLO. Southern Illinois Univ, Carbondale,
Yale Univesity Sch. of Med., SIU Sch. of Med.
10:00 LLL32 205.15 FDG PET in MCI with clinical follow-up for
three years. J. V. PARDO*; M. A. KUSKOWSKI; K. MUNCH;
J. T. LEE; M. W. DYSKEN. Minneapolis Veterans Affairs
Med. Ctr., Univ. of Minnesota.
11:00 LLL33 205.16 Hippocampal histone modification
involved in the impairment of neurogenesis with aging.
N. KUZUMAKI*; S. IMAI; D. IKEGAMI; M. NARITA; R.
TAMURA; A. SUZUKI; T. SUZUKI; M. NARITA. Hoshi Univ.
Sch.
8:00 LLL34 205.17 Regulation of microglial phagocytosis and
neuroinflammation by age-associated systemic changes. K.
L. IRVING*; S. A. VILLEDA; T. FUKUHARA; K. M. LUCIN; T.
WYSS-CORAY. Stanford Univ., Veterans Admin. Palo Alto
Hlth. Care Systems.
9:00 LLL35 205.18 Age-related changes of cytochrome c
oxidase in neuronal tissue of Drosophila melanogaster. J.
REN*; I. REBRIN; V. KLICHKO; T. SHIAO; W. C. ORR; R. S.
SOHAL. USC, Southern Methodist Univ.
Neuroscience 2010  |  Sunday AM  |  67 
POSTER
206. Neuroethology: Diverse Motor Behaviors
Theme F: Cognition and Behavior
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 LLL36 206.1 Unilateral hemispherectomy at adulthood
asymmetrically affects motor performance of male
Swiss mice. D. P. BRANCO*; Y. ABREU-VILLAÇA; A. C.
MANHÃES; C. C. FILGUEIRAS. Univ. do Estado do Rio de
Janeiro.
9:00 LLL37 206.2 Dynamic responses of decapods to
postural perturbations. A. A. SIMMONS; J. H. BELANGER*.
West Virginia Univ.
10:00 LLL38 206.3 Chromatophore control mechanisms
underlying crypsis and communication in cuttlefish. S. P.
HADJISOLOMOU*; F. W. GRASSO. Brooklyn Col.
11:00 LLL39 206.4  •  Behavioral patterns of the tentacle of
the jellyfish, Sanderia malaynesis. K. MORI*; J. AYERS.
Northeastern Univ.
8:00 LLL40 206.5 Modeling neural control of a muscular
hydrostat system: Squid tentacle extension. F. W. GRASSO*.
Brooklyn College, CUNY, The Grad. Ctr. of CUNY.
9:00 LLL41 206.6 A novel technique to monitor activation
of escape response circuitry in freely behaving zebrafish
larvae. F. A. ISSA*; G. S. O’BRIEN; P. KETTUNEN; A.
SAGASTI; D. L. GLANZMAN; D. M. PAPAZIAN. Univ. of
California Los Angeles, UCLA, The Sahlgrenska Academy,
Univ. of Gothenburg.
10:00 LLL42 206.7  •  The roboroach el cheapo: An under-
the-shelf technique for controlling insect locomotion. T. C.
MARZULLO*; L. JIN; C. ZHANG; A. SUHAIB; S. CHUNG; G.
GAGE. Backyard Brains, Univ. of Michigan.
11:00 LLL43 206.8 Differential deployment of the motor
pool during in vitro biting and swallowing in Aplysia. J.
MCMANUS*; H. LU; M. CULLINS; K. SHAW; H. J. CHIEL.
Case Western Reserve Univ.
8:00 LLL44 206.9 Aromatase distribution in the brain
of the golden-collared manakin (Aves: Pipridae). S. R.
WILKENING*; P. R. AYERS; L. B. DAY. Univ. of Mississippi.
9:00 LLL45 206.10 Estradiol does not improve motor deficits
after cerebellar lesions. J. HAMER*; G. W. STINSON, Jr.; W.
SOBECKI; L. B. DAY. Univ. of Mississippi.
POSTER
207. Neuroethology: Vocal Communication-Neurophysiology
and Behavior
Theme F: Cognition and Behavior
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 LLL46 207.1 Testosterone-induced premature song
crystallization abolishes LTD in the songbird premotor
nucleus RA. M. SIZEMORE*; D. J. PERKEL. Univ.
Washington, Univ. of Washington.
9:00 LLL47 207.2 Driver-type terminals in avian pallium
originating from brainstem: A pallial relay station? A. L.
BODOR*; J. A. THOMPSON; D. J. PERKEL. Univ. of
Washington.
10:00 LLL48 207.3 Serotonergic modulation of auditory
activity in zebra finch song nucleus RA. W. E. WOOD*; D. J.
PERKEL. Univ. Washington.
68  |  Society for Neuroscience
11:00 LLL49 207.4 Auditory tuning during vocal learning
in parallel cortico-thalamic basal ganglia loops. J. R.
MCGRADY ACHIRO*; S. W. BOTTJER. USC.
8:00 LLL50 207.5 The morphology of axonal projections
from the High Vocal Center to vocal motor cortex in
songbirds. Z. YIP; V. C. MILLER-SIMS; S. W. BOTTJER*.
USC, Univ. S California.
9:00 LLL51 207.6 Neural basis of cooperative behavior
in the plain-tailed wren (Thryothorus euophrys). M. J.
COLEMAN*; G. F. BALL; E. S. FORTUNE. The Claremont
Colleges, Johns Hopkins Univ.
10:00 LLL52 207.7 Effects of early LMAN ablation on the
fidelity of song imitation. K. C. ELLIOTT*; F. JOHNSON.
Florida State Univ.
11:00 LLL53 207.8 Recurrent architecture of cortico-basal
ganglia pathways in the songbird. K. HAMAGUCHI*; R.
MOONEY. Duke Univ, Med. Ctr.
8:00 LLL54 207.9 Dynamic contributions of a basal ganglia
circuit to the expression of vocal learning in adult songbirds.
T. L. WARREN*; E. C. TUMER; M. S. BRAINARD. Univ. of
California, San Francisco.
9:00 LLL55 207.10 A compact statistical model for the song
syntax of Bengalese finch. D. Z. JIN*; A. KOZHEVNIKOV.
Pennsylvania State Univ.
10:00 LLL56 207.11  •  Computational model of microcircuit
dynamics underlying bird song in the zebra finch. A. DAOU*;
F. JOHNSON; W. WU; R. BERTRAM. Florida State Univ.
11:00 LLL57 207.12 The emergence of selectivity for elements
of conspecific song in the starling auditory pathway. C.
D. MELIZA*; D. MARGOLIASH. Univ. Chicago, Univ. of
Chicago.
8:00 LLL58 207.13 Interactions between new and old
auditory memories in the European starling. D. G. ZARAZA*;
D. MARGOLIASH. Univ. Chicago.
9:00 LLL59 207.14 Spontaneous neuronal bursting
and sleep-mediated changes in vocal learning. M. E.
LUSIGNAN*; D. MARGOLIASH. Univ. of Chicago.
10:00 LLL60 207.15 Neuron incorporation into HVC is altered
by unilateral tracheosyringeal nerve cut in adult zebra
finches. E. RODRIGUEZ; C. L. PYTTE*. Queens Col.,
Macaulay’s Honors Col. at CUNY, The Grad. Center, City
Univ. of New York.
11:00 LLL61 207.16 Developmental changes in CBA/CaJ
mouse vocalizations. J. M. GRIMSLEY*; J. J. WENSTRUP.
NEOUCOM, Anat. and Neurobio.
POSTER
208. Data Analysis and Simulation Methodology
Theme G: Novel Methods and Technology Development
Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 LLL62 208.1 Multi-parameter optimization of
glutamatergic receptor models via annealing. B. DE
OLIVEIRA; T. ALBASH; S. HAAS; J. C. BOUTEILLER*; S. L.
ALLAM; E. Y. HU; R. GREGET; N. AMBERT; M. SARMIS; S.
BISCHOFF; M. BAUDRY; T. W. BERGER. USC, Rhenovia
Pharma.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
9:00 LLL63 208.2 Eons / Rhenoms modeling tool:
Optimization framework for multi-scale neuronal parameter
fitting. S. L. ALLAM*; E. Y. HU; B. D. OLIVEIRA; T. ALBASH;
S. HAAS; R. GREGET; N. AMBERT; M. SARMIS; S.
BISCHOFF; J. BOUTEILLER; M. BAUDRY; T. W. BERGER.
Univ. of Southern California, USC, Rhenovia Pharma.
10:00 LLL64 208.3 Bayesian inference and parameter
estimation through stochastic simulation in conductance-
based models of single neurones. D. VAVOULIS*; V. A.
STRAUB; J. FENG. Univ. of Warwick, Univ. of Leicester.
11:00 LLL65 208.4 Maximum noise entropy methods for
modeling neural input/output functions. J. D. FITZGERALD;
L. C. SINCICH; T. O. SHARPEE*. The Salk Inst. For Biol.
Studies, Univ. of California, San Francisco.
8:00 LLL66 208.5 Minimum sampling rate and resolution
for detection and classification of neuronal spikes in
extracellular recordings. P. T. THORBERGSSON*; M.
GARWICZ; J. SCHOUENBORG; A. J. JOHANSSON. Dept.
of Electrical and Info. Tech., Neuronano Res. Ctr., Lund Univ.
9:00 LLL67 208.6 Analyzing spike train similarity measures:
The effects of bursts and silence. D. LYTTLE*; J. FELLOUS.
Univ. of Arizona.
10:00 LLL68 208.7 The relation between mean firing rate
and rate correlations in neuronal analyses. V. MINCES; A. A.
CHIBA*. UCSD.
11:00 LLL69 208.8 Mapping functional connectivity of
neural networks from calcium data: A unified simulation
and estimation framework with parallel CPU/GPU
implementation. M. BUIBAS*; G. SILVA. UCSD.
8:00 LLL70 208.9 Dynamic causal models and physiological
inference: A validation study using anaesthetics in rodents.
R. J. MORAN; M. TITTGEMEYER; K. STEPHAN*; F. JUNG;
T. KUMAGAI; H. ENDEPOHLS; R. GRAF; R. J. DOLAN;
K. J. FRISTON. Univ. Col. London, Max Planck Inst. for
Neurolog. Res.
9:00 MMM1 208.10 Source stability index: A beamformer-
based localisation metric for magnetoencephalography data.
M. HYMERS*; S. R. JOHNSON; G. PRENDERGAST; W.
P. WOODS; G. G. R. GREEN. York Neuroimaging Centre,
Univ. of York.
10:00 MMM2 208.11 Meg-sim portal: Database of realistic meg
simulations for assessing functional connectivity. C. J. AINE*;
L. SANFRATELLO; D. RANKEN; E. BEST; T. WALLACE; J.
A. MACARTHUR; K. GILLIAM; J. M. STEPHEN. UNM Schl
Med., Los Alamos Natl. Lab., Mind Res. Network.
11:00 MMM3 208.12 Seizure prediction methodology for vagus
nerve stimulation patients. M. H. MYERS*; R. KOZMA. Univ.
of Memphis.
8:00 MMM4 208.13 Divergence modeling: Analyzing
perceptual representations via stimulus similarity and
information theory. A. D. CATE*; T. J. HERRON; D. L.
WOODS. Veterans Affairs Northern California Hlth. Care
Syst., UC Davis.
9:00 MMM5 208.14 Comparison of multivariate granger
causal connectivity techniques for fMRI: A simulation
approach. E. SHOKRI KOJORI*; H. ABDI; M. MOTES; B.
RYPMA; D. KRAWCZYK. Univ. of Texas at Dallas, The Univ.
of Texas at Dallas.
10:00 MMM6 208.15 A novel MRI visualization tool for white
matter pathology in multiple sclerosis. M. XIAO; T. DO; C.
HELMICK; J. SOH; O. MERUVIA-PASTOR; J. A. FISK; J. D.
FISK*; G. ROBERTSON; C. W. SENSEN. Univ. of Calgary,
Dalhousie Univ.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
11:00 MMM7 208.16 Whiskers area as extra-cerebral
reference region for the quantification of rat brain metabolism
using FDG PET. H. BACKES; M. WALBERER; H.
ENDEPOLS; B. NEUMAIER; R. GRAF; K. WIENHARD; G.
MIES*. Max-Planck-Inst Neurolog Res., Dept. of Neurology,
Univ. Hosp. of Cologne.
8:00 MMM8 208.17 Fully automated measurement of the
Sun. AM
human corpus callosum from MRI: Morphometry and
callosal-cortical correlations. T. J. HERRON*; X. KANG; A.
U. TURKEN; B. EDWARDS; D. L. WOODS. US Veterans
Affairs, NCHCS, Univ. of California.
9:00 MMM9 208.18 Sulcal pattern analysis using sulcal pit-
based tree structure and its spectral matching. K. IM; R.
PIENAAR; M. SAHIN*; P. GRANT. Children’s Hosp.
10:00 MMM10 208.19 Synergos index, identifying multiple
muscle coactivation during isotonic exercise. A.
POURMOGHADDAM*; M. DETTMER; W. H. PALOSKI; D. P.
O’CONNOR; J. PATEL; A. KHORRAM; Y. LOPEZ TAFURTH;
C. S. LAYNE. Univ. Houston.
11:00 MMM11 208.20 Computationally efficient simulation
of fractional order ATP diffusion in glial networks. B. P.
SPROUSE*; C. L. MACDONALD; G. A. SILVA. UCSD.
8:00 MMM12 208.21 A new algorithm for generating spike
activity of noisy neural networks. A. J. MILLER*; D. Z. JIN.
Penn State Univ.
9:00 MMM13 208.22 Modeling timing variation and
compositionality of zebra finch song. T. W. TROYER*; C. M.
GLAZE. Univ. Texas San Antonio, Univ. of Pennsylvania.
10:00 MMM14 208.23 Functional compositionality realized
in spiking neural networks by synfire chain competition.
A. HANUSCHKIN*; M. DIESMANN; A. MORRISON. BCF,
Functional Neural Circuits Group, Fac. of Biol., RIKEN Brain
Sci. Inst., RIKEN Computat. Sci. Res. Program,.
11:00 MMM15 208.24 Two cortical signatures of
compositionality: An application to linguistic binding. F. B.
PULVERMULLER*; B. CAPPELLE; Y. SHTYROV. MRC,
Univ. Col. Ghent.
8:00 MMM16 208.25 Ongoing and stimulus-dependent activity
in compositional networks of synfire chains. C. TRENGOVE*;
C. VAN LEEUWEN; M. DIESMANN. RIKEN.
9:00 MMM17 208.26 Control scheme compositionality in
rhythmic manual tasks. F. C. HUANG*; J. L. PATTON; F. A.
MUSSA-IVALDI. Rehabil Inst. of Chicago.
10:00 MMM18 208.27 NEURON simulations and model viewing
over the web. T. S. MCTAVISH*; G. M. SHEPHERD; M. L.
HINES. Yale Univ. Sch. of Med.
11:00 MMM19 208.28 NEST 2: a parallel simulator for large
scale neuronal simulations. M. GEWALTIG; M. DIESMANN;
J. M. EPPLER; M. HELIAS; A. MORRISON; H. E.
PLESSER*. Honda Res. Instiute Europe GmbH, RIKEN
Brain Sci. Inst., RIKEN Computat. Sci. Res. Program, Albert-
Ludwigs-University, Norwegian Univ. Life Sci.
8:00 MMM20 208.29 Simulating neuronal networks at the brain
scale on Blue Gene/P supercomputers with NEST. T. C.
POTJANS*; S. KUNKEL; A. MORRISON; H. E. PLESSER;
M. DIESMANN. Res. Ctr. Juelich, RIKEN Computat. Sci.
Res. Program, Albert-Ludwigs-University, Bernstein Ctr.
Freiburg, Norwegian Univ. of Life Sci., RIKEN Brain Sci. Inst.
9:00 MMM21 208.30 Billion-neuron memory models in slender
blue genes. L. D. WITTIE*; R. T. WELSCH; H. MEMELLI.
SUNY Stony Brook Univ.
Neuroscience 2010  |  Sunday AM  |  69 
10:00 MMM22 208.31 Chaotic dynamics reflected in the
output of a simulated neural network. D. W. PFAFF*; W. F.
WEINGARTEN; G. REEKE; V. VIMAL. Rockefeller Univ.

POSTER

209. Data Analysis and Statistics

Theme G: Novel Methods and Technology Development

Sun. 8:00 AM — San Diego Convention Center, Halls B-H
8:00 MMM23 209.1 Neuromodulatory interactions with the
amygdala: Data mining survey using the Allen Mouse Brain
Atlas. A. ZALDIVAR*; J. L. KRICHMAR. Univ. of California,
Irvine.
9:00 MMM24 209.2  •  Determination of optimal sets of marker
genes for anatomical structures in the mouse brain. P.
GRANGE*; H. WANG; P. MITRA. Cold Spring Harbor Lab.
10:00 MMM25 209.3 Gender differences in brain functional
connectivity density. D. TOMASI*; N. D. VOLKOW. NIH.
11:00 MMM26 209.4 A comparison between low- and high-
density analyses on 2D neuronal networks by means
of high resolution CMOS-MEAs. A. MACCIONE*; M.
GANDOLFO; M. TEDESCO; K. IMFELD; S. MARTINOIA;
L. BERDONDINI. Italian Inst. of Technol., Univ. of Genova,
CSEM.
8:00 MMM27 209.5 Direct positioning of a neural network’s
hidden units. W. C. LENNON*, JR; R. MINNETT; A. SMITH;
R. HECHT-NIELSEN. Univ. of California, UCSD.
9:00 MMM28 209.6  •  Quantification and automation of Irwin
test. A. SHAO; H. ZHAO; J. ZOU; Z. HU; J. ZHANG; L. ZHU;
J. WU; J. JIANG; C. CHAN; D. BIAN*. Wuxiapptec.
10:00 MMM29 209.7 Effective connectivity investigation of
acupuncture point specificity with spatial ICA and multivariate
Granger causality analysis. C. ZHONG; L. BAI; T. XUE; J.
TIAN*. Inst. Automation, CAS, Xidian Univ.
11:00 MMM30 209.8 On single-trial ERSP reproducibility
across multiple subjects/trials by semantic texton forests. A.
C. TSAI*; A. SAVOSTYANOV; M. LIOU. Inst. of Statistical
Science, Academia Sinica.
8:00 MMM31 209.9  •  SVM classification of gender and age in
the working memory network at rest. A. S. DESHPANDE*;
T. B. MEIER; J. C. MOTZKIN; D. G. MCLAREN; J. C.
WILDENBERG; D. TUDORASCU; V. A. NAIR; V. SINGH;
X. ZHU; G. R. KIRK; J. M. OLLINGER; J. B. NITSCHKE;
A. L. ALEXANDER; R. M. BIRN; B. B. BISWAL; M. E.
MEYERAND; V. PRABHAKARAN. Univ. of Wisconsin-
Madison, William S. Middleton Mem. Veteren’s Hosp., Univ.
of Med. and Dent. of New Jersey.
9:00 MMM32 209.10 Decoding what one likes or dislikes
from functional NIRS measurements. H. HOSSEINI*; M.
ROSTAMI; Y. MANO; M. TAKAHASHI; M. SUGIURA; R.
KAWASHIMA. Tohoku Univ.
10:00 MMM33 209.11 Update on the neuroimaging informatics
tools and resources clearinghouse (NITRC). D. N.
KENNEDY*. U. Massachusetts Med.
11:00 MMM34 209.12 Development of an efficient data-
management system in Matlab. J. B. WAGENAAR*; J. A.
HOKANSON; C. A. AYERS; D. J. WEBER. Univ. Pittsburgh.

70  |  Society for Neuroscience • Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
 Sunday PM
SPECIAL LECTURE San Diego Convention Center
210. Connecting Motor Circuits  CME
Sun. 1:00 PM - 2:10 PM — Ballroom 20
Speaker: S. ARBER, Biozentrum, Univ. of Basel.
Motor behavior represents the ultimate output of most
nervous system activity and is mediated by precisely
connected neuronal circuits. This lecture covers recent
progress in understanding the molecular mechanisms
involved in specification and connectivity of motor circuits
in the spinal cord. A hierarchy of sophisticated molecular
programs is at the core of controlling diversification
of neuronal subpopulations and precision of neuronal
connectivity to generate functional circuits.
SOCIAL ISSUES ROUNDTABLE San Diego Convention
Center
211. Child Poverty and Human Capital: New Insights from
Neuroscience
Sun. 1:00 PM - 3:00 PM — Room 10
Chair: Martha Farah
Poverty diminishes the health and well-being of those who
are poor and limits their social and economic contributions to
society. The impact of poverty on the developing individual
is complex, but most of the causal pathways involve the
brain. At this Round Table we will draw on human and
animal research to address the neural mechanisms whereby
childhood poverty impacts human capital, and discuss the
economic and policy implications of this new knowledge.
211.1 M. J. Meaney, Douglas Hosp Res Ctr.
211.2 S. Lipina, National Council of Research
(CONICET).
211.3 H. J. Neville, 1227 Univ Oregon.
211.4 M. J. Farah, Univ Pennsylvania, Philadelphia.
211.5 J. J. Heckman, Univ of Chicago.
SYMPOSIUM San Diego Convention Center
212. Ringing Ears: The Neuroscience of Tinnitus  CME
Sun. 1:30 PM - 4:00 PM — Room 6F
Chair: L. E. ROBERTS
Co-Chair: J. KALTENBACH
Tinnitus is a phantom sensation (ringing of the ears) that
impairs quality of life for millions around the world and for
soldiers returning from Iraq and Afghanistan. Most cases
are associated with hearing impairment caused by noise
exposure or the aging process. This symposium reports
ground breaking research into how tinnitus is generated
and modulated by the brain when hearing loss occurs.
The findings have implications for public policy and for
mechanisms of normal auditory perception.
1:30 212.1 Introduction.
1:35 212.2 Neural synchrony and neural plasticity in tinnitus
and in normal hearing. J. J. EGGERMONT. Univ. of Calgary.
2:10 212.3 Age-related changes in inhibitory circuits in the
auditory system: implications for normal hearing and tinnitus.
D. M. CASPARY. Southern Illinois Univ. Sch. Med.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
2:45 212.4 Cross modal integration and compensation in
auditory projection pathways. S. E. SHORE. Univ. Michigan.
3:20 212.5 Tinnitus: A problem of ear and brain. J. R.
MELCHER. Harvard Med. Sch.
3:55 212.6 Closing Remarks.
SYMPOSIUM San Diego Convention Center
Sun. PM
213. Removing Brakes on Adult Brain Plasticity: Molecular,
Cellular, and Behavioral Interventions  CME
Sun. 1:30 PM - 4:00 PM — Room 6B
Chair: D. BAVELIER
Brain plasticity and learning in the adult brain is well
established. Yet adult brain plasticity remains more restricted
in its scope than developmental plasticity, a major limitation
in rehabilitation of function. This symposium will address
the conditions under which brain plasticity and learning can
be facilitated in the adult brain, taking the visual system
as a model of choice. Brakes to plasticity in adulthood
will be reviewed. The ways genetic, pharmacological and
behavioral interventions may overcome these brakes will be
discussed.
1:30 213.1 Introduction.
1:35 213.2 Molecular brakes on plasticity. T. K. HENSCH.
Harvard Univ.
2:10 213.3 Neuromodulation of visual cortical processing and
plasticity. Y. DAN. UC Berkeley.
2:45 213.4 Action videogames as an exemplary learning tool.
D. BAVELIER. Univ. Rochester.
3:20 213.5 Critical period revisited: The case of amblyopia. D.
LEVI. UC Berkeley.
3:55 213.6 Closing Remarks.
SYMPOSIUM San Diego Convention Center
214. AD-360°: Nonamyloid Mechanisms in Alzheimer’s
Disease Pathogenesis  CME
Sun. 1:30 PM - 4:00 PM — Room 6A
Chair: S. W. PIMPLIKAR
It is becoming clear that amyloid-ß peptides do not account
for all the observations related to AD pathogenesis. Diverse
findings support the view that non-amyloid factors contribute
significantly to AD. Recent studies have uncovered
potential mechanisms that could be operative in disease.
This symposium provides a serious platform - not amyloid-
bashing - to discuss the non-amyloid pathways. A complete,
360° view of AD pathogenesis is needed to achieve effective
therapeutic strategies.
1:30 214.1 Introduction.
1:35 214.2 Novel influences of Presenilin 1 and ß-cleaved
APP on endosomal-lysosomal functions in AD. R. A. NIXON.
Nathan Klein Inst.
2:10 214.3 Involvement of presenlin and APP signaling in the
neurodegeneration of AD. N. K. ROBAKIS. Mount Sinai Sch.
of Medicine, NYU.
Neuroscience 2010  |  Sunday PM  |  71 
2:45 214.4 p25/Cdk5: linking synaptic plasticity to DNA
damage, amyloid pathology and neurodegeneration. L. TSAI.
MIT HHMI.
3:20 214.5 Calcium, neurotransmitter release and
neurodegeneration. J. SHEN. Brigham and Women’s
Hospital, Harvard Med. Sch.
3:55 214.6 Closing Remarks.
MINISYMPOSIUM San Diego Convention Center
215. Exploring Interdisciplinary Pathways: Enriching
Neuroscience Research by Connecting to Educational
Practice and Theory
Sun. 1:30 PM - 4:00 PM — Room 29D
Chair: M. IMMORDINO-YANG
Co-Chair: T. CAREW
Much recent discussion in the SfN has focused on the
benefit to education of collaborations among neuroscientists
and school teachers. This session begins the essential
complementary discussion, addressing how neuroscience
research itself can be strengthened by an educational
perspective. Cognitive neuroscientists doing research with
an integral connection to education will discuss the unique
contribution of the educational component, as well as
intellectual, pragmatic, and ethical issues.
1:30 215.1 Introduction.
1:35 215.2 Why mind, brain and education, and why now? K.
FISCHER. Harvard Univ.
1:55 215.3 Principles of success and failure in reading
instruction via the lens of systems neuroscience. B. D.
MCCANDLISS. Sackler Inst- Weill Med. Col.
2:15 215.4 ERPs and education: a story about rhyming. D.
COCH. Dartmouth Col.
2:35 215.5 Me, myself and you: Combining affective
neuroscience and educational approaches to study social
emotion. M. IMMORDINO-YANG. Univ. of Southern
Califorinia.
2:55 215.6 Reading in the brain: how literacy shapes visual
and auditory cortices. S. DEHAENE. INSERM.
3:15 215.7 Towards an educational cognitive neuroscience of
the calculating brain. D. ANSARI. Univ. of Western Ontario.
3:35 215.8 Closing Remarks.
MINISYMPOSIUM San Diego Convention Center
216. Regulation of the Postsynaptic Cytoskeleton:
Roles in Development, Plasticity, and Disorders  CME
Sun. 1:30 PM - 4:00 PM — Room 30E
Chair: S. SODERLING
The dendritic spine is exquisitely organized at the functional
level. Spatially distinct pools of actin orchestrate dynamic
features of the spine during synapse development and
plasticity. Emerging studies are illuminating how the
actin cytoskeleton regulates synaptic function and how
their disruption may lead to neurological disorders. This
minisymposium will discuss these recent findings and their
implications for our future understandings of mechanisms of
information processing and storage.
1:30 216.1 Introduction.
72  |  Society for Neuroscience
1:35 216.2 Molecular architecture of the neuronal
cytoskeleton. T. SVITKINA. Univ. of Pennsylvania.
1:55 216.3 BDNF regulates synaptogenesis by coordinating
the expression of the RhoA inhibitors Par6C and Rnd3. G. A.
WAYMAN. Washingtion State Univ.
2:15 216.4 VASP induces actin assembly in dendritic spines
to promote their development and potentiates synaptic
strength. D. WEBB. Vanderbilt Univ.
2:35 216.5 Rho regulators in synapse development and
disease. L. VAN AELST. Cold Spring Harbor Lab.
2:55 216.6 Regulation of spine formation and function by the
candidate mental retardation gene WRP. S. SODERLING.
Duke Univ. Med. Ctr.
3:15 216.7 Signaling mechanisms underline structural
plasticity of dendritic spines. R. YASUDA. Duke Univ. Med.
Ctr.
3:35 216.8 Closing Remarks.
PETER AND PATRICIA GRUBER LECTURE San Diego
Convention Center
217. Brain Circuits for Active Vision
Sun. 2:30 PM - 3:40 PM — Ballroom 20
Speaker: Robert Wurtz, PhD, National Eye Institute/National
Institutes of Health
Support contributed by The Peter & Patricia Gruber
Foundation
Our stunning visual perception results from coupling a high
resolution fovea with eye movements that direct it toward
threats and treats. These movements, however, require
brain mechanisms for shifting attention to the next foveal
target and compensating for the movement produced visual
disruptions. This lecture considers the integrated system in
the primate brain that both moves the eyes and contributes
to the attentional shifts and visual compensations. A
major segment of this system acts via ascending thalamic
pathways and provides insight into cortical modulation by the
thalamus.
PRESIDENTIAL SPECIAL LECTURE
San Diego Convention Center
218. Motivational Neuronal Circuits for Value, Salience,
and Information  CME
Sun. 5:15 PM - 6:25 PM — Ballroom 20
Speaker: O. HIKOSAKA, Natl. Eye Institute, NIH.
Support contributed by Johnson & Johnson
Recently we found that the inhibitory connection from the
lateral habenula (LHb) to midbrain dopamine (DA) neurons
plays an important role in behavioral choice based on
motivational value. Another group of DA neurons were less
influenced by the LHb and instead encoded motivational
salience. DA neurons also encoded preference for
information about future rewards. I will discuss how these
neuronal signals help animals to construct a road map to
optimal behavioral choice.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
NANOSYMPOSIUM
219. Signaling by Neurotrophins and Other Neuromodulators
Theme B: Neural Excitability, Synapses, and Glia:
Cellular Mechanisms
Sun. 1:00 PM — San Diego Convention Center, Room 6E
1:00 219.1 A role for the NAD+ dependent deacetylase Sirt-
1 in CREB mediated gene expression and in neurotrophin
signaling. S. FUSCO*; C. RIPOLI; S. CHIATAMONE
RANIERI; G. TOIETTA; M. MCBURNEY; A. RICCIO; C.
GRASSI; T. GALEOTTI; G. PANI. Univ. Cattolica Del Sacro
Cuore, IDI IRCCS, Ctr. for Cancer Therapeutics, Ottawa
Hosp. Res. Inst., Med. Res. Council Lab. for Mol. and Cell
Biology, Univ. Col. London.
1:15 219.2 Proneurotrophin signaling leads to retraction
of actin-rich structures in hippocampal neurons. K.
DEINHARDT*; B. L. HEMPSTEAD; M. V. CHAO. Skirball
Inst., Weill Cornell Med. Col.
1:30 219.3 Monitoring the retrograde transport of signaling
molecules fused to Halotag protein in NGF-dependent
sympathetic neurons. S. A. MOK*; K. LUND; R. B.
CAMPENOT. Univ. of Alberta.
1:45 219.4 Akt/mTOR signaling pathway regulates neurite
outgrowth in cerebellar granule neurons affected by
methylcobalamin. K. OKADA*; H. TANAKA; Y. KURODA; M.
OKAMOTO; H. MORITOMO; T. MURASE; H. YOSHIKAWA.
Osaka Univ., Osaka Kosei Nenkin Hosp.
2:00 219.5 Supplemental neurotrophins improve functional
recovery after simulated childbirth injury. C. DISSARANAN*;
B. C. GILL; B. M. BALOG; H. JIANG; H. B. GOLDMAN; M.
S. DAMASER. Glickman Urological and Kidney Institute,
Cleveland Clin., Cleveland VAMC.
2:15 219.6 Kidins220/ARMS mediates BDNF signalling
during the development of mouse central and peripheral
nervous system. F. CESCA*; A. YABE; B. SPENCER-DENE;
J. SCHOLZ-STARKE; P. BALDELLI; M. AL-QATARI; R.
H. ADAMS; F. BENFENATI; G. SCHIAVO. Italian Inst. of
Technol., Cancer Res. UK, The Natl. Hosp. for Neurol. and
Neurosurg., Max Planck Inst. for Mol. Biomedicine.
2:30 219.7 Rab11 monomeric GTPase is a down-stream target
of BDNF-TrkB signaling to induce dendritic arborization. O.
M. LAZO; F. C. C. BRONFMAN*; A. COUVE. Pontificia Univ.
Catolica De Chile, Univ. Chile.
NANOSYMPOSIUM
220. Alzheimer’s Disease: Anti-Abeta Therapy,
Pyroglutamate, APP Processing, Inflammation,
Immunization
Theme C: Disorders of the Nervous System
Sun. 1:00 PM — San Diego Convention Center, Room 32B
1:00 220.1 Anti-TNF-alpha reduces amyloid plaques and tau
phosphorylation and induces CD11c-positive dendritic-like
cells in the APP/PS1 transgenic mouse brains. J. XU*; J.
SHI; W. SHEN; J. CHEN; Y. CHEN; L. ZHONG; Y. CHEN; Y.
ZHU; Y. ZHANG. Nanjing Brain Hosp.
1:15 220.2  •  Efficacy of anti-Abeta13-28 antibodies in
ameliorating congnitive deficits in a mouse model of
Alzheimer’s disease. A. V. SAVONENKO*; T. MELNIKOVA;
H. KIM; D. GAINES; D. LEE; A. HIATT. Johns Hopkins Univ.,
MAPP Biopharmaceutical, Inc.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
1:30 220.3 In vivo follow-up of microhemorrhages during
aging and anti-amyloid immunotherapy in the mouse
lemur primate. N. JOSEPH-MATHURIN*; O. DORIEUX;
A. KRASKA; M. SANTIN; P. HANTRAYE; J. VERDIER; E.
SIGURDSSON; N. MESTRE-FRANCÉS; M. DHENAIN.
URA CEA CNRS 2210 - Mircen, UMR CNRS/MNHN 7179,
Mecadev, Inst. de Recherche SERVIER, Sanofi-Aventis,
INSERM U710 - EPHE - Univ. Montpellier 2, New-York Univ.
Sch. of Med.
1:45 220.4 Rivastigmine promotes alpha-secretase pathway
of β-amyloid precursor protein (APP) processing by up-
regulating ADAM complex and its implication in Alzheimer’s
disease (AD). B. RAY*; J. A. BAILEY; N. H. GREIG; D. K.
Sun. PM
LAHIRI. Indiana Univ., Natl. Inst. of Aging.
2:00 220.5  •  Novel effects of memantine on APP and synaptic
proteins in different cell lines are mediated by intracellular
targets. J. A. BAILEY*; B. RAY; P. K. BANERJEE; D. K.
LAHIRI. Indiana Univ., Indiana Univ. Sch. of Med., Forest
Labs.
2:15 220.6 Understanding the risk of homocysteine and
cholesterol in AD: Therapeutic targets. K. SAMBAMURTI*;
E. HOLLINGS; T. UTSUKI; N. H. GREIG; M. A. PAPPOLLA.
MUSC, Natl. Inst. on Aging.
2:30 220.7 Functional analysis of methyl-substituted nicotines
reveals different structural requirements for activation of
α4β2 and α7 nAChRs. H. XING*; K. WILDEBOER; Y. CHO;
F. SOTI; J. LINDSTROM; W. KEM. Univ. Florida, Univ. of
Pennsylvania.
2:45 220.8 Complement component C3 and its receptor
complement receptor type 3 mediate the phagocytosis
and clearance of Abeta by microglia. H. FU*; B. LIU; J.
L. FROST; S. HONG; M. JIN; I. M. COSTANTINO; M. C.
CARROLL; T. N. MAYADAS; D. J. SELKOE; C. A. LEMERE.
Ctr. For Neurologic Diseases, Brigham & Women’s Hosp.,
Harvard Med. Sch., Dartmouth Col., Immune Dis. Institute,
Children’s Hospital, Harvard Med. Sch., Brigham and
Women’s Hospital, Harvard Med. Sch.
3:00 220.9 Microglial CX3CR1 deficiency restores β-amyloid
clearance pathways in neurons and slows progression of
Alzheimer’s disease. S. E. HICKMAN*; E. ALLISON; U.
COLEMAN; N. ELPEK; T. R. MEMPLE; A. D. LUSTER; J. EL
KHOURY. Mass Gen Hosp.
3:15 220.10  •  Inhibiton of glutaminyl cyclase(s) - New drug
targets of Alzheimer’s disease therapy. H. U. DEMUTH*; M.
BUCHHOLZ; R. SOMMER; D. RAMSBECK; S. SCHILLING;
U. HEISER. Probiodrug AG, Anhalt Tech. Univ.
3:30 220.11  •  Pyroglutamate-beta-amyloid induced
neuropathology in two transgenic mouse models. A. S.
ALEXANDRU*; W. JAGLA; S. GRAUBNER; R. SEDLMEIER;
S. KOHLMANN; C. BÄUSCHER; A. P. OSMAND; S.
SCHILLING; S. VON HÖRSTEN; H. DEMUTH. Ingenium NANOSYMPOSIUM
Pharmaceuticals GmbH, Univ. of Tennessee, Probiodrug AG,
Univ. of Erlangen, Ingenium-Pharmaceuticals GmbH.
3:45 220.12  •  Transgenic mouse models with increased
pyroglutamate-Abeta formation show early phenotypic
changes. S. SCHILLING*; S. GRAUBNER; W. JAGLA; C.
BÄUSCHER; S. KOHLMANN; M. MITROVIC; S. KURAT; B.
HUTTER-PAIER; M. WINDISCH; H. DEMUTH. Probiodrug
AG, Ingenium Pharmaceuticals, JSW Life Sci.
4:00 220.13 Regulated secretory vesicles contain beta-amyloid
peptide forms with neuropeptides and catecholamines
that undergo co-secretion. V. Y. HOOK*; T. TONEFF; L.
FUNKELSTEIN; M. ZIEGLER; H. CYNIS; H. DEMUTH. Univ.
Calif, San Diego, Probiodrug AG.
Neuroscience 2010  |  Sunday PM  |  73 
 4:15 220.14  •  Overexpression of glutaminyl cyclase, the
enzyme responsible for pyroglutamate Abeta formation,
induces behavioral deficits and glutaminyl cyclase knock-
out rescues the behavioral phenotype in 5XFAD mice. T.
BAYER*; S. JAWAHR; O. WIRTHS; S. SCHILLING; S.
GRAUBNER; H. DEMUTH. Univerisity Med. Goettingen,
Probiodrug, Ingenium.
NANOSYMPOSIUM
221. Autism: Genetic and Animal Models I
Theme C: Disorders of the Nervous System
Sun. 1:00 PM — San Diego Convention Center, Room 25A
1:00 221.1 Using iPS cells to identify the cellular basis
of autism in patients with Timothy Syndrome. S. P.
PASCA*; M. YAZAWA; T. PORTMANN; A. M. PASCA; O.
SHCHEGLOVITOV; I. VOINEAGU; J. A. BERNSTEIN; D.
H. GESCHWIND; J. HALLMAYER; R. E. DOLMETSCH.
Stanford Univ. Sch. of Med., David Geffen Sch. of Medicine,
UCLA.
1:15 221.2 Modeling the functional genomics of autism using
human neurons. G. KONOPKA*; E. WEXLER; E. ROSEN;
L. CHEN; G. OSBORN; D. LU; F. GAO; G. COPPOLA; D. H.
GESCHWIND. UCLA.
1:30 221.3 In vitro studies of autism-related mutations of the
contactin genes. I. CLOËZ-TAYARANI*; O. MERCATI; M.
KONYUKH; C. LEBLOND; R. DELORME; M. LEBOYER;
T. BOURGERON. Inst. Pasteur CNRS URA 2182, Univ.
Paris Descartes, Univ. Paris Diderot, Hôpital Robert Debré,
INSERM U955, Fondation FondaMental, Hôpital Chenevier-
Mondor CHU Créteil.
1:45 221.4 A SNP associated with autism affects Dlx5/
Dlx6 regulation in the forebrain. L. POITRAS*; M. YU; C.
LESAGE-PELLETIER; R. B. MACDONALD; J. GAGNÉ; G.
HATCH; I. KELLY; S. P. HAMILTON; J. L. RUBENSTEIN; G.
G. POIRIER; M. EKKER. Univ. of Ottawa, Laval Univ., Univ.
of California.
2:00 221.5 Elucidating neural circuitry underlying sociability,
an autism relevant phenotype, in mouse models. A.
S. KREIBICH*; M. TORRE; E. S. BRODKIN. Univ.
Pennsylvania.
2:15 221.6 Using magnetic resonance imaging to probe
structural changes in a mouse model of autism. J.
ELLEGOOD*; J. P. LERCH; R. M. HENKELMAN. Hosp. For
Sick Children.
2:30 221.7 Identification of shared molecular pathways
involved in autism by brain transcriptome profiling. I.
VOINEAGU*; F. GAO; S. HORVATH; D. GESCHWIND.
UCLA.
NANOSYMPOSIUM
2:45 221.8 Searching for recessive autism mutations in
outbred populations using whole exome sequencing.
M. CHAHROUR*; C. R. SCHUBERT; T. W. YU; C. R.
STEVENS; R. HILL; S. B. GABRIEL; C. A. WALSH.
Children’s Hosp. Boston, Harvard Med. Sch., Massachusetts
Gen. Hosp., The Broad Inst. of MIT and Harvard.
74  |  Society for Neuroscience
NANOSYMPOSIUM
222. Epilepsy: Mechanisms
Theme C: Disorders of the Nervous System
Sun. 1:00 PM — San Diego Convention Center, Room 24A
1:00 222.1 Rapamycin suppresses mossy fiber and
somatostatin interneuron axon sprouting but not
epileptogenesis in a mouse model of temporal lobe epilepsy.
P. BUCKMASTER*; X. WEN; F. LEW. Stanford Univ.,
Washington State Univ.
1:15 222.2 High frequency network activity preceding epileptic
seizures in vitro. J. G. JEFFERYS*; P. JIRUSKA; W.
CHANG; A. F. BUJAN; J. CSICSVARI; R. W. DEARDEN.
Univ. Birmingham, Univ. of Oxford.
1:30 222.3 Inhibition of temporal lobe epilepsy development
in rat by NKCC1-block. W. S. MUELLER*; D. E. BRAGIN; S.
PETERSON; J. A. CONNOR. UNM Sch. Med., UNM HSC.
1:45 222.4 Hilar and CA3 contributions to recurrent excitatory
connectivity of dentate granule cells in a model of temporal
lobe epilepsy--A laser scanning glutamate uncaging study.
W. ZHANG*; J. R. HUGUENARD; P. S. BUCKMASTER.
Stanford Univ.
2:00 222.5 Persistent and resurgent sodium currents are
increased in EC layer II neurons in a rat model of temporal
lobe epilepsy. M. K. PATEL*; E. H. BERTRAM; N. J.
HARGUS. Univ. Virginia Hlth. Sys, Univ. of Virginia.
2:15 222.6 Multi-receptor analyses of human epileptic
neocortex. N. PALOMERO-GALLAGHER*; A.
SCHLEICHER; H. J. BIDMON; H. W. PANNEK; E.
J. SPECKMANN; K. ZILLES. Res. Ctr. Juelich, Univ.
Duesseldorf, Epilepsy-Centre Bethel, Univ. Muenster.
2:30 222.7 Cortical interictal activity in vivo: Electrophysiology
and 2-photon imaging. M. BRONDI; S. SULIS SATO; G. DE
VITO; L. DE VIVO; S. LANDI; G. RATTO*. IIT Italian Inst. of
Technol., Scuola Normale Superiore, Inst. of Nanoscience
CNR.
2:45 222.8 Regulation of the innate immune system in human
TLE: Simultaneous measurement of multiple proteins
by multiplex-immunoassay. A. A. KAN*; W. DE JAGER;
M. DE WIT; P. GOSSELAAR; P. C. VAN RIJEN; O. VAN
NIEUWENHUIZEN; P. N. E. DE GRAAN. Rudolf Magnus
Inst. of Neurosci., Univ. Med. Ctr. Utrecht.
NANOSYMPOSIUM
223. Demyelinating Disorders: Cellular Mechanisms
Theme C: Disorders of the Nervous System
Sun. 1:00 PM — San Diego Convention Center, Room 31C
1:00 223.1  •  Myelin thickness in the heterozygous R98C knock-
in mouse model of CMT1B does not respond to neuregulin
I type III overexpression. M. SHY; Y. BAI*; X. WU; L. M.
DILLON; J. KAMHOLZ; A. PATZKO. Wayne State University,
Dept. of Neurol.
1:15 223.2 Bone marrow transplantation worsens the altered
olivocerebellar dynamics in murine model of globoid cell
leukodystrophy. M. SANDS*; A. S. REDDY; D. F. WOZNIAK;
S. C. FOWLER. Washington Univ. Sch. of Med., Univ. of
Kansas.
1:30 223.3 Demyelinating effect of autoantibodies in a multiple
sclerosis disease model is prevented by administration of
phage displaying the immunodominant epitope of myelin. B.
SOLOMON*. Fac. Life Sci. Tel Aviv Univ.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
1:45 223.4 Unfolded protein response (UPR) activation in a
mouse model of early-onset CMT 1B. M. A. SAPORTA; Y.
BAI; B. SHY; A. PATZKO; M. PENNUTO; M. CROWTHER;
M. FELTRI; J. A. BENJAMINS*; D. KIRSCHNER; C.
SOUTHWOOD; A. GOW; L. WRABETZ; M. SHY. Wayne
State Univ. Sch. Med., San Raffaele Scientific Inst., Boston
Col.
2:00 223.5 Connexins in central myelinating glia: Heteromeric
interactions as a potential pathogenic mechanism for Cx32
and Cx47 related diseases. C. K. ABRAMS*; J. ORTHMANN
MURPHY; M. M. FREIDIN; S. S. SCHERER; K. A.
KLEOPAS. SUNY Downstate Med., U of Penn, The Cyprus
Inst. of Neurol. and Genet.
2:15 223.6  •  Novel compounds to promote remyelination in
multiple sclerosis. T. BORDET*; K. MAGALON; C. ZIMMER;
G. TARDIF; J. KHALDI; C. BOURBON; C. CHAIMBAULT;
M. MICHAUD; G. DUHAMEL; S. CONFORT; M. CAIRE; R.
M. PRUSS; A. VIOLA; P. DURBEC. Trophos, IBDML CNRS
UMR6216, CRMBM UMR CNRS 6612.
2:30 223.7 Forebrain, cerebellar and spinal cord directed
AAV2/5 gene therapy augments therapeutic effect of
bone marrow transplantation in murine model of globoid
cell leukodystrophy. A. S. REDDY*; J. H. KIM; S. SONG;
R. KLEIN; M. S. SANDS. Washington Univ. in St.Louis,
Washington Univ. in St. Louis.
2:45 223.8  •  Oral curcumin treatment of the R98C knock-in
mouse model of CMT1B. A. PATZKO*; I. KATONA; M. A.
SAPORTA; Y. BAI; A. JANI-ACSADI; L. M. DILLON; M. E.
SHY. Wayne State Univ.
3:00 223.9  •  Human oligodendrocytes MO3.13 conditioned
in a three-dimensional culture system as a model to study
oligodendrocyte injury induced by the Lyme disease
spirochete Borrelia burgdorferi. G. RAMESH*; K. H.
BENTRUP; B. PAHAR; M. T. PHILIPP. Tulane Natl. Primate
Res. Ctr., Tulane Med. Ctr.
3:15 223.10 Cerebrospinal fluid derived from progressive
multiple sclerosis patients promotes neuroectodermal
differentiation of human neural precursor cells in vitro. M.
CRISTOFANILLI*; S. A. SADIQ. Multiple Sclerosis Res. Ctr.
of New York.
3:30 223.11 Modulating Bone Morphogenic Protein
signalling during cuprizone-induced demyelination alters
oligodendrocyte numbers. T. J. KILPATRICK*; J. SABO; H.
CATE. The Univ. Melbourne.
3:45 223.12 Intrathecal methotrexate reduces demyelination
and astrogliosis in a non-inflammatory demyelination model.
S. A. SADIQ*; A. W. NASSERY; A. M. MUELLER. MS Rese
Ctr., MSRCNY.
NANOSYMPOSIUM
224. Neurotoxicity and Neurodegeneration II
Theme C: Disorders of the Nervous System
Sun. 1:00 PM — San Diego Convention Center, Room 23A
1:00 224.1 Gene expression studies in three different
mouse models support the case for neurologic sequelae
in iron overload disorders and provide new insights
into mechanism. D. JOHNSTONE*; B. ACIKYOL; R. M.
GRAHAM; D. TRINDER; J. K. OLYNYK; R. J. SCOTT; P.
MOSCATO; E. A. MILWARD. The Univ. of Newcastle, Univ.
of Western Australia.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
1:15 224.2 Geldanamycin protects against ischemia/
reperfusion-related cerebrovascular injury. C. M. MAIER*; C.
GOEDERS; N. EISERT; L. XU; P. NARASIMHAN; P. CHAN;
R. GIFFARD. Stanford Univ.
1:30 224.3 Tetrahydrobiopterin is critical to the survival
of thalamus neurons in vitro. L. YU*; J. WHITSETT; J.
VASQUEZ-VIVAR; S. TAN. Northshore Univ. Healthsystem,
Med. Col. of Wisconsin.
1:45 224.4 Effects of nigella sativa oil on haloperidol induced
deficit in rat model. T. MALIK*; D. HALEEM; S. H. HASAN;
S. PERVEZ; T. FATIMA. The Univ. of Karachi, The Aga Khan
Univ. Hosp.
Sun. PM
2:00 224.5 Small GTPase Rit promotes neuronal survival
via a p38 MAPK cascade. W. CAI; J. L. RUDOLPH; J.
BRELSFOARD; K. E. SAATMAN; D. A. ANDRES*. Univ. of
Kentucky Col. of Med.
2:15 224.6 Characterisation of a new ATF4 isoform that
is expressed in neuronal cells selected for resistance
against oxidative stress and mediates xCT expression. J.
LEWERENZ*; H. SATO; P. MAHER. Univ. Hosp Hamburg-
Ep, Salk Inst. for Biol. Studies, Yamagata Univ., Salk Insitute
for Biol. Studies.
2:30 224.7 The HIV glycoprotein gp120 dysregulates fast
axonal transport through an axon-autonomous mechanism.
S. H. BERTH*; G. MORFINI; T. SARMA; S. T. BRADY. Univ.
of Illinois-Chicago.
2:45 224.8  •  Early increases in oxidative stress in nerve
vulnerable to secondary degeneration: Near infra-red light
treatment. L. FITZGERALD*; C. A. BARTLETT; J. WELLS;
J. RODGER; A. R. HARVEY; S. A. DUNLOP. The Univ. of
Western Australia.
NANOSYMPOSIUM
225. New Molecular Targets in Psychotic Diagnoses
Theme C: Disorders of the Nervous System
Sun. 1:00 PM — San Diego Convention Center, Room 4
1:00 225.1 DISC1 aggregates recruit DTNBP1: Interaction
of two top schizophrenia susceptibility proteins. P. OTTIS;
R. LELIVELD; V. BADER; S. TROSSBACH; C. KORTH*.
Heinrich Heine Univ. Dusseldorf.
1:15 225.2  •  Decreased mu opioid receptor availability
in subjects with schizophrenia who died by suicide. E.
SCARR*; T. T. MONEY; B. DEAN. Mental Hlth. Res. Inst.,
Univ. of Melbourne.
1:30 225.3 VU0152100, a selective positive allosteric
modulator of M4 muscarinic acetylcholine receptors,
produces antipsychotic-like activity and enhancement
of cognition in rats. C. K. JONES*; N. BYUN; J. D.
NANOSYMPOSIUM
ROSANELLI; M. BUBSER; T. M. BRIDGES; C. W.
LINDSLEY; P. J. CONN. Vanderbilt Univ. Med. Ctr.,
Vanderbilt Program in Drug Discovery, U.S. Dept. of
Veterans Affairs.
1:45 225.4 Generation and characterization of induced
pluripotent stem (iPS) cells derived from adult human
olfactory neuroepithelial culture cells. R. D. MCCURDY*;
G. MING; G. XU; J. C. JOHNSTON; N. MIRZA; K.
BORGMANN-WINTER; C. HAHN. Univ. of Pennsylvania,
Johns Hopkins Univ. Sch. of Med., Hosp. of the Univ. of
Pennsylvania, Univ. of Pennsylvania Med. Ctr.
Neuroscience 2010  |  Sunday PM  |  75 
 2:00 225.5 DISC1 acts downstream of APP and DAB1 in
cortical development. T. L. YOUNG-PEARSE*; S. SUTH; E.
LUTH; A. SAWA; D. J. SELKOE. BWH/Harvard Med. Sch.,
Johns Hopkins Univ.
2:15 225.6 Glutathione un-GLU-ed: A role for glutathione in
neuronal glutamate metabolism. M. KOGA*; M. MESSMER;
A. SAWA; S. H. SNYDERR; T. W. SEDLAK. Johns Hopkins
Sch. of Med.
2:30 225.7 Specific regulation of NRG1 isoform expression by
neuronal activity. X. LIU*; W. XIONG; L. MEI. Med. Col. of
Georgia.
2:45 225.8 Microarray analysis of subtypes of pyramidal
and nonpyramidal neurons from auditory cerebral cortex in
schizophrenia. J. F. SMILEY; H. M. CHAO; A. J. DWORK; M.
J. ALLDRED; I. ELAROVA*; D. C. JAVITT; S. D. GINSBERG.
Nathan Kline Inst., City Col., NYU Med. Sch., New York
Psychiatric Inst., Columbia Univ.
NANOSYMPOSIUM
226. Extrastriate Cortex: Functional Organization I
Theme D: Sensory and Motor Systems
Sun. 1:00 PM — San Diego Convention Center, Room 33C
1:00 226.1 Retinotopically organized resting-state functional
connectivity of human visual cortex in amblyopia. L. B.
LEWIS*; F. CARBONELL; A. SHMUEL; J. D. MENDOLA.
McGill Univ., Montreal Neurolog. Inst.
1:15 226.2 Contour binding increases coherence between
local field potentials at distant sites in cortex. A. MARTIN*; R.
VON DER HEYDT. The Johns Hopkins Univ.
1:30 226.3 Correlated firing between primate prefrontal
neurons before and after learning to perform a cognitive
task. C. CONSTANTINIDIS*; X. QI; T. MEYER. Wake Forest
Univ. Sch. of Med., Carnegie Mellon Univ.
1:45 226.4 Temporal frequency tuning in non-retinotopic
cortex. J. O. GARCIA*; E. A. HECKER; D. A. BRIDWELL; R.
SRINIVASAN. UC Irvine.
2:00 226.5 Visual information represented at different levels of
functional hierarchy in inferior temporal cortex of monkeys
revealed by machine learning. M. TANIFUJI*; G. UCHIDA; T.
SATO; J. KITAZONO; M. OKADA. Riken BSI, Univ. of Tokyo.
2:15 226.6 A place area in the macaque occipitotemporal
sulcus localized by functional magnetic resonance imaging.
S. KORNBLITH*; D. Y. TSAO. MIT, Caltech.
2:30 226.7 Predicting face-selective fusiform voxels from
diffusion-based connectivity alone. Z. M. SAYGIN*; D. E.
OSHER; R. R. SAXE; J. D. E. GABRIELI. MIT.
2:45 226.8 Early vs. late components of category selectivity
NANOSYMPOSIUM
in the parahippocampal place area: A rapid acquisition fMRI
study. S. BOUVIER*; R. EPSTEIN. Univ. of Pennsylvania.
3:00 226.9 Abstracting visual information: Reading dynamic
word forms. A. M. RAUSCHECKER*; R. F. BOWEN; L. M.
PERRY; A. M. KEVAN; R. F. DOUGHERTY; B. A. WANDELL.
Stanford Univ.
3:15 226.10 Retinotopically organized resting-state functional
connectivity within and between areas of the human visual
cortex. K. CHA*; L. B. LEWIS; F. CARBONELL; J. D.
MENDOLA; A. SHMUEL. McGill Univ.
76  |  Society for Neuroscience
NANOSYMPOSIUM
227. Brain Machine Interface
Theme D: Sensory and Motor Systems
Sun. 1:00 PM — San Diego Convention Center, Room 5B
1:00 227.1  •  A brain-computer interface system for the real-time
analysis of position. C. GUGER*; T. GENER; G. EDLINGER;
S. BERMUDEZ I BADIA; P. VERSCHURE; M. SÁNCHEZ
VIVES. G.Tec Guger Technologies OEG, IDIBAPS, SPECS,
UPF.
1:15 227.2 Comparing the information content of EEG, MEG
and ECoG signals in a finger movement task. F. QUANDT*;
C. REICHERT; H. HINRICHS; S. DÜRSCHMID; E. F.
CHANG; R. T. KNIGHT; J. W. RIEGER. Otto-von-Guericke-
University, Univ. of California.
1:30 227.3 A hybrid brain-computer interface based on motor
imagery and steady-state visual evoked potentials. C.
BRUNNER*; B. Z. ALLISON; C. ALTSTÄTTER; C. NEUPER.
Graz Univ. of Technol.
1:45 227.4  •  Toward a multidimensional “hybrid” BCI based on
simultaneous SSVEP and ERD activity. B. Z. ALLISON*; C.
BRUNNER; S. GRISSMANN; C. NEUPER. Tech. Univ. of
Graz, Karl Franzens Univ.
2:00 227.5 Connectivity-based parcellation of human
thalamus and its relation to electrode position in deep brain
stimulation for essential tremor. M. BECKMANN*; L. LÄER;
A. GHARABAGHI. Universitätsklinik für Neurochirurgie,
Tübingen.
2:15 227.6  •  In vivo chronic cortical recordings using novel
ultra-small carbon fiber based implantable microthread
ultramicroelectrodes. T. D. KOZAI*; N. B. LANGHALS; P. R.
PATEL; X. DENG; H. ZHANG; J. LAHANN; N. KOTOV; D. R.
KIPKE. Univ. of Michigan.
2:30 227.7 Assessment of long-term neural recordings from
rodents using MEMS based moveable microelectrodes. A.
SRIDHARAN*; N. JACKSON; S. ANAND; J. SUTANTO; M.
OKANDAN; J. MUTHUSWAMY. Arizona State Univ., Sandia
Natl. Labs.
2:45 227.8 A novel technology for silicon-based neural
prosthetics for the central nervous system. M. HAN*; K.
YADAV; P. S. MANOONKITIWONGSA; V. PIKOV; D. B.
MCCREERY. Huntington Med. Res. Inst.
3:00 227.9 Characterizing tissue around intracortical
microelectrode interfaces using imaging strategies which
minimize morphological disruption. A. J. WOOLLEY*; H.
DESAI; M. A. STECKBECK; N. PATEL; K. J. OTTO. Purdue
Univ.
3:15 227.10 Inhibition of MAPKAP Kinase 2-mediated cytokine
release to reduce microglial encapsulation of chronic
microelectrodes. N. ONUNKWO; A. PANITCH; K. J. OTTO*.
Purdue Univ.
NANOSYMPOSIUM
228. The Bed Nucleus of the Stria Terminalis: Linking Stress,
Addiction, and Affect
Theme E: Homeostatic and Neuroendocrine Systems
Sun. 1:00 PM — San Diego Convention Center, Room 1B
1:00 228.1 Characterization of the physiological and genetic
phenotype of crf-expressing neurons in the bed nucleus of
the stria terminalis. D. G. RAINNIE*; J. GUO; R. HAZRA; J.
DABROWSKA; K. J. RESSLER. Emory Univ.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
1:15 228.2 The role of pituitary adenylate cyclase-activating
polypeptide (PACAP) in the bed nucleus of the stria
terminalis (BNST) in mediating the behavioral changes
associated with chronic stress. C. W. ROMAN; K. R.
LEZAK; M. KOCHO-SCHELLENBERG; B. A. GRIMMIG;
L. K. MICELI; W. A. FALLS; K. M. BRAAS; V. MAY; S. E.
HAMMACK*. Univ. of Vermont.
1:30 228.3 Mechanisms of orexin A induced anxiety in the bed
nucleus stria terminalis. W. A. TRUITT*; P. L. JOHNSON; A.
MOLOSH; E. LUNGWITZ; R. C. DEAL; A. D. DIETRICH; P.
E. MINICK; A. SHEKHAR. Indiana Univ. Sch. Med.
1:45 228.4 Stress modulates kappa opioid receptor-mediated
inhibition of gabaergic transmission in the bnst. T. KASH*; A.
M. JIJON; C. LI. UNC- Chapel Hill, UNC-Chapel Hill.
2:00 228.5 The bed nucleus of the stria terminalis exerts a
CRF1 receptor-mediated excitatory influence on midbrain
dopaminergic neurons. M. FORRAY*; A. P. MIRANDA; K.
GYSLING. Pont. Univ. Catolica de Chile.
2:15 228.6 D1/Src tyrosine kinases-dependent long-term
potentiation at GABA synapses contributes to cocaine
reinforcement. M. KRAWCZYK; X. MASON; R. SHARMA; C.
CHIANG; E. C. DUMONT*. Queen’s Univ.
2:30 228.7 Opposing regulation of norepinephrine and
dopamine in the bed nucleus of the stria terminalis of freely
moving rats by rewarding and aversive stimuli. J. PARK*; K.
FONTILLAS; R. KEITHLEY; R. M. WIGHTMAN. Univ. North
Carolina.
2:45 228.8 Orexin receptor antagonists attenuate yohimbine-
induced impairment of extinction of cocaine conditioned
place preference and excitatory transmission in the bed
nucleus of the stria terminalis (BNST). K. L. CONRAD*; A.
DAVIS; H. J. G. MATTHIES; S. SALEH; C. W. LINDSLEY; D.
G. WINDER. Vanderbilt Univ. Med. Ctr.
3:00 228.9 Nicotine self-administration but not passive nicotine
infusion triggers LTP in vivo. F. E. GEORGES*; M. CADOR;
O. MANZONI; S. CAILLÉ. INSERM, Univ. Bordeaux 2;
CNRS UMR 5227.
3:15 228.10 Pharmacological regulation of the bnsts role in
sustained startle increases. D. L. WALKER*; K. SINK; L.
MILES; M. DAVIS. Emory Univ. Sch. of Med.
3:30 228.11 Collateralized inputs to the central nucleus of the
amygdala (CEA) and bed nucleus of stria terminalis (BNST)
in rats. M. S. BIENKOWSKI*; L. M. RINAMAN. Univ. of
Pittsburgh.
NANOSYMPOSIUM
229. Prefrontal-Subcortical Interactions in Health and
Disease
Theme F: Cognition and Behavior
Sun. 1:00 PM — San Diego Convention Center, Room 2
1:00 229.1 Emotional valence and arousal uniquely affect
the neural connectivity predicting selective memory. J. D.
WARING*; E. A. KENSINGER. Boston Coll, Athinoula A.
Martinos Ctr. for Biomed. Imaging.
1:15 229.2 Aberrant threat-sensitive amygdala-frontal
interactions in returning combat veterans with ptsd before
and after treatment. C. A. RABINAK; K. D. PHAN*. VA Ann
Arbor Healthcare Syst., Univ. Michigan.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
1:30 229.3 Anxiety dissociates dorsal and ventral medial
prefrontal cortex functional connectivity with the amygdala at
rest. M. J. KIM*; D. G. GEE; R. A. LOUCKS; F. DAVIS; P. J.
WHALEN. Dartmouth Col., UCLA.
1:45 229.4 Neural responses to ambiguously valenced stimuli:
Effects of explicit vs. implicit task demands. M. NETA*; W. M.
KELLEY; M. J. KIM; D. G. GEE; P. J. WHALEN. Dartmouth
Coll, UCLA.
2:00 229.5 Subcortical and cortical predictors of hypervigilant
threat monitoring with greater trait anxiety. L. H.
SOMERVILLE*; P. J. WHALEN; W. M. KELLEY. Weill Cornell
Med. Col., Dartmouth Col.
Sun. PM
2:15 229.6 Negative appraisal of ambiguous social cues:
Subcortical responses to temporal unpredictability and the
influence of genetic background. C. DAVIS*; M. NETA; J.
KIM; A. R. HARIRI; P. J. WHALEN. Dartmouth Coll, Duke
Univ.
2:30 229.7 Fear bradycardia and activation of the human
periaqueductal grey. E. J. HERMANS*; M. J. A. G.
HENCKENS; K. ROELOFS; G. FERNÁNDEZ. Radboud
Univ. Nijmegen, Donders Inst., Radboud Univ. Nijmegen
Med. Centre, Dept. of Neurol., Univ. Med. Ctr. Utrecht,
Rudolf Magnus Inst. of Neurosci., Leiden Univ. Inst. for
Psychological Research, Clin. Psychology Unit, Leiden Inst.
for Brain and Cognition (LIBC).
2:45 229.8  •  Increased ability to sustain activity in fronto-
striatal circuits is related to improved positive affect
following treatment in major depression. A. HELLER*; T.
JOHNSTONE; M. J. PETERSON; G. G. KOLDEN; N. H.
KALIN; R. J. DAVIDSON. Waisman Lab. For Brain Imaging
and Behavior, Univ. of Wisconsin - Madison, Univ. of
Reading, Waisman Ctr. for Brain Imaging and Behavior.
3:00 229.9 Prefrontal-striatal activity during emotion regulation
in a high risk group for depression: A longitudinal study. C.
MOUTSIANA*; S. L. HALLIGAN; T. JOHNSTONE. Univ. of
Reading.
3:15 229.10 Medial prefrontal-ventral striatum connectivity in
major depressive disorder during emotional word processing.
M. VAN TOL; N. J. A. VAN DER WEE; D. J. VELTMAN;
A. ALEMAN; F. G. ZITMAN; M. A. VAN BUCHEM; T.
JOHNSTONE*. Leiden Univ. Med. Ctr., Leiden Inst. for
Brain and Cognition, VU university Med. Ctr., Univ. Med. Ctr.
Groningen, Univ. of Reading.
3:30 229.11 Neural substrates of emotion processing in the
psychosis prodrome. D. G. GEE; K. H. KARLSGODT; A. M.
JIMENEZ; T. A. LESH; L. KUSHAN; A. XU; J. TORRE; T. G.
M. VAN ERP; M. D. LIEBERMAN; C. E. BEARDEN; T. D.
CANNON*. UCLA.
3:45 229.12 Sensory and reward integration during decision
making: A role for the striatum. A. Y. WANG*; N. UCHIDA.
Alice Wang, Harvard Univ.
NANOSYMPOSIUM
NANOSYMPOSIUM
230. Neuroinformatics and Connectomics
Theme G: Novel Methods and Technology Development
Sun. 1:00 PM — San Diego Convention Center, Room 7B
1:00 230.1 Cognitive paradigm ontology: Experimental
conditions and contrasts. J. A. TURNER*; A. R. LAIRD.
MIND Res. Network, Univ. of Texas Hlth. Sci. Ctr.
Neuroscience 2010  |  Sunday PM  |  77 
 1:15 230.2 The whole brain catalog and multiscale
connectome browsing. S. D. LARSON*; C. APREA; J.
MARTINEZ; D. A. PETERSON; R. CARLOZ; D. LEE;
D. LITTLE; V. ASTAKHOV; H. S. KIM; A. MEMON; I.
ZASLAVSKY; H. POIZNER; M. E. MARTONE; M. E.
ELLISMAN. UC San Diego, CRBS 0446, San Diego
Supercomputing Ctr.
1:30 230.3 Using ontologies to represent and reason over
brain electrophysiology (ERP) data. G. A. FRISHKOFF*; R.
M. FRANK; P. LEPENDU; S. S. NIKOLIC; H. LIU; D. DOU.
Georgia State Univ., Univ. of Oregon, Stanford Univ.
1:45 230.4 A knowledge based approach to matching human
neurodegenerative disease and associated animal models.
S. M. MAYNARD*; C. J. MUNGALL; S. E. LEWIS; M. E.
MARTONE. UCSD, Lawrence Berkeley Natl. Lab.
2:00 230.5 An antibody registry for biological sciences. A.
E. BANDROWSKI*; V. ASTAKHOV; M. MARTONE; A. Y.
YELISETTY. UCSD.
2:15 230.6 Nifstd 1.8: A comprehensive ontology for
neuroscience. F. IMAM; S. LARSON; S. POLAVARAM; G. A.
ASCOLI; G. M. SHEPHERD; J. S. GRETHE; A. GUPTA*; M.
E. MARTONE. UCSD, George Mason Univ., Yale Univ.
2:30 230.7 Functional assessment of intrinsic connectivity
networks. A. R. LAIRD*; P. M. FOX; S. B. EICKHOFF; J.
A. TURNER; K. L. RAY; D. R. MCKAY; D. C. GLAHN; C. F.
BECKMANN; S. M. SMITH; P. T. FOX. Univ. of Texas Hlth.
Sci. Ctr., Univ. of Texas Hlth. Sci. Ctr. San Antonio, RWTH
Aachen Univ., The Mind Res. Network, Olin Neuropsychiatry
Res. Ctr., Univ. of Oxford.
2:45 230.8 Brain connectivity at your fingertips: CoCoMac
interfaced with the scalable brain atlas. R. BAKKER; G.
BEZGIN; R. KOTTER*. Radboud Univ. Med. Ctr.
3:00 230.9 Creation of a mouse brain transcriptome database
from meta analysis of microarray data deposited at gene
expression omnibus. B. B. SAMAL*; N. R. SAMAL. NIMH,
NIH, Samal.
POSTER
231. Patterning of Spinal Cord, Cerebellum, and Hindbrain
Theme A: Development
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 A1 231.1 Role of sonic hedgehog signaling in
human cerebellum development. P. V. HALDIPUR*; P.
GRESSENS; S. MANI. Natl. Brain Res. Ctr., InsermU676,
Univ. Paris 7, PremUP, Indian Inst. of Sci.
2:00 A2 231.2 Transcriptional regulation of Shh target
genes in the neuronal development. S. KURDIJA*; T.
OOSTERVEEN; Z. ALEKSEENKO; J. MUHR; J. ERICSON.
NANOSYMPOSIUM
Karolinska Institutet, Ludwig Inst. for Cancer Res.
3:00 A3 231.3 Shh-driven motor neuron differentiation
depends on calcium spike activity. Y. H. BELGACEM*; L. N.
BORODINSKY. Univ. California, Davis, Univ. of California
Davis.
4:00 A4 231.4 Interplay between calcium spike activity
and BMP defines differentiation of dorsal spinal phenotypes.
I. SWAPNA; L. N. BORODINSKY*. Univ. of California Davis,
Univ. California Davis.
1:00 A5 231.5 Striking correlation between the
cerebellar compartments determined by the birthdate of
Purkinje cells and zebrin II bands. M. HASHIMOTO*. RIKEN
BSI.
78  |  Society for Neuroscience
2:00 A6 231.6  •  Hox paralogue group 2 genes control
distinct steps of pontine neuron tangential migration in the
mouse brainstem. T. DI MEGLIO*; C. KRATOCHWIL; N.
VILAIN; S. DUCRET; F. RIJLI. Friedrich Miescher Inst.
3:00 A7 231.7 Neuropilin-2 expression is extensive
in developing solitary tract and brainstem gustatory relay
nucleus. M. KIM; C. M. MISTRETTA; R. M. BRADLEY*. Univ.
Michigan Sch. Dent.
4:00 A8 231.8 Teashirt3 regulates development of
neurons involved in both respiratory rhythm and airflow
control. X. CAUBIT*; P. FILIPPI; M. THOBY-BRISSON;
N. VOITURON; H. FARALLI; G. FORTIN; G. HILAIRE;
L. FASANO. IBDML Umr6216 CNRS, UPR2216, CNRS,
CRN2M, UMR6231 CNRS.
1:00 A9 231.9 The involvement of tissue interactions
and c-Hairy activity in the maintenance of the fourth ventricle
roof plate organiser of chick embryos. E. BROOM*; R. J. T.
WINGATE. King’s College, London.
2:00 A10 231.10 Matrix metalloproteinase-2 and -3 control
the development of the postnatal mouse cerebellar cortex.
I. VAN HOVE*; M. VERSLEGERS; T. BUYENS; S. VAN DE
VELDE; L. MOONS. K.U.Leuven.
3:00 B1 231.11 Characterization of the role of GPR177
in cerebellar development. J. T. YEUNG; T. HA; Y. TONG; K.
CHOI; D. GOLDOWITZ; D. J. SWANSON*. Univ. of British
Columbia, St. Jude Children’s Res. Hosp.
4:00 B2 231.12 A signal relay mechanism underlies
the sequential generation of motor neurons and
serotonergic neurons from a common pool of progenitors
in the developing CNS. J. DIAS*; J. APPLEQUIST; Z.
ALEKSEENKO; J. ERICSON. Karolinska Institutet.
1:00 B3 231.13 Conditional gene-targeting of Lrp6 in mid-
hindbrain development and disorders. C. ZHOU*; J. CHAN;
S. HAMAD; Y. WANG; T. ZHAO. Univ. California-Davis,
Shriners Hosp. for Children.
2:00 B4 231.14 Connectivity in locomotor circuits: A
monosynaptic, cell-type specific transsynaptic tracing
approach for use in vivo. F. J. STAM*; C. M. PADILLA; N.
WALL; E. M. CALLAWAY; M. GOULDING. Salk Inst. For
Biol. Studies.
3:00 B5 231.15 Chronic 5HT depletion approaches: are
pharmacological and dietetic manipulations equivalent? A.
CHAVEZ ARRIETA; G. M. FLORES CRUZ; A. ESCOBAR*.
Inst. de Investigaciones Bioméd UNAM.
4:00 B6 231.16  •  c-Jun expression pattern during
postnatal development of the mouse cerebellar cortex. L.
ALBANITO*; A. MUSTI. Inst. of Clin. Neurobiology, Univ. of
Wuerzburg.
1:00 B7 231.17  •  A homeodomain feedback circuit
underlies a stairway-like interpretation of the shh morphogen
gradient during ventral neural patterning. C. W. UHDE*; M.
LEK; J. M. DIAS; U. MARKLUND; S. KURDIJA; Q. LEI; L.
SUSSEL; J. L. RUBENSTEIN; M. MATISE; H. ARNOLD; T.
M. JESSELL; J. ERICSON. Cell and Mol. Biology, Karolinska
Inst., Sanofi-Aventis US, Columbia Univ., Univ. of California
San Francisco, Univ. of Med. and Dent. of New Jersey, Tech.
Univ. of Braunschweig.
2:00 B8 231.18 A differential role for Sonic Hedgehog and
FOXA2 in organizing the signaling centers and cell fates of
the midbrain. C. Y. BROWN; R. D. BAYLY; S. AGARWALA*.
Univ. of Texas at Austin, Stanford Univ., Univ. Texas at
Austin.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
3:00 B9 231.19 Wnt-planar cell polarity signaling controls
the rostral-caudal organization of monoaminergic axons.
A. FENSTERMAKER*; A. A. PRASAD; A. BECHARA; Y.
ADOLFS; F. TISSIR; A. GOFFINET; R. J. PASTERKAMP; Y.
ZOU. UCSD, Univ. Med. Ctr. Utrecht, Rudolf Magnus Inst. of
Neurosci., Univ. Catholique de Louvain.
4:00 B10 231.20 Hoxa2 represses rostral hindbrain
oligodendrogenesis. B. ZALC*; S. DUCRET; A. MIGUEZ;
M. VIDAL; A. YILDIRIMTURK; F. M. RIJLI; J. THOMAS.
Upmc;Inserm Umr_s975;Cnrs Umr7225, Friedrich Miescher
Inst. for Biomed. Res.
POSTER
232. Neuronal Differentiation I
Theme A: Development
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 B11 232.1 NuRD is a novel chromatin remodeling
complex that interacts with HDAC2 during cortical
development. J. NITARSKA*; A. NOTT; J. VEENVLIET; J.
WOHLSCHLEGEL; A. RICCIO. Univ. Col. London, UCLA.
2:00 B12 232.2 Altered prenatal melatonin signaling
changes brain lateralization and hippocampal gene
expression in the adult male rat. J. A. RIPPLE; K. C. PAGE*.
Bucknell Univ.
3:00 B13 232.3 PTEN coordinates retinal neurogenesis
by regulating Notch signaling. K. KANG; H. JO; J. LEE; G.
LEMKE; C. O. JOE; J. KIM*. Korea Advanced Inst. Sci. &
Technol., KAIST Inst. of BioCentury, Salk Inst.
4:00 B14 232.4 KLF11 directly regulates expression of
dopamine receptor D2 via the epigenetic regulator HP1:
Potential role in the neurobiology of addiction. S. SEO*;
G. A. LOMBERK; A. J. MATHISON; N. S. BUTTAR; W. S.
BRIMIJOIN; A. J. WINDEBANK; R. A. URRUTIA. Mayo Clin.
Grad Sch.
1:00 B15 232.5 Genome-wide analysis of Ascl1 (Mash1)
targets in the developing spinal cord. M. D. BORROMEO*;
R. HENKE; C. SHEN; J. E. JOHNSON. UT Southwestern
Med. Ctr.
2:00 B16 232.6 Vitamin B complex promotes early
maturation of neuronal spheroids and embryonic bodies.
K. DANIELYAN*; G. KEVORKIAN. H.Buniatian Inst. of
Biochemistry, NAS RA.
3:00 B17 232.7 Neuroplastin-65 and a mimetic peptide
derived from its homophilic binding site modulate neuronal
differentiation and synaptic plasticity. S. OWCZAREK*; V.
SOROKA; D. KIRYUSHKO; M. H. LARSEN; Q. YUAN; C.
SANDI; V. BEREZIN; E. BOCK. Bispebjerg Univ. Hosp.,
Univ. of Copenhagen, Ecole Polytechnique Federale de
Lausanne.
4:00 B18 232.8 The neurogenic role of glycine during
spinal cord development. S. CÔTÉ*; P. DRAPEAU. Univ. De
Montréal.
1:00 B19 232.9 Calcium transients in spinal progenitors
during neuronal differentiation in vivo. E. BRUSTEIN*;
J. GHISLAIN; P. DRAPEAU. Univ. of Montreal, Univ. of
Montreal, CHU St-Justine.
2:00 B20 232.10 UnRAvelling pathways: Role of Retinoic
Acid and its receptors in mesodiencephalic dopaminergic
neuron development. J. V. VEENVLIET; W. H. ALMIRZA; F.
M. J. JACOBS; M. SMIDT*. UMC-U.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
3:00 B21 232.11 Analysis of Dmrta1 as a downstream
gene of Pax6 in early development of the telencephalon. T.
KIKKAWA*; U. FUKUZAKI; K. NUMAYAMA-TSURUTA; M.
TAKAHASHI; N. OSUMI. Tohoku Univ. Grad. Sch. of Med.
4:00 B22 232.12 Aging in a dish: Endogenous Aβ
production in long-term cultures of hippocampal neurons.
S. J. BERTRAND*; M. AKSENOVA; M. AKSENOV; C.
MACTUTUS; R. BOOZE. Univ. of South Carolina.
1:00 B23 232.13 Panky, a novel photoreceptor-specific
ankyrin repeat protein, is a transcriptional cofactor that
suppresses CRX-regulated photoreceptor genes. R.
SANUKI*; T. FURUKAWA. Osaka Biosci. Inst., JST, CREST.
Sun. PM
2:00 B24 232.14 NIBP regulates neuronal differentiation
through NFκB signaling. W. HU*; J. LIU; F. LI; W. YEN; J.
GORDON; K. KHALILI. Temple Univ.
3:00 B25 232.15 Downstream target genes of the
transcription factors Lmx1a and Lmx1b in mesodiencephalic
dopamine neuron development. E. J. HOEKSTRA; F. M. J.
JACOBS; L. VON OERTHEL; A. J. A. VAN DER LINDEN;
R. D. SCHELLEVIS; J. H. BURBACH*; M. P. SMIDT. Rudolf
Magnus Inst. Neurosci.
4:00 B26 232.16 Valproic acid-sensitive Gadd45alpha
controls postmigratory differentiation of cortical neurons. M.
R. SARKISIAN*; D. MUELLER. Univ. Florida.
1:00 B27 232.17 Artemin induces neuronal differentiation
through RET and the neural cell adhesion molecule. J.
NIELSEN*; M. S. ILIEVA; I. KORSHUNOVA; K. GOTFRYD;
E. BOCK; V. BEREZIN. Univ. of Copenhagen.
2:00 B28 232.18 Engrailed is required for maintenance
and survival of anterior hindbrain-derived 5HT neurons. S. R.
FOX; E. S. DENERIS*. Case Western Reserve Univ.
3:00 C1 232.19  •  The cerebral dopamine neurotrophic
factor (CDNF) selectively promotes acquisition of an enteric
dopaminergic neuronal phenotype. A. CHALAZONITIS*;
P. LINDHOLM; M. D. GERSHON. Columbia Univ., Univ. of
Helsinki.
4:00 C2 232.20 Dmrt5, a novel transcription factor
involved in neurogenesis. E. FARLEY*; N. GENNET; E.
GALE; X. NAN; M. LI. Imperial Col.
1:00 C3 232.21 Ethanol suppresses Wnt signaling protein
expression in differentiating fetal human brain-derived neural
stem cells. S. D. VANGIPURAM*; W. D. LYMAN. Wayne
State Univ.
2:00 C4 232.22 On the role of SUMOylation in the
developing mouse forebrain. M. SAKURAI; A. YAMAMOTO;
O. A. ARANCIO*. Columbia Univ., Dept. of Neurol.
3:00 C5 232.23  •  Pax3 splice form expression and
isoform function in the trigeminal placode. J. S. ADAMS; M.
R. STARK*. Brigham Young Univ.
4:00 C6 232.24 Human cortical interneurons are
generated in vitro from dorsal progenitor cells. X. YU*; N.
ZECEVIC. Univ. of Connecticut Hlth. Ctr.
1:00 C7 232.25 Differential distribution of neurons in
the white matter of the human cerebral cortex. V. GARCIA-
MARIN*; L. BLAZQUEZ-LLORCA; J. RODRIGUEZ; J.
GONZALEZ-SORIANO; J. DEFELIPE. Ctr. For Neural
Science. New York Universty, Ctr. de Tecnologia Biomedica,
UPM & Inst. Cajal, CSIC, Vet. Fac.
Neuroscience 2010  |  Sunday PM  |  79 
2:00 C8 232.26 Morphine administration inhibits neuronal
differentiation and proliferation and promotes apoptosis in
the immature mouse brain. D. WILLNER*; R. R. LEKER; V.
LASRY; M. Y. SHAMIR; A. COHEN-YESHURUN. Hadassah
Univ. Hosp, Haddasah Univ. Hosp., Hebrew Univ.
3:00 C9 232.27 Differentiated hippocampal precursor
cells as model to study GABAergic dysfunction. S.
SUBBURAJU*; F. M. BENES. Mailman Res. Center, McLean
Hosp., Harvard Med. Sch.
4:00 C10 232.28 Expression of the steroid receptor
coactivators SRC-1 and CARM1 is modulated during
different phases of neurogenesis in the dentate gyrus of
adult female rats. T. D. CHARLIER*; S. L. LIEBLICH; J.
BALTHAZART; L. A. M. GALEA. Univ. Liege, Univ. of British
Columbia.
POSTER
233. Proliferation II
Theme A: Development
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 C11 233.1 Primary neuronal precursors in the
crayfish brain: Self-renewal or replenishment from another
source? J. L. BENTON; Y. ZHANG; C. R. KIRKHART; D. C.
SANDEMAN*; B. S. BELTZ. Wellesley Col.
2:00 C12 233.2 The effects of arachidonic acid and
docosahexaenoic acid on neural stem/progenitor cells. N.
SAKAYORI*; M. MAEKAWA; K. NUMAYAMA-TSURUTA; N.
OSUMI. Div. of Developmental Neuroscience, Tohoku Univ.
Grad. Sch. of Med., Lab. for Mol. Psychiatry, RIKEN BSI,
Grad. Sch. of Biomed. Engineering, Tohoku Univ., Tohoku
Neurosci. Global COE.
3:00 C13 233.3 IGF2 promotes murine forebrain neural
stem/progenitor cell self-renewal via the insulin receptor. A.
N. ZIEGLER*; A. M. ROWZEE; B. FORBES; T. L. WOOD;
S. W. LEVISON. UMDNJ-New Jersey Med. Sch., Univ. of
Adelaide.
4:00 C14 233.4 Mammalian neural stem cells undergo
pre-mitotic condensation associated with an increased
chloride conductance. C. W. HABELA*; H. SONTHEIMER;
M. L. OLSEN. Univ. Alabama.
1:00 C15 233.5 Sumoylation controls retinal progenitor
proliferation by repressing cell cycle exit in Xenopus. T.
FURUKAWA*; K. TERADA. Osaka Biosci Inst., JST, CREST.
2:00 C16 233.6 Proliferative effects of glaucalignan
purified from Polyalthia glauca on rat embryonic cerebral
cortex-derived neural stem cells. W. THANGNIPON*; N.
SUWANNA; P. TUCHINDA; S. BUASUNTORN. Inst. of Mol.
Biosci., Fac. of Sci.
3:00 C17 233.7 Phosphorylation by citron kinase
promotes a chromatin state required for neural progenitor
self-renewal. M. J. GIRGENTI*; K. PATEL; P. LAPIERRE; J.
LOTURCO. Univ. of Connecticut.
4:00 C18 233.8 Mammalian glial cells missing
genes induce Hes5 and are required for neural stem
cell generation. S. HITOSHI*; A. KUMAR; Y. ISHINO; T.
HOSOYA; Y. HOTTA; K. IKENAKA. Natl. Inst. Physiol Sci.,
RIKEN BSI, Res. Organization of Information and Systems.
80  |  Society for Neuroscience
1:00 C19 233.9 The role and signal pathways of
dopamine D3 receptor in regulation of adult neural stem
cell proliferation. L. CHU LAN*; H. LI; J. CHEN. Chang
Gung University/ Grad. Inst. of Biomed. Sci., Oregon Inst. of
Technol.
2:00 C20 233.10 Ethanol inhibits fibroblast growth factor-2
(FGF-2)-Induced miRNAs which are critical components for
neural stem renewal and maturation. S. BALARAMAN*; P.
TSAI; R. C. MIRANDA. Texas A&M Hlth. Sci. Center/College
of Med.
3:00 C21 233.11 Growth factor stimulated neural
stem cells, a route to cancer? O. R. LINDBERG*; A.
BREDERLAU; A. JANSSON; C. COOPER-KUHN; H. G.
KUHN. Inst. For Neurosci. and Physiology, CBR.
4:00 C22 233.12 In vivo imaging of NG2 cells in the adult
brain using transgenic rat. Y. TAMURA*; A. TACHIBANA; E.
HAYASHINAKA; Y. WADA; K. TAKAHASHI; Y. KATAOKA.
RIKEN, Ctr. for Mol. Imaging Sci.
POSTER
234. Development: Activity-Dependent Remodeling of
Synapses
Theme A: Development
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 C23 234.1 The role of the chondroitin sulfate
proteoglycan aggrecan in the formation of perineuronal nets.
K. A. GIAMANCO*; M. MORAWSKI; R. T. MATTHEWS.
Upstate Med. Univ., Univ. of Leipzig.
2:00 C24 234.2 effect of manipulation NMDA receptors
on the neurodevelopment cerebellar. L. T. GAYTAN*. Univ.
Guadalajara.
3:00 C25 234.3 Mechanisms underlying experience-
dependent maturation of neocortical gabaergic circuits in
vivo. Q. SUN*; Y. JIAO; Z. ZHANG; C. ZHANG; B. LU. Univ.
Wyoming, GlaxoSmithKline.
4:00 C26 234.4  Chronic alcohol exposure during early
postnatal development decreases KCC2 levels in the
CA3 hippocampal region. J. C. EVERETT*; S. ZUCCA; A.
WADLEIGH; C. F. VALENZUELA. U. of New Mexico HSC.
1:00 C27 234.5 Perturbing Cabin1 expression during
nervous system development. D. R. HAMMOND*; A. J.
UDVADIA. Univ. of Wisconsin-Milwaukee.
2:00 C28 234.6 EphA4-dependent signaling regulates the
expression of AMPA receptor in homeostatic plasticity. A. K.
FU*; K. HUNG; W. FU; C. SHEN; Y. CHEN; J. XIA; K. LAI; N.
Y. IP. The Hong Kong Univ. of Sci. and Technol.
3:00 C29 234.7 Experience-dependent plasticity and
modulation of growth regulatory molecules at central
synapses. F. ROSSI*; S. FOSCARIN; K. LETO; D.
PONCHIONE; M. GAWLAK; G. WILCZYNSKI; D. CARULLI.
Sci. Inst. Cavalieri-Ottolenghi Foundation, NIT, Univ. of Turin,
Nencki Inst. of Exp Biol.
4:00 C30 234.8 Dynamics of PSD-95 and CaMKII at
axodendritic contacts. C. E. TAFT*; G. G. TURRIGIANO.
Brandeis Univ.
1:00 C31 234.9 Flexible parametric models for the
statistical analysis of synaptic current rise time, decay time,
and charge transfer. L. D. LEWIS*; M. PHILLIPS; J. J.
GONG; M. CONSTANTINE-PATON; E. N. BROWN. MIT,
Massachusetts Gen. Hosp., Harvard Univ.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
2:00 C32 234.10 Network activity determines dorso-ventral
differences in neuronal maturation in the adult hippocampus.
V. C. PIATTI; M. F. TRINCHERO; L. A. MONGIAT; A. F.
SCHINDER*. Leloir Inst.
3:00 C33 234.11 Neuronal specific βPix-b stimulates actin-
dependent comet tail and dendritic filopodia/spine formation
through its interaction with N-WASP. Y. KIM; G. HUANG; S.
CHANG*. Seoul Natl. Univ.
4:00 C34 234.12 A novel model-based method for
the detection of synaptic modification using miniature
post-synaptic currents. M. PHILLIPS*; L. D. LEWIS; M.
CONSTANTINE-PATON; E. N. BROWN. MIT, Massachusetts
Gen. Hosp.
1:00 C35 234.13 Selective pharmacogenetic control of
neural activity in the inferior olive. I. SMITH*; M. HAUSSER.
Univ. Col. London.
2:00 C36 234.14 Inclusive labeling of the corticospinal
neurons innervating a single cervical segment with EYFP
by way of exo utero electroporation: quantitative analysis of
their terminals in the spinal gray matter during development.
N. MURABE; T. KAMIYAMA; M. SAKURAI*. Teikyo Univ,
Sch. Med.
3:00 C37 234.15 Differential effect of GluN2B KO vs.
GluN2A KO in corticospinal synapse elimination during
development. T. OHNO*; H. MAEDA; N. MURABE; T.
KAMIYAMA; N. YOSHIOKA; M. MISHINA; M. SAKURAI.
Teikyo Univ. Sch. Med., Grad Sch. Med, Univ. Tokyo.
4:00 C38 234.16 Characterization of spontaneous
electrical activity in developing spinal motor neurons of
zebrafish embryos. P. V. PLAZAS; N. C. SPITZER*. UCSD.
1:00 D1 234.17 Intracellular sodium regulation of NMDA
receptor-dependent neuronal plasticity. J. GEORGE*; D. G.
BADEN; T. F. MURRAY. Creighton Univ. Sch. of Med., Univ.
of North Carolina at Wilmington.
2:00 D2 234.18 AMPA signalling at the developing
entorhinal-CA1 synapse is not labile. R. MA; B.
GUSTAFSSON; M. XIAO; I. H. HAMMAR*. Inst. Neurosci &
Physiol.
3:00 D3 234.19 Activity-dependent regulation of synaptic
function by the metabolic sensor, AMPK. J. F. STURGILL*;
J. L. HAUSER; P. STEINER; J. SAULNIER; B. L. SABATINI.
Harvard Med. Sch.
4:00 D4 234.20 Role of local BDNF synthesis in spine
morphogenesis. L. L. OREFICE*; E. G. WATERHOUSE; B.
XU. Georgetown Univ.
1:00 D5 234.21 Retrograde BMP signaling controls
synaptic growth at the NMJ by regulating Trio expression in
motor neurons. R. BALL; K. TSURUDOME; J. WHITE; P.
HAGHIGHI*. McGill Univ.
2:00 D6 234.22 MHC Class I H2-Db is necessary
and sufficient for synapse elimination and eye-specific
segregation. H. LEE*; A. DATWANI; C. J. SHATZ. Stanford
Univ.
3:00 D7 234.23 Protein turnover affects dendritic
spine dynamics in hippocampal pyramidal neurons. A. M.
HAMILTON*; K. ZITO. Univ. of California.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
POSTER
235. Regeneration in CNS
Theme A: Development
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 D8 235.1 Expression of the transcription factor yin
yang 1 (YY1) during regeneration of the injured zebrafish
retina. S. KAISER; P. YURCO*. Le Moyne Col.
2:00 D9 235.2 APOBEC2a/2b knockdown in zebrafish
blocks retinal regeneration. C. POWELL; D. J. GOLDMAN*.
Univ. of Michigan.
3:00 D10 235.3 Developmentally regulated genes
Sun. PM
regulate retinal ganglion cell axon growth. E. C.
TRAKHTENBERG*; D. L. MOORE; N. SHARIFAI; A. P.
AMARAL; M. S. MATTHES; J. L. GOLDBERG. Univ. of
Miami Miller Sch. of Med., Ludwig - Maximilians Univ.
4:00 D11 235.4  •  Retino-thalamic axon regeneration in
the mature mouse optic nerve: combinatorial effects of
Oncomodulin and other factors. T. KURIMOTO*; Y. YIN; H.
GILBERT; K. OMURA; D. KIM; L. I. BENOWITZ. Children’s
Hospital, Harvard Med. Sch.
1:00 D12 235.5 Role of neuronal Nogo-A in retinal axon
regrowth after optic nerve injury. A. M. GUZIK-KORNACKA*;
V. E. PERNET; S. M. JOLY; J. L. MARTIN; M. E. SCHWAB.
Brain Res. Institute, Univ. of Zurich/ETH, Univ. Hosp. Zurich,
Loyola Univ. Med. Ctr.
2:00 D13 235.6 Identifying KLF binding partners in
primary retinal ganglion cells. A. APARA; M. BLACKMOORE;
S. BHATTACHARYA; J. L. GOLDBERG*. Univ. Miami, Miami
Project to Cure Paralysis.
3:00 D14 235.7  •  Cellular and molecular remodeling in
the adult rat spinal cord injury after Chondroitinase ABC
treatment. F. NOTHIAS*; U. MILBRETA; Y. VON BOXBERG;
S. SOARES. Upmc-Paris6, Cnrs-Umr7224, Inserm-U952.
4:00 D15 235.8 Comparison of polymer scaffolds in
rat spinal cord: A step towards quantitative assessment of
combinatorial approaches to spinal cord repair. B. CHEN*;
A. KNIGHT; L. GROSS; N. MADIGAN; J. NESBITT; G.
ROONEY; M. DADSETAN; M. YASZEMSKI; B. CURRIER;
A. WINDEBANK. Mayo Clin. Coll Med., Mayo Col. of Med.,
Mayo Clin. Col. of Med.
1:00 D16 235.9 Polysaccharide hydrogel blends for
repairing the injured spinal cord. J. M. ZUIDEMA; E. J.
MINNER; C. J. RIVET; F. A. MORRISON; P. G. POPOVICH;
R. J. GILBERT*. Rensselaer Polytechnic Inst., Michigan
Technol. Univ., The Ohio State Univ.
2:00 D17 235.10 EGFR (ErbB1) involvement in signalling
from neurite growth inhibitors. V. H. L. LEINSTER; M. T. JOY;
P. N. ANDERSON*; S. R. BOLSOVER. UCL.
3:00 D18 235.11 A 3d scaffold-free aligned astrocyte
construct for therapeutic applications. F. MENG*; V. HLADY;
P. TRESCO. Dept. of Bioengineering, Univ. Utah.
4:00 D19 235.12 LAR RPTPs are up-regulated in the adult
medicinal leech CNS following injury and promote neuronal
sprouting and regeneration. J. SETHI; E. R. MACAGNO*; M.
W. BAKER. Univ. Calfornia San Diego.
1:00 D20 235.13 Dopaminergic modulation of adult
neurogenesis in the striatum using transgenic mouse model
of Huntington’s disease. M. H. MCCOLLUM*; D. RUSH; R.
LEON; J. WEI. Florida Atlantic Univ.
Neuroscience 2010  |  Sunday PM  |  81 
2:00 D21 235.14 Genetic deletion of paired 3:00 D32 236.3 Balancing cholinergic tone through lynx1,
immunoglobulin-like receptor B does not promote axonal the toxin-like nicotinic receptor modulator. J. M. MIWA*; R.
plasticity or functional recovery after traumatic brain injury. S. SRINIVASAN; D. S. RHEE; H. A. LESTER. Caltech.
OMOTO*; M. UENO; S. MOCHIO; T. TAKAI; T. YAMASHITA.
4:00 D33 236.4 Withdrawn
Osaka Univ., The Jikei Univ. Sch. of Med., Tohoku Univ.
1:00 D34 236.5 Neuroprotective effect of nicotine against
3:00 D22 235.15 Regulation of axon growth by Krüppel-
nerve growth factor withdrawal in superior cervical ganglion
like transcription factors: Target identification and structure/
neurons. M. P. BADANAVALU*; S. C. PANDANABOINA; M.
function analysis. M. G. BLACKMORE*; D. L. MOORE; D.
SRIVATSAN. Arkansas State Univ.
MOTTI; J. L. BIXBY; V. P. LEMMON; J. L. GOLDBERG.
Univ. of Miami. 2:00 D35 236.6 α7 nicotinic acetylcholine receptors
contribute to amyloid-induced neuronal hyperexcitation. Q.
4:00 D23 235.16  •  Generation and analysis of
LIU*, Dr.; P. WHITEAKER; R. J. LUKAS; J. WU. Barrow
Nogo receptor and PirB compound mutant mice. T. L.
Neurolog. Inst.
DICKENDESHER*; M. L. MERCADO; B. BATES; D.
HOWLAND; M. M. ZALESKA; A. WOOD; R. J. GIGER. Univ. 3:00 D36 236.7  •  SUVN-F91201: A potent and selective
of Michigan, Pfizer Global Res. and Develop. nicotinic acetylcholine α4β2 receptor agonist for the
treatment of Alzheimer’s disease. P. JAYARAJAN*; S. S.
1:00 D24 235.17 Significant stimulation of glioblastoma
MOHANTY; S. K. MARIMUTHU; G. V. RAMALINGAYYA; D.
multiforme derived conditioned medium on neuronal growth.
SHANMUGANATHAN; S. L. JABARIS; R. ABRAHAM; R. M.
S. VASUDEVAN*; N. HALL; Y. KIM. Univ. of Texas At
GARIKAPATI; I. AHMAD; M. A. RASHEED; K. KUMAWAT; R.
Arlington.
YARAMASU; S. CHINTHANIPPULA; G. BHYRAPUNENI; R.
2:00 D25 235.18 Temporal-regulation of growth promoting NIROGI. Suven Life Sci.
factor genes following CNS injury in Lymnaea stagnalis. M.
4:00 D37 236.8 Both α6β2* and α4β2* nicotinic receptors
ALEKSIC*; Z. FENG. Univ. of Toronto.
modulate dopamine release with nigrostriatal damage. X. A.
3:00 D26 235.19 Transcriptome profiling of three distinct PEREZ*; T. BORDIA; Y. LEE; J. M. MCINTOSH; M. QUIK.
neural types using high-throughput RNA sequencing (RNA- SRI Intl., Univ. of Utah.
Seq) identifies novel gene targets and isoforms relevant to
1:00 D38 236.9 Nicotine treatment reduces vacuous
neuronal regeneration. J. K. LERCH-HANER*; S. YOUNG; F.
chewing movements in a rat model of tardive dyskinesias. T.
KUO; D. MOTTI; D. STRIKIS; O. GUTIERREZ-ARENAS; T.
BORDIA*; M. QUIK. SRI Intl.
SLEPAK; J. L. BIXBY; V. P. LEMMON. Univ. of Miami.
2:00 D39 236.10 Nicotinic receptor agonists decrease
4:00 D27 235.20 GDNF is necessary for maintenance
L-dopa-induced dyskinesias most effectively in moderately
of adult ventral mesencephalon and the striatum. I. M.
lesioned parkinsonian rats. L. Z. HUANG*; C. CAMPOS; Y.
STROMBERG*; N. NEVALAINEN; P. SCHOUTEN; M.
LEE; J. LY; I. F. CARROLL; T. BORDIA; M. QUIK. SRI Intl.,
CHERMENINA; A. REHNMARK; F. MARSCHINKE. Umea
RTI Intl. and Res. Triangle Park.
Univ.
3:00 D40 236.11 Interactions of nicotine, methadone
1:00 D28 235.21 Expression of the developmental
and buprenorphine in 3H-epibatidine -binding and calcium
transcription factor MASH-1 in the brainstem enhances the
fluorometry in nAChR -containing cell lines. R. TALKA*;
regeneration of noradrenergic axons across a Schwann cell
O. SALMINEN; P. WHITEAKER; R. J. LUKAS; R. K.
bridge. R. R. WILLIAMS; D. D. PEARSE; M. B. BUNGE*.
TUOMINEN. Univ. of Helsinki, Div. of Pharmacol. and
Univ. Miami Sch. Med.
Toxicology, St Joseph’s Hosp. and Med. Ctr.
2:00 D29 235.22 Colloids as mobile substrates for the
4:00 D41 236.12 A highly selective alpha3beta4 nicotinic
implantation and integration of differentiated neurons into the
receptor antagonist attenuates cocaine and morphine-
mammalian brain. D. JGAMADZE; J. BERGEN; D. STONE;
induced place preference. T. V. KHROYAN*; W. POLGAR;
D. V. SCHAFFER; E. Y. ISACOFF; S. PAUTOT*. CRT
F. JIANG; G. STAUBER; N. ZAVERI; L. TOLL. SRI Intl.,
Dresden, Univ. of California, Berkeley.
Astraea Therapeutics, LLC.
1:00 D42 236.13 The role of nicotinic acetylcholine
POSTER receptors in the acute effects of alcohol. A. J. DAWSON*.
Virginia Commonwealth Univ.
236. Nicotinic Acetylcholine Receptors: Potential Therapeutic
2:00 E1 236.14  •  SUVN-911: A potent and selective
Applications
nicotinic acetylcholine α4β2 receptor antagonist for the
Theme B: Neural Excitability, Synapses, and Glia: treatment of depression and other mood disorders. R. V.
Cellular Mechanisms NIROGI*; P. JAYARAJAN; I. AHMAD; G. BHYRAPUNENI;
V. KANDIKERE; M. A. RASHEED; N. S. REDDY; R.
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
ABRAHAM; K. MARIMUTHU; D. SHANMUGANATHAN; V.
1:00 D30 236.1  •  Modulation of cholinergic tone impacts BENADE; V. SRINIVAS. Suven Life Sci.
the efficacy of RG3487 / MEM3454, a novel, nicotinic alpha
3:00 E2 236.15  •  SUVN-911: Pharmacological and safety
7 receptor agonist. T. L. WALLACE*; G. CHIU; H. DAO; L.
profile of a novel and selective nicotinic acetylcholine α4β2
SANTARELLI; R. PORTER; S. BERTRAND; D. BERTRAND.
receptor antagonist for the treatment of depression and other
SRI Intl., F. Hoffmann-La Roche, HiQ Screen Sarl.
mood disorders. G. BHYRAPUNENI*; V. KANDIKERE; K.
2:00 D31 236.2 Loss of LTP in alpha7 neuronal nicotinic MUDIGONDA; V. R. C. PALACHARLA; R. S. SARALAYA;
receptor (a7*) knockout mice is strain dependent. S. L. K. BABURAO; K. MARIMUTHU; S. L. JABARIS; M. A.
GRAW*; R. FREUND; M. DELL’ACQUA; K. FLOYD; S. RASHEED; M. S. MULLA; V. K. GOYAL; R. NIROGI. Suven
LEONARD. Univ. Colorado Denver. Life Sci.

82  |  Society for Neuroscience • Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
4:00 E3 236.16 The role of the α5 nicotinic acetylcholine
receptor subunit in mediating nicotine-induced seizure. M.
A. PAOLINI*; E. E. PEREZ; D. Q. DAO; M. DE BIASI. Baylor
Col. of Med.
1:00 E4 236.17 Anticonvulsive drug lamotrigine blocks
neuronal alpha4beta2-nicotinic acetylcholine receptors. K.
YANG*; C. ZHENG; S. VALLÉS; F. J. BARRANTES; J. WU.
Barrow Neurologicial Inst., Inst. de Bioquímica and UNESCO
Chair of Biophysics and Mol. Neurobio.
2:00 E5 236.18  •  Correlation of analgesic effects
mediated by neuronal nicotinic acetylcholine receptor
agonists with desensitization of α4β2* receptors. J. ZHANG*;
K. VAN DYKE; Y. XIAO; K. JORDAN; P. HAMMOND;
A. MAZUROV; J. SPEAKE; S. R. LETCHWORTH; M.
BENCHERIF; T. HAUSER. Targacept.
3:00 E6 236.19  •  Effects of SUVN-F90101, a neuronal
nicotinic acetylcholine receptors agonist in animal models of
neuropathic pain. I. AHMAD*; S. L. JABARIS; V. GOURA;
R. ABRAHAM; D. SHANMUGANATHAN; R. YARAMASU;
K. MARIMUTHU; P. JAYARAJAN; R. NIROGI; I. AHMAD.
Suven Life Sci. Ltd.
4:00 E7 236.20 Anti-inflammation effects of nicotine
and GTS-21 via alpha7 nAChR in rat hippocampal slice
cultures and BV-2 cells. S. TANAKA; S. TAKAHASHI;
H. KAGEYAMA*; S. NUMAZAWA; T. YOSHIDA. Showa
University, Sch. of Pharm., Showa Univ. Sch. of Med.
1:00 E8 236.21 Role of the receptor for advanced
glycation end products (RAGE) in hyperglycemia-induced
autonomic malfunction. V. A. CAMPANUCCI*; C. CHANG.
Univ. of Saskatchewan.
2:00 E9 236.22 ASCL1 regulation of the nicotinic
acetylcholine receptor A5/A3/B4 gene cluster modulates
lung cancer growth. M. D. IMPROGO*; S. W. ROGERS; A.
R. TAPPER; P. D. GARDNER. Univ. of Massachusetts Med.
Sch., Univ. of Utah.
3:00 E10 236.23  •    Uncovering the structural basis for
cholesterol-sensitive acetylcholine receptors. L. DORNA;
J. C. PADILLA; C. VÉLEZ; M. LUCIANO; C. BÁEZ; J. D.
OTERO; O. QUESADA; J. A. LASALDE-DOMINICCI*. Univ.
of Puerto Rico, Univ. of Washington, Univ. Puerto Rico.
POSTER
237. Non-NMDA Glutamate Receptors: Localization and
Trafficking
Theme B: Neural Excitability, Synapses, and Glia:
Cellular Mechanisms
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 E11 237.1 Plasma membrane insertion of the AMPA
receptor GluA2 subunit is regulated by NSF binding and
Q/R editing site. Y. ARAKI*; D. LIN; R. L. HUGANIR. Johns
Hopkins Univ, Sch. of Med.
2:00 E12 237.2 Novel mechanism for regulation of
synaptic AMPA-type glutamate receptor activity through
TARPs phosphorylation. A. SUMIOKA*; D. YAN; S. TOMITA.
Yale Univ.
3:00 E13 237.3 Calcium-permeable AMPARs and the role
of TARPs in cerebellar stellate cells. C. BATS*; D. SOTO; M.
FARRANT; S. CULL-CANDY. Univ. Col. London.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
4:00 E14 237.4 Distance-dependent changes in
expression of synaptic GluR2 containing AMPA receptors
in cerebellar stellate cells. I. A. SAVTCHOUK*; S. LIU. LSU
Hlth. Sci. Ctr., The Pennsylvania State Univ.
1:00 E15 237.5 Neto1 and Neto2 regulate GluK2-
containing kainate receptor abudance at the postsynaptic
density. M. TANG*; E. IVAKINE; D. NG; R. R. MCINNES.
Hosp. For Sick Children, Univ. of Toronto, Columbia Univ.,
Lady Davis Inst. for Med. Res.
2:00 E16 237.6 Characterization of GluK2 ubiquitination
and its role in kainate receptor trafficking. S. MCNEIL*; Y.
NASU-NISHIMURA; R. J. YOULE; K. W. ROCHE. Natl. Inst.
of Neurolog. Disorders and Stroke, Johns Hopkins Univ.
Sun. PM
3:00 E17 237.7 Kainate receptor post-translational
modifications differentially regulate association with 4.1N,
which is critical for activity-dependent receptor endocytosis.
B. A. COPITS*; G. T. SWANSON. Northwestern Univ.
4:00 E18 237.8 Regulation of AMPA receptor stability and
trafficking by IQGAP1. L. A. JARZYLO*; H. MAN; K. FOO.
Boston Univ.
1:00 E19 237.9 Locations of endocytosis and exocytosis
of AMPA receptors in cultured hippocampal neurons. J. TAO-
CHENG*; V. CROCKER; C. A. WINTERS; J. CHLUDZINSKI;
T. S. REESE. NIH.
2:00 E20 237.10 The involvement of EPS15 in
ubiquitination-dependent AMPA receptor endocytosis. A. W.
LIN*; H. MAN. Boston Univ.
3:00 E21 237.11 Activity-dependent ubiquitinylation
and degradation of the AMPA receptor subunit GluA2. M.
LUSSIER*; K. W. ROCHE. NIH/NINDS.
4:00 E22 237.12 Loss of cerebellar granule cell AMPA
receptors contributes to ataxia in stargazer mice. M.
YAMAZAKI*; T. MIYAZAKI; M. FUKAYA; M. WATANABE; K.
SAKIMURA. Brain Res. Inst. Niigata Univ., Anat. Hokkaido
Univ. Grad Sch. Med.
1:00 E23 237.13 Lk6 affects synaptic localization of
glutamate receptors at Drosophila neuromuscular junction.
B. TOUNSEL*; D. BEATTY; F. LIEBL. Southern Illinois Univ.
Edwardsville.
2:00 E24 237.14 Role of syndig in ampa receptor
trafficking to synapses. I. KAUR; L. KIRK; E. DIAZ*. UC
Davis Sch. of Med.
3:00 E25 237.15 Atg1 positively regulates glutamate
cluster formation at the Drosophila NMJ. D. BEATTY*; C.
MCKEOWN; F. LIEBL. Southern Illinois Univ.
4:00 E26 237.16 The study of cornichon proteins on the
function of AMPA receptors. K. ISOZAKI*; Y. SUH; K. W.
ROCHE. NIH.
POSTER
238. Non-NMDA Glutamate Receptors: Physiology
Theme B: Neural Excitability, Synapses, and Glia:
Cellular Mechanisms
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 E27 238.1 Regulation of a kainate receptor by
NDRG2 and its possible involvement in Alzheimer’s disease.
N. STRUTZ-SEEBOHM*; F. LANG; M. HOLLMANN; G.
SEEBOHM. Univ. of Bochum, Univ. of Tuebingen.
Neuroscience 2010  |  Sunday PM  |  83 
2:00 E28 238.2 Role of an accessory subunit of kainate 3:00 E41 238.15 Maturation of glutamatergic synapses
receptors in the brain. C. STRAUB*; D. L. HUNT; P. E. in the developing retina that contain only AMPA receptors.
CASTILLO; S. TOMITA. Yale University, Sch. of Med., Albert M. CHONG*; I. K. OSSWALD; M. AUROUSSEAU; S.
Einstein Col. of Med. OLINOSKI; F. K. BEDFORD; D. BOWIE. McGill Univ.
3:00 E29 238.3 Activation of group I metabotropic 4:00 E42 238.16 Roles of AMPA receptor subunits in
glutamate receptors potentiates heteromeric kainate developmental refinement of somatosensory relay synapses
receptors. A. ROJAS*; J. WETHERINGTON; R. SHAW; G. in the thalamus. H. WANG; Z. ZHANG*. The Jackson Lab.
SERRANO; J. JIANG; S. SWANGER; R. DINGLEDINE.
1:00 E43 238.17 Characterization of philantotoxins as
Emory Univ. (SOM).
potential subtype-selective blockers of Ca2+-impermeable
4:00 E30 238.4 Kainate receptor subunit GluK2 editing AMPA receptors. M. H. POULSEN*; S. LUCAS; K.
affects short term synaptic plasticity in the hippocampus. L. STRØMGAARD; A. S. KRISTENSEN. Univ. of Copenhagen.
A. CHRISTIE; H. B. FERNANDES; K. ITO; T. RUSSELL; J.
2:00 E44 238.18 Functional study of ionotropic glutamate
XU; G. T. SWANSON; A. CONTRACTOR*. Northwestern
delta-1 receptor. R. YADAV*; M. SCOFIELD; R. A.
Univ. Feinberg Sch. Med., Univ. of Tokyo.
RIMERMAN; S. M. DRAVID. Creighton Univ.
1:00 E31 238.5  •  CaMKII enhances conductance of
3:00 E45 238.19 Activation of GluR5 kainate receptors
neuronal AMPA receptors via phosphorylation of GluA1
facilitates glutamate release in the basolateral amygdala. V.
Ser831. M. A. JENKINS*; A. S. KRISTENSEN; Y. MAKINO;
ARONIADOU-ANDERJASKA; V. PIDOPLICHKO; F. QASHU;
R. C. JOHNSON; R. HUGANIR; S. F. TRAYNELIS. Emory
M. F. BRAGA*. Uniformed Services Univ. of the Hlth. Sci.,
Univ., Univ. of Copenhagen, Johns Hopkins Univ. Sch. of
Uniformed Services Univ. Hlth. Sci.
Med.
2:00 E32 238.6 TARP and CNIH subunits allosterically
link AMPA receptor antagonists and potentiators. D. A. POSTER
SCHOBER*; M. B. GILL; H. YU; D. L. GERNERT; P. L.
ORNSTEIN; A. S. KATO; D. S. BREDT. Eli Lilly & Co. 239. GABAA Receptors: Structure and Trafficking
3:00 E33 238.7 Kinetic analysis of the S2-M3 linker Theme B: Neural Excitability, Synapses, and Glia:
mutation (R628E) in GluR2(flop). J. HARMS*; M. Cellular Mechanisms
BENVENISTE; L. STONE-ROY; K. M. PARTIN. Colorado
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
State Univ., Morehouse Sch. of Med.
1:00 E46 239.1 Impaired endocytosis affects GABAA
4:00 E34 238.8 Loss of ca2+ permeable ampa receptor
receptor lateral mobility at synapses. E. PETRINI*; T.
function in tonic neurons of the substantia gelatinosa
RAVASENGA; F. SUCCOL; T. C. JACOB; S. J. MOSS; A.
after sciatic chronic constriction injury. Y. L. CHEN*; V. A.
BARBERIS. Italian Inst. of Technol., Tufts Univ. Sch. of Med.
DERKACH; P. A. SMITH. Univ. of Alberta, Oregon Hlth. and
Sci. Univ. 2:00 E47 239.2  •  Role of protein kinase C phosphorylation
in neurosteroid modulation of extrasynaptic GABA(A)
1:00 E35 238.9 Modulation of AMPA and kainate
receptors. E. J. COMENENCIA ORTIZ*; A. M. ABRAMIAN;
receptor function by galectins. G. T. SWANSON*; B. A.
T. Z. DEEB; P. A. DAVIES; S. J. MOSS. Tufts Univ. Sch. of
COPITS; Y. NAKAMURA; S. FRAUSTO; J. ROBBINS; M.
Med.
B. GILL; C. SMITH; T. OGAWA; K. MURAMOTO; R. SAKAI.
Northwestern Univ., Hokkaido Univ., Tohoku Univ. 3:00 E48 239.3 GABAρ receptors in cultured
hippocampal neurons and their distribution in some areas
2:00 E36 238.10 The role of AKAP150-anchored PKA in
of the mouse brain. A. ROSAS-ARELLANO*. Univ. Nacional
the β adrenergic -glutamate receptors signaling complex. M.
Autónoma de México.
ZHANG*; H. QIAN; M. WEISENHAUS; J. A. WEMMIE; G.
MCKNIGHT; J. W. HELL. Univ. of California Davis, Univ. of 4:00 E49 239.4 Cdk5-dependent phosphorylation
Iowa, Univ. of Washington. regulates the gephyrin-dependent clustering of α1-containing
GABAARs at inhibitory synapses. J. MUKHERJEE*;
3:00 E37 238.11  •  Neuronal AMPA receptor gating
K. KRETSCHMANNOVA; H. MARIC; K. HARVEY; H.
controlled by both TARP and cornichon proteins. A. KATO*;
SCHINDELIN; S. J. MOSS. Tufts Univ., Univ. of Würzburg,
M. B. GILL; H. YU; Y. TU; E. R. SIUDA; H. WANG; Y. QIAN;
The school of Pharm.
E. S. NISENBAUM; D. S. BREDT. Eli Lilly & Co.
1:00 E50 239.5 PNUTS regulates membrane trafficking of
4:00 E38 238.12 Philanthotoxin block of AMPA receptors
the GABAc receptor rho1 subunit in the presence of protein
varies with channel conductance and TARP subtype. A. C.
phosphatase 1. E. DÜTTING; V. EULENBURG*; R. ENZ.
JACKSON*; A. D. MILSTEIN; D. SOTO; M. FARRANT; S. G.
Univ. of Erlangen, Inst. for Biochem. and Mol. Med.
CULL-CANDY; R. A. NICOLL. UCSF, Univ. Col. London.
2:00 E51 239.6 An E3 ubiquitin ligase interacts with
1:00 E39 238.13 Contribution of AMPA and kainate
GABAA receptors and promotes their degradation. H. JIN*;
receptors to excitatory postsynaptic currents recorded from
T. CHIOU; N. PINAL; C. MIRALLES; A. DE BLAS. Univ. of
CA1 stratum pyramidale interneurons in hippocampal slices
Connecticut.
from guinea pigs. E. ALEXANDROVA; E. F. PEREIRA*; E. X.
ALBUQUERQUE. Univ. Maryland Sch. Med. 3:00 E52 239.7 Network activity bidirectionally modulates
neurosteroid sensitivity of GABA-A receptors in cultured
2:00 E40 238.14 Pharmacology of cerebellar AMPA-only
hippocampal neurons. S. JOSHI*; J. KAPUR. Univ. Virginia.
synapses during development. D. M. MACLEAN; A. GALAN;
I. OSSWALD; S. OLINOSKI; M. CHONG; P. BROWN; F. 4:00 F1 239.8 Homeostatic scaling of GABAergic
BEFORD; D. BOWIE*. McGill Univ. synaptic strength is mediated by NMDA receptor activation.
M. D. RANNALS*; J. KAPUR. Univ. Virginia.

84  |  Society for Neuroscience • Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
1:00 F2 239.9 Interactions between gephyrin and α
subunits affect synaptic versus extrasynaptic targeting of
GABAA receptors. X. WU*; Y. GUO; R. ALI; S. MASUDA; R.
L. MACDONALD; A. DE BLAS; B. LUSCHER; G. CHEN. The
Pennsylvania State Univ., Univ. of Connecticut, Vanderbilt
Univ. Med. Ctr.
2:00 F3 239.10 Selective dependence of gephyrin on
GABAA receptors containing the alpha2 subunit for clustering
at perisomatic and axo-axonic postsynaptic sites in CA1
pyramidal cells. P. PANZANELLI*; M. SCHLATTER; C.
SIDLER; F. CRESTANI; P. SCHEIFFELE; U. RUDOLPH; J.
FRITSCHY. Dept. of Anatomy, Pharmacology, and Forensic
Medicine, Univ. Turin, Inst. of Pharmacol. and Toxicology,
Univ. of Zurich, Biozentrum, Univ. of Basel, Lab. of Genet.
Neuropharmacology, McLean Hospital, and Harvard Med.
Sch.
3:00 F4 239.11 The cell adhesion molecule neuroplastin
65 regulates GABAA receptor surface trafficking via the p38
MAPK pathway. I. SARTO-JACKSON; I. MILENKOVIC;
K. SMALLA; E. GUNDELFINGER; W. SIEGHART*. Ctr.
for Brain Res., Leibniz Inst. for Neurobio., Ctr. Brain Rese,
Vienna, Austria.
4:00 F5 239.12 A state-dependent interaction exists
between α1R120 and β2D163 of the GABA(A) receptor. K. T.
LAHA*; D. A. WAGNER. Marquette Univ.
1:00 F6 239.13 Disulfide tethering GABA-A receptor beta
subunit Loop 9 inhibits channel activation. E. MORLOCK*;
M. DEVINNEY; C. CZAJKOWSKI. Univ. of Wisconsin.
2:00 F7 239.14 Pharmacology of structural changes at
the GABA-A receptor transmitter binding site. G. AKK*; P. LI;
M. WANG; J. BRACAMONTES; J. STEINBACH. Washington
Univ. Sch. Med.
3:00 F8 239.15 Ginkgo biloba: Differential toxicities
in insects and vertebrates are due to to different GABA
receptor interactions. S. C. LUMMIS*; A. THOMPSON; I.
MCGONIGLE; R. DUKE; G. A. R. JOHNSTON. Univ. of
Cambridge, Dept of Pharmacol.
4:00 F9 239.16 The structure of extracellular domain loop
2 markedly affects ethanol sensitivity of GABAA receptors
in a mammalian expression system. L. R. WYATT; O.
OSTROVSKAYA; K. LI; D. PERKINS; D. L. DAVIES; R. L.
ALKANA*. USC, USC Sch. Pharm.
1:00 F10 239.17 Functional coupling of β2R207 β2F200
and β2Y97 of the GABAA receptor suggests a ternary
interaction that mediates GABA affinity. P. TRAN*; K. LAHA;
D. WAGNER. Marquette Univ.
2:00 F11 239.18 Mobility of channel lining transmembrane
segments in muscle nACh receptors. M. JANSEN*; G.
BRAHMAMUDI. TTUHSC.
3:00 F12 239.19 Agonist trapping by Cys-loop receptors. T.
G. HALES*; T. Z. DEEB; M. Y. GALLACHER; D. BAPTISTA-
HON. Univ. of Dundee, Tufts Univ.
4:00 F13 239.20 Modulation of synaptic GABAAR Γ2
surface expression by acute isoflurane exposure. D. J.
JOSEPH*; G. LIANG; H. WEI. Univ. of Pennsylvania.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
POSTER
240. Calcium Channel Physiology II
Theme B: Neural Excitability, Synapses, and Glia:
Cellular Mechanisms
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 F14 240.1 Effects of the calcium channel
alpha2delta-2 ‘ducky2J’ mutation on spontaneous spiking
activity in the cerebellum. X. WANG*; B. WHALLEY; G.
STEPHENS. Univ. of Reading.
2:00 F15 240.2 Synaptic release and synapse formation
in neuronal calcium channel α2δ subunit knockdown/
Sun. PM
knockout models. B. NIMMERVOLL*; M. CAMPIGLIO; B.
SCHLICK; V. DI BIASE; B. E. FLUCHER; G. J. OBERMAIR.
Med. Univ. Innsbruck.
3:00 F16 240.3 Study of the molecular mechanisms
relating to alpha2delta1 up-regulation in rat dorsal root
ganglion neurons: An in vitro model. M. D’ARCO; W. M.
MARGAS; A. C. DOLPHIN*. UCL.
4:00 F17 240.4 Temperature dependent changes of
calcium current kinetics in thalamic relay neuron. E. YU*; M.
SUGIMORI; R. R. LLINAS. New York Univ.
1:00 F18 240.5 Identification of a high affinity metal
binding site on Cav3.2 T-type calcium channels. H. KANG*;
I. VITKO; E. PEREZ-REYES; J. LEE. Sogang Univ., Univ. of
Virginia.
2:00 F19 240.6 Deletion of T-type Ca2+ channel α1G
results in impaired opioidergic descending analgesia.
C. PARK*; J. KIM; B. YOON; E. CHOI; C. J. LEE; H.
SHIN. Korea Inst. of Sci. and Technol., Grad. Sch. of
Biotechnology, Korea Univ., Univ. of Sci. and Technol. (UST).
3:00 F20 240.7 Chronic hypoxia up-regulates cav3.2
t-type ca2+ currents in rat drg neurons. V. COMUNANZA;
C. CALORIO; A. MARCANTONI*; V. CARABELLI; E.
CARBONE. Univ. of Turin.
4:00 F21 240.8  •  Parodoxical enhancement of sleep
delta oscillations by partial block of T-type Ca2+ channels:
A combined in vivo and computational study. F. DAVID; G.
ORBAN; G. DI GIOVANNI; V. N. UEBELE; J. J. RENGER; V.
CRUNELLI; N. LERESCHE; R. C. LAMBERT*. UMR 7102
CNRS UPMC, Neurosci. Div., Merck Res. Labs., UMR 7102
CNRS UPMR.
1:00 F22 240.9 Alternative splicing of an invertebrate
T-type channel modulates its trafficking to the plasma
membrane. A. SENATORE*; A. BOZORGZAD; J. D.
SPAFFORD. Univ. of Waterloo.
2:00 F23 240.10  •  Analgesic effects of A-1048400, a
novel orally active state-dependent mixed N- and T-Type
Ca2+ channel blocker. V. E. SCOTT*; T. VORTHERMS; W.
NIFORATOS; C. SHIEH; M. NAMOVIC; D. DONNELLY-
ROBERTS; B. PUTMAN; R. THIMMAPAYA; R. HELFRICH;
D. ZHANG; C. SUROWY; I. MILICIC; C. ZHONG; G.
SIMLER; C. ZHAN; J. M. BOYCE-RUSTAY; P. BHATIA; G.
DOHERTY; A. O. STEWART; M. F. JARVIS. Abbott Labs.
3:00 F24 240.11  •  TTA-P2, a novel and selective T-type
calcium channel blocker, is potent analgesic in animal
models of acute and chronic pain. S. M. TODOROVIC*; W.
CHOE; R. B. MESSINGER; E. LEACH; D. BOJADZIC; V.
N. UEBELE; J. J. RANGER; V. JEVTOVIC-TODOROVIC.
Univ. Virginia Hlth. Syst., Dept. of Anesthesiology,InJe Univ.
Ilsan Paik Hosp. & Col. of Med., Univ. of Virginia Hlth. Syst.,
Merck Res. Labs.
Neuroscience 2010  |  Sunday PM  |  85 
4:00 F25 240.12 Neuraminidase alters pain thresholds in
diabetic ob/ob mice. R. SALAJEGHEH*; K. KRISHNAN; D.
F. COVEY; V. JEVTOVIC-TODOROVIC; S. M. TODOROVIC.
Univ. of Virginia, Washington Univ.
1:00 F26 240.13 A novel system for studying AMPA
receptor trafficking and the associated proteins. W. TANG*;
K. BOBSIN; J. VON ENGELHARDT; R. SPRENGEL. MPIMF,
Dept. Clin. Neurobiology, Univ. of Heidelberg.
2:00 F27 240.14 STIM1 and STIM2 behave differently
in neurons during store operated calcium entry. J.
GRUSZCZYNSKA-BIEGALA; J. KUZNICKI*; P. POMORSKI.
Intl. Inst. of Mol. and Cell Biol., Nencki Inst. of Exptl. Biol.
3:00 F28 240.15 Gain of function in FHM-1 CaV2.1 knock-
in mice is related to the SHAPE of THE action potential. O.
D. UCHITEL*; C. GONZALEZ INCHAUSPE; F. J. URBANO;
M. N. DI GUILMI; I. D. FORSYTHE; M. D. FERRARI; A. M.
J. M. VAN DEN MAAGDENBERG. IFIBYNE UBA CONICET,
Neurotoxicity at the Synaptic Interface, MRC Toxicology Unit,
Univ. of Leicester, Dept. of Neurology, Leiden Univ. Med. Ctr.
4:00 F29 240.16 The number of synaptic calcium channels
at the first auditory synapse. T. FRANK; T. WANG; A. NEEF;
N. M. CHAPOCHNIKOV; T. MOSER*. Univ. Goettingen
Med. Sch., BFNT, MPI for Dynamics and Self-Organization,
BCCN.
1:00 F30 240.17 Dopaminergic modulation of spike
bursting in auditory brainstem interneurons. K. J. BENDER*;
C. P. FORD; L. O. TRUSSELL. Oregon Hlth. and Sci. Univ.
2:00 F31 240.18 Spontaneous firing in cultured mouse
hippocampal networks is regulated by Ca2+ channels, NGF
and BDNF: a study using multielectrode array (MEAs)
recording. J. ROJO-RUIZ; A. MARCANTONI; A. CARO; E.
CARBONE*. Univ. Turin, Inst. Molec Physiol & Genet.
3:00 F32 240.19 Role of ryanodine receptors in
skin permeability barrier homeostasis. S. DENDA*; M.
TSUTSUMI; M. GOTO; M. DENDA. Shiseido Res. Ctr.
4:00 F33 240.20 A novel role for calretinin in directly
regulating Cav2.1 Ca2+ channels. C. J. CHRISTEL*; O.
ARENDT; R. SCHAER; L. KREINER; D. GRABS; H.
SCHMIDT; J. EILERS; B. SCHWALLER; A. LEE. Univ. of
Iowa, Univ. of Leipzig, Univ. of Fribourg, Emory Univ.
1:00 F34 240.21 Caspase-3 cleaved type 1 inositol
1,4,5-trisphosphate receptor alters endoplasmic reticulum
calcium buffering. C. M. KOPIL*; J. K. FOSKETT; R. W.
NEUMAR. Univ. of Pennsylvania.
2:00 F35 240.22  •  Presynaptic calcium sensor protein
dependent modulation of Cav2.1 channels and synaptic
plasticity. K. LEAL*; S. MOCHIDA; T. SCHEUER; W. A.
CATTERALL. Univ. of Washington, Tokyo Med. Univ.
3:00 F36 240.23 Enhanced mobile buffer capacity
leads to Ca2+ influx normalization and lower resting Ca+2
concentration in CA1 pyramidal neurons from aging rats. F.
A. OLIVEIRA*; M. M. OH; J. WATERS; J. F. DISTERHOFT.
Northwestern Univ.
4:00 F37 240.24 The role of calbindin and fixed buffers
in shaping the time course of calcium signals in dentate
granule cells. E. A. MATTHEWS*; D. DIETRICH. Univ. Clin.
Bonn.
1:00 F38 240.25 Insights into CaBP4 regulation of L-type
calcium channel through systematic identification of novel
binding sites. P. S. YANG*; M. B. JOHNY; D. T. YUE. Johns
Hopkins Sch. Med.
86  |  Society for Neuroscience
2:00 F39 240.26 Identification and modulation of voltage-
gated calcium channels in zebrafish Rohon-Beard neurons.
Y. WON*; F. ONO; S. R. IKEDA. NIH/NIAAA.
3:00 F40 240.27 Knockdown of RGK proteins with
morpholino oligonucleotides interferes with early zebrafish
development. S. R. IKEDA*; Y. WON; J. M. URBAN; H. L.
PUHL, III; F. ONO. NIH/NIAAA.
POSTER
241. Neurotransmitter Release: Vesicle Docking and Fusion
Theme B: Neural Excitability, Synapses, and Glia:
Cellular Mechanisms
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 F41 241.1 Analysis of UNC-18/SNARE interactions
in vivo. E. G. BEND*; C. E. HOPKINS; J. E. RICHMOND; E.
M. JORGENSEN. Univ. of Utah, Howard Hughes Med. Inst.,
Univ. of Illinois at Chicago.
2:00 F42 241.2 Severe reduction in Syntaxin1 expression
levels decreases synaptic efficiency. M. ARANCILLO; S.
GERBER; J. RAH; M. C. WESTON*; T. C. SUDHOF; C.
ROSENMUND. Baylor Col. of Med., Univ. of Heidelberg,
Natl. Inst. of Neurolog. Disorders and Stroke, Howard
Hughes Med. Institute, Stanford Univ., Neurocure Neurosci.
Res. Ctr.
3:00 F43 241.3  •  Mapping Rab3 and Rab27 effector
interactions to secretory granule behavior. V. A. CAZARES*;
A. LAM; D. PASSMORE; A. SUBRAMANI; S. A. ERNST; E.
STUENKEL. Univ. of Michigan.
4:00 F44 241.4 Establishing a role of Rab27 in docking
and exocytosis of large dense-core granules in mouse
chromaffin cells. W. W. HOERAUF*; D. R. PASSMORE;
A. SUBRAMANI; S. A. ERNST; E. L. STUENKEL. Univ.
Michigan.
1:00 F45 241.5 Rabphilin supports evoked synaptic
release in Drosophila. M. PAUL*; D. LJASCHENKO; M.
HECKMANN; R. KITTEL. Inst. of Physiol., Rudolf Virchow
Center, DFG Res. Ctr. for Exptl. Biomedicine.
2:00 F46 241.6 Mapping the functional heterogeneity of
tomosyn isoforms in neurotransmission. E. L. STUENKEL*;
A. D. LAM; D. PASSMORE; S. A. ERNST; A. L. WILLIAMS.
Univ. Michigan.
3:00 F47 241.7 Three-dimensional nanometer-accuracy
tracking of single synaptic vesicles up to the moment of
exocytosis. H. PARK*; Y. LI; R. W. TSIEN. Mol. and Cell.
Physiol. Stanford Univ.
4:00 F48 241.8 Complexin has opposite effects on
two modes of synaptic vesicle fusion. K. FENZ; Z. HU; J.
MARTIN; J. S. DITTMAN*. Weill Cornell Med. Col., MGH/
Harvard Med. Sch.
1:00 F49 241.9 Defined protein-protein interactions
between snare complexes modulate synaptic vesicle
exocytosis in the Drosophila Melanogaster neuromuscular
junction. A. MEGIGHIAN*; D. ZANINI; M. SCORZETO; M.
RIGONI; O. ROSSETTO; S. PANTANO; M. A. ZORDAN; C.
MONTECUCCO. Univ. Padova, Inst. Pasteur of Montevideo.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
2:00 F50 241.10 αSNAP and βSNAP support synaptic
vesicle priming by regulating the recycling of free snare
proteins. A. BURGALOSSI; S. JUNG*; W. J. JOCKUSCH;
V. M. O’CONNOR; T. NISHIKI; M. TAKAHASHI; N.
BROSE; J. RHEE. MPI, Humboldt Univ. Berlin Bernstein
Ctr. for Computat. Neurosci. and Inst. for Biol., Carl Zeiss
MicroImaging GmbH, Univ. of Southampton,, Okayama Univ.
Grad. Sch. of Med., Kitasato Univ. Sch. of Med.
3:00 F51 241.11   Molecular analysis of synaptic
vesicle exocytosis. C. FISCHER; A. EAKLE; A. FOUST;
M. GRAHAM; K. GUTHMUELLER; D. POLING; D.
STEFANOVIC; M. YODER; A. HOLGADO*. Southwester
Oklahoma State Univ., Southwestern Oklahoma State Univ.
4:00 F52 241.12 Neurotransmitter release increase at
motoneuron terminals in a polyglutamine disease mouse
model. J. L. ROZAS; L. GÓMEZ-SÁNCHEZ; C. TOMÁS-
ZAPICO; J. J. LUCAS; R. FERNANDEZ-CHACON*. IBIS,
HUVR-CSIC-Univ. Sevilla& Dept Med. Physiol & Biophysics&
CIBERNED, Ctr. de Biología Mol. “Severo Ochoa” CSIC/
UAM & CIBERNED.
1:00 F53 241.13 Engineered botulinum neurotoxin c1 with
selective substrate specificity. D. WANG*; S. SUN; E. R.
CHAPMAN; M. DONG; M. B. JACKSON. Univ. Wisconsin,
Madison, Harvard Med. Sch.
2:00 F54 241.14  •  Phosphorylation of SNAP-25 regulates
dynamics of exocytotic fusion pore. Y. HSIAO*; N. CHIANG;
C. WANG. Natl. Taiwan Univ.
3:00 F55 241.15 Targeting of synaptotagmin proteins
from supraoptic nucleus to posterior pituitary after in vivo
electroporation. C. KAO*; H. JEN; T. LAI; L. HSU; C. WANG.
Natl. Taiwan Univ.
4:00 F56 241.16 Pituitary adenylate cyclase activating
polypeptide modulates exocytosis in PC12 cells. Y. DONG*;
M. HEIEN; G. NING; A. EWING. Shanghai Changzheng
Hosp., Pennsylvania State Univ., Univ. of Gothenburg.
1:00 F57 241.17 Imaging kinetics of granule fusions and
syntaxin clusters beneath them. M. MIDORIKAWA; W.
ALMERS*. Oregon Hlth. Sci. Univ.
2:00 F58 241.18 Analysis of the role of the Munc13 gene
in synaptic transmission at the Calyx of Held synapse. Z.
CHEN; F. VAROQUEAUX; S. M. YOUNG*, JR. Max Planck
Florida Inst., Max Planck Inst. for Exptl. Med.
3:00 G1 241.19 Fusion pore kinetics in peptidergic
vesicles of cultured rat lactotrophs. M. KREFT*; J.
JORGAčEVSKI; N. VARDJAN; M. STENOVEC; B.
RITUPER; R. ZOREC. Fac. of Medicine, Univ. of Ljubljana,
Celica Biomed. Ctr.
4:00 G2 241.20 Functional analysis of the accessory
α-helix of the SNARE-binding protein Complexin. T.
TRIMBUCH; M. XUE; C. ROSENMUND*. Charite Med. Sch.
Berlin, UCSD.
1:00 G3 241.21 The actin cytoskeleton regulates exocytic
site and vesicle mobilization in PC12 cells. D. RICHARDS*;
J. WANG. Cincinnati Childrens Hosp Med. Ctr.
2:00 G4 241.22 Structure-function studies of distinct
classes of BoNT/A inhibitors reveal novel features of
protease pharmacology. B. E. MOLLES*; E. K. COLLINS; W.
TUCKER; D. RUGE; F. ZEYTIN; G. OYLER; J. T. BARBIERI;
L. A. SMITH; K. D. JANDA; S. O’MALLEY; M. ADLER.
USAMRICD, BioSentinel LLC, Synaptic Res. LLC, Med.
Col. of Wisconsin, USAMRIID, Scripps Res. Inst., PanThera
Biopharma LLC.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
POSTER
242. Neurotransmitter Release: Vesicle Recycling and
Biogenesis
Theme B: Neural Excitability, Synapses, and Glia:
Cellular Mechanisms
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 G5 242.1 Regulation of quantal size and number by
GABA supply in hippocampal neurons. P. TU*; L. WANG; S.
SUPPLISSON. Ecole Normale Supérieure.
2:00 G6 242.2 Molecular mechanism of frequency
dependent alternate modes of synaptic vesicle cycling at
Sun. PM
adult mouse neuromuscular junction. Y. MAENO-HIKICHI*;
L. POLO-PARADA; K. KASTANENKA; L. T. LANDMESSER.
Case Western Reserve Univ., Univ. of Missouri.
3:00 G7 242.3 Endophilin function in endocytosis: A
membrane-bending molecule provided by exocytosis. J.
BAI*; J. S. DITTMAN; E. C. G. PYM; Z. HU; J. M. KAPLAN.
Massachusetts Gen. Hospital/Harvard Med. Sch., Weill
Cornell Med. Col.
4:00 G8 242.4 Dynasore, an inhibitor of dynamin,
increases the probability of transmitter release. H.
DOUTHITT; S. MCCANN; F. LUO; S. BURTON; T. TARR; S.
D. MERINEY*. Univ. Pittsburgh.
1:00 G9 242.5 Decoupling of synaptotagmin I mediated
synaptic vesicle endocytosis and exocytosis in hippocampal
neurons. J. YAO*; S. E. KWON; J. D. GAFFANEY; M. F.
DUNNING; E. R. CHAPMAN. Howard Hughes Med. Institute,
Univ. of Wisconsin - Madison.
2:00 G10 242.6 Autoantibodies against the amphiphysin
SH 3 domain disturb synaptic transmission and vesicle
endocytosis. B. GRÜNEWALD; C. GEIS*; S. HALLERMANN;
A. WEISHAUPT; K. V. TOYKA; M. HECKMANN; C.
SOMMER. Universitätsklinikum Würzburg, Univ. Wuerzburg,
Carl-Ludwig-Institute for Physiol., Inst. of Physiol.
3:00 G11 242.7 The role of calcium/calmodulin-activated
calcineurin in rapid and slow endocytosis at central
synapses. T. SUN; X. WU; J. XU; Z. P. PANG; W. YANG;
L. BAI; S. QADRI; D. T. YUE; J. D. MOLKENTIN; L. WU*.
NINDS, STANDFORD UNIVERSITY, JOHNS HOPKINS
UNIVERSITY SCHOOL OF MEDICINE, UNIVERSITY OF
CINCINNATI.
4:00 G12 242.8 Cdk5 dependent phosphorylation of
synapsin I affects synapsin dispersion during electrical
activity. A. M. VERSTEGEN*; T. TKATCH; A. FASSIO; F.
BENFENATI. Inst. Italiano Di Technologia, Univ. of Genoa.
1:00 G13 242.9 Differential effects of A2 type botulinum
toxin on spontaneous miniature and evoked transmitter
release from the rat spinal excitatory and inhibitory
synapses. T. MOTOMURA*; N. AKAIKE; Y. ITO; M. SHIN; K.
NONAKA; T. HARAKAWA; A. GINNAGA. Kumamoto Hlth.
Sci. Univ., The Chemo-Sero-Therapeutic Res. Inst.
2:00 G14 242.10 Optical and ultra-structural analysis
of motor nerve terminals from adult mice deficient for the
vesicular acetylcholine transporter. C. GUATIMOSIM*; E. A.
AMARAL; M. C. FONSECA; P. M. MARTINELLI; P. M. LIMA;
M. V. GOMEZ; M. A. PRADO; H. A. RODRIGUES. Federal
Univ. of Minas Gerais (UFMG), Biol. Sci. Inst. (ICB), Med.
School, Federal Univ. of Minas Gerais and Santa Casa de
Misericordia, Univ. of Western Ontario, London, ON.
3:00 G15 242.11  •  Acidic structures in snake motor
boutons. R. S. STEWART*; R. S. WILKINSON. Washington
Univ. Schl, Washington Univ. Sch. of Med.
Neuroscience 2010  |  Sunday PM  |  87 
4:00 G16 242.12 Activity-dependent GABA supply
regulates vesicle filling and inhibitory transmission in
hippocampal neurons. L. WANG*; P. TU; S. SUPPLISSON.
Ecole Normale Supérieure.
1:00 G17 242.13 Role of sterols in synaptic vesicle cycling.
J. S. DASON*; A. J. SMITH; L. MARIN; M. P. CHARLTON.
Univ. Toronto.
2:00 G18 242.14 Exocytosis is necessary for the
dispersion of synapsins during synaptic vesicle mobilization.
A. ORENBUCH; N. LIPSTEIN; D. GITLER*. Ben-Gurion
Univ., Max Planck Inst. of Exptl. Med.
3:00 G19 242.15 A novel optical probe to monitor synaptic
vesicle recycling. Y. HUA; R. SINHA; E. NEHER*; J.
KLINGAUF. Max-Planck Inst. Biophys Chem.
4:00 G20 242.16 Heterogeneity of average release
probability of readily releasable vesicles among small
hippocampal synapses. Y. S. ERMOLYUK*; F. G. ALDER; K.
E. VOLYNSKI. Inst. of Neurology, UCL.
1:00 G21 242.17 High-throughput quantitative analysis
of neurotransmitter content from individual mouse striatal
vesicles. M. L. HEIEN*; D. M. OMIATEK; A. G. EWING.
Penn State Univ., Univ. of Gothenburg.
2:00 G22 242.18 Movement of PA-GFP-Synaptophysin in
neurons. C. LIN; C. PAN*; E. LIN. Natl. Taiwan Univ.
3:00 G23 242.19 Effects of the A277C single nucleotide
polymorphism in the human vmat-1 gene on vmat-1 protein.
K. J. FISCHER-STENGER*; A. WATSON-SIRIBOE;
W. CHIU; J. K. STEWART. Univ. of Richmond, Virginia
Commonwealth Univ.
4:00 G24 242.20 AATYK1A phosphorylation by Cdk5
regulates the recycling endosome pathway. T. TAKANO*;
K. TSUTSUMI; T. SAITO; A. ASADA; M. TOMOMURA; M.
FUKUDA; S. HISANAGA. Tokyo Metropolitan Univ., MPL,
Meikai Univ. Sch. of Dent., Tohoku Univ.
1:00 G25 242.21 Developmental change of VGAT-Venus
expression in organotypic cultured cerebellar cortex and
cultured glial cells. S. YOSHIDA*; Y. KURIMOTO; T. OGO;
K. KOBAYASHI; N. HOZUMI; C. TAKAYAMA; A. FUKUDA.
Toyohashi Univ. Technol., Honda Electronics Co., Ltd., Aichi
Inst. of Technol., Dept. of Anat. 2, Univ. of the Ryukyu Fac. of
Med., Hamamatsu Univ. Sch. of Med.
2:00 G26 242.22 SorLA regulates lipoprotein lipase activity
through intracellular trafficking. S. GLERUP*; A. NYKJÆR;
S. KLINGER; G. OLIVECRONA; C. M. PETERSEN; M. S.
NIELSEN. Univ. of Aarhus, Umeå Univ.
POSTER
243. LTP: Physiology and Behavior I
Theme B: Neural Excitability, Synapses, and Glia:
Cellular Mechanisms
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 G27 243.1 Modulation of hippocampal synaptic
plasticity in the dentate gyrus by swim stress and water
maze learning in freely moving rats. H. TABASSUM*; N.
YERITSYAN; J. U. FREY. Leibniz Inst. For Neurobio.
2:00 G28 243.2 Behavioral tagging and capture: The
impact and the role of neuromodulatory and glutamatergic
innervation on hippocampus-dependent memory formation.
D. MONCADA*; F. BALLARINI; M. C. MARTINEZ; J. U.
FREY; H. VIOLA. Leibniz Inst. For Neurobio., Institue for Cell
Biol. and Neurocience - CONICET.
88  |  Society for Neuroscience
3:00 G29 243.3 The effect of swim stress on hippocampal
CA1-LTP and its modulation by the ventral tegmental area in
freely moving rats. N. B. YERITSYAN*; H. TABASSUM; J. U.
FREY. Dept. of Neurophysiology, Leibniz Inst. for Neurobio.
4:00 G30 243.4 Antidepressant treatment normalizes
stress induced alterations in synaptic plasticity, but not
anxiety state. A. MOSCICKI; J. T. KING*. Pomona Col.
1:00 G31 243.5 Protein kinase Mzeta inhibitor (ZIP) alters
cocaine sensitization and decreases VTA AMPA mediated
currents. M. E. VELEZ*; R. VAZQUEZ-TORRES; M. C.
VELAZQUEZ-MARTINEZ; J. R. NIEVES-MELENDEZ; N. G.
SANCHEZ-DIAZ; T. C. SACKTOR; C. A. JIMENEZ-RIVERA.
UPR-RCM, Univ. of Puerto Rico, Rio Piedras Campus,
SUNY Downstate Med. Ctr.
2:00 G32 243.6 Dopaminein motor cortex activates PLC
pathwa to influence motor learning and synaptic plasticity. M.
RIOULT-PEDOTTI; A. PEKANOVIC; C. OSEI ATIEMO; A. R.
LUFT*. Univ. Zurich, Brown Univ., Johns Hopkins Univ.
3:00 G33 243.7 Impairment of cognitive function and
hippocampal long-term potentiation after acute exposure to
clioquinol. S. TAKADA*; A. TAKEDA; M. ANDO; K. ITAGAKI;
H. TAMANO; M. SUZUKI; H. IWAKI; N. OKU. Univ. of
Shizuoka.
4:00 G34 243.8 Role of N-cadherin in maintaining
structural, functional, and behavioral plasticity in mature
brain. J. S. NIKITCZUK*; O. BOZDAGI; X. B. WANG; T. R.
ANDERSON; E. B. BLOSS; R. MESIAS; J. MARIANI; S.
MORTILLO; Q. ZHOU; D. L. BENSON; G. W. HUNTLEY.
Mount Sinai Sch. of Med., Genentech.
1:00 G35 243.9  •  Contextual cues relevance in the
expression of diazepam withdrawal: correlation to
hippocampal synaptic plasticity and hippocampal Arc protein
expression. M. C. MONTI*; M. F. PEREZ; O. A. RAMIREZ.
Cordoba Natl. Univ., IFEC-CONICET.
2:00 G36 243.10 The adenomatous polyposis coli protein
is required for normal learning and memory. J. L. MOHN; S.
LEE; P. G. HAYDON; M. H. JACOB*. Tufts Univ. Sch. Med.
3:00 G37 243.11 Role of astrocytes in long-term
memory consolidation in the rat. M. LOPEZ-HIDALGO*;
K. SALGADO-PUGA; R. PRADO-ALCALA; C. MEDINA-
FRAGOSO; J. GARCIA-COLUNGA. Inst. de Neurobiología,
UNAM.
4:00 G38 243.12 Contextual learning requires
synaptic AMPA receptor delivery in the hippocampus. D.
MITSUSHIMA*; K. ISHIHARA; A. SANO; T. TAKAHASHI.
Yokohama City Univ. Grad Sch. Med.
1:00 G39 243.13 NR1 NMDA receptor subunit down-
regulation with odor preference learning in the neonate rat.
R. LETHBRIDGE; Q. YUAN*. Mem. Univ.
2:00 G40 243.14 Prenatal ethanol exposure enhances
long-term potentiation in the adolescent female rodent
dentate gyrus in vivo. A. K. TITTERNESS*; B. R. CHRISTIE.
Univ. of British Columbia, Univ. of Victoria, Brain Res. Ctr.
3:00 G41 243.15 Modulation of the excitatory axonal and
synaptic transmission in isolated rat hippocampus by direct
current stimulation. A. Y. KABAKOV*; P. A. MULLER; F. E.
JENSEN; A. ROTENBERG. Children’s Hospital, Harvard
Med. Sch.
4:00 G42 243.16 Altered experience-dependent regulation
of vesicular zinc in metallothionein 3 deficient mice. A. S.
NAKASHIMA*; R. H. DYCK. Univ. of Calgary.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
1:00 G43 243.17 Plasticity of glutamatergic synapses
mediate neural morphallaxis of sensory fields during
regeneration. Z. R. LYBRAND*; C. A. CRAIG; M. J. ZORAN.
Texas A&M Univ.
2:00 G44 243.18 Long-term synaptic potentiation in layer II
of the lateral entorhinal cortex in the presence of dopamine
in vitro. S. G. BARRETT*; C. A. CHAPMAN. Concordia Univ.
3:00 G45 243.19 Aversive but not rewarding stimuli
modulate synaptic properties of mesoprefrontal dopamine
neurons. S. LAMMEL*; D. I. ION; R. C. MALENKA. Stanford
Univ.
4:00 G46 243.20 Mechanisms underlying disruption of
cortical function by neonatal isolation. T. MIYAZAKI*; K.
TAKASE; R. MALINOW; T. TAKAHASHI. Yokohama City
Univ. Grad. Sch. of Med., Himeji Dokkyo Univ., UCSD.
1:00 G47 243.21 Frequency-dependent effects of rTMS
on markers for neuroplasticity: Differential outcomes in
anaesthetized and awake animals. R. GERSNER*; E.
KRAVETZ; O. LEVIT; J. FEIL; A. ZANGEN. Weizmann Inst.
of Sci.
POSTER
244. Transcription and Translation in Plasticity II
Theme B: Neural Excitability, Synapses, and Glia:
Cellular Mechanisms
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 G48 244.1 Enriched environment increases
spinophilin mRNA expression and spinophilin
immunoreactive dendritic spines in hippocampus and cortex.
X. HU*; S. BERGSTRÖM; M. BRINK; A. RONNBACK; P.
DAHLQVIST. Umea Univ. Hospital/Department of Publ. Hlth.
and Clin. Med., Karolinska Inst.
2:00 G49 244.2 Gene expression analysis of
fluoxetine induced plasticity in the adult visual cortex. E.
TIRABOSCHI*; D. GRECO; E. CASTREN. Helsinki Univ.,
Dep of biotecnology.
3:00 G50 244.3 Neuronal nitric oxide contributes to the
activity-dependent phosphorylation of Elk-1, but not CREB,
in primary cortical neurons. E. F. GALLO*; C. IADECOLA.
Weill Med. Coll Cornell Univ.
4:00 G51 244.4 JNK phosphorylation of Hes1 stabilizes
Hes1 and potentiates its repression activity on GluR1
transcription in cultured cortical neurons. C. H. LIN*; E. H. Y.
LEE. Grad. Inst. of Life Sciences, Natl. Def. Med. Ctr., Inst.
of Biomed. Sciences, Academia Sinica.
1:00 G52 244.5 Modulation of haloperidol-induced
patterns of transcription factors Nur77 and Nor-1 expression
by serotoninergic and adrenergic drugs in the mouse brain.
J. MAHEUX; L. VUILLIER; M. MAHFOUZ; C. ROUILLARD*;
D. LEVESQUE. Univ. of Montreal, Ctr. De Recherche Du
CHUQ.
2:00 G53 244.6 Isoflurane anesthesia does not
cause anterograde amnesia by globally suppressing
IEG transcription. K. BUNTING*; R. NALLOOR; A.
VAZDARJANOVA. Med. Col. of Georgia.
3:00 G54 244.7 Nur77 interacts with NGFI-B responsive
elements (NBRE) in enkephalin and neurotensin promoters
in the mouse striatum. D. VOYER; E. BOURHIS; P. J.
BLANCHET*; C. ROUILLARD; D. LEVESQUE. Univ. of
Montreal, Univ. Montreal, Laval Univ. (CRCHUQ).
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
4:00 G55 244.8 Visual experience regulates histone
methylation in the mouse visual cortex. P. TOGNINI*; E.
PUTIGNANO; A. COATTI; T. PIZZORUSSO. Scuola Normale
Superiore, Neurosci. Inst, CNR, Univ. of Florence.
1:00 G56 244.9  •  Quantal and non-stationary variance
analyses of CREB-dependent persistent long-term
potentiation in hippocampal inhibitory interneurons. I. RAN*;
I. LAPLANTE; J. LACAILLE. Univ. de Montreal.
2:00 G57 244.10 The NF-κB/IκBα autoregulatory loop
is required for proper synaptic transmission, plasticity,
and learning/memory. D. J. SHIM*; L. YANG; Z. WANG;
B. PENG; P. CHIAO; H. ZHENG. Baylor Col. of Med., MD
Anderson Cancer Ctr.
Sun. PM
3:00 G58 244.11 Blockade of transcription by proteasome
inhibition during maintenance of late phase long-term
potentiation. S. NESTEROVA*; S. UPADHYA; A. N. HEGDE.
Wake Forest Univ.
4:00 H1 244.12 Npas4 regulates neurite outgrowth and
phosphorylated synapsin I. J. YUN*; T. NAGAI; Y. HIBI; H.
KOIKE; A. NITTA; K. KURODA; K. KAIBUCHI; K. YAMADA.
Nagoya Univ. Grad. Sch. of Med.
1:00 H2 244.13 Is FKBP16 is a calcineurin regulator? S.
PENG; C. SU*; Y. HUANG. Academia Sinica, Natl. Def. Med.
Center, Military Acad.
2:00 H3 244.14 Mechanisms underlying estrogen
receptor -β mediated hippocampal synaptic plasticity. F. LIU*;
R. ARIAS; G. ZHANG; R. REVILLA-SANCHEZ; S. J. MOSS;
A. RANDALL; M. N. PANGALOS; N. J. BRANDON. Pfizer,
Tufts Univ., Univ. of Bristol.
3:00 H4 244.15 Identification of signalling pathways
involved in cholinergic regulation of Arc transcription and
translation. J. J. SOULE*; M. SCHUBERT; C. R. BRAMHAM.
Univ. Bergen.
4:00 H5 244.16 Involvement of 3’-untranslated region of
brain-derived neurotrophic factor gene in activity-dependent
mRNA stabilization. M. FUKUCHI*; M. TSUDA. Univ. of
Toyama.
1:00 H6 244.17 Dendritic level of Kv4.2 mRNA is up-
regulated by synaptic activity. H. KIM*; A. JO; J. OH.
Chungbuk Natl. Univ.
2:00 H7 244.18 Identification of a cis-acting synaptic
RNA localization element in Aplysia sensory neurons. E. J.
MEER*; D. WANG; S. KIM; K. C. MARTIN. UCLA, Riken.
3:00 H8 244.19 Vesl-1s mRNA is a translation initiation
factor expressed in area CA3 of the rat hippocampus
following mossy fiber-dependent associative long-
term potentiation in the hippocampus in vivo. K. A.
BALLESTEROS*; W. RAMOS; S. J. ARRIAGA; J. L.
MARTINEZ, Jr. The Univ. of Texas at San Antonio.
4:00 H9 244.20 Fear extinction overtraining results in
induction and anisomycin-related superinduction of c-Fos in
selective brain regions. A. VAZQUEZ*; X. ZENG; M. PEREZ;
A. FELIX; C. OLIVARES; S. PENA. Adrinel Vazquez, Univ. of
Puerto Rico-Rio Piedras Campus.
1:00 H10 244.21 Nurr1 is a CREB-regulated immediate-
early gene required for consolidation of context fear
conditioning. S. V. RIVERA-BELTRAN; A. VAZQUEZ; H.
DÍAZ; S. PENA DE ORTIZ*. Dept. of Biology, Univ. of Puerto
Rico.
Neuroscience 2010  |  Sunday PM  |  89 
2:00 H11 244.22 The role of DNA ligase IV on hippocampal
synaptic plasticity and remote memory. J. Y. LAGUNA
TORRES*; M. COLÓN CESARIO; E. CASTRO; I. SANTOS
SOTO; K. SAIED SANTIAGO; S. PEÑA DE ORTIZ. Univ. of
Puerto Rico.
POSTER
245. Of Cells and Nets
Theme B: Neural Excitability, Synapses, and Glia:
Cellular Mechanisms
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 H12 245.1 Electro-optical feedback enables
modification of cortical circuits in freely-moving animals. E.
STARK*; T. KOOS; G. BUZSAKI. Rutgers, The State Univ. of
New Jersey.
2:00 H13 245.2 Long-lasting, temporally reliable cell
sequences via threshold-adaptation in the hippocampus. V.
ITSKOV*; C. CURTO; E. PASTALKOVA; G. BUZSAKI. Univ.
of Nebraska, HHMI, Rutgers Univ.
3:00 H14 245.3 Entrainment of specific neuronal
populations in the medial septum by light-activated
channelrhodopsin2 in the mouse in vivo. M.
VANDECASTEELE*; V. VARGA; D. ENGLISH; T. KOOS; K.
DEISSEROTH; H. ZENG; G. BUZSAKI. Rutgers Univ., Inst.
of Exptl. Med., Stanford Univ., Allen Inst. for Brain Sci.
4:00 H15 245.4 3-D topography of oscillatory patterns in
the CA1 hippocampal region of the behaving rat. J. PATEL*;
S. ROYER; G. BUZSAKI. Rutgers - The State Univ. of NJ.
1:00 H16 245.5 Perturbation of hippocampal cell
dynamics by halorhodopsin-assisted silencing of PV
interneurons. S. ROYER*; B. ZEMELMAN; A. LOSONCZY;
J. MAGEE; G. BUZSAKI. Janelia Farm Res. Campus,
Columbia Univ., Janelia Farm research campus, Rutgers.
2:00 H17 245.6 Segregated subcircuits in the
hippocampal CA1 region. K. MIZUSEKI*; K. DIBA; E.
PASTALKOVA; G. BUZSÁKI. Rutgers, State Univ. NJ,
Janelia Farm Res. Campus, HHMI.
3:00 H18 245.7 The slope of hippocampal place cell
phase precession varies as a function of both position and
the quadrants of the theta cycle. M. A. BELLUSCIO*; K.
MIZUKEI; G. BUZSAKI. Rutgers Univ.
4:00 H19 245.8 Hippocampal sharp-wave ripple
oscillations: Anatomical-physiological organization
and behavioral correlates. D. W. SULLIVAN*; S. M.
MONTGOMERY; K. MIZUSEKI; J. CSICSVARI; G.
BUZSAKI. Rutgers,State Univ. NJ, Univ. of Oxford.
1:00 H20 245.9 Theta and 4 Hz oscillations: Region-
specific coupling of PFC, VTA and hippocampus in a goal-
directed behavior. S. FUJISAWA*; G. BUZSAKI. State Univ.
New Jersey, Rutgers.
2:00 H21 245.10 Suppressing epileptic spike-and-wave
discharges by extracranial alternating current stimulation. A.
BERÉNYI*; M. BELLUSCIO; G. BUZSÁKI. Rutgers Univ.
3:00 H22 245.11 Dynamics of pair-wise correlation
patterns across sleep states. A. D. GROSMARK*;
E. PASTALKOVA; A. AMARASINGHAM; K. DIBA; K.
MIZUSEKI; G. BUZSAKI. JFRC, HHMI, Rutgers Univ.
4:00 H23 245.12 Rebound spiking in the entorhinal cortex
of anesthetized rats. P. P. QUILICHINI*; M. ADHIKARI; G.
BUZSÁKI; C. BERNARD. INSERM U751, CMBN Rutgers
Univ.
90  |  Society for Neuroscience
POSTER
246. Dendritic Excitability and Synaptic Integration
Theme B: Neural Excitability, Synapses, and Glia:
Cellular Mechanisms
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 H24 246.1 Role of TRPC channels in dendritic
integration and subthreshold membrane potential plateaus.
M. E. PETERSSON*; E. A. FRANSEN. Sch. of Computer
Sci. and Communication, Royal Inst. of Technol.
2:00 H25 246.2  •  Frequency preference of a layer V
pyramidal neuron in response to oscillatory inhibition at the
apical tuft dendrites. X. LI; K. MORITA; H. P. C. ROBINSON;
M. SMALL*. Hong Kong Polytechnic Univ., The Univ. of
Tokyo, Univ. of Cambridge.
3:00 H26 246.3 Local and non-linear dendritic integration
is required for spiking responses that encode spatio-
temporal patterns of EPSPs in pyramidal neurons. R. CAZE;
M. HUMPHRIES; B. S. GUTKIN*. Group For Neural Theory,
LNC INSERM U960, Ecole Normale Superieure, Group For
Neural Theory, LNC U960, Ecole Normale Superieure.
4:00 H27 246.4 Impact of local and global dendritic
geometry on Ca2+ dynamics in the dendrites of discharging
Purkinje neuron. A simulation study. I. B. KULAGINA*; T.
S. NOVORODOVSKA; S. M. KOROGOD. Dniepropetrovsk
Natnl Univ.
1:00 H28 246.5 Synaptically activated Ca2+ waves
and NMDA spikes locally suppress voltage dependent
Ca2+ signaling in hippocampal pyramidal cell dendrites. S.
MANITA*; W. N. ROSS. New York Med. Col.
2:00 H29 246.6  •  Three dimensional real-time scanning
revealed a new type of dendritic nmda spike in interneurons.
B. ROZSA*; G. KATONA; A. KASZÁS; G. F. TURI; A.
VÁGVÖLGYI; B. CHIOVINI; N. HÁJOS; G. TAMÁS; S.
E. VIZI. Inst.of Exptl. Med., 2Research Group for Cortical
Microcircuits of the Hungarian Acad. of Sci.
3:00 H30 246.7  •  Differential impact of inputs to
asymmetrical dendrites on intrinsic neuron codes. S. M.
KOROGOD*; I. B. KULAGINA. Dnipropetrovsk Natl. Univ.,
Intl. Ctr. for Mol. Physiol.
4:00 H31 246.8 Instantaneous 3D photostimulation
of the dendritic arbor using holographic illumination. S.
YANG; C. TANG*; E. PAPAGIAKOUMOU; V. DE SAR; R.
DI LEONARDO; V. EMILIANI. Univ. Maryland Sch. Med.,
Baltimore VA MC, Univ. of Paris Descartes, Univ. di Roma
‘La Sapienza’.
1:00 H32 246.9  •  Developmental profile of localized,
spontaneous Ca2+ release events in the dendrites of
hippocampal pyramidal neurons. K. MIYAZAKI; S. MANITA;
W. N. ROSS*. New York Med. Col.
2:00 H33 246.10 The slow afterhyperpolarization
modulates the dendritic action potential evoked calcium rise.
J. M. POWER*; P. CURBY; C. BOCKLISCH; P. SAH. Univ. of
Queensland.
3:00 H34 246.11 Active properties of CA3 pyramidal
neuron dendrites. S. KIM; S. J. GUZMAN; H. HU; M.
BARTOS*; P. JONAS. Inst. of Physiol. I, Univ. Freiburg, Inst.
of Sci. and Technol. (IST), Dept. of Physiol. at Inst. of Basic
Med. Sci. and Ctr. for Mol. Biol. and Neurosci. (CMBN), Univ.
Aberdeen.
4:00 H35 246.12  •  Action potential propagation in oblique
dendrites of CA1 pyramidal cells. W. ZHOU; S. D. ANTIC*.
UConn Hlth. Ctr.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
1:00 H36 246.13 Diversity in morphological features
of dendritic tree of thalamocortical neuron controls the
spatial pattern of signal propagation. R. ZOMORRODI
MOGHADDAM*; H. KRÖGER; I. TIMOFEEV. Laval Univ.,
Dept. of Physics, Dept of Psychiatry and Neurosci.
2:00 H37 246.14 Rebound spiking in CA1 pyramidal
neuron dendrites can be locally modulated by the A-type K+
current. M. MIGLIORE*; S. GASPARINI; V. MEDINILLA; G.
A. ASCOLI. Natl. Res. Council, Louisiana State Univ. Hlth.
Sci. Ctr., George Mason Univ.
3:00 H38 246.15 Pathophysiology of information
processing in neocortical dendrites in Fragile X Syndrome. Y.
ZHANG; A. BONNAN; M. GINGER; A. A. FRICK*. INSERM
U862, Neurocentre Magendie.
4:00 H39 246.16 Role of active dendritic conductances in
subthreshold input integration. M. W. REMME*; J. RINZEL.
New York Univ.
1:00 H40 246.17  •  Cell-type-specific and activity-
dependent dynamics of action potential-evoked Ca2+ signals
in dendrites of hippocampal inhibitory interneurons. L.
TOPOLNIK*. CRULRG, Univ. Laval.
2:00 H41 246.18 AMPA receptor-mediated electrical and
dendritic Ca2+ signals in the midbrain dopamine neurons. J.
JANG*; M. PARK. Sungkyunkwan Univ.
3:00 H42 246.19 Postsynaptic group II metabotropic
glutamate receptor activation in dentate gyrus granule cells.
J. BRUNNER; S. VAN-WEERT; F. KLEINE-BORGMANN; S.
JESSBERGER; J. SZABADICS*. Inst. of Exptl. Medicine,
Hungarian Acad. of Sci., ETH-Hönggerberg.
4:00 H43 246.20 Quantitative evaluation of anatomically-
detailed and reduced compartmental models in simulating
spinal motoneurons firing behaviors. S. M. ELBASIOUNY*;
R. K. POWERS; C. J. HECKMAN. Northwestern Univ., Univ.
of Washington.
1:00 H44 246.21 Dynamic regulation of recurrent inhibition
during theta activity controls synaptic integration and
neuronal output. S. REMY*; C. MÜLLER; H. BECK. Univ. of
Bonn, German Ctr. for Neurodegenerative Dis. (DZNE).
2:00 H45 246.22 Two photon excitation imaging of
dendritic membrane potential using fluorinated voltage-
sensitive dyes. C. D. ACKER*; P. YAN; L. M. LOEW. UConn
Hlth. Ctr.
3:00 H46 246.23 Dendritic Ca2+ rises through glutamate
receptors and voltage-operated Ca2+ channels in midbrain
dopamine neurons. M. JANG*; H. CHO; M. PARK.
Sungkyunkwan Univ. Sc. Med.
POSTER
247. Alzheimer’s Disease: Abeta, Energy Metabolism, Cell
Signaling, Autophagy
Theme C: Disorders of the Nervous System
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 H47 247.1 The role of local translation in Alzheimer´s
disease. J. BALERIOLA*; U. HENGST. Columbia Univ. Med.
Ctr.
2:00 H48 247.2 Low molecular weight Aβ induces
autophagosome accumulation via endoplasmic reticulum
aggregation. Q. ZHANG*; Y. CHEUNG; Y. HO; R. C. C.
CHANG. The Univ. of Hong Kong.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
3:00 H49 247.3 Beta-amyloid (Αβ) causes dysregulation
of autophagy through mTOR-dependent and -independent
pathways. F. BA; D. MACTAVISH; J. H. JHAMANDAS*. Univ.
of Alberta, Univ. Alberta.
4:00 H50 247.4 Amyloid β-petide oligomers impairs
neuronal energy metabolism. G. S. SEIXAS DA SILVA*; H.
M. MELO; W. S. DA-SILVA; W. L. KLEIN; S. T. FERREIRA;
F. G. DE FELICE. Federal Univ. of Rio De Janeiro,
Northwestern Univ.
1:00 H51 247.5 Study kinetics of calcineurin (can)
activation in an in vitro model of alzheimer’s disease (ad)
using spectral fluorescence resonance energy transfer
(fret). H. WU*; E. HUDRY; T. HASHIMOTO; K. UEMURA; Z.
Sun. PM
FAN; O. BEREZOVSKA; C. GROSSKREUTZ; B. BACSKAI;
B. HYMAN. Mass. Gen. Hosp., Mass general hospital,
Massachusetts Eye and Ear Indirmary.
2:00 H52 247.6 The potential protective effects of HspB1
in Alzheimer’s disease. M. G. CONWAY*; F. NAFAR; K. M.
MEAROW. Mem. Univ. of Newfoundland.
3:00 H53 247.7  •  Amyloid toxicity induced by in vivo
injection of Aβ25-35 oligomeric preparations is enhanced
after pharmacologic or genetic invalidation of the sigma-1
chaperone protein. T. MAURICE*; V. VILLARD; F. DUHR; N.
CHEVALLIER. INSERM U.710, Amylgen.
4:00 H54 247.8 Amyloid-beta regulates leptin expression
and tau phosphorylation through the mTORC1 signaling
pathway. G. A. MARWARHA*; J. SCHOMMER; O. GHRIBI.
Univ. of North Dakota.
1:00 H55 247.9 A chemical biology approach for the
elucidation of neurotoxicity associated with β-amyloid.
D. FRANCESCHINI; M. CAMARRI; L. TERZUOLI; T.
FERRARO; R. RONCARATI; G. POLLIO; D. DIAMANTI; L.
MAGNONI; A. TARDITI; S. BERNOCCO; S. RASMUSSEN;
B. NIELSEN; S. BRUNAK; A. SANTUCCI; L. MILLUCCI; A.
BILIA; A. KARIOTI; A. CARICASOLE*; G. C. TERSTAPPEN.
Siena Biotech Spa, Tech. Univ. of Denmark, Univ. of Siena,
Univ. of Florence.
2:00 H56 247.10 Ordering the pathway: Hierarchical
relation of caspase-2 and Bim in beta-amyloid induced
neuronal death. Y. Y. JEAN*; E. M. RIBE; L. A. GREENE; C.
M. TROY. Columbia Univ.
3:00 H57 247.11 Cerebral heme homeostasis in a mouse
model of Alzheimer disease. B. E. DWYER*; J. R. BEAN; G.
PERRY; X. ZHU; M. A. SMITH. VA Med. Ctr., Univ. of San
Antonio, Case Western Reserve Univ.
4:00 H58 247.12 Inhibition of GSK-3β activity alleviated
amyloid β25-35-induced toxicity and memory deficits in mice.
D. MEUNIER*; S. H. KIM; T. MAURICE. INSERM U.710,
EPHE, UMII, Inst. of Biomed. Science, Col. of Medicine,
Hanyang Univ.
1:00 H59 247.13 Enhanced expression of the voltage-
dependent anion channel (VDAC1) in Alzheimer’s transgenic
mice. M. CUADRADO-TEJEDOR; M. VILARIÑO; J.
CABODEVILLA; J. DEL RIO*; D. FRECHILLA; A. PÉREZ-
MEDIAVILLA. FIMA - CIMA, CIBERNED.
2:00 H60 247.14 Perturbation of endoplasmic reticulum
and mitochondria rather than reduced activity of mTOR
trigger autophagy in neurons exposed to low molecular
weight beta-Amyloid peptide. R. C. CHANG*; N. Q. ZHANG;
C. H. HUNG; Y. CHEUNG. Fac Med. Univ. Hong Kong.
Neuroscience 2010  |  Sunday PM  |  91 
3:00 H61 247.15 Relationship between low molecular
weight beta-amyloid peptide-induced fission/fusion
imbalance and mitochondrial functions. C. H. HUNG*; Y.
T. CHEUNG; S. WUWONGSE; N. Q. ZHANG; R. C. C.
CHANG. The Univ. of Hong Kong.
4:00 H62 247.16 Iron and amyloid β peptide oligomers
stimulate mitochondrial fission in primary hippocampal
neurons by enhancing ryanodine receptor-mediated
calcium release. C. SANMARTÍN*; A. C. PAULA-LIMA; S.
HÄRTEL; A. GARCÍA; M. NÚÑEZ; C. HIDALGO. CEMC,
UNIVERSIDAD DE CHILE, Univ. de Chile.
1:00 H63 247.17 Specific inhibition of the calcineurin/NFAT
pathway improves the pathological morphological changes
induced by Amyloid ß in primary neurons. E. HUDRY*; H.
WU; M. ARBEL; D. JOYNER; Z. FAN; T. L. SPIRES; B. J.
BACSKAI; B. T. HYMAN. MGH.
2:00 H64 247.18 Amyloid beta resistance in nerve cells
is mediated by metabolic reprogramming reminiscent of
the Warburg effect in cancer cells. J. T. EPSTEIN*; R. C.
CUMMING. Univ. of Western Ontario.
3:00 H65 247.19 Soluble oligomers of amyloid-beta
1-42 acutely impair spatial working memory, prevent task-
associated hippocampal metabolism, and reduce membrane
GluT4. J. PEARSON-LEARY*; E. C. MCNAY. Univ. At
Albany.
4:00 H66 247.20 Immunohistochemical evidence for
macroautophagy in neurons and endothelial cells in
Alzheimer’s disease. G. M. HALLIDAY*; J. MA; Y. HUANG;
S. CHEN. Prince of Wales Med. Res. Inst., Ruijin Hospital,
Shanghai Jiaotong Univ. Sch. of Med.
1:00 H67 247.21 The effects of mitochondrially targeted
catalase on amyloid beta pathology and mitochondrial
function in amyloid beta precursor-protein transgenic mice.
P. MAO*; M. MANCZAK; A. P. REDDY; M. J. CALKINS; P.
RABINOVITCH; P. H. REDDY. Oregon Hlth. & Sci. Univ.,
Univ. of Washington.
2:00 H68 247.22 GLUT-1 reduction at the BBB causes
neuronal dysfunction in a mouse model of AD. Y. NISHIDA*;
D. PERLMUTTER; R. LOVE-KASISCHKE; S. LANE; R. D.
BELL; E. WINKLER; M. THIYAGARAJAN; A. SAGARE; D. C.
DE VIVO; R. DEANE; B. V. ZLOKOVIC. Univ. of Rochester
Med. Ctr., Columbia Univ. CPS.
3:00 H69 247.23  •  Metabolite analysis in brain
extracts from Alzheimer transgenic mice. S.
SANKARANARAYANAN*; Y. HE; M. PIERDOMENICO; N.
ARANIBAR; D. BARTEN; P. SHIPKOVA; S. HNATYSHYN;
C. F. ALBRIGHT; M. REILY. Bristol-Myers Squibb.
4:00 H70 247.24 Impaired glucose tolerance in an APP/
PS1 mouse model of Alzheimer’s disease. L. N. MACKLIN*;
Y. CAI; X. YAN; G. M. ROSE; P. R. PATRYLO. Southern
Illinois Univ. Carbondale.
1:00 I1 247.25 Central injection of streptozotocin induces
an Alzheimer’s disease-like phenotype in mice. A. NIKKEL;
Y. LEE*; K. KOHLHAAS; N. RUSTAY; M. DAY; R. BITNER.
Abbott Labs.
2:00 I2 247.26  •  Dimebon (Latrepirdine) targets AMP-
activated protein kinase (AMPK) and promote neurite
outgrowth and mitochondrial protection in hippocampal
neurons. S. BERNALES*; I. E. ALFARO; D. VEGA; A. A.
PROTTER. Fundacion Ciencia Para La Vida, Medivation Inc.
92  |  Society for Neuroscience
3:00 I3 247.27 Reduced Alzheimer’s disease pathology
and enhanced insulin signaling in early type 1 diabetes
in an overexpressing amyloid beta mouse model. J. S.
SCHAPANSKY*; G. ODERO; T. ENNO; M. DEL BIGIO;
G. GLAZNER. St. Boniface Rese Ctr, Univ. Ma, Univ. of
Manitoba, St. Boniface Res. Ctr.
4:00 I4 247.28 Abnormal interaction of Drp1 with
amyloid beta in neurons from Alzheimer’s disease patients:
Implications for mitochondrial fragmentation and neuronal
damage. M. MANCZAK*; P. H. REDDY. Oregon Hlth. Sci.
Univ., Oregon Natl. Primate Res. Center, OHSU.
1:00 I5 247.29 Transcription factors nrf1 and ets1
regulate the core promoter activity of the human insulin
degrading enzyme gene. M. C. LEAL*; E. I. SURACE; E. M.
CASTAÑO; L. MORELLI. Fund Inst. Leloir.
2:00 I6 247.30 Effects of general anesthetic isoflurane
on autophagy in a cell model of Alzheimer’s disease. G.
LIANG; S. INAN; J. PENG; H. WEI*. Univ. Pennsylvania,
Second Affiliated Hosp. of Sun Yat-sen Univ.
POSTER
248. Alzheimer’s Disease: Role of Cholesterol and APOE in
the CNS
Theme C: Disorders of the Nervous System
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 I7 248.1 Elevated endolysosomal pH is involved
in LDL-induced amyloid beta over-production in primary
cultured neurons. L. HUI*; X. CHEN; R. L. GRENDELL; J. D.
GEIGER. Univ. of North Dakota.
2:00 I8 248.2  •  Blocking the binding between
apolipoprotein E and Aß reduces intraneuronal Aß
accumulation and ameliorates synaptic degeneration. M.
SADOWSKI*; M. KUSZCZYK; M. DUSZCZYK; M. GURIDI;
J. KIM; D. M. HOLTZMAN; P. M. SULLIVAN. New York Univ.
Sch. of Med., New York Univ. Sch. of Med., Washington
Univ. Sch. of Med., Duke Univ. Sch. of Med.
3:00 I9 248.3 Conformational analysis of apolipoprotein
E using pyrene fluorescence as a tool. G. BAINS; A. B.
PATEL; V. NARAYANASWAMI*. California State Univ. Long
Beach.
4:00 I10 248.4 Human apoE4 targeted replacement mice
show a reduced NMDA receptor-mediated neurotransmission
in dentate gyrus. S. YUN*; K. A. PARK; B. L. TROMMER.
Maimonides Med. Ctr., NorthShore Univ. HealthSystem,
Northwestern Univ. Med. Sch., SUNY Downstate Med. Ctr.
1:00 I11 248.5 Regulation of apolipoprotein-e gene
expression by pregnane x receptor (pxr) in h4 neuroglioma
cells. J. T. SCHOTT; B. MOGHIS; N. IZADI; N. V. PATEL*.
CSU - Fullerton, Ctr. for Applied Biotech. Studies, CSU-
Fullerton.
2:00 I12 248.6 siRNA to gadd153 reduces
27-hydroxycholesterol-induced Alzheimer’s disease
pathology. J. P. RANTHAM PRABHAKARA*; T. LARSON; J.
SCHOMMER; O. GHRIBI. Univ. North Dakota Sch. of Med.
and Hlth. Sci.
3:00 I13 248.7 Cholesterol enrichment manifests
cellular changes associated with Alzheimer’s disease-linked
presenilin mutations. Y. CHUN*; S. CHUNG. Sungkyunkwan
Univ. Sc. Med.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
4:00 I14 248.8 Altered cholesterol esterification in rat
hippocampus after kainate-induced neurodegeneration. J.
KIM*; W. ONG. Natl. Univ. of Singapore.
1:00 I15 248.9 Reduced CoQ10 in aged beagles
chronically treated with atorvastatin (Lipitor). G. CENINI*; S.
B. MARTIN; E. BARONE; D. A. BUTTERFIELD; E. HEAD.
Univ. of Kentucky, Sanders-Brown Ctr. on Aging.
2:00 I16 248.10 Predictive power of apolipoprotein
ε (APOE) status for volumes of medial temporal lobe
structures. J. P. HEGARTY II*; C. SUMIDA; C. MURPHY.
San Diego State Univ., UCSD.
3:00 I17 248.11 ApoE targets oligomeric amyloid-beta to
synapses, promoting its synaptotoxic effects. R. M. KOFFIE*;
S. HOU; D. JOYNER; T. HASHIMOTO; V. M. LEE; D. M.
HOLTZMAN; B. T. HYMAN; T. SPIRES-JONES. Harvard
Univ., Massachusetts Gen. Hosp., Univ. of Pennsylvania,
Washington Univ. in St. Louis.
4:00 I18 248.12 A systems biology model studying the
role of cholesterol in Alzheimer’s disease pathogenesis. C.
R. KYRTSOS*; J. S. BARAS; H. LEE. Univ. of Maryland.
1:00 I19 248.13 Overexpression of the LDL receptor
increases the metabolism of apoE and Aβ by primary
cultured astroglial cells. J. M. BASAK; J. KIM*; D. M.
HOLTZMAN. Washington Univ. Sch. of Med.
2:00 I20 248.14 Cellular cholesterol levels modulate Aβ
degradation. C. D. LEE*; Q. JIANG; S. MANDREKAR; G. E.
LANDRETH. Case Western Reserve Univ.
3:00 I21 248.15 Endolysosome involvement in LDL-
induced amyloid beta over-production in human skeletal
muscle cells. X. CHEN*; L. HUI; R. L. GRENDELL; J. D.
GEIGER. Univ. of North Dakota.
4:00 I22 248.16 Neuroinflammation with accelerated
amyloid deposition and tau phosphorylation in PDAPP
mice fed a high fat/high cholesterol diet. N. R. BHAT*; J.
HIRSCHHORN; S. MOHANTY. Med. Univ. South Carolina.
1:00 I23 248.17 Older APOE+ individuals exhibit
slower olfactory ERPs than middle age and young APOE+
individuals. M. LEE-PHILIPSEK*; C. D. MORGAN; C.
MURPHY. San Diego State Univ., Univ. of California San
Diego Med. Ctr.
2:00 I24 248.18 Increased expression of cholesterol 24S
hydroxylase due to the H63D variant of HFE: A risk factor for
Alzheimer Disease. F. ALI-RAHMANI*; S. LEE; W. NANDAR;
E. NEELY; J. CONNOR; C. SCHENGRUND. Pennsylvania
State Univ.
3:00 I25 248.19 Role of apoe lipidation status and
presence of the neuronal cell membrane in apoe/aβ complex
formation. P. B. VERGHESE; H. JIANG; A. R. SHAH; D. M.
HOLTZMAN*. Washington Univ. Sch. of Med.
POSTER
249. Tau: Cellular Pathways, Role in AD and
Neurodegeneration
Theme C: Disorders of the Nervous System
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 I26 249.1 Regulation of neuronal selenoprotein
S by glucose and ER stress: Implications for Alzheimer’s
disease and impact of type II diabetes. A. S. TAKEMOTO;
M. T. BELLINGER; L. R. WHITE; M. J. BERRY; F. P.
BELLINGER*. JABSOM, Univ. Hawaii, KUAKINI MEDICAL
CENTER.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
2:00 I27 249.2 Cellular mechanism involved in tau
oligomers neurotoxicity. C. A. LASAGNA-REEVES*; D.
CASTILLO-CARRANZA; U. SENGUPTA; A. CLOS; R.
KAYED. Univ. of Texas Med. Br.
3:00 I28 249.3 Interaction of 14-3-3 and tau
protein relate to the Alzheimer’s disease pathology
through interruption of axon development. Y. JOO*; B.
SCHUMACHER; C. OTTMANN; Y. SUH. Col. of Medicine,
Seoul Natl. Univ., Max-Planck-Society.
4:00 I29 249.4 Mapping O-GlcNAc modification sites on
tau and generation of a site-specific O-GlcNAc tau antibody.
S. YUZWA*; A. K. YADAV; Y. SKOROBOGATKO; T. CLARK;
K. VOSSELLER; D. VOCADLO. Simon Fraser Univ., Drexel
Sun. PM
Univ. Col. of Med.
1:00 I30 249.5 Role of polyphenols from grape seeds in
attenuation of tau pathology spreading. I. SANTA-MARIA*;
H. KSIEZAK-REDING; J. WANG; L. HO; G. M. PASINETTI.
Mount Sinai Sch. of Med.
2:00 I31 249.6 LR11 associates with pathological
tau in Alzheimer’s disease and Down’s syndrome. A. R.
SYLVESTER*; M. GEARING; E. J. MUFSON; L. KHOOGAR;
J. J. LAH; A. I. LEVEY. Emory Univ., Rush Univ.
3:00 I32 249.7 Post-transcriptional regulation of tau
proteins by Abeta peptide treatment in neuroblastoma cells
through GSK3beta-SC35 pathway. K. CHEN*; C. HU; C.
HSU. Shih Kong Wu Ho-Su Mem. Hosp., Taipei Med. Univ.
Shuang-Ho Hosp., China Med. Univ.
4:00 I33 249.8 Identifying protein complexes that fate
microtubule associated protein tau (MAPT) for degradation.
A. D. THOMPSON; V. BASRUR; K. S. J. ELENITOBA-
JOHNSON; C. A. DICKEY*; J. E. GESTWICKI. Univ. of
Michigan, Univ. South Florida.
1:00 I34 249.9 The dynamic analysis of microtubule
disruption caused by tau hyperphosphorylation. C. P.
CORBO*; E. ALANIZ; W. L’AMOREAUX; A. D. C. ALONSO.
City Univ. of New York Grad. Ctr., CUNY Col. of Staten
Island.
2:00 I35 249.10 Association of protein kinase C delta
with neurofibrillary tangles in Alzheimer brain tissues. Y.
SONODA*; K. MATSUO; M. TAKAHASHI; H. MUKAI; Y.
ONO; K. MAEDA; H. AKIYAMA; T. KAWAMATA. Kobe Univ.
Grad. Sch. of Hlth. Sci., Biosignal Res. Center, Kobe Univ.,
Kobe Univ. Grad. Sch. of Med., Tokyo Inst. of Psychiatry.
3:00 I36 249.11 Acetylation inhibits tau degradation and
contributes to tauopathies. S. MIN; S. CHO; Y. ZHOU; B.
SUN; S. SCHROEDER; W. W. SEELEY; E. J. HUANG; Y.
SHEN; E. MASLIAH; C. MUKHERJEE; P. A. COLE; M. OTT;
L. GAN*. Gladstone Inst. of Neurolog Dis, Gladstone Inst. of
Virology and Immunol., Univ. of California, San Francisco,
Sun Hlth. Res. Inst., UCSD, Johns Hopkins Univ.
4:00 I37 249.12 The bioactive product of inflammation
prostaglandin J2 induces tau cleavage and its aggregation
contributing to neuronal damage. M. METCALFE; M. E.
FIGUEIREDO-PEREIRA*. Hunter College, City Univ. of New
York, Hunter Col. CUNY.
1:00 I38 249.13  •  Development of single chain antibody
fragments against tau oligomers for immunotherapeutics and
drug discovery. E. J. DAVIDOWITZ*; H. TIAN; J. MOE; M.
SIERKS. OLIGOMERIX, Inc., Arizona State Univ.
2:00 I39 249.14  •  Small molecule drug discovery for
Alzheimer’s disease targeting tau oligomers. M. ASNANI*;
E. DAVIDOWITZ; R. KILKUSKIE; J. MOE. Oligomerix Inc.,
Michigan High Throughput Screening Ctr.
Neuroscience 2010  |  Sunday PM  |  93 
3:00 I40 249.15 Minocycline inhibits formation of insoluble
tau aggregates in vitro. T. ROLOVA; Y. YOSHIIKE; M.
MURAYAMA; J. E. KOISTINAHO*; A. TAKASHIMA. Univ.
Eastern Finland, RIKEN Brain Sci. Inst.
4:00 J1 249.16 β-Amyloid induced hyperphosphorylation
of tau: Possible involvement of insulin signal dysfunction.
T. TOKUTAKE; K. KASUGA; R. YAJIMA; H. KANEKO; T.
ISHIHARA; M. NISHIZAWA; T. IKEUCHI*. Niigata University,
Brain Res. Inst.
1:00 J2 249.17 Impact of Type 1 diabetes on Alzheimer’s
disease pathogenesis in the brain mouse. M. PAPON*; F.
MARCOUILLER; N. EL KHOURY; F. MORIN; E. PLANEL*.
Ctr. Hospitalier de l’Université Laval.
2:00 J3 249.18  •  HSP90 as target for neuro-degenerative
diseases. A. BUIST*; K. CALLAERTS; F. VAN LEUVEN; D.
MOECHARS. Janssen, KULeuven.
3:00 J4 249.19 Putative link between proteasome
dysfunction and ATP-depletion induced by the endogenous
product of inflammation prostaglandin J2 promotes
protein aggregation and neuronal loss. Q. HUANG*; M. E.
FIGUEIREDO-PEREIRA. CUNY, Hunter College, City Univ.
of New York.
4:00 J5 249.20 Neuron-selective toxicity of tau
peptide in a cell culture model of Alzheimer’s disease
and neurodegenerative tauopathy. L. WANG; K. ZHAO;
G. IPPOLITO; V. J. PRICE; M. KIM; G. CORNWELL; S.
FULENCHEK; G. BREEN; W. GOUX; S. R. D’MELLO*. Univ.
Texas Dallas.
1:00 J6 249.21 The effects of PPP2R2B on Alzheimer’s
disease pathogenesis correlate with tau phosphorylation,
but not CAG repeat lengths. R. KIMURA; T. MORIHARA; T.
KUDO*; K. KAMINO; M. TAKEDA. Osaka Gen. Med. Ctr.,
Osaka Univ, Grad Sch. of Med., Natl. Hosp. Organization,
Shoraiso Hosp.
2:00 J7 249.22  •  Evaluation of tau phosphorylation using
the gyros immunoassay platform. A. M. THOMAS; R. A.
DURHAM; S. G. BOYER; P. C. LOOS; C. D. HICKS; W. D.
HIRST*. Pfizer, Gyros.
3:00 J8 249.23  •  Induction of the P301L mutation
following the removal of doxycycline in tau transgenic
mice (rTg4510). T. T. KAWABE*; T. M. BROWN; K. E. G.
RICHTER; D. CAOUETTE; A. S. KLEIN; C. D. HICKS; A. J.
MILICI. Pfizer Inc.
POSTER
250. Parkinson’s Disease: In Vivo Therapies
Theme C: Disorders of the Nervous System
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 J9 250.1   Recombinant adeno-associated
virus mediated regulated striatal L-dopa expression
in the parkinsonian rat model. A. THOMAS*; F. P.
MANFREDSSON; R. J. MANDEL. Univ. of Florida McKnight
Brain Inst., Univ. of Florida Col. of Med.
2:00 J10 250.2  •  Knockout rat models for Parkinson’s
disease. D. FISHER*; D. JI; L. LITTLE; Y. WU; J. BOOKS;
E. WEINSTEIN; X. CUI. Sigma Advanced Genet. Engin.
(SAGE) Labs.
94  |  Society for Neuroscience
3:00 J11 250.3 Oral administration of Mucuna pruriens
water extract ameliorates parkinsonism without inducing
dyskinesias in the monkey model of Parkinson’s disease. C.
A. LIEU*; A. N. RAO; K. VENKITESWARAN; B. V. MANYAM;
T. SUBRAMANIAN. The Pennsylvania State Univ. Col. of
Med., Southern Illinois Univ.
4:00 J12 250.4   Enhanced endocannabinoid
neurotransmission is neuroprotective in an animal model
of Parkinson’s disease. T. R. JOHNSON*; M. MARELLA;
B. SMERKERS; T. L. STOLBERG; B. BOO SEO; A. YAGI;
A. MAKRIYANNIS; T. YAGI; C. FERRIS. Northeastern
University/Center For Translational Neuroimaging, The
Scripps Res. Inst., Northeastern University; Ctr. for
Translational NeuroImaging, Northeastern University; Ctr. for
Drug Discovery.
1:00 J13 250.5  •    Role of CB1 and D2 receptors in
globus pallidus on motor activity and GABA uptake and
release in hemiparkinsonian rats. M. MUNOZ ARENAS*;
L. DE JESUS; F. LUNA; F. PAZ; B. FLORAN; I. D.
LIMON. Lab. De Neurofarmacologia, BUAP, CENTRO DE
INVESTIGACION Y DE ESTUDIOS AVANZADOS-IPN.
2:00 J14 250.6  •  Differential effects of combined
adenosine A2A/A1 receptor antagonism on sleep-wake
architecture and EEG oscillations after acute versus
subchronic treatment in rats. W. DRINKENBURG*; A.
AHNAOU; H. HUYSMANS; A. HEYLEN; P. JACKSON; T.
MEERT; J. ATACK. J&J PRD, Janssen Pharmaceutica,
J&JPRD USA.
3:00 J15 250.7 Haloperidol-induced catalepsy modulation
by benzodiazepine microinjection in the inferior colliculus. L.
L. MELO*; J. G. TOSTES; P. MEDEIROS; N. C. COIMBRA;
E. A. M. FERRARI. Univ. Sao Francisco, Univ. de São Paulo,
Univ. Estadual de Campinas.
4:00 J16 250.8  •  Electroacupuncture improves motor
speed and causes changes in cortical glutamate levels in
parkinsonian rhesus monkeys. F. ZHAO; G. QUINTERO;
X. FAN; Y. AI; R. GRONDIN; X. WANG; G. GERHARDT;
Z. ZHANG*. Univ. Kentucky, Capital Univ. of Med., Univ.
of Kentucky, Morris K. Udall Parkinson’s Dis. Res. Ctr. of
Excellence.
1:00 J17 250.9 NRF2/SKN-1-dependent GST-Pi inhibits
dopamine neurodegeneration in Caenorhabditis elegans
models of Parkinson’s disease and manganism. R. NASS*;
J. LEVORA; N. VANDUYN; R. SETTIVARI. Indiana Univ.
Sch. Med.
2:00 J18 250.10 Sucrose accelerates neuroinflammation
in the rat substantia nigra. A. MCRAE*; A. ROGERS. Univ.
West Indies.
3:00 J19 250.11 Improved methods for electroacupuncture
and electromyographic recordings in normal and
parkinsonian rhesus monkeys. R. GRONDIN*; F. ZHAO; X.
FAN; R. EDWARDS; E. FORMAN; J. MOOREHEAD; G. A.
GERHARDT; X. WANG; Z. ZHANG. Anat. & Neurobiology,
Univ. of Kentucky Med. Ctr., Capital Med. Univ.
4:00 J20 250.12  •  The effect of docosahexaenoic acid on
visual evoked potentials in a mouse model of Parkinson’s
disease: the role of cyclooxygenase-2 and NFK-B. A.
AGAR*; O. OZSOY; S. DOGAN; N. DERIN; C. KENCEBAY;
N. UYSAL; B. GEMICI; P. A. YARGICOGLU; M. ASLAN.
Akdeniz Univ.
1:00 K1 250.13  •  Effects of pramipexole on rat sleep
EEG. K. M. WICKE*; G. GROSS. Neurosci. Research,
GPRD, Abbott.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
2:00 K2 250.14 Pharmacological repletion of neuronal
glutathione content in vivo. R. C. REYES*; S. WON; D.
P. JONES; R. A. SWANSON. Univ. of California, San
Francisco, San Francisco Veterans Affairs Med. Ctr., Emory
Univ.
3:00 K3 250.15 Long term behavioral effects of functional
dopaminergic neurons generated from human neural stem
cells in the rat 6-OH-DA Parkinson’s disease model. Effects
of the forced expression of Bcl-XL. T. RAMOS-MORENO;
C. G. CASTILLO*; M. GONZALEZ-MELLA; A. MARTINEZ-
SERRANO. Ctr. of Mol. Biol. “Severo Ochoa”, UAM,
U.A.S.L.P. Facultad De Medicina.
4:00 K4 250.16 In vivo electrochemical measurements
of striatal dopamine function following high fat diet
induced glucose intolerance in rats. J. K. MORRIS*; G. L.
BOMHOFF; B. K. GORRES; V. A. DAVIS; G. A. GERHARDT;
P. C. GEIGER; J. A. STANFORD. Univ. Kansas Med. Ctr.,
Univ. of Kentucky.
1:00 K5 250.17 Development of an hiPSC model for
the study of gene-environment interactions in Parkinson’s
disease. M. D. NEELY*; A. M. TIDBALL; P. HEDERA; K. C.
ESS; A. B. BOWMAN. Vanderbilt Univ. Med. Ctr.
2:00 K6 250.18 Mixed lineage kinase3 promotes axonal
self destruction following nerve injury. S. MEHROTRA; L.
PETTY; G. SONDARVA; A. G. KANTHASAMY; F. A. WHITE;
A. RANA*. Loyola Univ. Med. Ctr., Indiana Univ. Sch. of
Med., Iowa State Univ.
3:00 K7 250.19 MEF2 (myocyte enhancer factor 2)
knockdown attenuates spine loss in striatopallidal medium
spiny neurons in a mouse Parkinson’s Disease model. K.
E. GLAJCH*; C. S. CHAN; N. LANDECK; P. OSTEN; D. J.
SURMEIER. Northwestern Univ., Lund Univ., Cold Spring
Harbor Lab.
4:00 K8 250.20 Interactions between human umbilical
cord perivascular cells (hucpvcs) and populations of
dopaminergic neurons. M. M. CARVALHO*; G. BALTAZAR;
F. CAMPOS; C. FONSECA; A. CRISTOVÃO; J. FRAGA;
N. NEVES; R. REIS; N. SOUSA; A. SALGADO. ICVS,
Sch. of Hlth. Sci., Hlth. Sci. Res. Center, (CICS), Univ. of
Beira Interior, Life and Hlth. Sci. Res. Institute, Sch. of Hlth.
Sciences, Univ. of Minho, 3B’s Res. Group.
1:00 K9 250.21 Age-related motor deficits rescued by
L-dopa administration in Aldh-deficient mice: A potential
animal model for Parkinson’s disease. M. C. WEY*; P. A.
MARTINEZ; E. FERNANDEZ; R. STRONG. Univ. of Texas
Hlth. Sci. Ctr. at San Antonio, South Texas Veterans Hlth.
Care Network.
2:00 K10 250.22 Effect of Melatonin against
6-Hidroxydopamine: Comparation between gender. A.
GUTIÉRREZ VALDEZ; J. ORDOÑEZ LIBRADO; V. ANAYA
MARTÍNEZ; R. GARCÍA RUIZ; M. GARCÍA LÓPEZ; C.
TORRES ESQUIVEL; E. MONTIEL FLORES; J. ESPINOSA
VILLANUEVA; P. ALEY MEDINA; M. AVILA-COSTA*. UNAM,
Neuromorphology Lab.
3:00 K11 250.23 A biosignature of splice isoforms in the
blood of Parkinson’s Disease patients. J. A. POTASHKIN*;
C. SCHERZER; B. RAVINA; A. WATTS; A. LEONTOVICH.
Rosalind Franklin Univ. Med. & Sci., Harvard Med. Sch. and
Brigham and Women’s Hosp., Univ. of Rochester Sch. of
Med., The Mayo Clin.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
4:00 K12 250.24 Human term placental stem cell derived
neural progenitor cells (hpsc-npcs) prevent neuronal cell
death via an extrinsic paracrine mechanism. H. LEE*; H.
KIM; J. KANG; B. KIM; M. SUNG; H. JUNG; K. CHA; K. KIM;
G. KIM; J. MOON. CHA Univ., McLean Hospital, Harvard
Med. Sch.
1:00 K13 250.25 Motor alterations induced by manganese
exposure are reversed by L-Dopa administration. J.
ORDONEZ LIBRADO*; A. L. GUTIÉRREZ VALDEZ; V.
ANAYA MARTÍNEZ; M. GARCÍA LÓPEZ; E. MONTIEL
FLORES; J. SÁNCHEZ BETANCOURT; J. ESPINOSA
VILLANUEVA; P. ALEY MEDINA; M. AVILA COSTA. UNAM.
2:00 K14 250.26 Induction of abnormal movements by
Sun. PM
MPTP treatment in infant rhesus monkeys. Y. MA; X. HU;
H. JINNAH; A. GALVAN; Y. SMITH; T. WICHMANN*. Yerkes
Natl. Primate Res. Ctr. at Emory Univ., Emory Univ. Sch.
Med.
3:00 K15 250.27 Differential gene expression response
to paraquat in brain of two inbred mouse strains. L. YIN*;
A. TOMASZEWICZ; L. LU; E. RICHFIELD; B. JONES.
Neurosci. Grad. Program, Pennsylvania State Univ., Univ. of
Tennessee Hlth. Sci. Ctr., Robert Wood Johnson Med. Sch.
4:00 K16 250.28 Generation of induced pluripotent stem
cells from Parkinson and Huntington disease patients. W.
ZHOU*; C. R. FREED. Univ. Colorado Denver.
1:00 K17 250.29 The impact of psychological predatory
stress on neuroinflammation and nigral dopaminergic neuron
survival. C. J. BARNUM*; M. G. TANSEY. Emory Univ. Sch.
Med.
2:00 K18 250.30 Striatal dopamine oxidation is increased
during sub-chronic l-dopa treatment: Relevance to the loss
of l-dopa efficacy during pd therapy. M. L. SMITH*; C. G.
CHARLTON. Meharry Med. Col.
POSTER
251. Metabolism and Toxicity of Alpha-Synuclein II
Theme C: Disorders of the Nervous System
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 K19 251.1  •  mTOR inhibitor Ridaforolimus potently
protects in models of Parkinson’s disease. A. FERREE; K.
SMITH; K. THIBODEAU; M. WEIGELE; R. M. SQUILLACE;
B. L. WOLOZIN*. Boston Univ. Sch. of Med., Ariad
Pharmaceuticals, Boston Univ. Schl Med.
2:00 K20 251.2 Over expression of glucose regulated
protein 78 (GRP78/BiP) diminishes ER stress response
and neurotoxicity induced by alpha-synuclein. O. S.
GORBATYUK*; M. S. GORBATYUK; A. SHABASHVILI; W.
CHEN; C. MEYERS; L. F. SULLIVAN; K. WU; A. S. LEWIN;
N. MUZYCZKA. Univ. Florida.
3:00 L1 251.3 The role of alpha-synuclein in dopamine
biology: Insights from human dopaminergic cells. L.
LOURENCO VENDA*; J. ALEGRE; M. LUFINO; S. SENIOR;
K. JENNINGS; S. CRAGG; R. WADE-MARTINS. Univ. of
Oxford.
4:00 L2 251.4 Transglutaminase 2 and the toxicity of
misfolded α-synuclein in yeast. H. GROSSO*; J. IM; K.
LEE; E. JUNN; M. M. MOURADIAN. Umdnj-Robert Wood
Johnson Med. Sch.
Neuroscience 2010  |  Sunday PM  |  95 
1:00 L3 251.5 The pathogenic alterations of alpha-
synuclein and DA neuronal degeneration induced by
paraquat in rats are reversed by in vivo NADPH oxidase 1
knockdown. A. C. CRISTOVAO*; G. BALTAZAR; D. CHOI;
M. BEAL; T. JOH; Y. KIM. Hlth. Sci. Res. Center, Univ. of
Beira Interior, Weill Med. Col. of Cornell Univ., Univ. of
Coimbra, Kyunghee Universit.
2:00 L4 251.6  •  rAAV 2/7 -mediated overexpression of
wild type and A53T mutant α-synuclein in rat brain induces
rapid dopaminergic dysfunction. A. VAN DER PERREN; J.
TOELEN; A. VAN ROMPUY; V. REUMERS; C. VAN DEN
HAUTE; Z. DEBYSER; V. BAEKELANDT*. K.U.Leuven.
3:00 L5 251.7 The alpha-synuclein-regulating
transcription factor GATA2 increases in rat nigral
dopaminergic neurons in the rotenone model of
Parkinson’s disease. M. P. HOROWITZ*; L. MONTERO; J.
GREENAMYRE. Univ. Pittsburgh.
4:00 L6 251.8 A novel in vitro model of alpha-synuclein
aggregation and toxicity. C. P. DOHM; M. SCHNIEDER;
A. BAUMANN; J. LIMAN; F. S. WOUTERS; M. BÄHR; P.
KERMER*. Univ. Goettingen.
1:00 L7 251.9 Low-dose bafilomycin A1 attenuates
chloroquine-induced neuronal cell death: Implications for
Parkinson’s disease. V. N. PIVTORAIKO-KOSENKOVA*; B.
J. MADER; A. M. LUKER; K. A. ROTH; J. J. SHACKA. UAB
Lister Hill.
2:00 L8 251.10 Signalling pathways involved in
α-synuclein aggregation dependent cell death. L. B.
VESTERAGER; C. L. KRAGH; K. FOG; P. H. JENSEN*. H.
Lundbeck A/S, Univ. Aarhus.
3:00 L9 251.11 Modulation of Parkinson’s disease genes
in a sporadic disease model. J. R. CANNON*; T. SEW; L.
MONTERO; J. T. GREENAMYRE; E. A. BURTON. Univ. of
Pittsburgh.
4:00 L10 251.12 Role of alpha-synuclein on
proinflammatory signaling in human astrocytes. N.
SAFFARIAN-TOUSSI*; D. J. BUCK; R. L. DAVIS. Oklahoma
State Univ. Ctr. Hlth. Sci.
1:00 L11 251.13 Alpha-synuclein mutants that favor
oligomerization are more toxic. B. WINNER*; R. JAPPELLI;
S. MAJI; L. BOYER; P. DESPLATS; E. MASLIAH; F. H.
GAGE; R. RIEK. Salk Inst., Dept. of Neurosciences, Lab. of
Physical Chem.
2:00 L12 251.14 Changes in levels of neurosin directly
affect the accumulation of α-synuclein. B. J. SPENCER*; P.
DESPLATS; J. SHEN; C. PATRICK; E. ROCKENSTEIN; A.
ADAME; E. M. MASLIAH. UCSD.
3:00 M1 251.15 Microglia acquire distinct activation
profiles depending on the degree of α-synuclein
neuropathology in a rAAV based model of Parkinson’s
Disease. V. SANCHEZ-GUAJARDO; F. FEBBRARO; D.
KIRIK; M. ROMERO-RAMOS*. Dept. Med. Biochemistry,
Aarhus Univ., Lund Univ.
4:00 M2 251.16 Interactions between genetic and
environmental factors in a transgenic rat of Parkinson’s
disease. F. LELAN; R. THINARD; P. NAVEILHAN; P.
DAMIER; L. LESCAUDRON*. INSERM U-643, ITERT.
1:00 M3 251.17 Over-expression of Rab1A prevents
Golgi fragmentation and rescues motor function in a rat
model of Parkinson’s disease based on nigral expression
of human α-synuclein. P. COUNE; J. BENSADOUN; B.
L. SCHNEIDER; P. AEBISCHER*. Ecole Polytechnique
Federale De Lausanne.
96  |  Society for Neuroscience
2:00 M4 251.18  •  Alpha-synuclein secretion, uptake and
seeding of aggregates in neuronal cells. P. KALLUNKI*; A.
BERGSTRÖM; D. ANDERSSON; L. HELBOE; E. ANGOT;
C. HANSEN; J. A. STEINER; L. PIERI; R. MELKI; J. LI; P.
BRUNDIN; K. FOG. H. Lundbeck A/S, Wallenberg Neurosci.
Ctr., CNRS.
3:00 M5 251.19 FK506 binding protein 12: the main
peptidyl-prolyl isomerase influencing alpha-synuclein
aggregation in a cellular model for Parkinson’s disease.
A. DELEERSNIJDER; M. GERARD*; Z. DEBYSER; V.
BAEKELANDT. K.U.Leuven-Kortrijk.
4:00 M6 251.20 Development of a rat model of forebrain
synucleinopathy using neonatal AAV-vector mediated over-
expression of human alpha-synuclein. T. BJORKLUND*;
K. SCHULTZ; Å. PETERSÉN; D. KIRIK. Brain Repair
And Imaging in Neural Systems, Lund Univ., Translational
Neuroendocrine Res. Unit, Lund Univ.
1:00 M7 251.21 Development of a Drosophila
melanogaster Parkinson’s disease model for drug screening.
A. VILLALUZ*; J. SYMONDS; M. B. MAHONEY; C. M.
SINGH; L. T. DIGGINS. Vitruvean, LLC.
2:00 M8 251.22 Seeding of cross linked alpha-synuclein
oligomers in vitro and in vivo. M. INGELSSON*; T.
WAHLBERG; T. NÄSSTRÖM; C. SAHLIN; S. INGVAST; M.
KARLSSON; F. NIKOLAJEFF; M. EKBERG; A. KASRAYAN;
H. SCHELL; P. KAHLE; L. LANNFELT; J. BERGSTRÖM.
Uppsala Univ., BioArctic Neurosci., Univ. of Tübingen.
3:00 M9 251.23 Blocking endogenous alpha-syncuclein
prevents cell-to-cell propagation. P. A. DESPLATS*; B. J.
SPENCER; C. PATRICK; E. ROCKENSTEIN; S. LEE; E.
MASLIAH. UCSD, Konkuk University, Inst. of Biomed. Sci.
and Technol.
4:00 M10 251.24 Mitochondria are impaired by elevated
human alpha-synuclein. J. B. WATSON*; T. A. SARAFIAN;
M. L. SNEDDON; J. P. WHITELEGGE; C. M. RYAN; K. F.
FAULL; E. MASLIAH. David Geffen Sch. Med. UCLA, UCSD.
POSTER
252. Mitochondria in Parkinson’s Disease
Theme C: Disorders of the Nervous System
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 M11 252.1  •  Impact of Parkinson’s disease associated
variants in the mortalin/GRP75 gene on mitochondrial
function and dynamics. L. F. BURBULLA; C. SCHELLING;
H. KATO; D. RAPAPORT; D. WOITALLA; S. JUNG; A.
NORDHEIM; L. SCHÖLS; O. RIESS; R. KRUGER*. Ctr.
of Neurol. and Hertie Inst. for Clin. Brain Res., Univ. of
Tübingen, Grad. Sch. of Cell. and Mol. Neuroscience,
Univ. of Tübingen, Interfaculty Inst. for Biochemistry, Univ.
of Tübingen, Dept. of Neurology, St. Josef-Hospital, Ruhr-
University Bochum, Proteome Ctr. Tübingen, Interfaculty
Inst. for Cell Biology, Univ. of Tübingen, Med. Genetics, Univ.
of Tübingen.
2:00 M12 252.2 The therapeutic potential of PGC1-alpha
in Parkinson’s disease: Promise and pitfalls. C. CIRON;
J. BENSADOUN*; C. CANTO-ALVAREZ; V. MLYNARIK;
B. L. SCHNEIDER; P. AEBISCHER. Ecole Polytechnique
Federale De Lausanne.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
3:00 M13 252.3 The mitochondrial ClpXP complex
stabilizes and regulates the submitochondrial localization
of the Parkinson’s disease associated kinase Pink1. C.
MIRANDA*; R. MARONGIU; M. VERNOV; S. MUSATOV; M.
G. KAPLITT. Weill Cornell Med. Col., Neurologix.
4:00 M14 252.4 The effects of the ROC domain mutant
of LRRK2 on mitochondrial dynamics and dopaminergic
neuronal survival. E. ABDEL-MESSIH*; Y. ZHANG; R. J.
PARKS; R. S. SLACK; D. S. PARK. Univ. of Ottawa, Ottawa
Hosp. Res. Inst.
1:00 M15 252.5 Parkinson’s disease and mitochondrial
function: PINK1 regulates Complex I activity and synaptic
function. V. A. MORAIS*; K. CRAESSAERTS; A. SNELLINX;
L. OVERBERGH; A. O. HELBIG; A. J. R. HECK; W.
MANDEMAKERS; W. WURST; B. DE STROOPER.
K.U.Leuven, V.I.B., Utrecht Univ., Helmholtz Ctr. Munich,
Tech. Univ. Munich.
2:00 M16 252.6 Defining a role for parkin in
mitochondrion-to-lysosome vesicular trafficking. G.
MCLELLAND*; V. SOUBANNIER; H. M. MCBRIDE; E. A.
FON. Montreal Neurolog. Institute, McGill Univ., Univ. of
Ottawa Heart Inst.
3:00 M17 252.7 Loss of PINK1 decelerates glutamate-
induced mitochondrial fission in mouse primary cortical
neurons. W. M. LIN*; L. CHEN; D. M. WHITE; L. WON; X.
ZHUANG; U. J. KANG. Univ. Chicago.
4:00 M18 252.8 Increased PGC-1 predisposed
dopaminerigc cells from developing the oxidative stress but
not mitochondrial defects of pink1 silencing. D. K. CHAU*; J.
CORONA; M. DUCHEN; J. COOPER; A. SCHAPIRA. Clin.
Neurosciences, Cell & Developmental biology.
1:00 N1 252.9 Methylene blue enhances mitochondrial
electron transfer and attenuates rotenone induced
parkinsonism in rodents. Y. WEN; W. LI; E. POTEET; L. XIE;
C. TAN; L. YAN; X. JU; R. LIU; H. K. DAS*; M. A. MARVIN;
M. S. GOLDBERG; Z. MAO; J. W. SIMPKINS; S. YANG.
Univ. N. TX Hlth. Sci. Ctr. Ft. Worth, UT Southwestern Med.
Ctr., Emory Univ.
2:00 N2 252.10  •  PINK1 signaling and mitophagy. M.
A. TOCILESCU; C. VIVES-BAUZA; R. L. A. DE VRIES; D.
ALESSI; J. MAY; S. E. PRZEDBORSKI*. Columbia Univ.
3:00 N3 252.11 Stereotaxic injections of mitochondrial
or er stresses into substantia nigra generate parkinson’s
diseases-like mouse models. J. JEONG*; H. KOO; Y. SUNG;
C. KIM; Y. K. PAK. Col. of Medicine, Kyung Hee Univ.
4:00 N4 252.12 Functional recovery from mitochondrial
deficit in the dj-1 k.o. and pink1 k.o. mutant dopamine
neuronal cells. J. SHIM*; K. KIM; S. YOON; D. HYUN; H.
SON. Ewha Woman’s Univ.
1:00 N5 252.13 Overexpression of alpha-synuclein
caused mitochondria defect by interacting with voltage-
dependent anion channel. L. LU*; C. ZHANG; X. SUN; S.
ZHAO; H. YANG. Capital Med. Univ.
2:00 N6 252.14 Rotenone treatment enhances apoptosis
caused by G2019S familial Parkinson mutant LRRK2.
H. KUNUGI*; G. ITO; T. IWATSUBO. Dept. Neuropathol.
Neurosci., Grad. Sch. Pharm. Sci., Univ. of Tokyo, Dept.
Neuropathol., Grad. Sch. Med. Sci., Univ. of Tokyo.
3:00 N7 252.15 Calcium channel blockers induce
Parkinson’s disease-related neurotoxicity in vitro and in vivo.
M. LEE; J. CHOI; K. SHIN; S. KANG*. Sejong Univ., Kyung
Hee Univ.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
4:00 N8 252.16 DNA Damage precedes cell death
in rotenone rat model of Parkinson’s Disease. L. H.
SANDERS*; P. G. MASTROBERARDINO; V. TAPIAS; C. T.
CHU; J. T. GREENAMYRE. Univ. Pittsburgh.
1:00 N9 252.17 Dopamine dependent modulation of
aromatic l-amino acid decarboxylase in a MPTP mouse
model of Parkinson’s disease. J. M. KING*; G. MUTHIAN;
V. MACKEY; M. SMITH; W. DEAN, V; C. G. CHARLTON.
Meharry Med. Col., Tennessee State Univ.
2:00 N10 252.18 Adeno associated virus (AAV)-mediated
neuronal expression of Ogg1 protects DJ-1 KO mice
from MPTP-induced dopamine loss. M. Y. SANCHEZ-
CONTRERAS; J. A. LYDA; J. T. VAN LEUVEN; D.
Sun. PM
POULSEN; F. CARDOZO-PELAEZ*. Univ. of Montana, Univ.
Montana.
3:00 N11 252.19 Decreasd kinesin in remaining nigral
neurons of MPTP treated monkey. Y. CHU*; B. WANG;
Y. HE; L. LANGHAMER; G. MORFINI; S. BRADY; J.
KORDOWER. Rush Univ, Med. Ctr., Univ. of Illinois at
Chicago.
4:00 N12 252.20 24-Epibrassinolide, a phytosterol from the
brassinosteroid family, protects dopaminergic cells against
MPP+ -induced cellular death by modulating apoptosis and
anti-oxidative enzymes. J. CARANGE*; F. LONGPRÉ; J.
BOURNIVAL; B. DAOUST; M. MARTINOLI. UQTR - Lab.
De Recherche En Neurobiologie Cellulaire, UQTR - Organic
Chem.
1:00 N13 252.21 Activated protein C mutant with reduced
anticoagulant activity protects dopaminergic neurons and
blood-brain barrier integrity in the MPTP mouse model
of Parkinson’s disease. H. GUO*; T. M. BARRETT; B. V.
ZLOKOVIC. Univ. Rochester.
2:00 N14 252.22 The method of MPTP (1-methyl-4-phenyl-
1,2,3,6-tetrahydropyridine) administration predicts the
phenotypic resemblance in the primate model of Parkinson’s
disease. J. S. WHITHEAR; S. UTHAYATHAS*; C. A. LIEU; T.
SUBRAMANIAN; M. LUQUIN; S. M. PAPA. Emory Univ., The
Pennsylvania State Univ. Col. of Med., Univ. of Navarra.
3:00 N15 252.23 Expression of yeast NDi1 in mitochondrial
DNA transgenic Parkinson’s disease cybrids improves
respiratory capacity and mitochondrial function. P. A.
TRIMMER*; J. BARBER-SINGH; E. N. CRONIN-FURMAN;
M. K. BORLAND; T. YAGI. Univ. Virginia, The Scripps Res.
Inst., Univ. of Virginia.
POSTER
253. Ataxias
Theme C: Disorders of the Nervous System
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 N16 253.1 Nuclear accumulation of Hdac4 promotes
neuronal degeneration in ataxia telangiectasia. J. LI*; K.
HERRUP. Rutgers, State Univ. New Jersey.
2:00 N17 253.2 Loss of function of an EF-hand protein
causes Purkinje axon degeneration and cerebellar ataxia. Y.
LIU*; S. ACKERMAN. The Jackson Lab., Howard Hughes
Med. Inst.
3:00 N18 253.3 C termini of CACNA1A gene activates
BTG-1 expression and potentiates neuronal differentiation.
X. DU*; J. WANG; H. ZHU; D. COLLINS; K. HEKMAN; C. M.
GOMEZ. Univ. Chicago.
Neuroscience 2010  |  Sunday PM  |  97 
4:00 O1 253.4 A novel ankyrin domain-containing
protein Stim prevents cerebellar Purkinje cell loss caused
by an alanyl-tRNA synthetase mutation in mice. S. HOU*; J.
LEE; S. ACKERMAN. The Jackson Lab., Korea Res. Inst. of
Biosci. & Biotech.
1:00 O2 253.5 Cytosolic carboxypeptidase 1 deficiency
alters peptide levels and induces autophagy in the brain of
the Purkinje cell degeneration mouse. I. BEREZNIUK*; J.
SIRONI; L. D. FRICKER. Albert Einstein Col. Med., Albert
Einstein Col. of Med.
2:00 O3 253.6 Progression of symptoms in
spinocerebellar ataxia. J. H. ANDERSON*. Univ. Minnesota.
3:00 O4 253.7 Ck2-dependent phosphorylation of
ataxin-3 is inhibited by quercetin. T. MÜLLER*; P. BREUER;
H. TRICOIRE; M. WURGLICS; U. WÜLLNER. UKB
Universityclinic Bonn, CNRS, Goethe Univ.
4:00 O5 253.8 Deranged calcium signaling in
Purkinje cells and pathogenesis of spinocerebellar
ataxia 2. A. W. KASUMU*; J. LIU; T. S. TANG; H. TU; O.
NELSON; E. HERNDON; D. P. HUYNH; S. M. PULST; I.
BEZPROZVANNY. UT Southwestern Med. Ctr. At Dallas,
Univ. of Utah.
1:00 O6 253.9 Mutation in Inpp5a results in Purkinje cell
degeneration and ataxia in the mouse. A. W. YANG*; A. J.
SACHS; A. M. NYSTUEN. UNMC.
2:00 O7 253.10 Analysis of the MJD/SCA3 Tg mice from
the view of neuronal dysfunction. N. SAKAE*; Y. OHYAGI; J.
KIRA. Kyushu Univ.
3:00 O8 253.11 RNAi therapy for Spinocerebellar Ataxia
Type 1. M. K. SANDS*; R. L. BOUDREAU; B. L. DAVIDSON.
Univ. Iowa.
4:00 O9 253.12 Discovery of the Machado-Joseph
disease 1 (MJD1) gene mutation among the Puerto Rican
population. L. PEREIRA*; S. PENA. Univ. Puerto Rico- Rio
Piedras, Univ. of Puerto Rico.
1:00 O10 253.13 Deletion of Jnk3 is a protective modifier
of hippocampal neurodegeneration in the Inpp4awbl mutant
mouse. A. SACHS*; A. W. YANG; J. K. SCHWENDINGER;
C. R. WALCUTT; S. A. DAVID; W. N. FRANKEL; A. M.
NYSTUEN. Univ. of Nebraska Med. Ctr., The Jackson Labs.
2:00 O11 253.14 Cognitive sequence learning following
cerebellar damage. L. B. KURDZIEL*; R. M. C. SPENCER.
Univ. of Massachusetts.
3:00 O12 253.15 An analysis of motor control and auditory
function in a mouse model of episodic ataxia type-1 (EA1).
J. R. ISON*; C. KOPP-SCHEINPFLUG; G. D. PAIGE; C.
WALKER; R. RÜBSAMEN; P. D. ALLEN; A. KARCZ; B.
L. TEMPEL. Univ. Rochester, Univ. of Leicester, Univ. of
Washington, Univ. of Leipzig.
4:00 O13 253.16  •  Dysmyelination and tremor caused by
genetic incompatibility in mice. J. UMEMORI*; T. UNO; A.
MORI; S. YUASA; T. KOIDE. Natl. Inst. of Genet., Natl. Inst.
of Informatics, Univ. of Massachusetts Med. Sch., Natl. Ctr.
of Neurol. and Psychiatry.
1:00 O14 253.17 Age-dependant decrease of mutant TBP
clearance and its role in the pathogenesis of SCA 17. S.
YANG*; S. HUANG; X. LI; S. LI. Emory Univ.
98  |  Society for Neuroscience
2:00 O15 253.18 Mutant ΓPKC causing spinocerebellar
ataxia type 14 (SCA14) preferably interacts with heat shock
cognate protein 70 (Hsc70) and affects its translocation to
lysosome. T. SEKI*; K. YOSHINO; K. OGAWA; T. ONJI;
S. TANAKA; I. HIDE; N. SAITO; N. SAKAI. Dept Mol &
Pharmacol Neurosci, Grad Sch. Biomed Sci, Hiroshima
Univ., Lab. Mol Pharmacol, Biosig Res. Ctr, Kobe Univ.
POSTER
254. Epilepsy: Channels and Receptors
Theme C: Disorders of the Nervous System
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 O16 254.1 Hyperexcitable neural responses can be
suppressed by modulatory substances targeting the A-type
potassium channel. J. K. TIGERHOLM*; E. FRANSÉN.
Royal Inst. of Technol., Stockholm Brain Inst.
2:00 O17 254.2 Developmental alterations in the
expression of ion channels at axon initial segments
associated with age-dependent seizures. S. MALJEVIC*; H.
LERCHE. Hertie Inst. For Clin. Brain Research, Univ. Hosp.
Tuebingen.
3:00 O18 254.3 Increased expression of a hyperexcitable
CaV3.2 T-type calcium channel splice variant correlates with
robust oscillatory bursting in a rat absence epilepsy model.
J. R. TYSON; S. M. CAIN; K. L. POWELL; T. J. O’BRIEN; T.
P. SNUTCH*. Michael Smith Lab, UBC, Univ. of Melbourne.
4:00 P1 254.4  •  Involvement of A-type potassium
channels in suppression of synchronized synaptic input.
E. A. FRANSEN*; J. TIGERHOLM. Royal Inst. Technol.,
Stockholm Brain Inst.
1:00 P2 254.5 Effect of deletion of Nav1.1 channels on
sodium current in dissociated neocortical interneurons in
a mouse model of severe myoclonic epilepsy in infancy. Y.
ABE; F. KALUME; R. E. WESTENBROEK; T. SCHEUER*;
W. A. CATTERALL. Univ. Washington, Daiichi Sankyo Co,
Ltd.
2:00 P3 254.6 Scn1a-GFP BAC transgenic mouse lines
showed predominant expression of Nav1.1 in parvalbumin-
positive interneurons. I. OGIWARA*; N. TOKONAMI; E.
MAZAKI; I. INOUE; K. YAMAKAWA. RIKEN Brain Sci. Inst.
3:00 P4 254.7 Attenuation of EC layer II hyperexcitability
in epilepsy by Ni2+ application. N. J. HARGUS*; E. H.
BERTRAM; M. K. PATEL. Univ. Virginia, Univ. of Virginia.
4:00 P5 254.8 Misfolded nav1.1 (scn1a) epileptogenic
mutants: a cool story? G. BECHI; R. RUSCONI*; P.
STRIANO; F. ZARA; M. MANTEGAZZA. Neurolog. Inst.
C.Besta, Inst. of Mol. and Cell. Pharmacol. (IPMC), G.
Gaslini, G. Gaslini Inst.
1:00 P6 254.9  •  Relationship between different sleep
states and generalized tonic seizure in a mesial temporal
lobe epilepsy mouse model with sodium channel (scn2a)
mutaion. N. TIAN*; K. STROHL; K. KILE; P. FENG; D.
DURAND. Case Western Reserve Univ., Univ. of California
San Francisco, Oberlin Col.
2:00 P7 254.10 Genotype-phenotype correlations
in susceptibility to febrile seizures in mice with Scn1a
mutations. S. B. DUTTON*; M. WELCH; A. P. ESCAYG.
Emory Univ.
3:00 P8 254.11 The role of the voltage gated sodium
channel Scn8a in epilepsy. C. D. MAKINSON*; A.
SHANKAR; A. P. ESCAYG. Emory Univ.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
4:00 P9 254.12 Drosophila with a human GEFS+
mutation in para exhibit seizures and aberrant activity in
adult brain interneurons at elevated temperatures. L. SUN; J.
GILLIGAN; C. STABER; R. REENAN; D. K. O’DOWD*. UC
Irvine, Brown Univ.
1:00 P10 254.13 Dysfunction of the voltage-gated sodium
channel Nav1.1 is associated with dysinhibition in different
brain regions. U. B. HEDRICH*; M. MARTIN; C. LIAUTARD;
M. MANTEGAZZA; A. ESCAYG; H. LERCHE. Hertie-Institute
For Clin. Brain Res., Emory Univ., Nice-Sophia Antipolis.
2:00 P11 254.14 CA3-selective knockout of GluK2
kainate receptor subunits abrogates seizure induction. H.
B. FERNANDES*; J. XU; T. RUSSELL; A. FISAHN; J. N.
ARMSTRONG; A. CONTRACTOR. Northwestern Univ.,
Karolinska Inst., Univ. of Guelph.
3:00 P12 254.15  •  Decreased seizure susceptibility
following genetic knockout of either neurotensin receptor
subtype-1 (NTR1) or subtype-2 (NTR2) in C57BL6 mice.
M. D. SMITH*; H. S. WHITE; T. H. PRUESS; K. WADA; E.
WADA; M. M. MCINTYRE; J. M. MCINTOSH; E. L. MEYER.
Univ. of Utah, ADD Program, Natl. Inst. of Neuroscience,
NCNP.
4:00 P13 254.16 Nicotinic acetylcholine receptors and
epilepsy: The many faces of NFLE. D. C. BERTRAND*; O.
K. STEINLEIN. Med. Fac., Inst. of Human Genet.
1:00 P14 254.17 Genetic modification of idiopathic
generalized epilepsy mutations in common mouse strains.
W. N. FRANKEL*; B. BEYER; T. C. MCGARR; V. A. LETTS.
The Jackson Lab.
2:00 Q1 254.18 Stargazin and AMPA receptor protein
expression is elevated in the plasma membrane of
somatosensory cortex neurons in adult epileptic GAERS.
J. T. T. KENNARD; R. BARMANRAY; S. SAMPURNO;
C. A. REID*; L. PARADISO; G. D’ABACO; A. H. KAYE;
A. MOROKOFF; T. J. O’BRIEN; K. L. POWELL. Univ. of
Melbourne, Howard Florey Inst.
3:00 Q2 254.19 Characterization of long-term increases
in cannabinoid CB1 receptor mediated binding and g-protein
activation in the cortex of epileptic rats. K. W. FALENSKI*;
P. NGUYEN; R. BLAIR; L. SIM-SELLEY; R. DELORENZO.
Virginia Commonwealth Univ.
4:00 Q3 254.20 Ultrastructural distribution of glutamate
in the glutamine-synthetase-deficient epileptogenic rat
hippocampus. E. PEREZ; F. LAURITZEN; Y. WANG; D.
KANG; O. P. OTTERSEN; T. EID*. Yale Univ. Sch. Med.,
Yale University, Sch. Med., Univ. of Oslo.
POSTER
255. Epilepsy: GABA
Theme C: Disorders of the Nervous System
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 Q4 255.1 Receptor kinetic computational models
characterize anticonvulsant drug action at inhibitory and
excitatory synapses. D. E. NAYLOR*. HARBOR-UCLA.
2:00 Q5 255.2 GABABR-mediated tonic GABAAR subunit
ß3 downregulation and its role in chronic atypical absence
seizures. M. SONKIN*; Y. WU; L. Q. SHEN; M. A. CORTEZ;
O. C. SNEAD, 3rd. The Hosp. For Sick Children, Univ. of
Toronto.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
3:00 Q6 255.3 Glial signalling in the ventrobasal
thalamus of rats with absence seizures. T. M. PIRTTIMAKI*;
D. W. COPE; H. R. PARRI; V. CRUNELLI. Aston Univ.,
Cardiff Univ.
4:00 Q7 255.4 Defective cortical interneuronal signalling
results in generalised seizures. E. ROSSIGNOL*; I.
KRUGLIKOV; N. ROY; A. VAN DEN MAAGDENBERG; G.
FISHELL; B. RUDY. NYU Med. Ctr., Leiden Univ. Med. Ctr.
1:00 Q8 255.5 Rats fed a ketogenic diet show increased
number of GABA-positive cells in the dentate gyrus of
the hippocampus. B. V. PHILLIPS_FARFÁN; P. DURAN*;
G. GÓMEZ-LIRA; J. MÉNDOZA-TORREBLANCA; G.
GUTIERREZ-OSPINA; M. RUIZ GARCÍA; S. NAVARRETE-
Sun. PM
HERNÁNDEZ; L. GRANADOS-ROJAS. Inst. Nacional de
Pediatría, Inst. Neurobiol, UNAM, Inst. de Investigaciones
Biomédicas, UNAM.
2:00 Q9 255.6 A defined medium approach for directing
the differentiation of mouse embryonic stem cells toward
basal forebrain GABAergic fates. J. YANG*; X. MAISANO; L.
B. GRABEL; J. R. NAEGELE. Wesleyan Univ.
3:00 Q10 255.7  •  Fetal GABAergic progenitor transplants
in the dentate gyrus suppress spontaneous seizures in
mice with pilocarpine-induced temporal lobe epilepsy.
X. MAISANO; S. ROYSTON; E. RIBEIRO; J. YANG; E.
LITVINA; N. WOODS; J. RENDLEMAN; J. R. NAEGELE*.
Wesleyan Univ.
4:00 Q11 255.8 Target-selective GABAergic control of
entorhinal cortex output. C. VARGA*; S. Y. LEE; I. SOLTESZ.
Univ. of California, Irvine.
1:00 Q12 255.9 Gad67 expression in glutamatergic
mossy fibers of the epileptic human hippocampus.
G. SPERK*; S. PIRKER; T. CZECH; M. ORTLER; A.
WIESELTHALER-HÖLZL. Med. Univ. Innsbruck, Hosp.
Hietzing with Neurolog. Ctr. Rosenhügel, Med. Univ. of
Vienna.
2:00 Q13 255.10 Localization of SSADH, a GABA
degradation enzyme, in the adult mouse brain. M.
DELENCLOS; K. HOESTGAARD-JENSEN; M. ROMERO-
RAMOS; M. K. GIBSON; M. M. HOLM*; K. JENSEN. Aarhus
Univ., Michigan Technological Univ.
3:00 Q14 255.11 Role of brain γ-amino butyric acid
A-receptor subunits in a rodent model of genetic reflex
epilepsy. C. DE CABO DE LA VEGA*; A. I. PRIETO -
MARTÍN; J. D. AROCA AGUILAR; L. MUÑOZ DE LA
PASCUA; J. ESCRIBANO; D. E. LÓPEZ. Hosp. Gen. De
Albacete, Unidad De Neuropsicofarmacología, Fac. of
Medicine, Univ. de Castilla-La Mancha, INCYL-Universidad
de Salamanca.
4:00 Q15 255.12 Progesterone receptor-mediated seizure
susceptibility in female mice. D. S. REDDY*; A. MOHAN.
Texas A&M Hlth. Sci. Ctr.
1:00 Q16 255.13 Neurosteroid withdrawal upregulates
GABA-A receptor alpha4-subunit expression by activation of
Egr3 pathway. O. GANGISETTY*; D. S. REDDY. Texas A&M
Hlth. Sci. Ctr.
2:00 Q17 255.14 Reduced neuronal activity in sodium/
bicarbonate cotransporter NBCn1 (SLC4A7) knockout mice.
C. GONZALEZ-ISLAS; H. PARK; I. CHOI*. Emory Univ.
3:00 Q18 255.15  •  Reduced excitability of GABAergic
interneurons in the reticular nucleus of the thalamus and
sleep impairment in a mouse model of Severe Myoclonic
Epilepsy of Infancy. F. K. KALUME*; J. C. OAKLEY; R. E.
WESTENBROEK; T. SCHEUER; W. A. CATTERALL. Univ.
Washington Med. Ctr.
Neuroscience 2010  |  Sunday PM  |  99 
4:00 R1 255.16 Conditional deletion of Nav1.1 channels
in inhibitory interneurons is sufficient to cause the seizures
and premature death in a mouse model of SMEI. C. S.
CHEAH*; F. H. YU; R. E. WESTENBROEK; F. K. KALUME;
J. C. OAKLEY; J. L. RUBENSTEIN; W. A. CATTERALL.
Univ. of Washington, Seoul Natl. Univ., Univ. of California at
San Francisco.
1:00 R2 255.17 Altered GABAergic inhibitory tone in the
CA1 region of SV2A-deficient mice. K. VENKATESAN; P.
ALIX; A. MARQUET; M. DOUPAGNE; I. NIESPODZIANY; B.
ROGISTER; V. M. SEUTIN*. Univ. Liege, UCB Pharma.
2:00 R3 255.18 Loss of GABAergic tonic inhibition in a
mouse model of absence epilepsy correlates with decreased
thalamocortical bursting in vitro. K. P. MANGAN*; S.
PETROU; S. M. JOHNSON; K. B. HENGEN; M. V. JONES.
Univ. Wisconsin-Madison, Univ. of Melbourne.
3:00 R4 255.19 Functional characterization of novel
GABAA receptor mutants in idiopathic generalized epilepsy
patients. P. BROWN*; P. LACHANCE-TOUCHETTE; C.
MELOCHE; P. COSSETTE; D. BOWIE. McGill Univ., Univ.
de Montréal.
4:00 R5 255.20 Altered NPY-mediated modulation of
perisomatic inhibition on CCK basket cells after recurrent
seizures in mice. M. LEDRI*; L. NIKITIDOU; F. ERDELYI; G.
SZABO; M. KOKAIA. Lund Univ., Inst. of Exptl. Med.
1:00 R6 255.21 Strategies to enhance the brain
concentration of bumetanide. K. TÖLLNER*; C. BRANDT;
G. BRUNHOFER; T. ERKER; P. W. FEIT; W. LÖSCHER.
Universtity of Vet. Med., Univ. of Vienna.
2:00 R7 255.22 Seizures convert the antiepileptic actions
of phenobarbital to pro-epileptic ones by down regulating
KCC2 and enhancing GABA Excitation. R. NARDOU*; A.
BHAR; S. YAMAMOTO; O. DULAC; G. CHAZAL; Y. BEN-
ARI; I. KHALILOV. INMED U901, Pediatric Neurology,
Hôpital Necker, APHP.
3:00 R8 255.23 NKCC1 protein expression is sexually
dimorphic in the hippocampus and entorhinal cortex of
the rat during early postnatal development. M. E. URENA-
GUERRERO*; J. MURGUIA-CASTILLO; C. BEAS-ZÁRATE;
M. C. RIVERA-CERVANTES; A. I. FERIA-VELASCO. Univ.
De Guadalajara (CUCBA), CIBO-IMSS.
4:00 R9 255.24 Gaba-mediated depolarization: A
computational study. N. LEWIN*; E. AKSAY; C. E. CLANCY.
Weill Cornell Med. Col., Univ. of California, Davis.
1:00 R10 255.25 Chloride imbalance in the acute
hippocampal slice model of brain trauma. V. I. DZHALA*; M.
E. MAIL; K. J. STALEY. Massachusetts Gen. Hosp.
2:00 R11 255.26 Gabaergic excitation contributes to
seizure generation in vitro. K. P. LILLIS*; J. MERTZ; J. A.
WHITE; K. J. STALEY. Massachusetts Gen. Hosp., Boston
Univ., Univ. of Utah.
3:00 R12 255.27 CCL2 is rapidly increased in piriform
cortex, hippocampus, and neocortex but not in cerebellum
after pilocarpine-induced seizures. G. M. ARISI*; M. L.
FORESTI; K. KATKI; L. A. SHAPIRO. Texas A&M Col. of
Med., Scott & White Hosp., Central Texas Veterans Hlth.
Syst.
4:00 R13 255.28 Efferent projections of subregions of
the substantia nigra pars reticulata in rats. M. GERNERT*;
K. TÖLLNER. Univ. Vet. Med, Dept. of Pharmacology,
Toxicology, and Pharm.
100  |  Society for Neuroscience
POSTER
256. Ischemia: Models I
Theme C: Disorders of the Nervous System
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 R14 256.1 Chronic intermittent hypoxia increases
brain susceptibility to excitotoxic injury. R. JAGADAPILLAI;
N. MELLEN; L. R. SACHLEBEN, Jr.; E. GOZAL*. Univ.
Louisville.
2:00 R15 256.2 Silver staining reveals damage to axons
in the somatosensory thalamus in a rodent model of pediatric
asphyxial cardiac arrest. M. SHOYKHET*; D. J. SIMONS;
P. M. KOCHANEK; R. S. CLARK. Univ. of Pittsburgh Sch. of
Med., Children’s Hosp. of Pittsburgh of UPMC.
3:00 R16 256.3 Spatiotemporal patterns of spreading
depolarization in the gyrencephalic brain of cats. R. GRAF*;
H. NAKAMURA; S. VOLLMAR; M. SUÉ; M. BOUTELLE; P.
HASHEMI; R. BHATIA; A. J. STRONG. MPI Neurolog. Res.,
Imperial Col., King’s Col.
4:00 R17 256.4 Amp-activated kinase activation after
neonatal hypoxia-ischemia. C. I. ROUSSET*; F. LEIPER; D.
WANG; J. NG-BLICHFELDT; C. THORNTON; D. CARLING;
H. HAGBERG. Dept. of Reproductive Biology, Imperial Col.
London, Perinatal Ctr.
1:00 R18 256.5 Development of a simplified spinal cord
ischemia model in mice. H. SHENG*; Z. WANG; W. YANG;
G. W. BRITZ; F. W. LOMBARD; D. S. WARNER. Duke Univ.
Med. Ctr.
2:00 S1 256.6 Evaluation of a novel model of forced
use movement therapy in a rat model of unilateral forelimb
impairment. J. LIVINGSTON-THOMAS*; T. A. DOUCETTE;
R. A. TASKER. Univ. of Prince Edward Island.
3:00 S2 256.7 Progressive fixed-ratio schedule reveals
long-lasting motivation deficit after transient cerebral
ischemia in mice. J. LINDEN; D. FRANSOLET; J. L.
PLUMIER*; A. FERRARA. Univ. de Liège, Univ. Liege.
4:00 S3 256.8 Ouabain model of deep-brain
stroke - morphological and behavioral characteristic. M.
JANOWSKI*; E. GORNICKA-PAWLAK; H. KOZLOWSKA; K.
DOMANSKA-JANIK; B. LUKOMSKA. Med. Res. Ctr.
1:00 S4 256.9 The thalamocortical circuit of
somatosensory (barrel) cortex: A model for the study of
stroke damage and therapy. M. SONG*; O. MOHAMAD; X.
GU; L. WEI; S. YU. Emory Univ. Sch. of Med.
2:00 S5 256.10 The effect of shortened duration of flow
occlusion on stroke volume using an intraluminal middle
cerebral artery stroke model in mouse. S. ANSARI*; D.
MCCONNELL; S. GANJI; J. MOCCO. Univ. of Florida.
3:00 S6 256.11 Functional characterization of Npas4,
a key transcription factor regulated by excitatory synaptic
activity. M. SHAMLOO*; S. BERAKI; L. YINGXI; J.
VALENZUELA; M. PRIESTLEY; M. E. GREENBERG; J.
PHAM. SINTN, Stanford Univ. Sch. of Med., F. M. Kirby
Neurobio. Center, Children’s Hospital, Harvard Med. Sch.
4:00 S7 256.12 Evidence for the efficacy of statins in
the animal stroke models: A meta-analysis. L. GARCÍA
BONILLA*; D. GIRALT; M. CAMPOS; D. SALAT; P.
CHACÓN; A. ROSELL; J. MONTANER. Inst. of Res. Vall
Hebron.
1:00 S8 256.13 Early suppression of intracranial EEG
signals predicts hypoxic/ischemic brain injury in adult mice.
Y. EL-HAYEK*; C. WU; A. AL-SHARIF; S. HUANG; N.
PATEL; P. CARLEN; L. ZHANG. Toronto Western Res. Inst.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
2:00 S9 256.14 A novel rat model of vascular dementia
with ameroid constrictor. A. KITAMURA*; M. IHARA; Y.
FUJITA; H. ITO; H. ITO; R. TAKAHASHI. Kyoto Univ. Grad.
Sch. of Med.
3:00 S10 256.15 HTRA1 controls BMP2/4 signaling
via cleavage of proBMP2/4: Implication for molecular
pathogenesis of hereditary cerebral small vessel disease.
H. NOZAKI; A. SHIGA; M. NIHONMATSU; A. KOYAMA; O.
ONODERA*; M. NISHIZAWA. Brain Res. Institute, Niig.
4:00 S11 256.16 Mice with neonatal ischemia demonstrate
axonal abnormalities in addition to abnormal myelination.
E. ARAUZ; H. BODAGALA; A. W. PHILLIPS; J. ZHANG; M.
WILSON; M. V. JOHNSTON; S. FATEMI*. Johns Hopkins
Univ.
1:00 S12 256.17 Progress towards focal stroke animal
model: Photo-induced release of encapsulated ADP. E. G.
RANDLES*; K. J. HALLOCK; P. R. BERGETHON. Boston
Univ. Sch. of Med.
2:00 T1 256.18 Evaluation of therapeutic and diagnostic
procedures using an ovine stroke model. J. BOLTZE*.
Fraunhofer IZI, Translational Ctr. for Regenerative Med.
3:00 T2 256.19   LTP is preserved in surviving
hippocampal CA1 neurons following severe ischemic-
hypoxic episodes in mice. N. PATEL*; Y. EL-HAYEK; C. WU;
L. ZHANG. Toronto Western Res. Inst.
4:00 T3 256.20 Biomarkers for non-invasive prediction
of lesion development after transient cerebral ischemia. C.
BERTHET; H. LEI; R. GRUETTER; L. HIRT*. CHUV, EPFL,
Univ. of Lausanne, Univ. of Geneva.
1:00 T4 256.21 Early endogenous neurogenesis
activation and diffuse neuronal damage in the Stroke-
Prone Spontaneous Hypertensive rats (SHRSP) precedes
ischaemic events. L. COVA*; V. SILANI, M; A. MAURO;
A. COLONNA; E. MURA; L. SIRONI; P. GELOSA; M.
STRAMBA-BADIALE; G. MICHAILIDIS; F. MAGRINI; E.
ZENNARO; G. BUSCA; A. ZANCHETTI. Inst. Auxologico
Italiano, Univ. degli Studi, Univ. of Turin, Dept of Pharmacol.
Sciences-Università degli Studi, Cardiovasc. Med.
2:00 T5 256.22 Administration of d-amphetamine induces
behavioral recovery from neglect after photothrombotic
or aspiration lesions of rat medial agranular cortex. S.
J. WAGNER*; M. J. HYLIN; R. L. REEP; J. V. CORWIN.
Northern Illinois, Dept. of Phisiological Sci.
3:00 T6 256.23 From plasticity rules to functional
recovery: Modeling recovery of the somatosensory cortex
after stroke. A. BAINS*; N. SCHWEIGHOFER. USC.
4:00 T7 256.24 A mouse model of ischemic spinal
cord injury with delayed paralysis caused by aortic cross-
clamping. H. AWAD*; D. ANKENY; Z. GUAN; P. WEI; D.
MCTIGUE; P. POPOVICH. The Ohio State Univ. Med. Ctr.
1:00 T8 256.25 Distribution of activity-dependent
neuroprotective protein (ADNP) and PAC1 receptor in intact
and ischemic mouse brain. T. NAKAMACHI*; N. KAGAMI;
S. YOFU; K. ENDO; K. NAKAMURA; Y. WADA; M. HORI;
S. ARATA; S. SHIODA. Showa Univ., Showa Univ. Sch. of
Med., Kyoto Univ. Grad. school of Med.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
POSTER
257. Demyelination Disorders: Cellular Mechanisms of
Pathology
Theme C: Disorders of the Nervous System
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 T9 257.1 Gas6 deficiency increases damage but
does not inhibit initial recovery in response to cuprizone-
induced demyelination. M. D. BINDER*; J. XIAO; D. A.
KEMPER; G. Z. M. MA; S. S. MURRAY; T. J. KILPATRICK.
Howard Florey Inst., Univ. of Melbourne.
2:00 T10 257.2 Acute-phase inflammatory gene
Sun. PM
expression in cuprizone-induced demyelination model. R.
OKAZAKI*; T. UENO; K. MORIOKA; K. HAYAKAWA; K.
NAKAMURA; T. OGATA. NATIONAL REHABILITATION
CENTER / Res. Insutitute, Dept. of Orthopaedic Surgery,
Fac. of Medicine, Univ. of Tokyo.
3:00 T11 257.3 Role of cyclooxygenases in cuprizone-
induced demyelination. S. PALUMBO; C. D. TOSCANO; L.
PARENTE; S. AFONSO; R. WEIGERT; F. BOSETTI*. NIA,
NIH, NIDCR, NIH, NINDS, NIH.
4:00 T12 257.4 Elevated levels of chromogranin b in
mice with experimental autoimmune encephalomyelitis.
H. HOANG; M. MO; S. SCHMIDT; R. B. CLARK; B. E.
EHRLICH*. Yale Univ. Sch. Med., Univ. of Connecticut Med.
Sch.
1:00 T13 257.5 Nlrp3 inflammasome mediates Th1
and Th17 responses during development of experimental
allergic encephalitis. D. GRIS*; Z. YE; H. WEN; P. GRIS;
S. D. MILLER; J. P. Y. TING. LCCC UNC, MNI McGill Univ.,
Northwestern Univ. Med. Sch.
2:00 T14 257.6 Antigen induced expression of Fractalkine
in an animal model of multiple sclerosis. W. ZHU*; F.
BEGUM; E. FROST; M. NAMAKA. Univ. of Manitoba.
3:00 T15 257.7 The effect of experimental autoimmune
encephalomyelitis (EAE) on the blood brain barrier and
corticotrophin-releasing factor (CRF) system in the mouse
cortex. R. CLEMENTS*; J. MCDONOUGH; W. YONG; E.
FREEMAN; J. L. BLANK. Kent State Univ., Univ. of Calgary.
4:00 T16 257.8  •  Morphological characterization of early
myelinated axon injury induced by glutamate excitotoxicity
in an ex vivo model. W. TEO*; P. K. STYS. Hotchkiss Brain
Institute, Univ. of Calgary.
1:00 T17 257.9 Primary brain cell cultures treated with
exogenous gangliosides and TNF-alpha alter the expression
of pro-inflammatory cytokines. D. M. BYERS*; J. C.
GORBET; L. N. IRWIN. Univ. of Tennessee - Martin, Univ. of
Texas - El Paso.
2:00 T18 257.10 Very long chain and branched-chain fatty
acids-mediated toxicity in dissociated hippocampal neurons,
astrocytes and oligodendrocytes involves calcium and
mitochondrial dysregulation and signaling through free fatty
acid receptor. G. REISER*; N. KRUSKA. Otto-von-Guericke
Univ.
3:00 U1 257.11   Nitric oxide production is associated to
increased lipoperoxidation in a demyelinated brain region of
the taiep rat. G. SOTO-RODRIGUEZ; D. MARTINEZ-FONG;
R. ARROYO; P. AGUILAR-ALONSO; J. R. EGUIBAR; A.
UGARTE; J. CEBADA; J. A. GONZALEZ-BARRIOS; B.
LEON CHAVEZ*. Benemerita Univ. Autonoma de Puebla,
CINVESTAV, Hosp. Regional 1o. de Octubre, Benemerita
Univ. Autonoma Puebla.
Neuroscience 2010  |  Sunday PM  |  101 
4:00 U2 257.12 Identification of two major conformational
AQP4 epitopes for neuromyelitis optica autoantibodies
binding. F. PISANI; G. P. NICCHIA*; A. ROSSI; M. SVELTO;
A. FRIGERI. Univ. Bari.
1:00 U3 257.13 Nicotine and cigarette smoke condensate
affect experimental autoimmune encephalomyelitis
outcomes. Z. GAO*; S. TSIRKA. State Univ. of New York,
Stony Brook.
2:00 U4 257.14 The role of bone marrow mononuclear
and mesenchymal stem cells in the demyelination-
remyelination process. V. USACH; L. LAVALLE; R. MATINEZ
VIVOT; P. C. SETTON-AVRUJ*. Sch. of Pharm. and
Biochem.
3:00 U5 257.15 Saposins A and B combined deficiencies
in mice resulted in a severe neurological phenotype with
multiple glycosphingolipids accumulation. Y. SUN*; M.
ZAMZOW; H. RAN; B. QUINN; W. ZHANG; S. BARNES; G.
A. GRABOWSKI. Children’s Hosp Med. Ctr.
4:00 U6 257.16 Oligodendrocyte autophagy in the
Long Evans shaker rat. C. M. SMITH*; J. A. MAYER; I. D.
DUNCAN. Univ. of Wisconsin, Madison.
1:00 U7 257.17 Hyperoxia-induced oligodendrocyte
progenitor cell injury is associated with altered astrocyte-
mediated glutamate uptake. J. L. RITTER*; T. SCHMITZ; L.
CHEW; V. GALLO. Children’s Natl. Med. Ctr., Georgetown
Univ., Universitaetsmedizin Berlin-Charite.
2:00 U8 257.18 Myelin inhibition of oligodendrocyte
precursor cell maturation. J. R. PLEMEL*; J. HINZE; W.
TETZLAFF. Univ. British Columbia, Univ. of British Columbia.
3:00 U9 257.19  •  Dicer ablation in oligodendrocytes
provokes neuronal impairment in mice. D. SHIN*; J. SHIN; L.
PTACEK; Y. FU. UCSF.
4:00 U10 257.20 Oxidative stress inhibits oligodendrocyte
differentiation by upregulation of BMPs. J. B. GRINSPAN*;
M. REID; H. M. FRENCH; R. A. SIMMONS. Children’s Hosp
Philadelphia, St. Christopher’s Hosp. for Children, Drexel
Univ. Sch. of Med., Children’s Hosp Philadelphia and the
Univ. of Pennsylvania Med. Sch.
1:00 U11 257.21 Regulation of glioma formation by Olig
transcription factors. H. KIM*; J. CHOI; D. HWANG; B. G.
KIM. Brain Dis. Res. Ctr., Ajou Univ. Sch. of Med.
2:00 U12 257.22 Expression of PMP 22 and MPZ,
the Charcot Marie tooth neuropathy type 1a and type
1b, in diabetic neuropathy. M. D. MARTIN*; V. HAFTEL.
Morehouse Col.
3:00 U13 257.23 Pmp 22 tg rat dorsal root ganglia neurons
(drg) / schwann cells (sc) co-culture: A new and useful in
vitro model for charcot marie tooth (cmt) type 1a disease. N.
CALLIZOT*; R. STEINSCHNEIDER; N. CHOLET. Neuron
Experts, Pharnext SAS.
102  |  Society for Neuroscience
POSTER
258. Demyelinating Disorders: Cellular Mechanisms of Repair
Theme C: Disorders of the Nervous System
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 U14 258.1 Sox17 expression correlates with
oligodendrocyte differentiation in experimental models
of demyelination and in multiple sclerosis. N. MOLL; E.
HONG; C. KERNINON; M. NARUSE; V. TEPAVCEVIC; A.
KLOPSTEIN; L. CHEW; A. BARON-VAN EVERCOOREN; V.
GALLO; B. NAIT-OUMESMAR*. Inserm-Univ. Pierre & Marie
Curie, Ctr. for Neurosci. Research, Children’s Natl. Med. Ctr.
2:00 U15 258.2  •  Minocycline promotes remyelination in
aggregating rat brain cell cultures after interferon-Γ plus
lipopolysaccharide-induced demyelination. A. DEFAUX*; M.
ZURICH; P. HONEGGER; F. MONNET-TSCHUDI. Univ. of
Lausanne.
3:00 U16 258.3  •  Sufu regulates the oligodendrocyte
lineage during development and remyelination. A. J.
LANGSETH*; S. P. J. FANCY; T. HUYNH; C. D. POZNIAK;
D. H. ROWITCH; S. J. PLEASURE. UCSF, Genentech, Inc.
4:00 U17 258.4 Role of NG2 in neuroinflammation and
myelin repair. K. KUCHAROVA*; W. B. STALLCUP. Sanford-
Burnham Inst.
1:00 U18 258.5 Iron efflux from astrocytes is required
for remyelination. K. SCHULZ*; N. ANDREWS; M. GÖTZ;
S. DAVID. Ctr. For Res. In Neuroscience, McGill Univ. Hlth.
Ctr., Duke Univ. Sch. of Med., Inst. for Stem Cell Research,
HelmholtzZentrum Munich.
2:00 V1 258.6 Nicotine modulates CNS inflammatory
responses via alpha7 and non-alpha7 nicotinic receptors.
A. R. SIMARD*; J. HAO; G. H. TURNER; J. WU; P.
WHITEAKER; R. J. LUKAS; F. SHI. Barrow Neurol Inst.
3:00 V2 258.7 Forced-exercise attenuates experimental
autoimmune neuritis by altering the percent distribution
of autoreactive Th1 lymphocytes. M. W. CALIK*; E. B.
STUBBS, Jr. Edward Hines Jr. VA Hosp., Loyola Univ.
Chicago.
4:00 V3 258.8 The involvement of both precursor and
mature oligodendrocytes in remyelination following ethidium
bromide-induced demyelination in the mouse spinal cord.
Y. KONISHI*; S. FUSHIMI. Natl. Tottori Med. Ctr., Kawasaki
Med. Sch.
1:00 V4 258.9 Levels of BDNF impact oligodendrocyte
lineage cells following a cuprizone lesion. M. W. VONDRAN*;
H. SINGH; J. Z. HONEYWELL; C. F. DREYFUS. UMDNJ/
RWJMS, Rutgers Univ.
2:00 V5 258.10 CXCR4 promotes differentiation of
oligodendrocytes progenitors and remyelination. J. R.
PATEL*; E. E. MCCANDLESS; D. DORSEY; R. S. KLEIN.
Washington Univ. Sch. of Med.
3:00 V6 258.11 Galanin protects cuprizone-induced
demyelination via GalR1 and GalR2. L. ZHANG; Y. WU; J.
KONG; I. SCHROEDTER; M. VRONTAKIS-LAUTATZIS*.
Univ. of Manitoba.
4:00 V7 258.12 Reactive astrocytes can express markers
of oligodendrocyte precursors and might play the recovery
role in the remitting phase of EAE model. A. GUO*; T. CHU;
W. WU. The Univ. of Hong Kong.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
1:00 V8 258.13 The Notch pathway and the
promyelinating effect of aTf in toxic models of demyelination/
remyelination. E. APARICIO; M. F. ALMEIRA GUBIANI; V.
L. MILLANOVICH; A. M. ADAMO*. Facultad De Farmacia Y
Bioquímica. IIHMNO-UBA. IQUIFIB-CONICET.
2:00 V9 258.14 Golli myelin basic proteins stimulates
oligodendrocyte survival and proliferation in the
remyelinating adult brain. P. M. PAEZ*; D. FULTON; V.
SPREUR; V. HANDLEY; A. T. CAMPAGNONI. UCLA.
3:00 V10 258.15 Mir-23 regulation of laminb1 is required
for oligodendrocyte differentiation and myelination. S. LIN; S.
LIN*; S. B. HOWNG; L. J. PTACEK; Y. FU. Dept. of Neurol.,
Howard Hughes Med. Inst.
4:00 V11 258.16 Perk haploinsufficiency ameliorates
neuropathy in CMT1B(S63del) mice. N. MUSNER; M.
SIDOLI; D. ZAMBRONI; U. DEL CARRO; D. RON; M. L.
FELTRI; M. D’ANTONIO; L. WRABETZ*. San Raffaele Sci.
Inst, DIBIT, Univ. of Cambridge.
POSTER
259. Spinal Cord Injury: Posture and Locomotion
Theme C: Disorders of the Nervous System
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 V12 259.1 Sensory control of standing and
stepping enabled by epidural stimulation after a human
motor complete spinal cord injury. S. J. HARKEMA*; Y.
GERASIMENKO; J. HODES; J. W. BURDICK; C. ANGELI;
Y. CHEN; C. FERREIRA; E. REJC; V. R. EDGERTON. Univ.
Louisville, Frazier Rehab Inst, KSCIRC, UCLA, Univ. of
Louisville, California Insitute of Technol., Univ. of Udine.
2:00 V13 259.2 Responses to locomotor training and
identification of functional long tracts in children with severe,
chronic spinal cord injury. D. R. HOWLAND*; E. J. FOX; N.
J. TESTER; S. TRIMBLE; C. SENESAC; L. SPIERRE; J.
JOHNS; J. KLEIM; P. REIER; A. L. BEHRMAN. Univ. Florida
Col. Med., Malcom Randall VA Med. Ctr., Univ. of Florida,
Shands Jacksonville, Brooks Rehabil. Hosp.
3:00 V14 259.3 On-going recovery and musculoskeletal
health four years after locomotor training in a child with
severe, incomplete cervical spinal cord injury. A. L.
BEHRMAN*; E. J. FOX; N. J. TESTER; S. TRIMBLE; C.
PHADKE; P. NAIR; C. R. SENESAC; D. R. HOWLAND. Univ.
Florida, VA Brain Rehabil. Res. Ctr., Univ. of Florida, Queens
Univ., Seton Hall Univ.
4:00 V15 259.4 Use of patterned electrical stimulation of
the arms and legs to improve walking after spinal cord injury.
L. E. ALVARADO PACHECO*; R. J. OGILVIE; S. CHONG; V.
K. MUSHAHWAR. Univ. of Alberta.
1:00 V16 259.5 Cervical and Thoracolumbar spinal
stimulation produces multisegmental responses in the upper
and lower limbs. M. M. SABBAHI*; Y. S. SALIK. Texas
Woman’s Univ., Dokuz Eylul Univ.
2:00 V17 259.6 Inter-extremity coordination during
treadmill stepping post-motor incomplete spinal cord injury.
N. J. TESTER*; D. R. HOWLAND; S. P. SUTER; A. L.
BEHRMAN. Brain Rehabil. Res. Center, Malcom Randall VA
Med. Ctr., Univ. of Florida, Shands Hosp.
3:00 V18 259.7 Neuromuscular control across locomotor
tasks in children with spinal cord injury. E. J. FOX*; N. J.
TESTER; D. R. HOWLAND; S. A. KAUTZ; A. L. BEHRMAN.
Univ. of Florida, Malcom Randall VAMC, Med. Univ. of South
Carolina.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
4:00 W1 259.8 BDNF or NT-3 restore stepping in the
untrained adult spinal rat. V. S. BOYCE*; J. PARK; S. S.
REDDY; K. THOMAS; F. H. GAGE; L. M. MENDELL. SUNY
Stony Brook, Salk Inst.
1:00 W2 259.9 Locomotor network responsiveness
differs between fore- and hindlimbs in rats with cervical
incomplete spinal cord injury. L. P. FILLI*; B. ZÖRNER; M.
RÖTHLISBERGER; M. E. SCHWAB. Brain Res. Inst.
2:00 W3 259.10 Locomotor training during amphetamine
intoxication inhibits locomotor recovery following thoracic
spinal cord injury. J. K. WONG*; O. STEWARD. Univ. of
California, Irvine.
3:00 W4 259.11 Contribution of the spinal pattern
Sun. PM
generator to the recovery of locomotion after partial spinal
cord injuries. M. MARTINEZ*; H. LEBLOND; H. DELIVET-
MONGRAIN; S. ROSSIGNOL. Groupe De Recherche Sur Le
Système Nerveux Central/ Univ. De Montréal.
4:00 W5 259.12 Locomotor function and plasticity of
multiple pathways following spinal hemisection in the cat.
A. E. BLUM*; S. E. MONDELLO; S. C. JEFFERSON; D. R.
HOWLAND. Univ. of Florida Col. of Med., Malcom Randall
VAMC, McKnight Brain Inst., Univ. of Texas.
1:00 W6 259.13 Effects of chondroitinase treatment
duration on motor recovery and plasticity post-SCI. S.
E. MONDELLO*; A. E. BLUM; N. J. TESTER; S. C.
JEFFERSON; D. R. HOWLAND. Univ. of Florida Col. of
Med., Malcom Randall VAMC, McKnight Brain Inst., Univ. of
Texas.
2:00 W7 259.14  •  Longitudinal study of locomotor
recovery following chronic compressive spinal cord injury in
rats. O. ALLUIN*; S. KARIMI-ABDOLREZAEE; H. DELIVET-
MONGRAIN; M. MÉNARD; H. LEBLOND; M. FEHLINGS; S.
ROSSIGNOL. Univ. of Montreal, Univ. of Manitoba, Toronto
Western Hosp.
3:00 W8 259.15 Body weight supported treadmill training
improves behavior, hyperreflexia and urodynamic function
in contused rats. A. SINGH*; M. MURRAY; T. HIMES; J.
HOULE. Drexel Univ., Philadelphia Veterans Admin. Med.
Ctr.
4:00 W9 259.16 Effects of robotic training on velocity
dependent overground locomotor measures following SCI in
rats. N. D. NECKEL*; H. DAI; J. LARACY; M. MCATEE; B.
BREGMAN. Georgetown Univ.
1:00 W10 259.17 Upright bipedal locomotion in rat: A
suitable model for investigation of interventions after SCI?
U. SLAWINSKA; H. MAJCZYNSKI*; E. KISIELNICKA; L. M.
JORDAN. Nencki Inst. Exp Biol, Univ. of Manitoba.
2:00 W11 259.18 Task specific locomotor training delivered
at the appropriate time promotes recovery of function after
SCI in rats. D. BASSO*; C. N. HANSEN; L. FISHER. Ohio
State Univ.
3:00 W12 259.19 The recovery of locomotion after
lumbar spinal cord motoneuron depletion is affected by the
modulation of Sonic Hedgehog and Notch-1 pathways. R.
GULINO; M. GULISANO*. Univ. Catania.
Neuroscience 2010  |  Sunday PM  |  103 
4:00 W13 259.20 Segmental distribution of 5-HT2A and
5-HT2C receptor up-regulation one month after complete
spinal cord injury. L. M. JORDAN; H. FABCZAK; E.
KISIELNICKA; A. LESZCZYNSKA; H. MAJCZYNSKI; J. I.
NAGY; U. SLAWINSKA*. Univ. of Manitoba, Nencki Inst. of
Exptl. Biol.
1:00 W14 259.21 Should I stay or should I go: The state-
dependent effects of the histaminergic receptors on the
rat spinal neurons. G. TACCOLA*; T. COSLOVICH; M. C.
MAZZOTTA; D. FRATTAROLI; G. MAURA; M. MARCOLI.
SISSA - IMFR, Univ. of Genova, Natl. Inst. of Neurosci.
2:00 X1 259.22 Appropriate immunohistochemical
techniques for c-fos quantification. B. M. CHRISTIAN*; J.
BAMFORD; K. WONG; L. OGBEIDE; K. G. TODD; V. K.
MUSHAHWAR. Univ. of Alberta.
3:00 X2 259.23 Evaluation of a treadmill based gait
analysis system for functional assessment of rodent spinal
cord injury models. A. JOSE; J. P. GRIFFIN; A. TOFT; J. S.
RIDDELL*. Univ. of Glasgow.
4:00 X3 259.24 Electrophysiological assesment of
function after spinal cord contusion injury. A. TOFT*; J. P.
GRIFFIN; J. S. RIDDELL. Univ. of Glasgow.
1:00 X4 259.25 On the importance of supraspinal control
in locomotion following spinal cord injury. B. J. WHEATON*;
J. K. CALLAWAY; J. EK; K. M. DZIEGIELEWSKA; N. R.
SAUNDERS. Univ. of Melbourne.
2:00 X5 259.26 Effects of experimental treadmill training
and TMS on impaired gait and spasticity following low
cervical spinal cord injury (C-SCI). J. HOU*; R. NELSON;
J. KEENER; K. WILLIAMS; C. NEREIM; K. OBLEADA; R.
PARMER; F. J. THOMPSON; P. BOSE. Univ. of Florida,
North Florida/South Georgia Veterans Hlth. Syst.
3:00 X6 259.27 Deep brain stimulation of the midbrain
for the acute enhancement of locomotor function following
partial spinal cord injury. B. R. NOGA; F. J. SANCHEZ; S.
XIE; A. D. BYTHE; I. D. HENTALL*. Univ. Miami Schl Med.
4:00 X7 259.28 Optimizing the spinal cord neuronal
circuitry to restore locomotion after a spinal cord injury by
using functional electrical stimulation. E. BEAUMONT*; E.
GUEVARA; M. NAGAI; F. LESAGE; M. R. POPOVIC. Univ.
of Montreal, Ecole Polytechnique, Univ. of Toronto IBBME,
Toronto Rehabil. Inst.
POSTER
260. Neuroinflammation: Cellular and Molecular Mechanisms I
Theme C: Disorders of the Nervous System
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 X8 260.1 Acute p38-mediated inhibition of KCa
channels activated by Ca2+ influx through both NMDA
receptors and voltage-gated Ca2+ channels by interleukin-1β.
Y. HAYASHI*; R. ZHANG; L. SUN; Z. WU. Fac of Dent. Sci.
Kyushu Univ.
2:00 X9 260.2 Peroxisome proliferator-activated
receptor gamma (PPARG) isoform 2, carrying the P12A
polymophism, is the main splice variant expressed in human
brain neurons. K. CONDON; G. H. MURDOCH*. Univ. of
Pittsburgh, Univ. of Pittsburgh Sch. of Med.
3:00 X10 260.3 Involvement of the S1P3 receptor in
neuro-inflammation in vitro and in vivo. I. FISCHER*; C.
ALLIOD; N. MARTINIER; M. FROSSARD; C. BRANA; S.
POULY. Merck Serono Intl. S.A.
104  |  Society for Neuroscience
4:00 X11 260.4 TRAF6 in the central nervous system. C.
L. BUTLER*; J. N. CHANG; B. A. CITRON. Lab. of Mol. Biol.,
Bay Pines VA Healthcare Syst., Univ. of South Florida Col. of
Med.
1:00 X12 260.5 The biological role of Nogo receptor
in dendritic cells. C. MCDONALD*; K. STEINBACH; G.
DECHANT; R. MARTIN; C. BANDTLOW; M. REINDL.
Neurolog. Res. Lab., Inst. for Neuroimmunology and Clin.
Multiple Sclerosis Res., Innsbruck Med. Univ.
2:00 X13 260.6 Role of the PI-3K/Akt/mTOR pathway
in microglial inflammatory activity. A. C. OLIVEIRA*;
E. CANDELARIO-JALIL; M. F. D. MORAES; J. C. M.
SCHLACHETZKI; B. L. FIEBICH. Federal Univ. of Minas
Gerais, Univ. of Freiburg, Univ. of New Mexico, Univ. of
Erlangen.
3:00 X14 260.7   Matrix metalloproteinases mediate
α-synuclein-induced microglial activation via protease-
activated receptor-1. E. LEE*; I. CHOI; W. KIM; M. BAEK;
H. KIM. Ewha Womans Univ. Med. Sch., Korea Univ. Med.
Sch., Kyungpook Natl. Univ.
4:00 X15 260.8 Effects of manganese on ERK and JNK
phosphorylation in microglial cells activated with LPS. N. M.
FILIPOV*; I. I. GEORGIEVA; C. A. DODD. Univ. Georgia.
1:00 X16 260.9 Novel blood - brain barrier permeable
1, 2, 4-triazine derivatives decrease lps-induced apoptosis
in differentiated-pc12 cells: Role of anti-inflammatory
and anti-oxidant factors. M. R. RAMIN*; N. ANSARI; F.
KHODAGHOLI. Neurosci. Res. Center, Shahid Beheshti
Univ. of Med. Sci.
2:00 X17 260.10 Relative contribution of different
purinergic receptors in regulating microglial process motility.
S. GYONEVA*; S. F. TRAYNELIS. Emory Univ.
3:00 X18 260.11 Suppressive effect of nicotine on toll like
receptor signaling pathway in macrophages. W. CUI*; J. GU;
S. L. CHANG; M. D. LI. Univ. of Virginia, Peking Univ., Seton
Hall Univ.
4:00 Y1 260.12 The effect of advanced glycation end-
products on blood-nerve barrier. F. SHIMIZU*, ESQ; Y.
SANO; H. HARUKI; T. KANDA. Yamaguchi Univ. Grad. Sch.
of Med.
1:00 Y2 260.13 Involvement of cytokine IL-IRa in
regulating the secretion of VEGF in SH-SY5Y neuroblastoma
cells. L. K. DUFFY*; L. NICHOLAS-FIGUEROA; K. DUNLAP.
Univ. Alaska Fairban.
2:00 Y3 260.14 Neuroinflammation induced by the Toll-
like receptor-3 agonist poly(I:C) primes the nigrostriatal
dopaminergic system to degeneration via interleukin-1
signaling. M. DELEIDI*; P. HALLETT; J. KOPRICH; C.
CHUNG; O. ISACSON. McLean Hospital, Harvard Med. Sch.
3:00 Y4 260.15 NF-κB signaling regulates macrophage
migration inhibitory factor (MIF) gene. S. F. ZHANG; O. ZIS;
W. SONG*. Univ. British Columbia.
4:00 Y5 260.16 Proteomics for macrophages stimulated
by oxidized or reduced galectin-1, or bovine serum albumin.
K. YOSHIMURA*; F. KAMETANI; T. MIYAZAKI; H. SUZUKI;
Y. SAKAMOTO; M. KATO; M. NISHINA; M. SUZUKI; K.
KITAMURA; T. KADOYA. Nihon Inst. Med. Sci., Tokyo Inst.
Psychia., Tokyo Metro. Org. Med. Res.,, Saitama Med.
Univ.,, Maebashi Inst. Technol.,.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
1:00 Y6 260.17 HlA-DR and microglial morphology in
human brain. T. P. SCHNIEDER*; B. ILIEVSKI; A. STANKOV;
G. ROSOKLIJA; A. DWORK. New York State Psychiatric
Ins, CUNY, NYSPI, Sch. of Medicine, Univ. “Ss.Cyril &
Methodius”, Macedonian Acad.of Arts and Sci., Columbia
Univ.
2:00 Y7 260.18 NADPH oxidase regulates microglial
phenotype during neuroinflammation. S. CHOI*; S. AID; H.
KIM; S. H. JACKSON; F. BOSETTI. NIA, NIH, NIAID, NIH.
POSTER
261. Mechanisms of Cell Death: Oxidative Stress
Theme C: Disorders of the Nervous System
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 Y8 261.1 Role of GS28 on hydrogen peroxide-
induced cell death in human neuroblastoma cells. H. LEE;
Y. BYUN; M. SON; O. KWON; M. LEE*; S. JEONG. Catholic
Univ. Med. Col.
2:00 Y9 261.2 Effects of mercurials on oxidative stress,
glutathione and cystine-glutamate exchange. T. J. RUSH*; X.
LIU; J. HJELMHAUG; D. LOBNER. Marquette Univ.
3:00 Y10 261.3 Neuronal and microglial expression
of NOX isoforms in culture and in vivo. Y. EDLING; A.
MAVROPOULOS; M. VAN HOECKE; M. OLAH; S. WON; S.
SUH; K. BIBER; M. YENARI; R. A. SWANSON*. U.C.S.F.,
Univ. of Groningen, Univ. of Freiburg.
4:00 Y11 261.4 Sodium nitroprusside (snp) induces
autophagic cell death on vacuolar hydrogen-transporting
atpase c (atp6l) knock-downed c6 glioma cells by jnk
activation. Y. BYUN; H. LEE; M. SON; O. KWON; K. SUNG*;
S. JEONG. Col. of Medicine, The Catholic Univ. of Korea,
Catholic Univ. Med. Col.
1:00 Y12 261.5 Neurodegenerative effects of
recombinant HIV-1 Tat (1-86) are associated with direct
inhibition of microtubule formation and oxidative stress-
related reductions in microtubule-associated protein-2(a,b).
T. R. BUTLER*; K. J. SMITH; R. L. SELF; B. B. BRADEN; M.
A. PRENDERGAST. Univ. Kentucky.
2:00 Y13 261.6 Oxidative stress as a causative factor of
neurodegeneration in the spastic Han-Wistar rat, a model
of Ataxia: Hippocampus. N. ALFULAIJ*; R. W. COHEN.
California State Univ. Northridge.
3:00 Y14 261.7 Reduction in MnSOD levels,
aberrant mitochondrial superoxide production and and
Ca2+ dysregulation in adult sensory neurons isolated
from streptozotocin diabetic rats. E. K. AKUDE*; E.
ZHEREBITSKAYA; D. SMITH; P. FERNYHOUGH. St
Boniface Hosp. Res. Ctr.
4:00 Y15 261.8 Regulation of NADPH oxidase by
phospholipase A2 in neurons. Y. HE*; J. CUI; J. C. LEE; S.
DING; A. SIMONYI; A. Y. SUN; G. Y. SUN. Univ. Missouri,
Columbia, Univ. of Missouri.
1:00 Y16 261.9  •  GAPDH-Siah stress signaling cascade
facilitates epigenetic modifications. C. A. TRISTAN*; N.
SHAHANI; A. SAWA. Johns Hopkins Univ. SOM.
2:00 Y17 261.10 Oxidative stress as a causative factor of
neurodegeneration in the spastic Han-Wistar rat, a model
of Ataxia: Cerebellum. S. OO*; R. W. COHEN. Cal State
Northridge.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
3:00 Y18 261.11 Neuroprotection against high glucose-
induced oxidative stress and apoptosis in neuronal cells.
J. BOURNIVAL; M. FRANCOEUR; F. LONGPRÉ; M.
MARTINOLI*. Univ. Quebec a Trois-Rivieres.
4:00 Z1 261.12 Dyslipidemia and differential gene
expression in the etiology of peripheral diabetic neuropathy.
L. M. HINDER*; M. PANDE; Y. HONG; J. M. HAYES;
C. BACKUS; C. FIGUEROA-ROMERO; S. S. OH; E. L.
FELDMAN. Univ. of Michigan, Ann Arbor.
1:00 Z2 261.13 Amyloid-beta 25-35 and quinolinic acid
neurotoxicity: A story of RAGE. E. CUEVAS*; S. M. LANTZ;
G. NEWPORT; B. DIVINE; B. L. ROBINSON; M. G. PAULE;
A. SANTAMARIA; S. F. ALI. NCTR-FDA, Inst. Nacional de
Sun. PM
Neurología y Neurocirugía.
2:00 Z3 261.14 Effects of growth factors on cystine-
glutamate exchange. X. LIU*; T. RUSH; J. HJELMHAUG; D.
LOBNER. Marquette Univ.
3:00 Z4 261.15 Cytokines and superoxide contribute
to alcohol-induced innate immune gene induction and
neurodegeraration. L. QIN*; F. T. CREWS. Univ. North
Carolina, Sch. Med.
4:00 Z5 261.16 Myristoilated D-amino acid oxidase as a
tool to study membrane signaling in response to oxidative
stress. H. ALEYASIN*; R. HASKEW-LAYTON; R. SPEER; M.
W. ROUSSEAUX; S. J. HEWITT; D. S. PARK; R. R. RATAN.
Burke Med. Res. Institute, Weil Med. Col. of Cornell Univ.,
Univ. of Ottawa.
1:00 Z6 261.17 Modulation of lypotoxicity and
lipoapotosis in Schwann cell cultures. A. PADILLA*; A.
ALMEYDA; M. DE LEON. Loma Linda Univ.
2:00 Z7 261.18 Neuroprotective effect of maltol on
oxidative stress-induced apoptosis of retinal ganglion cells.
S. HONG*; C. KIM; J. LEE; G. SEONG. Yonsei Univ. Col. of
Med.
3:00 Z8 261.19 Two extracts from Ecballium elaterium, a
wild medicinal plant, protects dopaminergic neurons against
MPP+ -induced cellular death. J. CLOUTIER-BEAUPRÉ; J.
BOURNIVAL; F. LONGPRÉ; G. BRONCHTI*; E. ATTARD; M.
MARTINOLI. Univ. Quebec Trois-Rivieres, Univ. of Malta.
4:00 Z9 261.20   Kynurenic acid prevents oxidative
damage independently of NMDA and α7-nicotinic receptors
inhibition in different rat tissues. R. LUGO*; P. CARRILLO-
MORA; P. MALDONADO; J. PEDRAZA-CHAVERRÍ; I.
GONZÁLEZ-HERRERA; A. SANTAMARÍA; V. PÉREZ-DE
LA CRUZ*. Inst. Nacional De Neurologia Y Neurocirugia
Manuel Velasco Suarez, Inst. Nacional De Neurología
Y Neurocirugía, Manuel Velasco Suarez, Univ. Nacional
Autónoma de México, Facultad de Química.
1:00 Z10 261.21 DNA double strand break repair following
ionotropic glutamate receptor activation in rat cortical
neurons. G. PALCHIK*; T. JORGENSEN; A. KONDRATYEV.
Georgetown Univ. Med. Ctr.
2:00 Z11 261.22 The functional groups on (E)-4,4’-
disubstituted stilbenes influences their biological activity in
differentiated PC-12 cells. G. X. GARCIA*; S. LARSEN; C.
PYE; R. ISOVITSCH; E. A. FRADINGER. Whittier Col.
3:00 Z12 261.23 The effects of miconazole on the
neuroprotection of dopaminergic neurons. M. TERASHVILI*;
N. WICKRAMASEKERA; M. V. NOSTRAND; D. R.
HARDER. Med. Col. Wisconsin.
Neuroscience 2010  |  Sunday PM  |  105 
4:00 Z13 261.24 Alterations on the brain lipid profile and
antioxidant indicators of rats exposed to extremely low
frequency electromagnetic fields and movement restriction.
J. MARTINEZ-SAMANO; L. VERDUGO-DIAZ*; P. TORRES-
DURAN; M. A. JUAREZ-OROPEZA. Univ. Natl. Autonoma
Mexico.
1:00 Z14 261.25 Pretreatment with endoplasmic reticulum
stress inducers ameliorates 6-hydroxydopamine-induced
cytotoxicity. H. HARA*; T. KAMIYA; T. ADACHI. Gifu
Pharmaceut. Univ.
2:00 AA1 261.26 DJ-1 ameliorates neuronal cell death
in ischemic stroke via mitochondrial pathway. N. TAJIRI*;
Y. KANEKO; H. SHOJO; S. J. YU; E. C. BAE; C. V.
BORLONGAN. Univ. of South Florida Col. of Med.
POSTER
262. Neuro-Oncology I
Theme C: Disorders of the Nervous System
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 AA2 262.1 Changes in cognition and growth
hormone in a pediatric model of fractionated whole brain
irradiation. C. LINVILLE; V. PAYNE; R. CREER; M.
ROBBINS; J. K. BRUNSO-BECHTOLD*. Wake Forest Univ.
Hlth. Sc.
2:00 AA3 262.2 Biophysical and biomechanical aspects of
glioma invasion. S. M. WATKINS*; H. SONTHEIMER. Univ.
Alabama, Birmingham.
3:00 AA4 262.3 Chronic alterations in microglia and
cell proliferation in the adult rat hippocampus following
fractionated whole-brain irradiation at middle age. D. R.
RIDDLE*; M. E. FORBES; M. PAITSEL; L. SHI; M. C.
LINVILLE; J. K. BRUNSO-BECHTOLD. Dept. Neurobio. and
Anatomy, Wake Forest Univ. Sch. Med.
4:00 AA5 262.4 Calcium-activated potassium channels
BK and IK1 are functionally expressed in human gliomas
but do not regulate cell proliferation. I. F. ABDULLAYEV*; Y.
KUO; A. RUDKOUSKAYA; A. A. MONGIN. Albany Med. Col.
1:00 AA6 262.5 Reduction in hippocampal neuron
number in a pediatric model of fractionated whole brain
irradiation. R. CREER; V. PAYNE; D. MOLINA; L. SHI; R.
W. OPPENHEIM*; M. ROBBINS; J. BRUNSO-BECHTOLD.
Wake Forest Univ.
2:00 AA7 262.6 Expression of calcium-activated
potassium channels in glioblastoma multiforme surgical
tissue samples versus primary cell cultures. Y. KUO*; I. F.
ABDULLAYEV; A. A. MONGIN. Albany Med. Ctr.
3:00 AA8 262.7 A nonhuman primate model of radiation-
induced cognitive impairment. J. D. BOURLAND; K. T.
WHEELER; M. CLINE; D. GREENE-SCHLOESSER; S. A.
DEADWYLER; M. E. ROBBINS*. Wake Forest Univ. Sch.
Med.
4:00 AA9 262.8 Dose-dependent changes in
neurogenesis and microglial activation following single dose
and fractionated irradiation of the young adult rat brain. D. M.
GREENE-SCHLOESSER*; V. PAYNE; M. KOOSHKI; M. E.
ROBBINS. Wake Forest Univ. Baptist Med. Ctr.
1:00 AA10 262.9 MRI markers of neurocognitive ability in
human cancer survivors following brain irradiaition therapy.
A. M. PEIFFER*; S. R. RAPP; E. SHAW. Wake Forest Univ.
Sch. Med.
106  |  Society for Neuroscience
2:00 AA11 262.10 Bradykinin promotes the chemo-tactic
invasion of primary brain tumors. V. MONTANA*; H.
SONTHEIMER. Univ. of Alabama.
3:00 AA12 262.11   Analysis of operatively treated patients
with meningioma in period 2007-2010 at Cantonal Hospital
Zenica. M. POJSKIC*; R. SKOMORAC (MENTOR). Fac. of
Med. Sarajevo, Cantonal Hosp. Zenica.
4:00 AA13 262.12 Novel functions for id2 in oligodendrocyte
differentiation and glioma. M. C. HAVRDA*; B. R.
PAOLELLA; K. JERING; M. ISRAEL. Dartmouth Med. Sch.,
Dartmouth Col.
1:00 AA14 262.13 Transfer of an inducible transgene
expressing a soluble form of Gas1 elicits glioma cell arrest,
apoptosis and inhibits tumor growth. A. LÓPEZ-ORNELAS;
T. MEJÍA-CASTILLO; P. VERGARA; J. V. SEGOVIA-VILA*.
Cinvestav-IPN.
2:00 AA15 262.14 Nuclear presence of breast cancer
resistant protein in glioblastoma multiforme cell lines
presents a novel target for effective chemotherapy. P.
BHATIA*; M. BERNIER; I. W. WAINER. Natl. Inst. on Aging,
NIH.
3:00 AA16 262.15 Gene silencing of glutamate receptor
subunits modulates mRNA expression profile and cancer
cell growth. H. LUKSCH; A. STEPULAK; L. A. TURSKI*;
C. IKONOMIDOU. Dept. of Pediatric Neurol., Med. Univ. of
Lublin,, Solvay Pharmaceuticals BV, Univ. of Wisconsin.
4:00 AA17 262.16 CXCR4 and IGF-IR signaling crosstalk in
human neuroblastoma. R. A. NIAMAT*; C. M. VANGOLEN,.
Delaware State Univ.
1:00 AA18 262.17 Investigating the influence of the BMP-
pathway on cell cycle regulation and its potential to induce
differentiation of brain tumor initiating cells. D. RUDAN*; P.
MONFARED; T. VIEL; M. HADAMITZKY; E. KNOEDGEN; G.
SCHNEIDER; A. JACOBS. Max Planck Inst. for Neurolog.
Res., Univ. of Münster.
2:00 BB1 262.18 Degradome profiling fails to identify a
unique protease signature in primary malignant brain tumors.
D. M. JAWORSKI*; H. M. STRADECKI; P. L. PENAR; W. W.
PENDLEBURY; C. J. PENNINGTON; D. R. EDWARDS; W.
C. BROADDUS; H. L. FILLMORE. Univ. Vermont Col. Med.,
Univ. of East Anglia, Virginia Commonwealth Univ.
3:00 BB2 262.19 Regulation of aminoacylase expression
in neuroblastoma. P. M. LONG*; U. V. WESLEY; D. M.
JAWORSKI. Univ. of Vermont Col. of Med.
4:00 BB3 262.20 Propentofylline, a glial modulating agent,
targets microglial cells in the tumor microenvironment
decreasing glioblastoma tumor growth. V. L. JACOBS*; L. H.
TREAT; R. P. LANDRY, III; J. A. DE LEO. Dartmouth Med.
Sch.
1:00 BB4 262.21 Bone marrow-derived microglia in
experimental glioma. M. B. GRAEBER*; A. FLÜGEL. The
Brain & Mind Res. Institute, U Sydney, Univ. of Göttingen.
2:00 BB5 262.22  •  CytoReg reduces cellular viability
and chemosensitizes human brain tumor cells via acute
membrane disruption. M. D. LAIRD*; S. SUKUMARI-
RAMESH; S. SHARMA; B. STRAUSS; C. H. ALLEYNE, Jr.;
J. R. VENDER; K. M. DHANDAPANI. Med. Col. of Georgia.
3:00 BB6 262.23 Intramedullary spinal cord tumors:
neuroimaging features predict histopathology. S. C.
CRACIUNAS*; M. ASCHIE; A. ILIESIU; A. BANI-AHMED;
C. M. CIRSTEA. Bagdasar - Arseni Hosp., “Ovidius” Univ.,
KUMC.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
4:00 BB7 262.24 Recombinant Lenti virus encoding
shRNA for HuR protein is a possible tool for cancer cells
treatment. N. FILIPPOVA*; X. YANG; Y. G. GILLESPIE; C. P.
LANGFORD; L. B. NABORS. UAB.
1:00 BB8 262.25 Selective beta2-adrenergic receptor
agonists inhibit the proliferation of 1321N1 astrocytoma cells
in vitro and in vivo. L. R. TOLL*; N. WALEH; L. JIMENEZ;
W. POLGAR; J. ORDUNA; C. GREEN; J. GOW; K.
O’LOUGHLIN; M. BERNIER; I. W. WAINER. SRI Intl., Natl.
Inst. of Aging.
2:00 BB9 262.26 Investigation of β1-integrin and EGFR
signaling in brain tumor stem cells. M. SRIKANTH*; S. DAS;
J. A. KESSLER. Northwestern Univ.
3:00 BB10 262.27 The genetic interaction of the quaking
locus with p53 and patched. C. GAVINO; S. RICHARD*.
Departments of Med. and Oncology, McGill Univ., Terry Fox
Mol. Oncology Group, the Bloomfield Ctr. for Res. on Aging,
and the Segal Cancer Centre, Lady Davis Inst. for Med.
Research, Sir Mortimer B. Davis Jewish Gen. Hosp.
4:00 BB11 262.28  •  Inhibition of histone deacetylase
or DNA topoisomerase II reduces the viability of human
neuroectodermal cells. R. ROESLER*; C. NÖR; M.
JAEGER; C. B. DE FARIAS; A. L. ABUJAMRA; G.
SCHWARTSMANN; A. L. BRUNETTO. Federal Univ. of Rio
Grande do Sul, Univ. Hosp. Res. Ctr. (CPE-HCPA), Federal
Univ. of Rio Grande do Sul, Natl. Inst. for Translational Med.
(INCT-TM), Children’s Cancer Inst. (ICI-RS).
1:00 BB12 262.29 The membrane androgen receptor as a
therapeutic target for glioblastoma. A. M. BADEAUX*; M.
SINGH. Univ. North Texas, Hlth. Sci. Ctr., Inst. for Aging and
Alzheimer’s disease Res., Univ. of North Texas Hlth. Sci. Ctr.
2:00 BB13 262.30 A novel tumor suppressive function of
MyoD in an oncogenic Smoothened-driven mouse model of
medulloblastoma. J. DEY*; S. J. TAPSCOTT; J. M. OLSON.
Fred Hutchinson Cancer Res. Ctr. & Univ. of Washington.
POSTER
263. Approaches to Gene Therapy in Clinical Neuroscience
Theme C: Disorders of the Nervous System
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 BB14 263.1 Lentiviral vectors for in vivo conditional
rhoa inhibition. C. N. GUTEKUNST*; E. N. STEWART; J.
L. MERTZ; E. R. TORRE; C. R. HANDY; C. H. LEUNG; N.
M. BOULIS; R. J. MCKEON; L. WEI; R. E. GROSS. Emory
Univ.
2:00 BB15 263.2 In vivo optical imaging of siRNA
diffusion in brain extracellular space. R. G. THORNE*; C.
NICHOLSON. Univ. of Wisconsin-Madison, New York Univ.
Sch. of Med.
3:00 BB16 263.3 Adeno-associated mifepristone-regulated
viral vector system for controllable GDNF expression in
the central nervous system. Y. TERESHCHENKO*; A.
MADDALENA; M. BÄHR; S. KÜGLER. Viral Vectors Lab,
Dept. of Neurology, Univ. Med. Goettingen.
4:00 BB17 263.4 Characterization of a novel autoregulatory
expression cassette for gene therapy of neurodegenerative
disorders. T. VAGNER; A. MOURAVLEV; M. DURING; D.
YOUNG*. Univ. of Auckland Fac. of Med. & Hlth. Sci.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
1:00 BB18 263.5 Gene delivery with compacted DNA
nanoparticle rescues visual function in a mouse model
of Leber congenital amaurosis. T. MAEDA*; K. OKANO;
L. PADEGIMAS; T. H. KOWALCZYK; S. M. OETTE; A.
MAEDA; R. C. MOEN; G. PALCZEWSKA; K. PALCZEWSKI;
M. J. COOPER. Case Western Reserve Univ., Copernicus
Therapeut. , Inc, Polgenix, Inc.
2:00 CC1 263.6 Functional effects of a transgenic cell
line with enhanced GAD67 expression after transplantation
into the substantia nigra reticulata of Sprague-Dawley rats.
J. A. MEJIA-TOIBER*; A. GONZALEZ-GALLARDO; M.
GIORDANO. UNAM, Inst. de Neurobiología, UNAM.
3:00 CC2 263.7 Viral constructs encoding conopeptides
Sun. PM
for suppression of pain in spinal cord injured rats. F.
NASIRINEZHAD*; J. VASQUEZ; M. COLLADO; L.
COLLADO; R. SOLORZANO; C. PEREZ; M. VARGHESE;
J. LEE; S. GAJAVELLI; J. SAGEN. Univ. of Miami, Iran
university of medical sciences, William Patterson Univesity.
4:00 CC3 263.8 Prevention of diabetic neuropathy by
intermittent expression of erythropoietin from a regulatable
HSV-1 vector. Z. WU*; M. MATA; D. J. FINK. Univ. of
Michigan.
1:00 CC4 263.9 Gene therapy in vivo by application of
AAV2/6 vector in SMA type III mouse model. P. D’ ERRICO;
D. LOCATELLI; S. CAPRA; D. REGANO; V. SETOLA; A.
FINARDI; F. COLCIAGHI; P. NOBILI; P. AEBISCHER; G.
BATTAGLIA*. IRCCS Neurol Inst. C.Besta, EPFL.
2:00 CC5 263.10 The role of collagen type I a2
polymorphisms intracranial aneurysm in Korans. S. JOO*.
Chonnam Natl’ Uni. Med. Sch.
3:00 CC6 263.11  •  AAV-mediated gene delivery to retinal
ganglion cells in the macaque eye. L. YIN*; D. DALKARA; K.
GREENBERG; J. J. HUNTER; B. D. MASELLA; M. VISEL;
D. DILORETO JR.; J. FLANNERY; D. R. WILLIAMS; W. H.
MERIGAN. Univ. of Rochester, Univ. of California, Berkeley.
4:00 CC7 263.12 Spinal delivery of an acid α-glucosidase
(GAA)-expressing adeno-associated viral vector (AAV)
restores enzyme activity and enhances ventilatory function
in Pompe mice. D. D. FULLER*; K. QIU; D. J. FALK; P. J.
REIER; B. J. BYRNE. Univ. of Florida.
1:00 CC8 263.13  •  Assessment of hippocampal AAV gene
delivery via frameless stereotaxis in a nonhuman primate.
C. H. LEUNG*; M. A. KLIEM; B. L. HEEKE; T. FEDERICI;
S. MCPHEE; T. J. MCCOWN; N. M. BOULIS. Emory Univ.,
ASKLEPIOS BioPharmaceuticals, Inc., The Univ. of North
Carolina at Chapel Hill.
2:00 CC9 263.14 Spinal delivery of dicer-substrate
sirna targeting ccr2 prevents the pronociceptive action of
monocyte-chemoattractant-protein-1. V. BÉGIN-LAVALLÉE*;
M. DANSEREAU; S. D. ROSE; A. M. JACOBI; N. BEAUDET;
M. A. BEHLKE; S. MELIK-PARSADANIANTZ; P. SARRET.
Univ. De Sherbrooke, Integrated DNA Technologies Inc.,
Ctr. de recherche de l’Institut Cerveau Moelle, UMR S 975
INSERM, UMR 7225 CNRS, UPMC, Équipe Douleurs,
Faculté de Médecine Pitié Salpêtrière.
3:00 CC10 263.15 Regulated transgene expression of
GDNF in the striatum and its effect on engrafted embryonic
stem cell-derived dopamine neurons. D. M. YUREK*; A.
M. FLETCHER; W. A. CASS; F. P. MANFREDSSON; R. J.
MANDEL. Univ. Kentucky Col. Med., Univ. of Florida Col. of
Med.
Neuroscience 2010  |  Sunday PM  |  107 
POSTER
264. Human Brain Imaging in Psychiatric Illnesses
Theme C: Disorders of the Nervous System
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 CC11 264.1 Emotional and working memory task
responses in schizophrenia reveal inefficiency in functional
neurocircuitry. M. A. KIM*; H. LEE; S. G. POTKIN; J. H.
FALLON; F. BIRN; J. A. TURNER. Univ. of California - Irvine,
Chonbuk Nat’l Univ., The MIND Res. Network.
2:00 CC12 264.2 Impact of alcohol and cannabis use on
subcortical structures in schizophrenia. M. J. SMITH*; L.
WANG; W. CRONENWETT; M. B. GOLDMAN; D. MAMAH;
D. M. BARCH; J. G. CSERNANSKY. Northwestern Univ,
Feinberg, Washington Univ. Sch. of Med.
3:00 CC13 264.3 Auditory and visual integration differences
from left temporal cortex in schizophrenia. J. M. STEPHEN*;
L. URREA; A. GEEDA; L. ROMERO; A. GONZALES; C. J.
AINE; J. BUSTILLO. The Mind Res. Network, Univ. of New
Mexico Hlth. Sci. Ctr.
4:00 CC14 264.4 Abnormal white matter asymmetry in
schizophrenia revealed by voxel-based analysis. J. MIYATA*;
A. SASAMOTO; K. KOELKEBECK; M. KUBOTA; R.
KAWADA; H. TAKAHASHI; H. FUKUYAMA; N. SAWAMOTO;
T. MURAI. Kyoto Univ., Univ. of Muenster.
1:00 DD1 264.5 An mri study of globus pallidus internal
and external segments in schizophrenia. J. J. LEVITT*;
A. L. ALVARADO; P. PELAVIN; M. NIETHAMMER; R.
MCCARLEY; M. E. SHENTON. VA Boston Healthcare
System, Harvard Med. Sch., Univ. of North Carolina.
2:00 DD2 264.6 A language-independent fMRI paradigm
of prospective memory activates the bilateral rostral
prefrontal cortices in healthy subjects. H. N. HALAHALLI*; J.
P. JOHN; V. K. MANDAPATI; J. N. PERUVUMBA; S. JAIN;
K. KUMAR; V. ARUNACHALAM; S. USMAN. Natl. Inst. of
Mental Hlth. and Neuro Sci.
3:00 DD3 264.7 Brain structural change in polydipsic
schizophrenia. T. NAGASHIMA; M. INOUE; S. KITAMURA;
K. KIUCHI; J. KOSAKA; D. IKAWA; T. TAKEDA; S.
KIMOTO*; N. HIROTA; T. TAOKA; K. KICHIKAWA; T.
KISHIMOTO. Nara Med. Univ.
4:00 DD4 264.8 Cingular activation in first episode
psychosis and chronic schizophrenia. T. IKUTA*; S. SEVY;
D. ROBINSON; A. K. MALHOTRA; J. GALLEGO; P. B.
KINGSLEY; K. RHINDRESS; P. R. SZESZKO. The Feinstein
Inst. For Med. Research, North Shore-Lij Hlth. Syst., The
Zucker Hillside Hospital, North Shore-LIJ Hlth. Syst., Albert
Einstein Col. of Med., North Shore Univ. Hospital, North
Shore-LIJ Hlth. Syst., St. John’s Univ.
1:00 DD5 264.9  •  Two-channel near infrared spectroscopy
(NIRS) activation curves of oxyhemoglobin during frontal
lobe tasks in schizophrenia. M. IWASE*; M. AZECHI; K.
IKEZAWA; R. ISHII; H. TAKAHASHI; T. NAKAHACHI;
L. CANUET; Y. AOKI; R. KURIMOTO; H. KAZUI; M.
FUKUMOTO; N. IIKE; K. OHI; H. YAMAMORI; Y. YASUDA;
R. HASHIMOTO; M. TAKEDA. Osaka Univ. Grad Sch. Med.,
CREST, JST, Dept Mol Neuropsychiatry, Osaka Univ. Grad
Sch. Med., The Osaka-Hamamatsu Joint Res. Centr Child
Mental Dev, Osaka Univ.
108  |  Society for Neuroscience
2:00 DD6 264.10 White and gray matter integrity in
individuals with schizophrenia and their siblings. M. P.
HARMS*; K. D. AKHTER; J. G. CSERNANSKY; S. MORI;
D. M. BARCH. Washington Univ. Sch. of Med., The Johns
Hopkins Univ. Sch. of Med., Northwestern Univ. Feinberg
Sch. of Med.
3:00 DD7 264.11 Age-related cortical thinning in
schizophrenia. M. KUBOTA; J. MIYATA; R. KAWADA;
A. SASAMOTO; H. TAKAHASHI*; N. SAWAMOTO; H.
FUKUYAMA; T. MURAI. Grad. Sch. of Medicine, Kyoto Univ.
4:00 DD8 264.12 A test of the fronto-temporal
dysconnection hypothesis in schizophrenia: Prefrontal-
hippocampal coherence during transverse patterning
performance. F. M. HANLON*; J. M. HOUCK; A. R. MAYER;
J. LING; R. S. ZALESKI; S. D. KLIMAJ; C. D. TESCHE.
The Mind Res. Network, Univ. of New Mexico, Univ. of
New Mexico Ctr. on Alcoholism, Substance Abuse, and
Addictions.
1:00 DD9 264.13  •  Changes in small-world and long-
distance structural connectivity in Schizophrenia. S.
SRITHARAN*; M. KAISER; A. ROTARSKA-JAGIELA; W.
SINGER; P. J. UHLHAAS. Max Planck Inst. For Brain Res.,
Newcastle Univ., Seoul Natl. Univ., Johann Wolfgang Goethe
Univ.
2:00 DD10 264.14 Specific increases in myelination of the
bilateral arcuate fasciculus in schizophrenia patients with
frequent auditory verbal hallucinations. A. D. DE WEIJER*;
R. C. W. MANDL; S. F. W. NEGGERS; K. M. J. DIEDEREN;
R. S. KAHN; H. E. HULSHOFF POL; I. E. C. SOMMER.
Rudolf Magnus Inst. of Neurosci.
3:00 DD11 264.15 Anterior hippocampus and amygdala
shape differences in schizophrenic patients with water
imbalance congruent with their neuroendocrine dysfunction.
M. B. GOLDMAN*; L. WANG; C. WASHI; S. DAUDI; J.
CSERNANSKY; I. J. TORRES. Northwestern University,
Feinberg Sch. of Med., Northwestern Univ., Occidental Col.,
Simon Fraser Univ.
4:00 DD12 264.16 Relationship between fronto-temporal
anatomical connectivity and prefrontal-hippocampal
functioning in schizophrenia. S. D. KLIMAJ*; J. M. HOUCK;
R. S. ZALESKI; A. R. MAYER; C. D. TESCHE; F. M.
HANLON. The Mind Res. Network, Univ. of New Mexico,
Univ. of New Mexico Sch. of Med.
1:00 DD13 264.17 Developmental changes in functional
activation in subjects at clinical high risk for schizophrenia.
K. H. KARLSGODT*; J. H. SANZ; C. E. BEARDEN; T. D.
CANNON. UCLA, Kennedy Krieger Inst.
2:00 DD14 264.18 Hemodynamic response at prefrontal
cortex during electroconvulsive therapy as a predictor
of therapeutic effect in schizophrenia: A near-infrared
spectroscopy study. Y. FUJITA; K. HISAOKA; M.
TSUCHIOKA; M. TAKEBAYASHI*. Dept Psychiat, Natl. Hosp
Org Kure Med. Ctr., Inst. Clin. Res, Natl. Hosp Org Kure
Med. Ctr., Dep Psychiat Kusatsu Hosp, Dept Pharmacol,
Hiroshima Univ. Grad Sch. of Biomed Sci.
3:00 EE1 264.19 Functional abnormalities of the
orbitofrontal cortex in bipolar disorder: An fMRI study. R.
SENARATNE*; G. MACQUEEN; C. GREGORY; G. HALL.
McMaster Univ., Univ. of Calgary.
4:00 EE2 264.20 Longitudinal progression of frontal and
temporal lobe changes in schizophrenia. D. COBIA*; L.
WANG; J. CSERNANSKY. Northwestern Univ. Feinberg Sch.
of Med.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
1:00 EE3 264.21 Discriminant analysis of working memory,
default mode, and temporal lobe functional networks
in schizophrenia. K. M. HAUT*; S. RACHAKONDA; V.
CALHOUN; J. TURNER; S. G. POTKIN; A. BELGER; K. O.
LIM; D. MATHALON; D. O’LEARY; B. ROSEN; A. TOGA; J.
VOYVODIC; A. W. MACDONALD, III. Univ. of Minnesota,
The Mind Res. Network, Univ. of New Mexico, Univ. of
California, Irvine, Univ. of North Carolina, Univ. of California,
San Francisco, Univ. of Iowa, Massachusettes Gen. Hosp.,
Harvard Univ., UCLA, Duke Univ.
2:00 EE4 264.22 Aberrant complex structural brain
networks in schizophrenia. M. P. VAN DEN HEUVEL*; R.
MANDL; C. STAM; R. KAHN; H. HULSHOFF POL. Rudolf
Magnus Inst. of Neuroscience, Univ. Med. Ctr. Utrecht,
Rudolf Magnus Inst. of Neuroscience, Univ. Med. Ctr.
Utrecht, Dept. of Psychiatry, VU Med. Ctr. Amsterdam.
3:00 EE5 264.23 Abnormal neural responses associated
with feedback-driven switching in schizophrenia. J. A.
WALTZ*; Z. KASANOVA; T. J. ROSS; B. J. SALMERON; P.
K. KURUP; J. M. GOLD; E. A. STEIN. Univ. Maryland Sch.
Med., Natl. Inst. on Drug Abuse.
4:00 EE6 264.24 Anterior cingulate cortex exerts
exaggerated control of cortico-striatal circuits during working
memory in developmentally vulnerable adolescents. V. A.
DIWADKAR*; P. PRUITT; N. BAKSHI; M. KESHAVAN; E.
MURPHY; U. RAJAN; K. SANDHU; C. ZAJAC-BENITEZ.
Wayne State Univ. Sch. of Med., Georgetown Univ., Beth
Israel Deaconness Med. Ctr.
1:00 EE7 264.25 Quantitative tract-specific measures of
association fibers in major depression using diffusion tensor
imaging: a preliminary study. A. ZHANG; M. LAMAR; O.
AJILORE; S. YANG; A. KUMAR*; A. LEOW. Univ. of Illinois
at Chicago.
2:00 EE8 264.26 Emotion regulation during negative
social evaluation in major depression. C. L. FALES*; N. WU;
Z. YAN; T. J. DURBIN; T. E. CURL; A. Z. SNYDER; D. M.
BARCH; Y. I. SHELINE. Washington Univ. St Louis.
3:00 EE9 264.27 Increased activation during response
inhibition of Bipolar II depressed subjects using fMRI.
C. HEGARTY*; T. D. MOODY; J. TOWNSEND; L. C.
FOLAND-ROSS; S. Y. BOOKHEIMER; J. FISCHER; L. L.
ALTSHULER. UCLA.
4:00 EE10 264.28 Predictors of antidepressant response:
multivariate analysis of FDG-PET. C. L. MCGRATH*; M.
E. KELLEY; A. R. FRANCO; P. E. HOLTZHEIMER; W. E.
CRAIGHEAD; B. W. DUNLOP; H. S. MAYBERG. Emory
Univ.
1:00 EE11 264.29  •  Therapeutic application of navigation-
guided repetitive transcranial magnetic stimulation (rTMS)
to major depression and rTMS-induced alteration of gray
matter volume. M. NAKAMURA*; Y. NODA; T. SAEKI; E.
KAWAMOTO; Y. NAGAFUSA; M. INOUE; Y. YAMAMOTO;
H. IWAMA; H. IWANARI; Y. HIRAYASU. Kinkou Hospital,
Kanagawa Psychiatric Ctr., Yokohama City Univ., Univ. of
Tokyo.
2:00 EE12 264.30  •  Multivariate pattern analyses reveal
morphological abnormalities in major depressive disorder.
M. L. WASKOM; F. E. POLLI; S. S. GHOSH; S. J. DUTRA;
D. G. DILLON; A. J. HOLMES; D. V. IOSIFESCU; M. FAVA;
J. D. E. GABRIELI; D. A. PIZZAGALLI*. MIT, Harvard Univ.,
Massachusetts Gen. Hosp. and Harvard Med. Sch., McLean
Hosp. & Harvard Med. Sch.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
POSTER
265. Anxiety Disorders: Animal Models of Molecular and
Biochemical Effects
Theme C: Disorders of the Nervous System
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 EE13 265.1 Factor analysis of anxiety-like behavior
in mice reveals distinct patterns of genetic influence. G.
SOKOLOFF*; C. C. PARKER; J. LIM; A. A. PALMER. Univ.
Chicago, Duke Univ.
2:00 EE14 265.2 Using comparative analysis and
haplotype mapping approaches to identify quantitative trait
Sun. PM
loci in closely related strains. L. TARANTINO*; J. S. BAILEY;
B. M. STEFFY; L. GRABOWSKI-BOASE; T. WILTSHIRE; A.
EISENER DORMAN. Univ. North Carolina, Miracosta Col.,
Univ. of North Carolina, Genomics Inst. of the Novartis Res.
Fndn.
3:00 EE15 265.3 QTL for passive coping on chromosome
X confirmed by congenic rat strain. B. M. ANDRUS*; E.
TUNC-OZCAN; N. AHMADIYEH; K. DENNIS; K. SAAR; P.
T. VEDELL; G. A. CHURCHILL; E. E. REDEI. Northwestern
Univ., Brigham and Women’s Hosp. and Dana-Farber
Cancer Inst., Med. Genomics and Genet., Max-Delbrück Ctr.
for Mol. Med., The Jackson Lab.
4:00 EE16 265.4 Identifying trait anxiety: An investigation
into a behavioural and physiological phenotype of trait
anxiety in marmoset monkeys. Y. SHIBA; C. AGUSTÍN-
PAVÓN; K. BRAESICKE; Y. MIKHEENKO; A. ROBERTS*.
Univ. of Cambridge, Univ. Cambridge.
1:00 EE17 265.5  •  Rat strains show marked differences in
fear potentiation to a conditioning stimulus previously paired
with electric foot shock. L. VER DONCK*; R. WILLEMS; R.
KËRNJA; E. KARRAN. Janssen.
2:00 EE18 265.6 The role of Glo1 in anxiety. M. G.
DISTLER*; L. PLANT; I. ANEAS; G. SOKOLOFF; A. A.
PALMER. Univ. of Chicago.
3:00 FF1 265.7 Evidence for the involvement of
ceruloplasmin and iron metabolism in mouse behavior. S.
J. TEXEL*; S. CAMANDOLA; E. J. UNGER; J. L. CADET;
M. M. MATTSON. NATIONAL INSTITUTES OF HEALTH/
NATIONAL INSTITUTE ON AGING, Pennsylvania State
Univ., Natl. Inst. on Drug Abuse.
4:00 FF2 265.8 Inhibition of ASIC3 show reduced
anxiety-like behavior on the elevated plus maze. W. WU*; W.
CHUANG; C. CHEN. Academia Sinica, Natl. Def. Med. Ctr.,
Natl. Cheng-Kung Univ.
1:00 FF3 265.9 Characterization of behavioral
phenotypes in PKC/M zeta knockout mice. A. M. LEE*;
J. P. LIM; J. STECHER; J. DAGAR; T. MCMAHON; R. O.
MESSING. Ernest Gallo Clin. and Res. Ctr. At UCSF.
2:00 FF4 265.10 Adolescent social deprivation increases
aggressive behavior and decreases social interaction-
induced activation of the immediate early gene arc in the
medial prefrontal cortex of male and female rats. V. WALL;
E. K. FISCHER; N. HOWARD; L. R. WATKINS; S. F. MAIER;
S. T. BLAND*. Univ. of Colorado, Denver, Colorado State
Univ.
3:00 FF5 265.11 Hypermethylation of the BDNF gene
in the hippocampus of adult rats exposed to a predator-
based psychosocial animal model of PTSD. T. L. ROTH*;
P. R. ZOLADZ; J. D. SWEATT; D. M. DIAMOND. Univ. of
Delaware, Univ. of Alabama Birmingham, Ohio Northern
Univ., Univ. of South Florida, VA Hosp.
Neuroscience 2010  |  Sunday PM  |  109 
4:00 FF6 265.12 Chronic psychosocial stress in adult rats
produces PTSD-like sequelae, including heightened anxiety
and predator-based fear conditioning, 4 months following the
initiation of stress. D. M. DIAMOND*; P. R. ZOLADZ. Univ.
South Florida, VA Hosp., Ohio Northern Univ.
1:00 FF7 265.13 Role of oxidative stress in anxiety-like
behavior, blood pressure and insulin resistance in rats. S.
SALIM*; G. CHUGH; M. TANEJA; K. SAHA; M. ASGHAR.
Univ. Houston.
2:00 FF8 265.14 Inhibition of PTEN in the basolateral
amygdala leads to neuronal hypertrophy and increased
anxiety. M. E. HAWS*; F. ESPINOSA; S. JONES; C.
POWELL. UT Southwestern Med. Ctr.
3:00 FF9 265.15 Synaptic defects and their rescue in the
amygdala differ from the hippocampus in a mouse model of
Fragile X. A. SUVRATHAN*; C. A. HOEFFER; H. WONG;
S. KEDIA; E. KLANN; S. CHATTARJI. Natl. Ctr. for Biol Sc.,
New York Univ.
4:00 FF10 265.16 Developmental expression of RCAN1
regulates innate anxiety via inhibition of phosphatase
signaling. C. HOEFFER*, Jr.; P. CAIN; K. COWANSAGE;
H. WONG; B. ROTHERMEL; E. KLANN. Langone Med.
Ctr., Marymount Manhattan Col., New York Univ., New York
Universitty, UT Southwestern.
1:00 FF11 265.17 Attenuated CO2 and Doxapram evoked
fear in mice lacking T-cell death associated gene-8 (TDAG8)
receptor: Relevance to fear and panic. R. SAH*; L. LARKE;
J. HERMAN; S. GHOSAL. Univ. Cincinnati, Univ. of
Cincinnati.
2:00 FF12 265.18 An in vivo screen for pharmacologic
agents to treat obsessive-compulsive disorder. J. K. BRITT*;
C. PHILIP; M. CAPOTA; P. HUNTINGTON; J. ZHONG; G.
FENG; A. PIEPER. UT Southwestern Med. Ctr., Duke Univ.
Med. Ctr.
POSTER
266. Neural Plasticity and Addiction I
Theme C: Disorders of the Nervous System
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 FF13 266.1 Intra-accumbens infusions of gaboxadol
reduce cocaine-induced locomotion and stereotypy. N.
K. SIEGAL; V. VIALOU; E. J. NESTLER; D. L. DOW-
EDWARDS*. SUNY Brooklyn, Mount Sinai Sch. of Med.
2:00 FF14 266.2 Effects of rolipram on conditioned place
preference and sensitization to methamphetamine. K.
HOWELL*; S. CARMACK; S. ANAGNOSTARAS. UCSD.
3:00 FF15 266.3 Rapamycin attenuates the expression
of cocaine-induced place preference and locomotor
sensitization. J. BAILEY*; D. MA; K. K. SZUMLINSKI. Univ.
of California At Santa Barbara, Univ. of California at Santa
Barbara.
4:00 FF16 266.4 Gene-early environment interactions
determine cocaine-seeking behavior in mice. T. E. KIPPIN*;
J. C. CAMPBELL; K. K. SZUMLINSKI; C. P. KNIGHT. Univ.
California, Santa Barbara, Univ. of California.
1:00 FF17 266.5 Escalated cocaine self-administration
is paralleled by “normalization” of basal extracellular
dopamine levels within the medial prefrontal cortex. O.
BEN-SHAHAR*; K. K. SZUMLINSKI; K. D. LOMINAC; A.
COHEN; E. GORDON; K. L. PLOENSE; N. M. RUDY; A.
SACRAMENTO; K. PAGANO; A. N. NABHAN. UCSB.
110  |  Society for Neuroscience
2:00 FF18 266.6 Effect of sex and dose in selecting
between food and cocaine. K. A. KERSTETTER*;
M. BALLIS; S. M. DUFFIN-LUTGEN; J. TRAN; A. M.
BEHRENS; T. KIPPIN. UCSB, Univ. of California Santa
Barbara.
3:00 FF19 266.7 Distinct neurochemical adaptations within
the accumbens produced by IV self-administered versus
non-contingent methamphetamine. K. D. LOMINAC*; A.
SACRIMENTO; K. K. SZUMLINSKI; T. E. KIPPIN. Univ.
California- Santa Barbara.
4:00 FF20 266.8 An inverse relationship exists between
time-dependent changes in cocaine-seeking and Homer/
glutamate receptor expression within the NAC core. B.
W. MILLER; M. G. WROTEN; A. D. SACRAMENTO; N.
M. RUDY; N. WOODWARD; O. BEN-SHAHAR; K. K.
SZUMLINSKI*. Univ. California-Santa Barbara, Univ. of
California at Santa Barbara.
1:00 GG1 266.9 Drinking in the dark requires mGluR5/
homer2/PI3K signaling within the central nucleus of the
amygdala. D. K. COZZOLI*; A. CARUANA; J. COURSON; D.
GREENTREE; K. SZUMLINSKI. Univ. CA Santa Barbara.
2:00 GG2 266.10 Effects of binge drinking during
adolescence and alcohol dependence in adulthood on white
matter in the frontal cortex. W. VARGAS*; L. BENGSTON;
K. FIERRO; N. GILPIN; G. KOOB; H. N. RICHARDSON.
Univ. of Massachusetts-Amherst, Committee on Neurobio. of
Addictive Disorders, The Scripps Res. Inst.
3:00 GG3 266.11 The effect of binge drinking during
adolescence on anxiety related behavior in adulthood.
C. A. KARANIKAS*; K. FIERRO; W. VARGAS; H. N.
RICHARDSON. Univ. of Massachusetts-Amherst.
4:00 GG4 266.12 Development of mechanical allodynia
during ethanol dependence and following extended access
to heroin but not cocaine self-administration in rats. S.
EDWARDS*; K. MISRA; L. F. VENDRUSCOLO; S. WEE;
G. SCHULTEIS; G. F. KOOB. The Scripps Res. Inst., UCSD
and VA San Diego Healthcare Syst.
1:00 GG5 266.13 High levels of voluntary alcohol intake
induces region-specific alterations in the expression of
GDNF, an endogenous regulator of alcohol consumption. S.
AHMADIANTEHRANI*; S. BARAK; D. RON. UCSF, Gallo
Res. Ctr.
2:00 GG6 266.14  •  Effects of ethanol on a novel population
of dopamine neurons that innervate the extended amygdala.
C. LI*; T. KASH. Univ. North Carolina.
3:00 GG7 266.15 Effects of chronic ethanol exposure on
excitatory transmission in the dorsal-lateral bed nucleus of
the stria terminalis: Assessing contributions of GluN2B with
Ro25-6981. T. A. WILLS*; E. DELPIRE; D. G. WINDER.
Vanderbilt Univ.
4:00 GG8 266.16 Acute and chronic exposure to ethanol
differentially alters GABAergic transmission onto medium
spiny neurons of caudate and putamen in both monkey and
mouse models. V. C. CUZON CARLSON*; M. C. CAMP; K.
A. GRANT; D. M. LOVINGER. Natl. Inst. of Alcohol Abuse
and Alcoholism, Oregon Natl. Primate Res. Center, Oregon
Hlth. and Sci. Univ.
1:00 GG9 266.17 Inhibition of matrix metalloproteinases
attenuates excessive operant alcohol self-administration in
alcohol-dependent rats. A. SMITH*; J. W. WRIGHT; B. M.
WALKER. Washington State Univ.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
2:00 GG10 266.18  •  Adolescent oral consumption of ethanol,
nicotine, or concurrent ethanol and nicotine alters gene
expression of G coupled receptors in the anterior cingulate
during adulthood. Z. A. RODD*; J. TOALSTON; R. BELL;
W. MCBRIDE; W. TRUITT. Indiana Univ, Sch. Med., Purdue
Sch. of Science, IUPUI.
3:00 GG11 266.19 Adolescent oral consumption of
ethanol, nicotine, or concurrent ethanol and nicotine alters
gene expression of G coupled receptors in the nucleus
accumbens shell during adulthood. J. E. TOALSTON*; Z.
RODD; R. BELL; W. MCBRIDE; W. TRUITT. IUPUI-Purdue
Sch. Sci., Indiana Univ, Sch. Med.
4:00 GG12 266.20 The abused inhalant toluene induces
long-term depression of excitatory synapses in neurons of
the medial prefrontal cortex but not nucleus accumbens.
J. T. BECKLEY*; J. J. WOODWARD. Med. Univ. of South
Carolina.
1:00 GG13 266.21 Ketamine exerts differential effects on
the activities of neuronal nitric oxide syntase and glycogen
synthase kinase 3-beta. T. YAMAMOTO*; J. YAMAGUCHI;
H. YAMAMOTO. Yokohama City Univ., Tokyo Inst. of
Psychiatry.
POSTER
267. Alcohol: Behavioral
Theme C: Disorders of the Nervous System
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 GG14 267.1 Comparison of the effects of various
paradigms of adolescent ethanol exposure on long-term
motor function. J. T. WEBER*; A. FORBES; J. COOZE;
R. ROOME; C. MALONE; L. CORBETT; V. FRENCH; R.
TRASK. Mem. Univ. of Newfoundland.
2:00 GG15 267.2 Accumbal NMDA receptors function in
mice with different levels of ethanol behavioral sensitization.
K. P. ABRAHAO*; M. L. O. SOUZA-FORMIGONI. Univ.
Federal De São Paulo - UNIFESP.
3:00 GG16 267.3 An astrocytic source of adenosine
modulates the behavioral response to alcohol. S. R.
MCIVER*; P. G. HAYDON. Tufts Univ.
4:00 HH1 267.4 Controlled induction of alcohol deprivation
effect in early ethanol drinking in P rat. A. V. AZAROV*; D. J.
WOODWARD. Neurosci Res. Inst. North Carolina.
1:00 HH2 267.5   Binge alcohol exposure during
adolescence alters alcohol consumption in adulthood as
a function of the estrous cycle. L. A. MICHAEL*; A. M.
MALDONADO-DEVINCCI; C. L. KIRSTEIN. Univ. of South
Florida.
2:00 HH3 267.6  •  Alcohol interactions with glutamate
receptors: Escalated aggressive behavior in mice. K. A.
MICZEK*; A. CHU; A. TAKAHASHI; B. BAHAMON; E. L.
NEWMAN; J. F. DEBOLD. Tufts Univ.
3:00 HH4 267.7 A comprehensive historical review of
the relation between human light to moderate ethanol
consumption (‘social drinking’) and cognition, cognitive
decline and dementia. E. J. NEAFSEY*; M. A. COLLINS.
Loyola Univ. Chicago Stritch Sch. of Med., Loyola Univ.
Stritch Sch. Med.
4:00 HH5 267.8 The effect of ethanol pre-exposure on
conditioned place aversion to ethanol in adolescent and
adult dba/2j mice. B. M. FRITZ*; S. D. DICKINSON. St. Olaf
Col.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
1:00 HH6 267.9 Differential effects of acute alcohol
on the visual evoked potentials and reaction time. O. H.
HERNANDEZ*; V. MONTEON_PADILLA; R. LOPEZ-
ALCANTARA; R. GARCIA-MARTINEZ; T. DZIB-CAAMAL.
Univ. Autonoma Campeche.
2:00 HH7 267.10   Effects of ethanol on anxiety-related
behaviors in zebrafish (Danio rerio). Y. M. PENALOSA; R.
BLASER*. Univ. of San Diego.
3:00 HH8 267.11 The circadian clock modulates behavioral
responses to alcohol exposure in Drosophila. L. C. LYONS*;
K. VAN DER LINDE. Florida State Univ.
4:00 HH9 267.12 Electroencephalographic activity during
Sun. PM
the observation of erotic pictures in young men: Effects of
red wine. C. AMEZCUA*; M. HERNÁNDEZ- GONZALEZ; A.
SANZ-MARTIN; M. GUEVARA. Univ. De Guadalajara, Univ.
de Guadalajara.
1:00 HH10 267.13 Effects of intravenous ethanol alcohol
administration using the clamp on electrophysiological
responses to target and novel stimuli. H. M.
FICHTENHOLTZ*; J. KORETSKI; J. H. KRYSTAL;
A. C. PERRINO; G. ACAMPORA; T. WATSON; D. D.
LIMONCELLI; I. L. PETRAKIS. Yale Univ., Boston Univ. Sch.
of Med., Lewis & Clark Col., VA Connecticut Healthcare
Syst.
2:00 HH11 267.14 Extinction of ethanol self-administration in
rats: What does responding in the absence of ethanol mean?
C. J. HEYSER*. Franklin & Marshall Col.
POSTER
268. Nicotine: Reinforcement, Seeking, and Reinstatement
Theme C: Disorders of the Nervous System
Sun. 1:00 PM – San Diego Convention Center, Halls B-H
1:00 HH12 268.1 Stimulation of α2-adrenergic receptors
in the central nucleus of the amygdala attenuates stress-
induced reinstatement of nicotine seeking behavior in rats.
H. YAMADA*; R. M. BAUZO; A. W. BRUIJNZEEL. Univ. of
Florida Dept. of Psychiatry.
2:00 HH13 268.2 Effects of nicotine-associated stimuli
on subsequent nicotine self-administration, extinction,
and cue-induced reinstatement. J. J. CORTRIGHT*; G. R.
SAMPEDRO; P. VEZINA. Univ. Chicago.
3:00 HH14 268.3   The impact of nicotine exposure regimen
on the expression of sensitized dopamine overflow in the
nucleus accumbens. J. W. FORNERIS*; S. HERRERA;
N. BUBULA; J. J. CORTRIGHT; P. VEZINA. The Univ. of
Chicago.
4:00 HH15 268.4 Are nicotine-related cues susceptible to
the blocking effect? A. JAFFE*; S. GITISETAN; I. TARASH;
A. Z. PHAM; J. D. JENTSCH. UCLA.
1:00 HH16 268.5 Effects of nicotine on intake, palatability,
and operant responding for a gustatory CS paired with
sucrose. J. E. LANTZ; S. A. JONES; S. R. SCHUSTER; V.
MAYCUMBER; S. A. PAVELKA; M. I. PALMATIER*. Kansas
State Univ.
2:00 HH17 268.6 Repeated exposure to variable stress
induces behavioral sensitization and increases both break-
point and binge in rats subjected to intravenous nicotine self-
administration. R. M. LEÃO*; F. C. CRUZ; C. S. PLANETA.
UNESP - Col. of Pharmaceut. Sci.
Neuroscience 2010  |  Sunday PM  |  111 
3:00 HH18 268.7 Analysis of the mechanisms underlying
self-administration of the tobacco smoke constituents,
nicotine and norharmane in adult and adolescent rats. M.
M. ARNOLD*; A. TRAINA; J. PEREZ; J. D. BELLUZZI; F. M.
LESLIE. UC Irvine.
4:00 HH19 268.8 Reduced nicotine self-administration by a
β2-selective nicotinic receptor ligand, 5-iodo-A- 85380 in rats.
X. LIU*; C. JERNIGAN. Univ. of Mississippi Med. Ctr.
1:00 HH20 268.9 Pretreatment with yohimbine enhances
the acquisition of nicotine-seeking in a runway model of
drug self-administration. A. COHEN*; O. BEN-SHAHAR; A.
ETTENBERG. UCSB.
2:00 II1 268.10 Cue reactivity in smokers: When less
is more. M. N. SMOLKA*; A. KOBIELLA; M. JACOB;
S. VOLLSTÄDT-KLEIN; M. BÜHLER. Technische Univ.
Dresden, Central Inst. of Mental Hlth.
3:00 II2 268.11 Effects of the alpha2 adrenergic
antagonist idazoxan on nicotine self-administration in rats.
E. D. LEVIN; C. WELLS; S. SLADE; D. HAMPTON; V.
COUSINS; R. OMONDI; J. E. ROSE*. Duke Univ.
4:00 II3 268.12 N-acetylcysteine decreased nicotine
self-administration and cue-induced reinstatement of
nicotine-seeking in rats. A. M. RAMIREZ; M. S. DSOUZA;
S. G. SEMENOVA*; A. MARKOU. UCSD, California State
University, Los Angeles.
1:00 II4 268.13 Blockade of N-methyl-d-aspartate
receptors in the nucleus accumbens shell and core has a
differential effect on nicotine and food self-administration in
rats. M. S. D’SOUZA*; A. MARKOU. UCSD.
POSTER
269. Nicotine: Developmental Effects
Theme C: Disorders of the Nervous System
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 II5 269.1   Coordinated changes in nAChR subunit
RNA expression in thymus and brain. P. D. WILLIAMSON;
G. MEDRANO; R. A. BUCHANAN*; M. C. DOLAN; S. J.
BLOSSOM. Arkansas State Univ., Arkansas Children’s
Hopsital Res. Inst.
2:00 II6 269.2 Prenatal nicotine exposure modifies
expression of myelin-related genes in the limbic system
of adolescent rats in a brain region- and sex- dependent
manner. J. CAO*; J. B. DWYER; F. M. LESLIE; M. D. LI.
Dept. of Psychiatry & Neurobehavioral Sciences, Univ. of
Virginia, Univ. of California, Irvine.
3:00 II7 269.3 The role of the Cd81 gene in the
behavioral and gene expression response to nicotine. L. L.
LOCKLEAR; K. J. FRYXELL*. George Mason Univ.
4:00 II8 269.4 GABA-A receptor expression in the
preBotzinger region of neonatal rats prenatally exposed to
nicotine. S. JAISWAL*; R. FREGOSI. Univ. of Arizona.
1:00 II9 269.5 Prenatal nicotine exposure modulates
glutamatergic synapse components in rat hippocampus. H.
WANG*; W. YARL; M. I. DÁVILA-GARCÍA; M. C. GONDRÉ-
LEWIS. Howard Univ.
2:00 II10 269.6  •  The effects of prenatal exposure to
nicotine on ethanol consumption by male and female rats.
D. F. BERGER*; J. P. LOMBARDO; J. A. PECK; S. V.
FARAONE; F. A. MIDDLETON; S. L. YOUNGENTOB. SUNY
Cortland, SUNY Upstate Med. Univ.
112  |  Society for Neuroscience
3:00 II11 269.7 Sex-specific effects of chronic
neonatal nicotine exposure on gene expression in the rat
hippocampus during early postnatal development. J. C.
DAMBORSKY*; U. H. WINZER-SERHAN. Texas A&M Hlth.
Sci. Ctr.
4:00 II12 269.8 Time course of the effects of nicotine
exposure during lactation in the brain cholinergic system of
rats. A. N. FREITAS*; C. S. LIMA; A. RIBEIRO-CARVALHO;
A. C. DUTRA-TAVARES; E. G. MOURA; P. C. LISBOA; C. C.
FILGUEIRAS; A. C. MANHÃES; Y. ABREU-VILLAÇA. Univ.
do Estado do Rio de Janeiro.
1:00 II13 269.9 To be or not to be fostered: That is a
problem for subsequent nicotine-taking behavior in young
adult rat offspring. E. E. ROGUSKI*; S. G. MATTA. Univ. of
TN Hlth. Sci. Ctr.
2:00 II14 269.10 Cholinergic levels in the nucleus
accumbens (NAcc) are enhanced in adolescent versus adult
rats exposed to nicotine but are similar in both age groups
following nicotine withdrawal. J. E. ORFILA*; I. D. TORRES;
L. A. NATIVIDAD; E. CASTANEDA; L. E. O’DELL. Univ.
Texas At El Paso.
3:00 II15 269.11 Adolescent peak and sex differences in
nicotinic regulation of neural processing in auditory cortex.
H. KAWAI; H. KANG; R. LAZAR; R. METHERATE*. Univ.
California, Irvine, Soka Univ.
4:00 II16 269.12 Exposure to nicotine and/or ethanol in
adolescent mice: Memory/learning and glutamatergic effects.
A. C. MANHAES*; C. C. FILGUEIRAS; A. H. MEDEIROS;
R. S. QUARESMA; R. C. KUBRUSLY; Y. ABREU-VILLAÇA.
Univ. Estado do Rio de Janeiro, Univ. Federal Fluminense.
1:00 II17 269.13 Adolescent nicotine consumption predicts
anxiety-related behavior in agouti mice. J. P. GYEKIS;
C. M. RAGAN; M. A. DINGMAN; S. A. CAVIGELLI; D. J.
VANDENBERGH*. Penn State.
2:00 II18 269.14  •  Acute stress facilitates acquisition of
nicotine conditioned place preference in adolescent rats:
A role for corticotropin-releasing factor 1 receptors. J. M.
BRIELMAIER*; C. G. MCDONALD; R. F. SMITH. George
Mason Univ.
3:00 II19 269.15 Nucleus accumbens D2 receptor
expression correlates of age-dependent anxiety-like
behavior and nicotine-stimulated activity. A. M. FALCO*; C.
G. MCDONALD; S. E. BACHUS; C. J. BLANCHARD; R. F.
SMITH. George Mason Univ.
4:00 II20 269.16 Chronic adolescent nicotine exposure
presents no effect on cocaine conditioned place preference
induction, extinction or reinstatement. G. M. FERNANDEZ*;
J. M. BRIELMAIER; C. G. MCDONALD; R. F. SMITH.
George Mason Univ.
1:00 JJ1 269.17 Chronic co-administration of prazosin and
nicotine during adolescence attenuates nicotine’s influence
on anxiety-like behavior in adulthood. D. G. EHLINGER*; A.
M. FALCO; C. G. MCDONALD; R. F. SMITH. George Mason
Univ.
2:00 JJ2 269.18 Adolescent nicotine exposure enhances
the rewarding properties of nicotine in a graded manner
during adulthood. L. A. NATIVIDAD*; O. V. TORRES; H. A.
TEJEDA; L. E. O’DELL. Univ. of Texas at El Paso.
3:00 JJ3 269.19 Comparing adolescents and adults
on responding for a conditioned drug reward and
nicotine-induced locomotor activity. C. L. BURTON*; P. J.
FLETCHER. Univ. Toronto, Ctr. of Addiction and Mental
Hlth., Univ. of Toronto.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
4:00 JJ4 269.20 Exposure to cigarette smoke during
pregnancy in rats: Effects on adult behavior and neonatal
nicotinic receptor levels. M. PAUL*; M. SRIVATSAN.
Arkansas State Univ.
1:00 JJ5 269.21 Exposure to tobacco smoke containing
either high or low levels of nicotine during adolescence:
Differential effects on choline uptake in the cerebral cortex
and hippocampus. M. C. GUTHIERREZ*; A. H. MEDEIROS;
A. C. MANHÃES; C. C. FILGUEIRAS; M. A. MATTOS; M. S.
PEREIRA; R. C. C. KUBRUSLY; Y. ABREU-VILLAÇA. Univ.
do Estado do Rio de Janeiro, Univ. Federal Fluminense.
2:00 JJ6 269.22  •  Cigarette exposure associated with
abnormal white matter development in adolescent smokers.
M. KOHNO*; A. M. MORALES; E. D. LONDON. UCLA.
POSTER
270. Amphetamines: Reinforcement
Theme C: Disorders of the Nervous System
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 JJ7 270.1 Determinants of MDMA self-
administration. M. A. TAFFE*; M. J. WRIGHT; K. M.
CREEHAN; S. A. VANDEWATER. The Scripps Res. Inst.
2:00 JJ8 270.2 Involvement of 5-HT2A receptors in
MDMA reinforcement and cue-induced reinstatement
of MDMA seeking behaviour. P. M. ROBLEDO*; M. J.
OREJARENA; L. LANFUMEY; R. MALDONADO. Univ.
Pompeu Fabra, Univ. Pierre et Marie Curie.
3:00 JJ9 270.3 Differential regulation of striatal
neurotensin systems by maintenance and extinction
of METH self-administration. G. R. HANSON*; A. J.
HOONAKKER; M. E. ALBURGES; J. W. MCDOUGALL; P. S.
FRANKEL. Col. Pharm.
4:00 JJ10 270.4 Trace amine-associated receptor
1-mediated signaling in mice: Does it play a role in
methamphetamine’s in vivo manifestations? M. S. GRANDY;
A. PLACZEK; N. T. ALBRECHT; M. J. BECKSTEAD; J. R.
BUNZOW; G. P. MARK; T. S. SCANLAN; D. K. GRANDY*.
Oregon Hlth. & Sci. Univ., Univ. of Texas Hlth. Sci. Center-
San Antonio.
1:00 JJ11 270.5 Development of focused stereotypies
during extended access to methamphetamine self-
administration. M. HADAMITZKY*; S. MCCUNNEY; A.
MARKOU; R. KUCZENSKI. Univ. of California San Diego.
2:00 JJ12 270.6 Mirtazapine attenuates cue-
induced reinstatement in rats trained to self-administer
methamphetamine without altering spontaneous motor
activity. S. M. GRAVES*; T. C. NAPIER. Rush Univ. Med. Ctr.
3:00 JJ13 270.7 Modafinil reverses methamphetamine-
induced memory deficits on an object-in-place task in rats.
C. M. REICHEL*; M. SCHWENDT; L. A. RAMSEY; J. F.
MCGINTY; R. E. SEE. Med. Univ. of South Carolina.
4:00 JJ14 270.8 Effects of methamphetamine on impaired
responding for sensory reinforcers in rats with lesions of the
superior colliculus. L. J. BEYLEY*; A. M. GANCARZ; M. A.
KAUSCH; D. R. LLOYD; L. M. LEONARD; J. B. RICHARDS.
Univ. Buffalo, RIA, Res. Inst. on Addictions.
1:00 JJ15 270.9  Effects of methamphetamine and novelty
on conditioned and sensory reinforcers. D. R. LLOYD*;
M. A. KAUSCH; L. J. BEYLEY; A. M. GANCARZ; L. M.
LEONARD; J. B. RICHARDS. Univ. Buffalo, RIA, Res. Inst.
on Addictions.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
2:00 JJ16 270.10 Sensitivity to methamphetamine in
adulthood is increased in rats prenatally exposed to the
same drug. B. SCHUTOVA*; L. HRUBA; R. ROKYTA; R.
SLAMBEROVA. Charles Univ. In Prague, Third Fac. of Med.
3:00 KK1 270.11 Prenatal methamphetamine exposure
alters the effect of methamphetamine and cocaine challenge
dose on behavior and nociception in adult male rats.
R. SLAMBEROVA*; A. YAMAMOTOVA; L. HRUBA; B.
SCHUTOVA; R. ROKYTA. Charles Univ., Third Fac. Med.
4:00 KK2 270.12 The effect of methamphetamine exposure
and cross-fostering on behavior and anxiety of adult male
and female rats. L. HRUBA*; B. SCHUTOVA; R. ROKYTA;
R. SLAMBEROVA. Charles Univ. in Prague, Third Fac. of
Sun. PM
Med.
1:00 KK3 270.13  •  The likelihood of expression of
amphetamine-induced focused stereotypy in rats is higher
in a smaller than in a larger observation arena. S. C.
FOWLER*; L. P. MAHONEY. Univ. Kansas.
2:00 KK4 270.14 The mGluR5 antagonist MTEP decreases
d-amphetamine seeking and c-Fos expression in rats. P.
BACKSTROM*; P. HYYTIÄ. Natl. Inst. For Hlth. and Welfare,
Univ. of Helsinki.
3:00 KK5 270.15  •  Prenatal immune activation effects
upon conditioned place preference to amphetamine. N. M.
RICHTAND*; R. AHLBRAND; P. HORN; B. CHAMBERS; J.
DAVIS; S. BENOIT. Univ. Cincinnati Col. Med., Cincinnati
Veterans Affairs Med. Ctr., Univ. of Cincinnati.
4:00 KK6 270.16 Effects of the dopamine stabilizer (-)-
OSU6162 on amphetamine mediated locomotor activity
and c-fos in brain reward pathways. S. BRENE*; A.
SIERAKOWIAK; A. JOSEPHSON; A. CARLSSON; L.
OLSON. Karolinska Inst., Karolinska Institutet, Göteborgs
Universitet.
POSTER
271. Opioids: Transgenerational and Developmental Effects
Theme C: Disorders of the Nervous System
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 KK7 271.1 Transgenerational effects of adolescent
morphine exposure on play fighting and maternal
aggression. B. NEPHEW*; N. L. JOHNSON; L. M. CARINI;
M. E. SCHENK; E. M. BYRNES. Tufts Univ. Cummings Sch.
of Vet. Med.
2:00 KK8 271.2 How does morphine influence the
maturation and dendritic arborization of adult-generated
dentate gyrus granule cells? I. MASIULIS; M. A. JOHNSON;
A. J. EISCH*. UT Southwestern Med. Ctr.
3:00 KK9 271.3 Gene expression differences with
morphine tolerance at the level of the midbrain in adult
and newborn rat. D. BAJIC*; M. SOIZA-REILLY; K. G.
COMMONS. Children’s Hosp. Boston, Harvard Univ.
4:00 KK10 271.4 Enhancement of tolerance development
to morphine in rats prenatally exposed to morphine,
methadone, and buprenorphine. Y. CHIANG*; T. HUNG; C.
W. LEE; J. YAN; I. HO#. Natl. Hlth. Res. Inst.
1:00 KK11 271.5 Multigenerational effects of morphine
exposure on the mesolimbic dopamine system. E. M.
BYRNES*; N. L. JOHNSON; L. M. CARINI. Tufts Univ.
Cummings Sch. Vet Med.
Neuroscience 2010  |  Sunday PM  |  113 
2:00 KK12 271.6 Decreased locomotor response to opiates
in adolescents, when compared to adults. E. MERCADO*;
M. SMITH; K. TRUJILLO. Dept. of Psychology, California
State Univ. San Marcos.
3:00 KK13 271.7 Prenatal methadone and buprenorphine
exposure impairs sensorimotor gating function and increases
depressive behavior in adult male offspring. S. SHIH; S.
WANG*. Natl. Hlth. Res. Inst.
4:00 KK14 271.8 Prenatal opiate exposure alters the
rewarding and reinforcing properties of oxycodone in
adulthood. L. M. SCHROTT*; G. S. JOHNSON; L. M.
FRANKLIN. Lousiana State Univ. Hlth. Sci. C.
1:00 KK15 271.9 Second- and third-hand opium smoke
products on household surfaces, in air, and in the hair of
Afghanistan women and children. M. S. GOLD*; D. M.
MARTIN; N. A. GRAHAM; B. A. GOLDBERGER. Univ.
Florida Col. Med., JMJ Technologies, Inc., Univ. of Florida
Col. of Med., Univ. Florida Col. of Med.
2:00 KK16 271.10 Midazolam administered from 8 to 15-
days old mice induce alterations in cerebellar cortex. M.
MARQUEZ-OROZCO*; V. GASCA-RAMÍREZ; G. DE LA
FUENTE-JUÁREZ; A. MÁRQUEZ-OROZCO. Univ. of Mexico
(UNAM).
3:00 KK17 271.11  •  Effect of Heantos on morphine place
preference and naloxone-precipitated withdrawal symptoms.
C. DIAS*; T. SUNG; A. PHILLIPS. Univ. of British Columbia,
Inst. of Chemistry, Vietnamese Acad. of Sci. and Technol.
4:00 KK18 271.12  •  Heantos mitigates naloxone-precipitated
withdrawal effects on nucleus accumbens dopamine efflux
and behavior in rats given repeated morphine treatment.
S. AHN*; K. SO; T. SUNG; A. G. PHILLIPS. Univ. British
Columbia, Inst. of Chemistry, Vietnamese Acad. of Sci. and
Technol.
POSTER
272. Addiction: Translational and Clinical Studies
Theme C: Disorders of the Nervous System
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 LL1 272.1 Neural responses to self-perceptual
speech during psychotherapy sessions. J. M. HOUCK*; T. B.
MOYERS; C. D. TESCHE. Univ. of New Mexico, Mind Res.
Network.
2:00 LL2 272.2 Exploration of in vivo uses for DNA
aptamer technology to study dopamine dysregulation in
preclinical animal models of psychiatric disorders. M. R.
HOLAHAN*; D. MADULARU; E. MCCONNELL; R. WALSH;
M. DEROSA. Carleton Univ.
3:00 LL3 272.3 Development of lipophilic nalmefene
prodrugs to achieve a one-month sustained release. J. R.
ATACK*; T. GAEKENS; H. BORGHYS; A. VERMEULEN;
L. DE ZWART; A. MEGENS; J. LEYSEN; M. GUILLAUME.
Johnson & Johnson PRD.
4:00 LL4 272.4 Cannabinoids and opiate withdrawal
management: Experimental findings and implications for
treatment. J. L. SCAVONE*; R. C. STERLING; E. J. VAN
BOCKSTAELE. Thomas Jefferson Univ.
1:00 LL5 272.5 Novel mGluR5 negative allosteric
modulators for in vivo investigation. T. M. KECK*; P. ZHANG;
M. ZOU; A. H. NEWMAN. Natl. Inst. On Drug Abuse Res.
Program.
114  |  Society for Neuroscience
2:00 LL6 272.6 l-Isocorypalmine, a novel partial agonist
of D1-like receptors and an antagonist of D2-like receptors,
reduced cocaine-induced hyperactivity and sensitization. L.
LIU-CHEN*; W. XU; Z. MA; D. Y. LEE. Temple Univ. Sch.
Med., McLean Hospital, Harvard Med. Sch.
3:00 LL7 272.7 Bilateral lesions of the subthalamic
nucleus prevent escalation of cocaine intake in rats. C.
COHEN; S. LARDEUX; D. PALLERESSOMPOULLE; R.
PERNAUD; S. AHMED; C. BAUNEZ*. CNRS UMR6155-Univ
Provence, CNRS UMR5227-Univ Bordeaux 2.
4:00 LL8 272.8 Antagonism of the reinforcing effects of
methamphetamine and methamphetamine-heroin speedballs
by naltrexone in monkeys. C. ACHAT-MENDES*; R.
SPEALMAN. Harvard Med. School/NEPRC.
1:00 LL9 272.9  •  Electrophysiological and behavioral
characterization of mice deficient in alpha5* subunit
of the neuronal nicotinic acetylcholine receptors. S.
CHATTERJEE*; J. HOLGATE; N. D. SANTOS; F. W. HOPF;
A. BONCI; S. E. BARTLETT. Ernest Gallo Clin. and Res.
Center, Univ. of California San Francisco.
2:00 LL10 272.10 The α3β4* neuronal nicotinic
acetylcholine receptor plays an important role in ethanol
consumption and seeking. A. A. FEDUCCIA*; S.
CHATTERJEE; J. SIMMS; J. HOLGATE; S. E. BARTLETT.
Ernest Gallo Clin. and Res. Center, Univ. of California San
Francisco.
POSTER
273. Odor Coding: Antennal Lobe
Theme D: Sensory and Motor Systems
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 LL11 273.1 Sensory and learning-induced
classification at two stages of processing in the honey bee
brain. M. STRUBE-BLOSS; M. HERRERA-VALDEZ; B. H.
SMITH*. Arizona State Univ.
2:00 LL12 273.2 Chemical neuroanatomy of the olfactory
neuropil in honey bees: The GABAergic circuitry. D. T.
PROTAS*; I. SINAKEVITCH; F. LOCATELLI; B. H. SMITH.
Arizona State Univ., Univ. of Buenos Aires.
3:00 MM1 273.3 Role of glutamate in fragile x syndrome:
Insect models. I. SINAKEVITCH*; C. DUCH; B. H. SMITH.
Arizona State Univ.
4:00 MM2 273.4 Modeling associative reinforcement
mediated via inhibition in the honeybee antennal lobe. J.
CHEN*; C. ASSISI; B. SMITH; M. BAZHENOV. Univ. of
California, Riverside, Arizona State Univ.
1:00 MM3 273.5 Coincidence detection vs. temporal
integration in olfactory networks. C. G. ASSISI*; M.
STOPFER; M. BAZHENOV. Univ. of California, Riverside,
US Natl. Inst. of Hlth.
2:00 MM4 273.6  •  A model of competitive interactions
among mixture components in early olfactory processing.
M. K. MUEZZINOGLU*; R. HUERTA; F. LOCATELLI; F.
VILLAREAL; G. GALIZIA; B. H. SMITH. Univ. California San
Diego, Univ. de Buenos Aires, Arizona State Univ., Univ.
Konstanz.
3:00 MM5 273.7 Interglomerular inhibition does not
depend on distance in the antennal lobe of the honeybee. C.
C. GIRARDIN*; C. G. GALIZIA. Univ. of Konstanz.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
4:00 MM6 273.8 Functional difference between global
presynaptic and postsynaptic inhibition in the Drosophila
olfactory circuit. M. OIZUMI*; R. SATOH; H. KAZAMA; M.
OKADA. The Univ. of Tokyo, Harvard Med. Sch., Brain Sci.
Institute, RIKEN.
1:00 MM7 273.9 Development of a trackball apparatus
for linking Drosophila olfactory processing and behavior. Q.
GAUDRY*; J. KAIN; B. DE BIVORT; R. I. WILSON. Harvard
Med. Sch., Rowland Inst. at Harvard.
2:00 MM8 273.10 Olfactory neural circuit for reproductive
behaviors in Drosophila. N. TANAKA*; A. EJIMA. Kyoto Univ.
3:00 MM9 273.11  •  Coding of innate and learned odor
mixtures in the moth antennal lobe. J. RIFFELL*; J. G.
HILDEBRAND. Univ. of Arizona.
4:00 MM10 273.12 Critical rate dynamics explains the
dynamic range of the moth pheromone system. C. L.
BUCKLEY*; T. NOWOTNY. Univ. of Sussex, Universoty of
Sussex.
1:00 MM11 273.13 The neuromodulatory effects of dopamine
in the antennal lobes of manduca sexta. A. M. DACKS*; J.
RIFFELL; J. MARTIN; K. TETER; S. GAGE; A. NIGHORN.
Univ. Arizona, Univ. of Arizona.
2:00 MM12 273.14 Dynamic control of odor-induced
responses to a wide range of odor concentrations. H. LEI*;
H. CHIU; J. G. HILDEBRAND. Univ. Arizona.
3:00 MM13 273.15 Representations of odor identity and
concentration by a virtual ensemble of serially recorded
antennal lobe output neurons. E. M. STAUDACHER*; R.
TIEDE; J. SCHACHTNER; K. C. DALY. West Virginia Univ.,
Philips-Universität Marburg.
4:00 MM14 273.16 Nitric oxide modulates both inward and
outward currents in the Manduca sexta antennal lobe. M. R.
HIGGINS*; M. MILLER; A. NIGHORN. Univ. Arizona.
1:00 NN1 273.17 In vitro tests of roles for IgCAMs and
growth factor receptors in sorting of olfactory axons during
development. L. A. OLAND; J. T. PEARSON; N. J. GIBSON*;
L. P. TOLBERT. Univ. of Arizona.
2:00 NN2 273.18 Assembling the olfactory network
in the Drosophila embryo. L. L. PRIETO-GODINO; S.
DIEGELMANN; M. BATE*. Univ. of Cambridge, Univ. of
Wuerzburg.
POSTER
274. Auditory and Multisensory Processing: Visual-Auditory
Interactions
Theme D: Sensory and Motor Systems
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 NN3 274.1 Human auditory cortex activations
to speech and non-speech stimuli during auditory and
visual tasks. T. RINNE*; K. HARINEN; O. SALONEN; O.
AALTONEN. Univ. of Helsinki, Aalto Univ. Sch. of Sci. and
Technol., Helsinki Univ. Central Hosp.
2:00 NN4 274.2 Visual enhancement of theta-band phase
tracking in auditory cortex. H. LUO*; D. POEPPEL. Chinese
Acad. of Sci., New York Univ.
3:00 NN5 274.3 Behavioral and neural integration of faces
and voices in macaque monkeys. C. CHANDRASEKARAN*;
L. LEMUS; M. GONDAN; A. A. GHAZANFAR. Princeton
Univ., Univ. of Regensburg.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
4:00 NN6 274.4 Feeling the beat from ears and eyes:
Using EEG frequency-tagging to measure audiovisual
interaction in beat perception. S. NOZARADAN; M.
MISSAL*; I. PERETZ; A. MOURAUX. Univ. Catholique
de Louvain, Intl. Lab. for Brain, Music, and Sound Res.
(BRAMS).
1:00 NN7 274.5 Modulation of responses in primary
auditory cortex by visual stimuli. D. J. UHLRICH*; P. H.
SMITH; S. M. GRADY; M. I. BANKS. Univ. of Wisconsin.
2:00 NN8 274.6 fMRI investigation of visual and auditory
spatial attention reveals content-dependent and process-
dependent regions in human parietal and frontal cortex. L. Q.
KONG; S. L. SHEREMATA; B. G. SHINN-CUNNINGHAM; D.
Sun. PM
C. SOMERS*. Boston Univ., Massachusetts Gen. Hosp.
3:00 NN9 274.7 Temporal multisensory processing of low-
level audiovisual stimuli: An event-related potential analysis.
L. E. DOWELL*; M. T. WALLACE. Vanderbilt Univ.
4:00 NN10 274.8 Early processing of audiovisual emotional
information from body language and interjections. S.
JESSEN*; S. A. KOTZ. MPI For Human Cognitive and Brain
Sci., Cluster “Languages of Emotion”, Free Univ. of Berlin.
1:00 NN11 274.9 Neural correlates of auditory processing
in visual cortex of the blind. I. M. SCHEPERS*; J. F. HIPP;
T. R. SCHNEIDER; B. RÖDER; A. K. ENGEL. Dept.
Neurophys. and Pathophys., Univ. Med. Ctr. Hamburg, Biol.
Psychology and Neuropsychology, Univ. of Hamburg.
2:00 NN12 274.10 Spatiotemporal activation of multisensory
cortical regions during audiovisual integration. R. GABRIEL;
L. HINKLEY; A. HERMAN; V. VAN WASSENHOVE; S. S.
NAGARAJAN*. Univ. of California, San Francisco, Univ.
Calif, San Francisco.
POSTER
275. Auditory Processing: Vocalizations and Natural Sounds
Theme D: Sensory and Motor Systems
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 NN13 275.1 Wireless multi-channel single unit
recordings from the premotor cortex of freely roaming and
vocalizing marmosets. S. ROY*; X. WANG. Johns Hopkins
University, Dept of Biomed. Engin.
2:00 NN14 275.2  •  Band-specific modulations of neural
oscillations during habituation to vocalizations in the
primate ventrolateral prefrontal cortex. J. TSUNADA*; A. E.
BAKER; K. L. CHRISTISON-LAGAY; Y. E. COHEN. Univ. of
Pennsylvania Sch. of Med., Dept. of Neurobiology, Harvard
Univ.
3:00 OO1 275.3 Manipulating the sensory sensitive
phase for song learning in songbirds. N. AMIN*; F. E.
THEUNISSEN. UC Berkeley.
4:00 OO2 275.4  •  Comparison of responses in awake
and anesthetized zebra finches to birdsong measured
by noninvasive diffuse optical imaging. J. V. LEE*; E. L.
MACLIN; K. A. LOW; G. GRATTON; M. FABIANI; D. F.
CLAYTON. UIUC.
1:00 OO3 275.5 Increases in spine turnover at the input
of the basal ganglia pathway precede feedback-dependent
motor reorganization. K. A. TSCHIDA*; R. MOONEY. Duke
Univ.
Neuroscience 2010  |  Sunday PM  |  115 
2:00 OO4 275.6 Vocal and non-vocal acoustic
communication systems in the macaque brain. R.
REMEDIOS*; N. K. LOGOTHETIS; C. KAYSER. Max Planck
Inst. Biol. Cybernetics.
3:00 OO5 275.7 Local inhibition shapes the learned
responses to song in NCM. J. V. THOMPSON*; J. M.
JEANNE; T. Q. GENTNER. UCSD.
4:00 OO6 275.8 Speech reconstruction from spectro-
temporally tuned ECoG signals in human temporal,
parietal, and frontal cortex. B. N. PASLEY*; S. V. DAVID; N.
MESGARANI; A. FLINKER; S. A. SHAMMA; N. E. CRONE;
E. F. CHANG; R. T. KNIGHT. Univ. California-Berkeley, Univ.
of Maryland, Col. Park, Johns Hopkins Univ. Med. Sch.,
Univ. of California, San Francisco.
1:00 OO7 275.9 Mapping the macaque auditory system
using magnetic resonance imaging and complex sounds. M.
ORTIZ*; D. A. ARTCHAKOV; I. DEWITT; P. KUSMIEREK; J.
VANMETER; J. P. RAUSCHECKER. Dept. of Physiol. and
Biophysics, Georgetown Univ.
2:00 OO8 275.10 Hierarchical processing of vocalization
signals in the auditory forebrain. J. M. JEANNE*; T. O.
SHARPEE; T. Q. GENTNER. UCSD, Salk Inst. for Biol.
Studies.
3:00 OO9 275.11  •  Coding of vocalization variance in
the auditory-cortex lateral belt. J. LEE*; K. CHRISTISON-
LAGAY; Y. E. COHEN. Univ. of Pennsylvania, Univ. of
Pennsylvania Sch. of Med.
4:00 OO10 275.12 Rules of input-feature summation in
the auditory forebrain of a songbird. A. S. KOZLOV; T. Q.
GENTNER*. Univ. California, San Diego.
1:00 OO11 275.13 Neural correlates of speaking and
listening with altered feedback. N. S. KORT; M. I. VENTURA;
J. F. HOUDE*; S. S. NAGARAJAN. UCSF, Univ. of California,
Davis.
2:00 OO12 275.14 Responses of amygdalar neurons to
social vocalizations in big brown bats. M. A. GADZIOLA*;
J. J. WENSTRUP. NE Ohio Universities Col. of Med., Kent
State Univ.
3:00 OO13 275.15 Humans mimicking animals: Implications
for species-specific vocalization processing in humans. W.
J. TALKINGTON*; K. M. RAPUANO; C. A. FRUM; J. W.
LEWIS. West Virginia Univ.
4:00 OO14 275.16 Online encoding of instructive auditory
experience in vocal motor circuits. T. F. ROBERTS*; R.
MOONEY. Duke Univ. Med. Ctr.
1:00 OO15 275.17 Hearing the song in noise: Masking
noise-invariance in single neurons. R. C. MOORE*, III; P. R.
GILL; F. E. THEUNISSEN. UC Berkeley, Cornell Univ.
2:00 OO16 275.18 Responses to communication sounds
in the guinea pig auditory cortex during partial removal
of intracortical inhibitions. J. EDELINE*; C. HUETZ; B.
GOUREVITCH; Q. GAUCHER. CNPS, UMR CNRS 8195 &
Univ. Paris-Sud.
3:00 OO17 275.19 Discriminating communication calls
through selective versus differential responses in auditory
cortex. K. N. SHEPARD*; R. C. LIU. Emory Univ., Ctr. for
Behavioral Neurosci.
4:00 OO18 275.20 Effects of inter-stimulus interval and
presentation rate on speech discrimination in the adult
rat. T. M. ROSEN*; A. M. SLOAN; C. T. ENGINEER; R.
J. CHEUNG; C. L. MAINS; R. L. RENNAKER, II; M. P.
KILGARD. Univ. of Texas At Dallas.
116  |  Society for Neuroscience
1:00 PP1 275.21 Multifunctional cortical neurons exhibit
response enhancement during rapid switching from
echolocation to communication sound processing. B.
N. QUEENAN; Z. ZHANG; J. MA; R. T. NAUMANN; S.
MAZHAR; J. S. KANWAL*. Georgetown Univ. Med. Ctr.
2:00 PP2 275.22 Learning-dependent and independent
effects of noise on the representation of vocal
communication signals across multiple regions of the
auditory forebrain. E. CAPORELLO*; T. Q. GENTNER.
UCSD.
3:00 PP3 275.23 Auditory responses in the
superior colliculus to complex biological stimuli. M. J.
WOHLGEMUTH*, III; L. LOGIACO; C. M. MOSS. Ecole
Normale Supérieure, Univ. of Maryland.
4:00 PP4 275.24 Acoustic-phonetic processing and
temporal complexity in the auditory ventral stream: A meta-
analysis. I. DEWITT*; J. P. RAUSCHECKER. Georgetown
Univ.
1:00 PP5 275.25 Cortical mechanisms of auditory
feedback underlying speech motor control. E. F. CHANG*; S.
NAGARAJAN; R. KNIGHT; J. HOUDE. UCSF, UC Berkeley.
POSTER
276. Subcortical Visual Pathways: LGN
Theme D: Sensory and Motor Systems
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 PP6 276.1 Role of GABAa and GABAb receptors on
the spatial frequency tuning of relay cells in the dorsal lateral
geniculate nucleus of the cat. A. KIMURA; S. SHIMEGI; S.
HARA; M. OKAMOTO; H. SATO*. Osaka Univ.
2:00 PP7 276.2 GABAergic and non-GABAergic
mechanisms on the surround suppression in the cat lateral
geniculate nucleus. S. SHIMEGI*; A. KIMURA; S. HARA; M.
OKAMOTO; H. SATO. Osaka Univ., Fukushima Med. Univ.
3:00 PP8 276.3 Patch suppression in primate
parvocellular LGN cells. H. E. JONES; I. M. ANDOLINA;
B. AHMED; S. SHIPP; J. T. C. CLEMENTS; K. L. GRIEVE;
J. CUDEIRO; T. E. SALT; A. M. SILLITO*. UCL Inst. of
Ophthalmology, Univ. of Manchester, Univ. of A Coruña.
4:00 PP9 276.4 Is the first sensitivity to orientation
discontinuity in features deferred to the cortex in the primate
visual system? T. E. SALT*; I. M. ANDOLINA; B. AHMED; S.
SHIPP; J. T. C. CLEMENTS; K. L. GRIEVE; J. CUDEIRO; A.
M. SILLITO; H. E. JONES. UCL Inst. Ophthalmology, Univ. of
Manchester, Univ. of A Coruña.
1:00 PP10 276.5 The impact of accurate centering on
assessment of center surround interactions in primate
LGN cells. K. L. GRIEVE; I. M. ANDOLINA; B. AHMED; S.
SHIPP; J. T. C. CLEMENTS; J. CUDEIRO; T. E. SALT; A. M.
SILLITO; H. E. JONES*. Univ. of Manchester, UCL Inst. of
Ophthalmology, Univ. of A Coruña.
2:00 PP11 276.6 Feedback modulation of spatial
summation in primate LGN cells. I. M. ANDOLINA*; H. E.
JONES; B. AHMED; S. SHIPP; J. T. C. CLEMENTS; C.
COPELAND; K. L. GRIEVE; J. CUDEIRO; T. E. SALT; A. M.
SILLITO. UCL Inst. of Ophthalmology, Univ. of Manchester,
Univ. of A Coruña.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
3:00 PP12 276.7 The role of layer 6 cells in V1 as a conduit
for feedback effects from MT to the LGN. B. AHMED*; H. E.
JONES; I. M. ANDOLINA; S. SHIPP; J. T. C. CLEMENTS; K.
L. GRIEVE; J. CUDEIRO; T. E. SALT; A. M. SILLITO. UCL
Inst. of Ophthalmology, Unversity of Manchester, Univ. of A
Coruña.
4:00 PP13 276.8 Negative BOLD in the lateral geniculate
nucleus: Evidence for cortico-thalamic feedback. A.
GOUWS*; M. HYMERS; I. ALVAREZ; M. ASLET; J. BIRD;
R. DEARDEN; S. MASLANKA; M. UESAKI; A. MORLAND.
YNiC, Univ. of York, Dept Psychology, Univ. of York.
1:00 PP14 276.9 Optogenetic stimulation of the
corticothalamic pathway affects relay cells and GABAergic
neurons differently in the mouse visual thalamus. C. W.
JURGENS*; A. R. MCQUISTON; W. GUIDO. Virginia
Commonwealth Univ. Med. Ctr.
2:00 PP15 276.10 The cannabinoid system is involved
in visual processing in the rat dLGN. C. RIVADULLA*; M.
DASILVA; K. L. GRIEVE; J. CUDEIRO. Dept Medicine-
Neurocom, Univ. De Coruna and INIBIC, Univ. of
Manchester.
3:00 PP16 276.11 Downregulation of VGLuT1 and VGLuT2
gene and protein expression in the lateral geniculate
nucleus of the prosimian galago following brief monocular
inactivation. P. BALARAM*; T. TAKAHATA; J. H. KAAS.
Vanderbilt Univ.
4:00 PP17 276.12 Diversity of interspike interval
distributions in macaque retinal ganglion cells and thalamic
relay neurons. E. A. GUTILLA; T. O. SHARPEE; J. C.
HORTON; L. C. SINCICH*. Mills Col., The Salk Inst. for Biol.
Studies, UCSF.
1:00 PP18 276.13 Orientation selectivity in a subpopulation
of neurones in the primate lateral geniculate nucleus. S.
CHEONG; J. K. H. LIM; C. TAILBY; S. G. SOLOMON; P.
R. MARTIN*. Univ. of Sydney, Natl. Vision Res. Inst. of
Australia, Univ. of Melbourne.
2:00 QQ1 276.14 Lagged cells and inhibition in the LGN.
L. E. VIGELAND*; D. CONTRERAS; L. A. PALMER. Univ. of
Pennsylvania Sch. of Med.
3:00 QQ2 276.15 A compartmental model of an
LGN interneuron. G. HALNES; S. AUGUSTINAITE; P.
HEGGELUND; G. T. EINEVOLL*; M. MIGLIORE. Norwegian
Univ. Life Sci., Univ. of Oslo, Natl. Res. Council.
4:00 QQ3 276.16 Visual features evoke reliable bursts in
the perigeniculate sector of the thalamic reticular nucleus. V.
VAINGANKAR; C. SOTO SANCHEZ; X. WANG; A. BAINS;
F. T. SOMMER; J. A. HIRSCH*. USC, UC-Berkeley.
1:00 QQ4 276.17 Dynamic integrative properties of
thalamic reticular nucleus neuron dendrites. S. CRANDALL;
C. L. COX*. Univ. Illinois, Univ. of Illinois.
2:00 QQ5 276.18 The avian ventral lateral geniculate
nucleus and its oculomotor role: Behavioral consequences of
a centrifugal cholinergic gate of primary retinal synapses. J.
MPODOZIS*; S. TAPIA; T. VEGA-ZUÑIGA; N. MADRID; J.
LETELIER; G. MARIN. Univ. of Chile.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
POSTER
277. Striate Cortex: Local Circuitry
Theme D: Sensory and Motor Systems
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 QQ6 277.1 Mechanisms of surround modulation
depend on properties of the local map in models of V1. M.
STIMBERG*; K. OBERMAYER. Technische Univ. Berlin.
2:00 QQ7 277.2 The role of distinct types of cortical
inhibitory neurons in visual processing. B. ATALLAH; S.
OLSEN*; T. LIEN; W. BRUNS; M. SCANZIANI. UCSD/HHMI.
3:00 QQ8 277.3 Inputs from single neurons in the visual
Sun. PM
cortex affect spike-timing of locally connected neurons but
do not modulate their firing rate and sensory tuning curves.
H. TANAKA*; Y. ASADA; R. MIZOGUCHI; I. OHZAWA; I.
FUJITA; H. TAMURA. Osaka Univ.
4:00 QQ9 277.4 Synaptic input mechanisms for orientation
selectivity of mouse cortical neurons. B. LIU*; Y. LI; L. I.
ZHANG; H. W. TAO. USC Keck Sch. Med.
1:00 QQ10 277.5 Neural modulation of a realistic layered-
microcircuit model of visual cortex by bottom-up and
top-down signals. N. WAGATSUMA*; T. C. POTJANS; M.
DIESMANN; T. FUKAI. Res. Ctr. Juelich, RIKEN Brain Sci.
Inst.
2:00 QQ11 277.6 Visual tuning of genetically identified
neuronal types in the layer 2/3 of primary visual cortex in
Cre-transgenic mice. H. A. ZARIWALA*; L. MADISEN; K.
F. AHRENS; A. BERNARD; E. S. LEIN; A. R. JONES; H.
ZENG. Allen Inst. Brain Sci., NA.
3:00 QQ12 277.7 Laminar distribution of stimulus-
dependent gamma-band activity in cat primary visual cortex.
R. ROJNIC*; J. BAKER; R. HERIKSTAD; S. YEN; C. GRAY.
Montana State Univ. Bozeman, Weill Cornell Med. Col., Natl.
Univ. of Singapore.
4:00 QQ13 277.8  •  Dynamic properties of layer 6 inputs
to layer 4 in the cerebral cortex. S. P. BROWN*; S. E.
ARROYO; D. AZIZ; S. HESTRIN. Stanford Univ. Sch. Med.,
Univ. of Arizona.
1:00 QQ14 277.9 Structural and functional selectivity of
neurons in orientation pinwheel singularities. Z. LU*; Z.
SHEN; P. KARA. Med. Univ. South Carolina.
2:00 QQ15 277.10 Real-time emulation of binocular disparity
tuning in neural populations. Q. PENG; B. E. SHI; P. KARA*.
Hong Kong Univ. of Sci. & Technol., Med. Univ. South
Carolina.
3:00 QQ16 277.11 A comparison of ocular dominance and
binocular disparity maps in two primary visual cortical areas
(17 and 18). Z. SHEN*; P. KARA. Med. Univ. South carolina.
4:00 QQ17 277.12 Interacting sub-circuits in a primary
visual cortex column: Insights from a multi-layer rate model.
X. CHEN*; W. WEI; F. WOLF; D. BATTAGLIA. Max Planck
Inst. For Dynamics and Self-Organization, Bernstein Ctr. for
Computat. Neurosci.
1:00 QQ18 277.13 Microperiodic functional organization
of neocortical layer V. T. HOSOYA*; H. MARUOKA; S.
TSURUNO; K. KUBOTA; R. KUROKAWA. RIKEN.
2:00 QQ19 277.14 Functional organization of the excitatory
output of layer 6 of the neocortex: Interconnectivity between
claustrum- and thalamic-projecting neurons and their inputs
from layer 4. J. APERGIS-SCHOUTE*; S. R. WILLIAMS.
Univ. of Cambridge, Lab. of Mol. Biol., Univ. of Queensland.
Neuroscience 2010  |  Sunday PM  |  117 
3:00 QQ20 277.15 Columnar organization of on/off receptive
field structure in primary visual cortex. Y. WANG*; J. JIN; R.
LASHGARI; J. M. ALONSO. SUNY State Col. Optometry.
POSTER
278. Visual Motion: Behavioral Studies
Theme D: Sensory and Motor Systems
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 RR1 278.1 Anatomical correlates of interhemispheric
integration during the perception of apparent motion. E.
GENC*; W. SINGER; A. KOHLER. Max Planck Inst. for Brain
Res., Univ. Hosp. of Psychiatry.
2:00 RR2 278.2 Acting helps you see: Flexible recruitment
of visual areas during motor preparation. J. JASTORFF*; R.
ABDOLLAHI; G. A. ORBAN. KU Leuven, Med. Sch.
3:00 RR3 278.3 The relationship between vertical gaze
shifts and stride cycle in freely walking cats. T. J. RIVERS*;
N. A. SHAW; M. G. SIROTA; I. N. BELOOZEROVA. Barrow
Neurolog. Inst.
4:00 RR4 278.4 Visual-vestibular perceptual adaptation:
Visual dominance versus reliability-based model. D. E.
ANGELAKI*; A. H. TURNER. Washington Univ. Sch. Med.
1:00 RR5 278.5  •  The role of the object edge in visual
motion detection. C. JUNG*; S. KIM; S. LEE. Coll Medicine,
The Catholic Univ. of Korea.
2:00 RR6 278.6 Predicting abrupt changes in target
direction during ocular pursuit. S. A. WINGES*; J. C. AMES;
J. F. SOECHTING. Univ. Minnesota.
3:00 RR7 278.7 Effect of visual cues of realistic
background on vertical movement velocity profile during
visuo-motor conflict task. S. TOMA; F. DIONNET; R.
CHELLALI; T. POZZO*. Italian Inst. of Technol.
4:00 RR8 278.8 Population activity in macaque area
MSTd and the eccentricity dependence of visual and
vestibular heading discrimination in 3D. B. ADEYEMO; P.
MACNEILAGE; Y. GU; G. DEANGELIS; D. ANGELAKI; J.
DICKMAN*. Washington Univ. Med. Sch., Univ. of Rochester.
1:00 RR9 278.9 Effect of speed overestimation on flash
lag effect at low luminance. M. VAZIRI PASHKAM*; P.
CAVANAGH. Harvard Univ., Paris Descartes Univ. and
CNRS.
2:00 RR10 278.10 Visual motion processing in autism:
Atypical bounded integration. C. E. ROBERTSON*; R.
ROBERSON; G. L. WALLACE; A. MARTIN; S. BARON-
COHEN; C. I. BAKER. Autism Res. Ctr., NIMH, Cambridge
Univ.
3:00 RR11 278.11 Contrast dependent biases in pattern
motion perception and eye movement. R. D. KUMBHANI*;
M. SPERING; J. A. MOVSHON. New York Univ.
POSTER
279. Visual Learning and Categorization
Theme D: Sensory and Motor Systems
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 RR12 279.1 The influence of saccades on visual
feature selectivity in parietal cortex during a visual matching
task. C. A. RISHEL*; D. J. FREEDMAN. The Univ. of
Chicago.
118  |  Society for Neuroscience
2:00 RR13 279.2 Comparing the roles of the prefrontal,
lateral intraparietal, and medial intraparietal cortices in
category-based decision making. S. SWAMINATHAN*; S.
MCCLELLAN; D. J. FREEDMAN. Univ. of Chicago.
3:00 RR14 279.3 Learning of perceptual judgment under
internal and external uncertainties. S. LI*; F. YANG. Peking
Univ.
4:00 RR15 279.4 Category learning from examples: How
plastic synapses encode exemplars and compute similarity.
T. A. ENGEL*; X. WANG. Yale Univ.
1:00 RR16 279.5 A comparison of stimulus selectivity
between spiking and local field potential activity during visual
categorization. A. SARMA*; S. K. SWAMINATHAN; D. J.
FREEDMAN. Univ. of Chicago.
2:00 RR17 279.6  •  Neural decoding of natural object
categories from intracranial field potentials: A comparison
between human and monkey. A. B. ARSLAN*; M.
CAUCHOIX; D. FIZE; G. KREIMAN; J. R. MADSEN; T.
SERRE; J. M. SINGER. Brown Univ., Univ. de Toulouse,
Children’s Hosp. Boston, Harvard Med. Sch., Children’s
Hosp. Boston.
3:00 RR18 279.7 Differential processing of complex visual
object categories in human and non-human primates: An
event-related potential (ERP) study. R. GIL-DA-COSTA*; R.
FUNG; T. D. ALBRIGHT. Salk Inst. For Biol. Studies.
4:00 RR19 279.8  •  Age-related differences in visual shape
learning. S. KUAI*; J. SANDALL; H. WOLSTENCROFT; Z.
KOURTZI. Sch. of Psychology.
1:00 RR20 279.9 Investigating the time course of
visual categorization with rapid adaptation event-related
potentials. C. A. SCHOLL*; J. G. MARTIN; X. JIANG; M.
RIESENHUBER. Georgetown Univ. Med. Ctr.
2:00 SS1 279.10 Feedback model of visual perceptual
learning. S. MOLDAKARIMOV*; M. BAZHENOV; T. J.
SEJNOWSKI. Salk Inst., UCSD, UC Riverside.
3:00 SS2 279.11 Attention modulates the transfer of
perceptual learning. C. YU*; R. WANG; J. ZHANG. Beijing
Normal Univ.
4:00 SS3 279.12 Intact perceptual categorization and
generalization following bilateral removals of anterior inferior
temporal cortex in rhesus monkeys. N. MATSUMOTO*; R.
C. SAUNDERS; K. M. GOTHARD; B. J. RICHMOND. AIST,
NIH, Univ. of Arizona.
1:00 SS4 279.13 Perceptual and contextual learning of
a visual search. C. C. LE DANTEC*; A. R. SEITZ. Univ. of
California Riverside.
2:00 SS5 279.14 Impact of tectotectal interactions onto
lateralized visual information processing in the pigeon.
M. MANNS*; S. LETZNER; N. PATZKE; J. VERHAAL; S.
BLOCH. Ruhr-University Bochum.
3:00 SS6 279.15 Fast remapping of single neuron
responses in the human medial temporal lobe. M. J. ISON;
R. Q. QUIROGA*; I. FRIED. Univ. of Leicester, David Geffen
Sch. of Med. and Semel Inst. for Neurosci. and Human
Behavior, Univ. of California Los Angeles, Tel-Aviv Med. Ctr.
and Sackler Fac. of Med.
4:00 SS7 279.16 Decoding reveals trained-task
independent plasticity in V3A in association with motion
perceptual learning. K. SHIBATA*; L. CHANG; Y. SASAKI;
D. KIM; J. E. NÁÑEZ; Y. KAMITANI; T. WATANABE. Boston
Univ., Massachusetts Gen. Hosp., Caltech, Harvard Med.
Sch., Arizona State Univ., ATR.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
1:00 SS8 279.17 Neural segregation of letters and
numbers. J. PARK*; T. A. POLK; A. HEBRANK; D. C. PARK.
Univ. Michigan, Univ. of Texas, Dallas.
POSTER
280. Eye Movements and Perception
Theme D: Sensory and Motor Systems
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 SS9 280.1 Multivariate analysis of saccade
amplitude and direction selectivity in the human cortex.
F. LEONE*; I. TONI; W. MEDENDORP. Donders Ctr. for
Cognition, Radboud Univ. Nijmegen, Donders Inst.
2:00 SS10 280.2 The representation of value for saccade
goal selection in the lateral intraparietal area during visual
foraging. K. MIRPOUR*; J. W. BISLEY. UCLA.
3:00 SS11 280.3 Sensory information and previous
experience combine to inform decisions when faced with
uncertainty. S. JOSHI*; J. A. SHIRES; M. A. BASSO. Univ. of
Wisconsin, Madison.
4:00 SS12 280.4 Method for identifying image fragments
relevant for recognition and understanding. G. G. BONDAR*;
Y. I. GUSACH; S. A. IVLEV. A.B.Kogan Res. Inst. For
Neurocybernetics.
1:00 SS13 280.5 Saccade target selection based on
single or multiple remembered visual features. D. C.
CAPPADOCIA*; M. VESIA; P. A. BYRNE; X. YAN; J. D.
CRAWFORD. York Univ.
2:00 SS14 280.6 Suppression of neural activity in area LIP
associated with making a reach. M. A. HAGAN*; H. L. DEAN;
B. PESARAN. New York Univ.
3:00 SS15 280.7 Direct relationship between perceptual
and motor variability. D. B. LISTON*; L. S. STONE. NASA
Ames Res. Ctr., San Jose State Univ.
4:00 SS16 280.8 Different types of receptive field
remapping in macaque Superior Colliculus. J. CHURAN*; C.
C. PACK; D. E. GUITTON. McGill Univ.
1:00 SS17 280.9 S-cone responses in superior colliculus
using calibrated s-cone stimuli. N. J. HALL*; C. L. COLBY.
Univ. Pittsburgh.
2:00 SS18 280.10 Different geometry in the visual and
remapped receptive fields of LIP neurons. M. H. PHILLIPS*;
M. E. GOLDBERG. Columbia Univ., New York State
Psychiatric Inst.
3:00 SS19 280.11 Pulvinar inactivation alters cortical
responses during spatial decision making. M. WILKE*; I.
KAGAN; R. A. ANDERSEN. Caltech.
4:00 SS20 280.12 Top-down and bottom-up processes have
a simultaneous, graded influence on behavior in a simple
decision task. D. A. MARKOWITZ*; R. SHEWCRAFT; B.
PESARAN. New York Univ.
1:00 TT1 280.13 Frontal eye field, lateral prefrontal cortex,
and supplementary eye field single neuron activity during a
visual-saccadic metacognition task. P. MIDDLEBROOKS*;
M. A. SOMMER. Univ. Pittsburgh, Duke Univ.
2:00 TT2 280.14 Interactions between neural circuits in
posterior parietal cortex during a reach and saccade gating
task. H. L. DEAN*; B. PESARAN. New York Univ.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
3:00 TT3 280.15 Investigation into factors affecting
perceptual stability during smooth pursuit eye movement. S.
BOER*; J. A. PERRONE. Univ. of Waikato.
4:00 TT4 280.16 A computational model of predictive
remapping and visual stability in area LIP. A. ZIESCHE; F. H.
HAMKER*. Chemnitz Univ. of Technol.
1:00 TT5 280.17 The oculomotor system does not use LIP
visual gain fields to calculate saccade target positions. Y.
XU*; C. KARACHI; M. E. GOLDBERG. Columbia Univ., CR
ICM Pitie Salpetriere.
2:00 TT6 280.18 Correlations of neural activity in macaque
prefrontal cortex during a contrast detection task: Spikes
Sun. PM
and local field potentials. F. PIEPER*; A. SACHS; J. C.
MARTINEZ-TRUJILLO. Universitaetsklinikum Hamburg-
Eppendorf, McGill Univ., Ottawa Hosp.
3:00 TT7 280.19 Spontaneous fMRI activity reflects
a dynamic image of brain state. M. BIANCIARDI*; M.
FUKUNAGA; J. A. DE ZWART; J. H. DUYN. Advanced MRI
Section, LFMI, NINDS, NIH.
4:00 TT8 280.20 Frontal eye field activity predicts
performance in a visual stability judgment task. T. B.
CRAPSE*; M. A. SOMMER. Univ. of Pittsburgh.
1:00 TT9 280.21 Interplay of visually-evoked and saccade-
evoked activity in the primate superior temporal lobe. A.
M. BARTLETT*; N. K. LOGOTHETIS; K. L. HOFFMAN.
York Univ., Max Planck Inst. for Biol. Cybernetics, Univ. of
Manchester.
POSTER
281. Nociceptive Transduction Mechanisms: TRP Channels
Theme D: Sensory and Motor Systems
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 TT10 281.1 Ablation of TrpV1-expressing neurons
reveals their selective role in thermal pain sensation. S. K.
MISHRA*; M. A. HOON. NIH, NIDCR, NIH.
2:00 TT11 281.2 Systemic and intrathecal administration
resiniferatoxin in nociception. M. BISHNOI*; L.
PREMKUMAR; C. BOSGRAAF. Southern Illinois Univ.
3:00 TT12 281.3 Near abolition of noxious heat
responsiveness of superficial dorsal horn neurons
after ablation of the TRPV1-expressing population of
nociceptors in the mouse. J. ZHANG*; D. J. CAVANAUGH;
M. I. NEMENOV; A. I. BASBAUM. Univ. of California San
Francisco, Stanford Univ., Lasmed LLC.
4:00 TT13 281.4 Cold receptor activity in the tongue of
TRPM8 and TRPA1-deficient mice. B. L. DENLINGER*; F.
VIANA; C. BELMONTE. Inst. Neurosci.
1:00 TT14 281.5 TRPM8 selective antagonists fail to
demonstrate efficacy in rat models of neuropathic or
inflammatory pain. M. ZHANG*; B. YOUNGBLOOD; H.
DENG; S. CHEN; J. CLARINE; T. WANG; C. DAVIS; H.
MONENSCHEIN; M. NORMAN; N. TAMAYO; J. WANG;
W. WANG; J. TREANOR; K. WILD; S. LEHTO; N. GAVVA.
Amgen Inc.
2:00 TT15 281.6 Role of trpa1 channels in diabetic
peripheral neuropathy. L. S. PREMKUMAR*; D. CAO; L. E.
HUGHES. SIU, Sch. Med.
3:00 TT16 281.7 Mechanisms of TRPM8-mediated
[Ca2+]i oscillations in sensory neurons. M. S. YOREK*; P.
HOUIHAN; A. SLUPE; Y. M. USACHEV. Univ. Iowa.
Neuroscience 2010  |  Sunday PM  |  119 
4:00 TT17 281.8 Menthol response and adaptation in
nociceptive-like and nonnociceptive-like neurons: Role of
protein kinases. I. SARRIA*; J. GU. Univ. of Cincinnati.
1:00 TT18 281.9 Calmodulin disrupts AKAP150-mediated
sensitization of TRPV1. S. CHAUDHURY*; R. GOMEZ; M.
BAL; M. SHAPIRO; N. A. JESKE. Univ. of Texas Hlth. Sci.
Ctr.
2:00 TT19 281.10 Inflammation induces feed-forward
sensitization of TRPV1 through AKAP150. E. D. POR*; R.
GOMEZ; M. SHAPIRO; M. A. HENRY; N. A. JESKE. Univ. of
Texas Hlth. Sci. Ctr. - San Antonio.
3:00 TT20 281.11 Trpv1 agonist, capsaicin, significantly
reduces uterine contractions. H. B. BRADSHAW*; C.
WRIGHT. Indiana Univ.
4:00 UU1 281.12 Modulation of nociceptive synaptic
transmission by TNF-alpha and TRPV1 receptors in the
spinal cord dorsal horn. J. PALECEK*; D. SPICAROVA; V.
NERANDZIC. Inst. of Physiol.
1:00 UU2 281.13  •  Targeting spinal endocannabinoid/
endovanilloid system to inhibit neuropathic pain in rats.
K. STAROWICZ*; W. MAKUCH; B. PRZEWLOCKA. Inst.
Pharmacol PAS.
2:00 UU3 281.14 LTD in a nociceptive synapse requires
postsynaptic endocannabinoid synthesis and presynaptic
TRPV receptor activation. S. YUAN*; B. D. BURRELL. Univ.
South Dakota.
3:00 UU4 281.15 The expression and function of trp
channels in hippocampus. D. CAO*; L. ZHONG; L. S.
PREMKUMAR. Southern Illinois Univ. Sch. Med.
4:00 UU5 281.16 Distribution of TRPC3 in rat CNS and
sensory ganglia. R. J. GRANT*; D. BLAIS; M. PERKINS; P.
SEGUELA; D. O’DONNELL. AstraZeneca R&D Montreal,
McGill Univ.
1:00 UU6 281.17  •  Permeation of the lidocaine derivative
QX-314 in TRPV1 and TRPA1 channels: Is pore dilation
required? M. PUOPOLO*; A. M. BINSHTOK; G. L. YAO; C.
J. WOOLF; B. P. BEAN. Harvard Med. Sch., Hebrew Univ. of
Jerusalem, Children’s Hosp. Boston.
2:00 UU7 281.18 Permeation of gabapentinoids via TRPV1
channels increases their effectiveness. J. E. BIGGS*; P.
STEMKOWSKI; K. BALLANYI; P. A. SMITH. Univ. of Alberta.
3:00 UU8 281.19 Nociception, inflammation, and
thermoregulation of TRPV1 knockdown mice and after
application of TRPV1 antagonists. J. SZOLCSÁNYI*; Z.
SÁNDOR; G. PETHő; D. TÓTH; É. SZőKE; K. BÖLCSKEI;
V. TÉKUS; L. DÉZSI; A. VISEGRÁDY; C. HORVÁTH; É.
SZENTIRMAY; K. KVELL; B. BENDER. Univ. of Pécs, Med.
School, Dept. of Pharmacol. and Pharmacotherapy, Univ. of
Pécs and Gedeon Richter Plc. Analgetic Res. Lab., Univ. of
Pécs Med. Sch., Univ. of Pécs and Gedeon Richter Analgetic
Res. Lab., Gedeon Richter plc. Budapest, Hungary, Agr.
Biotech. Ctr.
4:00 VV1 281.20 Transient receptor potential melastatin 8
antagonists do not prevent acute oxaliplatin-induced painful
hypersensitivity to cold in rats. B. D. YOUNGBLOOD*; H.
DENG; D. ZHU; W. WANG; J. WANG; T. WANG; M. ZHANG;
H. MONENSCHEIN; M. NORMAN; N. TAMAYO; S. CHEN;
C. DAVIS; J. CLARINE; J. J. S. TREANOR; K. WILD; S.
LEHTO; N. GAVVA. Amgen Inc.
1:00 VV2 281.21 Divalent nickel ions directly activate
transient receptor potential vanilloid 1. M. LUBBERT*; D.
RADTKE; H. HATT; C. WETZEL. Ruhr Univ. Bochum.
120  |  Society for Neuroscience
2:00 VV3 281.22  •  Acidic pH activation and potentiation
of human TRPV1 involve key residue in transmembrane
domain 6. C. M. GRIMM*; L. CAO; E. ANEIROS; E.
STEVENS; S. C. PHILLIPS. Pfizer Ltd. PGRD.
3:00 VV4 281.23 N-acyl gamma-aminobutyric acid
activation of trpv1 drives map kinase with a strict structure
and concentration-dependence. D. MCHUGH*; S.
RABOUNE; H. B. BRADSHAW. Indiana Univ.
4:00 VV5 281.24 Phosphorylation by activated p38 MAPK
reduces functional desensitization of TRPV1. W. ZHU; N.
ASHPOLE; G. S. OXFORD*; A. HUDMON. Indiana Univ.
Sch. of Med., Indiana Univ. Sch. Med.
1:00 VV6 281.25 Small-molecule allosteric modulators
enhance TRPV1 function. K. KASZAS; C. E. C. ALVAREZ;
J. KELLER; K. A. JACOBSON; M. J. IADAROLA*. NIDCR,
NICHD, NIDDK.
2:00 VV7 281.26 A bivalent tarantula toxin irreversibly
activates the capsaicin receptor by targeting the outer pore
domain. A. PRIEL*; C. J. BOHLEN; J. SIEMENS; D. JULIUS.
Univ. of California, San Francisco.
POSTER
282. Spinal Cord Nociceptive Processing: Pharmacology
Theme D: Sensory and Motor Systems
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 VV8 282.1 Enhancement by zingerone of
spontaneous excitatory synaptic transmission in adult rat
spinal substantia gelatinosa neurons. H. YUE; T. FUJITA;
L. PIAO; M. INOUE; K. MIZUTA; C. JIANG; T. YASAKA; H.
HASUO*; E. KUMAMOTO. Dept. Physiol., Facult. Med.,
Saga Univ., Kurume Univ. Sch. Med.
2:00 VV9 282.2 Effects of local anesthetics on
spontaneous excitatory synaptic transmission in the adult rat
spinal dorsal horn. L. PIAO; T. FUJITA; H. YUE; M. INOUE;
C. JIANG; K. MIZUTA; T. YASAKA; E. KUMAMOTO*. Dept
Physiol, Saga Med. Sch.
3:00 VV10 282.3 Modulation by eugenol of glutamatergic
spontaneous excitatory synaptic transmission in adult rat
spinal dorsal horn neurons. M. INOUE; T. FUJITA; H. YUE;
L. PIAO; K. MIZUTA; D. TOMOHIRO; T. YASAKA*; E.
KUMAMOTO. Saga Univ.
4:00 VV11 282.4  •  Documentation of pain modulator
effects on pre- and postsynaptic levels in parasagital slices
from adult mice spinal cord. A. BRADAIA*; K. WADEL; B.
BUISSON. NEUROSERVICE.
1:00 VV12 282.5 Role of spinal Na+/H+ exchanger
in inflammatory pain. G. CASTANEDA-CORRAL*; V.
GRANADOS-SOTO. CINVESTAV, SEDE SUR.
2:00 VV13 282.6 Selective cannabinoid receptor 2 (CB2)
agonists administered intrathecally act as indirect agonists
and differentially alter p38 MAPK production in the spinal
cord and dorsal root ganglion in neuropathic rats. J. L.
WILKERSON*; K. R. GENTRY; E. C. DENGLER; A. A.
KERWIN; J. A. WALLACE; M. N. KUHN; G. A. THAKUR;
A. M. ZVONOK; A. MAKRIYANNIS; E. D. MILLIGAN.
Univ. of New Mexico Sch. of Med., Ctr. for Drug Discovery,
Northeastern Univ.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
3:00 VV14 282.7 Decrease of spinal nNOS
phosphorylation mediates sigma-1 receptor-induced pain
facilitation in mice: Involvement of PKC-dependent NR1
phosphorylation. D. ROH*; S. CHOI; S. YOON; H. SEO; S.
KANG; J. MOON; S. KWON; H. HAN; A. J. BEITZ; J. LEE.
Chonnam Natl. Univ., Col. of Vet. Medicine, Seoul Natl.
Univ., Univ. of Texas MD Anderson Cancer Ctr., Col. of Vet.
Med., Univ. of Minnesota.
4:00 VV15 282.8 Antihypersensitivity effects of tramadol
hydrochloride in a rat model of postoperative pain. M.
KIMURA*; H. OBATA; S. SAITO. Gunma Univ. Grad. Sch. of
Med.
1:00 VV16 282.9 Xenon inhibits excitatory but not inhibitory
transmission in rat spinal cord dorsal horn neurons. T.
KOHNO*; S. K. GEORGIEV; H. FURUE. Niigata Univ. Grad
Sch. Med. & Dent. Sci., Natl. Inst. for Physiological Sci.
2:00 VV17 282.10 Control of spinal excitatory and inhibitory
synaptic transmission by group ii metabotropic glutamate
receptors in neuropathic pain. H. ZHOU*; H. CHEN; S.
CHEN; H. PAN. UT M.D. Anderson Cancer Ctr.
3:00 VV18 282.11 Spinal mechanisms underlying
electroacupuncture-evoked anti-allodynia in models of
chronic pain. C. A. FAIRBANKS*; K. F. KITTO; P. D. BRAUN;
C. L. WADE; L. S. STONE; G. M. FLORES; G. L. WILCOX.
Univ. Minnesota, McGill Univ., GroundSpring Healing Ctr.
4:00 VV19 282.12 The hyperpolarisation activated cation
current (IH) blocker ZD7288 alters neuronal excitability and
spinal processing in neonatal mice. I. RIVERA-ARCONADA;
A. GARCIA DE LUCAS; J. A. LOPEZ-GARCIA*. Univ. Alcala.
1:00 VV20 282.13 Spinal administration of resolvin D1
attenuates inflammation-induced tactile allodynia. S.
ABDELMOATY; D. BELKIS BAS; S. CODELUPPI; S.
AWADY; Y. MOUSTAFA; A. ABDELHAMID; E. BRODIN;
C. I. SVENSSON*. Dept. of Physiol. and Pharmacology,
Karolinska Institutet, Suez Canal Univ., Dept. of
Neuroscience, Karolinska Institutet.
POSTER
283. Inflammatory Pain: Inflammatory Mediators
Theme D: Sensory and Motor Systems
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 WW1 283.1 The complement component c5a
mediates pain and inflammatory sensitivity in a postsurgical
pain model. D. LIANG*; X. LI; Y. SUN; P. SAHBAIE; W. LI; X.
SHI; D. J. CLARK. Stanford Univ.
2:00 WW2 283.2 Low GRK2 enhances and prolongs
epinephrine-induced hyperalgesia. H. WANG*; N.
EIJKELKAMP; C. HEIJNEN; A. KAVELAARS. Lab. For
Neuroimmunology and Developmental Origins of Dis.
(NIDOD), Universit.
3:00 WW3 283.3 Differential effects of phosphodiesterase
inhibitors on spinal glial TNF release and inflammatory
hyperalgesia. S. KARIMI; B. FITZSIMMONS; K. JOHANSEN;
J. SHIM; X. HUA*; T. YAKSH. Univ. of Gothenburg, UCSD.
4:00 WW4 283.4 Down-regulation of Cdk5 pathway in
TGF-β1-/- mice affects nociceptive signaling. E. S. UTRERAS
PURATICH*; A. TERSE; J. KELLER; M. J. IADAROLA; A.
B. KULKARNI. NIH, Neurobio. and Pain Therapeut. Section,
NIDCR, NIH.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
1:00 WW5 283.5 Serotonin enhances CGRP release from
rat and human trigeminal nociceptors. D. R. LOYD*; X. X.
SUN; E. E. LOCKE; K. M. HARGREAVES. Univ. Texas Hlth.
Sci. Ctr.
2:00 WW6 283.6 GRK2 controls duration of PGE2-
induced hyperalgesia by regulating Epac1 signalling. N.
EIJKELKAMP*; C. J. HEIJNEN; H. D. L. M. WILLEMEN; F. J.
ZWARTKRUIS; J. N. WOOD; R. DANTZER; K. W. KELLEY;
A. KAVELAARS. Wolfson Inst. For Biomed. Research, Univ.
Col. London, Univ. medical center Utrecht, Univ. of Illinois at
Urbana-Champaign.
3:00 WW7 283.7 Is the immune system engaged by a
noxious stimulus in infant rats the same way it is in the
Sun. PM
adult? D. A. HUNTER*; C. CHAI; G. A. BARR. NYSPI at
Columbia Univ. Med. Ctr., Children’s Hosp. of Philadelphia.
4:00 WW8 283.8 Activation of estrogen receptor alpha
rapidly enhances bradykinin responses in sensory neurons.
M. P. ROWAN*; K. A. BERG; K. M. HARGREAVES; J. L.
ROBERTS; W. P. CLARKE. Univ. of Texas Hlth. Sci. Ctr.
1:00 WW9 283.9 Role of IL-33 / ST2 in carrageenin-
induced innate inflammatory hyperalgesia in mice. W. A.
VERRI*; A. C. ZARPELON; T. M. CUNHA; D. XU; J. C.
ALVES-FILHO; F. Y. LIEW; S. H. FERREIRA; F. Q. CUNHA.
Univ. Estadual De Londrina, Univ. of Sao Paulo, Univ. of
Glasgow.
2:00 WW10 283.10 Interleukin-31 induces pruritus in
chronically inflamed skin via IL-31RA/OSMRβ activation.
F. CEVIKBAS*; X. WANG; A. IKOMA; V. FONG; S.
SEELLIGER; S. DILLON; M. FISCHER; A. ANTAL; P. REEH;
B. HOMEY; A. BASBAUM; M. STEINHOFF. UCSF, Univ.
of Goettingen, Zymogenetics, Univ. of Erlangen, Univ. of
Duesseldorf.
3:00 WW11 283.11 Mice over-expressing protease-activated
receptor-2 in keratinocytes show pruritic skin lesions with
increased nerve growth factor release and enhanced
scratching behavior. A. IKOMA*; F. CEVIKBAS; V. FONG;
E. CAMERER; S. R. COUGHLIN; M. STEINHOFF. Univ. of
California, San Francisco, Kyoto Univ., INSERM.
4:00 WW12 283.12 Targeted lipidomics in spinal cord and
skin after acute inflammation. S. RABOUNE*; J. M. STUART;
H. B. BRADSHAW. Indiana Univ.
1:00 WW13 283.13 Changes in the NGF metabolic cascade
in hairy and glabrous skin of the rat paw following chronic
inflammation. M. OSIKOWICZ*; G. LONGO; A. CUELLO; A.
RIBEIRO-DA-SILVA. McGill Univ.
2:00 WW14 283.14 The pronociceptive roles of CCR2
activation in inflammatory unilateral arthritis. M.
DANSEREAU*; A. MURZA; N. BEAUDET; E. MARSAULT;
S. MÉLIK-PARSADANIANTZ; P. SARRET. Univ. De
Sherbrooke, Univ. de Sherbrooke, Univ. Pierre et Marie
Curie.
3:00 WW15 283.15 Multiple cytokines/chemokines induced
in dorsal root ganglion and spinal cord during systemic
inflammation are blocked by minocycline. S. YOON*; J.
DAVIS; H. ZHANG; P. DOUGHERTY. MD Anderson Cancer
Ctr.
4:00 WW16 283.16 Role of peripheral interaction of ngf
with inflammatory mediators, 5-ht and na in developing
mo-induced hyperalgesia. Y. KAGAWA; S. YAMAMOTO; T.
IBUKI*; Y. IDA; K. OKANO; Y. KISHISHITA; Y. OWADA; T.
ISHIKAWA. Dev. of Neurosciences, Kyoto Prefectural Univ.
Med.
Neuroscience 2010  |  Sunday PM  |  121 
1:00 WW17 283.17 Endopeptidases EC24.15 and EC24.16
regulate bradykinin signaling in primary sensory neurons.
N. A. JESKE*; R. GOMEZ; K. A. BERG; W. P. CLARKE; M.
J. GLUCKSMAN. UTHSCSA, UTHSCA, Rosalind Franklin
Univ. of Med. and Science/Chicago Med. Sch.
2:00 WW18 283.18 The involvement of dorsal root ganglia
BDNF-trkB in inflammatory pain: In vivo and in vitro study.
Y. LIN*; J. CHEN. Chang Gung University/Graduate Inst. of
Biomed. Sci.
3:00 WW19 283.19 Inflammatory mediator-induced
potentiation of GABAa currents in rat dorsal root ganglion
neurons. K. LEE*; M. S. GOLD. Univ. of Pittsburgh.
4:00 WW20 283.20 Suppression of c-fos expression in
arthritic rat brain following treatment with N-(2-hydroxy
phenyl) acetamide. S. U. SIMJEE*; H. JAWED; S. A. SHAH;
S. JAMALL. H.E.J. Res. Inst. of Chem., H.E.J. Res. Inst.
of Chemistry, Intl. Ctr. for Chem. and Biol. Sci., Univ. of
Karachi.
1:00 XX1 283.21 Elucidating inflammatory pain pathways
mediated by substance P and bradykinin. L. OOI*; J. E.
LINLEY; N. GAMPER. Univ. of Leeds.
2:00 XX2 283.22 Estradiol effects on cytokine levels
in peripheral and central nervous system tissue and
nociceptive behaviors in ovariectomized C57BL female mice.
L. C. ABRAMS*; K. SHIVERS; N. AMADOR; D. HUNTER;
S. JENAB; V. QUINONES-JENAB. Hunter Coll CUNY, Grad.
Sch. & Univ. Center, CUNY.
3:00 XX3 283.23 Hyperalgesia is mediated in paw skin
through the Src/nuclear factor kappa B-coupled signal
transduction pathway. O. J. IGWE*. Univ. Missouri- KC.
POSTER
284. Cortical Plasticity and Reorganization
Theme D: Sensory and Motor Systems
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 XX4 284.1 A novel and rapid component of whisker
response plasticity in rat somatosensory (S1) barrel cortex.
L. LI*; D. E. FELDMAN. Univ. California Berkeley.
2:00 XX5 284.2 Neural plasticity in sensory systems
post-stroke: fMRI and DTT analysis reveals differences in
good and poor recovery. D. S. NICHOLS-LARSEN*; A. L.
BORSTAD; S. CHOI; P. SCHMALBROCK. Ohio State Univ.
3:00 XX6 284.3 Quantity of dendritic spines in NADPH-
diaphorase-positive cells in somatosensory cortex from
lactating food deprived rats. E. PEREZ-TORRERO*; M.
I. HERNANDEZ-URBIOLA. Facultad de Ingenieria Univ.
Autonoma de Queretaro, Univ. Nacional Autonoma de
Mexico.
4:00 XX7 284.4 Effects of unilateral dorsal column
section of the spinal cord on activation patterns in area 3b of
somatosensory cortex of squirrel monkeys: Comparisons of
fMRI, optical imaging, and microelectrode maps. H. X. QI*;
L. M. CHEN; B. C. DILLENBURGER; J. H. KAAS. Vanderbilt
Univ.
1:00 XX8 284.5 A role for α4* nicotinic receptors in
experience-driven cortical depression in adult mouse
somatosensory cortex in vivo. C. E. BROWN*; D.
SWEETNAM; M. BEANGE; T. WATSON; R. NASHMI. Univ.
of Victoria.
122  |  Society for Neuroscience
2:00 XX9 284.6 Subtypes of layer V pyramidal neurons
display different amounts of experience-dependent plasticity
in rat barrel cortex. V. JACOB*; N. F. WRIGHT; K. D. FOX.
Cardiff Univ.
3:00 XX10 284.7 Whisker deprivation induced experience-
dependent plasticity alters synapsin I expression in the adult
somatosensory barrel cortex. L. S. CHAU*; A. DAVIS; K.
SIRAJ; R. GALVEZ. Univ. of Illinois.
4:00 XX11 284.8  •  The first session of classical conditioning
training that induced aversive vocalization of adult mice: A
possible index of successful learning. E. SIUCINSKA*; A.
PŁAŹNIK; A. HAMED. Nencki Inst., Med. Univ. of Warsaw,
Inst. of Psychiatry and Neurol.
1:00 XX12 284.9 Neuroplasticity of face motor cortex
following molar teeth extraction and implant treatment. L.
AVIVI-ARBER*; J. LEE; M. FUNG; B. SESSLE. Univ. of
Toronto.
2:00 XX13 284.10 Back seat driving: Anatomical substrates
of spontaneous functional recovery from forelimb stroke.
M. L. STARKEY*; C. BLEUL; M. GULLO; B. ZÖRNER; N.
LINDAU; T. MUEGGLER; A. GHOSH; M. RUDIN; M. E.
SCHWAB. Brain Res. Inst., Animal Imaging Ctr. ETH Zurich,
Inst. of Neuroinformatics.
3:00 XX14 284.11  •  Examine the specificity and activity-
dependence of the effects of naturalistic habitat on barrel
cortex of juvenile mice. X. WANG*; Q. SUN. Univ. of
Wyoming.
4:00 XX15 284.12 Response field properties of area 3b
neurons in normal monkeys and monkeys with incomplete
lesions to the dorsal column of the spinal cord. J. L. REED*;
H. QI; P. POUGET; J. H. KAAS. Vanderbilt Univ.
1:00 XX16 284.13 A direct measure of E/I balance across
different layers of somatosensory cortex during postnatal
development. Z. ZHANG*; Q. SUN. Univ. Wyoming.
2:00 XX17 284.14 Effects of dorsal column section on
somatosensory cortex of primates: Behavior and longitudinal
fMRI. L. M. CHEN*; H. QI; F. WANG; M. J. AVISON; J. H.
KAAS. Vanderbilt Univ.
3:00 XX18 284.15 Sensory retraining in chronic stroke:
Evidence of cortical and behavioral changes. A. L.
BORSTAD*; P. SCHMALBROCK; D. S. LARSEN. The Ohio
State Univ.
POSTER
285. Tactile/Somatosensory: Functional Organization
Theme D: Sensory and Motor Systems
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 XX19 285.1 Somatosensory coordination of hand
shape. M. FLANDERS*; C. PESYNA; D. J. JOHNSON; K.
PUNDI. Univ. Minnesota.
2:00 XX20 285.2 Finger somatotopy in primary
somatosensory cortex in single human subjects: A 7T
fMRI study. R. MARTUZZI*; W. VAN DER ZWAAG; J.
FARTHOUAT; S. DIEGUEZ; S. IONTA; R. GRUETTER; O.
BLANKE. EPFL - LNCO, CIBM - EPFL, Dept. of Radiology,
Univ. de Lausanne, Dept. of Neurology, Geneva Univ. Hosp.
3:00 YY1 285.3 Frequency dependent activation of
auditory cortex during a tactile task. P. NORDMARK*; R. S.
JOHANSSON. Umeå University, Physiol. Section, Dept. of
Integrative Med. Biol.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
4:00 YY2 285.4 Mapping the sensation of wetness across
the body. R. ACKERLEY*; F. MCGLONE; H. OLAUSSON;
J. WESSBERG. Univ. Manchester, Univ. of Gothenburg,
Liverpool John Moores Univ., Sahlgrenska Univ. Hosp.
1:00 YY3 285.5  •  Continuous theta-burst TMS to area 5
modulates neural circuitry within primary motor cortex in
humans. A. PREMJI*; A. ZILUK; M. MANKU; A. J. NELSON.
Univ. of Waterloo.
2:00 YY4 285.6 An fMRI time-course analysis of brain
regions activated during self-stimulation to orgasm in
women. B. R. KOMISARUK*; N. J. WISE; E. FRANGOS; K.
ALLEN. Rutgers, The State Univ. of New Jersey, New Jersey
Med. Sch. of UMDNJ, Princeton Univ.
3:00 YY5 285.7 Immunocytochemical characterization of
Pacinian-like corpuscles in the labia minora of prepubertal
girls. Y. LITVIN*; L. C. MAYOGLOU; J. M. SCHOBER; D.
W. PFAFF; N. MARTÍN-ALGUACIL. Lab. of Neurobio. and
Behavior, The Rockefeller Univ., Hamot Med. Ctr., Sch. of
Vet. Medicine, Univ. Complutense de Madrid.
4:00 YY6 285.8 Organization of cutaneous sensory
receptors in the female labia minora and male foreskin. L. C.
MAYOGLOU*; J. M. SCHOBER; Y. LITVIN; D. W. PFAFF; N.
MARTIN-ALGUACIL. HAMOT Med. Ctr., Rockefeller Univ.,
Univ. Complutense de Madrid.
1:00 YY7 285.9 Sensory motor integration in the
secondary somatosensory cortex of the macaque monkey.
H. ISHIDA; L. FORNIA; M. UMILTA*; V. GALLESE. Univ. di
Parma, Inst. Italiano di Tecnologia (IIT), Unità di Parma.
2:00 YY8 285.10 Development of functional and
anatomical maps of the body in the somatosensory
cortex of infant rats. A. M. SEELKE*; D. F. COOKE; L. A.
KRUBITZER. Univ. California, Davis.
3:00 YY9 285.11 Organizational similarities and differences
in representation of the forelimb in barrel subfield cortex and
cuneate nucleus of adult rats. C. LI; R. S. WATERS*. Univ.
Tennessee.
4:00 YY10 285.12 Passive detection of whisker stimuli
requires primary somatosensory cortex. T. MIYASHITA*; D.
E. FELDMAN. UC Berkeley.
1:00 ZZ1 285.13 Responses in primary and secondary
somatosensory cortical regions in the cat to dual frequency
vibrotactile stimuli applied to the glabrous skin of the
forepaw. S. C. CHEN*; R. M. VICKERY, Male; A. W.
CARTER, Male; P. B. MATTEUCCI, Male; P. J. BYRNES-
PRESTON, Male; J. W. MORLEY, Male. Univ. of New South
Wales, Univ. of Western Sydney.
2:00 ZZ2 285.14 The murine angiotome: Topological basis
for differences in surface versus subsurface blood flow from
the vectorization of all vessels and cell nuclei across cortical
columns. P. BLINDER*; P. S. TSAI; J. P. KAUFHOLD; D.
KLEINFELD. UCSD, SAIC Intelligent Systems Div.
3:00 ZZ3 285.15 Anatomical investigations of the nuclear
differentiation within the ventroposterior lateral thalamic
nucleus in the rat. C. LIAO*; C. YEN. Central Laboratory,
Shin Kong Wu Ho-Su Mem. Hosp., Natl. Taiwan Univ.
4:00 ZZ4 285.16 Long-term imaging of large neuronal
ensembles in the mouse motor cortex. D. HUBER*; S.
PERON; L. PETREANU; D. O’CONNOR; L. TIAN; L.
LOOGER; K. SVOBODA. Janelia Farm Res. Campus,
Howard Hughes Med. Inst.
1:00 ZZ5 285.17 Whisker-based aperture width
discrimination in the mouse. E. E. THOMSON*; J. MELOY;
M. M. NICOLELIS. Duke Univ.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
2:00 ZZ6 285.18 Characterization and manipulation of
interneuron populations in the dorsal spinal cord to better
understand mechanoreception and pain. M. GARCIA DEL
BARRIO*; K. GROSSMANN; C. BIRCHMEIER-KOHLER;
D. WILLMANN; R. SCHULE; M. GOULDING. SALK
INSTITUTE, Max-Delbrück-Center for Mol. Med., Univ. of
Freibrug Med. Ctr.
3:00 ZZ7 285.19 A novel mechanism for crossmodal
interactions in normal rat S1 barrel cortex. A. GHOSHAL; M.
NELSON; P. POUGET; F. F. EBNER*. Vanderbilt Univ., Univ.
Pierre and Marie Curie.
4:00 ZZ8 285.20 Finding somatosensory area boundaries
in humans with the field sign technique. M. I. SERENO*; R.
Sun. PM
HUANG. Univ. Calif San Diego, Univ. Col. London.
1:00 ZZ9 285.21 Neural responses to the perception
of affective touch in CT-fiber denervated individuals. I.
MORRISON*; I. PERINI; J. MINDE. Sahlgrenska Univ. Hosp,
Univ. of Gothenburg, Gällivare Hosp.
2:00 ZZ10 285.22 Modified interhemispheric functional
connectivity between regions of S1 after corpus callosotomy
in adult rats. A. BORTEL*; S. NAAMAN; S. THOMAS; P.
O’CONNOR; S. NEUPANE; A. SHMUEL. Montreal Neurolog.
Inst.
3:00 AAA1 285.23 Multi-scale tactile sampling strategies
during natural exploratory behavior of the rat. B. TOWAL*; M.
J. Z. HARTMANN. Northwestern Univ.
POSTER
286. Spinal Cord Injury: Plasticity II
Theme D: Sensory and Motor Systems
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 AAA2 286.1 Interactions between bilateral arm
muscles after chronic spinal cord injury. K. L. BUNDAY*; M.
A. PEREZ. Univ. of Pittsburgh.
2:00 AAA3 286.2 Effects of soleus H-reflex conditioning on
locomotor EMG and kinematics. Y. CHEN*; L. CHEN; R. L.
LIU; Y. WANG; J. R. WOLPAW; X. Y. CHEN. Wadsworth Ctr,
NYS Dept Hlth. & SUNY.
3:00 AAA4 286.3 Time course study of alterations in
nociceptive behaviors and nociceptor sensitivity following
spinal cord injury in rats. J. DU*; G. L. HARGETT; S. M.
CARLTON. Univ. Texas Med. Br.
4:00 AAA5 286.4  •  Systemic treatment of SUN13837,
a small molecular compound with bFGF-like actions,
enhances functional recovery after spinal cord injury in
rats. M. KURODA; R. OGINO; S. IMAGAMA; R. TAUCHI;
Y. MATSUYAMA; N. ISHIGURO; K. KADOMATSU; M.
MASUMURA; S. NAKAMURA*; N. MURAYAMA; S. UENO.
Asubio Pharma Co., Ltd., Nagoya Univ. Grad. Sch. of Med.,
Hamamatsu Univ. Sch. of Med.
1:00 AAA6 286.5 The plastic changes of spinal excitatory
synaptic transmission in a murine model of cancer-induced
bone pain. Y. YANAGISAWA*; H. FURUE; T. KAWAMATA;
D. UTA; K. IMOTO; Y. IWAMOTO; M. YOSHIMURA. Kyushu
Univ., Natl. Inst. for Physiological Sci., Shinshu Univ. Sch. of
Med.
2:00 AAA7 286.6 Sensorimotor cortex ECoG activity in
rats: Acute relationships with background EMG, H-reflexes,
and SEPs. C. BOULAY*; B. K. LAPALLO; X. Y. CHEN; J. R.
WOLPAW. Wadsworth Ctr., Sch. Publ. Health, SUNY.
Neuroscience 2010  |  Sunday PM  |  123 
3:00 AAA8 286.7 GDNF protein levels change with age in
the spinal cord. M. MCCULLOUGH*; J. M. SPITSBERGEN.
Western Michigan Univ.
4:00 AAA9 286.8 Continuous electrical stimulation protects
against the impact of uncontrollable stimulation in the
isolated spinal cord. D. A. PUGA*; J. W. GRAU. Texas A&M,
Texas A&M Univ.
1:00 AAA10 286.9 Spinal cord injury induces serotonin
hypersensitivity in V2a interneurons. A. HUSCH*; R. M.
HARRIS-WARRICK. Cornell Univ.
2:00 AAA11 286.10 Properties of action potential that
determine diminished excitability after chronic spinal cord
hemisection: In vivo intra-axonal recording from lateral white
matter in adult rat. V. L. ARVANIAN*; A. S. HUNANYAN.
Northport VAMC, SUNY.
3:00 AAA12 286.11 Bilateral excitatory transcranial direct
current stimulation (tDCS) improves bimanual motor
performance in non-disabled individuals. J. RIOS-GOMES*;
M. DE ORNELAS; E. FIELD-FOTE. Univ. of Miami.
4:00 AAA13 286.12 H-reflex conditioning affects
electrocorticographic (ECoG) activity over sensorimotor
cortex in freely moving rats. J. R. WOLPAW*; B. K.
LAPALLO; C. B. BOULAY; X. Y. CHEN. Wadsworth Ctr, NYS
Dept Hlth., Sch. Publ. Health, SUNY.
1:00 AAA14 286.13  •  Delayed treatment of SUN13837, a
small molecular compound with bFGF-like actions, enhances
functional recovery without attenuation of infarction after
stroke in rats. S. UENO*; M. MASUMURA; R. OGINO; N.
MURAYAMA. Asubio Pharma Co., Ltd.
2:00 AAA15 286.14  •  Comparison of cellular responses
induced by SUN13837, a novel bFGF-like small molecular
compound, with those induced by bFGF. Y. SHIMMYO; T.
KADOSHIMA; M. KURODA; R. OGINO; T. MASUDA; T.
NOSHITA*; N. MURAYAMA; S. UENO. Asubio Pharma Co.,
Ltd.
3:00 AAA16 286.15 State dependent changes in the fractal
structure of spontaneous cord dorsum potentials induced
by peripheral nerve and spinal lesions in the anesthetized
cat. E. E. RODRIGUEZ-TORRES*; D. CHAVEZ; E.
HERNANDEZ; P. RUDOMIN. CINVESTAV, IPN, Univ.
Autónoma del Estado de Hidalgo.
4:00 AAA17 286.16 Sensory recovery after ventral root repair
in cervical root transections. M. HUANG*; Y. LIN; K. CHANG;
S. CHANG; Y. SHIH; H. CHENG. Taipei Veterans Gen.
Hosp, Neurolog. Institute, Taipei Veterans Gen. Hosp., Taipei
Med. Univ., Sch. of Medicine, Natl. Yang-Ming Univ.
1:00 AAA18 286.17 Relationships between spatio-temporal
pattern of the dendritic Ca2+ accumulation and alternation
of the directional selectivity in the identified projection
interneurons. H. OGAWA*; K. OKA. Hokkaido Univ., JST,
Keio Univ.
2:00 AAA19 286.18 Contribution of nicotinic receptors to
primary afferent depolarization in neonatal rat and mouse.
J. M. SHRECKENGOST*; J. CALVO; S. HOCHMAN; J.
QUEVEDO. Emory Univ., CINVESTAV.
3:00 AAA20 286.19 Transcutaneous stimulation of the
human lumbar spinal cord: Facilitating locomotor output in
spinal cord injury. K. MINASSIAN*; U. S. HOFSTOETTER;
K. TANSEY; F. RATTAY; W. MAYR; M. R. DIMITRIJEVIC.
Inst. of Analysis and Scientific Computing, Vienna Univ. of
Technol., Med. Univ. of Vienna, Shepherd Ctr., Emory Univ.,
Atlanta Veteran’s Admin. Med. Ctr., Baylor Col. of Med.
124  |  Society for Neuroscience
4:00 AAA21 286.20 Changes in activity of single dorsal horn
neurons during the generation of spontaneous cord dorsum
potentials associated with primary afferent depolarization.
E. CONTRERAS-HERNANDEZ*; D. CHAVEZ; E.
HERNANDEZ; P. RUDOMIN. CINVESTAV.
POSTER
287. Modulation of Rhythmic Pattern Generation: Invertebrate
Theme D: Sensory and Motor Systems
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 AAA22 287.1 Octopamine sensitivity in the axon of a
muscle tendon organ. A. MUNDER*; N. DAUR; W. STEIN.
Univ. of Florida, Univ. Ulm.
2:00 BBB1 287.2 Intraneuronal coregulated expression
of ionic currents in the stomatogastric ganglion of the
crab Cancer borealis. M. S. DESAI*; S. TEMPORAL; D.
J. SCHULZ; J. GOLOWASCH. NJIT, Univ. of Missouri-
Columbia.
3:00 BBB2 287.3 Dopamine modulation of Ih changes the
dependence of conduction velocity on spike frequency and
history in a stomatogastric motor axon. D. M. BUCHER*;
A. W. BALLO; Y. ZHANG; F. NADIM. Univ. Florida, NJIT,
Rutgers Univ. and NJIT.
4:00 BBB3 287.4 Does dopamine induce local translation
of shal in pyloric neuron? H. ZHANG*; K. J. KENT; J. FU; D.
J. BARO. Geogia State Univ.
1:00 BBB4 287.5 Stable dopamine (DA) induced changes
in ion current densities are mediated by new protein
synthesis. E. RODGERS*; M. F. OGINSKY; W. D. KRENZ;
D. J. BARO. Georgia State Univ., Georgia State Univerity.
2:00 BBB5 287.6 Different neuromodulators co-released
from a projection neuron affect the synaptic strength in
the target network depending on their temporal order. F.
NADIM*; A. SHEIBANIE. Rutgers Univ/Njit, UMDNJ.
3:00 BBB6 287.7   The modulatory PS neurons use
different neurotransmitters in different locations to
coordinate motor patterns in the American lobster, Homarus
americanus. M. A. KWIATKOWSKI*; E. GABRANSKI;
K. HUBER; M. C. CHAPLINE; A. E. CHRISTIE; P. S.
DICKINSON. Bowdoin Col., Mount Desert Island Biol. Lab.
4:00 BBB7 287.8 Ionic currents underlying neuropeptide
activation of rhythmic motor activity. J. C. RODRIGUEZ*; D.
M. BLITZ; M. P. NUSBAUM. Univ. Pennsylvania Sch. Med.
1:00 BBB8 287.9   Localization of allatostatin peptide in
the stomatogastric nervous system. R. T. MALLONEY;
M. GOERITZ; T. M. SZABO*; L. S. TANG; E. MARDER.
Brandeis Univ.
2:00 BBB9 287.10 SIFamide is a co-transmitter in MCN5,
a projection neuron that modulates the output of the
pyloric motor pattern in the stomatogastric ganglion of the
crab Cancer borealis. P. S. DICKINSON*; L. GAO; C. A.
WESSNER; C. H. WILSON; A. E. CHRISTIE. Bowdoin Coll,
Denison Univ., Mount Desert Island Biol. Lab.
3:00 BBB10 287.11 Motor pattern specification via modulation
of circuit feedback. D. M. BLITZ*; M. P. NUSBAUM. Univ.
Pennsylvania Sch. Med.
4:00 BBB11 287.12   Peptide hormones in the C-type
allatostatin family modulate the cardiac neuromuscular
system of Homarus americanus. T. WIWATPANIT*; B.
W. POWERS; A. E. CHRISTIE; E. S. DICKINSON; P. S.
DICKINSON. Bowdoin Col., Mount Desert Island Biol. Lab.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
1:00 BBB12 287.13 Calcitonin-like diuretic hormone:
Localization and sites of action in the cardiac neuromuscular
system of the lobster Homarus americanus. M. R.
BOWERS*; J. A. COHEN; A. E. CHRISTIE; P. S.
DICKINSON. Bowdoin Col., Mount Desert Island Biol. Lab.
2:00 BBB13 287.14 Co-activation of the central pattern
generators for flight and walking by pilocarpine and
aminergic modulation of temporal coupling. H. PFLUEGER*;
J. RILLICH; S. HARTFIL; P. A. STEVENSON. Free Univ.
Berlin, Univ. Leipzig.
3:00 BBB14 287.15 Neurochemical studies of the daphnia
magna motor behavioral repertoire. M. L. BECKMAN*.
Augsburg Col.
4:00 BBB15 287.16 Biogenic amines mediate transition
between crawling and swimming in C. elegans. J. T.
PIERCE-SHIMOMURA*; A. G. VIDAL-GADEA; S. TOPPER;
L. YOUNG; L. KRESSIN; M. BRAUNER; K. ERBGUTH;
A. GOTTSCHALK. Univ. Texas, Austin, Johann Wolfgang
Goethe-Universität Frankfurt am Main.
1:00 BBB16 287.17  •  Characterization of motorneurons of
the central pattern generator stimulating feeding behavior in
the pond snail Biomphalaria glabrata. J. WIERSMA*; N. W.
KLECKNER. Bates Col.
2:00 BBB17 287.18 Volume transmission events associated
with activity of interneurons that control feeding CPG in snail.
I. CHISTOPOLSKY; M. ALANIA*; D. SAKHAROV. RAS Inst.
for Developmental Biol., I.Javakhishvili Tbilisi State Univ.
3:00 BBB18 287.19   Dye and electrical coupling of buccal
A cluster neurons is related to modulation of the feeding
central pattern generator in the pond snail, Helisoma
trivolvis. M. M. CONTRACTOR; A. Y. ZHANG; N. W.
KLECKNER*. Bates Col.
4:00 BBB19 287.20 Feedforward compensation organized by
the central and peripheral actions of a single neuropeptide
identified using representational difference analysis. J.
JING*; J. V. SWEEDLER; E. C. CROPPER; V. ALEXEEVA;
J. PARK; E. V. ROMANOVA; F. XIE; N. C. DEMBROW; B.
C. LUDWAR; K. R. WEISS; F. S. VILIM. Mt Sinai Med. Ctr.,
Univ. of Illinois.
1:00 BBB20 287.21 Composite modulatory feedforward loop
contributes to the establishment of a network state. J. WU; F.
S. VILIM; N. G. HATCHER; M. R. DUE; J. V. SWEEDLER; K.
R. WEISS*; J. JING. Mt Sinai Sch. Med., Univ. of Illinois.
2:00 BBB21 287.22 Modulation of Aplysia gut activity by
ethanol, nicotine, and neuropeptides. F. S. VILIM*; E. M.
LUBIS; A. F. PILGRIM. Mt. Sinai Sch. Med., East Side
Middle Sch.
POSTER
288. Modulation of Rhythmic Motor Pattern Generation:
Vertebrate
Theme D: Sensory and Motor Systems
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 BBB22 288.1 Muscarinic modulation of the respiratory
generator in lampreys. J. GARIEPY*; K. MISSAGHI; S.
CHARTRÉ; S. CHEVALLIER; M. ROBERT; F. AUCLAIR; R.
DUBUC. Univ. de Montréal, Univ. du Québec à Montréal,
UMR CNRS 5248 - Univ. Bordeaux 1.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
2:00 CCC1 288.2 The rhythmogenic pre-Bötzinger complex
(preBötC) comprises a small distributed inspiratory network
in the isolated newborn rat brainstem. K. BALLANYI; N.
BOBOCEA; B. PANAITESCU; A. RUANGKITTISAKUL*.
Univ. of Alberta.
3:00 CCC2 288.3 Disturbance of inspiratory-related
motor activities in newborn rat in vitro brainstem models
in response to methylxanthines is due to blockade of
GABAA receptors. B. PANAITESCU*; J. KURIBAYASHI; A.
RUANGKITTISAKUL; V. LEUNG; K. BALLANYI. Univ. of
Alberta.
4:00 CCC3 288.4 Identity of the endocannabinoid mediating
retrograde signaling and plasticity in the spinal locomotor
Sun. PM
circuitry. J. SONG; A. KYRIAKATOS; A. EL MANIRA*.
Karolinska Inst., École Polytechnique Fédérale de Lausanne.
1:00 CCC4 288.5 Dopaminergic modulation of spinal
locomotor circuits in larval zebrafish. A. M. LAMBERT; T. M.
ANDERSON; M. A. MASINO*. Univ. Minnesota.
2:00 CCC5 288.6 Specificity and flexibility of intramuscular
activation during rhythms produced by spinal pattern
generators in the neonatal rat. D. A. KLEIN*; M. C. TRESCH.
Northwestern Univ.
3:00 CCC6 288.7  •  Locomotor activity can be induced by
electromagnetic spinal cord stimulation in rats, cats, and
humans. Y. P. GERASIMENKO*; R. GORODNICHEV; P.
MUSIENKO; R. SEIFNER; R. R. ROY; V. R. EDGERTON.
Pavlov Inst. of Physiol, Velikie Luky State Acad. of Physical
Educ. and Sport, TU Graz, Inst. for Med. Engin., Brain Res.
Institute, Univ. of California, Los Angeles.
4:00 CCC7 288.8 Differential modulatory effects on
fictive locomotion evoked by pharmacological application
or electrical stimulation are mediated by t-type calcium
channels. J. M. HUMPHREYS*; P. J. WHELAN. Hotchkiss
Brain Inst.
1:00 CCC8 288.9 Anatomical evidence for the capacity
of the sacral cholinergic system to increase discharge of
lumbar motoneurons during sensory-induced locomotor
like activity. E. FINKEL; A. ETLIN; A. LEV-TOV; L. L.
ANGLISTER*. Hebrew Univ. Hadassah Med. Sch.
2:00 CCC9 288.10 Lumbar serotonin levels at rest and
during drug-evoked locomotion in the in vitro neonatal rat
brainstem-spinal cord preparation. S. XIE; F. J. SANCHEZ;
A. D. BLYTHE; B. R. NOGA*. Univ. of Miami Sch. of Med.
3:00 CCC10 288.11 Serotonergic modulation of calcium
currents in commissural interneurons in the postnatal
developing mouse spinal cord. M. D. ABBINANTI*; R. M.
HARRIS-WARRICK. Cornell Univ.
4:00 CCC11 288.12 Purinergic receptor activation modulates
locomotor-related activity in the isolated mouse spinal cord.
E. WITTS; K. PANETTA; G. B. MILES*. Univ. St Andrews.
POSTER
289. Afferent Control of Rhythmic Motor Pattern Generation
Theme D: Sensory and Motor Systems
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 CCC12 289.1  •  Enhancement of sensorimotor
transmission following a burst of afferent activity. B. C.
LUDWAR*; E. C. CROPPER. Mount Sinai Sch. Med.
Neuroscience 2010  |  Sunday PM  |  125 
2:00 CCC13 289.2 Multiple forms of short term synaptic
plasticity determine synaptic transmission between a
mechanoafferent and a motor neuron. C. G. EVANS; B. C.
LUDWAR; J. ASKANAS; E. C. CROPPER*. Mt Sinai Sch.
Med., Johns Hopkins Univ.
3:00 CCC14 289.3 Detection of load and muscle force:
Physiological tests of a finite element model of responses of
cockroach trochanteral campaniform sensilla. S. N. ZILL*; S.
CHAUDHRY; D. NEFF. J.C. Edwards Sch. Med.
4:00 CCC15 289.4 Effects of load inversion on swing
trajectories in walking stick insects. S. FREITAG; C.
SCHUETZ; J. SCHMITZ*. Univ. of Bielefeld.
1:00 CCC16 289.5  •  Generation of goal directed locomotor
behavior: Task dependency of movement reinforcement
in local joint control. K. HELLEKES*; J. HOFFMANN; A.
BÜSCHGES. Bioscientific Ctr.
2:00 CCC17 289.6 Activated caspase-3, substance P and
CGRP expression in embryonic chick DRG neurons after
pyridoxine administration. Y. FEDOROVICH; A. A. SHARP*.
SIU Sch. Med.
3:00 CCC18 289.7 Complex cholinergic pharmacology
of alternating left-right lumbar motor rhythms. J. T.
ANDERSON*; S. P. DEWEERTH; S. HOCHMAN. Georgia
Inst. Tech/Emory Univ., Emory Univ. Sch. Med.
4:00 CCC19 289.8 Intra-motoneuronal responses to hip and
ankle muscle afferent stimulation during fictive locomotion
in the cat. A. FRIGON*; J. GOSSARD. Northwestern Univ.,
Univ. de Montreal.
1:00 CCC20 289.9 A dynamical systems analysis of
afferent control in a neuro-mechanical model of locomotion.
L. E. SPARDY; S. N. MARKIN; A. N. KLISHKO; N. A.
SHEVTSOVA*; B. I. PRILUTSKY; I. A. RYBAK; J. E. RUBIN.
Univ. of Pittsburgh, Drexel Univ. Col. of Med., Georgia Inst.
of Technol.
2:00 CCC21 289.10 Assessing the role of sensory information
to the spinal locomotor network after the loss of descending
brain inputs. J. M. ACEVEDO-ROSARIO; M. G. ROSARIO-
CANALES; M. E. DIAZ-RIOS*. Univ. Puerto Rico.
3:00 CCC22 289.11 Delayed functional recovery of crawling
locomotor movements after nerve cord transection. K. A.
MESCE*; J. G. PUHL; I. THOMAS; K. A. KLUKAS. Univ.
Minnesota.
4:00 DDD1 289.12 Excitatory effect of propiverine
hydrochloride on the urethral activities in rats. K.
KADEKAWA*; S. NISHIJIMA; K. ASHITOMI; K. SUGAYA.
Southern Knights’ Lab. LLP.
POSTER
290. Descending Control of Rhythmic Motor Pattern
Generation
Theme D: Sensory and Motor Systems
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 DDD2 290.1 Vestibulospinal inputs to sympathetic
motoneurons in the neonatal mouse. N. KASUMACIC*; J. C.
GLOVER; M. PERREAULT. Univ. Oslo.
2:00 DDD3 290.2   MI-orofacial neurons modulate activity
with stage of chewing sequence and phase of chewing
cycle. K. BROWN; K. TAKAHASHI; J. IRIARTE-DIAZ; N.
HATSOPOULOS; C. F. ROSS*. Univ. of Chicago.
126  |  Society for Neuroscience
3:00 DDD4 290.3 In vivo recording and stimulation of
commissural projections to the stomatogastric ganglion.
Development of a behavioral assay for the stomatogastric
nervous system of the crab Cancer pagurus. F. M. DIEHL*;
W. STEIN. Ulm Univ.
4:00 DDD5 290.4 A single descending neuron can control
intersegmental coordination of a flexible locomotor behavior.
J. G. PUHL*; K. A. MESCE. Univ. Minnesota.
1:00 DDD6 290.5 Descending brain inputs cause variability
in the behavioral responses to a swim excitatory neuron.
O. J. MULLINS*; J. T. HACKETT; W. O. FRIESEN. Univ. of
Virginia.
2:00 DDD7 290.6 Electrical stimulation of the nMLF-
midbrain region in larval zebrafish elicits the slow-swimming
pattern. K. E. SEVERI*; D. M. O’MALLEY; F. ENGERT.
Northeastern Univ., Harvard Univ.
3:00 DDD8 290.7 Effective sensory modality activating the
Mauthner cell switches from tactile to acoustic/vestibular
input in triggering escape behavior in developing zebrafish.
T. KOHASHI*; N. NAKATA; Y. ODA. Washington Univ., Grad.
Sch. of Science, Nagoya Univ.
4:00 DDD9 290.8 Sensory-evoked turning locomotion
in red-eared turtles. S. N. CURRIE*; D. B. WELCH. Univ.
California, Riverside, Univ. of California - Riverside.
1:00 DDD10 290.9 Scratch-like fictive motor output can
be elicited by drug application to cervical segments of
the isolated neonatal rat spinal cord. E. E. VASQUEZ-
DOMINGUEZ*; K. E. POWER; B. FEDIRCHUK. Univ. of
Manitoba.
2:00 EEE1 290.10 Differential reticulospinal activation of
descending ipsilateral spinal interneurons in the neonatal
mouse. K. SZOKOL*; M. DIAZ-RIOS; J. C. GLOVER; M.
PERREAULT. Univ. of Oslo, Inst. of Neurobiology, Univ. of
Puerto Rico, Inst. of Basic Med. Sciences, Univ. of Oslo.
3:00 EEE2 290.11 Neurons of the parapyramidal region
are active during a locomotor task and receive an excitatory
cholinergic input. E. COUTO-ROLDAN; Y. DAI; J. LIU; H. A.
GRAVES; E. S. DENERIS; L. M. JORDAN*. Univ. Manitoba,
Univ. of British Columbia, Case Western Reserve Univ.
4:00 EEE3 290.12 Distinct medullary-spinal systems
control different aspects of gait in the adult mouse. V. G.
VANDERHORST*; C. B. SAPER. BIDMC.
1:00 EEE4 290.13 Corticospinal projections from motor
cortex subregions in the mouse elicit muscle-specific
forelimb responses by contacting different spinal premotor
circuits. C. O. ASANTE*; J. H. MARTIN. City Col. of the City
Univ. of New York, City Col. of The City Univ. of New York.
2:00 EEE5 290.14 Cortical control of adaptive locomotion
in wild type mice and mutant mice lacking the Ephrin-Eph
effector protein alpha2-Chimaerin. J. H. MARTIN*; C.
ASANTE; A. CHU; M. FISHER; L. BENSON; A. BEG; P.
SCHEIFFELE. City Col. of the City Univ. of NY, Columbia
Univ., Univ. of Michigan, Biozentrum, Univ. of Basel.
3:00 EEE6 290.15 The role of slow-conducting pyramidal
tract neurons in precision stepping. E. E. STOUT*; I. N.
BELOOZEROVA. Barrow Neurol Inst.
4:00 EEE7 290.16 Sources of modulation of pyramidal
tract neurons during locomotion. P. V. ZELENIN*; T. G.
DELIAGINA; G. N. ORLOVSKY; A. KARAYANNIDOU;
N. DASGUPTA; M. G. SIROTA; I. N. BELOOZEROVA.
Karolinska Inst., Barrow Neurolog. Inst.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
POSTER
291. Finger and Grasp Control: Effects of Age and Pathology
Theme D: Sensory and Motor Systems
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 EEE8 291.1 Age-associated differences in motor
output variability during one and two finger constant
isometric tasks. A. D. MARZULLO*; O. PINTO NETO; D. M.
KENNEDY; Y. CHEN; E. A. CHRISTOU. Univ. of Florida.
2:00 EEE9 291.2 Action planning under risk and
uncertainty in Parkinson’s Disease. X. LI; M. PLANK; D.
LEE; S. GEPSHTEIN; H. POIZNER*. Univ. Calif, San Diego,
The Salk Inst. for Biol. Studies.
3:00 EEE10 291.3 Influence of age and expertise on force
control in adults. C. VOELCKER-REHAGE*; S. VIELUF; E.
REUTER; B. GODDE. Jacobs Univ. Bremen, Univ. Bielefeld.
4:00 FFF1 291.4 Differential SPP1 expression between
two new world monkeys: Correlation with the ability of
dexterous finger movement. T. YAMAMOTO; T. OISHI*;
N. HIGO; A. SATO; S. MURAYAMA; Y. NISHIMURA; Y.
MURATA; K. YOSHINO-SAITO; T. ISA; T. KOJIMA. Human
Tech. Res. Inst, AIST, Grad Sch. Comp Human Sci., Univ.
Tsukuba, Primate Res. Inst, Kyoto Univ., CREST, JST,
PRESTO, JST, Adv Sci. Inst, RIKEN, DeptNeuropathol,
Tokyo Metro Inst. Gerontol, Dept Dev Physiol, Natl. Inst.
Physiol Sci., Res. Equip Ctr, Hamamatsu Univ. Sch. Med.
1:00 FFF2 291.5 Age-related changes in digit-tip force
directions during grasp and manipulation. P. J. PARIKH; K. J.
COLE*. Univ. Iowa.
2:00 FFF3 291.6  •  Optogenetically induced suppression
of neural activity in the macaque primary motor cortex. M.
KINOSHITA*; K. KANEDA; H. KASAHARA; N. HATANAKA;
R. MATSUI; S. CHIKEN; K. ISA; H. MIZUKAMI; K.
OZAWA; D. WATANABE; A. NAMBU; T. ISA. Natl. Inst. For
Physiological Sci., Kyoto Univ., Jichi Med. Univ.
3:00 FFF4 291.7 Age-related changes in interhemispheric
inhibition are mediated through multiple cortico-cortical
connections. M. BOUDRIAS*; C. S. GONÇALVES; P.
TALELLI; J. ROTHWELL; W. D. PENNY; N. S. WARD. UCL
Inst. of Neurol.
4:00 FFF5 291.8 Beta band corticomuscular coherence
with an additional motor or non-motor task in healthy elderly
adults. A. N. JOHNSON*; M. SHINOHARA. Georgia Inst. of
Technol., Atlanta VA Rehabil. R&D Ctr. of Excellence.
1:00 FFF6 291.9 Relationship between shoulder/elbow
joint torques and associated wrist and finger force generation
in childhood hemiplegia. T. M. SUKAL-MOULTON*; R. L.
HAWE; J. P. A. DEWALD. Northwestern Univ.
2:00 FFF7 291.10 Influence of postural arm stability on
voluntary hand digit movement in hemiparetic stroke
survivors. G. HOFFMANN*; D. G. KAMPER; B. D. SCHMIT.
RIC, Illinois Inst. of Technol., Marquette Univ.
3:00 FFF8 291.11 Sensorimotor integration for multi-digit
grasping: Effect of carpal tunnel syndrome on trial-to-trial
adaptation to object mass. W. ZHANG*; J. A. JOHNSTON;
A. A. SMITH; M. A. ROSS; B. J. COAKLEY; M. SANTELLO.
Arizona State Univ., Univ. of Calgary, Mayo Clin. Hosp.
4:00 FFF9 291.12 Age-dependent changes in topological
configuration of functional brain networks during a motor
task. C. PARK*; M. BOUDRIAS; N. S. WARD. UCL Inst. of
Neurol.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
1:00 FFF10 291.13 Intact prediction of grip selection with
an amputated hand. B. A. PHILIP*; S. H. FREY. Univ. of
Oregon.
2:00 FFF11 291.14 Virtual reaching and grasping in
Parkinson’s disease. D. LEE*; J. W. SNIDER; D. L.
HARRINGTON; H. POIZNER. Univ. California San Diego, VA
San Diego Healthcare Syst. (116A-13).
3:00 FFF12 291.15 Grasping in virtual reality. J. SNIDER*;
D. LEE; D. HARRINGTON; H. POIZNER. UCSD, Veterans
Affairs San Diego Healthcare Syst.
4:00 FFF13 291.16 Variability in therapeutically driven
changes in brain activation patterns. M. OWEN*; M.
Sun. PM
BOUDRIAS; A. WALLACE; P. TALELLI; J. ROTHWELL; N.
S. WARD. UCL Inst. of Neurol.
1:00 FFF14 291.17 Hand preference influences acquisition
of a novel fine motor task in Rhesus monkeys. W. G.
DARLING*; S. M. HYNES; M. A. PIZZIMENTI; D. L.
ROTELLA; J. GE; K. S. STILWELL-MORECRAFT; D. W.
MCNEAL; K. M. SOLON; R. J. MORECRAFT. Univ. Iowa,
Univ. of South Dakota, Kansas Univ. Med. Ctr., Univ. of
Delaware.
2:00 FFF15 291.18 Aging and motor performance during
one and two finger goal-directed tasks. Y. CHEN*; O. PINTO
NETO; K. DEANNA; A. MARZULLO; E. CHRISTOU. Univ. of
Florida.
3:00 FFF16 291.19 Characteristics of the brain function
related to a simple motor task in schizophrenia patients. T.
UENO*; M. INOUE; R. FUJIKI; K. MORITA. Intl. Univ. of Hlth.
and Welfare, Kyushu Univ., Kawano Najima Hosp., Kurume
Univerisity.
4:00 FFF17 291.20 Neural mechanisms of impaired volitional
movement in conversion disorder. R. L. SCOTT*; B. I.
HYLAND; G. D. HAMMOND-TOOKE; E. A. FRANZ; J. G.
ANSON. Univ. of Otago, Univ. of Auckland.
1:00 FFF18 291.21 Aging and learning of fine sinusoidal
tasks. E. A. CHRISTOU*; H. S. BAWEJA; D. M. KENNEDY;
D. L. WRIGHT. Univ. of Florida, Texas A&M Univ.
POSTER
292. Voluntary Reaching: Adaptation and Generalization
Theme D: Sensory and Motor Systems
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 FFF19 292.1 Exploring the links between motor
learning and changes to somatosensory function. M.
DARAINY*; A. A. A. G. MATTAR; D. J. OSTRY. McGill Univ.,
Haskins Labs.
2:00 FFF20 292.2 Generalization of sensory change
following dynamics learning. A. A. MATTAR*; M. DARAINY;
D. J. OSTRY. Mcgill Univ., Shahed Univ., Haskins Labs.
3:00 FFF21 292.3 Spatial generalization following
adaptation to a sudden visuomotor perturbation in 3D space.
D. MONGEON; P. BLANCHET; J. Y. MESSIER*. Univ.
Montreal.
4:00 FFF22 292.4 Force-field interference prevents
normal adaptation to conflicting force-fields and modulates
the degree of learning generalization. L. N. GONZALEZ
CASTRO*; P. W. HUNG; M. A. SMITH. Harvard Univ. - MIT.
1:00 GGG1 292.5 Quantifying the contexts for state
dependence in motor adaptation. J. B. BRAYANOV*; O.
AKINFENWA; L. DALE; M. A. SMITH. Harvard Univ.
Neuroscience 2010  |  Sunday PM  |  127 
2:00 GGG2 292.6 Adaptation to visuomotor rotation remaps
both positions and movement vectors. H. G. WU*; M.
SMITH. Harvard Univ.
3:00 GGG3 292.7 The relationship between the temporal
structure of motor output variability and motor adaptation
rates. G. C. SING*; H. G. WU; L. N. GONZALEZ CASTRO;
G. GABRIEL; M. A. SMITH. Harvard Univ.
4:00 GGG4 292.8 Generalization patterns during reach
adaptation to target jump. S. WESTENDORFF*; B.
TAGHIZADEH; O. DONCHIN; A. GAIL. Bernstein Ctr. for
Computat. Neurosci. Goettingen - German Primate Ctr., Ben
Gurion Univ. of the Negev.
1:00 GGG5 292.9 Three systems with different timescales
in prism adaptation. M. INOUE*; M. UCHIMURA; A. KARIBE;
S. KITAZAWA. Juntendo Univ. Sch. of Medicine, Dept. of
Physiolgy 1.
2:00 GGG6 292.10 Enhanced motor adaptation with
stochastic error amplification. D. STERNAD*; C. J.
HASSON; M. O. ABE; X. HUANG. Northeastern Univ.
3:00 GGG7 292.11 Sensory weighting between vision and
proprioception in visuomotor rotation learning. N. SAIJO*; H.
GOMI. NTT Communication Sci. Labs.
4:00 GGG8 292.12 Do initial biases in force field learning
reflect muscle spindle responses or a visuomotor strategy?
N. YOUSIF; J. C. ROTHWELL*; J. COLE; J. DIEDRICHSEN.
Univ. Col. London, Inst. Neurol, Univ. of Southampton.
1:00 GGG9 292.13 Global and local adaptation of abstract
neuromotor mappings. A. JACKSON*; L. P. WOOD; C. F.
SCHOFIELD; K. NAZARPOUR. Newcastle Univ.
2:00 GGG10 292.14 The mechanism of savings and
interference for visuomotor rotations relates to operant
associations in hand space and not the sign of errors
in visual space. V. S. HUANG*; P. MAZZONI; J. W.
KRAKAUER. Columbia Univ.
3:00 GGG11 292.15 Dual adaptation to two opposing rotations
in altered visual feedback of the hand. R. J. BALDEO*; A.
ZHABOKRITSKY; J. L. NEVA; D. Y. P. HENRIQUES. York
Univ., Univ. of Waterloo.
4:00 GGG12 292.16 The effect of error awareness on
intermanual transfer of adaptation. J. A. TAYLOR*; G. J.
WOJACZYNSKI; C. S. GEE; R. B. IVRY. Univ. of California,
Berkeley.
1:00 GGG13 292.17 Left parietal regions are critical for
visuomotor adaptation. P. K. MUTHA*; R. L. SAINBURG; K.
Y. HAALAND. NM VA Healthcare Syst., Pennsylvania State
Univ., Univ. of New Mexico.
2:00 GGG14 292.18 Responsibility assignment in redundant
systems. J. DIEDRICHSEN*; O. WHITE. Univ. Col. London,
Bangor Univ.
3:00 GGG15 292.19 Inter-limb generalization of isometric
visuomotor adaptation is enhanced when the perturbation is
aligned in retinal and joint coordinates. T. J. CARROLL; A.
DE RUGY*. Univ. Queensland.
4:00 GGG16 292.20 Visuomotor learning for rhythmic
movement is driven by errors in previous movement
cycles: A system identification study. T. IKEGAMI*; M.
HIRASHIMA; R. OSU; D. NOZAKI. ATR Computat. Neurosci.
Labs., The Univ. of Tokyo, Natl. Inst. of Information and
Communications, NICT.
1:00 GGG17 292.21 Adaptation of wrist movements to a novel
dynamical environment modifies the directional tuning of
corticospinal excitability. H. KADOTA*; M. HIRASHIMA; D.
NOZAKI. The Univ. of Tokyo.
128  |  Society for Neuroscience
2:00 GGG18 292.22 Online correction of reaching movement
by auditory feedback information. S. FUJII*; M. HIRASHIMA;
D. NOZAKI. The Univ. of Tokyo, Japan Society for the
Promotion of Sci.
3:00 GGG19 292.23 Adaptation of finger movement to stable
and unstable force fields. H. FUKUDA*; M. ODAGAKI; O.
HIWAKI. Hiroshima City Univ.
4:00 GGG20 292.24  •  Reach adaptation during whole body
acceleration. L. P. SELEN*; I. A. H. CLEMENS; W. P.
MEDENDORP. Radboud Univ.
POSTER
293. Bimanual and Interlimb Movement Control
Theme D: Sensory and Motor Systems
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 GGG21 293.1 Cortico-muscular coherence during
bilateral isometric voluntary contractions in healthy humans.
M. A. PEREZ; D. S. SOTEROPOULOS; S. N. BAKER*.
Univ. of Pittsburgh, Ctr. for the Neural Basis of Cognition,
Newcastle Univ.
2:00 GGG22 293.2 Physiological changes underlying bilateral
isometric arm voluntary contractions in healthy humans. D.
S. SOTEROPOULOS; M. A. PEREZ*. Newcastle Univ., Univ.
of Pittsburgh, Ctr. for the Neural Basis of Cognition.
3:00 HHH1 293.3 A gain-field encoding of both limbs
kinematics revealed by the motor adaptation during
bimanual reaching movement. A. YOKOI*; M. HIRASHIMA;
D. NOZAKI. Univ. Tokyo, Japan Society for the Promotion of
Sci.
4:00 HHH2 293.4  •  Decrease in effective connectivity
from cerebellum to primary motor cortex during bimanual
movements. Y. ARAMAKI*; T. KOCHIYAMA; R. OSU;
D. NOZAKI. Nagoya Inst. of Technol., Natl. institute of
Information and Communications Technol., ATR-Promotion
Brain Activity Imaging Ctr., ATR Computat. Neurosci. Labs.,
The Univ. of Tokyo.
1:00 HHH3 293.5 Crosstalk in implicit assignment of
error information during bimanual visuomotor learning. S.
MORIYAMA*; D. NOZAKI. The Univ. of Tokyo.
2:00 HHH4 293.6 The asymmetry of bilateral transfer of
a visuo-motor rotated aiming task. Z. PAN*; A. W. A. VAN
GEMMERT. Louisiana State Univ.
3:00 HHH5 293.7 Transitions between rhythmic and
discrete performance in unimanual movements. M.
DUARTE*, SR; S. K. CHARLES; L. DIPIETRO; D.
STERNAD; N. HOGAN. Univ. of Sao Paulo, Johns Hopkins
Univ., Kennedy Krieger Inst., MIT, Northeastern Univ.
4:00 HHH6 293.8 Locomotor adaptation to gradually and
suddenly introduced force fields. E. VAN ASSELDONK*; B.
KOOPMAN; H. VAN DER KOOIJ. Univ. Twente, Tech. Univ.
Delft.
1:00 HHH7 293.9 Interlimb coordination during learning and
post-lesion recovery of bimanual skill in rhesus monkeys.
S. M. HYNES*; L. B. BARTEL; W. G. DARLING; M. A.
PIZZIMENTI; J. GE; K. S. STILWELL-MORECRAFT; R. J.
MORECRAFT. Univ. of Iowa, Univ. of South Dakota.
2:00 HHH8 293.10 Movement perception symmetry in left
handed individuals. D. E. ADAMO*; B. J. MARTIN. Wayne
State Univ., Univ. of Michigan.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
3:00 HHH9 293.11 Bilateral interference during visuomotor
adaptation is caused by conflicts between two stages of
motor planning. J. WANG*; R. SAINBURG. Univ. Wisconsin
MKE, Pennsylvania State Univ.
4:00 HHH10 293.12 Sequencing of complex bimanual
movements: Sex differences as related to complexity. G.
LEONARD*; J. CRANE; A. PTITO; T. BURKE. Montreal
Neurolog Inst., Univ. Col. Dublin.
1:00 HHH11 293.13  •  Neural primitives for position
and velocity dependent forces show distinct statistical
properties for the dominant and non-dominant hand. T.
NANAYAKKARA*; J. DIEDRICHSEN. King’s College, Univ.
of London, Univ. College, London.
2:00 HHH12 293.14 Viewing perspective interacts with
a model’s performance level to influence observational
learning processes. J. J. BUCHANAN*; N. DEAN. Texas A &
M Univ., Texas Lutheran Univ.
3:00 HHH13 293.15 Interaction of asymmetrical coupling with
task demands and handedness in bimanual isometric force
tasks. X. HU*; K. M. NEWELL. The Pennsylvania State Univ.
4:00 HHH14 293.16 Neural correlates of age-related
differences in motor cortex inhibition during interlimb
coordination. H. FUJIYAMA; M. R. HINDER; M. W.
SCHMIDT; M. I. GARRY; J. J. SUMMERS*. Univ. Tasmania.
1:00 HHH15 293.17  •  Neural correlates of social coordination:
Spatiotemporal analysis of brain and behavioral measures.
A. FUCHS*; E. TOGNOLI; D. BENITES; J. A. S. KELSO. FL
Atlantic Univ., Univ. Federal do Rio Grande do Sul, Univ. of
Ulster.
2:00 HHH16 293.18  •  Bilateral limb coupling for reaching to
spatially separated objects. L. G. RICHARDS*; A. SETHI; A.
CHEREPON. No.FL/So.GA Veterans, Univ. of Florida.
3:00 HHH17 293.19   Moving in and out of autopilot mode:
Alternating attentional-control strategy for synchronous multi-
limb motions. U. YARMUSH; E. B. TORRES*. Rutgers Univ.
4:00 HHH18 293.20 Two hands, one perception: How
bimanual haptic information is combined by the brain. V.
SQUERI*; A. SCIUTTI; M. GORI; L. MASIA; G. SANDINI; J.
KONCZAK. Inst. Italiano Tecnologia, Univ. of Minnesota.
1:00 HHH19 293.21 Non-dominant advantages for movement
accuracy depend on task conditions. A. PRZYBYLA*; R. L.
SAINBURG. The Pennsylvania State Univ.
2:00 HHH20 293.22  •  Motor learning of uni- and bi-manual
grip force modulation. H. SEKIGUCHI*; S. TAKEUCHI; H.
KADOTA; K. NAKAZAWA; M. MIYAZAKI; S. UCHIDA; D.
NOZAKI. Jobu Univ., The Univ. of Tokyo, Kochi Univ. of
Technol., Waseda Univ.
3:00 HHH21 293.23 Utilization of different body segments
on tapping variability: Preferred tapping speed versus
constrained tapping speed. T. S. FLINK*. Gannon Univ.
4:00 HHH22 293.24 Proprioceptive recalibration does
not transfer bimanually following reach adaptation. D.
SALOMONCZYK*; D. Y. P. HENRIQUES; E. K. CRESSMAN.
York Univ., Univ. of Ottawa.
1:00 HHH23 293.25 The relationship between corpus
callosum structure, function and motor performance in
young adults. B. W. FLING*; P. A. REUTER-LORENZ; R. C.
WELSH; S. F. TAYLOR; R. D. SEIDLER. Univ. of Michigan.
2:00 HHH24 293.26 Modulation of excitability in the primary
motor cortex associated with short-term bimanual movement
training. J. L. NEVA*; W. LEGON; R. J. IBEY; W. R.
STAINES. Univ. of Waterloo, Sunnybrook Hlth. Sci. Ctr.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
3:00 HHH25 293.27 Sensorimotor influences of upper-limb
phasic movement upon the contralateral homologous
muscles. R. J. IBEY*; W. LEGON; J. L. NEVA; W. R.
STAINES. Univ. of Waterloo, Sunnybrook Hlth. Sci. Ctr.,
Toronto Rehabil. Inst.
4:00 HHH26 293.28 Interdependence of object weight and
stability on the timing of bimanual reach and grasp tasks. S.
H. BROWN*; E. G. SCHWEIGER. Univ. of Michigan.
1:00 HHH27 293.29 Transfer effects in polyrhythmic bimanual
coordination. S. PARK*; T. M. H. DIJKSTRA; D. STERNAD.
Northeastern Univ., Radboud Univ.
Sun. PM
POSTER
294. BMI: Locomotion
Theme D: Sensory and Motor Systems
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 HHH28 294.1 Method for recording cortical activity from
the paramedian lobule of the rat cerebellum. J. GROTH*; M.
SAHIN. New Jersey Inst. of Technol.
2:00 HHH29 294.2 Network neural dynamics during
locomotion under varying elastic load and BMI conditions.
W. SONG*; I. CAJIGAS; E. N. BROWN; S. F. GISZTER.
Neurobio. & Anat., Massachusetts Inst. of Technol. &
Massachusetts Gen. Hosp., Drexel Univ. Col. of Med.
3:00 HHH30 294.3  •  Identifying the substrate for successful
robot rehabilitation in neonatal spinalized rats taught to walk:
The effect of trunk muscle afferents on hindlimb extensor
activity during fictive locomotion. U. I. UDOEKWERE*; C.
OZA. Drexel Univ.
4:00 HHH31 294.4  •  Intracortical chronic recording
and intraspinal acute recording with floating braided
microelectrodes. T. KIM*; C. OZA; S. F. GISZTER. Drexel
Univ. of Col. of Med.
1:00 HHH32 294.5 Adaptation to different elastic force
fields applied at the pelvis in intact rats and neonatal spinal
injured animals during treadmill locomotion. C. OZA*; U. I.
UDOEKWERE; T. KIM; S. F. GISZTER. Drexel Univ., Drexel
Univ. Col. of Med.
2:00 HHH33 294.6 Asynchronous brain-computer interface
control of ambulation simulator. Z. NENADIC*; P. T. WANG;
C. E. KING; A. H. DO; L. A. CHUI. UC Irvine, UC Irvine Med.
Ctr.
3:00 HHH34 294.7 Extraction of leg kinematics from the
sensorimotor cortex representation of the whole body. J. A.
WINANS*; A. J. TATE; M. A. LEBEDEV; M. A. L. NICOLELIS.
Duke Univ., Edmond and Lily Safra Intl. Inst. of Neurosci.
4:00 HHH35 294.8 EEG single-trial classification of left and
right foot motor imagery tasks. Y. HASHIMOTO*; J. USHIBA;
Y. TOMITA; A. KIMURA; M. LIU. Keio Univ., Keio Univ.
Tsukigase Rehabil. Ctr., Keio Univ. Sch. of Med.
1:00 HHH36 294.9 Correlation induction between cortical
extracellular spikes pattern and locomotion states by
microstimulation for a BMI control. O. FUKAYAMA*; T.
SUZUKI; K. MABUCHI. Univ. of Tokyo, The Univ. of Tokyo.
2:00 HHH37 294.10 Selective stimulation of regenerated
motor axons via macro-sieve electrodes. M. R. MACEWAN;
E. ZELLMER; D. Y. SIEWE; J. J. WHEELER; D. W.
MORAN*. Washington Univ.
Neuroscience 2010  |  Sunday PM  |  129 
POSTER
295. BMI: Sensory Interface
Theme D: Sensory and Motor Systems
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 HHH38 295.1 Assessing the utility of visual acuity
measures in visual prostheses. A. Z. ZIVOTOFSKY*; A.
CASPI. Bar Ilan Univ., Shamoon Col. of Engin.
2:00 HHH39 295.2  •  Speech-coding strategies for speech
prostheses. K. H. WEE; L. TURICCHIA*; R. SARPESHKAR.
NUS, MIT.
3:00 HHH40 295.3 Implantable neural decoding systems. B.
I. RAPOPORT*; W. WATTANAPANITCH; L. TURICCHIA; R.
SARPESHKAR. Harvard Med. Sch., MIT.
4:00 HHH41 295.4 An ultra-low-power 32-channel wireless
neural recording system. W. WATTANAPANITCH*; D.
KUMAR; B. DO VALLE; L. TURICCHIA; B. I. RAPOPORT; S.
K. ARFIN; S. MANDAL; E. HWANG; R. A. ANDERSEN; R.
SARPESHKAR. MIT, Harvard Med. Sch., Caltech.
1:00 HHH42 295.5 Real-time programmable wireless neural
stimulation. S. K. ARFIN*; J. T. GALE; C. MARTÍNEZ-
RUBIO; E. N. ESKANDAR; R. SARPESHKAR. MIT,
Massachusetts Gen. Hosp.
2:00 HHH43 295.6  •  Somatosensory discrimination in the
non-human primate fingertip. C. K. PIERCE*; S. I. HELMS
TILLERY. Arizona State Univ.
3:00 HHH44 295.7 Towards a bidirectional brain-machine
interface: Coding properties of proprioceptive cells in
somatosensory cortex. B. M. LONDON*; R. RUIZ TORRES;
L. E. MILLER. Northwestern Univ.
4:00 HHH45 295.8 Cortical microstimulation strategies
for tactile feedback in the somatosensory cortex. M. R.
FETTIPLACE*; B. M. DARBANDI; Z. LAI; P. POULIQUEN;
S. BENSMAIA; R. ARMIGER; J. VOGELSTEIN; S. S.
HSIAO. Krieger Mind Brain Inst., Johns Hopkins Univ., Univ.
of Chicago, Johns Hopkins Applied Physics Labs.
1:00 HHH46 295.9 A development of a BCI-based OT-
assist suit for paralyzed upper extremities. T. KOMATSU*;
K. TAKANO; S. IKEGAMI; K. KANSAKU. Cogn Funct Sect,
Dept of Rehab for Sens Funct, Res. Inst. Natl. Rehab Cent.
2:00 HHH47 295.10  •  Neuroprostheses : Neurone survival
on nanocrystalline diamond. A. BENDALI; V. FORSTER-
FRADOT; B. KOLOMIETS; S. A. PICAUD*; E. VAN HOVE;
S. SAADA; A. BONGRAIN; P. BERGONZO. Inst. De La
Vision, INSERM, U968, Paris, F-75012, France, UPMC Univ.
Paris 06, UMR_S 968, Inst. de la Vision, Paris, F-75012,
France, CEA, LIST, Diamond Sensors Laboratory, F-91191
Gif-sur-Yvette, France.
3:00 HHH48 295.11 Tensor based self-paced BCI in freely
moving animals. T. I. AKSENOVA; A. ELISEYEV; C. MORO;
N. TORRES; T. COSTECALDE; G. CHARVET*; S. GHARBI;
C. MESTAIS; A. BENABID. CEA/LETI/CLINATEC, CEA/
LETI/MINATEC, CEA/LETI/DTBS/STD/LESS.
4:00 III1 295.12 Novel stimulation paradigm to provide
somatosensory feedback in a neural prosthesis. J. A.
HOKANSON*; C. A. AYERS; R. A. GAUNT; D. J. WEBER.
Univ. of Pittsburgh.
1:00 III2 295.13 Combining plan and peri-movement
activities improves the performance of brain-machine
interfaces. M. M. SHANECHI; Z. WILLIAMS; G. W.
WORNELL; E. N. BROWN*. Massachusetts Inst. Technol.,
Massachusetts Gen. Hosp.
130  |  Society for Neuroscience
2:00 III3 295.14 How motion is encoded by sensory
afferent ensembles in monkeys? T. UMEDA*; T. SAKATANI;
O. YAMASHITA; M. SATOH; J. MORIMOTO; K. SEKI;
M. KAWATO; T. ISA. NIPS, ATR, Natl. Ctr. of Neurol. and
Psychiatry, the Graduated Univ. for Advanced Sci.
3:00 III4 295.15 Primary somatosensory cortex responses
to simple patterns of primary afferent microstimulation in L6/
L7 dorsal root ganglia of anesthetized cats. C. A. AYERS*;
R. A. GAUNT; J. A. HOKANSON; D. J. WEBER. Univ. of
Pittsburgh.
4:00 III5 295.16 Primary afferent neural activity recorded
with non-penetrating electrodes on lumbar DRG surface. T.
M. BRUNS*; R. A. GAUNT; T. W. SIMPSON; D. J. WEBER.
Univ. of Pittsburgh.
1:00 III6 295.17  •  The effects of micro-stimulation on
micro-electrode array performance - Implications for neural
prosthetics. R. A. PARKER*; R. VANWAGENEN; P. A.
HOUSE; B. GREGER. Univ. Utah, Blackrock Microsystems,
Univ. of Utah.
2:00 III7 295.18 AR-BMI operated with a HMD: Effects of
channel selection. K. TAKANO*; N. HATA; Y. NAKAJIMA; K.
KANSAKU. Cogn Funct Sect, Dept of Rehab for Sens Funct,
Res. Inst. Natl. Rehab Cent,, Mechatro Sect, Dept of Rehab
Eng, Res. Inst. Natl. Rehab Cent,.
3:00 III8 295.19 Faithful encoding of temporal information
of natural scenes in rd1 retinal ganglion cell activities evoked
by amplitude-modulated electrical pulses. S. RYU*; J. YE; Y.
GOO; K. KIM. Yonsei Univ., Chungbuk Natl. Univ. Med. Sch.
4:00 III9 295.20 Factors influencing microstimulation in
a chronically implanted microelectrode array. K. TORAB*;
T. DAVIS; P. HOUSE; R. NORMANN; B. GREGER. Univ. of
Utah.
1:00 III10 295.21 Using micro-electrodes to record
surface local field potentials from human neocortex for
neural prosthetic applications. S. KELLIS*; K. MILLER; K.
THOMSON; S. HANRAHAN; R. BROWN; P. HOUSE; B.
GREGER. Univ. of Utah, Univ. of Washington Sch. of Med.
2:00 III11 295.22 AR-BMI for operating home electronics
in a robot’s environment. K. KANSAKU*; K. TAKANO. Cogn
Funct Sect, Dept of Rehab for Sens Funct, Res. Inst. Natl.
Rehab Cent.
POSTER
296. Hormones and Cognition: Gonadal Steroids
Theme E: Homeostatic and Neuroendocrine Systems
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 III12 296.1 Modulation of cortisol levels at the
time of memory retrieval: Impact on emotional memories.
M. MARIN*; S. J. LUPIEN. Fernand-Seguin Res. Center,
Louis-H. Lafontaine Hosp., Univ. de Montreal.
2:00 III13 296.2 Changes in testosterone related to
competition outcome moderates response to emotional
faces. A. C. FERNANDES*; G. A. OLIVEIRA; T. GARCIA-
MARQUES; R. F. OLIVEIRA. ISPA - Inst. Universitário, IGC,
Champalimaud Neurosci. Programme.
3:00 III14 296.3 The role of the progesterone receptor
in regulation of MAP-2 in the developing medial prefrontal
cortex. J. WILLING*; K. L. GONZALES; C. K. WAGNER.
SUNY Albany.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
4:00 III15 296.4 Hormonal effects of progesterone or
medroxyprogesterone acetate on acquisition of learning
the conditioned eyeblink response in ovariectomized rats.
S. J. FURST*; M. C. WASSERMAN; K. C. H. PANG; R.
J. SERVATIUS; K. D. BECK. UMDNJ-Graduate Sch. of
Biomed. Sci., Neurobehavioral Res. Laboratory, VA New
Jersey Hlth. Care Syst., Stress and Motivated Behavior Inst.
1:00 III16 296.5 The progesterone-mediated
enhancement of object memory consolidation requires
mTOR activation. P. T. ORR*; L. FAN; K. M. FRICK. Yale
Univ., Univ. of Wisconsin-Milwaukee.
2:00 III17 296.6 The mTOR signaling pathway is involved
in the estradiol-induced enhancement of object memory
consolidation. L. FAN*; Z. ZHAO; P. T. ORR; K. M. FRICK.
Yale Univ., Univ. of Wisconsin-Milwaukee.
3:00 III18 296.7 The histone acetyltransferase inhibitor
garcinol blocks estradiol-induced enhancement of object
memory consolidation. K. M. FRICK*; Z. ZHAO; L. FAN.
Univ. of Wisconsin-Milwaukee, Yale Univ.
4:00 III19 296.8 Effects of intrahippocampal infusions of
ERα and ERβ agonists on object memory consolidation. B.
A. KENT*; Z. ZHAO; K. M. FRICK. Yale Univ. Psychology,
Univ. of Wisconsin-Milwaukee.
1:00 III20 296.9 Preoptic estrogen receptor alpha
and anxiety-like behavior in female rats. T. SPITERI; S.
MUSATOV; D. W. PFAFF; S. OGAWA; A. AGMO*. Univ. of
Tromsø, Neurologix, The Rockefeller Univ., Univ. of Tsukuba.
2:00 III21 296.10 Effects of perinatal exposure to low dose
of bisphenol A on anxiety behavior, monoamines, and activity
of MAO in the male mice. S. MATSUDA*; C. SUTOH; D.
ISHII; H. TOMIZAWA; D. MATSUZAWA; K. NAKAZAWA; J.
SAJIKI; E. SHIMIZU. Chiba Univ. Grad. Sch. of Med.
3:00 III22 296.11 Effect of different estrogens on
hippocampal neurogenesis and learning and memory in
aged females. C. K. BARHA*; S. E. LIEBLICH; J. H. K.
WONG; L. A. M. GALEA. Univ. British Columbi.
4:00 III23 296.12 Intrahippocampal infusions of estradiol
can enhance or impair place learning depending on timing of
treatment. D. L. KOROL*; C. J. SCAVUZZO; R. L. COLLIER;
S. L. PARK. Univ. of Illinois, Urbana-Champaign.
1:00 III24 296.13 Acute treatment with the phytoestrogen
genistein enhances place and impairs response learning
in female rats. S. L. PISANI*; A. D. GINSBERG; J. W.
ZHANG; D. R. DOERGE; W. G. HELFERICH; S. L. NEESE;
S. L. SCHANTZ; D. L. KOROL. Univ. of Illinois at Urbana-
Champaign, Natl. Ctr. for Toxicology Res.
2:00 III25 296.14 Acute exposure to estradiol in vivo
enhances CREB activation in the hippocampus. K. L.
MITTERLING*; D. L. KOROL. Univ. Illinois.
3:00 III26 296.15 Estrogen effects on aging-associated
memory decline: A matter of timing. M. C. BUHUSI*; C. V.
BUHUSI; A. GRANHOLM. Med. Univ. South Carolina.
4:00 III27 296.16 Hormonal status influences hippocampal
EEG power in the adult rat. P. PEARCE*; T. RADMAN;
V. SKUCAS; D. FRIEDMAN; N. J. MACLUSKY; C. E.
SCHROEDER; H. E. SCHARFMAN. New York Univ.
Langone Med. Ctr., Nathan Kline Inst., Columbia University,
Col. of Physicians and Surgeons, Univ. of Guelph.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
1:00 III28 296.17 Long-term effects of estrogen
replacement on spatial working memory and visuospatial
attention in aged female rhesus monkeys. L. RENNER; A.
WEISS; N. LANDAUER; S. G. KOHAMA; H. URBANSKI; M.
L. VOYTKO; M. NEURINGER*. Oregon Hlth. & Sci. Univ.,
Wake Forest Univ. Sch. of Med.
2:00 III29 296.18 Effects of immediate and delayed post-
acquisition estradiol benzoate on a socially transmitted
food preference in ovariectomized female CD1 mice. A. E.
CLIPPERTON-ALLEN*; I. FLAXEY; H. K. WEBSTER; C.
NEDIU-MIHALACHE; E. CHOLERIS. Univ. Guelph.
3:00 III30 296.19 Rapid effects of 17beta-estradiol
on social recognition and object recognition learning in
Sun. PM
female mice. A. PHAN*; C. S. GABOR; K. J. FAVARO; S.
L. KASCHACK; N. J. MACLUSKY; E. CHOLERIS. Univ.
Guelph.
4:00 III31 296.20 Differential effects of acute and chronic
estradiol replacement on the expression of steroidogenic
genes in the rhesus macaque brain. K. G. SORWELL; S. G.
KOHAMA; H. F. URBANSKI*. Oregon Natl. Prim Res. Ctr.
1:00 III32 296.21 Endogenous changes in sex hormones
influence memory for emotional stimuli. N. ERTMAN*; L.
CAHILL. Univ. of California, Irvine.
2:00 III33 296.22 Pubertal immune stress blocks estradiol’s
positive effects on cognitive function in adult female mice. N.
ISMAIL*; N. BOUCHENTOUF; K. UTLEY; A. ZALTSMAN; E.
FITZPATRICK; S. HRONOWSKI; J. D. BLAUSTEIN. Univ. of
Massachusetts.
POSTER
297. Neuroimmunology: Behavioral Effects
Theme E: Homeostatic and Neuroendocrine Systems
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 III34 297.1 Microglia and memory: Modulation by
early-life infection. L. L. WILLIAMSON*; S. D. BILBO. Duke
Univ.
2:00 III35 297.2 Combined influence of neonatal and adult
immune challenges on adult neuronal survival and activation
in the dentate gyrus. R. S. MISTRY*; L. L. WILLIAMSON; S.
D. BILBO. Duke Univ.
3:00 III36 297.3 Sex differences in the effect of prenatal
immune stress on social behavior and vasopressin mRNA
expression in juvenile rats. P. TAYLOR; S. ISAACS; R.
BREDEWOLD; A. H. VEENEMA; G. J. DE VRIES*. Univ.
Massachusetts.
4:00 III37 297.4 Early postnatal immune activation alters
anxiety-like behavior in adult prenatally stressed and control
rats. A. K. SALM*; B. E. LALLY; A. A. TOTH; G. W. KONAT.
West Virginia Univ. Sch. Med.
1:00 III38 297.5 Pubertal immune stress disrupts ovarian
steroid regulation of anxiety-like behavior in adult female
mice. K. M. OLESEN*; N. ISMAIL; J. D. BLAUSTEIN. Univ.
of Massachusetts, Amherst.
2:00 III39 297.6  •  The time-course of behavioral,
neuropathological and endocrine changes in a refined
model of CNS lupus. B. SAKIC*; G. LOHESWARAN; M. S.
KAPADIA. McMaster Univ.
3:00 III40 297.7 Mast cells influence hippocampal
neurogenesis, emotionality, and cognition. K. M. NAUTIYAL*;
R. SILVER. Columbia Univ., Barnard Col.
Neuroscience 2010  |  Sunday PM  |  131 
4:00 III41 297.8 Investigating the effects of fear memory
on the immune system. D. GEEM*; D. CHOI; K. RESSLER.
Emory Univ. Yerkes Natl. Primate Res. Ctr.
1:00 III42 297.9 Toll-like receptor 3 signaling inhibits
memory retention and hippocampal neurogenesis, and
promotes anxiety-like behavior. E. OKUN; K. GRIFFIOEN;
B. BARAK; N. J. ROBERTS; K. CASTRO; A. CHENG;
M. R. MUGHAL; M. GLEICHMANN*; U. ASHERY; M. P.
MATTSON. NATIONAL INSTITUTE ON AGING/ NATIONAL
INSTITUTES OF HEALTH, Tel Aviv Univ.
2:00 III43 297.10 Interleukin 1-beta acts in the accumbens
shell to cause swim-test depression. Y. CHEN; B. G.
HOEBEL*. Princeton Univ.
3:00 III44 297.11 Differential psychopharmacology:
Interleukin-2 effects on behaviour and neurochemistry. P.
SCHNEIDER; W. WEBER-FAHR; F. LEONARDI-ESSMANN;
R. SPANAGEL; A. SARTORIUS; C. R. PAWLAK*. Central
Inst. Mental Hlth., Univ. of Frankfurt.
4:00 III45 297.12  •  Mice genetically deficient in ICAM-1
show reduced anxiety-like and depressive-like behaviors.
G. OLIVARES; I. AFZAL; S. WAN; M. ZAPATA; L. J.
KASSELMAN; S. D. CROLL*. Queens Col. of CUNY, Grad.
Ctr. of CUNY.
1:00 III46 297.13 Validating predictive peptides of lupus
and CNS-lupus using MRL/lpr mice. S. WILLIAMS; S. A.
JOHNSTON; P. STAFFORD; S. A. HOFFMAN*. Arizona
State Univ.
2:00 III47 297.14 Behavioral conditioning of
immunosuppression in humans. M. SCHEDLOWSKI*; K.
OBER; A. KRIBBEN; H. ENGLER; O. WITZKE. Univ. Clin.
Essen.
3:00 III48 297.15 Effects of an acute experimental
endotoxemia on brain activity, social cognition and memory
performance. J. GRIGOLEIT*; J. S. KULLMANN; J. R.
OBERBECK; H. ENGLER; O. T. WOLF; E. R. GIZEWSKI;
M. SCHEDLOWSKI. Univ. Hosp. Essen, Ruhr-University
Bochum.
4:00 III49 297.16  •  Mitigation of sleep deprivation through
omega-3 fatty acids: Neurocognitive, inflammatory, eeg and
ekg evidence. R. R. JOHNSON*; A. BEHNEMAN; P. MILLS.
Advanced Brain Monitoring, Inc, UCSD.
1:00 III50 297.17 Influence of time of day on the locomotor
response to lipopolysaccharide administration in mice. J. A.
MURPHY*; E. M. MINTZ. Kent State Univ.
2:00 JJJ1 297.18 Overexpression of TLR4 reduces
neurogenesis in the subgranular zone of dentate gyrus
and impairs spatial learning in mice. M. SONG; J. KOU; A.
PATTANAYAK; J. LIM; J. JIN; J. REHMAN; R. LALONDE; D.
MALO; K. FUKUCHI*. Univ. of Illinois Col. of Med. Peoria,
Univ. de Rouen, McGill Univ.
3:00 JJJ2 297.19 Immune activation and defensive
behavior in rats and mice. A. J. DUNN*; M. WIECZOREK; A.
JENSEN; A. H. SWIERGIEL. Univ. of Hawaii, Univ. of Lodz,
Univ. of Gdansk.
4:00 JJJ3 297.20 Calorie restriction attenuates
LPS-induced sickness behaviour in rats and mice. L.
MACDONALD; M. RADLER; A. G. PAOLINI; S. KENT*. La
Trobe Univ.
132  |  Society for Neuroscience
POSTER
298. Respiratory Rhythm and Pattern Generation
Theme E: Homeostatic and Neuroendocrine Systems
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 JJJ4 298.1 Changes in neuronal number within
respiratory-related nuclei after incremental destruction of the
preBötzinger Complex. M. R. HODGES*; S. NEUMUELLER;
B. MARSHALL; K. L. KRAUSE; B. QIAN; L. G. PAN; H. V.
FORSTER. Med. Col. of Wisconsin, Marquette Univ., Zabloki
VAMC.
2:00 JJJ5 298.2 Role of the parafacial respiratory group
in generating expiration in vitro. S. M. BACA*; P. HSU; H.
ONIMARU; J. L. FELDMAN. David Geffen Sch. of Med. at
UCLA, Showa Univ. Sch. of Med.
3:00 JJJ6 298.3 Two types of independent bursting
mechanisms in inspiratory neuron: An integrative model. N.
TOPORIKOVA*; R. BUTERA. Georgia Inst. of Technol.
4:00 JJJ7 298.4 Control of respiratory pattern by
interacting pontine and pulmonary feedback loops. I. A.
RYBAK*; Y. HSIEH; R. DHINGRA; B. J. BACAK; Y. I.
MOLKOV; T. E. DICK. Drexel Univ. Col. of Med., Case
Western Reserve Univ.
1:00 JJJ8 298.5 Brainstem transcriptomes relevant to
ventilatory stability in the mouse. C. B. GILLOMBARDO;
S. S. L. CHAI; L. M. DONOVAN; M. W. MOORE; K. P.
STROHL*. Case Western Res. Univ.
2:00 JJJ9 298.6 Stimulation at the central nucleus of
the amygdala induces delayed learning and memory in
inspiratory and expiratory rhythms and inspiratory amplitude
in anesthetized rats. H. XU; G. SONG*; C. POON. MIT.
3:00 JJJ10 298.7 Persistent Na+ current is necessary and
sufficient for the intrinsic oscillatory bursting of pre-Bötzinger
complex neurons. T. YAMANISHI; L. S. MILESCU; H.
KOIZUMI; J. C. SMITH*. NINDS,NIH.
4:00 JJJ11 298.8 Excitatory and inhibitory inspiratory
neurons within the neonatal rat pre-Bötzinger complex.
H. KOIZUMI*; R. ZHANG; J. C. SMITH. Cell. & Systems
Neurobio. Sec, NINDS, NIH.
1:00 JJJ12 298.9 Selectively targeting glycinergic neurons
in the brainstem: Role of inhibitory networks for respiratory
pattern and rhythm generation. A. P. L. ABDALA; B. LIU; R.
ZHANG; I. A. RYBAK; J. C. SMITH; J. F. PATON*. Univ. of
Bristol - Bristol Heart Inst., NINDS, NIH, Drexel Univ. Col. of
Med.
2:00 JJJ13 298.10 Midbrain periaqueductal gray modulates
respiratory neuronal activity in the ventrolateral medulla.
H. H. SUBRAMANIAN*; Z. HUANG; R. J. BALNAVE; G.
HOLSTEGE. Univ. of Leeds, The Univ. of Sydney, Univ. Med.
Ctr. Groningen.
3:00 JJJ14 298.11 Postnatal development of NMDA receptor
subunits 2A, 2B, 2C, 2D, and 3B in the pre-Bötzinger
complex of rats. Q. LIU*; M. T. T. WONG-RILEY. Med. Col.
Wisconsin.
4:00 JJJ15 298.12   Prolongation of the expiratory pause
following unusual gasp events in urethane-anesthetized
neonatal rats. L. D. SALAY; I. M. REID; I. C. SOLOMON*.
SUNY Stony Brook.
1:00 JJJ16 298.13 Inhibition within the preBötzinger
Complex (preBötC) and Bötzinger Complex (BötC) does not
play an obligatory role in generation of respiratory rhythm.
W. A. JANCZEWSKI; A. TASHIMA; J. L. FELDMAN*. David
Geffen Sch. of Med. at UCLA.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
2:00 JJJ17 298.14 Dbx1 is necessary for the development
of the preBötC and for breathing in vivo. S. TUPAL; J. A.
HAYES; C. A. DEL NEGRO; P. A. GRAY*. Washington Univ.
Med. Sch., CNRS, Col. of William and Mary.
3:00 JJJ18 298.15 Blockade of dorsolateral pontine 5HT1A
receptors destabilizes the respiratory rhythm in wild-type
mice. R. R. DHINGRA; D. M. BAEKEY*; Y. HSIEH; F. J.
JACONO; M. DUTSCHMANN; D. M. KATZ; T. E. DICK. Case
Western Reserve Univ., Louis Stokes Cleveland VA Med.
Ctr., Univ. of Leeds.
4:00 JJJ19 298.16 Modulation of cardio-respiratory coupling
by the pedunculo-pontine tegmentum in the rat. J. WAXMAN;
I. A. TOPCHIY*; M. RADULOVACKI; D. W. CARLEY. Univ. of
Illinois at Chicago, Univ. Illinois, Chicago.
1:00 JJJ20 298.17 Sympatho-respiratory coupling:
Brainstem mechanisms. Y. I. MOLKOV*; D. B. ZOCCAL;
D. J. A. MORAES; D. M. BAEKEY; T. E. DICK; B. H.
MACHADO; J. F. R. PATON; I. A. RYBAK. Drexel Univ. Col.
of Med., Univ. of São Paulo, Case Western Reserve Univ.,
Univ. of Bristol, Bristol Heart Inst.
2:00 JJJ21 298.18   GABAergic influences on bullfrog
breathing rhythmogenesis and central CO2 chemosensitivity.
C. CARTAGENA*; C. M. BRUNDAGE; B. E. TAYLOR. Univ.
of Alaska Fairbanks, Inst. of Arctic Biol.
3:00 JJJ22 298.19 Expression of inactivity-induced phrenic
motor facilitation differs between substrains of Sprague-
Dawley rats. K. STREY; T. BAKER-HERMAN*. Univ. of
Wisconsin.
4:00 JJJ23 298.20 Episodic spinal alpha 1 receptor
activation induces phrenic motor facilitation in adult rats. A.
G. HUXTABLE*; P. M. MACFARLANE; G. S. MITCHELL.
Univ. of Wisconsin - Madison.
1:00 JJJ24 298.21 Erk-dependent erythropoietin-induced
phrenic motor facilitation also requires Akt activation. E. A.
DALE-NAGLE*; G. MITCHELL. Univ. Wisconsin.
2:00 JJJ25 298.22 TNF-alpha is necessary and sufficient for
induction of phrenic motor facilitation following hypocapnia-
induced respiratory neural inactivity. O. BROYTMAN*; K.
A. STREY; T. L. BAKER-HERMAN. Univ. of Wisconsin -
Madison.
3:00 JJJ26 298.23 Lumbar spinal cord 5HT1A receptors
activation modulates respiratory movements. L. YANG*; Y.
NING; G. SONG; C. POON. MIT.
4:00 JJJ27 298.24 Hypoactivity of raphe neurons induced by
prenatal nicotine exposure in mouse neonates is associated
to augmented 5-HT1A receptor expression. E. U. BRAVO; V.
CERPA; S. BELTRÁN-CASTILLO; I. LLONA; J. EUGENIN*.
Univ. de Santiago, USACH.
1:00 JJJ28 298.25 Differential expression of phrenic and
hypoglossal metaplasticity among two inbred colonies of
Lewis rats: Effects of repetitive intermittent hypoxia and
2-deoxyglucose. P. M. MACFARLANE*; S. VINIT; G. S.
MITCHELL; A. ROOPRA; A. FLOM. UW-Madison.
2:00 JJJ29 298.26  •  WAY-100635 attenuates phrenic long
term facilitation in rats. I. PAVLINAC; R. PECOTIC; Z.
DOGAS*; Z. VALIC; M. VALIC. Univ. of Split, Sch. of Med.
Split, Croatia.
3:00 JJJ30 298.27 Phrenic and hypoglossal long term
facilitation differs among colonies of LEWIS rats. S. VINIT*;
P. M. MACFARLANE; G. S. MITCHELL. UW Madison.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
POSTER
299. Food Intake and Energy Balance: Monoamines and
Amino Acids
Theme E: Homeostatic and Neuroendocrine Systems
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 JJJ31 299.1 Contrasting effects of systemic and
intracranial sibutramine administration on the intake of a
palatable diet in the rat. M. E. CONNOLLY*; W. E. PRATT.
Wake Forest Univ.
2:00 JJJ32 299.2 Anorexia coexists with psychoactive and
rewarding effects when mediated by serotonin 4 receptors
Sun. PM
in the nucleus accumbens. V. COMPAN*; A. JEAN; L.
LAURENT; O. ARIBO; C. MALAPRIS; C. DANTEC; M.
BARROT; R. NEVE; N. DUSTICIER; A. NIEOULLON; R.
HEN; J. BOCKAERT. Nimes University/CNRS/INSERM, MIT,
Columbia Univ.
3:00 JJJ33 299.3 Serotonin 5-HT4 receptors contribute to
the preferential vulnerability of female to eating disorders
under stress. L. LAURENT*; A. JEAN; R. PUECH; J.
BOCKAERT; G. BERTRAND; V. COMPAN. Inst. De
Génomique Fonctionnelle.
4:00 JJJ34 299.4 Adaptive feeding responses to stress
require the 5-HT4 receptors in the prefrontal cortex. A.
JEAN*; L. LAURENT; R. NEVE; M. BARROT; J. BOCKAERT;
V. COMPAN. Inst. For Functional Genomics, MIT, CNRS.
1:00 JJJ35 299.5 Prepulse inhibition of startle is disrupted
in human subjects with eating disorders. V. DUVVURI*; L.
MARCELINO; W. H. KAYE; V. B. RISBROUGH. UCSD Sch.
of Med.
2:00 JJJ36 299.6 Binge eating sucrose activates gene
pathways involved in substance abuse. N. M. AVENA*; F. H.
KOBAISSY; M. E. BOCARSLY; M. YANG; B. HOEBEL; M. S.
GOLD. Univ. of Florida, Princeton Univ.
3:00 JJJ37 299.7 Prenatal exposure to an obesogenic
environment compromises central dopamine synaptic
release in obesity-resistant female offspring. B. M. GEIGER*;
L. A. CAPPELLUCCI; E. N. POTHOS. Tufts Univ.
4:00 JJJ38 299.8 The influence of dietary history on
conditioning and inhibition of a place preference. G. J.
PRIVITERA*; D. MAYEAUX; K. SOTAK. St. Bonaventure
Univ.
1:00 JJJ39 299.9 Activation of dopamine D1-like receptors
in the medial prefrontal cortex is required for the acquisition
of flavor preferences conditioned by intragastric glucose
infusion in rats. K. TOUZANI*; R. J. BODNAR; A. SCLAFANI.
Brooklyn Col., Queens Col.
2:00 JJJ40 299.10 Opioid receptor subtype antagonist
modulation of GABA-B agonist-induced feeding: Ventral
tegmental area and nucleus accumbens regional interactions
in rats. P. MINER*; L. SHIMONOVA; A. KHAIMOV; Y.
BORUKHOVA; B. DHALIWAL; E. CHRISTOFOROU; E.
ILYAYEVA; R. SHERGILL; H. SHIN; R. J. BODNAR. The
Grad. Center, CUNY, Queens College, CUNY.
3:00 JJJ41 299.11  •  Dopamine and opioids modulate
fructose-conditioned flavor preferences in BALB/c and
SWR inbred mice. T. T. KRAFT*; Y. YAKUBOV; V. ACOSTA;
G. FITZGERALD; N. BORUKHOVA; L. BORUKHOV; M.
ELKOMOS BOTROS; L. LUU; K. TOUZANI; A. SCLAFANI;
R. J. BODNAR. Queens College, CUNY, Brooklyn College,
CUNY, Grad. Center, CUNY.
Neuroscience 2010  |  Sunday PM  |  133 
4:00 JJJ42 299.12  •  Acquisition and expression of corn oil-
conditioned flavor preferences in rats: Roles of dopamine
D1 and D2 and opioid receptors. J. DELA CRUZ*; D. P.
ICAZA; H. TAYABALI; V. GALANOPOULOS; C. SAMPSON;
D. BAMSHAD; K. TOUZANI; A. SCLAFANI; R. J. BODNAR.
Psychology, Queens College, CUNY, CUNY Grad. Ctr.,
Brooklyn College, CUNY.
1:00 JJJ43 299.13  •  Acquisition of fructose-conditioned
flavor preference is blocked by dopamine D1 and D2
receptor antagonists in the medial prefrontal cortex of rats.
D. C. MALKUSZ*; T. BANAKOS; T. VONGWATTANAKIT;
A. MOHAMMED; T. BOHN; F. MAHMUD; S. MARTINEZ;
S. SAEED; J. ORR; K. TOUZANI; A. SCLAFANI; R. J.
BODNAR. Queens College, CUNY, Grad. Center, CUNY,
Brooklyn College, CUNY.
2:00 JJJ44 299.14 Dopamine mediates satiety in the
cockroach Rhyparobia maderae. J. WAIER*; R. W. COHEN.
CSUN.
3:00 JJJ45 299.15   Assessment of metabolic syndrome
factors in mice with targeted disruption of the dopamine D2
receptor gene. M. ANANTH*; M. L. MILLER; J. CLARK; J.
O’ROURKE; J. PAGIAZITIS; J. MURMELLO; G. WANG; N.
D. VOLKOW; P. K. THANOS. Brookhaven Natl. Lab., NIAA,
NIH, Stony Brook Univ.
4:00 JJJ46 299.16 Tesofensine, a novel triple monoamine
reuptake inhibitor, induces appetite suppression and
weight loss with reversal of lowered striatal and prefrontal
cortical dopamine levels in the diet-induced obese rat. H. H.
HANSEN*; P. WEIKOP; A. H. BENTSEN; J. D. MIKKELSEN.
NeuroSearch A/S, Copenhagen Univ. Hosp.
1:00 JJJ47 299.17 Diet-induced obesity: decreased
dopamine transporter function, increased motivation for
high fat food reward and behavioral predictors of obesity. V.
NARAYANASWAMI*; A. G. DEACIUC; L. A. CASSIS; M. T.
BARDO; L. P. DWOSKIN. Univ. of Kentucky.
2:00 JJJ48 299.18 Epigenetic memory of chronic exposure
to high fat diet in reward-associated CNS circuitry. Z.
VUCETIC*; T. M. REYES. Univ. of Pennsylvania.
3:00 JJJ49 299.19 Effect of intermittent food restriction on
feeding behavior and dopamine D2 receptor expression in
rats: Implications for the neurochemistry of bulimia nervosa.
J. E. KOCH*; C. HASS; M. MICHAELIDES; P. K. THANOS.
Univ. Wisconsin, Oshkosh, Brookhaven Natl. Lab., Stony
Brook Univ., NIAAA/NIH.
4:00 JJJ50 299.20  •  How does olanzapine effect energy
balance in a rat model for antipsychotic-induced weight
gain? E. M. VAN DER ZWAAL*; M. C. M. LUIJENDIJK; M.
A. D. BRANS; M. A. VAN GESTEL; S. E. LA FLEUR; R. A.
H. ADAN. Rudolf Magnus Inst. of Neurosci., Academic Med.
Ctr.
1:00 KKK1 299.21 Cannabidiol reduces the hyperphagic
effect caused by serotonergic agonists in rats. A. A.
SCOPINHO*; F. S. GUIMARÃES; F. M. A. CORRÊA; L. B. M.
RESSTEL. FMRP-USP.
2:00 KKK2 299.22 The acetylcholinesterase inhibitor
galantamine attenuates obesity and alleviates obesity-
related pathologies in mice. V. PAVLOV*; S. SATAPATHY; M.
OCHANI; M. DANCHO; L. HUDSON; M. ROSAS-BALLINA;
S. I. VALDES-FERRER; P. S. OLOFSSON; T. HARRIS; J.
ROTH; S. CHAVAN; K. J. TRACEY. The Feinstein Inst. For
Med. Res., Long Island Jewish Med. Ctr.
134  |  Society for Neuroscience
3:00 KKK3 299.23 v7-3/SLC6A15 knockout supports roles
for neutral amino acid transport in regulating appetite and
food preferences. J. DRGONOVA*; F. S. HALL; G. R. UHL.
Natl. Inst. Drug Abuse, NIH.
4:00 KKK4 299.24 Regulation of the NF kappa B signaling
pathway in mesolimbic circuits during food restriction in
mice. S. M. GRAY*; D. J. GUARNIERI; D. CHRISTOFFEL;
S. J. RUSSO; R. J. DILEONE. Yale Univ., Mount Sinai Sch.
of Med.
1:00 KKK5 299.25  •  Adaptation of rats to diets containing
different levels of protein: Comprehensive amino acid
profiles in plasma, CSF, hypothalamus and cerebellum. K.
NAGAO; S. ETO; M. BANNAI; N. KAWAI; M. TAKAHASHI*;
T. KOBAYASHI. Ajinomoto Co., Inc.
2:00 KKK6 299.26  •  Voluntary wheel running mitigates lysine
deficiency in rats. M. BANNAI*; K. NAGAO; M. TAKAHASHI;
T. KOBAYASHI. Ajinomoto Co., Inc.
3:00 KKK7 299.27 Lateral hypothalamic NMDA receptors
mediate feeding elicited by accumbens shell inhibition. K.
URSTADT*; S. F. ZAIDI; B. G. STANLEY. Univ. of California,
Riverside.
4:00 KKK8 299.28 Binge eating sucrose increases
DeltaFosB expression in the nucleus accumbens. M. E.
BOCARSLY*; D. L. WALLACE; J. W. MUSCHAMP; E. J.
NESTLER; B. G. HOEBEL; N. M. AVENA. Princeton Univ.,
Univ. of California at Berkley, Harvard Med. Sch., Mount
Sinai Sch. of Med., Univ. of Florida.
POSTER
300. Sleep: Systems and Physiology
Theme E: Homeostatic and Neuroendocrine Systems
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 KKK9 300.1 In vivo stimulation of galaninergic
neurons in the Ventrolateral Preoptic area modulates sleep/
wake patterns. D. KROEGER*; M. E. CARTER; L. DE
LECEA. Stanford Univ.
2:00 KKK10 300.2 Sleep homeostasis in developing rats:
A role for preoptic area neurons. I. GVILIA; B. ANGARA;
D. MCGINTY; R. S. SZYMUSIAK*. VA Med. Ctr., Ilia State
Univ., Univ. of California at Los Angeles.
3:00 KKK11 300.3 Neuronal OFF periods increase during
sleep deprivation in the rat neocortex. G. TONONI*; V.
VYAZOVSKIY; U. OLCESE; Y. NIR; C. CIRELLI. Univ.
Wisconsin/Madison, Scuola Superiore Sant’Anna.
4:00 KKK12 300.4 Sleep spindles in humans: Insights from
intracranial EEG and unit recordings. T. ANDRILLON*; Y.
NIR; R. J. STABA; C. CIRELLI; G. TONONI; I. FRIED. Univ.
of Wisconsin, Ecole Normale Superieure, Univ. of California-
Los Angeles, Tel Aviv Univ.
1:00 KKK13 300.5 Local sleep and slow wave propagation
revealed by depth EEG and single-unit recordings in
humans. Y. NIR*; R. J. STABA; V. V. VYAZOVSKIY; C.
CIRELLI; I. FRIED; G. TONONI. Univ. of Wisconsin, Univ. of
California-Los Angeles, Tel Aviv Univ.
2:00 KKK14 300.6 Neuronal activity of the mesencephalic
locomotor region (MLR) during sleep-wake cycle in freely
behaving rats. S. THANKACHAN*; J. LU. BIDMC and
Harvard Med. Sch.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
3:00 KKK15 300.7 Extended sleep restriction inactivates
the astrocyte dependent homeostatic sleep response. L. I.
SCHMITT*; D. HINES; J. CLASADONTE; P. G. HAYDON.
Tufts Univ.
4:00 KKK16 300.8 Activation of the pontine reticular
formation accompanying rapid eye movements during REM
sleep: A high-resolution fMRI study. S. KAN*; T. KOIKE; S.
MIYAUCHI. NICT, CREST, JST.
1:00 KKK17 300.9 Sleep homeostasis in the rat: The
effect of lesion in preoptic hypothalamus. M. SVANIDZE;
N. LORTKIPANIDZE; E. CHIDJAVADZE; N. ONIANI; N.
DARCHIA; I. GVILIA*. I. Beritashvili Inst. of Physiol., Res.
Service, Veterans Affairs Greater Los Angeles Healthcare
Syst.
2:00 KKK18 300.10 Electrophysiological and cognitive
correlates of long-term chronic sleep restriction in college
students. L. T. TRUJILLO*; L. E. DICKEY; P. A. CARTER; D.
M. SCHNYER. Univ. of Texas at Austin.
3:00 KKK19 300.11 REM sleep deprivation early in the critical
period of brain maturation increases anxiety-like behavior in
adolescents and reduces synaptic plasticity in hippocampus
in adults. J. P. SHAFFERY*; I. A. PAUL; H. P. ROFFWARG.
Univ. Mississippi Med. Ctr.
4:00 KKK20 300.12 Rapid assessment of sleep/wake
behaviour in mice in response to pharmacological and
environmental manipulation. S. P. FISHER*; S. I. GODINHO;
M. W. HANKINS; R. G. FOSTER; S. N. PEIRSON. Univ. of
Oxford.
1:00 KKK21 300.13 Unsupervised paradoxical sleep
deprivation using polygraphic signals in rats: A new
alternative to the “flower pot” technique. P. LIBOUREL; A.
CORNEYLLIE; G. CHOUVET; P. LUPPI; D. GERVASONI*.
CNRS UMR5167.
2:00 KKK22 300.14 Homeostatic regulation of sleep-wake
and EEG patterns assessed using a novel naturalistic rat
model of chronic sleep restriction. S. DEURVEILHER*; B.
RUSAK; K. SEMBA. Dalhousie Univ.
3:00 KKK23 300.15 Tonic and phasic aspects of binocular
eye movements during natural REM sleep in the rat. A.
SÁNCHEZ LÓPEZ*; L. C. CERVANTES; M. ESCUDERO.
Neurociencia Y Comportamiento, Univ. of Seville.
4:00 KKK24 300.16 6 hours REM sleep restriction does not
affect concurrent spatial and reversal learning in the Morris
water maze. C. M. WALSH*; V. BOOTH; G. R. POE. Univ.
Michigan, Univ. of Michigan.
1:00 KKK25 300.17 Dynamic characterization of
topographically different sleep spindles in mice. D. KIM*;
M. LEE; H. SHIN; J. CHOI. Korea Inst. of Sci. and Technol.
(KIST), Univ. of Sci. and Technol.
2:00 KKK26 300.18 Modeling sleep-wake temporal
architecture in multiple species to investigate underlying
physiology of behavioral state regulation. C. DINIZ BEHN*;
D. PAL; G. VANINI; R. LYDIC; G. A. MASHOUR; V. BOOTH.
Univ. Michigan.
3:00 KKK27 300.19 Temporal structure of running-wheel
activity in waking predicts subsequent sleep architecture in
mice. V. V. VYAZOVSKIY*; G. TONONI; I. TOBLER. WISPiC,
Inst. of Pharmacol. and Toxicology.
4:00 KKK28 300.20 Discharge profiles of putative
glutamatergic neurons in the pontomesencephalic
tegmentum across the sleep-wake cycle. S. BOUCETTA*; B.
E. JONES. McGill Univ.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
1:00 KKK29 300.21 Role of the rostral ventrolateral medulla
in the regulation of paradoxical (REM) sleep in the rat. C.
SIRIEIX*; M. JOUANNEAU; D. GERVASONI; P. LUPPI; L.
LÉGER. CNRS UMR 5167, Univ. Claude Bernard Lyon 1.
2:00 KKK30 300.22  •  The simultaneous measurement of EEG
and glutamate during normal sleep and sleep deprivation
in a mouse model. D. A. JOHNSON*; D. AILLON; S.
GABBERT; H. HARMON; G. S. WILSON; E. NAYLOR; D. A.
JOHNSON. Pinnacle Technol, Inc., Univ. of Kansas.
3:00 KKK31 300.23 Daily patterns of Fos expression in sleep
and wakefulness-associated brain regions of diestrous and
pregnant rats (Rattus norvegicus). J. A. SCHRADER*; A. A.
NUNEZ; L. SMALE. Michigan State Univ.
Sun. PM
4:00 KKK32 300.24 Fasting- and novel environment-induced
arousal is attenuated in mice lacking functional ghrelin
receptor. M. ESPOSITO; J. PELLINEN; L. KAPAS*; E.
SZENTIRMAI. Washington State University, Spokane.
1:00 KKK33 300.25 Spontaneous MEG activity during sleep
correlated with improvement of a motor sequence learning
in motor related cortical areas. M. TAMAKI*; T. HUANG; F.
LIN; M. HÄMÄLÄINEN; T. WATANABE; Y. SASAKI. ATR
Computat. Neurosci. Labs., Boston Univ., Massachusetts
Gen. Hosp., Harvard Med. Sch.
2:00 KKK34 300.26 When a nap is not enough: Sleep-
related offline improvement of perceptual visual learning
as assessed by fMRI. L. MATARAZZO*; G. ALBOUY;
A. FORET; L. MASCETTI; V. MUTO; E. BALTEAU; C.
PHILLIPS; V. STERPENICH; C. SCHMIDT; A. LUXEN; R.
VOGELS; P. MAQUET. Univ. of Liège, Univ. of Montreal,
Univ. of Geneva, Univ. of Basel, Univ. of Leuven.
3:00 KKK35 300.27 Suppression of muscle tone by the
medulla: Distinct roles of nucleus gigantocellularis and
magnocellularis. Y. LAI*; T. KODAMA; J. M. SIEGEL. UCLA/
VAGLAHS Sepulveda, Tokyo Metropolitan Inst. for Med.
Res.
4:00 KKK36 300.28 Lesioning of the ventrolateral preoptic
nucleus alters isoflurane-induced hypnosis in a time-
dependent fashion. J. T. MOORE*; H. S. MCCARREN; S. G.
BECK; M. B. KELZ. Univ. of Pennsylvania.
1:00 KKK37 300.29 Hippocampal interneurons, sleep and
memory consolidation. H. S. GOMPF*; J. LU. Harvard Med.
Sch. - BIDMC, Beth Israel Deaconess Med. Ctr.
2:00 KKK38 300.30 Projections from the central nucleus
of the amygdala to the nucleus pontis oralis in the rat: An
anterograde labeling study. M. XI; J. ZHANG; S. J. FUNG;
S. SAMPOGNA; V. LIM; C. L. WILSON*; M. H. CHASE.
WebSciences Intl., VA Greater Los Angeles healthcare Syst.,
UCLA Sch. Med.
3:00 KKK39 300.31 Sirt1 regulation of wake-active neurons.
S. C. VEASEY*; P. FENIK; Y. ZHU; L. PANOSSIAN; G.
ZHAN; D. C. LIM; M. MCBURNEY. Univ. Pennsylvania, Univ.
of Pennsylvania, Ottawa Hosp. Res. Inst.
POSTER
301. Neural mechanisms: reward, emotion and pharmacology
Theme F: Cognition and Behavior
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 KKK40 301.1 Reward reduces conflict by enhancing
executive function and suppressing task-irrelevant
information. S. PADMALA*; L. PESSOA. Indiana Univ.
Neuroscience 2010  |  Sunday PM  |  135 
2:00 KKK41 301.2 Error prediction in cocaine dependent
patients: Evidence for a limited dynamic range of “default”
circuit activity and normalizing effects of methylphenidate.
S. R. BEDNARSKI*; X. LUO; D. MATUSKEY; P. T.
MORGAN; R. T. MALISON; S. RAJITA; K. M. CARROLL;
B. J. ROUNSAVILLE; C. R. LI. Yale Univ., VA Connecticut
Healthcare Systems.
3:00 KKK42 301.3 Association of error-related BOLD
activation and norepinephrine transporter availability is
disrupted in cocaine dependent patients. C. R. LI*; B.
PLANETA-WILSON; S. BEDNARSKI; D. MATUSKEY; W.
WILLIAMS; R. T. MALISON; R. E. CARSON; Y. DING. Yale
Univ.
4:00 KKK43 301.4 The effects of methylphenidate on resting
state fALFF and thalamic/midbrain functional connectivity in
cocaine dependent patients. D. MATUSKEY*; S. ZHANG; P.
T. MORGAN; R. MALISON; B. ROUNSAVILLE; C. LI. Yale
Univerity.
1:00 KKK44 301.5 The attentional blink and mood induction.
L. K. COULSON*; S. BRAEUTIGAM; M. L. KRINGELBACH;
K. P. EBMEIER*. Univ. of Oxford, Dept. of Psychiatry.
2:00 KKK45 301.6 Threat anticipation utilizes processing
resources needed for cognitive control. J. CHOI*; S.
PADMALA; L. PESSOA. Indiana Univ. -- Bloomington.
3:00 KKK46 301.7 Theanine reverses caffeine-induced
enhancement on executive control following exposure to
stress. C. R. MAHONEY*; T. T. BRUNYE; G. GILES; R.
KANAREK. Natick Soldier Ctr., Tufts Univ.
4:00 KKK47 301.8 Neural mechanisms underlying
exogenous affective guidance of spatial attention. C. C.
REECK*; K. S. LABAR; T. EGNER. Duke Univ.
1:00 KKK48 301.9 Investigation of effects of
benzylphenylpiperazine, trifluoromethylphenylpiperazine and
dexamphetamine on the event-related P300 in humans. H.
LEE*; R. R. KYDD; V. LIM; I. J. KIRK; B. R. RUSSELL. Univ.
of Auckland.
2:00 KKK49 301.10 Effects of modafinil on behavioral choice
and attentional selection. J. J. GENG*; K. MONLUX; N. E.
DIQUATTRO; M. J. MINZENBERG. Univ. of California Davis,
Univ. of California, Davis.
3:00 KKK50 301.11  •  H3 antagonist: The role of scientific
discovery on the path to therapeutic intervention. S.
BOYER*; D. PALUMBO. Pfizer Inc.
4:00 KKK51 301.12 Changes in neural activity associated
with response inhibition during acute nicotine administration.
E. C. MAZZULLA*; P. A. NEWHOUSE; S. M. LOCKE; A. S.
POTTER. Univ. of Vermont.
1:00 KKK52 301.13 Women attend to the negative: ERP
evidence for a gender difference in affective picture
processing. J. SIMPSON; S. M. LAWRIE; J. HALL; D.
I. DONALDSON*. Univ. of Stirling, Univ. of Edinburgh,
Psychological Imaging Lab.
2:00 KKK53 301.14 The effects of psychosocial stress on
salivary cortisol and alpha-amylase. V. V. GALVAN*; R.
CARTER; A. DHAR; C. GUTIERREZ DE VELAZCO; K.
CORREA; K. KENNEDY; M. LENARD. Univ. San Diego.
3:00 KKK54 301.15 Emotionally negative stimuli can
overcome attentional deficits in patients with visuo-spatial
hemineglect. A. M. GRABOWSKA*; A. MARCHEWKA; J.
SENIÓW; K. POLANOWSKA; K. JEDNORÓG; M. KOSSUT;
L. KRÓLICKI; A. CZLONKOWSKA. Nencki Inst. of Exptl.
Biol., Warsaw Sch. of Social Sci. and Humanities, Inst. of
Psychiatry and Neurol., Med. Univ. of Warsaw.
136  |  Society for Neuroscience
4:00 KKK55 301.16 Attentional modulation of affective vs
sensory processing: Functional connectivity and a top-
down biased activation theory of selective attention. F.
GRABENHORST*; E. T. ROLLS. Univ. of Cambridge, Oxford
Ctr. for Computat. Neurosci.
POSTER
302. Cognitive Development: Neural Systems
Theme F: Cognition and Behavior
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 KKK56 302.1 Interhemispheric functional connectivity
following pre- or perinatal brain injury predicts language
outcome. A. S. DICK*; A. RAJA BEHARELLE; S. C. LEVINE;
A. SOLODKIN; S. L. SMALL. The Univ. of Chicago, Rotman
Res. Institute, Baycrest Ctr.
2:00 KKK57 302.2   Imbalanced network interactions during
working memory in adolescent offspring of schizophrenia
parents revealed using dcm. N. BAKSHI*; V. DIWADKAR; P.
PRUITT; S. EICKHOFF. Wayne State Univ., Aachen Univ.
3:00 KKK58 302.3 White matter integrity after neonatal
hypoxia/ischaemia associated with congenital heart
disease. M. MUNOZ*; K. E. WATKINS; M. CHADWICK;
D. G. GADIAN; A. HOSKOTE; M. MISHKIN; F. VARGHA-
KHADEM. Inst. Child Hlth, Univ. Col. London, Univ. of
Oxford, Wellcome Trust Ctr. for Neuroimaging, UCL Inst. of
Child Hlth., Natl. Inst. of Mental Hlth.
4:00 KKK59 302.4 The development of cortical hubs and
frontal-parietal networks revealed by intrinsic functional
connectivity. K. HWANG*; B. LUNA. Univ. of Pittsburgh.
1:00 KKK60 302.5 Towards an electrocortical biomarker
of newborn cognition. J. R. ISLER*; A. R. TARULLO; P. G.
GRIEVE; E. HOUSMAN; M. KAKU; A. PEREZ; R. I. STARK;
W. P. FIFER. Columbia Univ.
2:00 KKK61 302.6 Influence of peers on social behavior
and underlying neural circuitry across development. R. M.
JONES*; L. H. SOMERVILLE; E. J. RUBERRY; V. G. LIBBY;
B. J. CASEY. The Sackler Inst.
3:00 KKK62 302.7 Magnetoencephalography reveals
thalamocortical dysrhythmia in children born very preterm. S.
DOESBURG; U. RIBARY*; A. HERDMAN; A. MOISEEV; T.
CHEUNG; S. MILLER; H. WEINBERG; R. GRUNAU. Univ.
of British Columbia, Smon Fraser Univ., Down Syndrome
Res. Fndn.
4:00 KKK63 302.8 Sex hormones and white matter
microstructure in adolescents. M. HERTING*; E. MAXWELL;
C. IRVINE; B. NAGEL. Oregon Hlth. & Sci. Univ.
1:00 KKK64 302.9 Developmental changes in functional
connectivity between anterior and posterior nodes of
the default-mode network. S. D. WASHINGTON*; E. M.
GORDON; J. BRAR; L. GIRTON; A. HAILU; A. WOLFE;
S. WARBURTON; J. MBWANA; W. GAILLARD; M.
KALBFLEISCH; J. W. VANMETER. Georgetown Univ. Med.
Ctr., Children’s Natl. Med. Ctr., Krasnow Investigations of
Developmental Learning and Behavior.
2:00 KKK65 302.10 Developmental trajectories of white
matter fascicles are associated with children’s reading
skills: A 3-year longitudinal study. J. YEATMAN*; E.
RYKHLEVSKAIA; M. BEN-SHACHAR; E. A. C. THOMAS;
G. K. DEUTSCH; B. A. WANDELL; R. F. DOUGHERTY.
Stanford Univ., Bar Ilan Univ.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
3:00 KKK66 302.11 Top-down regulation of activity in ventral
visual association areas in 7-11-year-old children. V. A.
VUONTELA*; P. JIANG; P. SAVOLAINEN; Y. MA; T. LIIRI; M.
AHLSTRÖM; T. FONTELL; E. T. ARONEN; O. SALONEN; S.
CARLSON. Inst. of Biomedicine, Kunming Inst. of Zoology,
Dept. of Gynecology and Pediatrics, Dept. of Radiology,
Brain Res. Unit/Low Temperature Lab., Med. Sch.
4:00 KKK67 302.12 Cortical resting gamma at 16 through 36
months predicts later language performance. Z. GOU*; N.
CHOUDHURY; A. A. BENASICH. Rutgers Univ., Ramapo
Col.
1:00 KKK68 302.13  •  Cognitive processing speed correlates
with differential use of prefrontal cortex in youths, young
adults, and elderly adults. M. A. MOTES*; J. F. GAMINO;
N. K. RAO; E. SHOKRI KOJORI; L. DEWEY; T. JANTZ; J.
HART, Jr; B. RYPMA; S. B. CHAPMAN. Univ. of Texas at
Dallas, Univ. of Texas Southwestern Med. Ctr.
2:00 KKK69 302.14 Amygdala functional connectivity
in children with and at risk for major depression. K. R.
LUKING*; G. REPOVS; A. C. BELDEN; M. S. GAFFREY;
K. N. BOTTERON; J. L. LUBY; D. M. BARCH. Washington
Univ. Sch. of Med., Univ. of Ljubljana.
3:00 KKK70 302.15 Reading-related correlates of non-speech
auditory executive function skills in kindergarteners. J. G.
FOY*; V. MANN; T. ADAMS; Y. ARANAS; A. MCFARLAND;
K. MURO; Y. SEI. Loyola Marymount Univ., Univ. of
California-Irvine.
POSTER
303. Social Cognition: Interpersonal Function
Theme F: Cognition and Behavior
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 LLL1 303.1 Neural correlates of aggression in
cocaine dependent individuals. K. MCCURRY*; G. BROWN;
R. DE LA GARZA; T. NEWTON; P. CHIU; B. KING-CASAS.
Baylor Col. of Med., Michael E. DeBakey Veterans Affairs
Med. Ctr.
2:00 LLL2 303.2 Neural correlates of dynamic
cooperativity: An FMRI investigation of synchronized finger
tapping with a “virtual partner” to explore leader-follower
relationships. M. T. FAIRHURST*; J. STELZER; P. JANATA;
B. H. REPP; P. KELLER. Max Planck Inst. For Cognitive
Brain Sci., Univ. of California, Haskins Labs.
3:00 LLL3 303.3 From eye-gaze detection to mentalizing:
Connectivity analysis using intersubject variation in
activation. M. SUGIURA*; Y. YOMOGIDA; Y. MANO; Y.
SASSA; T. KAMBARA; A. SEKIGUCHI; R. KAWASHIMA.
IDAC, Tohoku Univ., JSPS, IIARE, Tohoku Univ.
4:00 LLL4 303.4 Loneliness induced by lack of trusts from
others. T. TAKANO*; K. MOGI. Tokyo Inst. of Technol., Sony
Computer Sci. Labs.
1:00 LLL5 303.5 Brain dynamics of coordinated teams.
A. J. KOVACS*; E. TOGNOLI; D. AFERGAN; J. COYNE; G.
GIBSON; R. STRIPLING; S. KELSO. Florida Atlantic Univ.,
Naval Res. Lab., Strategic Analysis Inc., Office of Naval
Res., Univ. of Ulster.
2:00 LLL6 303.6 The neurobiology of diffusion of
responsibility in social dilemmas. B. KING-CASAS*; G.
CHRISTOPOULOS. Baylor Col. Med., Baylor Col. of Med. &
Michael E. DeBakey Veterans Affairs Med. Ctr.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
3:00 LLL7 303.7 Behavioral and neural correlates of trust
in major depressive disorder. A. ACEVEDO-RODRIGUEZ*;
G. CHRISTOPOULOS; C. SHARP; P. FONAGY; R.
MONTAGUE; B. KING-CASAS. Baylor Col. of Med., Michael
E. DeBakey Veterans Affairs Med. Ctr., Univ. of Houston,
Univ. Col. London.
4:00 LLL8 303.8 Perceived intentionality in the harmful
actions of another enhances recruitment of neural circuitry
processing aversive events. M. LILJEHOLM*; S. DUNNE; J.
P. O’DOHERTY. Trinity Col. Dublin, Caltech.
1:00 LLL9 303.9 Eyes on me. An fMRI study of the
effects of social gaze on action control. L. SCHILBACH*;
S. B. EICKHOFF; E. C. CIESLIK; N. SHAH; G. R. FINK;
Sun. PM
K. VOGELEY. Univ. of Cologne, Univ. of Aachen, Res. Ctr.
Juelich.
2:00 LLL10 303.10 Empathetic responses in the insular and
somatosensory cortices are modulated by attentional control.
X. GU*.
3:00 LLL11 303.11 No time to be ethical? K. TAIRYAN; C. A.
FEDERICO; G. H. GLOVER; P. B. REINER*; J. ILLES. Univ.
of British Columbia, Stanford Univ., Univ. British Columbia.
4:00 LLL12 303.12 Rating pain decreases ‘empathic’ brain
activity. E. G. BRUNEAU*; A. PLUTA; R. SAXE. MIT.
1:00 LLL13 303.13  •  A fMRI study of two brain interaction
using a novel dual-head MRI coil system. R. LEE*. Princeton
Univ.
2:00 LLL14 303.14 A neural precursor to individualized first
impressions: N200s predict use of individuating information.
J. T. KUBOTA*; T. A. ITO. Univ. Colorado Boulder.
3:00 LLL15 303.15 Different neural responses result from
imagining being the perpetrator or recipient of morally
valenced actions: An fMRI study. E. C. PORGES*; J.
DECETY. Univ. of Chicago.
4:00 LLL16 303.16 Neural substrates of interpersonal
function in post-traumatic stress disorder. J. EISEMAN*; D.
GRAHAM; B. C. FRUEH; T. KOSTEN; P. CHIU; B. KING-
CASAS. Baylor Col. of Med., Michael E. DeBakey Veterans
Affairs Med. Ctr., Univ. of Hilo.
POSTER
304. Attentional Mechanisms: Neural Studies
Theme F: Cognition and Behavior
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 LLL17 304.1 Modeling the neural generators of
monkey event-related potentials indexing covert shift of
attention. M. S. HOWELL YOUNG*; R. P. HEITZ; J. D.
SCHALL; G. F. WOODMAN. Vanderbilt Univ.
2:00 LLL18 304.2 Neural correlates of variations in event
processing during learning in central nucleus of amygdala.
D. J. CALU*; M. ROESCH; R. Z. HANEY; P. HOLLAND;
G. SCHOENBAUM. Univ. Maryland, Univ. of Maryland Col.
Park, Johns Hopkins Univ.
3:00 LLL19 304.3 Neural signaling in rat amygdala to added
cues and changes in reward during upshift and downshift
unblocking. J. TRAGESER*; G. SCHOENBAUM. Univ. of
Maryland Sch. of Med.
4:00 LLL20 304.4 Modulation of pre-stimulus activity
improves sensory representation in a discrimination task. T.
YOSHIDA*; D. B. KATZ. Brandeis Univ.
Neuroscience 2010  |  Sunday PM  |  137 
1:00 LLL21 304.5 An attentional modulation in area MT in
the macaque that is consistent with the feature similarity gain
model but not the biased competition model of attention. M.
R. DALIRI*; V. KOZYREV; S. TREUE. German Primate Ctr.,
Iran Univ. of Sci. and Technol., Inst. for Res. in Fundamental
Sci. (IPM), Bernstein Ctr. for Computat. Neurosci.
2:00 LLL22 304.6 Resolving attentional competition in the
dorsolateral prefrontal cortex. M. KADOHISA*; P. PETROV;
M. KUSUNOKI; N. SIGALA; H. NILI; D. GAFFAN; J.
DUNCAN. Med. Res. Council, Univ. of Oxford.
3:00 LLL23 304.7 An early salience response in posterior
parietal cortex. F. ARCIZET*; K. MIRPOUR; J. W. BISLEY.
UCLA.
4:00 LLL24 304.8 Optogenetically-evoked cortical
cholinergic transients in mice expressing channelrhodopsin-2
(ChR2) in cholinergic neurons. H. GRITTON*; W. M.
HOWE; V. L. HETRICK; J. D. BERKE; M. SARTER. Univ. of
Michigan.
1:00 LLL25 304.9 Prefrontal cortex gamma oscillations
coincide with transient increases in cholinergic
neurotransmission during attentional performance. M.
SARTER*; H. J. GRITTON; W. M. HOWE; V. L. HETRICK; J.
D. BERKE. Univ. Michigan.
2:00 LLL26 304.10 Prefrontal glutamatergic-cholinergic
interactions in attentional performance: Glutamatergic
transients code cue salience during good but not poor
performance. W. M. HOWE*; M. SARTER. Univ. Michigan.
3:00 LLL27 304.11 Visual search with electrical
microstimulation. N. P. BICHOT; M. T. HEARD; R.
DESIMONE*. McGovern Inst. Brain Res.
4:00 LLL28 304.12 Attention to space and time are separable
and depend on behavioral contingencies in macaque V1. J.
SHARMA*; H. SUGIHARA; M. SUR. MIT & Massachusetts
Gen. Hosp.
1:00 LLL29 304.13 Effects of SC inactivation on covert
selective attention and neuronal activity in MST. R. J.
KRAUZLIS*; A. ZENON. Salk Inst.
2:00 LLL30 304.14 Voluntary attention induces spatial
filtering of visual information in the primate lateral prefrontal
cortex. K. WATANABE*; S. FUNAHASHI. Kyoto Univ.,
Kokoro Res. Ctr., JSPS research fellow.
3:00 LLL31 304.15 Distribution of attentional modulation in
macaque V4 revealed by intrinsic signal optical imaging at
two illuminant wavelengths. H. TANIGAWA*; A. W. ROE.
Vanderbilt Univ.
4:00 LLL32 304.16 Layer-selective attentional selection
signals in macaque anterior cingulate cortex. M. L. BALE*;
I. JANEMI; S. EVERLING; T. WOMELSDORF. Univ. of
Western Ontario, Robarts Res. Inst.
1:00 LLL33 304.17 Selective theta synchronization conveys
attentional control information in macaque anterior cingulate
and ventromedial frontal cortex. I. JANEMI*; M. VINCK;
M. BALE; S. EVERLING; T. WOMELSDORF. The Univ. of
Western Ontario, Ctr. for Neuroscience, Univ. of Amsterdam,
Robarts Res. Inst.
2:00 LLL34 304.18 Neural mechanisms underlying the
allocation of spatial attention in the auditory modality within
the superior colliculus. L. C. POPULIN*; A. Z. RAJALA. Univ.
Wisconsin.
138  |  Society for Neuroscience
3:00 LLL35 304.19 Increase of gamma frequencies during
top-down processing in area V1. T. J. VAN KERKOERLE*;
M. W. SELF; P. R. ROELFSEMA. Netherlands Inst. For
Neurosci., Ctr. for Neurogenomics and Cognitive Res., Free
Univ. Amsterdam.
4:00 LLL36 304.20 Bursting its way to higher visual centers:
How pre-attentional volleys may capture attention? G.
J. MARÍN*; E. DURÁN; C. MORALES; E. SENTIS; C.
GONZALEZ-CABRERA; J. MPODOZIS; J. C. LETELIER.
Facultad De Ciencias, Univ. De Chile.
1:00 LLL37 304.21 The effect of hand position on visual
responses in area V4 neurons. C. PERRY*; S. M. JONES;
J. D. CRAWFORD; M. FALLAH. Ctr. For Vision Res., York
Univ., Canadian Action and Perception Network.
2:00 LLL38 304.22 Variations in gamma-frequency band
oscillatory activity in the nucleus accumbens predict reward
expectancy but not impulsivity. P. D. RICH; T. HOLTZMAN;
P. RUTHER; J. W. DALLEY*. Univ. Cambridge, Inst. fur
Mikrosystemtechnik.
3:00 LLL39 304.23 Neural mechanisms underlying
visual neglect. W. H. BARNES*; M. MUELLER; R. A. W.
GALUSKE. Max Plank Hirnforschun, Technische Univ.
Darmstadt, Technische Univsersitaet Darmstat, Max Planck
Inst. for Brain Res.
4:00 LLL40 304.24 Cross-cortical neural interactions
between the vlpfc & somatosensory cortex during a feature
attention task. M. GOMEZ-RAMIREZ*; N. TRZCINSKI; S. S.
HSIAO. Johns Hopkins Univ.
1:00 LLL41 304.25 Visual search patterns of rhesus
macaques: In the eyes of the beholder. A. L. MILLS*;
A. BARCZAK; V. TARTTER; Y. KAJIKAWA; C. E.
SCHROEDER. Nathan Kline Insit, The City Col. Of New
York, New York Univ. Sch. of Med., Nathan Kline Inst.,
Columbia Univ. Col. of Physicians and Surgeons.
2:00 LLL42 304.26 The chemoarchitecture of the avian
“prefrontal cortex” - A receptor autoradiographic study.
C. HEROLD*; K. ZILLES; C. THEISS; B. HELLMANN; S.
KRÖNER; O. GUNTURKUN; N. PALOMERO-GALLAGHER.
Heinrich-Heine Univ. Düsseldorf, C.&O.-Vogt Inst. For
Brain Res., Inst. of Medicine, Res. Ctr. Jülich, Dept. of
Cytology, Fac. of Medicine, Ruhr-University Bochum,
Dept. of Biopsychology, Inst. of Cognitive Neuroscience,
Fac. of Psychology, Ruhr-University Bochum, Dept. of
Neurosciences, Med. Univ. of South Carolina.
POSTER
305. Reward: Drug Motivational Mechanisms
Theme F: Cognition and Behavior
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 LLL43 305.1 Moderate cocaine exposure results in
inappropriate incentive learning via mu opioid receptor-
related processes in the basolateral amygdala. K. M.
WASSUM*; I. C. CELY; B. W. BALLEINE; N. T. MAIDMENT.
UCLA, Brain Res. Institute, Univ. of California Los Angeles,
Univ. of Sydney.
2:00 LLL44 305.2 T-type calcium channel antagonism
decreases motivation for nicotine and blocks nicotine-
and cue-induced reinstatement for a response previously
associated with nicotine self-administration. J. M.
USLANER*; J. VARDIGAN; J. DROTT; V. UEBELE; J.
RENGER; A. LEE; Z. LI; A. LE; P. HUTSON. Merck & Co.
Inc, Ctr. for Addiction and Mental Hlth.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
3:00 LLL45 305.3 Pharmacokinetic sampling during cocaine
self-administration studies in the rat and pharmacokinetic-
pharmacodynamic modelling of the exposure-response
relationship. E. R. DUNN-SIMS*; A. N. MEAD; A. WARR;
E. C. O’CONNOR; P. BUTLER; D. FAIRMAN; P. VAN DER
GRAAF; A. HOOKER; M. O. KARLSSON. Pfizer Limited,
Uppsala Univ.
4:00 LLL46 305.4  •  Pharmacological inhibition of dopamine
beta-hydroxylase blocks cocaine-primed reinstatement of
drug seeking in rats. D. A. COOPER*; J. P. SCHROEDER; J.
R. SCHANK; M. A. LYLE; M. GAVAL-CRUZ; N. POZDEYEV;
P. M. IUVONE; D. WEINSHENKER. Emory Univ.
1:00 LLL47 305.5 The behavioural/dopamine stabilizers
(-)OSU6162 and ACR16 block amphetamine induced
locomotor sensitization. R. D. COPPA-HOPMAN*; K.
NOBLE; S. KAPUR; J. N. NOBREGA; P. J. FLETCHER.
CAMH, Ctr. for Addiction and Mental Hlth., Univ. of London,
Ctr. for Addiction and Mental Health, Univ. of Toronto.
2:00 LLL48 305.6 Flavor cues and nicotine self-
administration. P. E. GREBENSTEIN; N. E. ROWLAND*.
Univ. Florida.
3:00 LLL49 305.7 The beta-carboline, FG7142, produces
anxiogenic behavior, but fails to induce reinstatement to
cocaine-seeking in rats. R. P. WATERS*; R. E. SEE. Med.
Univ. of South Carolina.
4:00 LLL50 305.8 Fos expression after exposure to social
and nicotine reward-conditioned environments. N. A.
PEARTREE*; A. WILLIAMS; L. E. HOOD; K. J. THIEL; J. L.
NEISEWANDER. Arizona State Univ.
1:00 LLL51 305.9   Amphetamine modulates BOLD
response in primary visual cortex: Drug and reward effects
on V1 in healthy volunteers. R. SHAH; U. S. CLARK; L. H.
SWEET; T. L. WHITE*. Brown Univ.
2:00 LLL52 305.10 Rewarding and aversive effects of intra-
ventral tegmental area nicotine produce opposite patterns
of neuronal encoding patterns in the shell of the nucleus
accumbens. N. SUN; H. TAN*; S. R. LAVIOLETTE. Univ. of
Western Ontario.
3:00 LLL53 305.11 Nicotine and COMT Val158Met genotype
regulate activation to rewarding stimuli in a cortico-striatal
network. C. GALLEN*; M. P. SCHROEDER; T. J. ROSS; M.
ENOCH; C. HODGKINSON; D. GOLDMAN; E. STEIN; M. R.
LEE. NIDA - IRP, NIH, Northwestern Univ., NIAAA - IRP, NIH.
4:00 LLL54 305.12 Hypofunction of the NMDA receptor and
NR2B subunit within the prelimbic cortex amplifies opiate
reward encoding by switching on a dopamine-dependent
neural reward pathway: Evidence for a cortical opiate
addiction switching mechanism. H. TAN; N. M. LAUZON; S.
F. BISHOP; S. R. LAVIOLETTE*. Univ. of Western Ontario.
1:00 LLL55 305.13 The medial preoptic area influences
cocaine-induced activity in the ventral tegmental area. D. J.
TOBIANSKY*; T. HATTORI; J. M. DOMINGUEZ. The Univ. of
Texas.
2:00 LLL56 305.14 Attenuated effects of experimenter-
administered heroin in periadolescent vs. adult male rats:
Locomotor sensitization and somatic signs of withdrawal. J.
M. DOHERTY*; P. DUNIGAN; A. LEE; B. WILLIAMS; K. J.
FRANTZ. Georgia State Univ.
3:00 LLL57 305.15 Effects of housing on morphine
conditioned-taste aversion on F344 and Lewis rats. T. J.
BRENNAN; I. GRAKALIC*; M. A. GOMEZ-SERRANO.
American Univ., NIH/NIAAA.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
4:00 LLL58 305.16 Examination of addictive behavior in rats
selectively bred for response to novelty. S. B. FLAGEL*;
P. LEE; L. MAYO; K. MILLS; J. GARCIA-FUSTER; P.
BLANDINO; S. M. CLINTON; S. J. WATSON; T. E.
ROBINSON; H. AKIL. Univ. Michigan, Univ. of Michigan.
1:00 LLL59 305.17 Synthesis of 3,4,5-trimethoxycinnamic
acid derivatives and evaluation of their anti-narcotic effect. S.
OH*; Y. LEE; S. MOON; J. JUNG; Y. LEEM. Ewha Womans
Univ, Sch. of Med.
POSTER
Sun. PM
306. Motivation and Emotion: Neurocircuitry of Decision
Making II
Theme F: Cognition and Behavior
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 LLL60 306.1 Functional neuroimaging of behavioral
flexibility in the context of certain versus uncertain outcomes.
A. D’CRUZ*; M. MOSCONI; M. RAGOZZINO; J. A.
SWEENEY. Univ. of Illinios at Chicago, Univ. of Illinois at
Chicago.
2:00 LLL61 306.2 Electrophysiological response to emotion
and executive functions. R. C. MCINTOSH*; M. ROSSELLI;
J. L. TARTAR; A. J. NASH. Florida Atlantic Univ., Nova
Southeastern Univ.
3:00 LLL62 306.3 A neural circuit model of decision-making
in insects. Z. WU*; A. GUO. Inst. of Biophysics, Chinese
Acad. of Sci., Inst. of Neuroscience, Chinese Acad. of Sci.
4:00 LLL63 306.4 Localized microstimulation of macaque
pregenual anterior cingulate cortex increases rejection of
cued outcomes in approach-avoidance decision-making. K.
AMEMORI*; A. M. GRAYBIEL. MIT.
1:00 LLL64 306.5 The utility of a smile: A comparison of
social and monetary value in affective decision-making. E.
A. HEEREY*; D. M. SHORE. Bangor University, Sch. of
Psychology.
2:00 LLL65 306.6 Dissociation of attention and emotion-
related neural activity in the nuclei of the primate amygdala.
C. P. MOSHER*; P. E. ZIMMERMAN; K. M. GOTHARD.
Univ. Arizona, Coll Med.
3:00 LLL66 306.7 Does the use of tactile stimulation by
cleanerfish has a role on its client fish stress response? M.
SOARES*; R. OLIVEIRA; A. GRUTTER; R. BSHARY. Inst.
Superior De Psicologia Aplicada, Univ. de Neuchâtel, Univ.
of Queensland.
4:00 LLL67 306.8 Disconnection of monkey orbitofrontal
and rhinal cortex impairs assessments of motivational value.
A. M. CLARK*; S. BOURET; A. M. YOUNG; E. A. MURRAY;
B. J. RICHMOND. Natl. Inst. of Mental Hlth.
1:00 LLL68 306.9 The BOLD response in the nucleus
accumbens quantitatively represents a reward prediction
error. E. J. DEWITT*; P. W. GLIMCHER. New York Univ.
2:00 LLL69 306.10 Differential effects of discrete subarea-
specific transient inactivation of the medial prefrontal cortex
on the motivated choice of pup- versus cocaine-associated
environments by early postpartum rats. M. PEREIRA*; J. I.
MORRELL. Rutgers, The State Univ. of New Jersey.
3:00 LLL70 306.11 Neuronal encoding of decision value
and goal value in the orbitofrontal cortex. C. PADOA-
SCHIOPPA*. Washington Univ.
Neuroscience 2010  |  Sunday PM  |  139 
4:00 MMM1 306.12 The “dark basement” of the moral 4:00 MMM14 307.8 Gaze following and anticipation in the
brain. Conflict-dependent dynamic of subthalamic nucleus scanpaths of monkeys viewing videos with social content.
oscillations during a moral decision task. M. FUMAGALLI; G. K. M. GOTHARD*; P. E. ZIMMERMAN; M. T. STIB; K. M.
GIANNICOLA; M. ROSA; S. MARCEGLIA; C. LUCCHIARI; FARSHAD; C. P. MOSHER. Univ. Arizona, Col. Med.
S. MRAKIC-SPOSTA; R. FERRUCCI*; D. SERVELLO; C.
1:00 MMM15 307.9 Individual differences in habituation
PACCHETTI; M. PORTA; A. FRANZINI; A. ALBANESE; G.
of visual exploration and facial expression reciprocation
PRAVETTONI; S. BARBIERI; A. PRIORI. Univ. degli Studi di
in monkeys looking at videos with social content. P. E.
Milano, Fondazione IRCCS Ca’ Granda, Ospedale Maggiore
ZIMMERMAN*; C. P. MOSHER; K. M. FARSHAD; M. T.
Policlinico, IRCCS Galeazzi, IRCCS Inst. Neurologico
STIB; K. M. GOTHARD. Univ. of Arizona.
Mondino, Fondazione IRCCS Inst. Neurologico Carlo Besta.
2:00 MMM16 307.10 Toward an animal model of consolation
1:00 MMM2 306.13 Putamen neurons predict primate’s
using monogamous prairie voles. J. P. BURKETT*; D. C.
preferences in a motivated choice learning task.
CHOI; L. J. YOUNG. Emory Univ., Yerkes Natl. Primate Res.
T. BORAUD*; S. LAQUITAINE; D. HANSEL; Y.
Ctr.
LOEWENSTEIN. CNRS - Univ. Bx2, Hebrew Univ.
3:00 MMM17 307.11 Mapping the adolescent mouse social
2:00 MMM3 306.14 Ventromedial prefrontal cortex shapes
brain with F18-flurodeoxyglucose. J. B. PANKSEPP*; G. P.
responses of nucleus accumbens shell neurons to suppress
LAHVIS. Oregon Hlth. and Sci. Univ.
unreinforced actions. A. GHAZIZADEH*; F. AMBROGGI; H.
L. FIELDS. Ernest Gallo Clin. & Res. Ctr. 4:00 MMM18 307.12 Up-regulation of GluR1 subunit protein
in the ventral tegmental area in male prairie voles: A role
3:00 MMM4 306.15 The difference in BOLD signal between
in pair-bonding? Y. CHEN*; J. T. CURTIS. Oklahoma State
goods predicts the likelihood of stochastic choice. S. C.
Univ.
LAZZARO*; R. B. RUTLEDGE; D. BURGHART; I. LEVY; P.
W. GLIMCHER. New York Univ., Yale Sch. of Med. 1:00 MMM19 307.13 Amygdala activation to erotic stimuli
in men, women, and women with androgen insensitivity
4:00 MMM5 306.16 Neuroeconomic decision-making is
syndrome. S. B. HAMANN*; J. WILSON; J. HASSETT; K.
altered following damage to anterior but not posterior insular
BRYK; C. QUIGLEY; S. BERENBAUM; K. WALLEN. Emory
cortex. K. CHEN*; T. R. KOSCIK; D. TRANEL. Univ. of Iowa.
Univ., The Pennsylvania State Univ., Indiana Univ.
1:00 MMM6 306.17 Different representation of action
2:00 MMM20 307.14 Emotional dyadic interactions - The
command in dorsolateral, dorsomedial, and ventral striatum
effect of incongruent mimic or speech content. C.
in decision making tasks. M. ITO*; K. DOYA. Okinawa Inst.
REGENBOGEN*; D. A. SCHNEIDER; T. KELLERMANN;
of Sci. and Technol., ATR.
F. SCHNEIDER; U. HABEL. Dept. of Psychiatry and
Psychotherapy.

POSTER 3:00 MMM21 307.15 Helping a cagemate in need: Empathy

and pro-social behavior in rats. I. BEN-AMI BARTAL*; J.
307. Emotions: Social Communication DECETY; P. MASON. Univ. of Chicago.

Theme F: Cognition and Behavior 4:00 MMM22 307.16 Viewing preferences among ethologically
relevant videos in the rhesus macaque. G. K. ADAMS*; J.
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
PEARSON; M. L. PLATT. Duke Univ.
1:00 MMM7 307.1 Effect of oxytocin on psychoemotional
1:00 MMM23 307.17 Context-dependent emotion recognition
parameters of behavior in rats: Gender differences. M.
in autism. O. TUDUSCIUC*; R. ADOLPHS. Caltech.
BUTSKHRIKIDZE*; N. G. BUKIA; Z. I. NANOBASHVILI.
I.Beritashvili Inst. of Physiol. 2:00 MMM24 307.18 Social interaction: Affective vs.
cooperative. S. F. CAPPA*; F. ALEMANNO; N. CANESSA; N.
2:00 MMM8 307.2  •  Vocalization pattern analysis as a
MANNARA; F. RIVA; A. ZANI; D. PERANI; A. PROVERBIO.
method for classification of emotional states in the common
Vita-Salute Univ. and San Raffaele Scientific Inst., Vita-
marmosets (Callithrix jacchus). H. GOKAN; A. OH-NISHI; H.
Salute San Raffaele Univ., Milano Bicocca Univ., CNR Inst.
ISHII; T. MINAMIMOTO; S. WATANABE; T. SUHARA*. Nat.
of Bioimaging and Mol. Physiol.
Inst. Radiol. Sci., Keio Univ.
3:00 MMM25 307.19 Gender difference in emotional
3:00 MMM9 307.3 Serotonin and playfulness in the juvenile
perception of love in a decision-making task. D. TAM*. Univ.
rat. S. M. SIVIY*; L. M. DERON. Gettysburg Col.
of North Texas.
4:00 MMM10 307.4 Modulating the vocal repertoire of mice
4:00 MMM26 307.20 Minocycline, an antibiotic with inhibitory
with environmental enrichment. V. R. JIMENEZ; G. P.
effects of microglial activation, sharpens sense of trust in
LAHVIS*; J. B. PANKSEPP. Oregon Hlth. and Sci. Univ.
social interaction. T. KATO*; M. WATABE; A. MONJI; H.
1:00 MMM11 307.5 Environmental complexity differentially HORIKAWA; S. KANBA. Dept. of Neuropsychiatry, Grad.
increases positive affect in a rat model of individual Sch. of Med. Sciences, Kyushu Univ., Innovation Ctr. for
differences in novelty seeking. R. SLUSKY; J. GARCIA- Med. Redox Navigation, Kyushu Univ., Waseda Univ.
FUSTER*; S. B. FLAGEL; J. PEREZ; W. ALDRIDGE; S. J.
1:00 MMM27 307.21 Locating empathy in the brain. P. B.
WATSON; H. AKIL. Univ. of Michigan, Univ. of California.
WILLIAMS*; M. SPEZIO; J. BARRAZA; P. J. ZAK. Claremont
2:00 MMM12 307.6 A comparative study of emotion-related Grad. Univ., Scripps Col.
measures in three strains of rats. C. NATUSCH*; R. K. W.
SCHWARTING. Philipps-University of Marburg.
3:00 MMM13 307.7  •  Lust, hunger, and disgust in the human
hypothalamus. J. D. MEIER*; M. S. A. GRAZIANO. Princeton
Univ.

140  |  Society for Neuroscience • Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
POSTER
308. Neuroethology: Vision and Integration
Theme F: Cognition and Behavior
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 MMM28 308.1 Influence of ventral optic flow on distance
estimation in the navigation of desert ants (Cataglyphis
fortis). S. BOLEK*; M. WITTLINGER; H. WOLF. Univ. Ulm
Neurobiologie M25, Univ. of Ulm.
2:00 MMM29 308.2 Celestial navigation in Drosophila. P.
WEIR*; M. H. DICKINSON. California Inst. of Technology.
3:00 MMM30 308.3 Vision-based altitude control in freely
flying Drosophila. F. A. ZABALA*; M. H. DICKINSON.
Caltech.
4:00 MMM31 308.4 Modulation of visual interneurons by
octopamine in Drosophila melanogaster. M. SUVER*; G.
MAIMON; M. H. DICKINSON. Caltech.
1:00 MMM32 308.5 Temporal sensitivity of the ocelli in
Drosophila. M. WITTLINGER*; M. H. DICKINSON. Univ. of
Ulm, Caltech.
2:00 MMM33 308.6 Flying Drosophila asymmetrically move
antennae to enhance visually-evoked turning responses. A.
MAMIYA*; A. D. STRAW; M. H. DICKINSON. Caltech.
3:00 MMM34 308.7 Comparative study of antenna-mediated
escape behaviors in cockroaches and crickets. Y. BABA*; A.
TSUKADA; C. M. COMER. Univ. of Montana, Toyama Natl.
Col. of Maritime.
4:00 MMM35 308.8 Born to run: assessing optimal prey
animal escape decisions with graphical models. J. L.
ZYLBERBERG; M. R. DEWEESE*. Univ. California.
1:00 MMM36 308.9 Frequency dependence of behavioral
responses to prey in the medicinal leech. C. M. HARLEY*; D.
A. WAGENAAR. Caltech.
2:00 MMM37 308.10 Visual acuity of the adult short-tailed
opossum (Monodelphis domestica). J. D. LUU*; L.
KRUBITZER. Univ. of California, Davis.
3:00 MMM38 308.11 Variability in a visual pathway processing
object approach. P. W. JONES*; F. GABBIANI. Baylor Coll
Med.
4:00 MMM39 308.12 Behavioral and electrophysiological
responses to visually perceived stationary objects in leopard
frogs and the role of the anterior thalamus. L. SKORINA;
E. RECKTENWALD; T. MASTERSON; E. R. GRUBERG*.
Temple Univ.
1:00 MMM40 308.13 Head direction cell activity recorded
during alteration of geomagnetic field polarity. V. L.
TRYON; A. A. HOUSH; J. H. PARRISH; S. R. STALEY; W.
DEGRAFFENREID; J. L. CALTON*. California State Univ.
2:00 MMM41 308.14 Simulation of sensory fusion of optical
and hydrodynamic flow in the lobster. D. BLUSTEIN*; J.
AYERS. Northeastern Univ. Marine Sci. Ctr.
• Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
POSTER
309. New Tools for the Study of Neurodegeneration and
Neuroprotection
Theme G: Novel Methods and Technology Development
Sun. 1:00 PM — San Diego Convention Center, Halls B-H
1:00 MMM42 309.1  •  Engineered vegf-a zinc finger activator is
neuroprotective following traumatic cns injury and stroke. S.
K. SPRATT*; P. M. D’ONOFRIO; M. M. MAGHARIOUS; M.
THAYAPARARAJAH; R. SUROSKY; G. LEE; M. GIEDLIN;
D. ANDO; M. FEHLINGS; P. D. KOEBERLE. Sangamo
BioSciences, Univ. of Toronto, Univ. Hlth. Network, Toronto
Wester Res. Inst.
Sun. PM
2:00 MMM43 309.2 Modulation of BMP signaling in
neuroprotection and regeneration via novel recombinant
adeno-associated vectors. A. MICHALSKI*; D. RIDDER;
M. SCHWANINGER; R. SPRENGEL. Max Planck Inst. For
Med. Res., Inst. for Pharmacol., Max-Planck-Institute for Mol.
Neurobio.
3:00 MMM44 309.3  •  Knockout rat models for the study
of Alzheimer’s disease. A. M. MCCOY*; D. JI; Y. WU;
L. LITTLE; J. BOOKS; E. WEINSTEIN; X. CUI. Sigma
Advanced Genet. Engin. Labs.
4:00 MMM45 309.4 Silencing NMDA receptor subunits
through amplicon vectors in vitro reduces Abeta oligomers
binding, and in vivo impairs memory. M. V. BAEZ*; A.
AGUIRRE; M. ADROVER; H. DECKER; M. MELENDEZ;
S. FERREIRA; A. EPSTEIN; D. JERUSALINSKY. Inst. De
Biología Celular Y Neurociencia -IBCN-, Inst. De Biología
Celular y Neurociencia (IBCN) CONICET-UBA, Univ. Federal
do Rio de Janeiro, CGMC, Univ. Claude Bernard, Lyon-1.
1:00 MMM46 309.5  •  Engineered zinc finger protein
transcription factors drive highly specific activation of the
endogenous GDNF gene and functional neuroprotection in
vivo. H. S. ZHANG*; J. LAGANIERE; A. P. KELLS; J. T. LAI;
D. GUSCHIN; D. E. PASCHON; X. MENG; L. K. FONG; Q.
YU; E. J. REBAR; P. D. GREGORY; K. S. BANKIEWICZ;
J. FORSAYETH. Sangamo BioSciences Inc., Univ. of
California, San Francisco.
2:00 MMM47 309.6 A murine dentate gyrus-specific promoter
for use in recombinant adeno-associated virus vectors. D.
ARCOS-DÍAZ*; R. SPRENGEL; P. SEEBURG. Max Planck
Inst. For Med. Res.
3:00 MMM48 309.7 Targeting the RAGE-Ligand signaling
pathway in neurodegenerative disorders. F. CHAN*; B.
ARGYLE. Echelon Biosci. Inc.
4:00 MMM49 309.8 Novel screening system for amyloid β
aggregation inhibitor utilizing amyloid β-conjugated gold
nanoparticle. S. HAN*; Y. CHANG; E. JUNG; I. MOOK-
JUNG. Seoul Natl. Univ.
1:00 MMM50 309.9  •  Biomarkers of CNS injury and
degeneration. G. SHAW*, Dr; C. YANG; Y. WANG; S.
LEWIS; R. TINSLEY; M. HORNE; M. WEISS; M. DOUGLAS-
ESCOBAR; N. RINGGER; S. GIGUERE. McKnight
Brain Inst., Univ. of Florida, EnCor Biotech. Inc, Univ. of
Melbourne, Baylor Col. of Med., Univ. of Georgia.
2:00 MMM51 309.10 Analytical ultracentrifugation (AUC)
of peptides and proteins: Functional implication of
neuroprotective peptides. T. ARAKAWA; T. NIIKURA*; F.
ARISAKA; Y. KITA. Alliance Protein Labs., Simon Fraser
Univ., Tokyo Inst. of Technol., KEIO Univ. Sch. of Med.
Neuroscience 2010  |  Sunday PM  |  141 
3:00 MMM52 309.11 Sustained delivery of HMGB1 A
box via biodegradable gelatin microspheres enhances
neuroprotective effect in the postischemic brain. Y. JIN; S.
KIM; I. KIM; F. CHENG; M. LEE; K. KIM; H. CHOI; J. LEE*.
Inha Univ. Sch. Med., Dept. of Electrical and Computer
Engineering, Univ. of Illinois, Dept. of Bioengineering, Col. of
Engineering, Hanyang Univ.

142  |  Society for Neuroscience • Indicated a real or perceived conflict of interest, see page 143 for details.

Indicates a high school or undergraduate student presenter.
 Conflict of Interest Statements
The following presenters, signified by a dot (•) in the program, indicated a real or perceived conflict of interest.
Presenters listed without a dot in the program had no financial relationships to disclose.
Abstract
Number Statement
110 J.S. Takahashi, ReSet Therapeutics, Inc.; ReSet
Therapeutics, Inc..
111.2 E. Donny, Global Research Award on Nicotine Dependence
(Pfizer), Research Grant; Varenicline donated from Pfizer,
Other Research Support.
113 T.F. Franke, NYU School of Medicine, Employment; NIH,
Research Grant; NSF, Research Grant; NARSAD, Research
Grant; G. Harold & Leila Y. Mathers Foundation, Research
Grant; Rockland Immunochemicals, Consultant/Advisory
Board; Abcam, Consultant/Advisory Board.
113 D.R. Weinberger, IRP, NIMH, NIH, A. Employment (full or
part-time).
113.2 J. Kim, John Hopkins University School of Medicine, A.
Employment (full or part-time).
113.3 A.J. Law, IRP, NIMH, NIH A; NARSAD B;
113.4 C.A. Hoeffer, New York University A;
113.6 A.R. Davis, Vanderbilt University A;
113.7 J. Beaulieu, Université Laval, Employment; CIHR, Research
Grant; NARSAD, Research Grant; NSERC, Research Grant;
FQRNT, Research Grant.
115.2 J.W. Westra, Genstruct Inc., A. Employment (full or part-time).
118.7 J. Price, Prof. Jack Price acted as a consultant and received
payment from ReNeuron group within the last 2 years,
Consultant/Advisory Board.
121.5 J.A. Rogers, MC10, Ownership Interest; B. Litt, MC10,
Startup company that has licensed our patents, Consultant/
Advisory Board.
122.10  R.A. Anderson, Integrity Nutraceuticals, Other Research
Support.
122.11 R.M. Adibhatla, University of Wisconsin, Employment; J.F.
Hatcher, University of Wisconsin, Employment.
127.9 M.L. Furey, pending use-patent for scopolamine as an
antidepressant, Ownership Interest; W.C. Drevets, pending
use-patent for scopolamine as an antidepressant, Ownership
Interest.
128.3 C.F. Benjamin, Children’s Hospital Boston, Employment;
Harvard Medical School, Employment; M. Lee, Children’s
Hospital Boston, Employment.
128.8 K.J. Kawabata Duncan, BBSRC, Research Grant; C.J.
Price, Wellcome Trust, Research Grant.
129.3 T. Robbins: Consultant/Advisory Board; Cambridge
Cognition. L. Clark: Cambridge Cognition.
129.8 H. Yamada, THE UEHARA MEMORIAL FOUNDATION
Research fellow, Other Research Support.
131.13 T. Ishizuka, Smoking Research Foundation, Research Grant;
Y. Watanabe, Smoking Research Foundation, Research
Grant.
132.2 P.C. Letourneau, National Institutes of Health, Research
Grant.
134.16 L.P. Bogdanik, NIH R01 NS054154, Research Grant;
Muscular Dystrophy Association - Postdoc Fellowship, Other
Research Support; Myasthenia Gravis Foundation - Postdoc
Fellowship, Other Research Support; R.W. Burgess, NIH R01
NS054154, Research Grant.
136.5 D.B. Edelman, Neurosciences Research Foundation, Other
Research Support
137.18 A. Kulik, DFG: SFB 780 A2, Research Grant.
138.1 W.S. Messer, Dr. William Messer holds several patents on
muscarinic agonists. He is the Chief Scientific Officer for and
has financial interest in Mithridion, Inc., Madison WI/Toledo
OH., Ownership Interest.
138.10 P.J. Savelkoul, Danone Research, Employment; M.M.
Merkes, Danone Research, Employment; A.A. Kuipers,
Danone Research, Employment; R.J.J. Hageman, Danone
Abstract
Number Statement
Research, Employment; L.M. Broersen, Danone Research,
Employment; EU FP7 LipiDiDiet, No 211696, Research Grant;
V. Dolezal, EU FP7 LipiDiDiet No 211696, Research Grant;
P.J. Kamphuis, Danone Research, Employment.
139.2 T. Takasusuki, NIH DA02110, Research Grant; T.L. Yaksh,
NIH DA02110, Research Grant.
139.24 E. Carbone, EC project CavNET (MRTN-CT-2006-035367),
Research Grant.
141.18 A.C.S. Costa, Forest Pharmaceuticals Inc., Other Research
Support.
142.4 M.P. Inderbitzin, European Community Seventh Framework
Programme (FP7/2007-2013) EU SYNTHETIC FORAGER
(FP7-217148) and EU RENACHIP (FP7-ICT-2007.8.3 FET
BIO-ICT Convergence), Other Research Support.
142.11 T. Aihara, MEXT, GCOE (17021036), Research Grant.
142.16 C. Itami, Grant-in-Aid for Scientific Research from MEXT,
Research Grant; Narishige Neuroscience Research
Foundation, Other Research Support; F. Kimura.
143.1 T. Murakami, Alexander von Humboldt foundation, Research
Grant.
143.9 Q. Hou, MH079407 to HY.M., Research Grant; H. Man,
MH079407 to HY.M., Research Grant.
144.1 N. Mellios, NIH grants EY017098, EY007023, Research
Grant; NEI postdoc fellowship 1F32EY020066-01, Other
Research Support; M. Sur, NIH EY017098 and EY 007023,
Research Grant.
144.5 N.R. Smalheiser, Jean Young and Walden W. Shaw
Foundation, NIH (Autism Center of Excellence P50
HD055751), and the Stanley Medical Research Institute,
Research Grant.
145.3 L. Diggins, Vitruvean, LLC, Employment.
145.13 H. Lee, “This study was supported by a research grant
from the Ministry of Education, Science and Technology
(KGC5401011), Republic of Korea”, Research Grant.
145.17 L.C. Johnston, Alzheimer’s drug discovery foundation,
Research Grant; C.E. Bond, The James Martin 21st Century
School Foundation, Other; S.A. Greenfield, Alzheimer’s drug
discovery foundation, Research Grant.
147.4 M.E. Modi, A patent for the use of Melanotan II in conjunction
with behavioral therapy for the treatment of autism has
been applied for by the authors., Ownership Interest; L.J.
Young, A patent for the use of Melanotan II in conjunction
with behavioral therapy for the treatment of autism has been
applied for by the authors., Ownership Interest.
147.5 W.E. Crusio, March of Dimes, Research Grant; S.
Pietropaolo, March of Dimes, Research Grant.
147.6 C. April, Illumina, Inc., Employment; Illumina, Inc., Ownership
Interest; J. Fan, Illumina, Inc., Employment; Illumina, Inc.,
Ownership Interest.
147.7 U. Rajamma, Fellowship from CSIR, Govt. of India, Research
Grant.
147.10 V. Brown-Kennerly, Sigma Advanced Genetic Engineering
Lab, Sigma-Aldrich, Employment; J. Books, Sigma Advanced
Genetic Engineering Labs, Sigma-Aldrich, Employment; D. Ji,
Sigma Advanced Genetic Engineering Labs, Sigma-Aldrich,
Employment; L. Little, Sigma Advanced Genetic Engineering
Labs, Sigma-Aldrich, Employment; Y. Wu, Sigma Advanced
Genetic Engineering Labs, Sigma-Aldrich, Employment; E.
Weinstein, Sigma Advanced Genetic Engineering Labs,
Sigma-Aldrich, Employment; X. Cui, Sigma Advanced Genetic
Engineering Labs, Sigma-Aldrich, Employment.
148.1 Z. Teng, NIH, Research Grant; IRSF, Research Grant; X.
Zhao, Corresponding author, Other.
149.5 B. Philpot, Carolina Institute for Developmental Disabilities,
Other Research Support.
Neuroscience 2010  |  Sunday Conflict of Interest Statements  |  143 
Abstract
Number Statement
150.2 V.N. Uebele, Merck and Co. Inc. (USA), Employment; J.J.
Renger, Merck and Co. Inc. (USA), Employment.
150.13 B.J. Gluckman, NIH R01NS065096, Research Grant.
151.4 M.J. Lehmkuhle, Epitel INC, Ownership Interest; F. Dudek,
Epitel, INC, Ownership Interest.
152.7 M. Murugan, National University of Singapore, Employment;
National Medical Research Council, Singapore, Research
Grant; C. Kaur, National University of Singapore, Singapore,
Employment; National Medical Research Council, Singapore,
Research Grant.
152.9 N.J. Rothwell, AstraZeneca, Consultant/Advisory Board.
153.1 J. Kim, 1. BK21 Project for Medical Science, Anatomy,
Yonsei Univ., Col. of Med., Seoul, South Korea, Employment;
2. Department of Anatomy, Yonsei University College
of Medicine, Seoul, Korea, Employment; This work was
supported by ‘System IC 2010’ project of Korea ministry of
Commerce, Industry and Energy., Research Grant.
153.6 W. Zhu, NS49210, NS20020, NS054684, NR03521,
Research Grant; S.J. Murphy, NS49210;NS20020;NS054684
;NR03521, Research Grant.
153.9 J. Liang, Yale University, Employment; National Institutes
of Health (HD-34852 and AT-004422) and American Hear
Association (0755993T)., Research Grant.
153.12 H.K. Suh-Kim, CBM33-A2300-01-00-00, Research Grant.
153.21 P.A. Lapchak, NINDS NS060685, Research Grant;
Simvastatin was a gift from Chong Kun Dang Pharmaceutical
Co., Ltd (Seoul, South Korea)., Other.
153.26 B. Zlokovic, B.V.Z. is the scientific founder of ZZ Biotech,
LLC, a startup biotechnology company, Other.
154.9 Y. Al-Abed, YAA is an inventor of certain MIF inhibitors that
are in pre-clinical development., Other.
154.13 K.D. Nantwi, NIH NS065397, Research Grant.
155.13 K. Spratt, Sangamo Biosciences Ltd., Employment; D.
Ando, Sangamo Biosciences Ltd., Employment; R. Surosky,
Sangamo Biosciences Ltd., Employment; G. Lee, Sangamo
Biosciences Ltd., Employment; M. Giedlin, Sangamo
Biosciences Ltd., Employment.
155.14 F. Renault-Mihara, Roche-Chugai company, Other Research
Support.
156.6 Z. Wang, “973” and NSFC, Research Grant.
156.15 H. Yang, Grant 2009K001285 from Brain Research Center of
the 21st Century Frontier Research Program funded by the
Ministry of Science, the Republic of Korea., Research Grant;
Y.C. Kim, Grant 2009K001285 from Brain Research Center
of the 21st Century Frontier Research Program funded by the
Ministry of Science, the Republic of Korea, Research Grant.
157.17 K. Hirata, Toyama Chemical Co. Ltd., Employment.
157.18 N. Srivastava, Millipore, Employment; F.A. Ahmadi,
Millipore, Employment; K. Long, Millipore, Employment; M.
Kunis, Millipore, Employment; W. Speckmann, Millipore,
Employment.
159.3 M.K. Stachowiak, SUNY Buffalo, Employment; NYSTEM,
Rett syndrome foundation, Research Grant; M. Bencheriff,
Targacept Inc, Employment.
159.7 M. Mavrikaki, Maria Mavrikaki was supported by a
scholarship from Alexander S. Onassis Public Benefit
Foundation., Other
159.13 W. Gao, Drexel University College of Medicine, Employment;
NIH R01 grant MH232395, Research Grant; NIH R21 grant
MH232307, Other Research Support.
159.16 S.L. Rushforth, Johnson and Johnson, Beerse, Belgium,
Research Grant; E.L. Malcolm, Johnson and Johnson,
Beerse, Belgium, Research Grant; A.S.J. Lesage, Johnson
and Johnson, Beerse, Belgium, Employment; F.E.N. LeBeau,
Johnson and Johnson, Beerse, Belgium, Research Grant;
T. Steckler, Johnson and Johnson, Beerse, Belgium,
Employment; M. Shoaib, Johnson and Johnson, Beerse,
Belgium, Research Grant.
159.17 N. Richtand, Ortho-McNeil Janssen Scientific Affairs, LLC,
Other Research Support.
144  |  Society for Neuroscience
Abstract
Number Statement
159.21 D.B. Timmermann, Neurosearch A/S, Employment; D.
Peters, Neurosearch A/S, Employment; H.H. Hansen,
Neurosearch A/S, Employment; J.D. Mikkelsen, Danish
MRC, Research Grant.
159.22 S.W. Jones, Repligen Corp, Employment; S.T. Carreiro,
Repligen Corp, Employment; J.R. Rusche, Repligen Corp,
Employment.
160.2 T. Kircher, research grants from Pfizer and Lundbeck,
Research Grant; fees for educational programs from Janssen-
Cilag, Eli Lilly, Servier, Lundbeck, Bristol Myers Squibb, Pfizer,
and Astra-Zeneca; travel support/sponsorship for congresses
from Servier, Other Research Support; speaker’s honoraria
from Janssen-Cilag, Speakers Bureau/Honoraria; A. Ströhle,
educational grants by the Stifterverband für die Deutsche
Wissenschaft, the Berlin Brandenburgische Akademie der
Wissenschaften, the Boehringer Ingelheim Fonds and the Eli
Lilly International Foundat, Research Grant; research funding
from the German Federal Ministry of Education and Research,
the European Commission (FP6) and Lundbeck, Other
Research Support; speaker honoraria from Pfizer, Eli Lilly &
Co, Wyeth and Lundbeck, Speakers Bureau/Honoraria.
160.9 A. Leow, Community Psychiatry Associates, Employment.
162.2 E. Ngo Bum, University of Ngaoundéré, Cameroon,
Employment.
162.6 E. Koch, employed, Employment; M. Noeldner, employed,
Employment.
162.7 B.P. Godsil, Institute de Recherches Internationales
SERVIER I.R.I.S. (France), Other Research Support; M.
Spedding, Servier, Employment; T.M. Jay, Institute de
Recherches Internationales SERVIER I.R.I.S. (France), Other
Research Support.
162.8 K. Takahama, Grant-in-Aid for scientific Research (B) from
Japanese Society for the Promotion of Science (JSPS),
Research Grant.
162.11 J. Raber, R01 MH77647, Research Grant; R.M. Duvoisin,
MH77647, Research Grant; L. Villasana, MH77647,
Research Grant; T. Pfankuch, MH77647, Research Grant;
H.B. Gossnel, MH77647, Research Grant; D. Winder,
MH77647, Research Grant.
162.14 A.M. Schuwald, Dr. Willmar Schwabe Pharmaceuticals,
Karlsruhe, Germany, Other; M. Nöldner, Dr. Willmar Schwabe
Pharmaceuticals, Karlsruhe, Germany, Employment; W.E.
Müller, Dr. Willmar Schwabe Pharmaceuticals, Karlsruhe,
Germany, Research Grant.
162.17 S.K. Leonard, Pfizer Neuroscience, Employment; P.
Dollings, Pfizer Neuroscience, Employment; M.A.
Olsen, Pfizer Neuroscience, Employment; C.N. Bender,
Pfizer Neuroscience, Employment; A.M. Gilbert, Pfizer
Neuroscience, Employment; E. McKillip, Pfizer Screening
Sciences, Employment; V. Soloveva, Pfizer Screening
Sciences, Employment; A. Perihar, Pfizer Screening
Sciences, Employment; J. LaRocque, Pfizer Screening
Sciences, Employment; J. Dunlop, Pfizer Neuroscience,
Employment; J. Paslay, Pfizer Screening Sciences,
Employment; R.H. Ring, Pfizer Neuroscience, Employment.
163.9 G.F. Koob, The Scripps Research Institute, Employment; O.
Deschaux, The Scripps Research Institute, Employment.
164.7 D.C. Mash, DA006227, Research Grant; J. Pablo,
DA006227, Research Grant; X. Xie, DA006227, Research
Grant; J. ffrench-Mullen, Genelogic Inc, Employment.
165.1 N.N. Sakellaridis, GGET PENED grant 03ΕΔ778, Research
Grant; D. Mangoura, GGET PENED grant 03ΕΔ778,
Research Grant.
166.6 B. Jansone, University of Latvia, Employment.
166.7 M. Kabbaj, 1 R21 MH083128-01A2, Research Grant; 1 R01
DA019627-01, Research Grant.
166.10 D.E. Grigoriadis, DEG is a full time employee of Neurocrine
Biosciences, Employment.
166.11 M.C. Carrillo, Northeastern University, Employment; NSF
0909854, Research Grant; L. Ricci, Northeastern University,
Employment; NSF 0909854, Research Grant; R. Melloni,
Northeastern University, Employment; NSF 0909854,
Abstract
Number Statement
Research Grant.
166.15 J.A. Mechanic: Employment; Trigemina, Inc.. Research
Grant; NIDA. Ownership Interest; Trigemina, Inc. D.R.
Jacobs: Trigemina, Inc.. Consultant/Advisory Board;
Trigemina, Inc. C. Pascual: Employment; Trigemina, Inc..
Research Grant; NIDA. Ownership Interest; Trigemina,
Inc. M.S. Angst: Trigemina, Inc.. Consultant/Advisory
Board; D.C. Yeomans: Ownership Interest; Trigemina, Inc..
Consultant/Advisory Board; Trigemina, Inc..
166.19 S. Sutton: Employment; Johnson & Johnson PR&D. J.
Shelton: Johnson & Johnson PR&D. R. Galici: Johnson &
Johnson PR&D. J.R. Shoblock: Johnson & Johnson PR&D.
B. Lord: Johnson & Johnson PR&D. C. Dugovic: Johnson &
Johnson PR&D. P. Bonaventure: Johnson & Johnson PR&D.
T. Lovenberg: Johnson & Johnson PR&D.
167.1 O.H. Schroeder, NeuroProof GmbH, Ownership Interest;
J. Schimmel, NeuroProof GmbH, Employment; K. Jügelt,
NeuroProof GmbH, Employment; L. Weber, OntoChem
GmbH, Ownership Interest; A. Gramowski, NeuroProof
GmbH, Ownership Interest.
167.8 A.C. Yu, National Natural Science Foundation of China
(30670644-30870818) and Beijing Natural Science
Foundation (7091004), Research Grant
168.3  M.E. Bardgett, Received JNJ10181457 from Johnson &
Johnson Pharmaceutical Research and Development, Other
Research Support.
168.10 N.S. Corral-Frias, GIDP in Neuroscience, Employment;
CONACyT, Research Grant.
168.16 T.J. Zarcone, Receives royalties from Bioanalytical Systems,
Inc. on the sale of the “Actimeter”, Other; S.C. Fowler,
Receives royalties from Bioanalytical Systems, Inc. on the
sale of the “Actimeter”, Other.
168.18 G.A. Higgins, CanCog Technologies Inc., Employment; L.
Silenieks, CanCog Technologies Inc., Employment; W. Lau,
CanCog Technologies Inc., Employment; S. Thevarkunnel,
CanCog Technologies Inc., Employment; A. Henderson,
AMRI, Employment; N. Moore, AMRI, Employment.
168.19 G.A. Higgins, CanCog Technologies, Employment; L.
Silenieks, CanCog Technologies, Employment; P.J. Fletcher,
CIHR, Research Grant.
168.24 V. Kandikere, Suven Life Sciences Ltd, Employment.
168.25 D. Shanmuganathan, Suven Life Sciences Ltd, Employment.
169.2 G. Lixia: Employment; Department of Rehabilitation Sciences,.
Research Grant; Hong Kong Research Grants Council
(PolyU5610/09M). Consultant/Advisory Board; jufanghe.
169.5 X. Li, The Hong Kong Polytechnic University, Employment;
Hong Kong Research Grants council (PolyU5610/09M),
Research Grant; Croucher Foundation, Other Research
Support.
169.6 E. Emmerich, BGN, Research Grant; M. Engelmann, BGN,
Research Grant; F. Richter, BGN, Research Grant.
169.13 P.E. Bestelmeyer: Employment; University of Glasgow,
Department of Psychology, Centre for Cognitive
Neuroscience. Research Grant; co-funded by ESRC/MRC;
RES-060-25-0010. D.R. Ladd: Employment; University of
Edinburgh, School of Philosophy, Psychology and Language
Science. P. Belin: University of Glasgow, Department of
Psychology, Centre for Cognitive Neuroscience, BRAMS,
Universities of Montreal and McGill.
169.15 M.V. Sanchez-Vives, MICINN, Research Grant; J. Abolafia,
FPI fellowship from MICINN, Research Grant.
170.24 M.P. Kilgard, MicroTransponder, Research Grant;
MicroTransponder, Ownership Interest; MicroTransponder,
Consultant/Advisory Board; N.D. Engineer,
MicroTransponder, Employment.
171.7 R.M. Douglas, CerebralMechanics, Ownership Interest; G.T.
Prusky, CerebralMechanics, Ownership Interest.
174.6 L. Cao, Pfizer Ltd. Global R&D, Employment; E. Stevens,
Pfizer Ltd. Global R&D, Employment.
174.11 A.S. Calamari, Merck & Co., Inc., Employment; E. Crown,
Merck & Co., Inc., Employment; S. Kane, Merck & Co., Inc.,
Abstract
Number Statement
Employment; C. Salvatore, Merck & Co., Inc., Employment.
175.11 N. Kiguchi, KAKENHI (19659404, 21791469), Research
Grant.
175.16 M. Chacur, FAPESP 07/58136-4;10/00570-3, Research
Grant; IASP Early Career Grant ;scan|design foundation BY
INGER & JENS BRUUN., Other Research Support.
175.22 S. Datta, Department of Veterans Affairs Merit Review Entry
Program, Research Grant; R. Wiley, chief Scientific Officer,
Advanced Targeting Systems, Other.
176.13 B.A. Winkelstein, The Center for Child Injury Prevention
Research, Other Research Support.
177.2 M. Ohishi, JSPS, Research Grant; T. Maeda, JSPS,
Research Grant; F. Harada, JSPS, Research Grant.
179.2 D.W.H. Mang, Michael Smith Foundation of Health Research,
Research Grant; G.P. Siegmund, MEA Forensic Engineers &
Scientist, Employment; ; J. Blouin, Michael Smith Foundation
of Health Research, Research Grant; Canada Foundation for
Innovation, Research Grant.
179.14 S. Sugino, This study was partly supported by Grants-in-Aid
for Scientific Research from the Ministry of Education, Culture
and Science of Japan (#20659289 to Y.Y.)., Research Grant.
180.8 D.P. White, Chief Medical Officer: Philips Respironics,
Employment
182.1 D. Cao, NIH U19 AAT004137 and NIH CO6 RR15433,
Research Grant.
183.15 V. Krishnamoorthy, K12 HD055931, Research Grant.
183.19 A. Klishko, Georgia Institute of Technology, Employment;
NIH HD032571, NS048844, Research Grant; B.J.
Farrell, NIH HD032571, NS048844, Research Grant;
M.L. Latash, Penn State University, Employment; NIH
AG018751,NS35032,AR048563, Research Grant; B.I.
Prilutsky, Georgia Institute of Technology, Employment; NIH
HD032571, NS048844, Research Grant.
185.10 M.B. Cruz, DGAPA-PAPIIT: IN 214508 and CONACyT 81898,
Research Grant.
186.13 T.A. Van Kempen, Weill Cornell Graduate School of Medical
Sciences, Employment.
187.1 L. Roque, SFRH/BD/23365/2005, Research Grant.
188.3 Y. Wu, Yale University Neurology and Physiology Department
and VAMC, Employment
188.9 H. Onimaru, KAKENHI (19500277, 22500296)., Research
Grant.
190.3 E.G. Krause, NIH HL096830, Research Grant; A.D. de Kloet,
AHA 09PRE2250169, Research Grant; R.R. Sakai, NIH
DK68273; NIH DK66596, Research Grant.
190.7 J.R. Yee, AG035627, Research Grant.
190.10 B.B. Garcia-Iglesias, 5R01TW006622, Research Grant; J.A.
Terrón, 5R01TW006622, Research Grant.
191.6 K.P. Skibicka, swedish institute and European Union
(FP7-HEALTH-2009-241592, KBBE-2009-245009),
Research Grant; E. Egecioglu, European Union
(FP7-HEALTH-2009-241592, KBBE-2009-245009),
Research Grant; S.L. Dickson, European Union (FP7-
HEALTH-2009-241592, KBBE-2009-245009), Research
Grant.
192.2 F. Foster, VisualSonics Inc., Employment; VisualSonics Inc.,
Research Grant; VisualSonics Inc., Other Research Support;
VisualSonics Inc., Ownership Interest; VisualSonics Inc.,
Consultant/Advisory Board.
192.8 R.J. Chambers, Merck Pharma, Speakers Bureau/Honoraria;
C.R. Savage, Merck Pharma, Speakers Bureau/Honoraria.
192.12 T. Kim, HIN grant: EB003324, EB003375, and NS44589,
Research Grant.
194.17 A. Clarke, Medical Research Council (UK) Doctoral
Training Grant (G0700025), Research Grant; K.I. Taylor,
Swiss National Science Foundation, Research Grant; L.K.
Tyler, Medical Research Council (UK) programme grant
(G0500842), Research Grant.
195.8 M.D. DelBello, AstraZeneca, Eli Lilly, Johnson & Johnson,
Shire, Janssen, Pfizer, Bristol Myers Squibb, Repligen,
Neuroscience 2010  |  Sunday Conflict of Interest Statements  |  145 
Abstract
Number Statement
Martek, Somerset, NARSAD, and GlaxoSmithKline, Research
Grant; Eli Lilly, Jansen, Ortho-McNeil, Bristol-Myers Squibb,
Merck, and Alza, Speakers Bureau/Honoraria; Eli Lilly,
Jansen, Ortho-McNeil, Bristol-Myers Squibb, Merck, and
Alza, Consultant/Advisory Board; C. Adler, AstraZeneca,
Eli Lilly, Johnson & Johnson, Shire, Janssen, Pfizer, Bristol
Myers Squibb, Repligen, Martek, Somerset, NARSAD, and
GlaxoSmithKline, Research Grant; Johnson & Johnson,
Merck, AZ, Speakers Bureau/Honoraria; S.M. Strakowski,
AstraZeneca, Eli Lilly, Johnson & Johnson, Shire, Janssen,
Pfizer, Bristol Myers Squibb, Repligen, Martek, Somerset,
NARSAD, and GlaxoSmithKline, Research Grant; Adamed
and CME Outfitters, Speakers Bureau/Honoraria; Pfizer and
Consensus Medical Communications, Consultant/Advisory
Board.
196.5 M. Grossman, Forest Labs, Consultant/Advisory Board;
Allon Therapeutics, Consultant/Advisory Board; Pfizer
Pharmaceuticals, Consultant/Advisory Board.
196.6 M. Dreyfuss, Dept of Neurology, University of Pennsylvania
School of Medicine, Employment; M. Grossman, Forest Labs,
Consultant/Advisory Board; Allon Therapeutics, Consultant/
Advisory Board; Pfizer Pharmaceuticals, Consultant/Advisory
Board.
196.7 M. Grossman, Pfizer, Allon, and Forest Pharmaceuticals,
Inc. and recieves compensation as Editor of Cognitive &
Behavioral Neurology, Consultant/Advisory Board.
196.8 M. Grossman, Consultant for Allon Pharmaceuticals, Pfizer
and Forest, Consultant/Advisory Board.
196.9 M. Grossman, Pfizer, Consultant/Advisory Board; Allon,
Consultant/Advisory Board; Forest Pharmaceuticals, Inc.,
Consultant/Advisory Board; Editor of Cognitive and Behavioral
Neurology, Other.
196.10 M. Grossman, Allon Therapeutics, Consultant/Advisory
Board; Pfizer Pharmaceuticals, Consultant/Advisory Board;
Forest Laboratories, Consultant/Advisory Board.
197.3 D.T. Chik, RIKEN Brain Science Institute, Employment;
Kakenhi grants, Japan, Research Grant; M. Kawasaki,
RIKEN Bran Science Institute, Employment; Y. Yamaguchi,
RIKEN Brain Science Institute, Employment.
197.5 D. Talsma, University of Twente, Employment.
197.17 A. Padmanabhan, RO1 MH067924, Research Grant; D.F.
Montez, RO1 MH067924, Research Grant; B. Luna, RO1
MH067924, Research Grant.
198.12 C.D. Woody, NIH, Research Grant; UCLA Academic Senate,
Other Research Support.
199.8 K. Tagai, Scientific Research from the Japanese Ministry
of Education, Culture, Sports, Science and Technology,
Research Grant; Japan Science and Technology Agency,
Research Grant.
199.10 H. Yamasue, JST, Research Grant.
200.13 D.A. Lewis, BMS Foundation, Research Grant; Bristol-Myers
Squibb, Research Grant; Curridium Ltd, Research Grant;
Pfizer, Research Grant; AstraZeneca, Consultant/Advisory
Board; Bioline RX, Consultant/Advisory Board; Bristol-
Myers Squibb, Consultant/Advisory Board; Hoffman-Roche,
Consultant/Advisory Board; Lilly, Consultant/Advisory Board;
Merck, Consultant/Advisory Board; Neurogen, Consultant/
Advisory Board; SK LifeScience, Consultant/Advisory Board.
201.11 J.L. Baker, IntElect Medical Inc., Research Grant; S.A. Shah,
IntElect Medical Inc., Research Grant; J. Ryou, IntElect
Medical Inc., Research Grant; N.D. Schiff, IntElect Medical
Inc., Research Grant; IntElect Medical Inc., Consultant/
Advisory Board; K.P. Purpura, IntElect Medical Inc., Research
Grant.
201.12 S.A. Shah, IntElect Medical, Inc, Other Research
Support; N.D. Schiff, IntElect Medical, Other Research
Support; IntElect Medical, Consultant/Advisory Board; K.P.
Purpura, IntElect Medical, Other Research Support.
201.13 S.A. Shah, IntElect Medical, Other Research Support; N.D.
Schiff, IntElect Medical, Other Research Support; IntElect
Medical, Consultant/Advisory Board; K.P. Purpura, IntElect
Medical, Other Research Support.
146  |  Society for Neuroscience
Abstract
Number Statement
201.16 S. Myers, NeurOp Inc., Employment; P. Lyuboslavsky,
NeurOp Inc., Employment; L. Wilson, NeurOp Inc.,
Employment; D.T. Laskowitz, Consultant of NeurOp Inc.,
Consultant/Advisory Board
201.22 M.D. Riedy, The Medical University of South Carolina,
Employment; P50 MH062196, Research Grant; D.E.
Moorman, MUSC, Employment; P50 MH062196, Research
Grant; Z.A. Cope, MUSC, Employment; G. Aston-Jones,
MUSC, Employment; P50 MH062196, Research Grant.
202.8 C.D. Conrad, Arizona Biomedical Research Commission,
Research Grant.
202.11 C.J. Scavuzzo, NSF IOB 05-20876, Other Research Support; 
R.L. Collier, NSF IOB 05-20876, Other Research Support;
D.L. Korol, NSF IOB 05-20876, Research Grant.
202.27 K.A.L. McAllister, Takeda Cambridge Ltd, Other Research
Support; L.M. Saksida, Medical Research Council UK and
the Wellcome Trust, Research Grant; T.J. Bussey, Medical
Research Council UK and the Wellcome Trust, Research
Grant.
204.2 J.A. Miranda, Pfizer Regenerative Medicine, Employment;
R. Dias, Pfizer Regenerative Medicine, Employment; J.R.
Huxter, Pfizer Regenerative Medicine, Employment.
206.4 K. Mori, Marine Science Center of Norhteastern University,
Employment.
206.7 T.C. Marzullo, Backyard Brans, Inc., Ownership Interest; G.
Gage, Backyard Brans, Inc., Ownership Interest.
207.11 F. Johnson, DC002035, Research Grant; W. Wu, DC002035,
Research Grant; R. Bertram, NIH DC002035, Research
Grant.
209.2 P. Grange, NIDA, Research Grant.
209.6 A. Shao, WuXi AppTec Co., Ltd., Ownership Interest; D.
Bian, WuXi AppTec Co., Ltd., Ownership Interest; H. Zhao,
WuXi AppTec Co., Ltd., Ownership Interest; J. Zou, WuXi
AppTec Co., Ltd., Ownership Interest; Z. Hu, WuXi AppTec
Co., Ltd., Ownership Interest; J. Zhang, WuXi AppTec Co.,
Ltd., Ownership Interest; L. Zhu, WuXi AppTec Co., Ltd.,
Ownership Interest; J. Wu, WuXi AppTec Co., Ltd., Ownership
Interest; J. Jiang, WuXi AppTec Co., Ltd., Ownership Interest;
C. Chan, WuXi AppTec Co., Ltd., Ownership Interest.
209.9 B.B. Biswal, RC1MH090912-01 NIH NIMH Challenge Grant,
Research Grant; M.E. Meyerand, RC1MH090912-01 NIH
NIMH Challenge Grant, Research Grant.
220.2 A.V. Savonenko, SBIR NIH, Research Grant; T. Melnikova,
SBIR NIH, Research Grant; D. Lee, SBIR NIH, Research
Grant; A. Hiatt, SBIR NIH, Research Grant; MAPP
BIOPHARMACEUTICAL, INC, Employment.
220.5 P.K. Banerjee, Forest Laboratories, Employment
220.10 H.U. Demuth, Probiodrug AG, Employment; BMBF grants ##
0315089, 0315223, 3013185, Research Grant; M. Buchholz,
Probiodrug AG, Employment; BMBF grants ## 0315089,
0315223, 3013185, Research Grant; R. Sommer, Probiodrug
AG, Employment; BMBF grants ## 0315089, 0315223,
3013185, Research Grant; D. Ramsbeck, Probiodrug AG,
Employment; BMBF grants ## 0315089, 0315223, 3013185,
Research Grant; S. Schilling, BMBF grants ## 0315089,
0315223, 3013185, Research Grant; Probiodrug AG,
Employment; U. Heiser, Probiodrug AG, Employment; BMBF
grants ## 0315089, 0315223, 3013185, Research Grant.
220.11 A.S. Alexandru, Ingenium Pharmaceuticals GmbH,
Employment; W. Jagla, Ingenium Pharmaceuticals GmbH,
Employment; S. Graubner, Ingenium Pharmaceuticals
GmbH, Employment; R. Sedlmeier, Ingenium
Pharmaceuticals GmbH, Employment; S. Kohlmann,
Ingenium Pharmaceuticals GmbH, Employment; C.
Bäuscher, Ingenium Pharmaceuticals GmbH, Employment;
S. Schilling, Stock Options, Ownership Interest; Probiodrug
AG, Employment; S. von Hörsten, Consultant for Probiodrug
AG, Consultant/Advisory Board; H. Demuth, Stock Options,
Ownership Interest; CSO and Vice-CEO of Probiodrug AG,
Employment.
220.12 S. Schilling, Probiodrug AG, Employment; S. Graubner,
Ingenium, Employment; W. Jagla, Ingenium, Employment; C.
Bäuscher, Ingenium, Employment; S. Kohlmann, Ingenium,
Abstract
Number Statement
Employment; M. Mitrovic, JSW Life Science, Employment; S.
Kurat, JSW Life Science, Employment; B. Hutter-Paier, JSW
Life Sciences, Employment; M. Windisch, CEO JSW Life
Science, Ownership Interest; H. Demuth, CSO Probiodrug
AG, Ownership Interest; CEO Ingenium, Ownership Interest.
220.14 T. Bayer, Probiodrug, Consultant/Advisory Board; S.
Schilling, Probiodrug, Employment; S. Graubner, Ingenium,
Employment; H. Demuth, CSO Probiodrug, Ownership
Interest.
223.1 M. Shy, Dr. Shy is an invited speaker of Athena Diagnostics.,
Speakers Bureau/Honoraria.
223.6 T. Bordet, Trophos SA, Employment; G. Tardif, Trophos SA,
Employment; M. Michaud, Trophos SA, Employment; C.
Chaimbault, Trophos SA, Employment; R.M. Pruss, Trophos
SA, Employment.
223.8 M.E. Shy, Dr. Shy is an invited speaker of Athena
Diagnostics., Speakers Bureau/Honoraria.
223.9 G. Ramesh, NIH grant 5R01NS048952-05 to M.T. Philipp,
Research Grant; M.T. Philipp, NIH grant 5R01NS048952-05
to M.T. Philipp, Research Grant.
224.8 L. Fitzgerald, National Health & Medical Research Council,
Australia Grant ID: 572550. Neurotrauma Research Program,
Western Australia, Research Grant; S.A. Dunlop, National
Health and Medical Research Council Grant ID: 254670,
Neurotrauma Research Program, Western Australia,
Research Grant.
225.2 E. Scarr, AstraZeneca, Speakers Bureau/Honoraria; B.
Dean, Janssen-Cilag, Speakers Bureau/Honoraria; Eli
Lilly, Speakers Bureau/Honoraria; Bristol-Myers Squibb,
Consultant/Advisory Board.
227.1 C. Guger, g.tec Guger Technologies OEG, Employment; G.
Edlinger, g.tec Guger Technologies OEG, Employment.
227.4 B.Z. Allison, EU FP7 Project BrainAble, Project Number
247447, Research Grant; EU FP7 Project Future BNCI,
Project Number 248320, Research Grant.
227.6 D.R. Kipke: Neuronexus Technologies; Ownership Interest.
229.8 N.H. Kalin, Astra Zeneca; Bristol-Myers-Squibb; CeNeRx
Biopharma; Corcept; Cyberonics; Forest Laboratories;
General Electric Corp; Jazz Pharmaceuticals, Ely Lilly;
Neuronetics; Sanofi Syntholabs; Wyeth Pharmaceut,
Consultant/Advisory Board.
231.6 T. Di meglio, EMBO, Research Grant.
231.16 L. Albanito, DFG, Research Grant.
231.17 Q. Lei, Sanofi-Aventis US, Employment
232.19 M.D. Gershon, Lexicon Genetics, Research Grant.
232.23 J.S. Adams, NIH R01HD046475, Research Grant; BYU
Graduate Mentoring Award, Other Research Support; M.R.
Stark, NIH R01HD046475, Research Grant.
235.4 L.I. Benowitz, NIH EY 05690 and the Adelson Medical
Research Foundation, Research Grant.
235.7 F. Nothias, CNRS, INSERM, UPMC, Research Grant; IRME
(Institut de Recherche sur la Moelle Epinière et l’Encéphale,
Other Research Support.
235.16 T.L. Dickendesher, Pfizer Global Research and
Development, Other; M.M. Zaleska, Pfizer Global Research
and Development, Other; A. Wood, Pfizer Global Research
and Development, Other; R.J. Giger, Pfizer Global Research
and Development, Other; B. Bates, Pfizer Global Research
and Development, Other; D. Howland, Pfizer Global
Research and Development, Other; M.L. Mercado, Pfizer
Global Research and Development, Other.
236.1 T.L. Wallace, Roche, Employment; G. Chiu, Roche,
Employment; H. Dao, Roche, Employment; L. Santarelli,
Roche, Employment; R. Porter, Roche, Employment; S.
Bertrand, Roche, Other Research Support; D. Bertrand,
Roche, Other Research Support.
236.7 P. Jayarajan, Suven Life Sciences Ltd, Employment.
236.14 R.V. Nirogi, Suven Life Sciences Ltd, Employment.
236.15 G. Bhyrapuneni, Suven Life Sciences Ltd, Employment.
236.18 J. Zhang, Targacept, Employment; K. Van Dyke, Targacept,
Abstract
Number Statement
Employment; Y. Xiao, Targacept, Employment; K. Jordan,
Targacep, Employment; P. Hammond, Targacept,
Employment; A. Mazurov, Targacept, Employment; J.
Speake, Targacept, Employment; S.R. Letchworth,
Targacept, Employment; M. Bencherif, Targacept,
Employment; T. Hauser, Targacept, Employment.
236.19 I. Ahmad, Suven Life Sciences Ltd, Employment.
236.23 L. Dorna, NIH grants 2U54NS43011, 2RO1GM56371 and
3RO1-N33202, Research Grant; J.C. Padilla, NIH grants
2U54NS43011, 2RO1GM56371 and 3RO1-N33202, Research
Grant; C. Vélez, NIH grants 2U54NS43011, 2RO1GM56371
and 3RO1-N33202, Research Grant; M. Luciano, NIH grants
2U54NS43011, 2RO1GM56371 and 3RO1-N33202, Research
Grant; C. Báez, NIH grants 2U54NS43011, 2RO1GM56371
and 3RO1-N33202, Research Grant; O. Quesada, NIH grants
2U54NS43011, 2RO1GM56371 and 3RO1-N33202, Research
Grant; J.A. Lasalde-Dominicci, NIH grants 2U54NS43011,
2RO1GM56371 and 3RO1-N33202, Research Grant.
238.5 S.F. Traynelis, Pfizer, Research Grant; Lundbeck, Research
Grant; NeurOp Inc., Consultant/Advisory Board.
238.11 A. Kato, Eli Lilly and Company, Employment; M.B. Gill,
Eli Lilly and Company, Employment; H. Yu, Eli Lilly and
Company, Employment; Y. Tu, Eli Lilly and Company,
Employment; E.R. Siuda, Eli Lilly and Company, Employment;
H. Wang, Eli Lilly and Company, Employment; Y. Qian,
Eli Lilly and Company, Employment; E.S. Nisenbaum, Eli
Lilly and Company, Employment; D.S. Bredt, Eli Lilly and
Company, Employment.
239.2 S.J. Moss, Wyeth Pharmaceuticals ( Principal investigator,
collaborator or consultant and grants already received),
Research Grant; Receipt of Drugs, supplies, equipment or
other in-kind support, Other Research Support.
240.8 J.J. Renger, Merck and Co. Inc. (USA), Employment.
240.10 V.E. Scott, Abbott Laboratories, Employment; T. Vortherms,
Abbott Laboratories, Employment; W. Niforatos, Abbott
Laboratories, Employment; C. Shieh, Abbott Laboratories,
Employment; M. Namovic, Abbott Laboratories, Employment;
D. Donnelly-Roberts, Abbott Laboratories, Employment; B.
Putman, Abbott Laboratories, Employment; R. Thimmapaya,
Abbott Laboratories, Employment; R. Helfrich, Abbott
Laboratories, Employment; D. Zhang, Abbott Laboratories,
Employment; C. Surowy, Abbott Laboratories, Employment; I.
Milicic, Abbott Laboratories, Employment; C. Zhong, Abbott
Laboratories, Employment; G. Simler, Abbott Laboratories,
Employment; C. Zhan, Abbott Laboratories, Employment;
J.M. Boyce-Rustay, Abbott Laboratories, Employment;
P. Bhatia, Abbott Laboratories, Employment; G. Doherty,
Abbott Laboratories, Employment; A.O. Stewart, Abbott
Laboratories, Employment; M.F. Jarvis, Abbott Laboratories,
Employment.
240.11 V.N. Uebele, Merck and Co, Inc (USA), Employment; stock
and/or stock options of Merck and Co., Inc. (USA), Ownership
Interest; J.J. Ranger, Merck and Co, Inc (USA), Employment;
stock and/or stock options of Merck and Co., Inc (USA),
Ownership Interest.
240.22 W.A. Catterall, NS0222625-24, Research Grant.
241.3 V.A. Cazares, R01 NS-053978, R01 DK077050, Research
Grant; E. Stuenkel, R01 NS-053978, R01 DK077050,
Research Grant.
241.14 Y. Hsiao, NSC-97-2311-B-002-001-MY2, Research Grant;
NSC-97-2311-B-002-007-MY3, Research Grant; NSC-97-
2321-B-002-042, Research Grant; NSC-98-2321-B-002-009,
Research Grant; N. Chiang, NSC-97-2311-B-002-001-MY2,
Research Grant; NSC-97-2311-B-002-007-MY3, Research
Grant; NSC-97-2321-B-002-042, Research Grant; NSC-
98-2321-B-002-009, Research Grant; C. Wang, NSC-97-
2321-B-002-042, Research Grant; NSC-98-2321-B-002-009,
Research Grant; NSC-97-2311-B-002-001-MY2, Research
Grant; NSC-97-2311-B-002-007-MY3, Research Grant.
242.11 R.S. Stewart, Washington University, Employment; NIH,
Research Grant; R.S. Wilkinson, Washington University,
Employment; NIH, Research Grant.
243.9 M.C. Monti, CONICET, Research Grant; M.F. Perez,
CONICET, Research Grant; O.A. Ramirez, CONICET,
Neuroscience 2010  |  Sunday Conflict of Interest Statements  |  147 
Abstract
Number Statement
Research Grant.
244.9 I. Ran, Savoy Foundation, Research Grant; J. Lacaille, CIHR,
Research Grant; CRC, Research Grant; FRSQ, Research
Grant.
246.2 K. Morita, KAKENHI 21700366 from MEXT, Research Grant;
M. Small, CERG, PolyU 5279/08E, Research Grant.
246.6 B. Rozsa, Femtonics, Ownership Interest; G. Katona,
Femtonics, Ownership Interest; S.E. Vizi, Femtonics,
Ownership Interest.
246.7 S.M. Korogod, International Center for Molecular Physiology,
NASU, Employment.
246.9 W.N. Ross, NIH NS016295, Research Grant.
246.12 S.D. Antic, NIH R01MH063503, Research Grant; NARSAD
Young Investigator 2009, Other Research Support.
246.17 L. Topolnik, CIHR, NSERC, Savoy Foundation, Research
Grant.
247.7 T. Maurice: Anavex Life Science, Amylgen; Consultant/Advisory
Board. V. Villard: Amylgen; Employment.
247.23 S. Sankaranarayanan, Bristol-Myers Squibb, Employment;
Y. He, Bristol-Myers Squibb, Employment; M. Pierdomenico,
Bristol-Myers Squibb, Employment; N. Aranibar, Bristol-
Myers Squibb, Employment; D. Barten, Bristol-Myers
Squibb, Employment; P. Shipkova, Bristol-Myers Squibb,
Employment; S. Hnatyshyn, Bristol-Myers Squibb,
Employment; C.F. Albright, Bristol-Myers Squibb,
Employment; M. Reily, Bristol-Myers Squibb, Employment.
247.26 S. Bernales, Medivation Inc, Consultant/Advisory Board;
I.E. Alfaro, Medivation Inc, Other Research Support; A.A.
Protter, Medivation Inc, Employment; D. Vega, Medivation
Inc, Other Research Support.
248.2 M. Sadowski, NIH AG31221 and 34176, Research Grant;
Phillips North America, Consultant/Advisory Board; D.M.
Holtzman, NIH grant AG13956, Research Grant.
249.13 E.J. Davidowitz, OLIGOMERIX, Inc., Employment; NIH grant
# 1R43AG029777-01, Research Grant; H. Tian, Arizona State
University, Employment; NIH grant # 1R43AG029777-01,
Research Grant; J. Moe, OLIGOMERIX, Inc., Employment;
NIH grant # 1R43AG029777-01, Research Grant; M.
Sierks, Arizona State University, Employment; NIH grant #
1R43AG029777-01, Research Grant.
249.14 R. Kilkuskie, Michigan High Throughput Screening Center,
Employment.
249.18 A. Buist, Janssen, Employment; K. Callaerts, Janssen,
Employment; D. Moechars, Janssen, Employment.
249.22 A.M. Thomas, Pfizer, Employment; W.D. Hirst, Pfizer,
Employment; S.G. Boyer, Pfizer, Employment; P.C. Loos,
Pfizer, Employment; C.D. Hicks, Pfizer, Employment; R.A.
Durham, Gyros, Employment.
249.23 T.T. Kawabe, Pfizer, Employment; T.M. Brown, Pfizer,
Employment; K.E.G. Richter, Pfizer, Employment;
D. Caouette, Pfizer, Employment; A.S. Klein, Pfizer,
Employment; C.D. Hicks, Pfizer, Employment; A.J. Milici,
Pfizer, Employment.
250.2 D. Fisher, Sigma Advanced Genetic Engineering (SAGE)
Labs, Employment; D. Ji, Sigma Advanced Genetic
Engineering (SAGE) Labs, Employment.
250.5 M. Munoz Arenas, Grant 50428 by Conacyt given to Dr
Floran., Research Grant; Lab. of Neuropharmacology, BUAP,
Other Research Support.
250.6 W. Drinkenburg, Janssen, Employment; A. Ahnaou, J&J
PRD, Janssen Pharmaceutica, Employment; H. Huysmans,
J&J PRD, Janssen Pharmaceutica, Employment; A. Heylen,
J&J PRD, Janssen Pharmaceutica, Employment; T. Meert,
J&J PRD, Janssen Pharmaceutica, Employment; J. Atack,
J&J PRD, Janssen Pharmaceutica, Employment; P. Jackson,
J&J PRD USA, Employment.
250.8 G. Gerhardt, Quanteon LLC, Ownership Interest.
250.12 A. Agar, This study is supported by Akdeniz University
Scientific Research Projects Management (Project number:
2007.01.0103.016), Research Grant.
250.13 K.M. Wicke, Abbott GmbH & Co KG, Employment; G. Gross,
148  |  Society for Neuroscience
Abstract
Number Statement
Abbott GmbH & Co KG, Employment.
251.1 M. Weigele, Ariad Pharmaceuticals, Employment; R.M.
Squillace, Ariad Pharmaceuticals, Employment.
251.6 V. Baekelandt, KUL, Employment; IWT, Research Grant.
251.18 P. Kallunki, H. Lundbeck A/S, Employment; A. Bergström, H.
Lundbeck A/S, Employment; D. Andersson, H. Lundbeck A/S,
Employment; L. Helboe, H. Lundbeck A/S, Employment; K.
Fog, H. Lundbeck A/S, Employment.
252.1 L.F. Burbulla, Charitable Hertie Foundation, Other; R.
Kruger, Charitable Hertie Foundation to L.F.B., Other.
252.10 S.E. Przedborski, PDF, Hartman Foundation, NIA, Research
Grant.
253.16 J. Umemori, Transdisciplinary Research Integration
Center, Research Organization of Information and Systems,
Employment; Grant-in-Aid for Exploratory Research,
Research Grant.
254.9 N. Tian, Grant from Walter H Coulter Foundation, Research
Grant; D. Durand, Grant from Walter H Coulter Foundation,
Research Grant; K. Kile, Grant from Walter H Coulter
Foundation, Research Grant.
254.15 M.D. Smith, NeuroAdjuvants, Inc., Employment; H.S. White,
NIH NO1-NS-9-2313, Research Grant; NeuroAdjuvants,
Inc, Salt Lake City, UT, Scientific Co-founder, Ownership
Interest; Johnson & Johnson Pharmaceutical Research &
Devel. (PND), Springhouse, PA, Consultant, Consultant/
Advisory Board; Valeant Pharmaceuticals, Costa Mesa,
CA, Consultant, Consultant/Advisory Board; T.H. Pruess,
NeuroAdjuvants, Inc., Employment; J.M. McIntosh, NIH
GM48677, Research Grant; Ben B. & Iris M. Margolis
Foundation Grant, Research Grant.
255.7 J.R. Naegele, McKnight Brain Disorders Award, Research
Grant; Connecticut Stem Cell, Other Research Support.
255.15 F.K. Kalume, 2R01NS015751-29A2, Research Grant;
5K01NS062862-02, Other Research Support; W.A. Catterall,
2R01NS015751-29A2, Research Grant.
257.8 W. Teo, Hotchkiss Brain Institute, Employment; University of
Calgary, Employment.
257.19 D. Shin, University of California San Francisco, Employment.
258.2 A. Defaux, Multiple Sclerosis Swiss Society, Research
Grant; F. Monnet-Tschudi, Multiple Sclerosis Swiss Society,
Research Grant.
259.14 O. Alluin, Multidisciplinary Team in Locomotor Rehabilitation,
Research Grant; S. Karimi-Abdolrezaee, Craig H. Neilsen
Foundation, Research Grant; H. Delivet-Mongrain,
University of Montreal, Employment; M. Ménard, University of
Montreal, Employment; H. Leblond, University of Montreal,
Employment; S. Rossignol, CIHR, Research Grant; Canada
Research Chair on the Spinal Cord, Research Grant.
261.9 A. Sawa, NIH, CHDI, HighQ, NARSAD, Stanley, RUSK, S-R,
Wyeth, Astellas, Eisai, Taisho, Otsuka, Sucampo, Tanabe-
Mitsubishi, Employment; Astrazeneca, Research Grant;
Sanofi-Aventis, Lilly, Tanabe-Mitsubishi, Otsuka-Maryland,
Taisho, Other Research Support.
262.22 K.M. Dhandapani, non-paid, scientific consultant for Cytorex
Biosciences, Inc., Consultant/Advisory Board.
262.28 R. Roesler, Federal University of Rio Grande do Sul,
Employment; National Council for Scientific and Technological
Development (CNPq) grant number 303703/2009-1, Research
Grant; Children’s Cancer Institute award, Research Grant;
South American Office for Anticancer Drug Development
Award, Research Grant; Co-founder and partner, NeuroAssay
Ltd., Ownership Interest; NeuroAssay Ltd., Consultant/
Advisory Board; Eurofarma Laboratories Ltd., Consultant/
Advisory Board; C.B. de Farias, Children’s Cancer Institute
(ICI-RS), Employment; A.L. Abujamra, Children’s Cancer
Institute (ICI-RS), Employment; G. Schwartsmann, Federal
University of Rio Grande do Sul, Employment; A.L. Brunetto,
Federal University of Rio Grande do Sul, Employment.
263.11 D.R. Williams, Optos, Consultant/Advisory Board.
263.13 S. McPhee, ASKLEPIOS BioPharmaceuticals, Inc.,
Employment; T.J. McCown, ASKLEPIOS BioPharmaceuticals,
Inc., Research Grant; N.M. Boulis, ASKLEPIOS
Abstract
Number Statement
BioPharmaceuticals, Inc., Research Grant.
264.3 D. Iosifescu, Aspect Medical Systems, Research Grant;
Forest Laboratories, Aspect Medical Systems, Research
Grant; Janssen Pharmaceuticals, Research Grant; Eli Lilly
& Co., Speakers Bureau/Honoraria; Pfizer, Inc., Speakers
Bureau/Honoraria; Forest Laboratories, Speakers Bureau/
Honoraria; Reed Medical Education, Speakers Bureau/
Honoraria; M. Fava, Abbott Laboratories, Research Grant;
Alkermes, Inc., Research Grant; Aspect Medical Systems,
Research Grant; AstraZeneca, Research Grant; BioResearch,
Research Grant; BrainCells Inc., Research Grant; Britol-
Myers Squibb, Research Grant; Cephalon, Inc., Research
Grant; Clinical Trials Solutions, LLC, Research Grant; Eli Lilly
and Company, Research Grant; EnVivo Pharmaceuticals,
Inc., Research Grant; Forest Pharmaceuticals, Inc.,
Research Grant; Ganeden Biotech, Inc., Research Grant;
GlaxoSmithKline, Research Grant; Johnson & Johnson
Pharmaceutical Research and Development, Research
Grant; Lichtwer Pharma GmbH, Research Grant; Lorex
Pharmaceuticals, Research Grant; Novartis AG, Research
Grant; Organon Pharmaceuticals, Research Grant; PamLab
LLC, Research Grant; Pfizer Inc, Research Grant; Pharmavite
LLC, Research Grant; Roche, Research Grant; RTC Logic,
LLC, Research Grant; sanofi-aventis US LLC, Research
Grant; Shire, Research Grant; Solvay Pharmaceuticals, Inc.,
Research Grant; Wyeth-Ayerst Laboratories, Research Grant;
Adamed, Co, Speakers Bureau/Honoraria; Advanced Meeting
Partners, Speakers Bureau/Honoraria; American Psychiatric
Association, Speakers Bureau/Honoraria; American Society
of Clincial Psychopharmacology, Speakers Bureau/Honoraria;
AstraZeneca, Speakers Bureau/Honoraria; Belvoir Media
Group, Speakers Bureau/Honoraria; Boehringer Ingelhein
GmbH, Speakers Bureau/Honoraria; Bristol-Myers Squibb,
Speakers Bureau/Honoraria; Cephalon Inc., Speakers
Bureau/Honoraria; Eli Lilly & Company, Speakers Bureau/
Honoraria; Forest Pharmaceuticals, Speakers Bureau/
Honoraria; GlaxoSmithKline, Speakers Bureau/Honoraria;
Imedex, LLC, Speakers
Bureau/Honoraria; MGH Psychiatry Academy/Primedia,
Speakers Bureau/Honoraria; MGH Psychiatry Academy/Reed
Elsevier, Speakers Bureau/Honoraria; Novartis AG, Speakers
Bureau/Honoraria; Organon Pharmaceuticals, Speakers
Bureau/Honoraria; Pfizer Inc., Speakers Bureau/Honoraria;
PharmaStar, Speakers Bureau/Honoraria; United BioSource,
Wyeth-Ayerst Laboratories, Speakers Bureau/Honoraria;
Compellis, Ownership Interest; Abbott Laboratories,
Consultant/Advisory Board; Affectis Pharmaceuticals AG,
Consultant/Advisory Board; Amarin Pharma Inc., Consultant/
Advisory Board; Aspect Medical Systems, Consultant/
Advisory Board; AstraZeneca, Consultant/Advisory Board;
Auspex Pharmaceuticals, Consultant/Advisory Board; Bayer
AG, Consultant/Advisory Boarmad; Best Practice Project
Management, Inc., Consultant/Advisory Board; BioMarin
Pharmaceuticals, Inc., Consultant/Advisory Board; BioAvail
Corporation, Consultant/Advisory Board; BrainCells Inc.,
Consultant/Advisory Board; Bristol-Myers Squibb Company,
Consultant/Advisory Board; Cephalon Inc., Consultant/
Advisory Board; Clinical Trials Solutions, LLC, Consultant/
Advisory Board; CNS Response, Inc., Consultant/Advisory
Board; Compellis Pharmaceuticals, Consultant/Advisory
Board; Cypress Pharmaceuticals, Inc., Consultant/Advisory
Board; Dov Pharmaceuticals Inc., Consultant/Advisory Board;
Esai Inc., Consultant/Advisory Board; Eli Lilly and Company,
Consultant/Advisory Board; EPIX Pharmaceuticals, Inc.,
Consultant/Advisory Board; Eurythmics Bioscience Inc.,
Consultant/Advisory Board; Fabre-Kramer Pharmaceuticals,
Inc, Consultant/Advisory Board; Forest Pharmaceuticals
Inc., Consultant/Advisory Board; GlaxoSmithKline,
Consultant/Advisory Board; Grunethal GmBH, Consultant/
Advisory Board; Janssen Pharmaceutica, Consultant/
Advisory Board; Jazz Pharmacueticals, Inc., Consultant/
Advisory Board; Johnson & Johnson Pharmaceutical
Research and Development, LLC, Consultant/Advisory
Board; Knoll Pharmaceuticals Corp, Consultant/Advisory
Board; Labopharm Inc., Consultant/Advisory Board; Lorex
Pharmaceuticals, Consultant/Advisory Board; Lundbeck,
Inc., Consultant/Advisory Board; MedAvante Inc., Consultant/
Advisory Board; Merck & Co, Inc., Consultant/Advisory
Abstract
Number Statement
Board; Methylation Sciences, Consultant/Advisory Board;
Neuronetics, Inc., Consultant/Advisory Board; Novartis
AG, Consultant/Advisory Board; Nutrition 21, Consultant/
Advisory Board; Organon Pharmaceuticals, Consultant/
Advisory Board; PamLab LLC, Consultant/Advisory Board;
Pfizer, Inc., Consultant/Advisory Board; PharmaStar,
Consultant/Advisory Board; Pharmavite LLC, Consultant/
Advisory Board; Precision Human Biolaboratory, Consultant/
Advisory Board; Prexa Pharmaceuticals, Inc., Consultant/
Advisory Board; PsychoGenics, Consultant/Advisory Board;
Psylin Neurosciences, Inc., Consultant/Advisory Board;
Ridge Diagnostics, Inc., Consultant/Advisory Board; Roche,
Consultant/Advisory Board; RCT Logic LLC, Consultant/
Advisory Board; Sanofi-Aventis US LLC, Consultant/
Advisory Board; Sepracor, Inc., Consultant/Advisory
Board; Schering-Plough Corporation, Consultant/Advisory
Board; Solvay Pharmaceuticals, Inc., Consultant/Advisory
Board; Synthelabo, Consultant/Advisory Board; Takeda
Pharmaceutical Company Limited, Consultant/Advisory
Board; Tetragenex Pharmaceuticals, Inc., Consultant/Advisory
Board; TransForm Pharmaceuticals, Inc., Consultant/Advisory
Board; Transcept Pharmaceuticals Inc., Consultant/Advisory
Board. Consultant/Advisory Board; Vanda Pharmaceuticals
Inc, Consultant/Advisory Board; Wyeth Ayerst Laboratories,
Consultant/Advisory Board. D. Pizzagalli, AstraZeneca,
Speakers Bureau/Honoraria; ANT North America Inc.
(Advanced Neuro Technology), Consultant/Advisory Board;
AstraZeneca, Consultant/Advisory Board;
264.9 M. Iwase, Grant-in-Aid, Japan, 20591402, Research Grant.
264.13 M. Kaiser, National Research Foundation of Korea funded
by the Ministry of Education, Science and Technology
(R32-10142, Research Grant; the Royal Society (RG/2006/
R2), Research Grant; CARMEN e-science project (www.
carmen.org.uk) funded by EPSRC (EP/E002331/1), and (EP/
G03950X/1)., Research Grant.
264.29 M. Nakamura, Grant-in-Aid for Young Scientists, Ministry
of Education, Culture, Sports, Science and Technology,
Research Grant.
265.5 R. Willems, Johnson & Johnson, Employment; L. Ver Donck,
Johnson&Johnson, Employment; E. Karran, Johnson &
Johnson, Employment.
266.14 T. Kash, NIAAA, Research Grant.
266.18 Z.A. Rodd, AA07642, Research Grant; AA07611, Research
Grant; AA019366, Research Grant; AA10256, Research
Grant.
267.6 K.A. Miczek, NIH, Research Grant.
269.6 S.V. Faraone, R21MH/NS66191, Research Grant; NIH,
Research Grant; S.L. Youngentob, R01AA014871, Research
Grant; NIH-NIAAA, Research Grant
269.14 J.M. Brielmaier, CP-154,526 provided by Pfizer, Other
Research Support.
269.22 E.D. London, Phillip Morris USA, Research Grant.
270.13 S.C. Fowler, University of Kansas, Employment; MH042439,
Research Grant; HD002528, Other Research Support; BASi,
Ownership Interest.
270.15 N.M. Richtand, Ortho-McNeil Janssen Scientific Affairs,
LLC, Research Grant; AstraZeneca Pharmaceuticals, Other
Research Support; Merck, Speakers Bureau/Honoraria;
Novartis, Speakers Bureau/Honoraria; Bristol-Meyers
Squibb, Speakers Bureau/Honoraria; Bristol-Meyers Squibb,
Consultant/Advisory Board; Gerson Lehrman Group,
Consultant/Advisory Board.
271.11 T. Sung, Has a patent on Heantos, Ownership Interest.
272.9 S.E. Bartlett, NIH, 1R01AA017924-01 (to S.E.B.), DOD,
#W81XWH-08-1-0016 (to S.E.B), Research Grant.
273.6 M.K. Muezzinoglu, ONR N00014-07-1-0741, Research
Grant; Jet Propulsion Laboratory 1396686, Research Grant;
R. Huerta, ONR N00014-07-1-0741, Research Grant; Jet
Propulsion Laboratory 1396686, Research Grant; B.H. Smith,
NIH NCRR RR014166, Research Grant.
273.11 J. Riffell, R01-DC02751, Research Grant; IOS 01-082270,
Research Grant.
Neuroscience 2010  |  Sunday Conflict of Interest Statements  |  149 
Abstract
Number Statement
275.2 J. Tsunada, NIH DC007172, Research Grant; NIH
DC009224, Research Grant; Y.E. Cohen, NIH-NIDCD,
Research Grant.
275.4 J.V. Lee, potentially seeking patent, Ownership Interest.
275.11 Y.E. Cohen, NIH-NIDCD, Research Grant.
277.8 D. Aziz, Midbar West, Inc., Employment.
278.5 C. Jung, This research was supported by Basic Science
Research Program through the National Research Foundation
of Korea(NRF) funded by the Ministry of Education, Science
and Technology(2010-0012276)., Research Grant; The
authors wish to acknowledge the financial support of the
Catholic Medical Center Research Foundation made in the
program year of 2010., Other Research Support.
279.6 A.B. Arslan, Brown University, Employment; M. Cauchoix,
Université de Toulouse, Employment; D. Fize, Université
de Toulouse, Employment; G. Kreiman, Children’s Hospital
Boston, Harvard Medical School, Employment; T. Serre,
Brown University, Employment; J.M. Singer, Children’s
Hospital Boston, Harvard Medical School, Employment; J.R.
Madsen, Children’s Hospital Boston, Employment.
279.8 S. Kuai, School of Psychology, University of Birmingham,
Employment; This work was supported by grants from the
Biotechnology and Biological Sciences Research Council
to ZK [D52199X, E027436], Research Grant; J. Sandall,
This work was supported by grants from the Biotechnology
and Biological Sciences Research Council to ZK [D52199X,
E027436], Research Grant; H. Wolstencroft, This work was
supported by grants from the Biotechnology and Biological
Sciences Research Council to ZK [D52199X, E027436],
Research Grant; Z. Kourtzi, School of Psychology, University
of Birmingham, Employment; This work was supported
by grants from the Biotechnology and Biological Sciences
Research Council to ZK [D52199X, E027436], Research
Grant.
281.13 K. Starowicz, Institute of Pharmacology Polish Academy of
Sciences, 12 Smetna str, 31-343 Cracow PL, Employment;
N N401 015235, Research Grant; Homing FNP and the EEA
Financial Mechanism, Other Research Support.
281.17 M. Puopolo, Endo Pharmaceuticals, Research Grant; G.L.
Yao, Endo Pharmaceuticals, Research Grant; C.J. Woolf,
Endo Pharmaceuticals, Research Grant; B.P. Bean, Endo
Pharmaceuticals, Research Grant.
281.22 C.M. Grimm, Pfizer Ltd. Global R&D, Employment; L. Cao,
Pfizer Ltd. Global R&D, Employment; E. Aneiros, Pfizer Ltd.
Global R&D, Employment; E. Stevens, Pfizer Ltd. Global
R&D, Employment; S.C. Phillips, Pfizer Ltd. Global R&D,
Employment.
282.4 A. Bradaia, NEUROSERVICE, Employment; K.
Wadel, NEUROSERVICE, Employment; B. Buisson,
NEUROSERVICE, Employment.
284.8 A. PŁaŹnik, Dept. of Neurochemistry, Institute of Psychiatry
and Neurology, Warsaw, Poland, Employment
284.11 X. Wang, Univ. of Wyoming, Employment.
285.5 A.J. Nelson, Natural Sciences and Engineering Council,
Research Grant.
286.4 M. Kuroda, Asubio Pharma Co., Ltd., Employment; R. Ogino,
Asubio Pharma Co., Ltd., Employment; S. Imagama, Asubio
Pharma Co., Ltd., Research Grant; R. Tauchi, Asubio Pharma
Co., Ltd., Research Grant; K. Kadomatsu, Asubio Pharma
Co., Ltd., Research Grant; M. Masumura, Asubio Pharma
Co., Ltd., Employment; S. Nakamura, Asubio Pharma
Co., Ltd., Employment; N. Murayama, Asubio Pharma
Co., Ltd., Employment; S. Ueno, Asubio Pharma Co., Ltd.,
Employment.
286.13 S. Ueno, Asubio Pharma Co., Ltd., Employment; M.
Masumura, Asubio Pharma Co., Ltd., Employment; R. Ogino,
Asubio Pharma Co., Ltd., Employment; N. Murayama, Asubio
Pharma Co., Ltd., Employment.
286.14 Y. Shimmyo, Asubio Pharma Co., Ltd., Employment; T.
Kadoshima, Asubio Pharma Co., Ltd., Employment; M.
Kuroda, Asubio Pharma Co., Ltd., Employment; R. Ogino,
Asubio Pharma Co., Ltd., Employment; T. Masuda, Asubio
Pharma Co., Ltd., Employment; T. Noshita, Asubio Pharma
150  |  Society for Neuroscience
Abstract
Number Statement
Co., Ltd., Employment; N. Murayama, Asubio Pharma
Co., Ltd., Employment; S. Ueno, Asubio Pharma Co., Ltd.,
Employment.
287.17 J. Wiersma, NSF RUI 0744305, Research Grant; NIH P20
RR-016463 from the INBRE Program of the National Center
for Research Resources, Other Research Support; N.W.
Kleckner, NSF RUI 0744305, Research Grant; NIH P20 RR-
016463 from the INBRE Program of the National Center for
Research Resources, Other Research Support.
288.7 Y.P. Gerasimenko, Russian Foundation for Basic Research,
Grant -10-04-01172a, Other Research Support; NIH NS
062009-01A1, Other Research Support; P. Musienko,
Russian Foundation for Basic Research, Grant -10-04-
01172a, Other Research Support; R.R. Roy, NIH NS 062009-
01A1, Research Grant; V.R. Edgerton, NIH NS 062009-01A1,
Research Grant.
289.1 E.C. Cropper, NIH MH-51393, Research Grant.
289.5 K. Hellekes, DFG grant Bu857/10, Research Grant; J.
Hoffmann, by DFG grant Bu857/10, Research Grant; A.
Büschges, DFG grant Bu857/10, Research Grant.
291.6 M. Kinoshita, Strategic Research Program for Brain Sciences
(SRPBS), Research Grant.
292.24 L.P. Selen, Donders Institute for Brain Cognition and
Behaviour, Employment; NWO-400-07-003, Research Grant.
293.4 Y. Aramaki, KAKENHI (22700596), Research Grant; D.
Nozaki, KAKENHI (20670008), Research Grant.
293.13 T. Nanayakkara, King’s Collge, London, Employment; King’s
College, London start up grant, Research Grant; BBSRC,
Other Research Support.
293.17 A. Fuchs, NIMH, Other Research Support; E. Tognoli, NIMH,
Research Grant; J.A.S. Kelso, NIMH, Research Grant.
293.18 L.G. Richards, NIH 1 R03 HD051624-01A1, Research Grant;
VA RR&D B5033W, Research Grant.
293.22 H. Sekiguchi, The Ministry of Education, Culture, Sports,
Science, and Technology (MEXT), Research Grant.
294.3 U.I. Udoekwere, NIH NS54894, Research Grant; C. Oza, NIH
NS54894, Research Grant.
294.4 T. Kim, Patents, Ownership Interest; S.F. Giszter, Patents,
Ownership Interest.
295.2 L. Turicchia, National Institutes of Health NS-056140,
Research Grant; Office of Naval Research Grant N00014-09-
1-1015, Research Grant; R. Sarpeshkar, National Institutes
of Health NS-056140, Research Grant; Office of Naval
Research Grant N00014-09-1-1015, Research Grant.
295.6 S.I. Helms Tillery, NIH R01-NS050256, Research Grant.
295.10 A. Bendali, INSERM, U968, Paris, F-75012, France,
Employment; UPMC Univ Paris 06, UMR_S 968, Institut de
la Vision, Paris, F-75012, France, Employment; European
project DREAMS, Research Grant; Agence Nationale
la Recherche (ANR MEDINAS), Research Grant; V.
Forster-Fradot, INSERM, U968, Paris, F-75012, France,
Employment; UPMC Univ Paris 06, UMR_S 968, Institut de la
Vision, Paris, F-75012, France, Employment; B. Kolomiets,
INSERM, U968, Paris, F-75012, France, Employment;
UPMC Univ Paris 06, UMR_S 968, Institut de la Vision,
Paris, F-75012, France, Employment; S.A. Picaud, INSERM,
U968, Paris, F-75012, France, Employment; UPMC Univ
Paris 06, UMR_S 968, Institut de la Vision, Paris, F-75012,
France, Employment; European project DREAMS, Research
Grant; Agence Nationale la Recherche (ANR MEDINAS),
Research Grant; E. Van Hove, CEA, LIST, Diamond Sensors
Laboratory, F-91191 Gif-sur-Yvette, France, Employment; S.
Saada, CEA, LIST, Diamond Sensors Laboratory, F-91191
Gif-sur-Yvette, France, Employment; A. Bongrain, CEA, LIST,
Diamond Sensors Laboratory, F-91191 Gif-sur-Yvette, France,
Employment; P. Bergonzo, CEA, LIST, Diamond Sensors
Laboratory, F-91191 Gif-sur-Yvette, France, Employment.
295.17 R. VanWagenen, Blackrock Microsystems, Employment.
297.6 B. Sakic, McMaster University, Employment; CIHR, Research
Grant.
297.12 S.D. Croll, Shareholder, Regeneron Pharmaceuticals,
Ownership Interest; Consultant, Regeneron Pharmaceuticals,
Abstract
Number Statement
Consultant/Advisory Board
297.16 R.R. Johnson, Advanced Brain Monitoring, Inc, Employment;
ONR contract: N00014-09-C-0583, Research Grant;
Advanced Brain Monitoring, Inc, Ownership Interest; A.
Behneman, Advanced Brain Monitoring, Inc, Employment;
ONR contract: N00014-09-C-0583, Research Grant;
Advanced Brain Monitoring, Inc, Ownership Interest.
298.26 Z. Dogas, Croatian Ministry of Scince, Educatin and Sport
Grants 216-2163166-3342 and 216-2163166-0513, Research
Grant
299.11 K. Touzani, NIH DK071761, Research Grant; A. Sclafani,
NIH DK071761, Research Grant; R.J. Bodnar, NIH
DK071761, Research Grant.
299.12 K. Touzani, NIH DK071761, Research Grant; A. Sclafani,
NIH DK071761, Research Grant; R.J. Bodnar, NIH
DK071761, Research Grant.
299.13 K. Touzani, NIH DK071761, Research Grant; A. Sclafani,
NIH DK071761, Research Grant; R.J. Bodnar, NIH
DK071761, Research Grant.
299.20 E.M. Van Der Zwaal, T2-105, Research Grant; M.A. van
Gestel, T5-210-1, Research Grant.
299.25 K. Nagao, Ajinomoto Co., Inc., Employment; S. Eto,
Ajinomoto Co., Inc., Employment; M. Takahashi, Ajinomoto
Co., Inc., Employment; M. Bannai, Ajinomoto Co., Inc.,
Employment; T. Kobayashi, Ajinomoto Co., Inc., Employment;
N. Kawai, Ajinomoto Co., Inc., Employment.
299.26 M. Bannai, Ajinomoto Co., Inc., Employment; K. Nagao,
Ajinomoto Co., Inc., Employment; M. Takahashi, Ajinomoto
Co., Inc., Employment; T. Kobayashi, Ajinomoto Co., Inc.,
Employment.
300.22 D.A. Johnson, Pinnacle Technology, Employment; D. Aillon,
Pinnacle Technology, Employment; S. Gabbert, Pinnacle
Technology, Employment; H. Harmon, Pinnacle Technology,
Employment; E. Naylor, Pinnacle Technology, Employment;
D.A. Johnson, Pinnacle Technology, Employment.
Abstract
Number Statement
301.11 S. Boyer, Pfizer Inc, Employment; D. Palumbo, Pfizer Inc,
Employment.
302.13 M.A. Motes, ARRA Middle School Brain Years Project,
Texas, Research Grant; J.F. Gamino, ARRA Middle School
Brain Years Project, Texas, Research Grant; J. Hart, ARRA
Middle School Brain Years Project, Texas, Research Grant;
B. Rypma, NIH AG029523, Research Grant; S.B. Chapman,
ARRA Middle School Brain Years Project, Texas, Research
Grant.
303.13 R. Lee, Princeton University, Employment.
305.4 D. Weinshenker, Patent: US-2010-0105748-A1, Other.
307.2 T. Suhara, NIRS, Employment.
307.7 J.D. Meier, NIH 5 R90 DA023419, Research Grant.
309.1 S.K. Spratt, Sangamo BioSciences Inc, Employment; R.
Surosky, Sangamo BioSciences Inc, Employment; G.
Lee, Sangamo BioSciences Inc, Employment; M. Giedlin,
Sangamo BioSciences Inc, Employment; D. Ando, Sangamo
BioSciences Inc, Employment.
309.3 A.M. McCoy, Sigma Advanced Genetic Engineering Labs,
Employment; D. ji, Sigma Advanced Genetic Engineering
Labs, Employment.
309.5 H.S. Zhang, Sangamo BioSciences, Inc., Employment;
J. Laganiere, Sangamo BioSciences, Inc., Employment; 
J.T. Lai, Sangamo BioSciences, Inc., Employment; D.
Guschin, Sangamo BioSciences, Inc., Employment; D.E.
Paschon, Sangamo BioSciences, Inc., Employment; X.
Meng, Sangamo BioSciences, Inc., Employment; L.K. Fong,
Sangamo BioSciences, Inc., Employment; Q. Yu, Sangamo
BioSciences, Inc., Employment; E.J. Rebar, Sangamo
BioSciences, Inc., Employment; P.D. Gregory, Sangamo
BioSciences, Inc., Employment.
309.9 G. Shaw, EnCor Biotechnology Inc., Ownership Interest; Y.
Wang, EnCor Biotechnology Inc., Employment.
Neuroscience 2010  |  Sunday Conflict of Interest Statements  |  151 
Convention Center Floor Plans
San Diego Convention Center Floor Plan, Upper Level

Featured and
Special Lectures

Student and Postdoc

Hospitality Suite

San Diego Convention Center Floor Plan, Mezzanine Level

 SfN Members’ Business Meeting

Speaker Ready Room

Attendance
Certificate of Pick-up
es s Ba dg e
Ex pr
Food Court ramming
ics and Prog
ad qu ar te rs — Logist
He
sk
Housing De
und
Lost and Fo
em be rs hi p
M
g Room
NeuroJobs Meeting Planner Viewin
ur os ci en ce Pi ck -u p
Ne ide
d Exhibit Gu
Program an
Re gi st ra tio n
ge Center
Sails Messa n Booth
io
SfN Informat ort
pp
Wireless Su

SfN Executive Meeting Room

Press
Press Conference Press
Room Room Interview
Room
KiddieCorp
Infant
Child Care
Care
San Diego Convention Center Floor Plan, Exhibit Halls

ABST RACT
L OCATOR

A 10 J10 J11 K 10 K 11
B 14 B 15 C 19 C 20 D21 D22 E26 E27 F30
F29 G29 G30
A9
J9 J12 K 9 K 12 L6 L7 N10
B 13 B 16 C 18 C 21 D20
D23
E25 E28 F31 M 9 M 10 N9 O9
O10
Q10
F28 G28 G31 Q9 R9 R10 S7 T9 T10 U
A8 J8 J13 K 13 M8 N11 S6 U9
B 12 K8 L5 L8 M 11 N8 O8 O11
B 17 C 17 C 22 D19 D24 E24 E29 F27 F32 Q8 Q11 R8 R11
G27 G32 H35 H36 I 32 I 33 K 14 S5 S8 T8 T11 U8 U
A7 C 23 J7 J14 K7 L4 L9 M7 M 12 N12
B 11 B 18 C 16 D18 D25 E23 N7 O7 O12 Q12 R12
E30 F26 F33 G26 G33 H34 P7 P8 Q7 R7 S4 S9 T7 T12
U7
A6 H37 I 31 I 34 J6 J15 K 6 K 15 U
L3 L10 M 6 M 13 N13
B 10 B 19 C 15 C 24 D17 D26 E22 F34 N6 O6 O13 P6 P9 Q6 Q13 R6 R13 T13
F25 G25 G34 S 3 S 10 T6
E31 H33 H38 16 U6 U
A5 C 14 C 25
I 30 I 35 J5 J16 K5 K L2 L11 M 5 M 14
N5 N14
B9 B 20 D16 D27 E21 E32 F24 F35 O5 O14 Q14 R14
P 5 P 10
G24 G35 H32 H39 I 29 I 36
Q5 R5 S 2 S11 T5 T14 U5 U
A4 B8 J4 J17 K 4 K 17 L1 L12 M 4 M 15 N4 N15
C 13 C 26 D15 D28 04 O15
B 21 E20 E33 F23 F36 P 4 P 11 Q4 Q15 R4 R15 S 1 S 12 T4 T15
H31 H40 I 28 I 37 U4
A3 B7 B 22 C 12 C 27 D14 D29 E19 F37 G J3 J18 K 3 K 18
L
M 3 M 16 N3 N16 O3 O16 P 12 Q16 R16
U

A2 B 6 B 23 C 11 C 28 D30
E34 F22 H30 H41 I 27 I 38 J2 J19 K 2 K 19 M 2 M 17 O2 O17
P3 Q3 R3
S T3 T16 U3 U
D13 E35 F21 F38 N2 N17 P 2 P 13 R17
E18 H42 I 26 I 39 Q2 Q17 R2 T2 T17
H29 J1 J 20 K 1 K 20 M 1 M 18
U2 U
A1 D12 D31 N1 N18
B 5 B 24 C 10 C 29 E36 F20 F39 O1 O18 P 1 P 14 Q1 Q18 R1 R18
E17 H28 H43 I 25 I 40 T1 T18 U1 U
A B C J K M N Q
D E F H I O P R
T U
B4 B 25 C 9 C 30 D11 D32 F40
E16 E37 F19 G23 G36
B 3 B 26
H27 H44 I 24 Rogue
C8 C 31 D10 D33 E38 F41 136 236
E15 F18 G22 G37 H26 H45
I 23
Research, 337 436 437 536 537
B 2 B 27
737 836
C7 C 32 D9 D34
E14 E39
F17 F42
G21 G38 H25
Inc.
H46 I 22
B 1 B 28 C 33 D35
134 135 234 235 335
D8 F43 434 435 534
C6 E13 E40 F16 G20 G39 H24 H47 I 21
535 634 635 735 834 835 935 Neu
B C5
C 34 D7 D36 E12 E41
F15 F44 G19 H23 H48 I 20 132 133 232 I
C 35
G40 333 432 433 532 533 632
C4 D6
D37
E11 E42 F45 H22
633 732 733 832 833 932
F14 G18 G41 H49 I 19
C 3 C 36 D5 D38 E10 E43 130 231
F13 F46 G17 G42 H21 H50 I 18
330 331 430 530 531 730 830 831
C 2 C 37 D4 D39 E9 E44 F12 F47
G16 H20 H51
931 1030 1031
G43 I 17
D3 D40
128 129 228 229 328 329
C 1 C 38 E8 E45
F11 F48
428 429 528 529 628 629
G15 G44 H19 H52 728 729 828 829 928 929 1028
C
Hall H Cambridge
University
Hall G
AB OC

Press
L
ST AT

D2 D41 E7 E46 F49

RA OR

F10 G14 G45 H18 H53 I 16

CT

D1 D42 E6 E47 F9 F50 720

G13 G46 H17 H54 I 15 122 223 322 323 422 423 522 523 622 623 723 822
E5 E48 F8 922 923 1022
D F51 G12 G47 H16 H55 I 14 1023
E4 E49
F7
F52 G11 120 221 320 321
G48 H15 H56 I 13 420 421 520 521 620 621 721 820 821 920 921 1020
E3 E50 F6 F53 G10 G49
1021
H14 H57 I 12
118 119 218
E2 E51 F5 F54 G9 H13 I 11
G50 H58
E1 E52 F4 F55 G8 116
G51 H12 H59 I 10 216 217
517 616
E F3 F56 G7 G52 H11 H60 I9 Charles Thorlabs, 817 916 917 1016 1017
F57 114 214 215 314 315 River
Inc.
F2 G6 I8 414
G53 H10 H61 515
914 1014 1015
F58 G5
EN

F1 H9 I7
G54 H62 112 113 212 213 312 313 412 413 513 712
TR

612
F 813 912 913 1012 1013
AN
CE

G4 G55 H8 H63

G3 G56 H7 H64
EN

I6
G2 G57 H65
100 AISLE

H6
200 AISLE

300 AISLE

400 AISLE

107 206
500 AISLE
TR

307 406
600 AISLE
407 506

1000 AISLE
800 AISLE
507 606

900 AISLE
H5 I5 707 806
G1 G58

700 AISLE
H66 907
AN

I4
G H4 H67
105 305 404 405
CE

504 505 604 605 704 705

H3 H68 I3 804 1004 1005
H2 H69 I2 1 03 203 402 502 503 602 603 702 902 903 1003
EN

H1 H70 I1
100 101 201
TR

200 300 301 400 401 500 501 600 601 700 701 800 801 900 901
H I Sutter Instrument
1000 1001
AN

Company
CE

WOM EN MEN
ENTRANCE W
ENTRANCE
ENTRANCE ENTRANCE
Lobby H
Lobby G Lo
UP TO REGISTRATION
AND MEETING ROOMS

BOX OFFICE G
Neuroscience 2010 — Exhibits and Poster Sessions Coat and Lobby G
Luggage Message
San Diego Convention Center: Halls B-H Check Center
Meeting Dates: Nov. 13–17
Exhibit Dates: Nov. 14–17

NOTE: Hall entrances open at noon on Saturday, Nov. 13 and at 7 a.m. on Sunday, Nov. 14 to Wednesday, Nov. 17 for poster presenter setup.
Poster sessions are open for all attendees at 1 p.m. on Saturday, Nov. 13 and 8 a.m. on Sunday, Nov. 14 to Wednesday, Nov. 17.
 ABST RACT
L OCATOR

GG8 GG9
T9 T10 U 10 V 10 Z8 FF10 FF11 HH11
U9 V9 X10 Y 10 HH10 I I 10 I I 11 JJ9
Z7 10 GG7 GG10 JJ8
X9 Y9 A A9 A A B B9 B B
10
T8 T11 U 8 U 11 DD7 DD8 EE9 EE10 FF9 FF12 2
V 8 V 11 Y 8 Y 11 Z6 Z9 HH9 HH1 I I9 JJ7 JJ10 K K 10 NN7 NN8
X8 X11 11 GG6 GG11 I I 12 K K9
T12 A A8 A A B B8 B B 11 DD6 DD9 EE11
T7 U7 U 12 Z5 Z10 EE8 FF8 FF13
V7 V 12 W8
X7 X12 Y 12 HH8 HH1
3
I I8 JJ6 JJ11 K K 11 LL6 NN6 NN9
W7 Y7 A A7 A A
12
B B7 B B
12 GG5 GG12 I I 13 K K8
T6
T13
V 13 Z11 C C7 C C8 DD5 DD10 EE7 EE12 FF7 FF14 4 LL8
U 6 U 13 W6 W9
Z4
HH7 HH1 I I7 JJ12 K K 12 NN5 NN10
V6 X6 X13 Y 6 Y 13
A A6 A A
13 GG4 GG13 I I 14 JJ5 LL5
B B6 B B 13 DD4 DD11
K K7 M M7 M M8
T5 T14 U 5 U 14 V 14 Z3
Z12 C C6 C C9 EE6 EE13 FF6 FF15 LL9 NN11
V5 W5 W10 X14 Y 5 Y 14 A A 14 4 HH6 HH15 I I6 I I 15 JJ4 JJ13 K K 13 LL4 NN4
X5 A A5 B B5 B B 14 DD3 DD12 GG3 GG1 K K6 M M6 M M9
T4 T15 C C5 C C 10 EE5 EE14 FF5 FF16
U4 U 15 V 15 Z2 Z13 HH5 HH16 I I5 I I 16 JJ14 K K 14 LL3 LL10 NN3
NN12
V4 Y 4 Y 15 15 JJ3
W4 W11 X4 X15 A A4 A A B B4 B B
15
C C4 C C 11 DD2 DD13 GG2 GG15 K K5 M M5 M M 10
T3 T16 U 16 V 16 Z1 Z14 EE4 EE15 FF4 FF17 LL11
U3 7 JJ2 JJ15 K K 15 LL2 NN2 NN13
V3 W3 W12 X3 X16 Y 3 Y 16 A A3 A A 16 GG1 GG16 HH4 HH1 I I4 I I 17 M M4 M M 11
B B3 B B 16 C C3 C C
12 DD1 DD14 EE3 EE16
K K4
T2 T17 U 17 FF3 FF18 8 LL1 LL12
U2 V 17 Y 2 Y 17 HH3 HH1 I I3 I I 18 JJ1 JJ16 K K 16 NN1 NN14
V2 W2 W13 X2 X17 A A2 A A 17 B B2 B B
17
M M3 M M 12
T1 T18
Z
C C2 C C
13 EE2 EE17 FF2 FF19 GG K K3
U 1 U 18
V 1 V 18 W1 W14 X1 X18 Y 1 Y 18 A A1 A A 18
DD HH2 HH19 I I2 I I 19
K K2
K K 17
NN
B B1 B B
18 C C1 C C 14
EE1 EE18 FF1 FF20 JJ LL
M M2 M M 13
T U V W X Y HH1 HH2
0 I I1 I I 20 K K 18
AA BB CC EE FF
K K1 M M1 M M 14

HH II KK MM

1137
1536 1636 1637 1936 2036
Neuralynx, 2137 2236
935 2537 2636 2736
1135
Inc. 1435 1534 1535 1634 1635
Eppendorf 1835 1934 1935 2034 2035 Olympus
2535
1232 1233 1433 1532 1533 1632 North America, Inc. 2635
1732 1833 1932
America 2033
Millipore 2532
931 1030 1031 1231 1330
2632 2633 2732
1431 1530 1630 1730 Corporation
929 1028
1831 2031 2130 2231
1129 1228 1229 1328
1529 1628 1629 1728 1729 1829 1928 1929 2129
Hall F

2100 AISLE
2429 2528 2529 2628 2629 2728

Hall E Hall D
1800 AISLE

923 1022 1023 PerkinElmer

1523 1622 1723 Bio - Rad
Inc. 1822 1923 2022
Laboratories 2422 Newport
921 1020 2623
1021 1120 1121 1220 1221 1520 1521 1620
Corporation
1621 1720 1721 1820 1821 1921 2020
2221 2320 2321 2420 2421 2521 2620 2621 2720
1200 AISLE

1300 AISLE

Society
1400 AISLE

917 1016 Kopf

1500 AISLE

1017 for
1600 AISLE

1117

2500 AISLE
1700 AISLE

2600 AISLE
2300 AISLE
1900 AISLE

2000 AISLE

1417 1516

2400 AISLE
Instruments, 1517 1616 1617

2200 AISLE
Nikon 1917 Neuroscience 2217 2316 2317 2416 2417
Inc. 2516
1014 1015 1114 1115
1415 1514 Instruments, (SfN)
2617

Inc. 1915 2314 M

913 1012 1013 2515 2614 2615
1112 1113 1212 1213 1413 1512 1513 1612 1613 1712 1812 1913 2012 2013 2213 2312 2412
2313 2413 2512 2513 2612 2613
1000 AISLE

1100 AISLE

907

1004 1005 1105 WOM EN MEN Exhibit Exhibitor Exhibitor

Elsevier ENTRANCE ENTRANCE
03 1003 1103 ENTRANCE Management Registration Lounge
01 1000 1001 1100 1101 1200
STAR
BUCKS

WOM EN MEN A TM Lobby D

ENTRANCE
NCE
Lobby E
Lobby F

Shuttle Office

BOX OFFICE E
Express Badge, Shuttle SfN
Program, and Information Information
Exhibit Guide Booth
Pick-up
Key
Abstract Locators Institutions

Concession Areas Nonprofits

Publishers Row Sustaining Associate Members

 BAYSIDE RO LL UP
DOOR

TELE COM
E LV

FRE IGHT RO LL UP
E LE VATORS DOOR
MSI MEN
N ETWORK BAYSIDE
S UPP ORT S HOW
O FFICE C
LOBBY
WOMEN TL TL

WS

ABST RACT
SERVICE CE NT E R L OCATOR

C C C 11 C C C 12 EEE5 EEE6
NN7 NN8 Y Y5 Y Y6 ZZ5 ZZ6 A AA 11 A AA 12 B BB 11 B BB 12 DDD5 DDD6 FFF11 FFF12 G
U U4 U U5 Y Y7 ZZ7 EEE4 EEE7
OO9 OO10 QQ10 QQ11 RR10 RR11 S S 10 S S 11 TT10 TT11 V V 10 V V 11 WW10 WW11 XX10 XX11 Y Y4 ZZ4 A AA 10 A AA 13 B BB 10 B BB 13 C C C 10 C C C 13 FFF10 FFF13 G
LL8 NN6 NN9 DDD4 DDD7
P P9 P P 10
U U3 U U6 Y Y3 Y Y8 ZZ3 ZZ8 A AA9 A AA 14 B BB 14 C C C9 C C C 14 DDD3 DDD8 EEE3 EEE8
LL9 M M7 M M8 NN5 NN10 OO8 OO11 QQ9 QQ12 RR9 RR12 S S9 S S 12 TT9 TT12 V V9 V V 12 WW9 WW12 XX9 XX12 B BB9 FFF9 FFF14 G
P P8 P P 11 A AA8 A AA 15 C C C8 C C C 15
M M6 M M9 NN11 OO7 OO12 QQ8 QQ13 RR8 RR13 S S8 S S 13 TT8 TT13 U U2 U U7 V V8 V V 13 WW8 WW13 XX8 XX13 Y Y2 Y Y9 ZZ2 ZZ9 B BB8 B BB 15 DDD2 DDD9 EEE2 EEE9 FFF8 FFF15 G
LL10 NN4
P P7 P P 12
Y Y1 Y Y 10 C C C7 C C C 16 EEE1 EEE10
M M5 OO6 OO13 QQ7 QQ14 RR14 S S7 S S 14 TT7 TT14 U U1 U U8 ZZ1 ZZ10 A AA7 A AA 16 B BB7 B BB 16 DDD1 DDD10 FFF7 FFF16 G
LL11 M M 10 NN3 NN12 RR7 V V7 V V 14 WW7 WW14 XX7 XX14
P P6 P P 13
LL12 M M4 M M 11 NN2 NN13 OO5 OO14
P P5 P P 14
QQ6 QQ15 RR6 RR15 S S6 S S 15 TT6 TT15 UU V V6 V V 15 WW6 WW15 XX6 XX15
YY ZZ A AA6 A AA 17 B BB6 B BB 17
C C C6 C C C 17
DDD EEE FFF6 FFF17 G

QQ16 RR16 S S 16 TT16 C C C5 C C C 18

OO4 OO15 QQ5 RR5 V V5 V V 16 WW5 WW16 XX5 XX16 A AA5 A AA 18 B BB 18 FFF5 FFF18 G
M M3 M M 12 NN1 NN14 S S5 TT5 B BB5
P P4 P P 15 C C C4
OO3 OO16 QQ4 QQ17 RR17 S S4 S S 17 TT4 TT17 A AA4 A AA 19 B BB4 B BB 19 C C C 19
L M M2 M M 13
NN P P3 P P 16
RR4 V V4 V V 17 WW4 WW17 XX4 XX17 FFF4 FFF19 G

OO2 OO17 C C C3
M M1 M M 14 QQ3 QQ18 RR3 RR18 S S3 S S 18 TT3 TT18 V V3 V V 18 WW3 WW18 XX3 XX18 A AA3 A AA 20 B BB3 B BB 20 C C C 20 FFF3 FFF20 G
P P2 P P 17
OO1 12 11 A AA2 A AA 21 C C C2 C C C 21 10
QQ2 QQ19 RR2 RR19 S S2 S S 19 TT2 TT19 V V2 WW2 WW19 XX2 XX19 B BB2 B BB 21 G
MM OO18
P P1 P P 18
V V 19 FFF2 FFF21
C C C1
OO QQ1 QQ20 RR1 RR20 S S1 S S 20 TT1 TT20 V V1 V V 20 WW1 WW20 XX1 XX20 A AA1 A AA 22 B BB1 B BB 22
C C C 22
FFF1 FFF22 G
PP
QQ RR SS TT VV WW XX AAA BBB CCC FFF
2537
Montreal Neurological Institute
2636
2736
2535
2635 2933 3133 3332 3432 3533 3732 NDP 3932 4 032 4033 4132
2735 2834
2
2632
2633 2732 2831 2930 2931 3130 3131 3231 3330 3331 3531 3630 3631 3730 3731 3830 3831 3930 3931 4030 4031 4130 F
2733 2832
2929 3028 3029 3228 3229 3328 3329 3428 3529 3728 3729 3828 3928 3929 4
2830
2529 2628
2629 2728 2926 3027 3326 3327 3426 3427 3627 3726 3826 3926 3927 4 126
2729 2828
2825 2924 2925 3025 3124 3125 3224 3225 3324 3325 3424 3425 3524 3525 3624 3625 3724 3725 3824 3825 3924 3925 4024 4025 4124 4

Hall C Hall B2
2700 AISLE

2623 Hamamatsu
2521 2620
Corporation TILL
2621 2720 2721 3019 3118 Photonics 3319 3419 3518 3618 3619 3719 3819 3918 3919 4018 4019
GmbH
AISLE

2916 3017 3116 3117 3217 3316 3317 3416 3516 3517 3616 3617 3716 3717 3816 3817 3916 3917 4016 4017 4116
2600 AISLE

Lecia
2617
Microsystems
Carl Zeiss 2815 3314 3414 3714 3715 3814 3815 4114 4
2515 2614 Microimaging
2615 , 2912 3013 3312 3313 3412 3712 3713 3812 3813 4112 4
Inc. 6 5 4
2513 2612
2613
2712 2811 2910 3411 4110 4

2809 3308 Sigma 3708 3709 3808 3809

Life NIH
2900 AISLE

3000 AISLE

4100 AISLE
3100 AISLE

3200 AISLE

3300 AISLE

3400 AISLE

3500 AISLE

3600 AISLE

3700 AISLE

3800 AISLE

3900 AISLE

4000 AISLE
2800 AISLE

2807 2907 3007 Science 3706 3707 3806 3807 National N

Institute
2904 3005 3104 3105 3304 3305 3405 3504 Molecular 3704 3804 3805 3904 3905 4004 on Drug o
Devices, Abuse
3003 3102 3203 3302 3403 Inc. 3703 3802 3803 3902 3903 4002 (NIDA)
ENTRANCE 2801 2900 2901 3000 3001 3100 3101 3200 3201 3300 3301 3400 3401 3500 3501 3601 3700 3701 3800 3801 3900 3901 4000 4001 4

TL
TL
TL WOMEN TL TL MEN RESTAURANTS
ENTRANCE ENTRANCE ENTRANCE
RESERVATIONS
ENT
ATM

Lobby C E LV L
DOWN S TAR
B UCKS
TO PARK ING
E LV T O PARKING

Express First Aid Coat and Luggage Check

Badge
Pick-up
Key
Abstract Locators Institutions

Concession Areas Nonprofits

Publishers Row Sustaining Associate Members

 RO LL UP
DOOR

RO LL UP
DOOR

MEN MEN
TL

EXIT
WOMEN S HO W WOMEN S HO W
O FFICE B O FFICE A
E XIT
WS WS

E XIT

ABST RACT
L OCATOR
P PP 34
HHH12 HHH13 I I I 26 NNN25 NNN26
I I I 25 JJJ 25 JJJ 26 M M M 37 M M M 38 OOO37 OOO38
GGG12 P PP 33
FFF11 FFF12 GGG11
HHH11 HHH14 I I I 24 I I I 27 JJJ 24 JJJ 27 M M M 36
M M M 39 NNN24 NNN27
OOO36
OOO39
P PP 32
GGG13 HHH10 HHH15 JJJ 28 M M M 40 NNN23 NNN28
FFF10 FFF13 GGG10 I I I 23 I I I 28 JJJ 23 K KK 35 K KK 36 LLL35 LLL36 M M M 35 OOO35 OOO40
HHH16 M M M 41 P PP 31
GGG14
JJJ 22 JJJ 29
NNN22 NNN29 OOO41
FFF9 FFF14 GGG9 HHH9 I I I 22 I I I 29 K KK 34 LLL34 LLL37 M M M 34 OOO34
K KK 37
P PP 30
HHH8 HHH17 M M M 42 NNN21 NNN30
FFF8 FFF15 GGG8 GGG15 I I I 21 I II 30 JJJ 21 JJJ30 K KK 33 K KK 38 LLL33 LLL38 M M M 33 OOO33 OOO42
HHH18 JJJ31 M M M 43 NNN31 P PP 29
GGG16 HHH7 I I I 20 I II 31 JJJ 20 K KK 32 K KK 39 NNN20
FFF7 FFF16 GGG7 LLL32 LLL39 M M M 32 OOO32 OOO43
P PP 28
FFF6 FFF17 GGG6 GGG17 HHH6 HHH19
III JJJ K KK 31
K KK 40 LLL31 LLL40 M M M 31
M M M 44
OOO31 OOO44
P PP 27
GGG18 HHH20 K KK 30 K KK 41 M M M 45
FFF5 FFF18 GGG5 HHH5 LLL30 LLL41 M M M 30 OOO30 OOO45
HHH21 P PP 26
FFF4 FFF19 GGG4 GGG19 HHH4 M M M 46
K KK 29 K KK 42 LLL29 LLL42 M M M 29 OOO29 OOO46
P PP 25
HHH3 HHH22 M M M 47
FFF3 FFF20 GGG3 GGG20 K KK 28 K KK 43 LLL28 LLL43 M M M 28 OOO28 OOO47
8 P PP 24 7
FFF2 FFF21 GGG2 GGG21 HHH2 HHH23 9 M M M 48 OOO48
K KK 27 K KK 44 LLL27 LLL44 M M M 27 OOO27
P PP 23 E XIT
FFF1 FFF22 GGG1 GGG22 HHH1 HHH24 M M M 49 OOO49
K KK 26 K KK 45 LLL26 LLL45 M M M 26 OOO26
P PP 22
FFF GGG HHH KKK LLL MMM NNN OOO P PP 21

P PP 20

P PP 19

HHH25 I I I 19 I II 32 JJJ 19 JJJ32 K KK 25 K KK 46 LLL25 LLL46 M M M 25 M M M 50 NNN19 NNN32 OOO25 OOO50 P PP 18

33 4132 National 4233 M M M 24 M M M 51 OOO51
HHH26 I I I 18 I II 33 JJJ 18 JJJ33 K KK 24 K KK 47 LLL24 LLL47 NNN18 NNN33 OOO24 P PP 17
Science
I I I 17 I I I 34 JJJ 17 JJJ 34 K KK 23 K KK 48 LLL23 LLL48 M M M 23 M M M 52 NNN17 NNN34 OOO23 OOO52
31 4130 Foundation 4231
HHH27 P PP 16
M M M 53 NNN35 OOO53
(NSF) HHH28 I I I 16 I I I 35 JJJ 16 JJJ 35 K KK 22 K KK 49 LLL22 LLL49 M M M 22 NNN16 OOO22 P PP 15

4129 HHH29 I I I 15 I I I 36 JJJ 15 JJJ 36 K KK 21 K KK 50 LLL21 LLL50 M M M 21 M M M 54 NNN15 NNN36 OOO21 OOO54 P PP 14

ELEVA TORS
HHH30 I I I 14 I I I 37 JJJ 14 JJJ 37 K KK 20 K KK 51 LLL20 LLL51 M M M 20 M M M 55 NNN14 NNN37 OOO20 OOO55

S ER VICE
4 126 4 227

Lecture Overflow Hall

I I I 13 I I I 38 JJJ 13 JJJ 38 K KK 19 K KK 52 LLL19 LLL52 M M M 19 M M M 56 NNN13 NNN38 OOO19 OOO56
HHH31

HHH32 I I I 12 I I I 39 JJJ 12 JJJ 39 K KK 18 K KK 53 LLL18 M M M 18 M M M 57 NNN12 NNN39 OOO57

LLL53 OOO18
25 4124 4125 4224 4225
I I I 11 I I I 40 JJJ 11 JJJ 40 K KK 17 K KK 54 LLL17 LLL54 M M M 17 M M M 58 NNN11 NNN40 OOO17 OOO58

Hall B1
19
HHH33

HHH34
I I I 10 I I I 41

I II 9 I I I 42
JJJ 10 JJJ 41

JJJ 9 JJJ 42
K KK 16

K KK 15
K KK 55

K KK 56
LLL16

LLL15
LLL55

LLL56
M M M 16

M M M 15
M M M 59

M M M 60
NNN10

NNN9
NNN41

NNN42
OOO16

OOO15
OOO59

OOO60
Hall A
I II 8 I I I 43 JJJ 8 JJJ 43 K KK 14 LLL14 M M M 14 M M M 61 NNN8 NNN43
17 4116 HHH35 K KK 57 LLL57 OOO14 OOO61
JJJ 44 M M M 13 M M M 62 NNN7 NNN44
HHH36 I II 7 I I I 44 JJJ 7 K KK 13 K KK 58 LLL13 LLL58 OOO13 OOO62
4114 4115 4215
HHH37 K KK 12 K KK 59 LLL12 LLL59 M M M 12 M M M 63 OOO12 OOO63
P PP 13

P PP 12
K KK 11 K KK 60 LLL11 LLL60 M M M 11 M M M 64 OOO11 OOO64
HHH38
4112 4113 P PP 11
3 K KK 10 K KK 61 LLL10 LLL61 M M M 10 M M M 65 2 OOO10 OOO65 1
HHH39
P PP 10
K KK9 K KK 62 LLL9 LLL62 M M M9 M M M 66 OOO9
4110 4111 4210 HHH40 OOO66
P PP9
K KK8 K KK 63 LLL8 LLL63 M M M8 OOO8
HHH41 M M M 67 OOO67
P PP8
4209 K KK7 K KK 64 LLL7 M M M7 M M M 68 OOO7
HHH42 LLL64 OOO68
P PP7
NIH NIH
4100 AISLE

4200 AISLE

HHH43 I II 6 I I I 45 JJJ 6 JJJ 45 K KK6 K KK 65 LLL6 LLL65 M M M6 M M M 69 NNN6 NNN45 OOO6 OOO69
National 4207
National HHH44 I II 5 I I I 46 JJJ 5 JJJ 46 K KK 5 K KK 66 LLL5 LLL66 M MM 5 M M M 70 NNN5 NNN46 OOO5 OOO70
P PP6

nstitute Institute P PP 5
4205 I II 4 I I I 47 JJJ 4 JJJ 47 K KK4 LLL4 M M M4 NNN4 NNN47 OOO4
n Drug of Mental HHH45 K KK 67 LLL67 M M M 71 OOO71
P PP4
JJJ 48
Abuse Health HHH46 I II 3 I I I 48 JJJ 3 K KK3 K KK 68 LLL3 LLL68 M M M3 M M M 72 NNN3 NNN48 OOO3 OOO72
P PP3
NIDA) (NIMH) HHH47 I II 2 I II 49 JJJ 2 JJJ49 K KK2 K KK 69 LLL2 LLL69 M M M2 M M M 73 NNN2 NNN49 OOO2 OOO73
P PP2
HHH48 I II 1 I II 50 JJJ 1 JJJ50 K KK1 K KK 70 LLL1 LLL70 M M M1 M M M 74 NNN1 NNN50 OOO1 OOO74
001 4101 4201 P PP1

TIDES
HHH III JJJ KKK LLL MMM NNN 000
PPP
ABST RACT
L OCATOR

TL TL TL TL TL
WOMEN MEN WOMEN MEN

ENTRANCE ENTRANCE
ATM

E LV Lobby B Lobby A
B OX S TAR
O FFICE A B UCKS
E LV T O PARKING DOWN
TO PARK ING

SfN Lobby A Express Program and

Information Message Badge Exhibit Guide
Booth Center Pick-up Pick-up
Hotel Floor Plans
Manchester Grand Hyatt Floor Plan
Marriott Hotel & Marina Floor Plan
South Tower North Tower
Level 1

Lobby Level
Second Floor
Marriott Hotel & Marina Floor Plan (continued)

South Tower Level 3

Lobby Level
Bayside
Seaview

1st Floor
Laguna
Leucadia
Oceanside
Pacific
Point Loma
Santa Rosa
Solana
Business Center

3rd Floor
Balboa
Board Room
Cardiff
Carlsbad
Del Mar
Encinitas
Green Room
Marina Ballroom D-G
Mission Hills

4th Floor
Coronado Room/Terrace
Irvine
Los Angeles
Newport Beach
Rancho Las Palmas
Level 4
Torrance
Warner Center

North Tower
Lobby Level
Columbia Rooms 1–3
Manchester Rooms 1–2
Torrey Rooms 1–3
San Diego Ballrooms A–C

Marriott Hall
Anaheim
Atlanta
Chicago
Marriott Hall 1–6
New York
Orlando
San Francisco
Hilton San Diego Bayfront

Colbalt Level 

Indigo Level 
Hilton San Diego Bayfront (continued)
Sapphire Level 
Se e you i n
Washington, DC!
November 12–16, 2011
 Society for N e u r o sc i e n c e

Final program

November 14, 2010

Sunday
San Diego
California
Scientific Sessions Listings
Sessions 110 – 309